Citrus Sinensis ID: 003659

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-----
Protein Sequence
MISKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR
Secondary Structure (PSIPRED)
ccccccccccEEEcccccccccccccEEEcccccccccccccccEEEEcccccccccHHHHHHHcccccccEEEEEEcccccEEEEEEEEccccccccccccEEEEEEccEEEEEcccccccEEEEEEEEEccccEEEEEEEccccEEEEEEEEEEEccccccccccccccccccccccccccEEEEEEEEccccccccccccccccccccccccccccccEEEEccccEEEEccccccccccHHHHHHccccccccccccccEEEEEEEcccccccEEEEEEEEEEccccccEEEEEEEcccccccccccccccccccccEEEEEEEEEccccccEEEEEcccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHEEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccEEEEccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHccccccccccccccEEEEccccccccccccccccccccccccccccccccEEEEEEccccccccHHHHHHcccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccEEEEccccccccccccEEEEccccccccccccccEccccccccccccccccEEEEEEccccEEEEEccccccEEEEEEEEEcccccccccccEEEEEEccEEEEccccccccEEEEEEEEccccEEEEEEEcccccEEEEEEEEEEccccHccccccccccccccccccccccEEEEEEEEccccccccccccccEEccccccccccccccEEccccccEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEEcccccEEEEEEEEEEEEccccccEEEEEEEcccEEcccccHHHHcccccccEEEEEEEEEcccccEEEEEEccccccccccccEEcccEEEEEccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccEEEccccccEEEEEEccccEEEEEEcccccHccHHHHHHHHHHHHHHHHHHHHHHEccccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccHHHEEEEHHHEEEEccccHHHcccccccccEEEEEEcccccccHHHHHHHHccccccHHHHHHEEHHHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccc
Coil and Loop (DISEMBL)
miskfdpadnylidcgsrtnttvgnrvfvadnsaskflstpqNVVANISEsvtssndsqlyQTARIFtgsskytfsisgrgrhwiRLYFYPFvyqsynmsrasfsvstndhvllnnfsvssNVFKEFsvnvtsdsldvifspsnnsfaFINAlevvsvpdqlitddassisppgkyqglvFQTFETVHrvnmggplvtpendtlwrtwvpdqsflvnrnlaksvsnipavkyvqggatkesapntvygtatrmnsdddpnanfnvtwefdvdsgfqYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISigrstlhdtypdaILNGLEIMKMKnlqgslgnssskkhVGVIVGVTIGVSVAALLAGILFMLCRkrrqlpqlghskawipvsinggnshtmgskyshgtttsansnsgyrfpFVAVQEatnnfdeswvIGIGGFgkvykgelndgtkvavkrgnprsqqgLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEngtlkghlygsglpslswKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAdfglsktgpeidqthvstavkgsfgyldpeyfrrqqlteksdvySFGVVLFEVLcarpvidptlprEMVNLAEWAMKWQNkgqldqiidptlagkirpdslRKFGETAEKCLAdfgvdrpsmgDVLWNLEYALQLQEAvvhgdpdenstnligelspqihnfsqvdtsvnaaaqsdvsavddisgVSMSRVFSQLVKSEGR
Flexible Loop (DISEMBL)
miskfdpadnylidcgsrtnttvGNRVFVADNSASKFLSTPQNVVANISEsvtssndsqlyQTARiftgsskytfsisgrgrHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNrnlaksvsnipavkyvqggatkesapNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRIsigrstlhdtyPDAILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGlsktgpeidqthvSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVsavddisgvsMSRVFSqlvksegr
Low Complexity Region (SEG)
MISKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSSKKHvgvivgvtigvsvAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTsvnaaaqsdvsavddISGVSMSRVFSQLVKSEGR
Disordered region (IsUnstruct)
*********NYLIDCGSRTNTTVGNRVFVADNSASKFL*****VV**************LYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG************************ANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNL**********KHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSIN***********************GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAV***********AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG***********************************************************
Disordered Region (DISOPRED)
*ISKFDPADNYLIDCGSRTNTTVGNRVFVADNSAS************************LYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRM****DPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIG**************G**************************GVTIGVSVAALLAGILFMLCRK********************************************RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVA***************QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL*************************************************************LVKS***
Disordered Region (DISEMBL)
MISKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR
Disordered Region (DISPRO)
**SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKF***PQNVVANIS*SVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNL**********KHVGVIVGVTIGVSVAALLAGILFMLCRKRRQ*************************************NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV*************************************************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MISKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	805	2.2.26 [Sep-21-2011]
Q9LX66	830	Receptor-like protein kin	yes	no	0.983	0.954	0.680	0.0
Q9FN92	829	Probable receptor-like pr	no	no	0.977	0.949	0.678	0.0
Q9LK35	855	Receptor-like protein kin	no	no	0.983	0.926	0.533	0.0
Q9T020	878	Probable receptor-like pr	no	no	0.983	0.902	0.503	0.0
Q9FLW0	824	Probable receptor-like pr	no	no	0.972	0.950	0.500	0.0
Q9FLJ8	842	Probable receptor-like pr	no	no	0.931	0.890	0.516	0.0
Q9SJT0	871	Probable receptor-like pr	no	no	0.985	0.910	0.486	0.0
O80623	815	Probable receptor-like pr	no	no	0.937	0.926	0.488	0.0
Q9SA72	849	Probable receptor-like pr	no	no	0.922	0.875	0.457	0.0
Q9SCZ4	895	Receptor-like protein kin	no	no	0.985	0.886	0.429	0.0

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score = 1130 bits (2923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 555/815 (68%), Positives = 657/815 (80%), Gaps = 23/815 (2%)

Query: 5   FDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTA 64
           F P DNYLI+CGS TN T+  R+F++D  +SK L++ + ++A    SV  ++ S +Y TA
Sbjct: 25  FTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILA----SVGGNSGSDIYHTA 80

Query: 65  RIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV-SSNV 123
           R+FT  S Y FS++ RGRHW+RLYF PF YQ++ M  A F+VS+  HVLL++F+V SS V
Sbjct: 81  RVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVTSSKV 139

Query: 124 FKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQT 183
            KE+S+NVT++ L + F+PS+ SFAF+NA+EV+S+PD LIT     +  P ++  +  Q 
Sbjct: 140 VKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFVGNPAQFPDMSMQG 199

Query: 184 FETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAP 243
            ET+HRVNMGGPLV   NDTL RTWVPD  FL+ +NLAKS+S    V +V G AT++SAP
Sbjct: 200 LETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATEDSAP 259

Query: 244 NTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSW 303
            TVYG+ T MNS D+PN+ FNVTWEFDVD GFQY  RFHFCDIVS  LNQLYFN+Y+DS 
Sbjct: 260 RTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSM 319

Query: 304 IAVRDLDLSTYSTNTLAAAYYIDMVT-VQTASSKLRISIGRSTLHDTYPDAILNGLEIMK 362
           +A  D+DLST   NTLA AY +D VT     S+K+R+SIG ST+H  YP+AI+NGLEIMK
Sbjct: 320 VAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPSTVHTDYPNAIVNGLEIMK 379

Query: 363 MKNLQGSLGNSS--------SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGH 414
           M N +G L   +        SK ++G+IVG  IG  +A +  G  F+L +KR++  Q GH
Sbjct: 380 MNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKR-GQDGH 438

Query: 415 SKAWIPVSINGGNSHTMGSKYSHGTT-TSANSNSGYRFPFVAVQEATNNFDESWVIGIGG 473
           SK W+P SING    +MGSKYS+GTT TS  +N+ YR PF AV++ATNNFDES  IG+GG
Sbjct: 439 SKTWMPFSING---TSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVGG 495

Query: 474 FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 533
           FGKVYKGELNDGTKVAVKRGNP+SQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE NEMI
Sbjct: 496 FGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 555

Query: 534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI 593
           LIYEYMENGT+K HLYGSGLPSL+WKQRLEICIG+ARGLHYLHTG +K VIHRDVKSANI
Sbjct: 556 LIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSANI 615

Query: 594 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 653
           LLDENFMAKVADFGLSKTGPE+DQTHVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVV
Sbjct: 616 LLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVV 675

Query: 654 LFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAE 713
           LFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQIID +L G IRPDSLRKF ET E
Sbjct: 676 LFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETGE 735

Query: 714 KCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSV 773
           KCLAD+GVDRPSMGDVLWNLEYALQLQEAV+ G+P++NSTN+IGEL PQI+NFSQ DTSV
Sbjct: 736 KCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQGDTSV 795

Query: 774 N---AAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           N    A + + S++DD+SGVSMS+VFSQLVKSEGR
Sbjct: 796 NVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score = 1096 bits (2834), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 553/815 (67%), Positives = 651/815 (79%), Gaps = 28/815 (3%)

Query: 7   PADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARI 66
           P DNYLI+CGS TN TV +RVF++DN AS FL++P  ++A    +   +++S +YQTARI
Sbjct: 27  PVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILA----ASNRNSNSDIYQTARI 82

Query: 67  FTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKE 126
           FTG SKY FS++ RGRHWIRL+F PF YQ++ M  A FSVS+  HVLL++F+VSS V KE
Sbjct: 83  FTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVSSRVMKE 141

Query: 127 FSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFET 186
           +S+NV +D L++ F+PS +SFAF+NALEVVSVPD L + D S    PGK+QGL +Q  ET
Sbjct: 142 YSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSPGKFQGLSWQALET 201

Query: 187 VHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTV 246
           V+RVNMGGP VTP NDTL R W PD  FLV +NL KSVS I +V YV G AT+E+AP TV
Sbjct: 202 VYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATEETAPRTV 261

Query: 247 YGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAV 306
           YGT T MNS D+P++NFNVTW+FDVD GFQY +RFHFCDIVS  LNQLYFN+Y+DS   V
Sbjct: 262 YGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFNLYVDSMDVV 321

Query: 307 RDLDLSTYSTNTLAAAYYIDMVTVQTASSK-LRISIGRSTLHDTYPDAILNGLEIMKMKN 365
            +LDLS+Y +NTL+ AY +D VT     +K +R+SIGRS++H  YP AILNGLEIMKM N
Sbjct: 322 ENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPTAILNGLEIMKMNN 381

Query: 366 LQGSLG---------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSK 416
            +  L          +S++KK+VG+I+G+TIG  +A ++ G  F+L +KR +  Q G+SK
Sbjct: 382 SKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGGFFVLYKKRGR-DQDGNSK 440

Query: 417 AWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGK 476
            WIP+S     S+   S  +  T  S  SNS YR P VAV+EATN+FDE+  IG+GGFGK
Sbjct: 441 TWIPLS-----SNGTTSSSNGTTLASIASNSSYRIPLVAVKEATNSFDENRAIGVGGFGK 495

Query: 477 VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 536
           VYKGEL+DGTKVAVKR NP+SQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE NEMIL+Y
Sbjct: 496 VYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVY 555

Query: 537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
           EYMENGTLK HLYGSGL SLSWKQRLEICIGSARGLHYLHTG AK VIHRDVKSANILLD
Sbjct: 556 EYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLD 615

Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
           EN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV+FE
Sbjct: 616 ENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFE 675

Query: 657 VLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 716
           VLCARPVIDPTL REMVNLAEWAMKWQ KGQL+ IIDP+L GKIRPDSLRKFGET EKCL
Sbjct: 676 VLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCL 735

Query: 717 ADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAA 776
           AD+GVDRPSMGDVLWNLEYALQLQEAVV GDP E+STN+IGEL  + ++++  DTSVN +
Sbjct: 736 ADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP-EDSTNMIGELPLRFNDYNHGDTSVNFS 794

Query: 777 AQSDVSAVDD------ISGVSMSRVFSQLVKSEGR 805
              +    ++       SGVSMS+VFSQL+KSEGR
Sbjct: 795 VAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  834 bits (2155), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 448/839 (53%), Positives = 569/839 (67%), Gaps = 47/839 (5%)

Query: 5   FDPADNYLIDCGSRTNTTVGNRVFVADN-SASKFLSTPQNVVANISESVTSSNDSQLYQT 63
           F+P DNYLI CGS  N T  NR+FV D+  +S  L    + VA  + S  S+  + +YQT
Sbjct: 26  FNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVLKIGNSSVATSTTSNNST--NSIYQT 83

Query: 64  ARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVS--- 120
           AR+F+  + Y F I+  GRHWIRL+F P    ++N++ AS +V T D VLLNNFS +   
Sbjct: 84  ARVFSSLASYRFKITSLGRHWIRLHFSPINNSTWNLTSASITVVTEDFVLLNNFSFNNFN 143

Query: 121 -SNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGL 179
            S +FKE++VNVTS+ L + F PSNNS  F+NA+EVVSVPD LI D A +++P   + GL
Sbjct: 144 GSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVNAIEVVSVPDNLIPDQALALNPSTPFSGL 203

Query: 180 VFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFL-VNRNLAKSVSNIPAVKYVQGGAT 238
               FETV+R+NMGGPL+T +NDTL R W  D  +L VN ++    +N  ++KY     T
Sbjct: 204 SLLAFETVYRLNMGGPLLTSQNDTLGRQWDNDAEYLHVNSSVLVVTANPSSIKY-SPSVT 262

Query: 239 KESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNV 298
           +E+APN VY TA  M   +  + +FNVTW   VD  F+Y VR HFCDIVS  LN L FN+
Sbjct: 263 QETAPNMVYATADTMGDANVASPSFNVTWVLPVDPDFRYFVRVHFCDIVSQALNTLVFNL 322

Query: 299 YIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK--LRISIGRSTLHDTYPDAILN 356
           Y++  +A+  LDLST  TN L   Y+ D ++  +  S   L +S+G  +  D   +A +N
Sbjct: 323 YVNDDLALGSLDLSTL-TNGLKVPYFKDFISNGSVESSGVLTVSVGPDSQADIT-NATMN 380

Query: 357 GLEIMKMKNLQGSLGNSSSKKHV------------GVIVGVTIGVSVAALLAGILFMLC- 403
           GLE++K+ N   SL   SS K +             VI+G  +G     LL  +    C 
Sbjct: 381 GLEVLKISNEAKSLSGVSSVKSLLPGGSGSKSKKKAVIIGSLVGAVTLILLIAVCCYCCL 440

Query: 404 ---RKRRQL-PQLG-HSKAWIPVSINGGNSHTMGSKYSHGTTTS-----ANSNSGYRFPF 453
              RK+R   PQ G +   W+P+ + G +     S  SH + T+     A+++ G  F F
Sbjct: 441 VASRKQRSTSPQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMF 500

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 513
             + +ATN FDES ++G+GGFG+VYKG L DGTKVAVKRGNPRS+QG+AEF+TEIEMLS+
Sbjct: 501 QEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSK 560

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
            RHRHLVSLIGYCDE++EMIL+YEYM NG L+ HLYG+ LP LSWKQRLEICIG+ARGLH
Sbjct: 561 LRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLH 620

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLHTG ++++IHRDVK+ NILLDEN +AKVADFGLSKTGP +DQTHVSTAVKGSFGYLDP
Sbjct: 621 YLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDP 680

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           EYFRRQQLTEKSDVYSFGVVL EVLC RP ++P LPRE VN+AEWAM WQ KG LDQI+D
Sbjct: 681 EYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMD 740

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE-AVVHGDPDENS 752
             L GK+ P SL+KFGETAEKCLA++GVDRPSMGDVLWNLEYALQL+E +    +PD+NS
Sbjct: 741 SNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALMEPDDNS 800

Query: 753 TNLI-----GELSPQIHNFSQVDT-SVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           TN I       + P  ++ S +D   VN+   +D    DD    + S VFSQLV   GR
Sbjct: 801 TNHIPGIPMAPMEPFDNSMSIIDRGGVNSGTGTD----DDAEDATTSAVFSQLVHPRGR 855

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  771 bits (1990), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/836 (50%), Positives = 540/836 (64%), Gaps = 44/836 (5%)

Query: 5   FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 63
           F PAD+ LIDCGS++++ T   RVF +D    +++   +++   +S   +    S +Y T
Sbjct: 52  FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDI--QVSAPPSDKVASPIYLT 109

Query: 64  ARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN- 122
           ARIF   + Y F ++  G HW+RL+F  F    +++ +A+FSV T  +VLL+NF +S+N 
Sbjct: 110 ARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNN 169

Query: 123 ------VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKY 176
                 V KE+ VN+T     + F P  +S AFINA+EVVS PD+LI+D  +++ P   +
Sbjct: 170 NDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGF 229

Query: 177 QGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIP-AVKYVQG 235
            GL    +++V+RVN+GGPL+ P+NDTL RTW+PD+ FL + NLAK V   P A+KY   
Sbjct: 230 SGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKY-PP 288

Query: 236 GATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLY 295
             T   AP TVY TA  M +    + NFNV+W F  +  F YL+R HFCDIVS  LN LY
Sbjct: 289 EVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLY 348

Query: 296 FNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQT-ASSKLRISIGRSTLHDTYPDAI 354
           FNVYI+   A+  LDLST + N LAA YY D+V   T    +L++ IG         +AI
Sbjct: 349 FNVYINGKTAISGLDLSTVAGN-LAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAI 407

Query: 355 LNGLEIMKMKN----LQGSLG----NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKR 406
           LNG+E++KM N    L G  G     +   KH  V     + +  A +  G +    +KR
Sbjct: 408 LNGVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKR 467

Query: 407 RQLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY--RFPFVAVQEATNNF 463
            Q  Q  +S  +W+ + I+ G+S  M SK     +   NS  G    F    +QEAT NF
Sbjct: 468 PQDWQKRNSFSSWL-LPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNF 526

Query: 464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           + S +IG+GGFG VY G L+DGTKVAVKRGNP+S+QG+ EFQTEI+MLS+ RHRHLVSLI
Sbjct: 527 EASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLI 586

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           GYCDE +EMIL+YE+M NG  + HLYG  L  L+WKQRLEICIGSARGLHYLHTG A+ +
Sbjct: 587 GYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGI 646

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           IHRDVKS NILLDE  +AKVADFGLSK      Q HVSTAVKGSFGYLDPEYFRRQQLT+
Sbjct: 647 IHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTD 705

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 703
           KSDVYSFGVVL E LCARP I+P LPRE VNLAEWAM+W+ KG L++IIDP LAG I P+
Sbjct: 706 KSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPE 765

Query: 704 SLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSP-- 761
           S++KF E AEKCL D+GVDRP+MGDVLWNLEYALQLQEA   G  +E        ++P  
Sbjct: 766 SMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEETENAKPDVVTPGS 825

Query: 762 -QIHNFSQVDTSV--NAAAQSDV---------SAVDDISGVSMSRVFSQLVKSEGR 805
             + + S +  SV  N AA   V         +AVD+ SG +M   F+Q     GR
Sbjct: 826 VPVSDPSPITPSVTTNEAATVPVPAKVEENSGTAVDEHSGTAM---FTQFANLNGR 878

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1

 Score =  763 bits (1970), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/821 (50%), Positives = 545/821 (66%), Gaps = 38/821 (4%)

Query: 3   SKFDPADNYLIDCGSRTNTTV-GNRVFVADNS--ASKFLSTPQNVVANISESVTSSNDSQ 59
           + F P DNYLI+ GS TNT+    R F++D+S   S FLST +++  +IS++  S +   
Sbjct: 24  AAFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSI--SISDTNPSPDSPV 81

Query: 60  LYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV 119
           LY TAR+F     Y F ++ +G H+IRL+F PF    +N+  A F V  N   ++N+FS 
Sbjct: 82  LYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFST 141

Query: 120 SSNVFKEFSVNVTSDSLDVIFSPSNNS-FAFINALEVVSVPDQLITDDASSISPPGKYQ- 177
           SS V KEF + +    L++ F P   S F F+NA+EV S P   I D  + +  P   Q 
Sbjct: 142 SSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQI 201

Query: 178 --GLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQG 235
              L  Q  ETVHR+N+GG  +TP NDTLWRTWV D ++L+ R  A+      +  Y  G
Sbjct: 202 FSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNG 261

Query: 236 GATKESAPNTVYGTATRMNSDD-DPNANFNVTWEFDVDSG-FQYLVRFHFCDIVSDGLNQ 293
           GAT+E AP+ VY TA  M+ D+ +  A FN++W F VD     +LVR HFCDIVS  LNQ
Sbjct: 262 GATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQ 321

Query: 294 LYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHD-TYPD 352
           LYFNV+I+ ++A +D+DLST + + LA+  YID V     S  LRIS+G S L +    +
Sbjct: 322 LYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVN 381

Query: 353 AILNGLEIMKMKNLQGSLGNSSSKKHVGVIVGVTIG--VSVAALLAGILFMLCRKRRQLP 410
           A+LNG+EIM++ +   S   S  +  V ++VG  +G  V ++     +L  LCR++    
Sbjct: 382 ALLNGVEIMRILSPVSSEVVSGKRNVVWIVVGSVLGGFVFLSLFFLSVL-CLCRRKNNKT 440

Query: 411 QLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY---RFPFVAVQEATNNFDESW 467
           +   S  W P+    G+S++        TT    S+SGY   R  F  +Q  TNNFD S 
Sbjct: 441 RSSESTGWTPLRRFRGSSNSR-------TTERTVSSSGYHTLRISFAELQSGTNNFDRSL 493

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           VIG+GGFG V++G L D TKVAVKRG+P S+QGL EF +EI +LS+ RHRHLVSL+GYC+
Sbjct: 494 VIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCE 553

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           E++EMIL+YEYM+ G LK HLYGS  P LSWKQRLE+CIG+ARGLHYLHTG ++ +IHRD
Sbjct: 554 EQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRD 613

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           +KS NILLD N++AKVADFGLS++GP ID+THVST VKGSFGYLDPEYFRRQQLT+KSDV
Sbjct: 614 IKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 673

Query: 648 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRK 707
           YSFGVVLFEVLCARP +DP L RE VNLAEWA++WQ KG LDQI+DP +A +I+P SL+K
Sbjct: 674 YSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKK 733

Query: 708 FGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQ--IHN 765
           F ETAEKC AD+GVDRP++GDVLWNLE+ LQLQE+     P+E+  ++    + +  + N
Sbjct: 734 FAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDVTDPRTARQGLSN 793

Query: 766 FSQVDTSVNAAAQSDVSAVDDISG-VSMSRVFSQLVKSEGR 805
            S ++              D  SG +S ++VFSQL+ + GR
Sbjct: 794 GSNIERDYG----------DGTSGIISSTQVFSQLMTNAGR 824

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1

 Score =  760 bits (1963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 417/808 (51%), Positives = 527/808 (65%), Gaps = 58/808 (7%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGN-RVFVADNSASKFLSTPQNVVANI-SESVTSSNDSQL 60
           S F PADNYLIDCGS   T + + R F +D  +  FL T +++  ++ S  +T SN S L
Sbjct: 26  SSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSVAFLQTDEDIKTSVDSIPITDSNASTL 85

Query: 61  --YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFS 118
             Y TARIF G S Y+F IS  GRHWIRL+FYP  +  YN++ + FSV+T+  VLL++FS
Sbjct: 86  PLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTVLLHDFS 145

Query: 119 V---SSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGK 175
               SS VFKE+ +   ++ L + F P   S AFINA+E+VSVPD+L+ D ASS+     
Sbjct: 146 AGDTSSIVFKEYLI-YAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASSVPQAPD 204

Query: 176 YQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPA-VKYVQ 234
           ++GL   + E +HR+N+GG L++P+ D L RTW+ D+ +      +++V+  P+ + Y  
Sbjct: 205 FKGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTVDPSTITYPD 264

Query: 235 GGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQL 294
           GGAT   APN VY TA  M        NFN++W   VD G  Y +R HFCDIVS  LN L
Sbjct: 265 GGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCDIVSKSLNDL 324

Query: 295 YFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMV--TVQTASSKLRISIGRS-TLHDTYP 351
            FNV+I+   A+  LDLS+  T+ L  AYY D V       +  + + +G +  L    P
Sbjct: 325 IFNVFINKLSAISALDLSSL-TSALGTAYYADFVLNASTITNGSILVQVGPTPNLQSGKP 383

Query: 352 DAILNGLEIMKMKNLQGSL--------------GNSSSKKHVGVIVGVTIGVSVAALLAG 397
           +AILNGLEIMK+ N  GSL              G  SSKK    I G+   +++ A L G
Sbjct: 384 NAILNGLEIMKLNNAAGSLDGLFGVDGKYKGPIGGMSSKKLA--IAGIGFVMALTAFL-G 440

Query: 398 ILFMLCRKRRQ--------------LPQLGHSKAWIPVSINGGNSHTM---GSKYSHGTT 440
           ++ +L R +R+              LP      ++I  S  G  S  M   GSK S    
Sbjct: 441 VVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYIS-SKGGSTSRRMSIFGSKKSKSNG 499

Query: 441 TSA---NSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS 497
            S+   N   G  FPF  +Q AT NFDE+ V G+GGFGKVY GE++ GT+VA+KRG+  S
Sbjct: 500 FSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRGSQSS 559

Query: 498 QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG----- 552
           +QG+ EFQTEI+MLS+ RHRHLVSLIG+CDE  EMIL+YEYM NG L+ HLYGS      
Sbjct: 560 EQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKENDPN 619

Query: 553 -LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
            +P+LSWKQRLEICIGSARGLHYLHTG A+ +IHRDVK+ NILLDEN +AKV+DFGLSK 
Sbjct: 620 PIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFGLSKD 679

Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
            P +D+ HVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGVVLFEVLCARPVI+P LPRE
Sbjct: 680 AP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQLPRE 738

Query: 672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 731
            VNLAE+AM    KG L++IIDP + G I   SLRKF E AEKCLA++GVDRP MGDVLW
Sbjct: 739 QVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMGDVLW 798

Query: 732 NLEYALQLQEAVVHGDPDENSTNLIGEL 759
           NLEYALQLQEA    D  E+ T +  E+
Sbjct: 799 NLEYALQLQEASAQVDLSEDKTTMNIEM 826

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1

 Score =  754 bits (1947), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/829 (48%), Positives = 524/829 (63%), Gaps = 36/829 (4%)

Query: 5   FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 63
           F PAD+ LIDCGS+++T T   RVF +D+   +++    ++   +S   +    S +Y T
Sbjct: 51  FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDI--QVSAPPSDKLPSPIYLT 108

Query: 64  ARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN- 122
           A+IF   + Y F ++  G HW+RL+F+ F    +++ +A+FSV T  +VLL+NF +S++ 
Sbjct: 109 AKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSNDN 168

Query: 123 ------VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKY 176
                 V KE+ +N+T     + F P   S AFIN +E+VS PD+LI+D  +S+ P   +
Sbjct: 169 NDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVNGF 228

Query: 177 QGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG 236
            GL    +++V+RVN+GGPL+TP+NDTL RTW PD+ +L + NLAK V   P       G
Sbjct: 229 SGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYPPG 288

Query: 237 ATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYF 296
            T   AP TVY T   M      + NFNVTW F  +  F Y +R HFCDI+S  LN LYF
Sbjct: 289 VTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDLYF 348

Query: 297 NVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQT-ASSKLRISIGRSTLHDTYPDAIL 355
           NVYI+   A+  LDLST + + L+A YY D+V   T  +S+L++ IG         +AIL
Sbjct: 349 NVYINGKTAISGLDLSTVAGD-LSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNAIL 407

Query: 356 NGLEIMKMKNLQGSL-------GNSSSKKHVGVIVGVTIGVSVAALLA-GILFMLCRKRR 407
           NG+E++KM N   SL       G  +S    G++      +   A +  G +    +KR 
Sbjct: 408 NGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKWKKRP 467

Query: 408 QLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANS--NSGYRFPFVAVQEATNNFD 464
           Q  Q  +S  +W+ + I+ G+S  M SK     +   NS    G  F    +QE T NFD
Sbjct: 468 QDWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTKNFD 526

Query: 465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            S +IG+GGFG VY G ++DGT+VA+KRGNP+S+QG+ EF TEI+MLS+ RHRHLVSLIG
Sbjct: 527 ASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVSLIG 586

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
           YCDE  EMIL+YEYM NG  + HLYG  L  L+WKQRLEICIG+ARGLHYLHTG A+ +I
Sbjct: 587 YCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQGII 646

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRDVKS NILLDE  +AKVADFGLSK      Q HVSTAVKGSFGYLDPEYFRRQQLT+K
Sbjct: 647 HRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDK 705

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 704
           SDVYSFGVVL E LCARP I+P LPRE VNLAEWAM W+ KG L++IIDP L G + P+S
Sbjct: 706 SDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNPES 765

Query: 705 LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGD--------PDENSTNLI 756
           ++KF E AEKCLAD+GVDRP+MGDVLWNLEYALQLQEA   G         P   +    
Sbjct: 766 MKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQGKAEAEEVETPKPVAVPAA 825

Query: 757 GELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
              SP     +  +  V+   + D S VD  SG +M   F+Q     GR
Sbjct: 826 APTSPAATTAAASERPVSQTEEKDDSTVDQHSGTTM---FTQFASLNGR 871

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1

 Score =  746 bits (1925), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/831 (48%), Positives = 534/831 (64%), Gaps = 76/831 (9%)

Query: 8   ADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSN---DSQLYQTA 64
           +D + I+CGS TN TV NR FV+DN          N+V   S   T SN   +S L+QTA
Sbjct: 28  SDTFFINCGSPTNVTVNNRTFVSDN----------NLVQGFSVGTTDSNSGDESTLFQTA 77

Query: 65  RIFT--GSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS- 121
           R+F+   SS Y F I   G   IR+YF P V  S +++ A FSVS  +  L+  +  S+ 
Sbjct: 78  RVFSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSVSAQNFTLIREYKPSTT 137

Query: 122 NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVF 181
           +V +E+ +NVT+DSL + F P   S +FINALEV+ +P+ LI +DA  I      + L  
Sbjct: 138 SVVREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPEDAKLIGTQKDLK-LSS 196

Query: 182 QTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKES 241
              ETV RVNMG   V+ + D LWR W  D ++    +    V N+ AV +  GG T + 
Sbjct: 197 HAMETVSRVNMGNLSVSRDQDKLWRQWDSDSAY--KAHFGTPVMNLKAVNFSAGGITDDI 254

Query: 242 APNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGL---NQLYFNV 298
           AP  VYGTATR+NSD DPN N N+TW F V+ GF Y VRFHFC+I+ D      Q+ F++
Sbjct: 255 APVYVYGTATRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFCNIIVDPFGFERQIRFDI 314

Query: 299 YIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK--LRISIGRSTLHDTYPDAILN 356
           +++S   VR +D++     T  A +++D V  +  S +  L +SIG      +YP + +N
Sbjct: 315 FVNSE-KVRTIDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLSIGLVMDVSSYPVSFIN 373

Query: 357 GLEIMKMKNLQGSLG------------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLC- 403
           G EI K+ N + SL             N SS   VG+I G++  + VA +   ++   C 
Sbjct: 374 GFEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAALCVALVFGVVVSWWCI 433

Query: 404 ----RKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEA 459
               R+ RQ+ Q  HS+         G+ H +    +  +   ++S  GYR+P   ++EA
Sbjct: 434 RKRRRRNRQM-QTVHSR---------GDDHQIKKNETGESLIFSSSKIGYRYPLALIKEA 483

Query: 460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           T++FDES VIG+GGFGKVYKG L D T+VAVKRG P+S+QGLAEF+TE+EML+QFRHRHL
Sbjct: 484 TDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHL 543

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTG 578
           VSLIGYCDE +EMI++YEYME GTLK HLY     P LSW+QRLEIC+G+ARGLHYLHTG
Sbjct: 544 VSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTG 603

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             +A+IHRDVKSANILLD+NFMAKVADFGLSKTGP++DQTHVSTAVKGSFGYLDPEY  R
Sbjct: 604 STRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTR 663

Query: 639 QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 698
           QQLTEKSDVYSFGVV+ EV+C RPVIDP+LPRE VNL EWAMK   KG+L+ IIDP L G
Sbjct: 664 QQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVG 723

Query: 699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ----EAVVHGDPDENSTN 754
           K++ + ++K+ E  EKCL+  G++RP+MGD+LWNLE+ LQ+Q    +A +  D  E S  
Sbjct: 724 KVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQAKDEKAAMVDDKPEASV- 782

Query: 755 LIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
                             V +  Q  V+ V DI+GVSMS+VF+Q+V+ E R
Sbjct: 783 ------------------VGSTMQFSVNGVGDIAGVSMSKVFAQMVREETR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  669 bits (1727), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/782 (45%), Positives = 486/782 (62%), Gaps = 39/782 (4%)

Query: 8   ADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIF 67
           + ++L+DCGS   T V  R +V D S +K ++         S S  SS  +++Y+TAR+F
Sbjct: 30  SKSFLVDCGSNATTEVDGRTWVGDLSPNKSVTLQGFDAITASTSKGSSVYAEIYKTARVF 89

Query: 68  TGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVS------- 120
                YTF    +G +++RL+F PF  +++N++ +SFSV  +   L+ + +++       
Sbjct: 90  DAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGEIAHKN 149

Query: 121 ------------SNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDAS 168
                       S++ KEF +      L + F P   SF F+NA+E+VSV D+L  +  +
Sbjct: 150 LILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLFKESVT 209

Query: 169 SISPPGKYQGLVFQTFETVHRVNMGGPLVTPEND-TLWRTWVPDQSFLVNRNLAKSVSNI 227
            +       GL  +  ET++R+N+GGP + P  D  L+RTW  D S++V  N    V N 
Sbjct: 210 KVGGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVKNS 269

Query: 228 PAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIV 287
             + Y     +   AP  VY TA  M++ +     FN++W+F+VD  F YLVR HFC+++
Sbjct: 270 SNITYALADDSP-VAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELL 328

Query: 288 SDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLH 347
            D  NQ  F +YI++  A  + D+  ++       Y   +  V + +  L I +G  +  
Sbjct: 329 VDKQNQRIFRIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVSSKNDVLWIQLGPDSSV 388

Query: 348 DTYPDAILNGLEIMKMK---NLQ-----GSLGNSSSKKHVGVI---VGVTIGVSVAALLA 396
               DA+L+GLEI K+    NL       S G+S S   + +I   VG  I + +  +  
Sbjct: 389 GASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAGIAIIIFFVFL 448

Query: 397 GILFM-LCRKRRQLPQLGHSK--AWIPVSINGGNSHTMGSKYSHGT---TTSANSNSGYR 450
           GIL + LC+KRR       +    W P+ ++  NS T  +K + G+    T A S  G +
Sbjct: 449 GILVVCLCKKRRSKSDESKNNPPGWRPLFLHVNNS-TANAKATGGSLRLNTLAASTMGRK 507

Query: 451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM 510
           F    ++ AT NFD+   IG+GGFGKVY+GEL DGT +A+KR  P SQQGLAEF+TEI M
Sbjct: 508 FTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVM 567

Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           LS+ RHRHLVSLIG+CDE NEMIL+YEYM NGTL+ HL+GS LP LSWKQRLE CIGSAR
Sbjct: 568 LSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSAR 627

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           GLHYLHTG  + +IHRDVK+ NILLDENF+AK++DFGLSK GP +D THVSTAVKGSFGY
Sbjct: 628 GLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFGY 687

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 690
           LDPEYFRRQQLTEKSDVYSFGVVLFE +CAR VI+PTLP++ +NLAEWA+ WQ +  L+ 
Sbjct: 688 LDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLES 747

Query: 691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 750
           IID  L G   P+SL K+GE AEKCLAD G +RP MG+VLW+LEY LQ+ EA +     E
Sbjct: 748 IIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEAWLRKQNGE 807

Query: 751 NS 752
           NS
Sbjct: 808 NS 809

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/878 (42%), Positives = 517/878 (58%), Gaps = 85/878 (9%)

Query: 3   SKFDPADNYLIDCGSRTN--TTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQL 60
           + + P +  L++CG   +  T   NR++++D   SKFLS+               +  ++
Sbjct: 28  ADYSPTEKILLNCGGGASNLTDTDNRIWISD-VKSKFLSSSSEDSKTSPALTQDPSVPEV 86

Query: 61  -YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV 119
            Y TAR+F     YTF ++  GR ++RLYFYP  Y   N + + FSVS   + LL NFS 
Sbjct: 87  PYMTARVFRSPFTYTFPVAS-GRKFVRLYFYPNSYDGLNATNSLFSVSFGPYTLLKNFSA 145

Query: 120 SSN--------VFKEFSVNVTSDSLDVIFSPSN---NSFAFINALEVVSVPDQLITDDAS 168
           S          + KEF VNV   +L++ F+P +   N++AF+N +EV S+PD   + D +
Sbjct: 146 SQTAEALTYAFIIKEFVVNVEGGTLNMTFTPESAPSNAYAFVNGIEVTSMPDMYSSTDGT 205

Query: 169 --SISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDT-LWRTWVPDQSFLVNRNLAKSVS 225
              +   G          E V+R+N+GG  ++P  DT L+R+W  DQ ++    L    +
Sbjct: 206 LTMVGSSGSVTIDNSTALENVYRLNVGGNDISPSADTGLYRSWYDDQPYIFGAGLGIPET 265

Query: 226 NIP--AVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHF 283
             P   +KY  G  T   AP  VY TA  M      N N+N+TW F +DSGF YLVR HF
Sbjct: 266 ADPNMTIKYPTGTPTY-VAPVDVYSTARSMGPTAQINLNYNLTWIFSIDSGFTYLVRLHF 324

Query: 284 CDIVSD--GLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVT---VQTASSKLR 338
           C++ S+   +NQ  F +Y+++  A  + D+  + T++    ++ D V           L 
Sbjct: 325 CEVSSNITKINQRVFTIYLNNQTAEPEADVIAW-TSSNGVPFHKDYVVNPPEGNGQQDLW 383

Query: 339 ISIGRSTLHDT-YPDAILNGLEIMKMKNLQGSLGNSS---------------------SK 376
           +++  + ++   Y D++LNG+EI KM    G+L  ++                     SK
Sbjct: 384 LALHPNPVNKPEYYDSLLNGVEIFKMNTSDGNLAGTNPIPGPQVTADPSKVLRPTTRKSK 443

Query: 377 KHVGVIVGVTIGVSVAALLAGILFMLCRKRRQL----PQLGHSKAWIPVSINGGNSHTMG 432
            +  +I G   G  V AL+ G       +RR+     P    +  W+P+S+ G NSH+ G
Sbjct: 444 SNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG-NSHSAG 502

Query: 433 SKYSHGTTTSANS---NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGT-KV 488
           S  ++ T + A+S   N    F F  ++ AT NFDES V+G+GGFGKVY+GE++ GT KV
Sbjct: 503 SAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKV 562

Query: 489 AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL 548
           A+KRGNP S+QG+ EFQTEIEMLS+ RHRHLVSLIGYC+E  EMIL+Y+YM +GT++ HL
Sbjct: 563 AIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHL 622

Query: 549 YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 608
           Y +  PSL WKQRLEICIG+ARGLHYLHTG    +IHRDVK+ NILLDE ++AKV+DFGL
Sbjct: 623 YKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGL 682

Query: 609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 668
           SKTGP +D THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARP ++PTL
Sbjct: 683 SKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTL 742

Query: 669 PREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGD 728
            +E V+LAEWA     KG LDQI+DP L GKI P+  +KF ETA KC+ D G++RPSMGD
Sbjct: 743 AKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGD 802

Query: 729 VLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVS------ 782
           VLWNLE+ALQLQE+      +EN   + G++      +   +        SDV       
Sbjct: 803 VLWNLEFALQLQESA-----EENGKGVCGDMDMDEIKYDDGNCKGKNDKSSDVYEGNVTD 857

Query: 783 ---------------AVDDISGVSMSRVFSQLVKSEGR 805
                          A +D  G++ S VFSQ++  +GR
Sbjct: 858 SRSSGIDMSIGGRSLASEDSDGLTPSAVFSQIMNPKGR 895

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	805
224054892	832	predicted protein [Populus trichocarpa]	0.995	0.962	0.784	0.0
224104501	833	predicted protein [Populus trichocarpa]	0.995	0.961	0.770	0.0
359478665	1006	PREDICTED: receptor-like protein kinase	0.986	0.789	0.756	0.0
356542591	837	PREDICTED: receptor-like protein kinase	0.995	0.956	0.727	0.0
147816692	802	hypothetical protein VITISV_009237 [Viti	0.947	0.951	0.759	0.0
449461015	839	PREDICTED: receptor-like protein kinase	0.992	0.952	0.724	0.0
357472565	840	Kinase-like protein [Medicago truncatula	0.992	0.951	0.702	0.0
351725301	811	protein kinase precursor [Glycine max] g	0.962	0.955	0.702	0.0
351726174	833	protein kinase precursor [Glycine max] g	0.991	0.957	0.722	0.0
297815788	829	hypothetical protein ARALYDRAFT_905825 [	0.985	0.956	0.687	0.0

>gi|224054892|ref|XP_002298383.1| predicted protein [Populus trichocarpa] gi|222845641|gb|EEE83188.1| predicted protein [Populus trichocarpa]

 Score = 1308 bits (3385), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 636/811 (78%), Positives = 704/811 (86%), Gaps = 10/811 (1%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQ 62
           S F P DNYLIDCGS TNTTVGNRVFVADNSAS FLSTP+N  AN S SVTS +DS LYQ
Sbjct: 24  SGFTPVDNYLIDCGSLTNTTVGNRVFVADNSASNFLSTPKNTFANASISVTSGDDSPLYQ 83

Query: 63  TARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN 122
           TARIF G+SKYTF I+  GRHWIRLYFYPFV  SYNMS ASF VST ++  L+NFSV ++
Sbjct: 84  TARIFDGTSKYTFLINQPGRHWIRLYFYPFVSGSYNMSNASFGVSTLNYAFLSNFSVKAS 143

Query: 123 VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQ 182
           V KEFSVNVTS +L +  +PS NSFAF+NALEVVSVPD+LITDDA + +P G+++GL +Q
Sbjct: 144 VVKEFSVNVTSKNLVITITPSGNSFAFLNALEVVSVPDELITDDAETFNPVGRFKGLSWQ 203

Query: 183 TFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESA 242
             ETVHRVNMGGP V+ ENDTL RTWVPDQSFL+  NLA +VSNI AVKYV GGAT++SA
Sbjct: 204 ALETVHRVNMGGPTVSFENDTLGRTWVPDQSFLIQNNLAINVSNIAAVKYVVGGATQDSA 263

Query: 243 PNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDS 302
           PN VYGTA+RMNSD++P++NFNVTWEF+V  GFQYLVRFHFCDIVS  LN+LYF+VYIDS
Sbjct: 264 PNAVYGTASRMNSDNNPSSNFNVTWEFNVQPGFQYLVRFHFCDIVSRNLNELYFDVYIDS 323

Query: 303 WIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRS-TLHDTYPDAILNGLEIM 361
           W+   ++D ST + NTLA A+Y+D VT  T S+KLR+SIG + T+   YP+AILNGLEIM
Sbjct: 324 WLVAENVDPSTIA-NTLAVAFYMDFVTAATVSNKLRVSIGPTNTISSAYPNAILNGLEIM 382

Query: 362 KMKNLQGSL-------GNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGH 414
           KM N  GSL        NSSSKK+VGVIVG++IG  + A+LAGI FM CRKRR+L + GH
Sbjct: 383 KMNNSLGSLSGTAPAVANSSSKKNVGVIVGLSIGALILAVLAGIFFMFCRKRRRLARQGH 442

Query: 415 SKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGF 474
           SK WIP SINGGNSHTMGSKYS+GT TS   N GYR PFVAVQEATN+FDESWVIGIGGF
Sbjct: 443 SKTWIPFSINGGNSHTMGSKYSNGTATSLGYNLGYRIPFVAVQEATNSFDESWVIGIGGF 502

Query: 475 GKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 534
           GKVY+G LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL
Sbjct: 503 GKVYRGVLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 562

Query: 535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL 594
           IYEYMENGTLK HLYGSG P+LSWK RLEICIG+ARGLHYLHTGYAKAVIHRDVKSANIL
Sbjct: 563 IYEYMENGTLKSHLYGSGSPTLSWKDRLEICIGAARGLHYLHTGYAKAVIHRDVKSANIL 622

Query: 595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           LDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL
Sbjct: 623 LDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 682

Query: 655 FEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK 714
            EVLCARPVIDP+LPREMVNLAEWAMKWQ +GQL+QIID  LAGKIRPDSLRKFGETAEK
Sbjct: 683 LEVLCARPVIDPSLPREMVNLAEWAMKWQKRGQLEQIIDAALAGKIRPDSLRKFGETAEK 742

Query: 715 CLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVN 774
           CLADFGVDRPSMGD+LWNLEYALQLQEAV+ GDP+ENSTN+IGELSPQI+NFS  D SV 
Sbjct: 743 CLADFGVDRPSMGDILWNLEYALQLQEAVLPGDPEENSTNMIGELSPQINNFSHSDDSV- 801

Query: 775 AAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           +AAQ + S+VD +SGVSMSRVFSQLVKSEGR
Sbjct: 802 SAAQFEASSVDGLSGVSMSRVFSQLVKSEGR 832

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104501|ref|XP_002313457.1| predicted protein [Populus trichocarpa] gi|222849865|gb|EEE87412.1| predicted protein [Populus trichocarpa]

 Score = 1288 bits (3333), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 625/811 (77%), Positives = 702/811 (86%), Gaps = 10/811 (1%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQ 62
           S F P DNYLIDCGS TNTTVG RVFVAD+SAS FLSTP++ +A+ S+SVTS +DS LYQ
Sbjct: 25  SGFTPVDNYLIDCGSPTNTTVGGRVFVADDSASIFLSTPKSTLASSSKSVTSGDDSPLYQ 84

Query: 63  TARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSN 122
           TARIF G+SKY+FSI   GRHWIRLYF PFV  SY+MS ASF VST +HV L+NFSV ++
Sbjct: 85  TARIFDGTSKYSFSIRQPGRHWIRLYFNPFVSGSYDMSGASFDVSTPNHVFLSNFSVKTS 144

Query: 123 VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQ 182
           V KEFS NVTS  L + F+PS NSFAF+NALEVVSVPD+LITDDA + +P G+++GL +Q
Sbjct: 145 VVKEFSANVTSKDLVITFTPSGNSFAFLNALEVVSVPDELITDDAETFNPAGRFKGLSWQ 204

Query: 183 TFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESA 242
             ETV+RVNMGGP V+ ENDTL RTWVPD+S+LV  NLA +VSNI AVKYV GGAT++SA
Sbjct: 205 ALETVYRVNMGGPTVSFENDTLGRTWVPDKSYLVGNNLATNVSNIAAVKYVAGGATQDSA 264

Query: 243 PNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDS 302
           PN VYGTA RMNS++DPN+NFNVTWEF+V+ GFQYLVRFHFCDIVS  LN LYFNVYIDS
Sbjct: 265 PNAVYGTAIRMNSENDPNSNFNVTWEFNVNPGFQYLVRFHFCDIVSSSLNNLYFNVYIDS 324

Query: 303 WIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRS-TLHDTYPDAILNGLEIM 361
           W+   D D S+++ N LA A+Y D VT  T S+KLR+SIG + T+   YP+AILNGLEIM
Sbjct: 325 WLVAEDEDPSSFA-NALAVAFYKDFVTAATVSNKLRVSIGPTNTIAVAYPNAILNGLEIM 383

Query: 362 KMKNLQGSLG-------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGH 414
           KM N  GSL        +SSSKK+VGVIVG++IG  +  +LAGI F+ CRKRR+L + G+
Sbjct: 384 KMNNSLGSLSGPAPDVSDSSSKKNVGVIVGLSIGAVILVVLAGIFFVFCRKRRRLARQGN 443

Query: 415 SKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGF 474
           SK WIP+SINGGNSHTMG+KYS+GTT + +SN GY  PF AV EATNNFDESWVIGIGGF
Sbjct: 444 SKMWIPLSINGGNSHTMGTKYSNGTTATLDSNLGYCIPFAAVHEATNNFDESWVIGIGGF 503

Query: 475 GKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 534
           GKVYKG LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL
Sbjct: 504 GKVYKGVLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL 563

Query: 535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL 594
           IYEYMENGTLK HLYGSG PSL WK RLEICIG+ARGLHYLHTGYAKAVIHRDVKSANIL
Sbjct: 564 IYEYMENGTLKSHLYGSGSPSLCWKDRLEICIGAARGLHYLHTGYAKAVIHRDVKSANIL 623

Query: 595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           LDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD+YSFGVVL
Sbjct: 624 LDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDIYSFGVVL 683

Query: 655 FEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK 714
           FEVLCARPVIDP+LPREMVNLAEWAMKWQ +GQL++IIDPTL GKIRPDSLRKFGETAEK
Sbjct: 684 FEVLCARPVIDPSLPREMVNLAEWAMKWQKRGQLEEIIDPTLVGKIRPDSLRKFGETAEK 743

Query: 715 CLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVN 774
           CLADFGVDRPSMGDVLWNLEYALQLQEAVV GDP++NS N+IGELSPQI+NFS  D+SV 
Sbjct: 744 CLADFGVDRPSMGDVLWNLEYALQLQEAVVLGDPEDNSINMIGELSPQINNFSHTDSSV- 802

Query: 775 AAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           +AA+ + S+VDD+SGVSMSRVFSQLVKSEGR
Sbjct: 803 SAAKFEASSVDDLSGVSMSRVFSQLVKSEGR 833

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478665|ref|XP_002281617.2| PREDICTED: receptor-like protein kinase HERK 1-like [Vitis vinifera]

 Score = 1266 bits (3277), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 609/805 (75%), Positives = 696/805 (86%), Gaps = 11/805 (1%)

Query: 9    DNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANI-SESVTSSNDSQLYQTARIF 67
            D+YLIDCGS TNT+V  RVF+AD S+  +LSTP+ ++AN  ++S +SS+D  LYQTARIF
Sbjct: 205  DDYLIDCGSTTNTSVAGRVFLADTSS--YLSTPEKLLANTATKSDSSSDDLPLYQTARIF 262

Query: 68   TGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS-NVFKE 126
            TG+SKYTFS+    R+WIRLYF+PFVY +YNMS A+FSVST +HVL++NFS  + +  KE
Sbjct: 263  TGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMSTANFSVSTQNHVLISNFSPKAGSAMKE 322

Query: 127  FSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFET 186
            FS NVTSD+L + F+PS+NSFAF+NALEVVSVP++LI+DDA +I+P GK++GLV Q  ET
Sbjct: 323  FSENVTSDTLVITFAPSSNSFAFLNALEVVSVPNELISDDAITITPSGKFKGLVTQALET 382

Query: 187  VHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTV 246
            V RVNMGGP VT ENDTLWRTW+PDQ+FLV  NLA +VS I AV Y +GG TK  AP +V
Sbjct: 383  VARVNMGGPTVTSENDTLWRTWLPDQNFLVENNLATNVSKIGAVIYAKGGPTKLIAPASV 442

Query: 247  YGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAV 306
            YGTAT+MNSD +P  NFNVTWEFDVD GFQYLVR+HFCDIVS  LNQLYFNVY+DS++  
Sbjct: 443  YGTATKMNSDANPQYNFNVTWEFDVDPGFQYLVRYHFCDIVSISLNQLYFNVYLDSYLVY 502

Query: 307  RDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNL 366
             +LDLST + N L A YY+D+VT     SKLR+SIG S++H  YPDAILNGLEIMKM + 
Sbjct: 503  EELDLSTLAFNILGAPYYLDVVTGTRVGSKLRVSIGPSSIHTEYPDAILNGLEIMKMNSS 562

Query: 367  QGSLG------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIP 420
             GSL       N SSKK+V V++G ++GV  A +LAG+ F++ R+RR+L + GHSK W+ 
Sbjct: 563  MGSLSGSVIVSNPSSKKNVAVVIGASVGVFAALILAGVFFLVYRRRRKLARQGHSKTWMA 622

Query: 421  VSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG 480
             S NGGNSHTMGSKYS+GT  SA SN GYR PF+AVQEATNNFDESWVIGIGGFGKVYKG
Sbjct: 623  FSTNGGNSHTMGSKYSNGTIASAGSNFGYRIPFLAVQEATNNFDESWVIGIGGFGKVYKG 682

Query: 481  ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 540
             LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME
Sbjct: 683  TLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME 742

Query: 541  NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 600
            NGT+K HLYGSGLPSL WK+RLEICIG+ARGLHYLHTGYAKAVIHRDVKSANILLDEN M
Sbjct: 743  NGTVKSHLYGSGLPSLDWKERLEICIGAARGLHYLHTGYAKAVIHRDVKSANILLDENLM 802

Query: 601  AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
            AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA
Sbjct: 803  AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 862

Query: 661  RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 720
            RPVIDPTLPREMVNLAEWAMKWQ +GQL+QIIDP L GKIRPDSLRKFGETAEKCL+DFG
Sbjct: 863  RPVIDPTLPREMVNLAEWAMKWQKRGQLEQIIDPNLVGKIRPDSLRKFGETAEKCLSDFG 922

Query: 721  VDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSD 780
            VDRPSMGD+LWNLEYALQLQEAV+ GDP+ENSTNLIGEL+PQ++NF+  DTSV +AAQ +
Sbjct: 923  VDRPSMGDILWNLEYALQLQEAVLVGDPEENSTNLIGELAPQVNNFNHADTSV-SAAQFE 981

Query: 781  VSAVDDISGVSMSRVFSQLVKSEGR 805
            VS+VDD+SG+SMSRVFSQLVKSEGR
Sbjct: 982  VSSVDDLSGISMSRVFSQLVKSEGR 1006

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542591|ref|XP_003539750.1| PREDICTED: receptor-like protein kinase HERK 1-like [Glycine max]

 Score = 1227 bits (3175), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 594/816 (72%), Positives = 691/816 (84%), Gaps = 15/816 (1%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANIS-ESVTSSNDSQLY 61
           + F P DNYLIDCGS TNT + +R F AD+    FLST Q++VA+ S +S+TS++DS LY
Sbjct: 24  ANFVPTDNYLIDCGSPTNTPIDSRNFTADSFYKNFLSTQQDIVASTSLKSITSTSDSPLY 83

Query: 62  QTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS 121
            TARIFT  SKYTF I+ +GRHWIRLYF+PF Y+ YN+S A F+VST ++ LL++FSV  
Sbjct: 84  STARIFTAPSKYTFPINKKGRHWIRLYFFPFAYEKYNLSAAKFAVSTQNYNLLSDFSVQK 143

Query: 122 N-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLV 180
           N V KE+S+NVTSD+L + FSPS+NS AF+NA+EVVSVPD LI DDA++++P G Y GL 
Sbjct: 144 NPVMKEYSLNVTSDTLVITFSPSDNSIAFVNAIEVVSVPDDLIIDDANTLNPAGSYSGLF 203

Query: 181 FQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKE 240
            Q  ETV RVNMGGP ++  +DTL RTWVPD+ FL+  NLA++ +NI AVKYV GG T+ 
Sbjct: 204 AQALETVFRVNMGGPTISSGSDTLQRTWVPDEKFLIQPNLARNFTNIGAVKYVDGGPTEN 263

Query: 241 SAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYI 300
           +AP +VYGT T+MNS DDP +NFNVTW+FDV+  FQYLVR HFCDI+S  LN+LYFNVYI
Sbjct: 264 TAPPSVYGTLTQMNSADDPRSNFNVTWQFDVEPQFQYLVRLHFCDIISKSLNELYFNVYI 323

Query: 301 DSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEI 360
           +SW   +DLDLST + N LAA ++ DM+T  +AS+K+ ISIG ST++  YP+AILNGLEI
Sbjct: 324 NSWFVAKDLDLSTINNNILAAPFFKDMITAPSASTKIFISIGPSTVNSNYPNAILNGLEI 383

Query: 361 MKMKNLQGSLGNSSS----------KKHVGVIVGVTIGVSVAALLAGILF-MLCRKRRQL 409
           MKM N   SL +S++           K VG+IVGV++G  +A ++ G+ F +LCRKR++L
Sbjct: 384 MKMNNSVSSLSSSTAVPLSSTSGSGSKKVGLIVGVSVGAFLAVVIVGVFFFLLCRKRKRL 443

Query: 410 PQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVI 469
            + GHSK W+P+SIN G SHTMGSKYS+ TT SA SN GYRFPFV VQEATNNFDESWVI
Sbjct: 444 EKEGHSKTWVPLSINDGTSHTMGSKYSNATTGSAASNFGYRFPFVTVQEATNNFDESWVI 503

Query: 470 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 529
           GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE+
Sbjct: 504 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER 563

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
           NEMILIYEYME GTLK HLYGSG PSLSWK+RLEICIG+ARGLHYLHTGYAKAVIHRDVK
Sbjct: 564 NEMILIYEYMEKGTLKSHLYGSGFPSLSWKERLEICIGAARGLHYLHTGYAKAVIHRDVK 623

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
           SANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 624 SANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 683

Query: 650 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 709
           FGVVLFEVLCARPVIDPTLPREMVNLAEW+MK Q +GQL+QIIDPTLAGKIRPDSLRKFG
Sbjct: 684 FGVVLFEVLCARPVIDPTLPREMVNLAEWSMKLQKRGQLEQIIDPTLAGKIRPDSLRKFG 743

Query: 710 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQV 769
           ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV GDP+ENSTN+IGELSPQ++NF+  
Sbjct: 744 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVQGDPEENSTNMIGELSPQVNNFNH- 802

Query: 770 DTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           + SV +AAQ + +++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 803 EVSV-SAAQFEATSLDDLSGVSMSRVFSQLVKSEGR 837

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147816692|emb|CAN77769.1| hypothetical protein VITISV_009237 [Vitis vinifera]

 Score = 1223 bits (3164), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 586/772 (75%), Positives = 669/772 (86%), Gaps = 9/772 (1%)

Query: 42  QNVVANI-SESVTSSNDSQLYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMS 100
           + ++AN  ++S +SS+D  LYQTARIFTG+SKYTFS+    R+WIRLYF+PFVY +YNMS
Sbjct: 32  KKLLANTATKSDSSSDDLPLYQTARIFTGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMS 91

Query: 101 RASFSVSTNDHVLLNNFSVSS-NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVP 159
            A+FSVST +HVL++NFS  + +  KEFS NVTSD+L + F+PS++SFAF+NALEVVSVP
Sbjct: 92  TANFSVSTQNHVLISNFSPKAGSAMKEFSENVTSDTLVITFAPSSDSFAFLNALEVVSVP 151

Query: 160 DQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRN 219
           ++LI+DDA +I+P GK++GLV Q  ETV RVNMGGP VT ENDTLWRTW+PDQ+FLV  N
Sbjct: 152 NELISDDAITITPSGKFKGLVTQALETVARVNMGGPTVTSENDTLWRTWLPDQNFLVENN 211

Query: 220 LAKSVSNIPAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLV 279
           LA +VS I AV Y +GG TK  AP +VYGTAT+MNSD +P  NFNVTWEFDVD GFQYLV
Sbjct: 212 LATNVSKIGAVIYAKGGPTKLIAPASVYGTATKMNSDANPQYNFNVTWEFDVDPGFQYLV 271

Query: 280 RFHFCDIVSDGLNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRI 339
           R+HFCDIVS  LNQLYFNVY+DS++   +LDLST + N L A YY+D+VT     SKLR+
Sbjct: 272 RYHFCDIVSISLNQLYFNVYLDSYLVYEELDLSTLAFNILGAPYYLDVVTGTRVGSKLRV 331

Query: 340 SIGRSTLHDTYPDAILNGLEIMKMKNLQGSLG------NSSSKKHVGVIVGVTIGVSVAA 393
           SIG S++H  YPDAILNGLEIMKM +  GSL       N SSKK+V V++G ++GV  A 
Sbjct: 332 SIGPSSIHTEYPDAILNGLEIMKMNSSMGSLSGSVIVSNPSSKKNVAVVIGASVGVFAAL 391

Query: 394 LLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPF 453
           +LAG+ F++ R+RR+L + GHSK W+  S NGGNSHTMGSKYS+GT  SA SN GYR PF
Sbjct: 392 ILAGVFFLVYRRRRKLARQGHSKTWMAFSTNGGNSHTMGSKYSNGTXASAGSNFGYRIPF 451

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 513
           +AVQEATNNFDESWVIGIGGFGKVYKG LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ
Sbjct: 452 LAVQEATNNFDESWVIGIGGFGKVYKGTLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 511

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
           FRHRHLVSLIGYCDEKNEMILIYEYMENGT+K HLYGSGLPSL WK+RLEICIG+ARGLH
Sbjct: 512 FRHRHLVSLIGYCDEKNEMILIYEYMENGTVKSHLYGSGLPSLDWKERLEICIGAARGLH 571

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLHTGYAKAVIHRDVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP
Sbjct: 572 YLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 631

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ +GQL+QIID
Sbjct: 632 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKRGQLEQIID 691

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 753
           P L GKIRPDSLRKFGETAEKCL+DFGVDRPSMGD+LWNLEYALQLQEAV+ GDP+ENST
Sbjct: 692 PNLVGKIRPDSLRKFGETAEKCLSDFGVDRPSMGDILWNLEYALQLQEAVLVGDPEENST 751

Query: 754 NLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           NLIGEL+PQ++NF+  DTSV +AAQ +VS+VDD+SG+SMSRVFSQLVKSEGR
Sbjct: 752 NLIGELAPQVNNFNHADTSV-SAAQFEVSSVDDLSGISMSRVFSQLVKSEGR 802

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461015|ref|XP_004148239.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus] gi|449523606|ref|XP_004168814.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus]

 Score = 1202 bits (3111), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 591/816 (72%), Positives = 666/816 (81%), Gaps = 17/816 (2%)

Query: 5   FDPADNYLIDCGSRTNTTVGNRVFVAD-NSASKFLSTPQNVVANISES---VTSSNDSQL 60
           F+P DNYLIDCGS  N +VGNRVF+AD N ASKFLSTPQ ++A+ + S    TSSNDS L
Sbjct: 26  FNPVDNYLIDCGSAANVSVGNRVFMADDNLASKFLSTPQVIMADTNTSSLLATSSNDSLL 85

Query: 61  YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVS 120
           ++TAR+FTG+SKY F I   GRHWIRLYF+PFV+  YNMS A+FSVST D VLL + +  
Sbjct: 86  FKTARVFTGTSKYKFPIKA-GRHWIRLYFFPFVFSVYNMSAANFSVSTQDFVLLRDLAGG 144

Query: 121 SN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGL 179
            N + KEFSVN+ SD+L+VIF+P N S A++NA+EV+SVPD LI D+A  + P GK+QGL
Sbjct: 145 KNPIIKEFSVNLASDTLEVIFAPVNGSIAYVNAIEVISVPDILIGDEAILLEPSGKFQGL 204

Query: 180 VFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATK 239
             Q +ETV RVNMGGP V P+ND L R+WV D SF+VN+NLA S SNI AVKY   GA  
Sbjct: 205 SNQAYETVARVNMGGPKVAPDNDPLTRSWVSDDSFIVNKNLATSFSNIAAVKYSAEGAAP 264

Query: 240 ESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVY 299
           E APN VYGT + MNS DDPN+NFNVTW+F VD  FQYLVRFHFCDIVS  L++LYFNVY
Sbjct: 265 EIAPNVVYGTLSEMNSKDDPNSNFNVTWKFKVDPEFQYLVRFHFCDIVSKSLHELYFNVY 324

Query: 300 IDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLE 359
           IDSW+ V  LDLS    N L+ AYYID V+    + +L +SIG + + + YP+AILNGLE
Sbjct: 325 IDSWLVVGGLDLSVPLNNALSTAYYIDSVSGVINNDELLVSIGPANIANVYPNAILNGLE 384

Query: 360 IMKMKNLQGSLG----------NSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQL 409
           IMKM N  GSL           ++SS KH+GVIVGV +G  VAALL GILF+L ++RR+ 
Sbjct: 385 IMKMNNSVGSLSGKDSVISFPDSNSSSKHIGVIVGVCVGAFVAALLVGILFILHKRRRKG 444

Query: 410 PQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVI 469
                SK WI +S  G  SHTMGSKYS+GT TSA SN GYR PF  VQEATNNFDESWVI
Sbjct: 445 MHQATSKTWISISTAGEMSHTMGSKYSNGTITSAASNYGYRIPFATVQEATNNFDESWVI 504

Query: 470 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 529
           GIGGFGKVYKG LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE+
Sbjct: 505 GIGGFGKVYKGVLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDER 564

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
           NEMILIYEYME GTLK HLYGS  PSLSWK+RLE+CIG+ARGLHYLHTGYAK VIHRDVK
Sbjct: 565 NEMILIYEYMEQGTLKSHLYGSDFPSLSWKERLEVCIGAARGLHYLHTGYAKPVIHRDVK 624

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
           SANILLDE  MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 625 SANILLDETLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 684

Query: 650 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 709
           FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQIID TL GKIR  SLRKFG
Sbjct: 685 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDSTLVGKIRSTSLRKFG 744

Query: 710 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQV 769
           ETAEKCLAD+GVDRPSMGDVLWNLEYALQLQEAV+  DP++NSTN+IGELSPQI+NF+ +
Sbjct: 745 ETAEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIETDPEDNSTNMIGELSPQINNFNNI 804

Query: 770 DTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           +  V +A + D+  VDD+SGVSMSRVFSQLVKSEGR
Sbjct: 805 EAGV-SATRFDIPGVDDLSGVSMSRVFSQLVKSEGR 839

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357472565|ref|XP_003606567.1| Kinase-like protein [Medicago truncatula] gi|355507622|gb|AES88764.1| Kinase-like protein [Medicago truncatula]

 Score = 1167 bits (3020), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 575/819 (70%), Positives = 670/819 (81%), Gaps = 20/819 (2%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRV-FVADNSASKFLSTPQNVVANIS-ESVTSSND-SQ 59
           + F P DNYLIDCGS TNT++G+ + F +D     FLST ++++AN + +S+ S+ D S 
Sbjct: 26  ANFVPIDNYLIDCGSHTNTSIGSNLNFTSDTFFKNFLSTQEDILANTTLKSINSTTDFSP 85

Query: 60  LYQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV 119
           LYQTARIF  SSKYTF I+ +GRHWIRLYF+PF YQ+YN+S A+F+V+T  ++LL++FSV
Sbjct: 86  LYQTARIFISSSKYTFPINKKGRHWIRLYFFPFSYQNYNLSAANFAVTTEHNILLSSFSV 145

Query: 120 SSN--VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQ 177
                V KE+ VNVT D+L + F+PSNNS AF+NA+EVVSVPD LI DDA +++P  +Y 
Sbjct: 146 PKKNPVMKEYLVNVTLDTLVITFTPSNNSTAFVNAIEVVSVPDDLIADDAIALNPRREYT 205

Query: 178 GLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGA 237
           GL+   FETV R+NMGGP V+   D L RTWVPD SFL+  NLA + S+I AVKY +GGA
Sbjct: 206 GLLTDAFETVFRLNMGGPSVSSSVDPLHRTWVPDTSFLIQPNLATNFSSIGAVKYAKGGA 265

Query: 238 TKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFN 297
           T+  AP +VYGT T MNSD DP +NFNVTW+FDV+ GFQYLVR HFCDIVS GLN+LYFN
Sbjct: 266 TENIAPPSVYGTLTEMNSDGDPRSNFNVTWKFDVEPGFQYLVRLHFCDIVSKGLNELYFN 325

Query: 298 VYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNG 357
           VYI S +A +DLD+   + NTLA  Y++D VT  +  +K+ +SIG S ++  YP+AILNG
Sbjct: 326 VYITSLLAAKDLDIGEKTHNTLATPYFMDFVTTPSVDNKILVSIGPSDVNSDYPNAILNG 385

Query: 358 LEIMKMKNLQGSL----------GNSSSKKHVGVIVGVTIGVSVAAL-LAGILFMLCRKR 406
           LEIMKM N   SL           + S  K VGVIVGV++G+  A + + G  F+L ++R
Sbjct: 386 LEIMKMNNSISSLSASAAVSLPSSHGSKSKKVGVIVGVSLGIFCALVAMVGGFFVLRKRR 445

Query: 407 RQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDES 466
           RQL Q G SK W+P+S   G SHTMGSKYS+ TT SA SN GYRFPF  VQEATNNFDES
Sbjct: 446 RQLAQQGDSKTWVPLS--DGTSHTMGSKYSNATTASAASNFGYRFPFAVVQEATNNFDES 503

Query: 467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           WVIG+GGFGKVYKGEL+DGTKVA KRGNPRS QGLAEF+TEIEMLSQFRHRHLVSLIGYC
Sbjct: 504 WVIGVGGFGKVYKGELSDGTKVACKRGNPRSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 563

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           DE+NEMILIYEYMENGT+K HLYGSGLPSLSWK+RLEICIG+ARGLHYLHTGYAKAVIHR
Sbjct: 564 DERNEMILIYEYMENGTVKSHLYGSGLPSLSWKERLEICIGAARGLHYLHTGYAKAVIHR 623

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           DVKSANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD
Sbjct: 624 DVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 683

Query: 647 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 706
           VYSFGVVL EVLCARPVIDP+LPRE VNLAEWAMKWQ KG+L +I+DPTLAGKIRPDSLR
Sbjct: 684 VYSFGVVLLEVLCARPVIDPSLPRERVNLAEWAMKWQKKGELARIVDPTLAGKIRPDSLR 743

Query: 707 KFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNF 766
           KF ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV GDP+ENSTN+IGEL PQI+NF
Sbjct: 744 KFAETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVKGDPEENSTNMIGELCPQINNF 803

Query: 767 SQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
            Q + SV +  QS+ S++DD+SGVSMS+VFSQLVKSEGR
Sbjct: 804 EQ-EPSV-SVEQSEASSLDDLSGVSMSKVFSQLVKSEGR 840

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351725301|ref|NP_001235040.1| protein kinase precursor [Glycine max] gi|223452398|gb|ACM89526.1| protein kinase [Glycine max]

 Score = 1164 bits (3012), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 573/816 (70%), Positives = 661/816 (81%), Gaps = 41/816 (5%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANIS-ESVTSSNDSQLY 61
           + F P DNYLIDCGS TNT++ +R F AD+    FLST Q+++A+ S +S+TS+ DS LY
Sbjct: 24  ANFVPIDNYLIDCGSPTNTSIDSRNFSADSFYKNFLSTQQDILASTSLKSITSTRDSPLY 83

Query: 62  QTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS 121
            TARIFT  SKYTF I+ +GRHWIRLYF+PF Y+ Y++S A F+VST ++ LL++FSV  
Sbjct: 84  STARIFTAPSKYTFPINKKGRHWIRLYFFPFAYEKYDLSAAKFAVSTQNYNLLSDFSVLK 143

Query: 122 N-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLV 180
           N V KE+S+                         +VSVPD LI DDA +++P G Y GL 
Sbjct: 144 NPVMKEYSL-------------------------IVSVPDDLIIDDAFTLNPAGSYSGLF 178

Query: 181 FQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKE 240
            Q  ETV RVNMGGP V+  +DTL RTW+PD+ FL+  NLA++ +NI AVKYV GG T  
Sbjct: 179 AQALETVFRVNMGGPTVSSGSDTLQRTWLPDKKFLIQPNLARNFTNIGAVKYVDGGPTAN 238

Query: 241 SAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYI 300
           +AP  VYGT T+MNS DDP +NFNVTW+FDV+  FQYLVR HFCDI+S  LN+LYFNVYI
Sbjct: 239 TAPPIVYGTLTQMNSADDPRSNFNVTWQFDVEPQFQYLVRLHFCDIISKSLNELYFNVYI 298

Query: 301 DSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEI 360
           +SW   +DLDLST   N L A ++ DM+T  +AS+K+ +SIG ST+ + YP+AILNGLEI
Sbjct: 299 NSWFVAKDLDLST-RNNILGAPFFKDMITAPSASTKILVSIGPSTVSNDYPNAILNGLEI 357

Query: 361 MKMKNLQGSLGNSSS----------KKHVGVIVGVTIGVSVAALLAGILF-MLCRKRRQL 409
           MKM N   SL +S++           K VG+IVGV++G  +A  + G+ F +LCRKR++ 
Sbjct: 358 MKMNNSVSSLSSSTAVPLSSTSGSGSKKVGLIVGVSVGAFLAVFIVGVFFFLLCRKRKRS 417

Query: 410 PQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVI 469
            + GHSK WIP+SIN G SHTMGSKYS+ TT SA SN GYRFPFV VQEATNNFDESWVI
Sbjct: 418 GKEGHSKTWIPLSINDGTSHTMGSKYSNATTGSAASNLGYRFPFVTVQEATNNFDESWVI 477

Query: 470 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 529
           GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDEK
Sbjct: 478 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDEK 537

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
           NEMILIYEYME GTLK HLYGSG PSLSWK+RLEICIG+ARGLHYLHTGYAKAVIHRDVK
Sbjct: 538 NEMILIYEYMEKGTLKSHLYGSGFPSLSWKERLEICIGAARGLHYLHTGYAKAVIHRDVK 597

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
           SANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS
Sbjct: 598 SANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 657

Query: 650 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 709
           FGVVLFE LCARPVIDPTLPREMVNLAEW+MKWQ +GQL+QIIDPTLAGKIRPDSLRKFG
Sbjct: 658 FGVVLFEALCARPVIDPTLPREMVNLAEWSMKWQKRGQLEQIIDPTLAGKIRPDSLRKFG 717

Query: 710 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQV 769
           ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVV GDP+ENSTN+IGELSPQ++NF   
Sbjct: 718 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVQGDPEENSTNMIGELSPQVNNFDH- 776

Query: 770 DTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           + SV +AAQ + +++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 777 EVSV-SAAQFEATSLDDLSGVSMSRVFSQLVKSEGR 811

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351726174|ref|NP_001235070.1| protein kinase precursor [Glycine max] gi|223452412|gb|ACM89533.1| protein kinase [Glycine max]

 Score = 1154 bits (2985), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 589/815 (72%), Positives = 659/815 (80%), Gaps = 17/815 (2%)

Query: 3   SKFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQ--L 60
           + F P DNYLIDCG+ T+T+VG R F+ADN     LST +++VA  S    +S+     L
Sbjct: 24  ATFVPVDNYLIDCGATTSTSVGTRNFIADNK--DLLSTQKDIVATTSSKSATSSSDDSSL 81

Query: 61  YQTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVS 120
           YQTAR+FT SSKYTF I+ +GRHWIRLYF PF Y+ YN+  A F+VST +HVL  + ++ 
Sbjct: 82  YQTARVFTASSKYTFKINQKGRHWIRLYFLPFAYEKYNLRAADFTVSTQNHVLFRSLNMQ 141

Query: 121 SN-VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGL 179
            + V KE+SVNVTSDSL + F+PS +S AF+NA+EVVSVPD LI DD  ++ P     GL
Sbjct: 142 KDPVMKEYSVNVTSDSLVLTFAPSGSSIAFVNAIEVVSVPDDLIVDDGFALDPSVTSSGL 201

Query: 180 VFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYV-QGGAT 238
           V Q  ETV RVNMGGP VTP NDTL RTWVPDQSFL+  NLA   SNI  VKY   G AT
Sbjct: 202 VTQALETVWRVNMGGPTVTPINDTLQRTWVPDQSFLLQSNLASFSSNIKGVKYENHGQAT 261

Query: 239 KESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNV 298
           + +AP TVYGT T+MNS  DP   FNVTW+FDV  GFQYLVR HFCD+VS  LN+LYFN 
Sbjct: 262 ENTAPPTVYGTLTQMNSTYDPRNIFNVTWQFDVSPGFQYLVRLHFCDVVSKALNELYFNA 321

Query: 299 YIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGL 358
           Y+DS +A    D ST S N L   YY D+VT    S  LR+SIG S ++  YP+AILNGL
Sbjct: 322 YVDSKLAASSADPSTTSNNALGVPYYRDLVTAVAVSKTLRVSIGPSEVNKEYPNAILNGL 381

Query: 359 EIMKMKNLQGSL-------GNSSSKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQ 411
           EIMKM N  GSL        + SS K  G+IVGV++GV  A +LAG+ F+LCRKRR+L Q
Sbjct: 382 EIMKMNNSMGSLIPGAVAITSGSSSKKTGMIVGVSVGVVGAVVLAGVFFVLCRKRRRLAQ 441

Query: 412 LGHSKAWIPVSINGGNS-HTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIG 470
              SK W+P+SIN G + HTMGSKYS+GTT SA SN  YR PFVAVQEATNNFDESWVIG
Sbjct: 442 R-QSKTWVPLSINDGTTFHTMGSKYSNGTTLSAASNFEYRVPFVAVQEATNNFDESWVIG 500

Query: 471 IGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN 530
           IGGFGKVYKGEL+DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE+N
Sbjct: 501 IGGFGKVYKGELSDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDERN 560

Query: 531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 590
           EMILIYEYME GTLKGHLYGSGLPSLSWK+RLEICIG+ARGLHYLHTGYAKAVIHRDVKS
Sbjct: 561 EMILIYEYMEKGTLKGHLYGSGLPSLSWKERLEICIGAARGLHYLHTGYAKAVIHRDVKS 620

Query: 591 ANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSF 650
           ANILLDEN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSF
Sbjct: 621 ANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSF 680

Query: 651 GVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE 710
           GVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQL+QIID TLAGKIRPDSLRKFGE
Sbjct: 681 GVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLEQIIDQTLAGKIRPDSLRKFGE 740

Query: 711 TAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVD 770
           TAEKCLAD+GVDR SMGDVLWNLEYALQLQEAVV GDP+ENSTN+IGELSPQ++NF+Q D
Sbjct: 741 TAEKCLADYGVDRSSMGDVLWNLEYALQLQEAVVQGDPEENSTNMIGELSPQVNNFNQ-D 799

Query: 771 TSVNAAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
            S  +  Q   S++DD+SGVSMSRVFSQLVKSEGR
Sbjct: 800 ASA-SVTQFAGSSLDDLSGVSMSRVFSQLVKSEGR 833

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297815788|ref|XP_002875777.1| hypothetical protein ARALYDRAFT_905825 [Arabidopsis lyrata subsp. lyrata] gi|297321615|gb|EFH52036.1| hypothetical protein ARALYDRAFT_905825 [Arabidopsis lyrata subsp. lyrata]

 Score = 1138 bits (2944), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 561/816 (68%), Positives = 659/816 (80%), Gaps = 23/816 (2%)

Query: 5   FDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTA 64
           F P DNYLI+CGS TN T+  R+F++D  +SK L++P+ ++A  SESV ++  S +YQTA
Sbjct: 22  FTPQDNYLINCGSPTNGTLMGRIFMSDKLSSKLLTSPKEILA--SESVNNAG-SDIYQTA 78

Query: 65  RIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV-SSNV 123
           R+FT  S Y FSI+ RGRHW+RLYF PF YQ++ M  A F+VS+  HVLL++F+V S+ V
Sbjct: 79  RVFTEVSSYKFSIT-RGRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFNVKSTRV 137

Query: 124 FKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQT 183
            KE+S+NVT++ L + F+PS  SFAF+NA+EV+S+PD LIT     I  P ++  +  Q 
Sbjct: 138 VKEYSLNVTTNDLVLTFTPSGGSFAFVNAIEVISIPDTLITGSPRFIGNPVQFPDMSMQG 197

Query: 184 FETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAP 243
            ET+HRVNMGGPLV   NDTL RTWVPD  FL+ +NLAK+VS    V +V G AT++SAP
Sbjct: 198 LETIHRVNMGGPLVAANNDTLTRTWVPDSGFLLEKNLAKTVSKFSTVNFVPGYATEDSAP 257

Query: 244 NTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSW 303
            TVYG+ T MNS D+PN+ FNVTWEFDV+ GFQY  RFHFCDIVS  LNQLYFN+Y+DS 
Sbjct: 258 RTVYGSCTEMNSADNPNSIFNVTWEFDVEPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSM 317

Query: 304 IAVRDLDLSTYSTNTLAAAYYIDMVT-VQTASSKLRISIGRSTLHDTYPDAILNGLEIMK 362
           +A  D+DLST   NTLA AY +D VT     S+K+R+SIG ST+H  YP+AI+NGLEIMK
Sbjct: 318 VAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKIRVSIGPSTVHTDYPNAIVNGLEIMK 377

Query: 363 MKNLQGSLGNSS---------SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLG 413
           M N +G L   S          + ++G+IVG  IG  +A +  G  F+L +KR++  Q G
Sbjct: 378 MNNSKGQLSTGSFVPGSSSSSKQSNIGMIVGSAIGSLLAVVFLGSCFVLYKKRKR-GQDG 436

Query: 414 HSKAWIPVSINGGNSHTMGSKYSHGTT-TSANSNSGYRFPFVAVQEATNNFDESWVIGIG 472
           HSK W+P SING    +MGSKYS+GTT TS  +N+ YR PF AV++ATNNFDES  IG+G
Sbjct: 437 HSKTWMPFSING---TSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVG 493

Query: 473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 532
           GFGKVYKGELNDGTKVAVKRGNP+SQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE NEM
Sbjct: 494 GFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEM 553

Query: 533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 592
           ILIYEYMENGT+K HLYGSGLPSL+WKQRLEICIG+ARGLHYLHTG +K VIHRDVKSAN
Sbjct: 554 ILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSAN 613

Query: 593 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 652
           ILLDENFMAKVADFGLSKTGPE+DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV
Sbjct: 614 ILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 673

Query: 653 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 712
           VLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQIID +L G IRPDSLRKF ET 
Sbjct: 674 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLCGNIRPDSLRKFAETG 733

Query: 713 EKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTS 772
           EKCLAD+GVDRPSMGDVLWNLEYALQLQEAVV G+P++NSTN+IGEL PQI+NFSQ DTS
Sbjct: 734 EKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGEPEDNSTNMIGELPPQINNFSQGDTS 793

Query: 773 VN---AAAQSDVSAVDDISGVSMSRVFSQLVKSEGR 805
           VN    A Q + S++DD+SGVSMS+VFSQLVKSEGR
Sbjct: 794 VNVPGTAGQFEESSIDDLSGVSMSKVFSQLVKSEGR 829

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	805
TAIR|locus:2075346	830	HERK1 "hercules receptor kinas	0.982	0.953	0.670	1.2e-289
TAIR|locus:2174249	829	AT5G59700 [Arabidopsis thalian	0.977	0.949	0.674	2e-285
TAIR|locus:2151349	855	THE1 "THESEUS1" [Arabidopsis t	0.556	0.523	0.587	7.6e-220
TAIR|locus:2178707	824	AT5G24010 [Arabidopsis thalian	0.970	0.947	0.496	3.6e-199
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.414	0.396	0.669	9.6e-198
TAIR|locus:2039717	815	AT2G39360 [Arabidopsis thalian	0.944	0.932	0.487	1.4e-188
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.921	0.845	0.500	5.2e-184
TAIR|locus:2050080	871	AT2G21480 [Arabidopsis thalian	0.913	0.843	0.485	7e-180
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.783	0.743	0.488	3.6e-174
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.470	0.423	0.595	2.3e-172

TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2782 (984.4 bits), Expect = 1.2e-289, P = 1.2e-289
 Identities = 547/816 (67%), Positives = 641/816 (78%)

Query:     5 FDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTA 64
             F P DNYLI+CGS TN T+  R+F++D  +SK L++ + ++A    SV  ++ S +Y TA
Sbjct:    25 FTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILA----SVGGNSGSDIYHTA 80

Query:    65 RIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV-SSNV 123
             R+FT  S Y FS++ RGRHW+RLYF PF YQ++ M  A F+VS+  HVLL++F+V SS V
Sbjct:    81 RVFTEVSSYKFSVT-RGRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVTSSKV 139

Query:   124 FKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQT 183
              KE+S+NVT++ L + F+PS+ SFAF+NA+EV+S+PD LIT     +  P ++  +  Q 
Sbjct:   140 VKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFVGNPAQFPDMSMQG 199

Query:   184 FETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAP 243
              ET+HRVNMGGPLV   NDTL RTWVPD  FL+ +NLAKS+S    V +V G AT++SAP
Sbjct:   200 LETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYATEDSAP 259

Query:   244 NTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSW 303
              TVYG+ T MNS D+PN+ FNVTWEFDVD GFQY  RFHFCDIVS  LNQLYFN+Y+DS 
Sbjct:   260 RTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFNLYVDSM 319

Query:   304 IAVRDLDLSTYSTNTLAAAYYIDMVTVQT--ASSKLRISIGRSTLHDTYPDAILNGLEIM 361
             +A  D+DLST   NTLA AY +D VT QT   S+K+R+SIG ST+H  YP+AI+NGLEIM
Sbjct:   320 VAATDIDLSTLVDNTLAGAYSMDFVT-QTPKGSNKVRVSIGPSTVHTDYPNAIVNGLEIM 378

Query:   362 KMKNLQGSLG--------NSSSKKHXXXXXXXXXXXXXAALLAGILFMLCRKRRQLPQLG 413
             KM N +G L         +SSSK +             A +  G  F+L +KR++  Q G
Sbjct:   379 KMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKR-GQDG 437

Query:   414 HSKAWIPVSINGGNSHTMGSKYSHGTT-TSANSNSGYRFPFVAVQEATNNFDESWVIGIG 472
             HSK W+P SING +   MGSKYS+GTT TS  +N+ YR PF AV++ATNNFDES  IG+G
Sbjct:   438 HSKTWMPFSINGTS---MGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGVG 494

Query:   473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM 532
             GFGKVYKGELNDGTKVAVKRGNP+SQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE NEM
Sbjct:   495 GFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEM 554

Query:   533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 592
             ILIYEYMENGT+K HLYGSGLPSL+WKQRLEICIG+ARGLHYLHTG +K VIHRDVKSAN
Sbjct:   555 ILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSAN 614

Query:   593 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 652
             ILLDENFMAKVADFGLSKTGPE+DQTHVSTAVKGSFGYLDPEYFRRQQLT+KSDVYSFGV
Sbjct:   615 ILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGV 674

Query:   653 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 712
             VLFEVLCARPVIDPTLPREMVNLAEWAMKWQ KGQLDQIID +L G IRPDSLRKF ET 
Sbjct:   675 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAETG 734

Query:   713 EKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTX 772
             EKCLAD+GVDRPSMGDVLWNLEYALQLQEAV+ G+P++NSTN+IGEL PQI+NFSQ DT 
Sbjct:   735 EKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQGDTS 794

Query:   773 XXXXXXXXXXXXXXI---SGVSMSRVFSQLVKSEGR 805
                           I   SGVSMS+VFSQLVKSEGR
Sbjct:   795 VNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)]

 Score = 2742 (970.3 bits), Expect = 2.0e-285, P = 2.0e-285
 Identities = 550/815 (67%), Positives = 636/815 (78%)

Query:     7 PADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARI 66
             P DNYLI+CGS TN TV +RVF++DN AS FL++P  ++A    S  +SN S +YQTARI
Sbjct:    27 PVDNYLINCGSSTNVTVTSRVFISDNLASNFLTSPNEILA---ASNRNSN-SDIYQTARI 82

Query:    67 FTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKE 126
             FTG SKY FS++ RGRHWIRL+F PF YQ++ M  A FSVS+  HVLL++F+VSS V KE
Sbjct:    83 FTGISKYRFSVA-RGRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDFTVSSRVMKE 141

Query:   127 FSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQTFET 186
             +S+NV +D L++ F+PS +SFAF+NALEVVSVPD L + D S    PGK+QGL +Q  ET
Sbjct:   142 YSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSGDPSFAGSPGKFQGLSWQALET 201

Query:   187 VHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTV 246
             V+RVNMGGP VTP NDTL R W PD  FLV +NL KSVS I +V YV G AT+E+AP TV
Sbjct:   202 VYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFATEETAPRTV 261

Query:   247 YGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSWIAV 306
             YGT T MNS D+P++NFNVTW+FDVD GFQY +RFHFCDIVS  LNQLYFN+Y+DS   V
Sbjct:   262 YGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFNLYVDSMDVV 321

Query:   307 RDLDLSTYSTNTLAAAYYIDMVTVQTASSK-LRISIGRSTLHDTYPDAILNGLEIMKMKN 365
              +LDLS+Y +NTL+ AY +D VT     +K +R+SIGRS++H  YP AILNGLEIMKM N
Sbjct:   322 ENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPTAILNGLEIMKMNN 381

Query:   366 LQGSL--------GNSSS-KKHXXXXXXXXXXXXXAALLAGILFMLCRKRRQLPQLGHSK 416
              +  L        G+SS+ KK+             A ++ G  F+L +KR +  Q G+SK
Sbjct:   382 SKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGGFFVLYKKRGR-DQDGNSK 440

Query:   417 AWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGK 476
              WIP+S NG  S + G+     T  S  SNS YR P VAV+EATN+FDE+  IG+GGFGK
Sbjct:   441 TWIPLSSNGTTSSSNGT-----TLASIASNSSYRIPLVAVKEATNSFDENRAIGVGGFGK 495

Query:   477 VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 536
             VYKGEL+DGTKVAVKR NP+SQQGLAEF+TEIEMLSQFRHRHLVSLIGYCDE NEMIL+Y
Sbjct:   496 VYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVY 555

Query:   537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
             EYMENGTLK HLYGSGL SLSWKQRLEICIGSARGLHYLHTG AK VIHRDVKSANILLD
Sbjct:   556 EYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLD 615

Query:   597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
             EN MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV+FE
Sbjct:   616 ENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFE 675

Query:   657 VLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 716
             VLCARPVIDPTL REMVNLAEWAMKWQ KGQL+ IIDP+L GKIRPDSLRKFGET EKCL
Sbjct:   676 VLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGEKCL 735

Query:   717 ADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIHNFSQVDTXXXXX 776
             AD+GVDRPSMGDVLWNLEYALQLQEAVV GDP E+STN+IGEL  + ++++  DT     
Sbjct:   736 ADYGVDRPSMGDVLWNLEYALQLQEAVVDGDP-EDSTNMIGELPLRFNDYNHGDTSVNFS 794

Query:   777 XXXXX------XXXXXISGVSMSRVFSQLVKSEGR 805
                              SGVSMS+VFSQL+KSEGR
Sbjct:   795 VAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0007131 "reciprocal meiotic recombination" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

GO:0042138 "meiotic DNA double-strand break formation" evidence=RCA

GO:0045132 "meiotic chromosome segregation" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1334 (474.7 bits), Expect = 7.6e-220, Sum P(2) = 7.6e-220
 Identities = 273/465 (58%), Positives = 329/465 (70%)

Query:   355 LNGLEIMKMKNLQGSLGNSSSKKHXXXXXXXXXXXXXAALLAGILFMLC----RKRRQL- 409
             L+G+  +K   L G  G+ S KK                LL  +    C    RK+R   
Sbjct:   394 LSGVSSVKSL-LPGGSGSKSKKK--AVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTS 450

Query:   410 PQLG-HSKAWIPVSINGGNSHTMGSKYSHGTTTS-----ANSNSGYRFPFVAVQEATNNF 463
             PQ G +   W+P+ + G +     S  SH + T+     A+++ G  F F  + +ATN F
Sbjct:   451 PQEGGNGHPWLPLPLYGLSQTLTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKF 510

Query:   464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
             DES ++G+GGFG+VYKG L DGTKVAVKRGNPRS+QG+AEF+TEIEMLS+ RHRHLVSLI
Sbjct:   511 DESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLI 570

Query:   524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
             GYCDE++EMIL+YEYM NG L+ HLYG+ LP LSWKQRLEICIG+ARGLHYLHTG ++++
Sbjct:   571 GYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSI 630

Query:   584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
             IHRDVK+ NILLDEN +AKVADFGLSKTGP +DQTHVSTAVKGSFGYLDPEYFRRQQLTE
Sbjct:   631 IHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTE 690

Query:   644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 703
             KSDVYSFGVVL EVLC RP ++P LPRE VN+AEWAM WQ KG LDQI+D  L GK+ P 
Sbjct:   691 KSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPA 750

Query:   704 SLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE-AVVHGDPDENSTNLI-G-ELS 760
             SL+KFGETAEKCLA++GVDRPSMGDVLWNLEYALQL+E +    +PD+NSTN I G  ++
Sbjct:   751 SLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETSSALMEPDDNSTNHIPGIPMA 810

Query:   761 PQIHNFSQVDTXXXXXXXXXXXXXXXISGVSMSRVFSQLVKSEGR 805
             P     + +                     + S VFSQLV   GR
Sbjct:   811 PMEPFDNSMSIIDRGGVNSGTGTDDDAEDATTSAVFSQLVHPRGR 855

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)]

 Score = 1928 (683.7 bits), Expect = 3.6e-199, P = 3.6e-199
 Identities = 407/819 (49%), Positives = 535/819 (65%)

Query:     5 FDPADNYLIDCGSRTNTTV-GNRVFVADNS--ASKFLSTPQNVVANISESVTSSNDSQLY 61
             F P DNYLI+ GS TNT+    R F++D+S   S FLST +++  +IS++  S +   LY
Sbjct:    26 FTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSI--SISDTNPSPDSPVLY 83

Query:    62 QTARIFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS 121
              TAR+F     Y F ++ +G H+IRL+F PF    +N+  A F V  N   ++N+FS SS
Sbjct:    84 NTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSFSTSS 143

Query:   122 NVFKEFSVNVTSDSLDVIFSPSNNS-FAFINALEVVSVPDQLITDDASSISPPGKYQ--- 177
              V KEF + +    L++ F P   S F F+NA+EV S P   I D  + +  P   Q   
Sbjct:   144 VVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQIFS 203

Query:   178 GLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGA 237
              L  Q  ETVHR+N+GG  +TP NDTLWRTWV D ++L+ R  A+      +  Y  GGA
Sbjct:   204 NLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQNGGA 263

Query:   238 TKESAPNTVYGTATRMNSDDDP-NANFNVTWEFDVDSG-FQYLVRFHFCDIVSDGLNQLY 295
             T+E AP+ VY TA  M+ D+    A FN++W F VD     +LVR HFCDIVS  LNQLY
Sbjct:   264 TREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLNQLY 323

Query:   296 FNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHD-TYPDAI 354
             FNV+I+ ++A +D+DLST + + LA+  YID V     S  LRIS+G S L +    +A+
Sbjct:   324 FNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARVNAL 383

Query:   355 LNGLEIMKMKNLQGSLGNSSSKKHXXXXXXXXXXXXXAALLAGILFMLC--RKRRQLPQL 412
             LNG+EIM++ +   S    S K++               L    L +LC  R++    + 
Sbjct:   384 LNGVEIMRILSPVSS-EVVSGKRNVVWIVVGSVLGGFVFLSLFFLSVLCLCRRKNNKTRS 442

Query:   413 GHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGY---RFPFVAVQEATNNFDESWVI 469
               S  W P+    G+S++        TT    S+SGY   R  F  +Q  TNNFD S VI
Sbjct:   443 SESTGWTPLRRFRGSSNSR-------TTERTVSSSGYHTLRISFAELQSGTNNFDRSLVI 495

Query:   470 GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 529
             G+GGFG V++G L D TKVAVKRG+P S+QGL EF +EI +LS+ RHRHLVSL+GYC+E+
Sbjct:   496 GVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEEQ 555

Query:   530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
             +EMIL+YEYM+ G LK HLYGS  P LSWKQRLE+CIG+ARGLHYLHTG ++ +IHRD+K
Sbjct:   556 SEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDIK 615

Query:   590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
             S NILLD N++AKVADFGLS++GP ID+THVST VKGSFGYLDPEYFRRQQLT+KSDVYS
Sbjct:   616 STNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVYS 675

Query:   650 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG 709
             FGVVLFEVLCARP +DP L RE VNLAEWA++WQ KG LDQI+DP +A +I+P SL+KF 
Sbjct:   676 FGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKFA 735

Query:   710 ETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQ--IHNFS 767
             ETAEKC AD+GVDRP++GDVLWNLE+ LQLQE+     P+E+  ++    + +  + N S
Sbjct:   736 ETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDVTDPRTARQGLSNGS 795

Query:   768 QVDTXXXXXXXXXXXXXXXISGV-SMSRVFSQLVKSEGR 805
              ++                 SG+ S ++VFSQL+ + GR
Sbjct:   796 NIERDYGDGT----------SGIISSTQVFSQLMTNAGR 824

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1166 (415.5 bits), Expect = 9.6e-198, Sum P(2) = 9.6e-198
 Identities = 233/348 (66%), Positives = 270/348 (77%)

Query:   421 VSINGGN-SHTM---GSKYSHGTTTSA---NSNSGYRFPFVAVQEATNNFDESWVIGIGG 473
             +S  GG+ S  M   GSK S     S+   N   G  FPF  +Q AT NFDE+ V G+GG
Sbjct:   476 ISSKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGG 535

Query:   474 FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI 533
             FGKVY GE++ GT+VA+KRG+  S+QG+ EFQTEI+MLS+ RHRHLVSLIG+CDE  EMI
Sbjct:   536 FGKVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMI 595

Query:   534 LIYEYMENGTLKGHLYGSG------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             L+YEYM NG L+ HLYGS       +P+LSWKQRLEICIGSARGLHYLHTG A+ +IHRD
Sbjct:   596 LVYEYMSNGPLRDHLYGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRD 655

Query:   588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
             VK+ NILLDEN +AKV+DFGLSK  P +D+ HVSTAVKGSFGYLDPEYFRRQQLT+KSDV
Sbjct:   656 VKTTNILLDENLVAKVSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDV 714

Query:   648 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRK 707
             YSFGVVLFEVLCARPVI+P LPRE VNLAE+AM    KG L++IIDP + G I   SLRK
Sbjct:   715 YSFGVVLFEVLCARPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRK 774

Query:   708 FGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNL 755
             F E AEKCLA++GVDRP MGDVLWNLEYALQLQEA    D  E+ T +
Sbjct:   775 FVEAAEKCLAEYGVDRPGMGDVLWNLEYALQLQEASAQVDLSEDKTTM 822

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)]

 Score = 1828 (648.5 bits), Expect = 1.4e-188, P = 1.4e-188
 Identities = 403/826 (48%), Positives = 529/826 (64%)

Query:     8 ADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSN---DSQLYQTA 64
             +D + I+CGS TN TV NR FV+DN          N+V   S   T SN   +S L+QTA
Sbjct:    28 SDTFFINCGSPTNVTVNNRTFVSDN----------NLVQGFSVGTTDSNSGDESTLFQTA 77

Query:    65 RIFT--GSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSS- 121
             R+F+   SS Y F I   G   IR+YF P V  S +++ A FSVS  +  L+  +  S+ 
Sbjct:    78 RVFSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSVSAQNFTLIREYKPSTT 137

Query:   122 NVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVF 181
             +V +E+ +NVT+DSL + F P   S +FINALEV+ +P+ LI +DA  I    K   L  
Sbjct:   138 SVVREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPEDAKLIGTQ-KDLKLSS 196

Query:   182 QTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKES 241
                ETV RVNMG   V+ + D LWR W  D ++    +    V N+ AV +  GG T + 
Sbjct:   197 HAMETVSRVNMGNLSVSRDQDKLWRQWDSDSAY--KAHFGTPVMNLKAVNFSAGGITDDI 254

Query:   242 APNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSD--GLN-QLYFNV 298
             AP  VYGTATR+NSD DPN N N+TW F V+ GF Y VRFHFC+I+ D  G   Q+ F++
Sbjct:   255 APVYVYGTATRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFCNIIVDPFGFERQIRFDI 314

Query:   299 YIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSK--LRISIGRSTLHDTYPDAILN 356
             +++S   VR +D++     T  A +++D V  +  S +  L +SIG      +YP + +N
Sbjct:   315 FVNSE-KVRTIDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLSIGLVMDVSSYPVSFIN 373

Query:   357 GLEIMKMKNLQGSL---------GNSSSKKHXXXXXXXXXXXXX--AALLAGILFML-C- 403
             G EI K+ N + SL         G+SS+K                  AL+ G++    C 
Sbjct:   374 GFEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAALCVALVFGVVVSWWCI 433

Query:   404 RKRRQLP---QLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEAT 460
             RKRR+     Q  HS+         G+ H +    +  +   ++S  GYR+P   ++EAT
Sbjct:   434 RKRRRRNRQMQTVHSR---------GDDHQIKKNETGESLIFSSSKIGYRYPLALIKEAT 484

Query:   461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
             ++FDES VIG+GGFGKVYKG L D T+VAVKRG P+S+QGLAEF+TE+EML+QFRHRHLV
Sbjct:   485 DDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLV 544

Query:   521 SLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGY 579
             SLIGYCDE +EMI++YEYME GTLK HLY     P LSW+QRLEIC+G+ARGLHYLHTG 
Sbjct:   545 SLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTGS 604

Query:   580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +A+IHRDVKSANILLD+NFMAKVADFGLSKTGP++DQTHVSTAVKGSFGYLDPEY  RQ
Sbjct:   605 TRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTRQ 664

Query:   640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 699
             QLTEKSDVYSFGVV+ EV+C RPVIDP+LPRE VNL EWAMK   KG+L+ IIDP L GK
Sbjct:   665 QLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGK 724

Query:   700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGEL 759
             ++ + ++K+ E  EKCL+  G++RP+MGD+LWNLE+ LQ+Q        DE +  ++ + 
Sbjct:   725 VKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQAK------DEKAA-MVDD- 776

Query:   760 SPQIHNFSQVDTXXXXXXXXXXXXXXXISGVSMSRVFSQLVKSEGR 805
              P+    S V +               I+GVSMS+VF+Q+V+ E R
Sbjct:   777 KPEA---SVVGSTMQFSVNGVGD----IAGVSMSKVFAQMVREETR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1785 (633.4 bits), Expect = 5.2e-184, P = 5.2e-184
 Identities = 383/765 (50%), Positives = 490/765 (64%)

Query:     5 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQT 63
             F PAD+ LIDCGS++++ T   RVF +D    +++   +++  +   S   ++   L   
Sbjct:    52 FKPADDILIDCGSKSSSKTPDGRVFKSDQETIQYIEAKEDIQVSAPPSDKVASPIYLTAR 111

Query:    64 ARIFTGSSKYTFSISGRGRHWIRLYFYP---FVYQ--SYNMSRASFSVSTNDHVLLNNFS 118
                   + K+  +  G     +    +P   F  Q  ++++    + +  N  +  NN  
Sbjct:   112 IFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKISNNNND 171

Query:   119 VSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQG 178
               + V KE+ VN+T     + F P  +S AFINA+EVVS PD+LI+D  +++ P   + G
Sbjct:   172 SQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFPVIGFSG 231

Query:   179 LVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIP-AVKYVQGGA 237
             L    +++V+RVN+GGPL+ P+NDTL RTW+PD+ FL + NLAK V   P A+KY     
Sbjct:   232 LSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPSAIKYPPE-V 290

Query:   238 TKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFN 297
             T   AP TVY TA  M +    + NFNV+W F  +  F YL+R HFCDIVS  LN LYFN
Sbjct:   291 TPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSKSLNDLYFN 350

Query:   298 VYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASS-KLRISIGRSTLHDTYPDAILN 356
             VYI+   A+  LDLST + N LAA YY D+V   T    +L++ IG         +AILN
Sbjct:   351 VYINGKTAISGLDLSTVAGN-LAAPYYKDIVVNATLMGPELQVQIGPMGEDTGTKNAILN 409

Query:   357 GLEIMKMKN----LQGSLG----NSSSKKHXXXXXXXXXXXXXAALLAGILFMLCRKRRQ 408
             G+E++KM N    L G  G     +   KH             A +  G +    +KR Q
Sbjct:   410 GVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLGAMVYKWKKRPQ 469

Query:   409 LPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYR--FPFVAVQEATNNFDE 465
               Q  +S  +W+ + I+ G+S  M SK     +   NS  G    F    +QEAT NF+ 
Sbjct:   470 DWQKRNSFSSWL-LPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLSELQEATKNFEA 528

Query:   466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
             S +IG+GGFG VY G L+DGTKVAVKRGNP+S+QG+ EFQTEI+MLS+ RHRHLVSLIGY
Sbjct:   529 SQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKLRHRHLVSLIGY 588

Query:   526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             CDE +EMIL+YE+M NG  + HLYG  L  L+WKQRLEICIGSARGLHYLHTG A+ +IH
Sbjct:   589 CDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHYLHTGTAQGIIH 648

Query:   586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
             RDVKS NILLDE  +AKVADFGLSK      Q HVSTAVKGSFGYLDPEYFRRQQLT+KS
Sbjct:   649 RDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLTDKS 707

Query:   646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
             DVYSFGVVL E LCARP I+P LPRE VNLAEWAM+W+ KG L++IIDP LAG I P+S+
Sbjct:   708 DVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDPHLAGTINPESM 767

Query:   706 RKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 750
             +KF E AEKCL D+GVDRP+MGDVLWNLEYALQLQEA   G  +E
Sbjct:   768 KKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAEE 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)]

 Score = 1746 (619.7 bits), Expect = 7.0e-180, P = 7.0e-180
 Identities = 371/764 (48%), Positives = 485/764 (63%)

Query:     5 FDPADNYLIDCGSRTNT-TVGNRVFVADNSASKFLSTPQNVVANI--SESVTSSN--DSQ 59
             F PAD+ LIDCGS+++T T   RVF +D+   +++    ++  +   S+ + S     ++
Sbjct:    51 FKPADDILIDCGSKSSTKTPEGRVFKSDSETVQYIEAKDDIQVSAPPSDKLPSPIYLTAK 110

Query:    60 LYQTARIFTGSSKYTFSISGRGRHWIRLYFYP---FVYQ--SYNMSRASFSVSTNDHVLL 114
             +++   I+    K+  +  G     +  + +P   F  Q  ++++    + +  N  +  
Sbjct:   111 IFREEAIY----KFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHNFKLSN 166

Query:   115 NNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPG 174
             +N    + V KE+ +N+T     + F P   S AFIN +E+VS PD+LI+D  +S+ P  
Sbjct:   167 DNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTSLFPVN 226

Query:   175 KYQGLVFQTFETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQ 234
              + GL    +++V+RVN+GGPL+TP+NDTL RTW PD+ +L + NLAK V   P      
Sbjct:   227 GFSGLSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKTNPTAIIYP 286

Query:   235 GGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQL 294
              G T   AP TVY T   M      + NFNVTW F  +  F Y +R HFCDI+S  LN L
Sbjct:   287 PGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDIISKSLNDL 346

Query:   295 YFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTA-SSKLRISIGRSTLHDTYPDA 353
             YFNVYI+   A+  LDLST + + L+A YY D+V   T  +S+L++ IG         +A
Sbjct:   347 YFNVYINGKTAISGLDLSTVAGD-LSAPYYKDIVVNSTLMTSELQVQIGPMGEDTGKKNA 405

Query:   354 ILNGLEIMKMKN----LQGSLG----NSSSKKHXXXXXXXXXXXXXAALLAGILFMLCRK 405
             ILNG+E++KM N    L G  G     +S  K              A +  G +    +K
Sbjct:   406 ILNGVEVLKMSNSVNSLDGEFGVDGQRASMGKQGMVATAGFVMMFGAFVGLGAMVYKWKK 465

Query:   406 RRQLPQLGHS-KAWIPVSINGGNSHTMGSKYSHGTTTSANS--NSGYRFPFVAVQEATNN 462
             R Q  Q  +S  +W+ + I+ G+S  M SK     +   NS    G  F    +QE T N
Sbjct:   466 RPQDWQKRNSFSSWL-LPIHAGDSTFMTSKTGSHKSNLYNSALGLGRYFSLSELQEVTKN 524

Query:   463 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
             FD S +IG+GGFG VY G ++DGT+VA+KRGNP+S+QG+ EF TEI+MLS+ RHRHLVSL
Sbjct:   525 FDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQMLSKLRHRHLVSL 584

Query:   523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
             IGYCDE  EMIL+YEYM NG  + HLYG  L  L+WKQRLEICIG+ARGLHYLHTG A+ 
Sbjct:   585 IGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAARGLHYLHTGTAQG 644

Query:   583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
             +IHRDVKS NILLDE  +AKVADFGLSK      Q HVSTAVKGSFGYLDPEYFRRQQLT
Sbjct:   645 IIHRDVKSTNILLDEALVAKVADFGLSKD-VAFGQNHVSTAVKGSFGYLDPEYFRRQQLT 703

Query:   643 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 702
             +KSDVYSFGVVL E LCARP I+P LPRE VNLAEWAM W+ KG L++IIDP L G + P
Sbjct:   704 DKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLEKIIDPHLVGAVNP 763

Query:   703 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
             +S++KF E AEKCLAD+GVDRP+MGDVLWNLEYALQLQEA   G
Sbjct:   764 ESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQEAFSQG 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1539 (546.8 bits), Expect = 3.6e-174, Sum P(2) = 3.6e-174
 Identities = 320/655 (48%), Positives = 417/655 (63%)

Query:   118 SVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQ 177
             + +S++ KEF +      L + F P   SF F+NA+E+VSV D+L  +  + +       
Sbjct:   159 ATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLFKESVTKVGGSEVEL 218

Query:   178 GLVFQTFETVHRVNMGGPLVTPENDT-LWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG 236
             GL  +  ET++R+N+GGP + P  D  L+RTW  D S++V  N    V N   + Y    
Sbjct:   219 GLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIENAGVEVKNSSNITYALAD 278

Query:   237 ATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYF 296
              +   AP  VY TA  M++ +     FN++W+F+VD  F YLVR HFC+++ D  NQ  F
Sbjct:   279 DSPV-APLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVRLHFCELLVDKQNQRIF 337

Query:   297 NVYIDSWIAVRDLDLSTYSTNTLAAAY--YIDMVTVQTASSKLRISIGRSTLHDTYPDAI 354
              +YI++  A  + D+  ++       Y  Y+D V+  + +  L I +G  +      DA+
Sbjct:   338 RIYINNQTAAGNFDIFAHAGGKNKGIYQDYLDPVS--SKNDVLWIQLGPDSSVGASGDAL 395

Query:   355 LNGLEIMKMK---NLQ-----GSLGNSSSKKHXXXXXXXXXXXXXAALL---AGILFM-L 402
             L+GLEI K+    NL       S G+S S                  +     GIL + L
Sbjct:   396 LSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAGIAIIIFFVFLGILVVCL 455

Query:   403 CRKRRQLPQLGHSK--AWIPVSINGGNSHTMGSKYSHGT---TTSANSNSGYRFPFVAVQ 457
             C+KRR       +    W P+ ++  NS T  +K + G+    T A S  G +F    ++
Sbjct:   456 CKKRRSKSDESKNNPPGWRPLFLHVNNS-TANAKATGGSLRLNTLAASTMGRKFTLAEIR 514

Query:   458 EATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR 517
              AT NFD+   IG+GGFGKVY+GEL DGT +A+KR  P SQQGLAEF+TEI MLS+ RHR
Sbjct:   515 AATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLAEFETEIVMLSRLRHR 574

Query:   518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
             HLVSLIG+CDE NEMIL+YEYM NGTL+ HL+GS LP LSWKQRLE CIGSARGLHYLHT
Sbjct:   575 HLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRLEACIGSARGLHYLHT 634

Query:   578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             G  + +IHRDVK+ NILLDENF+AK++DFGLSK GP +D THVSTAVKGSFGYLDPEYFR
Sbjct:   635 GSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVSTAVKGSFGYLDPEYFR 694

Query:   638 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 697
             RQQLTEKSDVYSFGVVLFE +CAR VI+PTLP++ +NLAEWA+ WQ +  L+ IID  L 
Sbjct:   695 RQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSWQKQRNLESIIDSNLR 754

Query:   698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENS 752
             G   P+SL K+GE AEKCLAD G +RP MG+VLW+LEY LQ+ EA +     ENS
Sbjct:   755 GNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIHEAWLRKQNGENS 809

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 2.3e-172, Sum P(2) = 2.3e-172
 Identities = 234/393 (59%), Positives = 290/393 (73%)

Query:   375 SKKHXXXXXXXXXXXXXAALLAGI-LFMLCRKRRQ---LPQLGHSKAWIPVSINGGNSHT 430
             SK +              AL+ G  +F   R+R++    P    +  W+P+S+ G NSH+
Sbjct:   442 SKSNTAIIAGAASGAVVLALIIGFCVFGAYRRRKRGDYQPASDATSGWLPLSLYG-NSHS 500

Query:   431 MGSKYSHGTTTSANS---NSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGT- 486
              GS  ++ T + A+S   N    F F  ++ AT NFDES V+G+GGFGKVY+GE++ GT 
Sbjct:   501 AGSAKTNTTGSYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTT 560

Query:   487 KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 546
             KVA+KRGNP S+QG+ EFQTEIEMLS+ RHRHLVSLIGYC+E  EMIL+Y+YM +GT++ 
Sbjct:   561 KVAIKRGNPMSEQGVHEFQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMRE 620

Query:   547 HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF 606
             HLY +  PSL WKQRLEICIG+ARGLHYLHTG    +IHRDVK+ NILLDE ++AKV+DF
Sbjct:   621 HLYKTQNPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDF 680

Query:   607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP 666
             GLSKTGP +D THVST VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE LCARP ++P
Sbjct:   681 GLSKTGPTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNP 740

Query:   667 TLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM 726
             TL +E V+LAEWA     KG LDQI+DP L GKI P+  +KF ETA KC+ D G++RPSM
Sbjct:   741 TLAKEQVSLAEWAPYCYKKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSM 800

Query:   727 GDVLWNLEYALQLQEAVVHGDPDENSTNLIGEL 759
             GDVLWNLE+ALQLQE+      +EN   + G++
Sbjct:   801 GDVLWNLEFALQLQESA-----EENGKGVCGDM 828

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LX66	HERK_ARATH	2, ., 7, ., 1, 1, ., -	0.6809	0.9838	0.9542	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	805
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	8e-64
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	9e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-28
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-26
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-22
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-22
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-22
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-22
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-20
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-20
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-19
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-18
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-16
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-16
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-15
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-14
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-10
pfam11721	164	pfam11721, Malectin, Di-glucose binding within end	5e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-06
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	7e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	7e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-04

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  216 bits (553), Expect = 8e-64
 Identities = 96/375 (25%), Positives = 146/375 (38%), Gaps = 64/375 (17%)

Query: 13  IDCGSRTNTTV----GNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFT 68
           IDCG  +N +         +V+D     F+ T ++   NIS+  +SS  S+ Y+T R F 
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSDAG---FIDTGKS--GNISKENSSSFLSKPYKTLRSFP 55

Query: 69  GSSK--YTFSI--SGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNV- 123
              +  YT  +      ++ IR  F    Y   N    S   S +   L    ++ + V 
Sbjct: 56  DGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSV--SSPPSFD---LYLGVNLWTTVN 110

Query: 124 ---------FKEFSVNVT-SDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPP 173
                     KE+ ++VT SD+L V    +     FI+ALE+  +PD L      S    
Sbjct: 111 LSNDSGDSVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSGGS---- 166

Query: 174 GKYQGLVFQTFETVHRVNMG--GPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVK 231
                   Q  + V R+N G     +   +D   R W P  S      ++ S+S      
Sbjct: 167 --------QALKLVARLNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQISTSLSVD---- 214

Query: 232 YVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGL 291
            +         P+ V  TA    +    +A  N TW+   D  F+Y V  HF +I S  L
Sbjct: 215 -ISSNNAPYIPPSAVLQTAVTPTNA---SAPLNFTWDLV-DPNFEYYVYLHFAEIQS--L 267

Query: 292 NQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGR---STLHD 348
               F++YI+      D+        T   A Y+D     +    L IS+     STL  
Sbjct: 268 ETREFDIYINGKTVYGDVSP--KYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTL-- 323

Query: 349 TYPDAILNGLEIMKM 363
                +LN LEI K+
Sbjct: 324 ---PPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  190 bits (485), Expect = 3e-55
 Identities = 71/210 (33%), Positives = 111/210 (52%), Gaps = 19/210 (9%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FG+VYKG+L       T+VAVK  + +   ++   +F  E  ++ +  H ++V 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE-RKDFLKEARVMKKLGHPNVVR 60

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-------YGSGLPSLSWKQRLEICIGSARGLHY 574
           L+G C E+  + L+ EYME G L  +L             +LS K  L   I  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           L    +K  +HRD+ + N L+ E+ + K++DFGLS+   + D     T  K    ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 635 YFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
             +    T KSDV+SFGV+L+E+  L A P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  185 bits (472), Expect = 2e-53
 Identities = 70/206 (33%), Positives = 109/206 (52%), Gaps = 18/206 (8%)

Query: 468 VIGIGGFGKVYKGELNDG-----TKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FG+VYKG L         +VAVK      S+Q + EF  E  ++ +  H ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C E+  ++++ EYM  G L  +L  +    LS    L   +  ARG+ YL    +K
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SK 122

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA---VKGSFGYLDPEYFRR 638
             IHRD+ + N L+ EN + K++DFGLS+   + D   V      ++    ++ PE  + 
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKE 178

Query: 639 QQLTEKSDVYSFGVVLFEV--LCARP 662
            + T KSDV+SFGV+L+E+  L   P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  183 bits (467), Expect = 1e-52
 Identities = 71/206 (34%), Positives = 111/206 (53%), Gaps = 19/206 (9%)

Query: 468 VIGIGGFGKVYKGELND-----GTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FG+VYKG+L         +VAVK      S+Q + EF  E  ++ +  H ++V 
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C E+  + ++ EYME G L  +L  +  P LS    L   +  ARG+ YL    +K
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEYLE---SK 121

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA---VKGSFGYLDPEYFRR 638
             IHRD+ + N L+ EN + K++DFGLS+   + D          ++    ++ PE  + 
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKE 177

Query: 639 QQLTEKSDVYSFGVVLFEV--LCARP 662
            + T KSDV+SFGV+L+E+  L  +P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  180 bits (458), Expect = 2e-51
 Identities = 68/198 (34%), Positives = 105/198 (53%), Gaps = 10/198 (5%)

Query: 468 VIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FG+VYKG L        TKVAVK      S++   EF  E  ++ +  H ++V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C +   + ++ EYM  G L   L   G   L+ K  L++ +  A+G+ YL    +K
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---SK 121

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
             +HRD+ + N L+ EN + K++DFGLS+   E D        K    ++ PE  +  + 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 642 TEKSDVYSFGVVLFEVLC 659
           T KSDV+SFGV+L+E+  
Sbjct: 182 TSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (440), Expect = 2e-49
 Identities = 72/192 (37%), Positives = 99/192 (51%), Gaps = 10/192 (5%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 526
           +G GGFG VY       G KVA+K         L E    EIE+L +  H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           +++N + L+ EY E G+LK  L       LS  + L I +    GL YLH   +  +IHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 587 DVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ-LTEK 644
           D+K  NILLD  N   K+ADFGLSK             + G+  Y+ PE    +   +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 645 SDVYSFGVVLFE 656
           SD++S GV+L+E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (421), Expect = 2e-46
 Identities = 88/275 (32%), Positives = 129/275 (46%), Gaps = 37/275 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G FG VYK      G  VAVK    RS+  +     + EI +L +  H ++V LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             ++K+ + L+ EY E G L  +L   G   LS  +  +I +   RGL YLH   +  +I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTE 643
           HRD+K  NILLDEN + K+ADFGL+K       + ++T V G+  Y+ PE          
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ--IIDPTLAGKIR 701
           K DV+S GV+L+E+L  +P                   +  +  LDQ  +I   L   + 
Sbjct: 179 KVDVWSLGVILYELLTGKPP------------------FSGENILDQLQLIRRILGPPLE 220

Query: 702 PDS--LRKFGETA----EKCLADFGVDRPSMGDVL 730
            D        E A    +KCL      RP+  ++L
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  165 bits (419), Expect = 4e-46
 Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 43/275 (15%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 525
            +G G FGKVY   +   G  VA+K    +  +   E    EI++L + +H ++V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSARGLHYLHTGYAKAV 583
            ++++++ L+ EY E G L   L   G  S    +    +I       L YLH   +K +
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH---SKGI 118

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           +HRD+K  NILLDE+   K+ADFGL++   ++D     T   G+  Y+ PE    +   +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 703
             D++S GV+L+E+L  +P   P               +    QL ++       K    
Sbjct: 176 AVDIWSLGVILYELLTGKP---P---------------FPGDDQLLELFKKIGKPKPPFP 217

Query: 704 S-LRKFGETA----EKCLADFGVD---RPSMGDVL 730
                    A     K L     D   R +  + L
Sbjct: 218 PPEWDISPEAKDLIRKLLV---KDPEKRLTAEEAL 249

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  152 bits (386), Expect = 2e-41
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG VY     D G  +AVK    +  S++ L   + EI +LS  +H ++V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 525 -YCDEKNEMILIY-EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
              DE+   + I+ EY+  G+L   L   G       ++    I    GL YLH   +  
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--LEGLAYLH---SNG 121

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           ++HRD+K ANIL+D + + K+ADFG +K   +I+    + +V+G+  ++ PE  R ++  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 643 EKSDVYSFGVVLFEVLCARPV 663
             +D++S G  + E+   +P 
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  130 bits (329), Expect = 5e-34
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 8/190 (4%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            IG GGFG+VYK      G +VA+K     S++   +   EI++L + +H ++V   G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +K+E+ ++ E+   G+LK  L  +    L+  Q   +C    +GL YLH   +  +IHR
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLH---SNGIIHR 122

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+ANILL  +   K+ DFGLS    +    +      G+  ++ PE    +    K+D
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPYDYKAD 179

Query: 647 VYSFGVVLFE 656
           ++S G+   E
Sbjct: 180 IWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 2e-32
 Identities = 66/190 (34%), Positives = 103/190 (54%), Gaps = 12/190 (6%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G FG V  G+   G KVAVK    +     A+ F  E  +++  RH +LV L+G   
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           + N + ++ EYM  G+L  +L   G   ++  Q+L   +    G+ YL     K  +HRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           + + N+L+ E+ +AKV+DFGL+K   E  Q   S   K    +  PE  R ++ + KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG--KLPVKWTAPEALREKKFSTKSDV 182

Query: 648 YSFGVVLFEV 657
           +SFG++L+E+
Sbjct: 183 WSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 8e-32
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 26/206 (12%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +IG G FG VYKG  L  G  VA+K+            L     EI++L   +H ++V  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA--LKSIMQEIDLLKNLKHPNIVKY 64

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP-SLS---WKQRLEICIGSARGLHYLH 576
           IG  +  + + +I EY ENG+L+  +  +G   P SL      Q L+       GL YLH
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQ-------GLAYLH 116

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
               + VIHRD+K+ANIL  ++ + K+ADFG++      D +    +V G+  ++ PE  
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVI 171

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
                +  SD++S G  + E+L   P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 3e-31
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 10/200 (5%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G FGKVY     +DG    +K  +    S++   +   E+++L +  H +++    
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 525 YCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
             +EK ++ ++ EY + G L   +            +Q L+  +     L YLH+   + 
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           ++HRD+K  NI L  N + K+ DFG+SK           T V G+  YL PE  + +   
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181

Query: 643 EKSDVYSFGVVLFEVLCARP 662
            KSD++S G VL+E+   + 
Sbjct: 182 YKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 9e-31
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 9/192 (4%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G FG VYKG L   T+VAVK         L  +F  E E+L Q+ H ++V LIG C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           +K  + ++ E +  G+L   L       L+ K+ L++ + +A G+ YL    +K  IHRD
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKG-SFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + K++DFG+S+   E    + VS  +K     +  PE     + T +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 646 DVYSFGVVLFEV 657
           DV+S+G++L+E 
Sbjct: 177 DVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  121 bits (305), Expect = 2e-30
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 467 WVIGIGGFGKVYKGEL------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
             +G G FGKV+ GE       ND   VAVK      S     +F+ E E+L+ F+H ++
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHL------------YGSGLPSLSWKQRLEICIG 567
           V   G C E +  I+++EYME+G L   L              S +  L+  Q L+I + 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A G+ YL    ++  +HRD+ + N L+  + + K+ DFG+S+     D   V       
Sbjct: 131 IASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
             ++ PE    ++ T +SDV+SFGVVL+E+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (298), Expect = 9e-30
 Identities = 60/189 (31%), Positives = 100/189 (52%), Gaps = 5/189 (2%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V++G   +  +VA+K           +FQ E++ L + RH+HL+SL   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + +I E ME G+L   L       L     +++    A G+ YL     +  IHRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + NIL+ E+ + KVADFGL++     +  ++S+  K  + +  PE       + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188

Query: 649 SFGVVLFEV 657
           SFG++L+E+
Sbjct: 189 SFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  118 bits (296), Expect = 1e-29
 Identities = 67/191 (35%), Positives = 107/191 (56%), Gaps = 10/191 (5%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E +++ +  H  LV L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            E++ + L++E+ME+G L  +L  +     S +  L +C+    G+ YL +     VIHR
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 647 VYSFGVVLFEV 657
           V+SFGV+++EV
Sbjct: 184 VWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  118 bits (298), Expect = 2e-29
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 17/224 (7%)

Query: 469 IGIGGFGKVYKGE---LNDGT--KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV       L D T  +VAVK  N    +Q  ++F+ EIE+L    H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 523 IGYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C++     + LI EY+ +G+L+ +L       ++ K+ L       +G+ YL +   
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS--- 127

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS--FGYLDPEYFRR 638
           +  IHRD+ + NIL++   + K++DFGL+K  PE    +       S  F Y  PE  R 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186

Query: 639 QQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 680
            + +  SDV+SFGV L+E+          P     M+ +A+  M
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 3e-29
 Identities = 67/199 (33%), Positives = 108/199 (54%), Gaps = 15/199 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           VIG G FG+V +G L    K    VA+K    G+   Q+   +F TE  ++ QF H +++
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNII 68

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGY 579
            L G   +   +++I EYMENG+L   L  +     +  Q + +  G A G+ YL    Y
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
               +HRD+ + NIL++ N + KV+DFGLS+   + + T+ +   K    +  PE    +
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 640 QLTEKSDVYSFGVVLFEVL 658
           + T  SDV+SFG+V++EV+
Sbjct: 184 KFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 8e-28
 Identities = 65/189 (34%), Positives = 98/189 (51%), Gaps = 5/189 (2%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK   P +      F  E +++ + RH  LV L   C E
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L       L   Q +++    A G+ YL    ++  IHRD+
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + NIL+ EN + K+ADFGL++   E D+       K    +  PE     + T KSDV+
Sbjct: 130 AARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188

Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 189 SFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 2e-27
 Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 5/190 (2%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V++G  N+ T VAVK   P +     +F  E +++ + RH  L+ L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ E M+ G+L  +L G    +L   Q +++    A G+ YL    A+  IHRD+
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDL 129

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N+L+ EN + KVADFGL++   E D        K    +  PE     + + KSDV+
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 189 SFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  111 bits (279), Expect = 3e-27
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 25/221 (11%)

Query: 451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAE 503
           FP   +QE T        +G G FG+V+  +          T V VK       +   +E
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54

Query: 504 FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-------GLPSL 556
           F+ E++M  +  H+++V L+G C E     +I EY + G LK  L  +         P L
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114

Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 616
           S KQ++ +C   A G+ +L        +HRD+ + N L+      KV+   LSK      
Sbjct: 115 STKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNS 170

Query: 617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           + +          +L PE  +    + KSDV+SFGV+++EV
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  109 bits (274), Expect = 2e-26
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 467 WVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           W +G G FGKV+  E        D   VAVK     S+    +FQ E E+L+  +H+H+V
Sbjct: 11  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-------------LPSLSWKQRLEICIG 567
              G C E   +++++EYM +G L   L   G                L+  Q L I   
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A G+ YL + +    +HRD+ + N L+ +  + K+ DFG+S+     D   V       
Sbjct: 131 IASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE    ++ T +SD++SFGVVL+E+ 
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  107 bits (267), Expect = 2e-25
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV+  E        D   VAVK     S     +F  E E+L+  +H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 523 IGYCDEKNEMILIYEYMENGTL----KGH-----LYGSGLP--SLSWKQRLEICIGSARG 571
            G C E + +I+++EYM++G L    + H     L   G     L+  Q L I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL + +    +HRD+ + N L+ EN + K+ DFG+S+     D   V         ++
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  106 bits (265), Expect = 2e-25
 Identities = 71/218 (32%), Positives = 111/218 (50%), Gaps = 17/218 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG V  G+   G KVAVK  + +  +Q     F  E  +++Q RH +LV L+G 
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67

Query: 526 -CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL    A   +
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFV 124

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRD+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R ++ + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTK 179

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMK 681
           SDV+SFG++L+E+     V  P +P +++V   E   K
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  109 bits (271), Expect = 2e-25
 Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 24/277 (8%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRH-RHLVSLI 523
            +G G FG+VY         VA+K    + +   + +  F  EI++L+   H  ++V L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 524 GYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            +  ++  + L+ EY++ G+L+  L        LS  + L I       L YLH+   K 
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 583 VIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQT----HVSTAVKGSFGYLDPEYFR 637
           +IHRD+K  NILLD +  + K+ DFGL+K  P+   T     + +   G+ GY+ PE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 638 RQQL---TEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
              L   +  SD++S G+ L+E+L    P                 +  +          
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--LKIILELPTPSLASPL 239

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                ++   +        +K LA    +R S    L
Sbjct: 240 SPSNPELISKAASDL---LKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 2e-25
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 20/213 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQF 514
            N+    ++G G FG+VY   +++ G ++AVK+      +P +++ +   + EI++L   
Sbjct: 2   TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 515 RHRHLVSLIGYCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARG 571
           +H  +V   G C   +E + I+ EYM  G++K  L  YG+   +++ K   +I      G
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EG 116

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKGSFG 629
           + YLH+     ++HRD+K ANIL D     K+ DFG SK    I    T + + V G+  
Sbjct: 117 VEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPY 172

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           ++ PE    +    K+DV+S G  + E+L  +P
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  105 bits (263), Expect = 2e-25
 Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 12/212 (5%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA-EFQTEIEMLSQFRHRHLVSLIGYC 526
           ++G G FG+V+KG L D T VAVK       Q L  +F +E  +L Q+ H ++V LIG C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            ++  + ++ E +  G     L       L  KQ ++  + +A G+ YL +   K  IHR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHR 117

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG-SFGYLDPEYFRRQQLTEKS 645
           D+ + N L+ EN + K++DFG+S+   E D  + S+ +K     +  PE     + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 646 DVYSFGVVLFEV----LCARPVIDPTLPREMV 673
           DV+S+G++L+E     +C  P +     RE V
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 4e-25
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 12/192 (6%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FG V+ G+      VA+K     +   ++E  F  E +++ +  H +LV L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 527 DEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            ++  + ++ EYM NG L  +L    G     W   L++C      + YL +      IH
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLES---NGFIH 123

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ E+ + KV+DFGL++   + DQ   S   K    +  PE F   + + KS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 646 DVYSFGVVLFEV 657
           DV+SFGV+++EV
Sbjct: 183 DVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  104 bits (260), Expect = 8e-25
 Identities = 67/192 (34%), Positives = 107/192 (55%), Gaps = 14/192 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +IG G FG V +GE   G KVAVK  N +       F  E  ++++  H++LV L+G   
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI- 68

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             N + ++ E M  G L   L   G   +S  Q L+  +  A G+ YL +   K ++HRD
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125

Query: 588 VKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           + + NIL+ E+ +AKV+DFGL++ G   +D + +   VK    +  PE  + ++ + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVK----WTAPEALKHKKFSSKSD 179

Query: 647 VYSFGVVLFEVL 658
           V+S+GV+L+EV 
Sbjct: 180 VWSYGVLLWEVF 191

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  104 bits (263), Expect = 8e-25
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 8/206 (3%)

Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEM 510
             V+  +    +     IG G  G+VYK  +   G +VA+K+   R Q        EI +
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILI 68

Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +   +H ++V         +E+ ++ EYM+ G+L   +  + +  ++  Q   +C    +
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQ 127

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           GL YLH   ++ VIHRD+KS NILL ++   K+ADFG +    +      S  V G+  +
Sbjct: 128 GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFE 656
           + PE  +R+    K D++S G++  E
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIE 208

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  103 bits (259), Expect = 1e-24
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)

Query: 469 IGIGGFGKVYKG----ELNDGT---KVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           +G G FG+VY+G     L  G+   +VAVK   +G    ++   EF  E  ++S F H +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARGLH 573
           +V L+G C       +I E ME G L  +L  +     G P L+ K+ L+IC+  A+G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 574 YLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           YL   +    IHRD+ + N L+ E     + + K+ DFGL++   + D            
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++ PE     + T +SDV+SFGV+++E+L
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  103 bits (259), Expect = 2e-24
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)

Query: 469 IGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV+  E        D   VAVK     +     +FQ E E+L+  +H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEICIGS 568
            G C + + +I+++EYM++G L   L   G  +              L   Q L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A G+ YL + +    +HRD+ + N L+  N + K+ DFG+S+     D   V        
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++ PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  103 bits (259), Expect = 2e-24
 Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 30/213 (14%)

Query: 469 IGIGGFGKVYKGEL---NDG---TKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           +G G FGKVYKGEL   N+    T VA+K       P+ QQ   EF+ E E++S  +H +
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQHPN 69

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 564
           +V L+G C ++    +++EY+ +G L   L                +   SL     L I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            I  A G+ YL    +   +HRD+ + N L+ E    K++DFGLS+     D   V +  
Sbjct: 130 AIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
                ++ PE     + T +SD++SFGVVL+E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (254), Expect = 6e-24
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 14/199 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG+V++G L    +    VA+K   P  +++   +F +E  ++ QF H +++ L
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            G   +    ++I EYMENG L  +L        S  Q + +  G A G+ YL       
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MN 127

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            +HRD+ + NIL++ N   KV+DFGLS+     PE   T+ ++  K    +  PE    +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE--GTYTTSGGKIPIRWTAPEAIAYR 185

Query: 640 QLTEKSDVYSFGVVLFEVL 658
           + T  SDV+SFG+V++EV+
Sbjct: 186 KFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (254), Expect = 7e-24
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 41/216 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           IG G FGKVY    L+ G  +AVK       +P++ + +A+   E+++L   +H +LV  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNLVKY 64

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGS-----ARGLHYLH 576
            G    + ++ +  EY   GTL+  L +G  L         E  I         GL YLH
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD--------EHVIRVYTLQLLEGLAYLH 116

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-------TGPEIDQTHVSTAVKGSFG 629
           +     ++HRD+K ANI LD N + K+ DFG +        T  E  Q+   T       
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA----- 168

Query: 630 YLDPEYFRRQQLTEK---SDVYSFGVVLFEVLCARP 662
           Y+ PE     +       +D++S G V+ E+   + 
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (252), Expect = 8e-24
 Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 5/190 (2%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N+ TKVAVK   P +   +  F  E  ++   +H  LV L     +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM  G+L   L       +   + ++     A G+ Y+     K  IHRD+
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 129

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++AN+L+ E+ M K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 130 RAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 649 SFGVVLFEVL 658
           SFG++L+E++
Sbjct: 189 SFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  101 bits (253), Expect = 8e-24
 Identities = 69/200 (34%), Positives = 113/200 (56%), Gaps = 14/200 (7%)

Query: 468 VIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG VY G L  +DG K+  AVK  N  +  + + +F  E  ++  F H +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 523 IGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +G C   E + ++++  YM++G L+ +   S   + + K  +   +  A+G+ YL +   
Sbjct: 62  LGICLPSEGSPLVVL-PYMKHGDLR-NFIRSETHNPTVKDLIGFGLQVAKGMEYLAS--- 116

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           K  +HRD+ + N +LDE+F  KVADFGL++     E    H  T  K    ++  E  + 
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 639 QQLTEKSDVYSFGVVLFEVL 658
           Q+ T KSDV+SFGV+L+E++
Sbjct: 177 QKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 1e-23
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 25/206 (12%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FG VY+G  L+DG   AVK           Q+ + + + EI +LS+ +H ++V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--YGS---GLPSLSWKQRLEICIGSARGLHYLHT 577
           +G   E++ + +  E +  G+L   L  YGS    +  L  +Q L        GL YLH 
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------GLEYLH- 119

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              +  +HRD+K ANIL+D N + K+ADFG++K   E        + KGS  ++ PE   
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA---KSFKGSPYWMAPEVIA 174

Query: 638 RQQL-TEKSDVYSFGVVLFEVLCARP 662
           +Q      +D++S G  + E+   +P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G           T+VA+K  N  +      EF  E  ++ +F   H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLEICIGSARGLH 573
           L+G        +++ E M  G LK +L           GL   + ++ +++    A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-- 631
           YL    AK  +HRD+ + N ++ E+   K+ DFG+++   E D        KG  G L  
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185

Query: 632 ---DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
               PE  +    T KSDV+SFGVVL+E+  L  +P
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  100 bits (251), Expect = 2e-23
 Identities = 76/230 (33%), Positives = 112/230 (48%), Gaps = 29/230 (12%)

Query: 468 VIGIGGFGKV--YKGE-LNDGTK--VAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           V+G G FGKV  Y  +  NDGT   VAVK   R     QQ  + ++ EI +L    H ++
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENI 68

Query: 520 VSLIGYCDEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLH 573
           V   G C E+      LI EY+  G+L+ +L       L+  Q L    +IC     G+ 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQIC----EGMA 121

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLD 632
           YLH   ++  IHRD+ + N+LLD + + K+ DFGL+K  PE  + + V         +  
Sbjct: 122 YLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 680
            E  +  + +  SDV+SFGV L+E+L  C      P    EM+   +  M
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-23
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 46/218 (21%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEF-QT---EIEMLSQFRHRHLVSLI 523
           IG G +G+VYK      G  VA+K+   R +     F  T   EI++L + RH ++V L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKK--IRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 524 GYC--DEKNEMILIYEYME---NGTLKGHLYGSGLPSL-SW-KQRLEICIGSARGLHYLH 576
                  K  + +++EYM+    G L           +  + KQ LE       GL YLH
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------GLQYLH 117

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKGSFGYLD 632
           +     ++HRD+K +NIL++ + + K+ADFGL    +K         V T       Y  
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT-----LWYRP 169

Query: 633 PE-------YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
           PE       Y        + D++S G +L E+   +P+
Sbjct: 170 PELLLGATRY------GPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 98.8 bits (246), Expect = 7e-23
 Identities = 63/190 (33%), Positives = 97/190 (51%), Gaps = 6/190 (3%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVA+K     S    A F  E  ++ Q +H  LV L      
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVV-T 71

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + +++    A G+ ++     K  IHRD+
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDL 128

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ E    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 129 RAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187

Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 188 SFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSL- 522
           VIG G FGKV   +  D  K+ A+K  N +    +  +     E  +L +  H  LV+L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEIC-IGSARGLHYLHTGYA 580
             + DE+N M L+ + +  G L+ HL  S     S +Q +  IC I  A  L YLH+   
Sbjct: 67  YSFQDEEN-MYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLA--LEYLHS--- 118

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           K +IHRD+K  NILLDE     + DF ++        T   T+  G+ GY+ PE   RQ 
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQG 175

Query: 641 LTEKSDVYSFGVVLFEVLCAR 661
            +   D +S GV  +E L  +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 44/218 (20%)

Query: 468 VIGIGGFGKVYK-GELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            IG G FG V K    +DG  +  K         + +Q L    +E+ +L + +H ++V 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV- 62

Query: 522 LIGYCDE----KNEMILIY-EYMENGTL--------KGHLYGSGLP-SLSWKQRLEICIG 567
              Y D      N+ + I  EY E G L        K   Y   +     W+   ++ + 
Sbjct: 63  --RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFIWRILTQLLLA 117

Query: 568 SARGLHYLHTGYAK--AVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVST 622
               L+  H        V+HRD+K ANI LD N   K+ DFGL+K         +T+V T
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGT 173

Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
                  Y+ PE        EKSD++S G +++E LCA
Sbjct: 174 PY-----YMSPEQLNHMSYDEKSDIWSLGCLIYE-LCA 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 9e-23
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGL--AEFQTEIEMLSQFRHRH 518
           +F+    IG G FG V+K     D    A+K+ +          E   E  +L++    +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLP-SLSWKQRLEICIGSARGLHY 574
           ++       +K ++ ++ EY ENG L   L    G  LP    W+  ++I +G    L +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH+   K ++HRD+KS N+ LD     K+ D G++K     D T+ +  + G+  YL PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPE 171

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLC 659
               +   EKSDV++ GVVL+E  C
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE-CC 195

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 97.8 bits (243), Expect = 1e-22
 Identities = 67/196 (34%), Positives = 104/196 (53%), Gaps = 18/196 (9%)

Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+ G L  D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +K  + ++ E ++ G     L   G P L  K+ +++   +A G+ YL +   K  IHR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHR 118

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA------VKGSFGYLDPEYFRRQQ 640
           D+ + N L+ E  + K++DFG+S+   E D  + ST       VK    +  PE     +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVK----WTAPEALNYGR 172

Query: 641 LTEKSDVYSFGVVLFE 656
            + +SDV+SFG++L+E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 27/226 (11%)

Query: 469 IGIGGFGKVYKGEL------NDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF-RHRHL 519
           +G G FG+V K E       N+ + VAVK  + +  +++ L++  +E+EM+    +H+++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 520 VSLIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGLP-----SLSWKQRLEIC 565
           ++L+G C ++  + ++ EY  +G L          G       P     +L+ K  +   
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              ARG+ +L +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  +
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
               ++ PE    +  T +SDV+SFGV+L+E+        P +P E
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 28/210 (13%)

Query: 468 VIGIGGFGKVYKGEL----NDGTK--VAVK-RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG+VY+G       D  +  VAVK      S+Q  ++F  E  ++S+F H+++V
Sbjct: 13  ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGS----GLPS-LSWKQRLEICIGSARGLHYL 575
            LIG   E+    ++ E M  G LK  L  +      PS L+ K  L      A+G  YL
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 576 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGS----- 627
                   IHRD+ + N LL       +AK+ADFG+++     D    S   KG      
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLP 184

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
             ++ PE F     T K+DV+SFGV+L+E+
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 97.6 bits (243), Expect = 2e-22
 Identities = 67/210 (31%), Positives = 107/210 (50%), Gaps = 25/210 (11%)

Query: 468 VIGIGGFGKVYKGELN--DGT--KVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V +G+L+  DG+  KVAVK  + +  +   + EF +E   +  F H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 522 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGLPSLSWK---QRL-EICIGSARG 571
           LIG C E + +      ++I  +M++G L   L  S L  L  K   Q L +  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSF 628
           + YL     +  IHRD+ + N +L E+    VADFGLSK    G    Q  ++   K   
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++  E    +  T KSDV++FGV ++E+ 
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 469 IGIGGFGKVYK-GELNDGT----KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FGKV    + + G     KV  K+   + ++ +    TE  +LS+  H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                + ++ L+ EY   G L  HL   G  S    +     I  A  L YLH   +  +
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA--LEYLH---SLGI 114

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           I+RD+K  NILLD +   K+ DFGL+K     + +  +T   G+  YL PE    +   +
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKGYGK 172

Query: 644 KSDVYSFGVVLFEVLCARP 662
             D +S GV+L+E+L  +P
Sbjct: 173 AVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 10/195 (5%)

Query: 469 IGIGGFGKVYKGE----LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V +GE          VAVK          + +F  E  ++    H +L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G       ++++ E    G+L   L    L         +  +  A G+ YL +   K  
Sbjct: 63  GVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGSFGYLDPEYFRRQQLT 642
           IHRD+ + NILL  +   K+ DFGL +  P+ +  +V    +K  F +  PE  R +  +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 643 EKSDVYSFGVVLFEV 657
             SDV+ FGV L+E+
Sbjct: 179 HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 98.2 bits (244), Expect = 3e-22
 Identities = 68/227 (29%), Positives = 115/227 (50%), Gaps = 27/227 (11%)

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E         N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               LS+K  +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+L+E+        P +P E
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 97.0 bits (241), Expect = 3e-22
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 128

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 129 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 649 SFGVVLFEVLCARPVIDPTL-PREMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 30/205 (14%)

Query: 468 VIGIGGFGKVYKGELNDGTK--VAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G G  G VYK   +  T    A+K+    G+   ++ L     E++ L      ++V 
Sbjct: 8   VLGQGSSGVVYKV-RHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVK 63

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGL---PSLSWKQRLEICIGSARGLHYLHTG 578
             G   ++ E+ ++ EYM+ G+L   L   G    P L+      I     +GL YLHT 
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT- 117

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEY 635
             + +IHRD+K +N+L++     K+ADFG+SK      +   T V T       Y+ PE 
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPER 171

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCA 660
            + +  +  +D++S G+ L E  CA
Sbjct: 172 IQGESYSYAADIWSLGLTLLE--CA 194

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 96.5 bits (240), Expect = 4e-22
 Identities = 62/191 (32%), Positives = 96/191 (50%), Gaps = 10/191 (5%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FG V  G+      VA+K  +    S+    EF  E +++ +  H  LV L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            ++  + ++ EYM NG L  +L           Q LE+C     G+ YL +   K  IHR
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+ + N L+D+    KV+DFGLS+   + D+   S   K    +  PE     + + KSD
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 647 VYSFGVVLFEV 657
           V++FGV+++EV
Sbjct: 184 VWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.4 bits (240), Expect = 6e-22
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 30/216 (13%)

Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           IG G FG+V++            T VAVK      S    A+FQ E  ++++F H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL--------------------YGSGLPSLSWKQR 561
           L+G C     M L++EYM  G L   L                     G     LS  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 621
           L I    A G+ YL     +  +HRD+ + N L+ EN + K+ADFGLS+     D    S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
                   ++ PE     + T +SDV+++GVVL+E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 48/297 (16%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           IG G +G VYK  +   G  VA+K+   R +          EI++L +  H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
              K ++ L++E+M+   L   +       L             +GL + H   +  ++H
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCH---SHGILH 121

Query: 586 RDVKSANILLDENFMAKVADFGLSKT--GPEIDQTH-VSTAVKGSFGYLDPE-YFRRQQL 641
           RD+K  N+L++   + K+ADFGL+++   P    TH V T       Y  PE     +  
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176

Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI--IDPTLAGK 699
           +   D++S G +  E+L  RP+                  +  K ++DQ+  I  TL G 
Sbjct: 177 STPVDIWSVGCIFAELLSRRPL------------------FPGKSEIDQLFKIFRTL-GT 217

Query: 700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL------EYALQLQEAVVHGDPDE 750
             P+   KF   A     ++    P    +            AL L   ++H DP +
Sbjct: 218 PDPEVWPKFTSLAR----NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.4 bits (240), Expect = 7e-22
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 34/208 (16%)

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           +G G FG V   EL        N G  VAVK+    + + L +F+ EIE+L   +H ++V
Sbjct: 12  LGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 521 SLIGYCDE--KNEMILIYEYMENGTLKGHL-------YGSGLPSLSWKQRLEICIGSARG 571
              G C    +  + L+ EY+  G+L+ +L           L   +     +IC    +G
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS----QIC----KG 120

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS--FG 629
           + YL    +K  +HRD+ + NIL++     K+ DFGL+K  P+  + +       S  F 
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           Y  PE     + +  SDV+SFGVVL+E+
Sbjct: 178 YA-PESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 12/200 (6%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G FGKVYK +    G   A K     S++ L +F  EI++LS+ +H ++V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +N++ ++ E+ + G L   +       L+  Q   +C      L++LH   +  VIHRD
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-----FRRQQLT 642
           +K+ NILL  +   K+ADFG+S       Q    T + G+  ++ PE      F+     
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYD 186

Query: 643 EKSDVYSFGVVLFEVLCARP 662
            K+D++S G+ L E+    P
Sbjct: 187 YKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 95.8 bits (238), Expect = 1e-21
 Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)

Query: 468 VIGIGGFGKVYKGEL-NDGTKV--AVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +  DG ++  A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L  S +               +LS +Q L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+ G E+        VK + 
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 182

Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 25/209 (11%)

Query: 468 VIGIGGFGKVYKG---ELNDGTK--VAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G G FG VYKG      +  K  VA+K      S +   E   E  +++   H H+V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL------YGSGLPSLSWKQRLEICIGSARGLHYL 575
           L+G C    ++ LI + M  G L  ++       GS    L+W      C+  A+G+ YL
Sbjct: 74  LLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQY-LLNW------CVQIAKGMSYL 125

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                K ++HRD+ + N+L+      K+ DFGL+K     ++ + +   K    ++  E 
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLC--ARP 662
              +  T KSDV+S+GV ++E++   A+P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 60/196 (30%), Positives = 90/196 (45%), Gaps = 12/196 (6%)

Query: 469 IGIGGFGKVYKGEL----NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V KG          +VAVK         G  EF  E  +++Q  H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G C  +  ++L+ E    G L    Y      +      E+    A G+ YL +   K  
Sbjct: 63  GVCKGE-PLMLVMELAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 584 IHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           +HRD+ + N+LL     AK++DFG+S+  G   D    +TA +    +  PE     + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 643 EKSDVYSFGVVLFEVL 658
            KSDV+S+GV L+E  
Sbjct: 177 SKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 469 IGIGGFGKVY---KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSL 522
           I  G +G+V+   K    D    A+K           +     TE ++LSQ +  ++V L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 523 I-GYCDEKNEMILIYEYMENGTLKG--HLYGSGLPSLSWKQRL-EICIGSARGLHYLHTG 578
              +  +KN + L+ EY+  G L       GS L     +  + EI +     L YLH  
Sbjct: 59  YYSFQGKKN-LYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLA----LEYLH-- 110

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK------GSFGYLD 632
            +  +IHRD+K  NIL+D N   K+ DFGLSK G    Q +++   K      G+  Y+ 
Sbjct: 111 -SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE    Q  ++  D +S G +L+E L   P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAE-FQTEIEMLSQFRHRHLV 520
            +G G F   Y+  ++  GT +AVK     R     Q+ + E  + EI ++++  H H++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
            ++G   E +   L  E+M  G++   L  YG+   ++      ++     RGL YLH  
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE- 121

Query: 579 YAKAVIHRDVKSANILLDEN-FMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDP 633
               +IHRDVK AN+L+D      ++ADFG    L+  G    +      + G+  ++ P
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAFMAP 177

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           E  R +Q     DV+S G V+ E+  A+P
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 9/201 (4%)

Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           FD    +G G +G VYK      G  VA+K      ++ L E   EI +L Q    ++V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVK 62

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
             G   +  ++ ++ EY   G++   +      +L+ ++   I   + +GL YLH   + 
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVS-DIMKITNKTLTEEEIAAILYQTLKGLEYLH---SN 118

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
             IHRD+K+ NILL+E   AK+ADFG+S  G   D       V G+  ++ PE  +    
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 642 TEKSDVYSFGVVLFEVLCARP 662
             K+D++S G+   E+   +P
Sbjct: 177 NNKADIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 9e-21
 Identities = 75/289 (25%), Positives = 129/289 (44%), Gaps = 59/289 (20%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR---------GNPRSQQGLAEFQTEIEMLSQFRHR 517
           +IG G FG VY G   + G  +AVK+            R +  L     EI +L + +H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSW---KQRLEICIGSARGL 572
           ++V  +G   + + + +  EY+  G++   L  YG+   +L     +Q L       +GL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-------KGL 119

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-------VK 625
           +YLH    + +IHRD+K ANIL+D     K++DFG+SK   +++   +ST        ++
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQ 173

Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 685
           GS  ++ PE  ++   T K+D++S G ++ E+L          P            + + 
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG------KHP------------FPDC 215

Query: 686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLAD-FGVD---RPSMGDVL 730
            QL  I    +     P+        A   L   F +D   RP+  ++L
Sbjct: 216 TQLQAIF--KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-R 515
           ++F    +IG G F  V    E     + A+K  + R    ++ +   + E E+L++   
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 516 HRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           H  ++ L   + DE+N +  + EY  NG L  ++   G  SL  K            L Y
Sbjct: 61  HPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEY 117

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID--------------QTHV 620
           LH   +K +IHRD+K  NILLD++   K+ DFG +K                    Q   
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 621 STAVKGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           +     SF G   Y+ PE    +   + SD+++ G +++++L  +P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 92.8 bits (230), Expect = 1e-20
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 30/213 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK----------RGNPRSQQGLAEFQTEIEMLSQFRH 516
           +IG G +G+VY    +  G  +AVK          R + R +  +   ++EIE L    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 517 RHLVSLIGYCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLS---WKQRLEICIGSAR 570
            ++V  +G  +   E + I+ EY+  G++   L  YG     L     +Q LE       
Sbjct: 68  LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------- 119

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           GL YLH+   K ++HRD+K+ N+L+D + + K++DFG+SK   +I     + +++GS  +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 631 LDPE--YFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           + PE  +   Q  + K D++S G V+ E+   R
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 93.5 bits (232), Expect = 1e-20
 Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 27/227 (11%)

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E         N    VAVK   +  + + L++  +E+EM+    +H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + ++ EY   G L+ +L     P               L++K  +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+L+E+        P +P E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 66/210 (31%), Positives = 106/210 (50%), Gaps = 7/210 (3%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK   P +    + F  E +++ + RH  LV L     E
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L      +L     +++    A G+ Y+        IHRD+
Sbjct: 73  E-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 128

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           +SANIL+ +  + K+ADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 129 RSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 649 SFGVVLFEVLCARPVIDPTL-PREMVNLAE 677
           SFG++L E++    V  P +  RE++   E
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 62/194 (31%), Positives = 101/194 (52%), Gaps = 16/194 (8%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FG V+ G+     KVA+K  N   +  ++E  F  E +++ +  H  LV L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 527 DEKNEMILIYEYMENGTLKGHL---YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
            ++  + ++ E+MENG L  +L    G     LS    L +C     G+ YL      + 
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLER---NSF 121

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           IHRD+ + N L+    + KV+DFG+++   + D+   S+  K    +  PE F   + + 
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 644 KSDVYSFGVVLFEV 657
           KSDV+SFGV+++EV
Sbjct: 181 KSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 20/202 (9%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           VIG G FG+V  G L    K    VA+K    G    Q+   +F +E  ++ QF H +++
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNII 68

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-TGY 579
            L G   +   ++++ EYMENG+L   L        +  Q + +  G A G+ YL   GY
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGY 127

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYF 636
               +HRD+ + NIL++ N + KV+DFGLS+     PE   T  +   K    +  PE  
Sbjct: 128 ----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--TRGGKIPIRWTAPEAI 181

Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+S+G+V++EV+
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++    IG G +G VYK  ++  G  VA+K             Q EI ML + RH ++V+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
             G    ++++ ++ EY   G+L+  +Y      LS  Q   +C  + +GL YLH     
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G---YLDPEYF- 636
             IHRD+K ANILL E+   K+ADFG+S    ++  T    A + SF G   ++ PE   
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT---IAKRKSFIGTPYWMAPEVAA 174

Query: 637 --RRQQLTEKSDVYSFGVVLFE 656
             R+     K D+++ G+   E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 32/211 (15%)

Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLY----------GSGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSL  K+ +++    A G
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAGEIADG 131

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG-- 629
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D        KG  G  
Sbjct: 132 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKGLL 183

Query: 630 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
              ++ PE  +    T  SDV+SFGVVL+E+
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 91.6 bits (227), Expect = 3e-20
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 35/215 (16%)

Query: 468 VIGIGGFGKVYKGELN-DGTKV--AVKRGNP-RSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V +  +  DG K+  A+K      S+    +F  E+E+L +   H ++++L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + +  EY   G L   L  S +               +L+ +Q L+     
Sbjct: 69  LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A G+ YL     K  IHRD+ + N+L+ EN  +K+ADFGLS+ G E+        VK + 
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR-GEEV-------YVKKTM 177

Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T KSDV+SFGV+L+E++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 61/190 (32%), Positives = 99/190 (52%), Gaps = 6/190 (3%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ E+M  G+L   L       L   Q +++    A G+ Y+        IHRD+
Sbjct: 73  E-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDL 128

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +N + K+ADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 129 RAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187

Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 188 SFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 57/187 (30%), Positives = 87/187 (46%), Gaps = 15/187 (8%)

Query: 488 VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 546
           VAVK   P  S     +F  E+++LS+    ++  L+G C     + +I EYMENG L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 547 HLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 597
            L               SLS+   L +    A G+ YL +      +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK 165

Query: 598 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           N+  K+ADFG+S+     D   V         ++  E     + T KSDV++FGV L+E+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 658 --LCARP 662
             LC   
Sbjct: 226 LTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 67/209 (32%), Positives = 109/209 (52%), Gaps = 16/209 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G FG+V +G L    K    VA+K  +     +Q   +F +E  ++ QF H +++ 
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L G   +   +++I E+MENG L   L  +     +  Q + +  G A G+ YL      
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---M 125

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE--IDQTHVST-AVKGSFGYLDPEYFRR 638
             +HRD+ + NIL++ N + KV+DFGLS+   +   D T+ S+   K    +  PE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 639 QQLTEKSDVYSFGVVLFEVLC--ARPVID 665
           ++ T  SDV+S+G+V++EV+    RP  D
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 46/276 (16%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVS---- 521
           +G G +G VYK + L+D    A+K  +    SQ+   +   EI +L+   H +++S    
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 522 -LIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPS-LSWKQRLEICIGSARGLHY 574
            L G     N++ ++ EY   G L     K       +P    W+  +++     RGL  
Sbjct: 68  FLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQA 118

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH    + ++HRD+KSANILL  N + K+ D G+SK    + +    T + G+  Y+ PE
Sbjct: 119 LH---EQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GTPHYMAPE 171

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 694
            ++ +  + KSD++S G +L+E+    P      P E  ++ +   K Q +G+   I   
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAP------PFEARSMQDLRYKVQ-RGKYPPI--- 221

Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                I    L+ F       L      RP+   +L
Sbjct: 222 ---PPIYSQDLQNF---IRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 89.9 bits (223), Expect = 6e-20
 Identities = 59/191 (30%), Positives = 96/191 (50%), Gaps = 8/191 (4%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGSFGYLDPEYFRRQQLTEKSD 646
           + + N L+ EN + KVADFGLS+       T+ + A  K    +  PE     + + KSD
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 647 VYSFGVVLFEV 657
           V++FGV+L+E+
Sbjct: 188 VWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA------EFQTEIEMLSQFRHRHLVS 521
           V+G G +G VY G  N G  +AVK+    +   LA      + Q E+++L   +H ++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSW----KQRLEICIGSARGLHYLH 576
            +G C + N + +  E++  G++   L   G LP   +    KQ L+       G+ YLH
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-------GVAYLH 119

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGSFGYLD 632
                 V+HRD+K  N++L  N + K+ DFG ++     G     +++  ++ G+  ++ 
Sbjct: 120 N---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE         KSD++S G  +FE+   +P
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D        KG  G    
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGLLPV 185

Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
            ++ PE  +    T  SD++SFGVVL+E+
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 90.4 bits (224), Expect = 1e-19
 Identities = 61/227 (26%), Positives = 114/227 (50%), Gaps = 27/227 (11%)

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + E         +    VAVK   +  + + LA+  +E+E++    +H++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 564
           +++L+G C ++  + +I EY   G L+  L     P               LS+K  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ E+ + K+ADFGL++   +ID    ++  
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFG++++E+        P +P E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 21/201 (10%)

Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSL 522
            IG G FG VY+G      N+   VAVK     +   + E F  E  ++ QF H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSW-KQRLEICIGSARGLHYLHTGY 579
           IG   E N + ++ E    G L+ +L      L   S      ++       L YL +  
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS----TALAYLES-- 125

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFR 637
            K  +HRD+ + N+L+      K+ DFGLS+    ++      A KG     ++ PE   
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESIN 181

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            ++ T  SDV+ FGV ++E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGFG+V   ++    K+ A K+ + +    ++G      E ++L +   R +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHTGYA 580
             + K+++ L+   M  G LK H+Y  G P     + +    +I  G    L +LH    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           + +++RD+K  N+LLD++   +++D GL+       +        G+ GY+ PE  + + 
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170

Query: 641 LTEKSDVYSFGVVLFEVLCAR 661
                D ++ G  L+E++  R
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 18/206 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG+VY   +++ G ++A K+      +P + + ++  + EI++L   +H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 522 LIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 577
             G   ++ E  + +  EYM  G++K  L  YG+   S++ K   +I      G+ YLH 
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLH- 123

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLDPEYF 636
             +  ++HRD+K ANIL D     K+ DFG SK    I  +     +V G+  ++ PE  
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +    K+DV+S G  + E+L  +P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 12/212 (5%)

Query: 468 VIGIGGFGK--VYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           V+G G FG+  +Y+    D + V  K  N    S++   +   EI +LS  +H ++++  
Sbjct: 7   VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
            +  + N +++  EY   GTL   +          +  L         + Y+H      +
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGI 122

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           +HRD+K+ NI L +  + K+ DFG+SK  G E   +   T V G+  Y+ PE  +  +  
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SMAETVV-GTPYYMSPELCQGVKYN 179

Query: 643 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 674
            KSD+++ G VL+E+L  +   D T P  +V 
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 92.2 bits (229), Expect = 4e-19
 Identities = 84/299 (28%), Positives = 136/299 (45%), Gaps = 26/299 (8%)

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 512
           + + +  ++  E  VI  G  G  YKG+ + +G +  VK  N      +    +EI  + 
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN--DVNSIPS--SEIADMG 738

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           + +H ++V LIG C  +    LI+EY+E   L   L       LSW++R +I IG A+ L
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKAL 793

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYL 631
            +LH   + AV+  ++    I++D      +    LS  G    D     ++      Y+
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISS-----AYV 845

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN--LAEWAMKWQNKGQLD 689
            PE    + +TEKSD+Y FG++L E+L  +    P      V+  + EWA    +   LD
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEWARYCYSDCHLD 902

Query: 690 QIIDPTLAGK--IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
             IDP++ G   +  + + +    A  C A     RP   DVL  LE A +   + V G
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCVTG 961

Length = 968

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG+VYK         VA+K  +   ++  + + Q EI+ LSQ R  ++    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLP--SLSWKQRLEICIGSARGLHYLHTGYAKAV 583
             + +++ +I EY   G+    L    L    +++  R E+      GL YLH    +  
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-EVL----LGLEYLH---EEGK 119

Query: 584 IHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
           IHRD+K+ANILL E    K+ADFG    L+ T      +  +T V   F ++ PE  ++ 
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTST-----MSKRNTFVGTPF-WMAPEVIKQS 173

Query: 640 QLTEKSDVYSFGVVLFEVLCARP 662
              EK+D++S G+   E+    P
Sbjct: 174 GYDEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 87.9 bits (219), Expect = 5e-19
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 38/161 (23%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT--EIEMLSQFRHR 517
           +G G +G VYK  +   G  VA+K+        G P +           EI +L + +H 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST--------ALREISLLKELKHP 58

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP-----SLSWKQRLEICIGSAR 570
           ++V L+     + ++ L++EY +   LK +L      L      S+ + Q L       R
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMY-QLL-------R 109

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
           GL Y H   +  ++HRD+K  NIL++ + + K+ADFGL++ 
Sbjct: 110 GLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G   FGK+YKG L     +    VA+K   +  + Q   EFQ E  ++++  H ++V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLY---------------GSGLPSLSWKQRLEICIG 567
           +G   ++  + +++EY+  G L   L                G+   SL     L I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A G+ YL + +    +H+D+ + NIL+ E    K++D GLS+     D   V       
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++SFGVVL+E+ 
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 66/200 (33%), Positives = 106/200 (53%), Gaps = 15/200 (7%)

Query: 469 IGIGGFGKV----YKGE-LNDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV    Y  E  N G +VAVK   P S    +A+ + EIE+L    H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 523 IGYCDEK--NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C E   N + LI E++ +G+LK +L       ++ KQ+L+  +   +G+ YL +   
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGS--- 127

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPEYFRR 638
           +  +HRD+ + N+L++     K+ DFGL+K   E D+ +  V   +     +  PE   +
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKA-IETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 639 QQLTEKSDVYSFGVVLFEVL 658
            +    SDV+SFGV L+E+L
Sbjct: 187 SKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 6/190 (3%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+    N  TKVAVK   P S   +  F  E  ++   +H  LV L      
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV-T 71

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K  + +I E+M  G+L   L           + ++     A G+ ++     +  IHRD+
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 128

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+  + + K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 129 RAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 188 SFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)

Query: 468 VIGIGGFGKVYKGELN-DGTKV--AVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +  DG ++  A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L  S +               +LS +Q L      
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+ G E+        VK + 
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 170

Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 30/282 (10%)

Query: 461 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFR 515
               E   +G G  G V K  L N G   A+K      NP  Q+ +     E+E+    +
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57

Query: 516 HRHLVSLIG-YCDEKNEMILI-YEYMENGTLKGHLYGSGLPS---LSWKQRLEICIGSAR 570
             ++V   G + DE +  I I  EY E G+L   +Y         +  K   +I     +
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           GL YLH+   + +IHRD+K +NILL      K+ DFG+S    E+  +   T    SF Y
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSF-Y 169

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVI-DPTLPREMVNLAEWAMKWQNKGQL 688
           + PE  + +  +  SDV+S G+ L EV   R P   +   P   + L  + +   N    
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP--- 226

Query: 689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
            ++ D    G    +  + F    ++CL      RP+  D+L
Sbjct: 227 -ELKDEPGNGIKWSEEFKDF---IKQCLEKDPTRRPTPWDML 264

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 469 IGIGGFGKVYKGELNDGT---KVAVKRGN----PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +G+LN      KVAVK        RS+  + +F +E   + +F H +++ 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMR 64

Query: 522 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGL---PSLSWKQRL-EICIGSARG 571
           LIG C +  E       ++I  +M++G L   L  S L   P     Q L +     A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL +   K+ IHRD+ + N +L+EN    VADFGLSK     D        K    ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
             E    +  T KSDV+SFGV ++E+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG+VY   + + G ++AVK+      +P + + +   + EI++L    H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 522 LIGYCDEKNEMIL--IYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 577
             G   +  E  L    E+M  G++K  L  YG+   +++ K   +I      G+ YLH+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFGYLDPEYF 636
                ++HRD+K ANIL D     K+ DFG SK    I  +     +V G+  ++ PE  
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +    K+D++S G  + E+L  +P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 22/206 (10%)

Query: 463 FDESWVIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           F +  V+G GGFG+V        G++    K+  KR   R  + +A    E ++L +   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 572
           R +VSL    + K+ + L+   M  G LK H+Y  G       + +    EIC G    L
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----L 115

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
             LH    + +++RD+K  NILLD++   +++D GL+   PE  QT +   V G+ GY+ 
Sbjct: 116 EDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTVGYMA 169

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE  + ++ T   D ++ G +L+E++
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)

Query: 460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 512
             NF     IG G F  VYK   L DG  VA+K+       + +++Q   +   EI++L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK---GHLYGSG--LPSLS-WKQRLEICI 566
           Q  H +++  +    E NE+ ++ E  + G L     H       +P  + WK  +++C 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
                L ++H+   K ++HRD+K AN+ +    + K+ D GL +      +T  + ++ G
Sbjct: 117 ---SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVG 168

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           +  Y+ PE         KSD++S G +L+E+   +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE---FQTEIEMLSQFRHRH 518
            +++  V+G G FG V+        K+ + +  P  Q    E    Q E ++L    H  
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP- 59

Query: 519 LVSLIGYCD---EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
             ++I Y +   E   ++++ EY   GTL  ++       L     L   +     LH++
Sbjct: 60  --NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 576 HTGYAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           HT   K ++HRD+K+ NILLD++ M  K+ DFG+SK    +     +  V G+  Y+ PE
Sbjct: 118 HT---KLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPE 171

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL 658
               +   +KSD+++ G VL+E+ 
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 22/206 (10%)

Query: 463 FDESWVIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           F +  V+G GGFG+V        G++    ++  KR   R  + +A    E ++L +   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 572
           + +V+L    + K+ + L+   M  G LK H+Y  G P    ++ L    EI  G    L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----L 115

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
             LH    +  ++RD+K  NILLD+    +++D GL+   PE +         G+ GY+ 
Sbjct: 116 EDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMA 169

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE    Q+ T   D +  G +++E++
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR--GNPRSQQGLAE---FQTEIEMLSQFR 515
           N+    ++G G FG+VY   + + G ++AVK+   +P SQ+   E    + EI++L   R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSAR 570
           H  +V   G C    E+ ++ +  EYM  G++K  L  YG+   +++ +   +I     +
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFG 629
           G+ YLH   +  ++HRD+K ANIL D     K+ DFG SK    I  +     +V G+  
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           ++ PE    +    K+DV+S    + E+L  +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           VIG+G    VY    L +  KVA+KR +  + Q  + E + E++ +SQ  H ++V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 526 CDEKNEMILIYEYMENGTL----KGHLYGSGLPSLSWKQRLEICI-----GSARGLHYLH 576
               +E+ L+  Y+  G+L    K      GL         E  I        +GL YLH
Sbjct: 68  FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--------EAIIATVLKEVLKGLEYLH 119

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLDPE 634
           +      IHRD+K+ NILL E+   K+ADFG+S +          V     G+  ++ PE
Sbjct: 120 S---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 635 YFRRQQ-LTEKSDVYSFGVVLFE 656
              +      K+D++SFG+   E
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIE 199

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE---FQTEIEMLSQFRHRH 518
            ++    IG G FGK+Y  +    ++  V +    ++  + E    + E+ +L++ +H +
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V+      E   + ++ EY + G L   +        S  Q L   +  + GL ++H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD- 119

Query: 579 YAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + ++HRD+KS NI L +N M AK+ DFG+++     D   ++    G+  YL PE  +
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQ 175

Query: 638 RQQLTEKSDVYSFGVVLFEVLCA 660
            +    K+D++S G VL+E LC 
Sbjct: 176 NRPYNNKTDIWSLGCVLYE-LCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 42/225 (18%)

Query: 468 VIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLV 520
            +G G FGKV K            T VAVK     +    L +  +E  +L Q  H H++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGS----------------------GLPSLSW 558
            L G C +   ++LI EY + G+L+  L  S                         +L+ 
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 559 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 618
              +      +RG+ YL       ++HRD+ + N+L+ E    K++DFGLS+   E D  
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED-- 181

Query: 619 HVSTAVKGSFG-----YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              + VK S G     ++  E       T +SDV+SFGV+L+E++
Sbjct: 182 ---SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 82.3 bits (203), Expect = 5e-17
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 21/189 (11%)

Query: 488 VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 546
           VAVK   P  ++    +F  E+++LS+ +  +++ L+G C +++ + +I EYMENG L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 547 HLY--------GSG---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
            L          +G         LP++S+   L + +  A G+ YL +      +HRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA 165

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
           + N L+ EN   K+ADFG+S+     D   +         ++  E     + T  SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 650 FGVVLFEVL 658
           FGV L+E+L
Sbjct: 226 FGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 468 VIGIGGFGKV----YKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V     K E     KVAVK  + +  S   + EF  E   + +F H +++ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 522 LIGYCDEKNEM------ILIYEYMENGTLKGHLYGSGLP----SLSWKQRLEICIGSARG 571
           LIG              ++I  +M++G L   L  S +     +L  +  +   I  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL +   K  IHRD+ + N +L+EN    VADFGLSK     D      A K    +L
Sbjct: 126 MEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             E       T  SDV++FGV ++E++
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG++ +G L   +K    VA+   R     +Q    F  E   L QF H ++V 
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYA 580
           L G     N M+++ EYM NG L   L       L   Q + +  G A G+ YL   GY 
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGY- 128

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL--DPEYFRR 638
              +H+ + +  +L++ + + K++ F       E     + T + G    L   PE  + 
Sbjct: 129 ---VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 639 QQLTEKSDVYSFGVVLFEVLC--ARPVID 665
              +  SDV+SFG+V++EV+    RP  D
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 52/185 (28%), Positives = 93/185 (50%), Gaps = 16/185 (8%)

Query: 488 VAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG 546
           VAVK      ++    +F  EI+++S+ ++ +++ L+G C   + + +I EYMENG L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106

Query: 547 HL----------YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
            L          + + +PS+S    L + +  A G+ YL +      +HRD+ + N L+ 
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVG 163

Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
            ++  K+ADFG+S+     D   +         ++  E     + T  SDV++FGV L+E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223

Query: 657 V--LC 659
           +  LC
Sbjct: 224 MFTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 468 VIGIGGFGKVYKG---ELNDGTK--VAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V+KG      D  K  VA+K    RS +Q   E    +  +    H ++V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C     + L+ +    G+L  H+      SL  ++ L  C+  A+G++YL      
Sbjct: 74  LLGIC-PGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEE---H 128

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            ++HR++ + NILL  + + ++ADFG++      D+ +  +  K    ++  E     + 
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 642 TEKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 189 THQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.1 bits (208), Expect = 1e-16
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 19/193 (9%)

Query: 485 GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI--GYCDEKNEMILIYEYM 539
           G +VA+K      P  +   A F+ E  + ++  H ++V+L+  G       +  ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---D 596
              TL+  L   G        RL       + L  L   + + ++HRD+K  NI++    
Sbjct: 62  PGRTLREVLAADGALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 597 ENFMAKVADFGLSKTGP---EIDQTHVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 651
               AKV DFG+    P   + D   ++  T V G+  Y  PE  R + +T  SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 652 VVLFEVLCARPVI 664
           ++  E L  + V+
Sbjct: 177 LIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 53/167 (31%), Positives = 85/167 (50%), Gaps = 29/167 (17%)

Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQ---FRH 516
           ++E   IG G +G VYK  +LN G  VA+K+   P S++G+      EI +L Q   F H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 517 RHLVSLIGYC-----DEKNEMILIYEYMEN--GTLKGHLYGSGLPS-----LSWKQRLEI 564
            ++V L+  C     D + ++ L++E+++    T        GLP      L   Q L  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL-- 117

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
                RG+ +LH+     ++HRD+K  NIL+  +   K+ADFGL++ 
Sbjct: 118 -----RGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 16/209 (7%)

Query: 464 DESWVI----GIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           +E W I    G G FGKVYK +  + G   A K    +S++ L ++  EIE+L+   H +
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V L+G      ++ ++ E+   G +   +       L+  Q   IC      L YLH+ 
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS- 128

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
               +IHRD+K+ N+LL  +   K+ADFG+S    +  Q   S    G+  ++ PE    
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI--GTPYWMAPEVVMC 184

Query: 639 QQLTE-----KSDVYSFGVVLFEVLCARP 662
           + + +     K+D++S G+ L E+    P
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 65/267 (24%), Positives = 119/267 (44%), Gaps = 34/267 (12%)

Query: 477 VYKGELNDGTKVAV---KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY----CDEK 529
           +YKG  N+  +V +   K+ +   +  +   + EI+ L +    +++ + G+     D+ 
Sbjct: 36  IYKGIFNN-KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
             + LI EY   G L+  L       LS+K +L++ I   +GL+ L+    K   ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDV 647
           S + L+ EN+  K+   GL K        +V+  V     Y   +       + T K D+
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDI 205

Query: 648 YSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRK 707
           YS GVVL+E+   +      +P E  NL         K   D II+   + K+  D   +
Sbjct: 206 YSLGVVLWEIFTGK------IPFE--NLT-------TKEIYDLIINKNNSLKLPLDCPLE 250

Query: 708 FGETAEKCLADFGVDRPSMGDVLWNLE 734
                E C +   + RP++ ++L+NL 
Sbjct: 251 IKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 34/214 (15%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI- 523
            IG G +G V        G KVA+K+ +P   Q   + +T  EI++L +F+H +++ ++ 
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGILD 70

Query: 524 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EIC-----IGSARG 571
                  +  N++ ++ E ME          + L  L   Q L    I      I   RG
Sbjct: 71  IIRPPSFESFNDVYIVQELME----------TDLYKLIKTQHLSNDHIQYFLYQI--LRG 118

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGY 630
           L Y+H   +  V+HRD+K +N+LL+ N   K+ DFGL++   PE D T   T    +  Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 663
             PE     +   K+ D++S G +L E+L  RP+
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 68/228 (29%), Positives = 107/228 (46%), Gaps = 41/228 (17%)

Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EI 508
           F  V E TN + +   +G+G FG V    +   G  VA+K+   P S   LA+ +T  E+
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK-RTYREL 60

Query: 509 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----- 563
           ++L   RH +++SL    D     I I   +E+      L G+ L  L   + LE     
Sbjct: 61  KLLKHLRHENIISL---SD-----IFISP-LEDIYFVTELLGTDLHRLLTSRPLEKQFIQ 111

Query: 564 -ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
                  RGL Y+H+     V+HRD+K +NIL++EN   K+ DFGL++      Q    T
Sbjct: 112 YFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMT 163

Query: 623 AVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARPV 663
                 GY+   Y+R        Q+   + D++S G +  E+L  +P+
Sbjct: 164 ------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 78.6 bits (193), Expect = 5e-16
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G +G VYK   +N G   A+K       +  A  Q EI M+   +H ++V+  G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            ++++ +  E+   G+L+   + +G   LS  Q   +   + +GL+YLH+   K  +HRD
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRD 131

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF----GYLDPEYF---RRQQ 640
           +K ANILL +N   K+ADFG+S       Q   + A + SF     ++ PE     R+  
Sbjct: 132 IKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 641 LTEKSDVYSFGVVLFEVLCARP 662
             +  D+++ G+   E+   +P
Sbjct: 186 YNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 12/200 (6%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSL 522
           V+G G FGKV   EL    ++     +K+        +    TE  +L+   +H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
                 K+ +  + EY+  G L  H+  SG       +     I    GL +LH    + 
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE---RG 116

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           +I+RD+K  N+LLD     K+ADFG+ K G     T  ++   G+  Y+ PE    Q   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174

Query: 643 EKSDVYSFGVVLFEVLCARP 662
              D ++ GV+L+E+L  + 
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 30/170 (17%)

Query: 458 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-R 515
           + T  F+   VIG G +GKVYK      G  VA+K  +    +   E + E  +L ++  
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61

Query: 516 HRHLVSLIGYCDEKN------EMILIYEYMENGT----LKGHLYGSGLPSLSWKQRLE-- 563
           H ++ +  G   +KN      ++ L+ E    G+    +KG             +RL+  
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--------LRKKGKRLKEE 113

Query: 564 ----ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 609
               I   + RGL YLH      VIHRD+K  NILL +N   K+ DFG+S
Sbjct: 114 WIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 66/216 (30%), Positives = 97/216 (44%), Gaps = 17/216 (7%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           +G GG+G+V+  +  D G  VA+KR        L E +   TE ++L+  +   LV L+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
              +   + L  EY+  G  +  L   G L     +  +     +   LH L  GY    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL--GY---- 122

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           IHRD+K  N L+D +   K+ DFGLSK          + +V GS  Y+ PE  R +    
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKGYDF 177

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNLAEW 678
             D +S G +L+E LC  P    + P E   NL  W
Sbjct: 178 TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 63/230 (27%), Positives = 105/230 (45%), Gaps = 34/230 (14%)

Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC- 565
           E++++ + R  ++VS  G    +N + +  E+M+ G+L   +Y  G P       +EI  
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPI-----PVEILG 106

Query: 566 ---IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVS 621
              +    GL YL+      ++HRD+K +NIL++     K+ DFG+S +    I  T V 
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164

Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK 681
           T+      Y+ PE  +  + T KSDV+S G+ + E+   +       P    N+ +    
Sbjct: 165 TST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGK------FPFAFSNIDDDGQD 213

Query: 682 WQNKGQLD---QIID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPS 725
               G LD   QI+    P L     P+ LR F    + CL     +RP+
Sbjct: 214 DP-MGILDLLQQIVQEPPPRLPSSDFPEDLRDF---VDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 66/239 (27%), Positives = 112/239 (46%), Gaps = 28/239 (11%)

Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G++Y +   T    +  + FP        NN      +G G FGKV +       + +  
Sbjct: 13  GNEYVYIDPTQLPYDLKWEFP-------RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAV 65

Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK   P +     E   +E++++S    H ++V+L+G C     +++I EY   G 
Sbjct: 66  MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 603
           L   L       L+ +  L      A+G+ +L +   K  IHRD+ + N+LL    + K+
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKI 182

Query: 604 ADFGLSKTGPEIDQTHVST-AVKGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
            DFGL++     D  + S   VKG+      ++ PE       T +SDV+S+G++L+E+
Sbjct: 183 CDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 18/212 (8%)

Query: 462 NFDESWVI----GIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           N +E W I    G G FGKVYK + N  T V  A K  + +S++ L ++  EI++L+   
Sbjct: 2   NPEEFWEIIGELGDGAFGKVYKAQ-NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD 60

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N + ++ E+   G +   +     P L+  Q   +C  +   L+YL
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRVVCKQTLEALNYL 119

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H      +IHRD+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE 
Sbjct: 120 HE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEV 174

Query: 636 F-----RRQQLTEKSDVYSFGVVLFEVLCARP 662
                 + +    K+DV+S G+ L E+    P
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 69/265 (26%), Positives = 121/265 (45%), Gaps = 28/265 (10%)

Query: 469 IGIGGFGKVYKGELNDGTK--VAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G FG+V+KG +++ T+  VA+K  +   ++  + + Q EI +LSQ    ++    G 
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             +  ++ +I EY+  G+    L             L+  +   +GL YLH+   +  IH
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIH 124

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+K+AN+LL E    K+ADFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182

Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           D++S G+   E+    P      P  ++ L            + +   PTL G    +  
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFL------------IPKNNPPTLTG----EFS 226

Query: 706 RKFGETAEKCLADFGVDRPSMGDVL 730
           + F E  + CL      RP+  ++L
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 468 VIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           V+G GG+GKV++     G         KV  K    R+Q+  A  + E  +L   +H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHT 577
           V LI       ++ LI EY+  G L  HL   G  +   +     EI +     L +LH 
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----LEHLHQ 118

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              + +I+RD+K  NILLD     K+ DFGL K    I +  V+    G+  Y+ PE   
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE--SIHEGTVTHTFCGTIEYMAPEILM 173

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           R    +  D +S G +++++L   P
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 34/218 (15%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
           N ++   V+G G +G V K      G  VA+K  + +   +        E+++L Q RH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLP-----SLSWKQRLEICIGSARG 571
           ++V+L      K  + L++EY+E   L+       GLP     S  W Q L       + 
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIW-QLL-------QA 112

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + Y H   +  +IHRD+K  NIL+ E+ + K+ DFG ++       + ++        Y+
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YV 162

Query: 632 DPEYFRRQQLTEKS-------DVYSFGVVLFEVLCARP 662
              ++R  +L           DV++ G ++ E+L   P
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 28/207 (13%)

Query: 469 IGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           IG G  G V+K  +   G  VA+K+   R  +G    Q   EI+ L   +H ++V L+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHT 577
               +  +L+ EYM           S L  +   +   +     +        G+ Y+H 
Sbjct: 68  FPHGSGFVLVMEYM----------PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH- 116

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPE-Y 635
             A  ++HRD+K AN+L+  + + K+ADFGL++    E  + + S  V  +  Y  PE  
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY-SHQV-ATRWYRAPELL 172

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
           +  ++     D+++ G +  E+L   P
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 52/172 (30%), Positives = 87/172 (50%), Gaps = 37/172 (21%)

Query: 463 FDESWVIGIGGFGKVYKG---ELNDGTKVAVK--RGNPRSQQGLAEFQT---EIEMLSQF 514
           ++    IG G +G+VYK       DG + A+K  +G+     G++  Q+   EI +L + 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLREL 59

Query: 515 RHRHLVSLIGYCDEKNEMI--LIYEYMEN---GTLKGH-------LYGSGLPSLSWKQRL 562
           +H ++VSL+    E  +    L+++Y E+     +K H       +  S + SL W Q L
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW-QIL 118

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK 610
                   G+HYLH+ +   V+HRD+K ANIL+     E  + K+ D GL++
Sbjct: 119 N-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 22/201 (10%)

Query: 468 VIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G GGFG+V        G++    K+  KR   R  + +A    E  +L +   R +VS
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS 64

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHT 577
           L    + K+ + L+   M  G LK H+Y  G P    ++ +    E+C G    L  L  
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LEDLQR 120

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              + +++RD+K  NILLD+    +++D GL+   PE +         G+ GY+ PE   
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPEVIN 174

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            ++ T   D +  G +++E++
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 16/198 (8%)

Query: 469 IGIGGFGKVYKG-------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V KG       +++   KV +K  N +S +   E   E E++ Q  + ++V 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKV-LKNENEKSVRD--EMMREAEIMHQLDNPYIVR 59

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           +IG C+ +  M L+ E    G L   L       ++    +E+    + G+ YL     K
Sbjct: 60  MIGVCEAEALM-LVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYLE---GK 114

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +HRD+ + N+LL     AK++DFGLSK  G +       +A K    +  PE    ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 641 LTEKSDVYSFGVVLFEVL 658
            + +SDV+S+G+ ++E  
Sbjct: 175 FSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 61/227 (26%), Positives = 111/227 (48%), Gaps = 32/227 (14%)

Query: 468 VIGIGGFGKVYKG---------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           V+G G FG VYKG         ++    K+  +   P++     EF  E  +++   H H
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN---VEFMDEALIMASMDHPH 70

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGL 572
           LV L+G C     + L+ + M +G L  +++      GS L  L+W      C+  A+G+
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQL-LLNW------CVQIAKGM 122

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YL     + ++HRD+ + N+L+      K+ DFGL++     ++ + +   K    ++ 
Sbjct: 123 MYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREMVNLAE 677
            E    ++ T +SDV+S+GV ++E++    +P  D    RE+ +L E
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY-DGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 73/248 (29%), Positives = 114/248 (45%), Gaps = 48/248 (19%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKR-----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           IG G +G V+K    + G  VA+K+      +P  ++ +A    EI ML Q +H +LV+L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKK-IA--LREIRMLKQLKHPNLVNL 65

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           I     K ++ L++EY ++ T+   L     G+P    K+   I   + + +++ H    
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH---K 118

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQT-HVSTAVKGSFGYLDPEYF- 636
              IHRDVK  NIL+ +    K+ DFG ++  TGP  D T +V+T       Y  PE   
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLV 173

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI--IDP 694
              Q     DV++ G V  E+L  +P+                  W  K  +DQ+  I  
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPL------------------WPGKSDVDQLYLIRK 215

Query: 695 TLAGKIRP 702
           TL G + P
Sbjct: 216 TL-GDLIP 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 469 IGIGGFGKVY-----KGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FG VY     K    +  KV     V   NP       +   E ++LS+  H  +
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNET---VQANQEAQLLSKLDHPAI 64

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           V       E++   +I EY E   L   L        +LS  Q  E  I    G+HY+H 
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              + ++HRD+K+ NI L  N + K+ DFG+S+    +    ++T   G+  Y+ PE  +
Sbjct: 125 ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALK 178

Query: 638 RQQLTEKSDVYSFGVVLFEVLC 659
            Q    KSD++S G +L+E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 11/196 (5%)

Query: 469 IGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    E + G +VAVK+ + R QQ       E+ ++  + H ++V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   R L YLH    + VIHRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143

Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +     ++ G+  ++ PE   R     + D
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTEVD 200

Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 201 IWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 22/201 (10%)

Query: 468 VIGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G GGFG+V        G++    K+  KR   R  + +A    E ++L +   R +VS
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVS 64

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGLHYLHT 577
           L    + K+ + L+   M  G LK H+Y  G P    ++ +    EI  G    L  LH 
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LEDLHR 120

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              + +++RD+K  NILLD+    +++D GL+   PE +   +   V G+ GY+ PE  +
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVK 174

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            ++ T   D +  G +++E++
Sbjct: 175 NERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.0 bits (188), Expect = 8e-15
 Identities = 59/230 (25%), Positives = 96/230 (41%), Gaps = 66/230 (28%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR-GNPRSQQGLAEFQT---------EIEMLSQFRH 516
            IG G +G V        G KVA+K+  N         F           EI++L   RH
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNV--------FDDLIDAKRILREIKLLRHLRH 58

Query: 517 RHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLE------- 563
            +++ L+        ++ N++ ++ E ME          + L   +   Q L        
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELME----------TDLHKVIKSPQPLTDDHIQYF 108

Query: 564 ---ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTH 619
              I     RGL YLH+     VIHRD+K +NIL++ N   K+ DFGL++   P+ D+  
Sbjct: 109 LYQIL----RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161

Query: 620 VSTAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCARP 662
             T       Y+   ++R         + T+  D++S G +  E+L  +P
Sbjct: 162 FLT------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 66/263 (25%), Positives = 108/263 (41%), Gaps = 43/263 (16%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G  G V K      G  +AVK      N   Q+ +     E+++L +    ++V  
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIVGF 64

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G      ++ +  EYM+ G+L   L      +P     +   I +   +GL YLH  + 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKGLTYLHEKHK 121

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID---QTHVSTAVKGSFGYLDPEYFR 637
             +IHRDVK +NIL++     K+ DFG+S  G  ++   +T V T+      Y+ PE  +
Sbjct: 122 --IIHRDVKPSNILVNSRGQIKLCDFGVS--GQLVNSLAKTFVGTSS-----YMAPERIQ 172

Query: 638 RQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID--- 693
               + KSD++S G+ L E+   R P      P + +              L  I++   
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-----------FELLQYIVNEPP 221

Query: 694 PTLAGKIRPDSLRKFGETAEKCL 716
           P L         + F      CL
Sbjct: 222 PRLPSGKFSPDFQDF---VNLCL 241

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 11/196 (5%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G VY   ++  G +VA+K+ N + Q        EI ++ + +H ++V+ +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ EY+  G+L   +  + +      Q   +C    + L +LH   +  VIHRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCRECLQALEFLH---SNQVIHRD 140

Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS NILL  +   K+ DFG  ++  PE  Q+  ST V G+  ++ PE   R+    K D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 647 VYSFGVVLFEVLCARP 662
           ++S G++  E++   P
Sbjct: 198 IWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 52/203 (25%), Positives = 103/203 (50%), Gaps = 11/203 (5%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
             D    IG G  G V    + + G +VAVK+ + R QQ       E+ ++  ++H ++V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            +       +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L +LH   A
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLH---A 133

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
           + VIHRD+KS +ILL  +   K++DFG  ++   E+ +     ++ G+  ++ PE   R 
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPEVISRL 190

Query: 640 QLTEKSDVYSFGVVLFEVLCARP 662
               + D++S G+++ E++   P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)

Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   KV A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +  ++ +I EY+  G+    L    L      Q   I     +GL YLH+   +  IHR
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGPLDE---TQIATILREILKGLDYLHS---EKKIHR 125

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183

Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+   E+    P
Sbjct: 184 IWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNP----RSQQGLAEFQTEIEMLSQFR 515
           ++F+    +G G FG+V         K  A+K  +     + +Q +     E  +L   R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59

Query: 516 HRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGL 572
           H  LV+L G + D+ N + L+ EY+  G L  HL  SG       +    ++ +     L
Sbjct: 60  HPFLVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----L 114

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YLH+     +++RD+K  N+LLD +   K+ DFG +K       T   T       YL 
Sbjct: 115 EYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLA 166

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE    +   +  D ++ G++++E+L   P
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 26/207 (12%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK--RGNPRS--QQGLAEFQT---EIEMLSQFRHRHLV 520
           +G G +  VYK      G  VA+K  +   R   + G+    T   EI++L + +H +++
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--FTALREIKLLQELKHPNII 65

Query: 521 SLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
            L+  +  + N + L++E+ME   L+  +       L+        + + RGL YLH+ +
Sbjct: 66  GLLDVFGHKSN-INLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTH-VSTAVKGSFGYLDPE-Y 635
              ++HRD+K  N+L+  + + K+ADFGL+++   P    TH V T       Y  PE  
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELL 174

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
           F  +      D++S G +  E+L   P
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 34/206 (16%)

Query: 469 IGIGGFGK-VYKGELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           IG G FGK +      DG +  +K     + +P+ ++   E + E+ +LS  +H ++V  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQY 64

Query: 523 IGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
               +E   + ++ +Y E G L       +G L+      L W   ++IC+     L ++
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF-PEDQILDW--FVQICLA----LKHV 117

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLD 632
           H    + ++HRD+KS NI L ++   K+ DFG+++   +  E+ +T + T       YL 
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-----YLS 169

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE    +    KSD+++ G VL+E+ 
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 82/278 (29%), Positives = 114/278 (41%), Gaps = 51/278 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           IG G FG VY   ++     VA+K+ +   +Q   ++Q    E+  L Q RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK----QRLEI---CIGSARGLHYLHT 577
               ++   L+ EY           GS    L       Q +EI   C G+ +GL YLH+
Sbjct: 83  CYLREHTAWLVMEY---------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY- 635
                 IHRD+K+ NILL E    K+ADFG  S   P    + V T       ++ PE  
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--NSFVGTPY-----WMAPEVI 183

Query: 636 --FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQII 692
                 Q   K DV+S G+   E+   +P   P      M  L   A   QN        
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIA---QND------- 230

Query: 693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
            PTL+     D  R F    + CL     DRPS  ++L
Sbjct: 231 SPTLSSNDWSDYFRNF---VDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 28/265 (10%)

Query: 469 IGIGGFGKVYKGELNDGTK--VAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G FG+VYKG +++ TK  VA+K  +   ++  + + Q EI +LSQ    ++    G 
Sbjct: 12  IGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             +  ++ +I EY+  G+    L    L        L   +   +GL YLH+   +  IH
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS---ERKIH 124

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+K+AN+LL E    K+ADFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182

Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           D++S G+   E+    P      P  ++ L            + +   PTL G+      
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQYS---- 226

Query: 706 RKFGETAEKCLADFGVDRPSMGDVL 730
           + F E  E CL      RP+  ++L
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 43/165 (26%), Positives = 83/165 (50%), Gaps = 12/165 (7%)

Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGL 553
           +F  EI+++S+ +  +++ L+  C   + + +I EYMENG L         +     + +
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 554 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 613
            ++S+   + +    A G+ YL +      +HRD+ + N L+ +N+  K+ADFG+S+   
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             D   +         ++  E     + T  SDV++FGV L+E+L
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 25/206 (12%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIG 524
           ++G G +G V K +  + G  VA+K+        + +     EI ML Q RH +LV+LI 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 525 YCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
               K  + L++E++++  L     Y +GL     ++ L   +   RG+ + H+     +
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEFCHS---HNI 121

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKT--GP-EIDQTHVST----AVKGSFGYLDPEYF 636
           IHRD+K  NIL+ ++ + K+ DFG ++T   P E+   +V+T    A +   G  D +Y 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYG 179

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
           R        D+++ G ++ E+L   P
Sbjct: 180 R------AVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 26/203 (12%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQTEIEMLSQ------FRHRHLV 520
           V+G G FGKV   EL    +  A+K    +    L +   E  M+ +      + H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIK--ALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 521 SLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLHYL 575
            L  +C    K  +  + EY+  G L  H+  SG    + + R    EI  G    L +L
Sbjct: 60  HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIICG----LQFL 112

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H    K +I+RD+K  N+LLD++   K+ADFG+ K    ++    ++   G+  Y+ PE 
Sbjct: 113 HK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEI 167

Query: 636 FRRQQLTEKSDVYSFGVVLFEVL 658
            + Q+  E  D +SFGV+L+E+L
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 67/248 (27%), Positives = 104/248 (41%), Gaps = 39/248 (15%)

Query: 469 IGIGGFGKVYKGELNDGTKVA---VKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           IG G FGKV  GE + G   A   VK       P  Q     F  E++   +  H +++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL---LFLQEVQPYRELNHPNVLQ 59

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLH 576
            +G C E    +L+ E+   G LK +L       + +      QR+   +  A GL +LH
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLH 117

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG--YLDPE 634
                  IH D+   N  L  +   K+ D+GL+    +  + +  T    +    +L PE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALE--QYPEDYYITKDCHAVPLRWLAPE 172

Query: 635 YF--RRQQL-----TEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ-- 683
               R Q L     T+KS+++S GV ++E+     +P   P L  E V L +   +    
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV-LKQVVREQDIK 229

Query: 684 -NKGQLDQ 690
             K QLD 
Sbjct: 230 LPKPQLDL 237

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 4e-14
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 36/223 (16%)

Query: 463 FDESWVIGIGGFGKVYKGELND-GTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRH 518
           FD    IG G +G+VYK    D G  VA+K+    N +    +   + EI++L Q  HR+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 519 LVSL----------IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQR 561
           +V+L          + +  +K    L++EYM++  L G L  SGL   S        KQ 
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMG-LLESGLVHFSEDHIKSFMKQL 125

Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 621
           LE       GL+Y H    K  +HRD+K +NILL+     K+ADFGL++     +    +
Sbjct: 126 LE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 622 TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 663
             V  +  Y  PE     ++     DV+S G +L E+   +P+
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 75.3 bits (185), Expect = 4e-14
 Identities = 38/103 (36%), Positives = 62/103 (60%), Gaps = 3/103 (2%)

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           +H++H+   K +IHRD+KSANILL  N + K+ DFG SK         V     G+  Y+
Sbjct: 156 VHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 674
            PE +RR+  ++K+D++S GV+L+E+L  +   D     E+++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Length = 496

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.6 bits (178), Expect = 6e-14
 Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 36/221 (16%)

Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
            +   E  V+G G +G VY   +L+   ++A+K    R  + +     EI + S  +HR+
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +V  +G   E     +  E +  G+L      S L    W              KQ LE 
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSL------SALLRSKWGPLKDNEQTIIFYTKQILE- 119

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTA 623
                 GL YLH      ++HRD+K  N+L++  + + K++DFG SK    I+    +  
Sbjct: 120 ------GLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTET 168

Query: 624 VKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 662
             G+  Y+ PE   +        +D++S G  + E+   +P
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.8 bits (178), Expect = 6e-14
 Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 11/211 (5%)

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 512
           V++ +    +     IG G  G V+   ++  G +VA+K+ N + Q        EI ++ 
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + L
Sbjct: 72  ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQAL 128

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 631
            +LH   A  VIHRD+KS N+LL  +   K+ DFG  ++  PE  Q+  ST V G+  ++
Sbjct: 129 EFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 182

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE   R+    K D++S G++  E++   P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGL----AEFQTEIEMLSQFRHRHLVSL 522
           IG+G +G VYK  + + G  VA+K      ++ GL          ++ L  F H ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 523 IGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           +  C     D + ++ L++E+++   L+ +L     P L  +   ++     RGL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-TAVKGSFGYLDPEYF 636
                ++HRD+K  NIL+      K+ADFGL++    I    ++ T V  +  Y  PE  
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLAR----IYSCQMALTPVVVTLWYRAPEVL 179

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPV 663
            +       D++S G +  E+   +P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 38/232 (16%)

Query: 459 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEF--QTEIEMLSQFR 515
              +++    +G G FG+VYK  ++  G  VA+K+    +++         EI++L + +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 516 HRHLVSLI--------GYCDEKNEMILIYEYME---NGTLKG---HLYGSGLPSLSWKQR 561
           H ++V LI            ++  + ++  YM+   +G L+     L  S +      Q 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI-KCYMLQL 124

Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---------TG 612
           LE       G++YLH      ++HRD+K+ANIL+D   + K+ADFGL++          G
Sbjct: 125 LE-------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 613 PEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARPV 663
                T   T +  +  Y  PE     ++ T   D++  G V  E+   RP+
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 48/142 (33%), Positives = 76/142 (53%), Gaps = 6/142 (4%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G VYK   L+ G   AVK          +  Q EI M+ + +H ++V+  G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            + ++ +  EY   G+L+   + +G   LS  Q   +C  + +GL YLH+   K  +HRD
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHS---KGKMHRD 131

Query: 588 VKSANILLDENFMAKVADFGLS 609
           +K ANILL +N   K+ADFG++
Sbjct: 132 IKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 62/243 (25%), Positives = 119/243 (48%), Gaps = 27/243 (11%)

Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRD 141

Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +     ++ G+  ++ PE   R     + D
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPELISRLPYGPEVD 198

Query: 647 VYSFGVVLFEVLCARP------------VIDPTLPREMVNLAEWAMKWQNKGQLDQII-- 692
           ++S G+++ E++   P            +I   LP ++ NL + +     KG LD+++  
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL--KGFLDRLLVR 256

Query: 693 DPT 695
           DP 
Sbjct: 257 DPA 259

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.1 bits (176), Expect = 1e-13
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 11/211 (5%)

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 512
           V+V +    +     IG G  G VY   ++  G +VA+K+ N + Q        EI ++ 
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + L
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 128

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 631
            +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  ST V G+  ++
Sbjct: 129 DFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 182

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE   R+    K D++S G++  E++   P
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 469 IGIGGFGKVY------KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G GGFG+V        G+L    K+  KR   R  +G      E  +L++   R +VSL
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
                 K ++ L+   M  G L+ H+Y      P     +          GL +LH    
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
           + +I+RD+K  N+LLD +   +++D GL+   K G    + +  T      G++ PE  +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP-----GFMAPELLQ 170

Query: 638 RQQLTEKSDVYSFGVVLFEVLCAR 661
            ++     D ++ GV L+E++ AR
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 59/232 (25%), Positives = 94/232 (40%), Gaps = 48/232 (20%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVKRGNP-----RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G FG+V+     D  +V A+K         R+Q  +A  + E ++L+      +V 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADADSPWIVK 65

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSARGLHYLHT-G 578
           L     ++  + L+ EYM  G L   L    +      +    E+ +     L  +H  G
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA----LDSVHKLG 121

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-------------------- 618
           +    IHRD+K  NIL+D +   K+ADFGL K   +                        
Sbjct: 122 F----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 619 --------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                     ++ V G+  Y+ PE  R      + D +S GV+L+E+L   P
Sbjct: 178 RDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 55/204 (26%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 465 ESWV-IGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           E+++ IG G  G V    E + G +VAVK  + R QQ       E+ ++  ++H+++V +
Sbjct: 24  ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM 83

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
                   E+ ++ E+++ G L   +  +    L+ +Q   +C    + L YLH   ++ 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH---SQG 137

Query: 583 VIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           VIHRD+KS +ILL  +   K++DFG    +SK  P+        ++ G+  ++ PE   R
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISR 191

Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
                + D++S G+++ E++   P
Sbjct: 192 TPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 14/199 (7%)

Query: 469 IGIGGFGKV------YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G GGFG+V        G++    K+  KR   +S + +A  + EI  L +     +V+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
               + K  + L+   M  G LK H+Y  G   L  ++ +        G+ +LH+     
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           +++RD+K  N+LLD+    +++D GL+    E+      T   G+ GY+ PE  + +  +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 643 EKSDVYSFGVVLFEVLCAR 661
              D ++ G  ++E++  R
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHR 517
           NF     IG G F +VY+   L DG  VA+K+    +    +  A+   EI++L Q  H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLK---GHLYGSG--LPSLS-WKQRLEICIGSARG 571
           +++       E NE+ ++ E  + G L     H       +P  + WK  +++C      
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L ++H+   + V+HRD+K AN+ +    + K+ D GL +      +T  + ++ G+  Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYM 173

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE         KSD++S G +L+E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 67/247 (27%), Positives = 116/247 (46%), Gaps = 32/247 (12%)

Query: 463 FDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLV 520
           F+   ++G G +G+VYKG  +  G   A+K  +    +   E + EI ML ++  HR++ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 66

Query: 521 SLIGYCDEKN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           +  G   +KN      ++ L+ E+   G++   +  +   +L  +    IC    RGL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HVSTAVKGSFGYLDP 633
           LH      VIHRD+K  N+LL EN   K+ DFG+S    ++D+T        G+  ++ P
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAP 180

Query: 634 EYFRRQQLTE-----KSDVYSFGVVLFEVL-CARPVID----------PTLPREMVNLAE 677
           E     +  +     KSD++S G+   E+   A P+ D          P  P   +   +
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 678 WAMKWQN 684
           W+ K+Q+
Sbjct: 241 WSKKFQS 247

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 75/280 (26%), Positives = 112/280 (40%), Gaps = 39/280 (13%)

Query: 469 IGIGGFGKVYKGELND---------GTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRH 518
           +G G F  +YKG L           G +V+V      S    +  F     ++SQ  H+H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHT 577
           LV L G C  ++E I++ EY++ G L   L+      SL WK  L++    A  LHYL  
Sbjct: 63  LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 578 GYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
              K ++H +V   NIL+         V    LS  G  I        V+    ++ PE 
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPEC 175

Query: 636 FRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
            R  Q  LT  +D +SFG  L E+           P   ++ +E    +Q++ +L     
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGE-----EPLSTLSSSEKERFYQDQHRLPMPDC 230

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 733
             LA  I             +C       RPS   +L +L
Sbjct: 231 AELANLIN------------QCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAE-FQTEIEMLSQFRHRHLVSLIG 524
           +G+GGFG+V   ++       A+K    R   + G  E   +E E+L +  H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
              +K  + ++ EY   G L   L   GL      +    C+  A    YLH    + +I
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLA--FEYLH---NRGII 115

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           +RD+K  N+LLD N   K+ DFG +K      +T   T   G+  Y+ PE    +     
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDFS 172

Query: 645 SDVYSFGVVLFEVLCARP 662
            D +S G++L+E+L  RP
Sbjct: 173 VDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 63/203 (31%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVK-------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           VIG G FGKV   +   DG   AVK             +  +AE      +L   +H  L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV---LLKNVKHPFL 58

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V L       +++  + +Y+  G L  HL           +     I SA G  YLH+  
Sbjct: 59  VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS-- 114

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +I+RD+K  NILLD      + DFGL K G E  +T  ++   G+  YL PE  R+Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171

Query: 640 QLTEKSDVYSFGVVLFEVLCARP 662
                 D +  G VL+E+L   P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 20/198 (10%)

Query: 469 IGIGGFGKVYKG--ELNDGTK-VAVK-RGNPRSQQGLA-EFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V KG  ++    K VAVK   N  +   L  E   E  ++ Q  + ++V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G C+ ++ M L+ E  E G L   L  +    ++ K   E+    + G+ YL        
Sbjct: 63  GICEAESWM-LVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNF 116

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEID-----QTHVSTAVKGSFGYLDPEYFRR 638
           +HRD+ + N+LL     AK++DFGLSK     +     +TH    VK    +  PE    
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAPECMNY 172

Query: 639 QQLTEKSDVYSFGVVLFE 656
            + + KSDV+SFGV+++E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 70.9 bits (173), Expect = 4e-13
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 11/198 (5%)

Query: 468 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH  L SL 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                K+ +  + EY+  G L  HL    + S    +     I SA  L YLH+G    +
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG---KI 116

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           ++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 644 KSDVYSFGVVLFEVLCAR 661
             D +  GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 472 GGFGKVYKGELNDGT-----KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           G FG+++ G L D       +V VK   +  S+  +     E  +L    H++++ ++  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 526 CDEKNE--MILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGLHYLHT 577
           C E  E   +L Y YM  G LK  L        +   +LS +Q + + I  A G+ YLH 
Sbjct: 77  CIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              + VIH+D+ + N ++DE    K+ D  LS+    +D   +         ++  E   
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 638 RQQLTEKSDVYSFGVVLFEV--LCARPV--IDP 666
            ++ +  SDV+SFGV+L+E+  L   P   IDP
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 23/211 (10%)

Query: 462 NFDESWVIGIGGFGKVY----KGELNDGT----KVAVKRGNPRSQQGLAEFQTEIEMLSQ 513
           NF+   V+G G +GKV+     G  + G     KV  K    +  +     +TE ++L  
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 514 FRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARG 571
            R    LV+L        ++ LI +Y+  G L  HLY     + S    + + I      
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFG 629
           L +LH      +I+RD+K  NILLD      + DFGLSK     E ++ +   +  G+  
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171

Query: 630 YLDPEYFRRQQLTEKS--DVYSFGVVLFEVL 658
           Y+ PE  R          D +S GV+ FE+L
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 65/270 (24%), Positives = 120/270 (44%), Gaps = 31/270 (11%)

Query: 468 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLI- 523
           V+G G +G+V       DG +  +K+ N R  S++     + E ++LSQ +H ++V+   
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
            +  E   + ++  + E G L   L       L   Q +E  +  A  L YLH    K +
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           +HRD+K+ N+ L    + KV D G+++     +Q  +++ + G+  Y+ PE F  +    
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP- 702
           KSDV++ G  ++E+   +                      N   ++ ++   + GK+ P 
Sbjct: 182 KSDVWALGCCVYEMATLKHAF-------------------NAKDMNSLVYRIIEGKLPPM 222

Query: 703 --DSLRKFGETAEKCLADFGVDRPSMGDVL 730
             D   + GE     L+     RPS+  +L
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.5 bits (171), Expect = 8e-13
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 45/215 (20%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT--------EIEMLSQF-RHRH 518
           +G G FG VY     + G  VA+K+          +F +        E++ L +   H +
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHY 574
           +V L     E +E+  ++EYME     G+LY           S      I     +GL +
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 575 LHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-----THVSTAVKGSF 628
           +H  G+     HRD+K  N+L+    + K+ADFGL++   EI        +VST      
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTR----- 162

Query: 629 GYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 662
            Y  PE   R    +   D+++ G ++ E+   RP
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.1 bits (169), Expect = 8e-13
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 35/212 (16%)

Query: 469 IGIGGFGKVYKG---ELNDG-----TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           +G G F K++KG   E+ D      T+V +K  +   +     F     M+SQ  H+HLV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGY 579
              G C   +E I++ EY++ G+L  +L  +  L ++SWK  LE+    A  LH+L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118

Query: 580 AKAVIHRDVKSANILLDEN---------FMAKVADFGLSKT--GPEIDQTHVSTAVKGSF 628
            K + H +V + N+LL            F+ K++D G+S T    EI    +        
Sbjct: 119 -KGLTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKEILLERIP------- 169

Query: 629 GYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLC 659
            ++ PE     Q L+  +D +SFG  L+E+  
Sbjct: 170 -WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 61/233 (26%), Positives = 100/233 (42%), Gaps = 43/233 (18%)

Query: 469 IGIGGFGKVYKGELNDG--TKVAVKR---GNPRSQQGLAEFQTEIEML--------SQFR 515
           +G G FG VYK    +     +A+K     NP   +   E    I  +         Q R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-----------WKQRLEI 564
           H ++V       E + + ++ + +E   L  H       SL            W   +++
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF-----NSLKEKKQRFTEERIWNIFVQM 122

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTA 623
            +     L YLH    K ++HRD+   NI+L E+    + DFGL+K   PE       T+
Sbjct: 123 VLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL----TS 172

Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA 676
           V G+  Y  PE  + +   EK+DV++FG +L+++   +P    T    M++LA
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSLA 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 26/203 (12%)

Query: 468 VIGIGGFGK--VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G FG+  + +   +D      +   P+S   + + + E  +L++ +H ++V+    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 526 CDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
            +    + ++ EY + G L       +G L+      L W   +++C+G    + ++H  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT-ILQW--FVQMCLG----VQHIHE- 118

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYF 636
             K V+HRD+KS NI L +N   K+ DFG ++  T P     +  T V G+  Y+ PE +
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPYYVPPEIW 172

Query: 637 RRQQLTEKSDVYSFGVVLFEVLC 659
                  KSD++S G +L+E LC
Sbjct: 173 ENMPYNNKSDIWSLGCILYE-LC 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 62/223 (27%), Positives = 110/223 (49%), Gaps = 23/223 (10%)

Query: 455 AVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 513
           A+++    F+   V+G G +G+VYKG  +  G   A+K  +    +   E + EI ML +
Sbjct: 10  ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKK 68

Query: 514 F-RHRHLVSLIGYCDEK------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           +  HR++ +  G   +K      +++ L+ E+   G++   +  +   +L       IC 
Sbjct: 69  YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAV 624
              RGL +LH   A  VIHRD+K  N+LL EN   K+ DFG+S    ++D+T    +T +
Sbjct: 129 EILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI 182

Query: 625 KGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCARP 662
            G+  ++ PE     +  +     +SD++S G+   E+    P
Sbjct: 183 -GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.0 bits (168), Expect = 1e-12
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 11/211 (5%)

Query: 454 VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 512
           V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 129

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYL 631
            +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  ST V G+  ++
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWM 183

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE   R+    K D++S G++  E++   P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 66/228 (28%), Positives = 103/228 (45%), Gaps = 29/228 (12%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLS 512
            F++   IG G +G VY+  +   G  VA+K+        G P S   L     EI +L 
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS--SL----REITLLL 61

Query: 513 QFRHRHLVSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS 568
             RH ++V L    +G     + + L+ EY E   L   L     P  S  Q   + +  
Sbjct: 62  NLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQL 117

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
            RGL YLH  +   +IHRD+K +N+LL +    K+ADFGL++T     +      V  + 
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TL 172

Query: 629 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
            Y  PE        T   D+++ G +L E+L  +P++      E ++L
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 18/199 (9%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLS-QFRHRHLVSL 522
           ++G G FGKV+  EL    +     A+K+        +     E  +LS  + H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL---YGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
                 K  +  + EY+  G L  H+   +   LP  ++     IC     GL +LH+  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS-- 114

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K +++RD+K  NILLD +   K+ADFG+ K    +      T   G+  Y+ PE    Q
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN-MLGDAKTCTFC-GTPDYIAPEILLGQ 171

Query: 640 QLTEKSDVYSFGVVLFEVL 658
           +     D +SFGV+L+E+L
Sbjct: 172 KYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 5/90 (5%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A  L +LH+     +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+ 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTV 162

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            Y+ PE   R+  T+ +D +SFGV++FE+L
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 469 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQ---FRHRHLVS 521
           IG G +GKV+K     N G  VA+KR   ++ +      T  E+ +L     F H ++V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 522 LIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
           L   C     D + ++ L++E+++   L  +L     P +  +   ++     RGL +LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     V+HRD+K  NIL+  +   K+ADFGL++           T+V  +  Y  PE  
Sbjct: 128 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEVL 181

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPV 663
            +       D++S G +  E+   +P+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFRRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 31/212 (14%)

Query: 463 FDESWVIGIGGFGKVYKGELN-DGTK----VAVKR----GNPRSQQGLAEFQTEIEMLSQ 513
           F +  V+G G FG VYKG    +G K    VA+K      +P++ +   E   E  +++ 
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK---EILDEAYVMAS 65

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICI 566
             + H+  L+G C   + + LI + M  G L       K ++    L  L+W      C+
Sbjct: 66  VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNW------CV 116

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A+G++YL     + ++HRD+ + N+L+      K+ DFGL+K     ++ + +   K 
Sbjct: 117 QIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++  E    +  T +SDV+S+GV ++E++
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 15/198 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTE---IEMLSQFRHRHLV 520
           V+G G FGKV   E     ++    A+K+G+  ++  +     E    E  +  RH  LV
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +L      ++ +  + EY   G L  H++ + + S         C+    GL YLH    
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACV--VLGLQYLHE--- 119

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +++RD+K  N+LLD     K+ADFGL K G        ST   G+  +L PE      
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEVLTETS 177

Query: 641 LTEKSDVYSFGVVLFEVL 658
            T   D +  GV+++E+L
Sbjct: 178 YTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHR 517
           + +    +G G FG+V+   +       A+K         L + Q    E  +L +  H 
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
            ++ L     ++  + ++ EY+  G L  +L  SG  S S        I  A  L YLH+
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA--LEYLHS 119

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              K +++RD+K  NILLD+    K+ DFG +K     D+T     + G+  YL PE  +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---TLCGTPEYLAPEVIQ 171

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            +   +  D ++ G++++E+L   P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 78/276 (28%), Positives = 121/276 (43%), Gaps = 47/276 (17%)

Query: 469 IGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLI 523
           IG G FG VY    N  T   VAVK+ +   +Q   ++Q    E++ L Q +H + +   
Sbjct: 29  IGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTG 578
           G   +++   L+ EY            S L  +  K  Q +EI     G+ +GL YLH+ 
Sbjct: 88  GCYLKEHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY-- 635
               +IHRD+K+ NILL E    K+ADFG  SK+ P       + +  G+  ++ PE   
Sbjct: 140 --HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVIL 190

Query: 636 -FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 694
                Q   K DV+S G+   E+   +P         + N+   +  +     + Q   P
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNDSP 238

Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
           TL      DS R F    + CL     +RP+  ++L
Sbjct: 239 TLQSNEWTDSFRGF---VDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 25/201 (12%)

Query: 449 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR---GNPRSQQGLAEF 504
           Y FPF    +  + +++   IG G FG+V+K         VA+K+    N +    +   
Sbjct: 3   YEFPFC---DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL 59

Query: 505 QTEIEMLSQFRHRHLVSLIGYCDEKNEM--------ILIYEYMENGTLKGHLYGSGLP-S 555
           + EI++L   +H ++V+LI  C  K            L++E+ E+  L G L    +  +
Sbjct: 60  R-EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFT 117

Query: 556 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GP 613
           LS  +++   + +  GL+Y+H      ++HRD+K+ANIL+ ++ + K+ADFGL++     
Sbjct: 118 LSEIKKVMKMLLN--GLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Query: 614 EIDQTHVSTAVKGSFGYLDPE 634
           +  + +  T    +  Y  PE
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 68.9 bits (168), Expect = 4e-12
 Identities = 52/194 (26%), Positives = 93/194 (47%), Gaps = 24/194 (12%)

Query: 492 RGNPRSQQGLAEF------------QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM 539
           RG+   ++ +A+F            ++E+  L+   H  +V         ++++LI EY 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147

Query: 540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY-----LHTGYAKAVIHRDVKSANIL 594
             G L   +          K+ L         L Y     L   +++ ++HRD+KSANI 
Sbjct: 148 SGGDLNKQI------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201

Query: 595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           L    + K+ DFG SK   +     V+++  G+  YL PE + R++ ++K+D++S GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261

Query: 655 FEVLCA-RPVIDPT 667
           +E+L   RP   P+
Sbjct: 262 YELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 69/292 (23%), Positives = 128/292 (43%), Gaps = 41/292 (14%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQF 514
           NF     IG G F +VY+   L D   VA+K+       + +++Q   +   EI++L Q 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK---EIDLLKQL 59

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY-----GSGLPSLS-WKQRLEICIGS 568
            H +++  +    E NE+ ++ E  + G L   +         +P  + WK  +++C   
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC--- 116

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
              + ++H+   + V+HRD+K AN+ +    + K+ D GL +      +T  + ++ G+ 
Sbjct: 117 -SAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            Y+ PE         KSD++S G +L+E+      +      + +NL     K      +
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQK------I 220

Query: 689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 740
           +Q   P L  +   + LR   E    C+      RP +G V    + A Q+ 
Sbjct: 221 EQCDYPPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 22/201 (10%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ------FRHRHLV 520
           V+G G FGKV   EL   G   AVK    +    L +   E  M+ +      + +  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHT 577
            L      K  +  + E++  G L  H+   G   L   ++     +C     GL +LH+
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-----GLQFLHS 114

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              K +I+RD+K  N++LD +   K+ADFG+ K    +   + ++   G+  Y+ PE  +
Sbjct: 115 ---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDYIAPEILQ 169

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
             + T   D +SFGV+L+E+L
Sbjct: 170 GLKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 15/165 (9%)

Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW-KQRL-EICIG 567
           M+ Q    ++  L      K+ + L+ EY+  G     +   G     W KQ + E+ +G
Sbjct: 50  MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG 109

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
               +  LH    + +IHRD+K  N+L+D+    K+ DFGLS+ G        +    G+
Sbjct: 110 ----VEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGT 156

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
             YL PE        + SD +S G V+FE L   P      P  +
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 474 FGKVYKGEL------NDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 526
           FGKVYKG L           VA+K    +++  L  EF+ E  M S+ +H ++V L+G  
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 527 DEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLE------ICIGSARGL 572
            ++  + +I+ Y  +  L   L         GS     + K  LE      I    A G+
Sbjct: 78  TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            +L + +   V+H+D+ + N+L+ +    K++D GL +     D   +         ++ 
Sbjct: 138 EFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMS 194

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE     + +  SD++S+GVVL+EV 
Sbjct: 195 PEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 45/213 (21%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +IG GGFG+VY     D  K+ A+K   +   + +QG      E  MLS      LVS  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53

Query: 524 GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSAR 570
           G C             +++  I + M  G L  HL   G+ S + + R    EI +G   
Sbjct: 54  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRFYAAEIILG--- 109

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKG 626
            L ++H    + V++RD+K ANILLDE+   +++D GL    SK  P     H S    G
Sbjct: 110 -LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---G 157

Query: 627 SFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
           + GY+ PE  ++    + S D +S G +LF++L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 66.5 bits (162), Expect = 9e-12
 Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 34/211 (16%)

Query: 468 VIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIE-----MLSQFRHRHLVS 521
           VIG G FGKV   +  +DG+  AVK    ++     E Q  I      +L   +H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG---------- 571
           L        ++  + +Y+  G L  HL           QR E C    R           
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL-----------QR-ERCFLEPRARFYAAEVASA 108

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YLH+     +I+RD+K  NILLD      + DFGL K G E ++T  ++   G+  YL
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYL 163

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE  R++      D +  G VL+E+L   P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 16/205 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSL 522
           VIG G + KV    L    ++     VK+      + +   QTE  +  Q   +  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLHYLHTGYA 580
                  + + L+ EY+  G L  H+     LP    +    EICI     L++LH    
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLHE--- 114

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           + +I+RD+K  N+LLD +   K+ D+G+ K G  +     ++   G+  Y+ PE  R ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 641 LTEKSDVYSFGVVLFEVLCARPVID 665
                D ++ GV++FE++  R   D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 59/198 (29%), Positives = 88/198 (44%), Gaps = 11/198 (5%)

Query: 468 VIGIGGFGKV-YKGELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           ++G G FGKV    E   G   A+K   +    ++  +A   TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                 + +  + EY   G L  HL    + S    +     I SA  L YLH+     V
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYLHS---CDV 116

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           ++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 644 KSDVYSFGVVLFEVLCAR 661
             D +  GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 39/210 (18%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +IG GGFG+VY     D G   A+K   +   + +QG      E  MLS      LVS  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVS-T 53

Query: 524 GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
           G C             +++  I + M  G L  HL   G+   S K+          GL 
Sbjct: 54  GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLE 111

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVSTAVKGSFG 629
           ++H  +   V++RD+K ANILLDE+   +++D GL    SK  P     H S    G+ G
Sbjct: 112 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHG 160

Query: 630 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
           Y+ PE  ++    + S D +S G +LF++L
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 8/169 (4%)

Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G    +   ++ I +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              RGL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 109 --LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 160

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
           +  Y+ PE  +    T +SD++S G+ L E+   R  I P   +E+  +
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRG------NPRSQQG-LAEFQTEIEMLSQFRHRHL 519
           VIG G FGKV   +   DG   AVK        N + Q+  +AE      +L   +H  L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV---LLKNVKHPFL 58

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGS-ARGLHYLHT 577
           V L        ++  + +++  G L  HL      P    + R        A  L YLH+
Sbjct: 59  VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHS 114

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +++RD+K  NILLD      + DFGL K G  I Q+  +T   G+  YL PE  R
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVIR 169

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           +Q      D +  G VL+E+L   P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 81/300 (27%), Positives = 132/300 (44%), Gaps = 49/300 (16%)

Query: 469 IGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI- 523
           IG G FG V+   +  DG +VA+K+  P   Q L   +    E++ML  F+H +++S + 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKK-MPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 524 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK----QRLEICIGSARGLHYL 575
                + D   E+ ++ E M++   K  +    L S   K    Q L       RGL YL
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL-------RGLKYL 119

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     ++HRD+K  N+L++ N + K+ DFGL++     +  H++  V   + Y  PE 
Sbjct: 120 HSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175

Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 694
               +  T   D++S G +  E+L  R +     P +               QLD I D 
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---------------QLDLITD- 219

Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL-----EYALQLQEAVVHGDPD 749
            L G    +++R   E A   +   G  +P    VL+ L       A+ L   ++  DPD
Sbjct: 220 -LLGTPSLEAMRSACEGARAHILR-GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 468 VIGIGGFGKVYKGEL-NDGTKVAVK--RGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLI 523
           V+G G FGKV    L   G   AVK  + +   Q    E   TE  +LS  R+   ++ +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 524 GYCDEKNE-MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
             C +  + +  + E++  G L  H+  S     +  +     I SA  L +LH    K 
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHD---KG 116

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           +I+RD+K  N+LLD     K+ADFG+ K G  I     ++   G+  Y+ PE  +     
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEILQEMLYG 174

Query: 643 EKSDVYSFGVVLFEVLC 659
              D ++ GV+L+E+LC
Sbjct: 175 PSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 32/210 (15%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGY 525
           +IG G +G VY+G+    G  VA+K  N  +    +++ Q E+ +LSQ R     ++  Y
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 526 --CDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIG-----SARGLHYLH 576
                K   + +I EY E G+++         +L     + E  I          L Y+H
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVR---------TLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDP 633
                 VIHRD+K+ANIL+      K+ DFG++           T V T       ++ P
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-----WMAP 170

Query: 634 EYFRR-QQLTEKSDVYSFGVVLFEVLCARP 662
           E     +    K+D++S G+ ++E+    P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 469 IGIGGFGKVYKGELNDG---TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           IG G FGKV  GE+N G    +V VK  R +   Q+ + +F  E +     +H +L+  +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQM-KFLEEAQPYRSLQHSNLLQCL 61

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLHTG 578
           G C E    +L+ E+   G LKG+L          P  +  QR+   I  A GL +LH  
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHK- 118

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
                IH D+   N LL  +   K+ D+GLS    + D       +     ++ PE    
Sbjct: 119 --NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 639 QQ-------LTEKSDVYSFGVVLFEVL 658
                     T++S+V+S GV ++E+ 
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 40/162 (24%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQ-QGLAEFQT-EIEMLSQFRHRHLVSLIGY 525
           IG G +G VYKG     G  VA+K+    S+ +G+      EI +L + +H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 526 CDEKNEMILIYE-----------------YMENGTLKGHLYGSGLPSLSWKQRLEICIGS 568
             +++ + LI+E                 YM+   +K +LY          Q L+     
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY----------QILQ----- 112

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
             G+ + H   ++ V+HRD+K  N+L+D   + K+ADFGL++
Sbjct: 113 --GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.3 bits (162), Expect = 4e-11
 Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           IG GG G+VY   +     +VA+K+       NP  ++    F  E ++ +   H  +V 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAADLIHPGIVP 66

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPS-----LSWKQRLEICIGSARG 571
           +   C + + +     Y+E  TLK  L  S      L        S    L I       
Sbjct: 67  VYSICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG--LSKTGPEIDQTHVSTAVKGSF- 628
           + Y+H+   K V+HRD+K  NILL       + D+G  + K   E D   +    +    
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 629 -------------GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                         Y+ PE       +E +D+Y+ GV+L+++L
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 12/168 (7%)

Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRL-EI 564
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G +P    +Q L ++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKV 108

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            I   +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ + 
Sbjct: 109 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
            G+  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.6 bits (157), Expect = 5e-11
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 11/198 (5%)

Query: 468 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                 + +  + EY   G L  HL    + +    +     I SA  L YLH+   + V
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLHS---RDV 116

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           ++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE         
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 644 KSDVYSFGVVLFEVLCAR 661
             D +  GVV++E++C R
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.7 bits (157), Expect = 5e-11
 Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 10/198 (5%)

Query: 468 VIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH  L +L 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                 + +  + EY   G L  HL    + S    +     I SA  L YLH+   K V
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHS--EKNV 117

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           ++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE         
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 644 KSDVYSFGVVLFEVLCAR 661
             D +  GVV++E++C R
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 31/157 (19%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           IG G +G VYK  +   G  VA+K+        G P +         EI +L +  H ++
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI------REISLLKELNHPNI 60

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL------EICIGSARGLH 573
           V L+     +N++ L++E++ +  LK ++     P       L      ++     +G+ 
Sbjct: 61  VRLLDVVHSENKLYLVFEFL-DLDLKKYM--DSSPLTGLDPPLIKSYLYQLL----QGIA 113

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           Y H+     V+HRD+K  N+L+D     K+ADFGL++
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V L+     +N++ L++E++ +  LK  +  S L  +             +GL + H  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
            +  V+HRD+K  N+L++     K+ADFGL++
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 20/172 (11%)

Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---- 562
           E+++L +    ++V   G      E+ +  E+M+ G+L           L   +R+    
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKEAKRIPEEI 104

Query: 563 --EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
             ++ I   RGL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   +
Sbjct: 105 LGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--M 158

Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           + +  G+  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 1e-10
 Identities = 56/197 (28%), Positives = 81/197 (41%), Gaps = 22/197 (11%)

Query: 472 GGFGKVY---KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           G  G+V+   K       KV VK        G      EI++L    HR +++LI     
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHAYRW 157

Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K+ + ++   M         Y      L  +Q + I       L YLH    + +IHRDV
Sbjct: 158 KSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDV 211

Query: 589 KSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLD---PEYFRRQQLTEK 644
           K+ NI LDE   A + DFG + K     D    +    G  G L+   PE         K
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPD----TPQCYGWSGTLETNSPELLALDPYCAK 267

Query: 645 SDVYSFGVVLFEVLCAR 661
           +D++S G+VLFE+    
Sbjct: 268 TDIWSAGLVLFEMSVKN 284

Length = 392

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 24/164 (14%)

Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEIC 565
           EIE+L    H ++V      D   E+ ++ E+M+ G+L+G H+      +   +Q L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTA 623
                G+ YLH    + ++HRD+K +N+L++     K+ADFG+S+    + QT    +++
Sbjct: 180 -----GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSS 228

Query: 624 VKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCAR 661
           V G+  Y+ PE      L          D++S GV + E    R
Sbjct: 229 V-GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 18/220 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           V+G G FG VYKG  + DG      VA+K  R N  S +   E   E  +++     ++ 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L+G C   + + L+ + M  G L  ++       +  +  L  C+  A+G+ YL     
Sbjct: 73  RLLGIC-LTSTVQLVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFRRQ 639
             ++HRD+ + N+L+      K+ DFGL++   +ID+T   +   K    ++  E    +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHR 186

Query: 640 QLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREMVNLAE 677
           + T +SDV+S+GV ++E++   A+P  D    RE+ +L E
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           +I +   + L YLH+  +  VIHRDVK +N+L++ N   K+ DFG+S  G  +D     T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161

Query: 623 AVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEV 657
              G   Y+ PE       ++    KSDV+S G+ + E+
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 106/225 (47%), Gaps = 33/225 (14%)

Query: 474 FGK----VYKGELNDGTKVAVKRGNPRSQQGLAEFQT---------------EIEMLSQF 514
           FGK    V   +L +GT   V +G  +  + L   +                E+ +L   
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLH 573
           +H ++V+L      +  + L++EY+++  LK +L   G  +L     ++I +    RGL 
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLS 117

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           Y H    + ++HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P
Sbjct: 118 YCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 172

Query: 634 EYFRRQQLTEKS---DVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
           +       TE S   D++  G +L+E+   RP+   +  +E ++L
Sbjct: 173 DVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 62.8 bits (152), Expect = 2e-10
 Identities = 73/277 (26%), Positives = 115/277 (41%), Gaps = 46/277 (16%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           IG G FG VY   ++ +   VA+K+ +   +Q   ++Q    E+  L + RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTGY 579
               ++   L+ EY            S L  +  K  Q +EI     G+ +GL YLH+  
Sbjct: 83  CYLREHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY--- 635
              +IHRDVK+ NILL E  + K+ DFG  S   P       +    G+  ++ PE    
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 185

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
               Q   K DV+S G+   E+   +P         + N+   +  +     + Q   P 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPA 233

Query: 696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN 732
           L      +  R F    + CL     DRP+  +VL  
Sbjct: 234 LQSGHWSEYFRNF---VDSCLQKIPQDRPT-SEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 62.6 bits (153), Expect = 2e-10
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 59/226 (26%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-----GNPRSQQGLAEFQT--EIEMLSQFR-HRHL 519
           +G G +G V+K  +      VA+K+      N    Q     +T  EI  L +   H ++
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPNI 69

Query: 520 VSLIGYCDEKN--EMILIYEYMEN--------GTLKG-H----LYGSGLPSLSWKQRLEI 564
           V L+     +N  ++ L++EYME           L+  H    +Y          Q L  
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIMY----------QLL-- 117

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                + L Y+H+G    VIHRD+K +NILL+ +   K+ADFGL+++  E+++   +  +
Sbjct: 118 -----KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGV-------VLFEVLCARPV 663
                Y+   ++R  ++   S  Y+ GV       +L E+L  +P+
Sbjct: 170 T---DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 44/215 (20%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE-FQT---------EIEMLSQFRHR 517
           +G G +G+V        G KVA+K+        L+  FQ+         E+ +L    H 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKK--------LSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 518 HLVSLIG-YC-DEKNEMIL-IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GS 568
           +++ L+  +      E    +Y          HL G+ L ++   Q+L    I       
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVT-------HLMGADLNNIVKCQKLSDDHIQFLVYQI 127

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
            RGL Y+H+     +IHRD+K +NI ++E+   K+ DFGL++   +    +V+T      
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR----- 179

Query: 629 GYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            Y  PE         +  D++S G ++ E+L  + 
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 40/161 (24%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           IG G +G V+K         VA+KR        G P S         EI +L + +H+++
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 61

Query: 520 VSLIGYCDEKNEMILIYEYME----------NGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           V L        ++ L++EY +          NG +   +  S +  L             
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------L 109

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           +GL + H   +  V+HRD+K  N+L+++N   K+ADFGL++
Sbjct: 110 KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 40/225 (17%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKR--------GNPRSQQGLAE----FQT--EIEMLSQ 513
           +G G +GKV K      G  VA+K+           + +Q +      F T  E++++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 514 FRHRHLVSLIG-YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA--R 570
            +H +++ L+  Y  E + + L+ + M    LK  +      + S  +    CI      
Sbjct: 77  IKHENIMGLVDVYV-EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVK----CILLQILN 130

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-------TGPEIDQTHVS-- 621
           GL+ LH  Y    +HRD+  ANI ++   + K+ADFGL++       +        +   
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 622 ---TAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              T+   +  Y  PE     ++     D++S G +  E+L  +P
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 45/275 (16%)

Query: 469 IGIGGFGKVY-KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           IG G FG VY   ++     VA+K+ +   +Q   ++Q    E++ L + +H + +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTGY 579
               ++   L+ EY            S L  +  K  Q +EI     G+ +GL YLH+  
Sbjct: 93  CYLREHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-- 143

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY--- 635
              +IHRD+K+ NILL E    K+ADFG  S   P       + +  G+  ++ PE    
Sbjct: 144 -HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------ANSFVGTPYWMAPEVILA 195

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
               Q   K DV+S G+   E+   +P         + N+   +  +     + Q   PT
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPT 243

Query: 696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
           L      D  R F    + CL     DRP+  ++L
Sbjct: 244 LQSNEWSDYFRNF---VDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 16/205 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G + KV    L    ++     VK+      + +   QTE  +  Q   H  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLHYLHTGYA 580
                 ++ +  + EY+  G L  H+     LP    +    EI +     L+YLH    
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE--- 114

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           + +I+RD+K  N+LLD     K+ D+G+ K G     T  ++   G+  Y+ PE  R + 
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGED 172

Query: 641 LTEKSDVYSFGVVLFEVLCARPVID 665
                D ++ GV++FE++  R   D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 27/197 (13%)

Query: 472 GGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK 529
                + K +    T VAVK+ N    S++ L   Q EI    Q +H +++  +      
Sbjct: 13  LMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 530 NEMILIYEYMENGT----LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           +E+ ++   M  G+    LK H +  GLP L+      I       L Y+H+   K  IH
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTH-FPEGLPELAIAF---ILKDVLNALDYIHS---KGFIH 124

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS-------FGYLDPEYFRR 638
           R VK+++ILL  +    ++  GL  +   I        V            +L PE  + 
Sbjct: 125 RSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ- 181

Query: 639 QQL---TEKSDVYSFGV 652
           Q L    EKSD+YS G+
Sbjct: 182 QNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 50/213 (23%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ------GLAEFQTEIEMLSQFRHRHLVS 521
           IG G +GKVYK  + N G  VA+K+      +       L E    ++MLS+    ++V 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL-LQMLSE--SIYIVR 65

Query: 522 LIG--YCDEKNEMILIY---EYMENGTLK-----GHLYGSGLPSLSWKQRL-EICIGSAR 570
           L+   + +EKN    +Y   EY+++   K     G   G  LP+ + K  + ++  G A 
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA- 124

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKT------------------ 611
              + H      V+HRD+K  N+L+D+     K+AD GL +                   
Sbjct: 125 ---HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178

Query: 612 GPEI--DQTHVSTAVK-GSFGYLDPEYFRRQQL 641
            PE+    TH ST V   S G +  E  R+Q L
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 34/214 (15%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G + KV   EL    ++     +K+      + +   QTE  +      H  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR-----------LEICIGSARG 571
                 ++ +  + E++  G L  H+          +QR            EI +     
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQ---------RQRKLPEEHARFYSAEISLA---- 108

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L++LH    + +I+RD+K  N+LLD     K+ D+G+ K G  I     ++   G+  Y+
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
            PE  R +      D ++ GV++FE++  R   D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 469 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           +G G +  VYKG  +L D   VA+K      ++G       E+ +L   +H ++V+L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
              +  + L++EY++   LK +L   G  S++            RGL+Y H    + V+H
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLH 127

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTEK 644
           RD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+        + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYSTQ 185

Query: 645 SDVYSFGVVLFEVLCARPV 663
            D++  G + +E+   RP+
Sbjct: 186 IDMWGVGCIFYEMSTGRPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 68/247 (27%), Positives = 110/247 (44%), Gaps = 38/247 (15%)

Query: 462 NFDESWVIGIGGFGKVY---KGELNDGTKV----AVKRGNPRSQQGLAEF-QTEIEMLSQ 513
           NF+   V+G G +GKV+   K   +D  K+     +K+     +    E  +TE ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 514 FRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARG 571
            R    LV+L        ++ LI +Y+  G L  HL          +Q ++I  G     
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L +LH      +I+RD+K  NILLD N    + DFGLSK   E D+   + +  G+  Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYM 173

Query: 632 DPEYFRRQQLTEKS--DVYSFGVVLFEVLC-----------------ARPVI--DPTLPR 670
            P+  R          D +S GV+++E+L                  +R ++  +P  P+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 233

Query: 671 EMVNLAE 677
           EM  LA+
Sbjct: 234 EMSALAK 240

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 25/201 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           ++G G  G VYK   L     +AVK          Q+   +  +E+E+L +    +++  
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK---QIMSELEILYKCDSPYIIGF 64

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSARGLHYLHTGYAK 581
            G    +N + +  E+M+ G+L   +Y   +P    +  L  I +   +GL YL   ++ 
Sbjct: 65  YGAFFVENRISICTEFMDGGSLD--VYRK-IP----EHVLGRIAVAVVKGLTYL---WSL 114

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
            ++HRDVK +N+L++     K+ DFG+S +    I +T+V     G+  Y+ PE    +Q
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169

Query: 641 LTEKSDVYSFGVVLFEVLCAR 661
               SDV+S G+   E+   R
Sbjct: 170 YGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 30/152 (19%), Positives = 55/152 (36%), Gaps = 24/152 (15%)

Query: 10  NYLIDCGSRTNTTVGNRVFVADNS----ASKFLSTPQNVVANISESVTSSNDSQLYQTAR 65
              I+CG   +T      + AD      ++ +  +  N  ++I      + D +LYQT R
Sbjct: 2   VLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSI----AGTTDPELYQTER 57

Query: 66  IFTGSSKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFK 125
               S  Y       G + + L+F    +    + R  F V     ++L +F    ++  
Sbjct: 58  YSPSSFSYYIPCLENGNYTVILHFAEIYFGEDGLGRRVFDVYVQGKLVLKDF----DIVA 113

Query: 126 E------------FSVNVTSDSLDVIFSPSNN 145
           E              V VT  +L++ F  +  
Sbjct: 114 EAGGKGKTAHKEYIPVTVTDGTLEIHFYWAGK 145

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A GL +LH+   K +I+RD+K  N++LD     K+ADFG+ K      +T  +    G+ 
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
            Y+ PE    Q   +  D ++FGV+L+E+L  +P  D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 469 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           +G G +  V+KG  +L +   VA+K      ++G       E+ +L   +H ++V+L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVI 584
                 + L++EY++   LK ++   G  ++     ++I +    RGL Y H    + V+
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHR---RKVL 126

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 643
           HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+      + + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184

Query: 644 KSDVYSFGVVLFEVLCARPV 663
           + D++  G + FE+   RP+
Sbjct: 185 QIDMWGVGCIFFEMASGRPL 204

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 17/200 (8%)

Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPR---SQQGLAEFQTEIEML---SQFRHRHLVS 521
           IG G FG+VY+    D  ++ A+K  + +   +++ +A    E  +L          +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLHYLHTGYA 580
           L       +++ L+ +YM  G L  HL   G  S   + R +  I      L +LH    
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLHK--- 114

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +++RD+K  NILLD      + DFGLSK    +     +    G+  YL PE    ++
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 641 -LTEKSDVYSFGVVLFEVLC 659
             T+  D +S GV++FE+ C
Sbjct: 173 GYTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 27/217 (12%)

Query: 456 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKV----------AVKRGNPRSQQGLAEFQ 505
           +Q    ++D   VIG G FG+V         KV           +KR +       A F 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS------AFFW 91

Query: 506 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
            E ++++      +V L     +   + ++ EYM  G L   +    +P   W +     
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK----- 145

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
             +A  +  L   ++  +IHRDVK  N+LLD++   K+ADFG      E       TAV 
Sbjct: 146 FYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204

Query: 626 GSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 658
           G+  Y+ PE  + Q        + D +S GV LFE+L
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 70/273 (25%), Positives = 108/273 (39%), Gaps = 89/273 (32%)

Query: 468 VIGIGGFGKVYK------GELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQF-RHR 517
            +G G FGKV +       +      VAVK    G   S+       TE+++L     H 
Sbjct: 14  PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY--KALMTELKILIHIGHHL 71

Query: 518 HLVSLIGYCDEKN-EMILIYEYMENGTLKGHL----------------YGSGLPSLSWKQ 560
           ++V+L+G C +    +++I EY + G L  +L                          KQ
Sbjct: 72  NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131

Query: 561 RLE-----------------------------------------IC--IGSARGLHYLHT 577
           RL+                                         I      ARG+ +L +
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKGS----FGYL 631
              +  IHRD+ + NILL EN + K+ DFGL++   +I  D  +V    KG       ++
Sbjct: 192 ---RKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KGDARLPLKWM 242

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
            PE    +  T +SDV+SFGV+L+E+  L A P
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVK--RGNPRSQQGLAE-FQTEIEMLSQFR-HRHLVSL 522
           V+G G FGKV   EL    +V A+K  + +   Q    +   TE  +L+    H  L +L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
                 K+ +  + EY+  G L   +  S        +     +  A  L +LH      
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFLHR---HG 116

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           VI+RD+K  NILLD     K+ADFG+ K G  I     +T   G+  Y+ PE  +  +  
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTFCGTPDYIAPEILQELEYG 174

Query: 643 EKSDVYSFGVVLFEVLCARP 662
              D ++ GV+++E++  +P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 35/90 (38%), Positives = 47/90 (52%), Gaps = 11/90 (12%)

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID-QTHVSTAVKGSFGY 630
           LHYL   +   VIHRDVK +NILLD +   K+ DFG+S  G  +D +    +A  G   Y
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAKTRSA--GCAAY 180

Query: 631 LDPEYFRRQQLTEK----SDVYSFGVVLFE 656
           + PE         K    +DV+S G+ L E
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVE 210

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 14/100 (14%)

Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID---QTHV 620
           I + + + L+YL       +IHRDVK +NILLD N   K+ DFG+S  G  +D   +T  
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSIAKTRD 167

Query: 621 STAVKGSFGYLDPEY---FRRQQLTEKSDVYSFGVVLFEV 657
           +    G   Y+ PE      R     +SDV+S G+ L+EV
Sbjct: 168 A----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 26/204 (12%)

Query: 469 IGIGGFGKV----YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVS 521
           +G G FG+V    +KG    G   A+K    R    + + Q    E  +L +  H  +V+
Sbjct: 26  LGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82

Query: 522 LI-GYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWK-QRLEICIGSARGLHYLHTG 578
           ++  + DE     L+ E++  G L  HL  +G  P+   K    E+ +       YLH+ 
Sbjct: 83  MMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLHS- 136

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             K +I+RD+K  N+LLD     KV DFG +K  P+   T     + G+  YL PE  + 
Sbjct: 137 --KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQS 189

Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
           +   +  D ++ GV+L+E +   P
Sbjct: 190 KGHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 2e-09
 Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 34/215 (15%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
            IG G +G V    +   G KVA+K+  +      LA+ +T  E+++L  F+H +++++ 
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK-RTLRELKILRHFKHDNIIAIR 70

Query: 524 G-YCDEKNEMILIY---EYMENGTLKGHLYGSGLPSLSWK-------QRLEICIGSARGL 572
                   +   +Y   + ME+     H+  S  P L+ +       Q L       RGL
Sbjct: 71  DILRPPGADFKDVYVVMDLMESDL--HHIIHSDQP-LTEEHIRYFLYQLL-------RGL 120

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFG 629
            Y+H   +  VIHRD+K +N+L++E+   ++ DFG+++   + P   +  ++  V  +  
Sbjct: 121 KYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRW 176

Query: 630 YLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
           Y  PE      + T   D++S G +  E+L  R +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 30/210 (14%)

Query: 469 IGIGGFGKVYKGELNDGTKVA---VKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           IG G FGKV   E+   T VA   VK      + + Q    EF  + +     +H +++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN---EFLQQGDPYRILQHPNILQ 59

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL------YGSGLPSLSWKQRLEICIGSARGLHYL 575
            +G C E    +L++EY E G LK +L        +    L  +   EI  G    +H  
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH-MHKH 118

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           +       +H D+   N  L  +   KV D+G+  +  + D             +L PE 
Sbjct: 119 N------FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 636 FRRQQ-------LTEKSDVYSFGVVLFEVL 658
                        T+ S+V++ GV L+E+ 
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 32/220 (14%)

Query: 458 EATNNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-R 515
           + T+ ++    IG G +GKVYK     DG+  AVK  +P S     E + E  +L     
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPN 77

Query: 516 HRHLVSLIG--YCDEK---NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------I 564
           H ++V   G  Y  +K    ++ L+ E    G++   + G     L   QRL+      I
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL----LICGQRLDEAMISYI 133

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--ST 622
             G+  GL +LH      +IHRDVK  NILL      K+ DFG+S    ++  T +  +T
Sbjct: 134 LYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNT 187

Query: 623 AVKGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEV 657
           +V   F ++ PE    +Q  + S     DV+S G+   E+
Sbjct: 188 SVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 469 IGIGGFGKVYKG---ELNDGTKVAVKR-GNPRSQQGLAEFQT-EIEMLSQFR-HRHLVSL 522
           +G G +G V      E ++   VA+K+  N  S++ LA+    E+++L  FR H+++  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 523 ----IGYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
               I +    NE+ L  E ME   +  ++     SG P L+             GL Y+
Sbjct: 68  YDMDIVFPGNFNELYLYEELMEADLHQIIR-----SGQP-LTDAHFQSFIYQILCGLKYI 121

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLD 632
           H+     V+HRD+K  N+L++ +   K+ DFGL++     P  +   ++  V  +  Y  
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRA 177

Query: 633 PEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 663
           PE     Q   K+ DV+S G +L E+L  +PV
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 14/201 (6%)

Query: 468 VIGIGGFGKVY-----KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FGKV        E     KV  K+   + ++          +L   +H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC-IGSARGLHYLHTGYAK 581
                  +++  + +Y+  G L  HL       L  + R     I SA G  YLH+    
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALG--YLHS---L 115

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +++RD+K  NILLD      + DFGL K   E + T  ++   G+  YL PE   +Q  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPY 173

Query: 642 TEKSDVYSFGVVLFEVLCARP 662
               D +  G VL+E+L   P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 76/279 (27%), Positives = 116/279 (41%), Gaps = 41/279 (14%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNP-----RSQQGLAEFQTEIEMLSQFR 515
           +FD   VIG G FG+V         +V A+K  +      RS    A F  E ++++   
Sbjct: 44  DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS--AFFWEERDIMAHAN 101

Query: 516 HRHLVSL-IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGL 572
              +V L   + D+K  + ++ EYM  G L   +    +P   W +    E+ +     L
Sbjct: 102 SEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLA----L 155

Query: 573 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGS 627
             +H+ G+    IHRDVK  N+LLD++   K+ADFG    +   G         TAV G+
Sbjct: 156 DAIHSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG----MVRCDTAV-GT 206

Query: 628 FGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 683
             Y+ PE  + Q        + D +S GV L+E+L       P     +V      M  +
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT---PFYADSLVGTYSKIMDHK 263

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD 722
           N       I+ +   K   D +  F    E  L   GVD
Sbjct: 264 NSLTFPDDIEISKQAK---DLICAFLTDREVRLGRNGVD 299

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 17/102 (16%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI--DQTHVSTAVKG 626
           ARG+ +L +   +  IHRD+ + NILL EN + K+ DFGL++   +I  D  +V    KG
Sbjct: 184 ARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVR---KG 234

Query: 627 S----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
           S      ++ PE    +  T +SDV+SFGV+L+E+  L A P
Sbjct: 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 462 NFDESWVIGIGGFGKVY---------KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS 512
           NF+   V+G G +GKV+          G+L    KV  K    +  + +   +TE  +L 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLY-AMKVLQKAALVQKAKTVEHTRTERNVLE 59

Query: 513 QFRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR- 570
             R    LV+L      + ++ LI +Y+  G +  HLY          QR        R 
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----------QRDNFSEDEVRF 109

Query: 571 -------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                   L +LH      +++RD+K  NILLD      + DFGLSK     ++   + +
Sbjct: 110 YSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYS 165

Query: 624 VKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
             G+  Y+ PE  R +    K+ D +S G+++FE+L
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 7e-09
 Identities = 55/226 (24%), Positives = 105/226 (46%), Gaps = 38/226 (16%)

Query: 456 VQEATNNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLS 512
           + E  + + +   +G G +G V    +   G KVA+K+     Q  L   +   E+ +L 
Sbjct: 10  IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69

Query: 513 QFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
             +H +++ L+         D  ++  L+  +M  GT  G L       LS + R++  +
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMK--HEKLS-EDRIQFLV 124

Query: 567 GSA-RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAV 624
               +GL Y+H   A  +IHRD+K  N+ ++E+   K+ DFGL++ T  E+         
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT-------- 173

Query: 625 KGSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
               GY+   ++R  ++       T+  D++S G ++ E+L  +P+
Sbjct: 174 ----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 58.7 bits (142), Expect = 7e-09
 Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 13/148 (8%)

Query: 469 IGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           I  G FGKVY G   + +K+     VK+ +  ++  + + Q E + L+  +   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 525 YCDEKNEMILIYEYMENGTLKG--HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
                N + L+ EY+  G +K   H+YG     ++ K   E+    A  L YLH      
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEV----ALALDYLHR---HG 124

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSK 610
           +IHRD+K  N+L+      K+ DFGLSK
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRHR 517
           +F+   VIG G FG+V   +L +  KV A+K  N       AE   F+ E ++L    ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICIGSARGL 572
            + +L     ++N + L+ +Y   G L   L  +   LP   +  +   + I I S   L
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           HY         +HRD+K  NIL+D N   ++ADFG      E D T  S+   G+  Y+ 
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYIS 171

Query: 633 PEYFR-----RQQLTEKSDVYSFGVVLFEVL 658
           PE  +     + +   + D +S GV ++E+L
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 39/212 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ-----GLAEFQTEIEMLSQFRHRHLVSL 522
           IG G F +V K      G   A+K      +       L E Q  +  LS   H +++ L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQA-LRRLSP--HPNILRL 63

Query: 523 IGYC-DEK-NEMILIYEYMENGT---LKGHLYGSGLPSLSWKQRL-EICIGSARGLHYLH 576
           I    D K   + L++E M+      +KG      LP    K  + ++     + L ++H
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRP--LPEKRVKSYMYQLL----KSLDHMH 117

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 634
                 + HRD+K  NIL+ ++ + K+ADFG  +    I      T    +  Y  PE  
Sbjct: 118 ---RNGIFHRDIKPENILIKDDIL-KLADFGSCRG---IYSKPPYTEYISTRWYRAPECL 170

Query: 635 ----YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
               Y+       K D+++ G V FE+L   P
Sbjct: 171 LTDGYY-----GPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 42/226 (18%)

Query: 465 ESWVIGIGGFGKVYKGELNDGTK---VAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           E   +G G +G VYK +  DG      A+K+  G   S         EI +L + +H ++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNV 60

Query: 520 VSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----- 570
           +SL    + + D K  + L+++Y E+     H+      S + K+ +++  G  +     
Sbjct: 61  ISLQKVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 571 ---GLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK-----TGPEIDQT 618
              G+HYLH  +   V+HRD+K ANIL+     E    K+AD G ++       P  D  
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 619 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 663
            V      +F Y  PE     +  T+  D+++ G +  E+L + P+
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 6/89 (6%)

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            GL YLH   A+ +IHRDVK+ NI +++     + D G ++  P +    +  A  G+  
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA--GTVE 221

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              PE   R +   K+D++S G+VLFE+L
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 24/213 (11%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHL 519
           NF +   +G G +  VYKG     G  VA+K  +  +++G       EI ++ + +H ++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL-------SWKQRLEICIGSARGL 572
           V L      +N+++L++EYM+   LK ++   G+          S+  +L       +G+
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQL------LKGI 113

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 631
            + H      V+HRD+K  N+L+++    K+ADFGL++  G  ++ T  +  V  +  Y 
Sbjct: 114 AFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV--TLWYR 167

Query: 632 DPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 663
            P+     +    S D++S G ++ E++  RP+
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 25/216 (11%)

Query: 461 NNFDESWVIGIGGFGKVY---KGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR 515
            +FD   ++G G FG+V    +    D    KV +K+    +Q+ ++ F+ E ++LS   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSISN 59

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGL-PSLSWKQRLEICIGSARGL 572
              +  L     +K+ + L+ EY   G L   L  Y       ++     E+ +     +
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA----I 115

Query: 573 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H +H  GY    +HRD+K  N+L+D     K+ADFG S      ++   S    G+  Y+
Sbjct: 116 HSVHQMGY----VHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYI 170

Query: 632 DPEYFRRQQLTEKS------DVYSFGVVLFEVLCAR 661
            PE         K       D +S GV+ +E++  R
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 11/138 (7%)

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS--ARGLHYLHTGYAKAVIHRD 587
           + +  + EY+  G L   +   G     +K+   +   +  A GL +LH+   K +I+RD
Sbjct: 74  DRLYFVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRD 126

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           +K  N++LD     K+ADFG+ K    +     +    G+  Y+ PE    Q   +  D 
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184

Query: 648 YSFGVVLFEVLCARPVID 665
           ++FGV+L+E+L  +   +
Sbjct: 185 WAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 36/146 (24%), Positives = 76/146 (52%), Gaps = 14/146 (9%)

Query: 472 GGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSL--IG 524
           G +G VY+  +   G  VA+K+    + ++G     T   EI +L + +H ++V++  + 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP--ITSLREINILLKLQHPNIVTVKEVV 73

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
                +++ ++ EY+E+  LK  L  +        +   + +    G+ +LH      ++
Sbjct: 74  VGSNLDKIYMVMEYVEH-DLKS-LMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWIL 128

Query: 585 HRDVKSANILLDENFMAKVADFGLSK 610
           HRD+K++N+LL+   + K+ DFGL++
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 7/136 (5%)

Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
           + +  + EY+  G L  H+   G       Q +      + GL +LH    + +I+RD+K
Sbjct: 74  DRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLK 128

Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
             N++LD     K+ADFG+ K    +     +    G+  Y+ PE    Q   +  D ++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 650 FGVVLFEVLCARPVID 665
           +GV+L+E+L  +P  D
Sbjct: 187 YGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 11/198 (5%)

Query: 469 IGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           IG G FGKV +    D  ++     +++ +  S+  +     E  +L+Q     +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
                 ++ L+  ++  G L  HL   G   LS + R      +A  L  L   +   VI
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFY----TAELLCALENLHKFNVI 115

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           +RD+K  NILLD      + DFGL K    +     +    G+  YL PE       T+ 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173

Query: 645 SDVYSFGVVLFEVLCARP 662
            D ++ GV+L+E+L   P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 11/207 (5%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGLAEFQT--EIEMLSQFRHR 517
           N F+   V+G G +G V K    +  + VA+K+     +    +  T  E++ML   +  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
           ++V L      + ++ L++EY+E   L+      +G+P    +  +   I   + +H+ H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLI---KAIHWCH 117

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                 ++HRD+K  N+L+  N + K+ DFG ++   E    + +  V   + Y  PE  
Sbjct: 118 K---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW-YRSPELL 173

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPV 663
                 +  D++S G +L E+   +P+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 85  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 139

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRR 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 140 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192

Query: 639 QQLTEKSDVYSFGVVLFEVLCARPVIDPT 667
               +  D++S G ++ E+L  R +   T
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 35/97 (36%), Positives = 57/97 (58%), Gaps = 7/97 (7%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 627
           A+G+ +L +   +  IHRD+ + NILL EN + K+ DFGL++   + D  +V     +  
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLP 244

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
             ++ PE    +  T +SDV+SFGV+L+E+  L A P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 29/209 (13%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ---GLAEFQT-EIEMLSQFRHRHLVSL- 522
           IG G +G VYK  +      +A+K+   R +Q   G+      EI +L + +H ++V L 
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKK--IRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67

Query: 523 -IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-----ARGLHYLH 576
            + + +++  + L++EY++   LK H+  S  P  +   RL   I +      RG+ Y H
Sbjct: 68  DVVHSEKR--LYLVFEYLDL-DLKKHMDSS--PDFAKNPRL---IKTYLYQILRGIAYCH 119

Query: 577 TGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 634
           +     V+HRD+K  N+L+D    A K+ADFGL++      +T     V  +  Y  PE 
Sbjct: 120 S---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEI 174

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
               +  +   D++S G +  E++  +P+
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPL 203

Length = 294

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.8 bits (132), Expect = 9e-08
 Identities = 84/321 (26%), Positives = 129/321 (40%), Gaps = 79/321 (24%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVS--- 521
           VIG G +G V    + + G KVA+K+ N   +          EI++L   RH  +V    
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 522 --LIGYCDEKNEMILIYEYME---------NGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
             L     E  ++ +++E ME         N  L    +   L  L             R
Sbjct: 67  IMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQL------------LR 114

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-----TGPEIDQT-HVSTAV 624
            L Y+HT     V HRD+K  NIL + +   K+ DFGL++     T   I  T +V+T  
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR- 170

Query: 625 KGSFGYLDPE----YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWA 679
                Y  PE    +F +   T   D++S G +  EVL  +P+     P + +V+     
Sbjct: 171 ----WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPL----FPGKNVVH----- 215

Query: 680 MKWQNKGQLDQIID------PTLAGKIRPDSLRKFGETAEKCLA-DFGVDRPSMGDVLWN 732
                  QLD I D      P    ++R +  R++  +  K     F    P+  D L  
Sbjct: 216 -------QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPN-ADPL-- 265

Query: 733 LEYALQLQEAVVHGDPDENST 753
              AL+L E ++  DP +  T
Sbjct: 266 ---ALRLLERLLAFDPKDRPT 283

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 61/226 (26%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           IG G +G V   + ++   KVA+K+        +   +T  EI++L    H +++++   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 526 C-----DEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEICI 566
                 +  N++ ++YE M+         + TL   H    LY          Q L    
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLY----------QLL---- 118

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              RGL Y+H+     V+HRD+K +N+LL+ N   K+ DFGL++T          T+ KG
Sbjct: 119 ---RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART----------TSEKG 162

Query: 627 SF--GYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            F   Y+   ++R  +L       T   DV+S G +  E+L  +P+
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 42/226 (18%)

Query: 465 ESWVIGIGGFGKVYKGELNDGT---KVAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           E   +G G +G VYK +  DG    + A+K+  G   S         EI +L + +H ++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNV 60

Query: 520 VSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----- 570
           ++L    + + D K  + L+++Y E+     H+      S + K+ +++     +     
Sbjct: 61  IALQKVFLSHSDRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQ 116

Query: 571 ---GLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK-----TGPEIDQT 618
              G+HYLH  +   V+HRD+K ANIL+     E    K+AD G ++       P  D  
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 619 HVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 663
            V      +F Y  PE     +  T+  D+++ G +  E+L + P+
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 37/121 (30%), Positives = 60/121 (49%), Gaps = 13/121 (10%)

Query: 554 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 613
           P+LS+   +      A G+ +L +   K  +HRD+ + N+L+ E  + K+ DFGL++   
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR--- 287

Query: 614 EIDQTHVSTAV-KGS----FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL 668
             D    S  + KGS      ++ PE       T  SDV+SFG++L+E+        P L
Sbjct: 288 --DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345

Query: 669 P 669
           P
Sbjct: 346 P 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 39/128 (30%), Positives = 63/128 (49%), Gaps = 13/128 (10%)

Query: 536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 595
           Y+   +  +K  L   G   L+    L      ARG+ +L +   K  +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270

Query: 596 DENFMAKVADFGLSKTGPEIDQTHVSTAV-KGS----FGYLDPEYFRRQQLTEKSDVYSF 650
            +  + K+ DFGL++     D  H S  V KGS      ++ PE       T  SDV+S+
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325

Query: 651 GVVLFEVL 658
           G++L+E+ 
Sbjct: 326 GILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 23/153 (15%)

Query: 468 VIGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
            +G G +  VYKG  +L     VA+K      ++G A F    E  +L   +H ++V+L 
Sbjct: 12  KLGEGSYATVYKGRSKLTG-QLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLH 69

Query: 524 GYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSARGLHYLHT 577
                K  + L++EY++   LK ++   G GL   + +    Q L       RGL Y H 
Sbjct: 70  DIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQ 121

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
              + V+HRD+K  N+L+ E    K+ADFGL++
Sbjct: 122 ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 469 IGIGGFGKVYKG--ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIG 524
           +G G +  VYKG   +N G  VA+K  + ++++G+  F    E  +L   +H ++V L  
Sbjct: 13  LGEGSYATVYKGISRIN-GQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKA 582
               K  +  ++EYM     +   Y    P     +  RL       RGL Y+H    + 
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIH---GQH 123

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQL 641
           ++HRD+K  N+L+      K+ADFGL++      QT+ S  V  +  Y  P+        
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181

Query: 642 TEKSDVYSFGVVLFEVLCARPV 663
           +   D++  G +  E+L  +P 
Sbjct: 182 SSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 61/238 (25%), Positives = 102/238 (42%), Gaps = 51/238 (21%)

Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV------- 520
           +G G  G V+    +D   +VAVK+      Q +     EI+++ +  H ++V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 521 -------SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS----LSWKQRLEICIGSA 569
                    +G   E N + ++ EYME   L   L    L      L   Q L       
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLL------- 124

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           RGL Y+H+     V+HRD+K AN+ ++ E+ + K+ DFGL++    I   H S       
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLAR----IVDPHYSHK----- 172

Query: 629 GYLD----PEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
           GYL      +++R  +L       T+  D+++ G +  E+L  +P+       E + L
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 18/197 (9%)

Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +  VYKG+   +G  VA+K    + ++G   F    E  +L   +H ++V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDI 71

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVI 584
              K  + L++EY+     +   Y    P     + +++ +    RGL Y+H  Y   ++
Sbjct: 72  IHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRD+K  N+L+ +    K+ADFGL++       T+ +  V  +  Y  P+       TE 
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--TEY 181

Query: 645 S---DVYSFGVVLFEVL 658
           S   D++  G +  E++
Sbjct: 182 STCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 41/292 (14%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGY 525
           +G G +G VYK  L+  T V +     R +   ++F     E+++L +    ++V   G 
Sbjct: 9   LGKGNYGSVYKV-LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKAV 583
              +  + +  EYM+ G+L   LY  G+ +  +       I     +GL +L   +   +
Sbjct: 68  FFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 584 IHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSFGYLDPEYFR----- 637
           IHRDVK  N+L++ N   K+ DFG+S      + +T++     G   Y+ PE  +     
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPN 179

Query: 638 -RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID--- 693
                T +SDV+S G+ + E+   R    P  P    N+           QL  I+D   
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRY---PYPPETYANIF---------AQLSAIVDGDP 227

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 745
           PTL      D+ + F     KCL      RP+   +L    + ++ + A V 
Sbjct: 228 PTLPSGYSDDA-QDF---VAKCLNKIPNRRPTYAQLL-EHPWLVKYKNADVD 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 48/228 (21%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDG-TKVAVKRGNPRS-------QQGLAEFQTEIEMLS 512
            +F+   +I  G +G VY     +   + A+K+ N ++       QQ   E     ++L+
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER----DILT 56

Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSAR- 570
              +  +VS+    + K  + ++ EY+E G     L   G LP           +  AR 
Sbjct: 57  FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALP-----------VDMARM 105

Query: 571 -------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG----------- 612
                   L YLH      ++HRD+K  N+L+      K+ DFGLSK G           
Sbjct: 106 YFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162

Query: 613 -PEID-QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             E D +  +   V G+  Y+ PE   RQ   +  D ++ G++L+E L
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 11/93 (11%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS- 627
           A+G+ +L    +K  IHRDV + N+LL +  +AK+ DFGL++     D  +V   VKG+ 
Sbjct: 222 AQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYV---VKGNA 274

Query: 628 ---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
                ++ PE       T +SDV+S+G++L+E+
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 69/235 (29%), Positives = 105/235 (44%), Gaps = 41/235 (17%)

Query: 451 FPFVAVQEATNNF---DESW----VIGIGGFGKVYKGELN--DGTKVAVKRGNPRSQQGL 501
           FP        ++F    ++W     IG G +GKV+K  LN  +G+K AVK  +P      
Sbjct: 1   FPLSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDID- 58

Query: 502 AEFQTEIEMLSQFR-HRHLVSLIGYC---DEKN--EMILIYEYMENGTLKGHLYGSGLPS 555
            E + E  +L     H ++V   G     D KN  ++ L+ E    G++   + G     
Sbjct: 59  EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF---- 114

Query: 556 LSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 609
           L   +R+E      I   +  GL +LH       IHRDVK  NILL      K+ DFG+S
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Query: 610 KTGPEIDQTHV--STAVKGSFGYLDPEYFR-RQQL----TEKSDVYSFGVVLFEV 657
               ++  T +  +T+V   F ++ PE     QQL      + DV+S G+   E+
Sbjct: 172 A---QLTSTRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 58/253 (22%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRH 516
            +F    VIG G FG+V   +  D  K+   +   +S+      LA  + E ++L++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI--CIGSARGLHY 574
             +VSL     +   + LI E++  G L   L      S     R  +  C+ +   +H 
Sbjct: 61  PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-VTRFYMAECVLAIEAVHK 119

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS------------------------- 609
           L  G+    IHRD+K  NIL+D     K++DFGLS                         
Sbjct: 120 L--GF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173

Query: 610 --KTGPEIDQTHVSTAVK------------------GSFGYLDPEYFRRQQLTEKSDVYS 649
             +    +D  +++ + K                  G+  Y+ PE F +Q   ++ D +S
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233

Query: 650 FGVVLFEVLCARP 662
            G ++FE L   P
Sbjct: 234 LGAIMFECLIGWP 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 11/94 (11%)

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS- 627
           A+G+ +L +   K  IHRD+ + NILL    + K+ DFGL++     D  +V   VKG+ 
Sbjct: 224 AKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD-IRNDSNYV---VKGNA 276

Query: 628 ---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                ++ PE       T +SDV+S+G++L+E+ 
Sbjct: 277 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 24/212 (11%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRH 516
           ++F+   VIG G FG+V   ++    ++ A+K  N       AE   F+ E  +L     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICIGSARG 571
           + + +L     ++N + L+ +Y   G L   L  +   LP   +  +   + + I S   
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           LHY         +HRD+K  N+LLD N   ++ADFG S      D T  S+   G+  Y+
Sbjct: 121 LHY---------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYI 170

Query: 632 DPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 658
            PE  +  +        + D +S GV ++E+L
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 54/249 (21%), Positives = 101/249 (40%), Gaps = 44/249 (17%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           ++F+   VIG G FG+V   +  D   +     +++ +   ++ +A  + E ++L +   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYL 575
             +V +     +K  + LI E++  G +   L      S    Q  +   + +   +H L
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGL--------------------------- 608
                   IHRD+K  N+LLD     K++DFGL                           
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 609 ---SKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              SK   E    ++  ++ +  G+  Y+ PE F +    +  D +S GV+++E+L   P
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 663 VIDPTLPRE 671
                 P+E
Sbjct: 235 PFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 4e-06
 Identities = 82/370 (22%), Positives = 144/370 (38%), Gaps = 54/370 (14%)

Query: 13  IDCGSRTN--TTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGS 70
           I CG+R N  T   N ++  D + +  +       + I+  +         +T R F  S
Sbjct: 28  ISCGARVNVRTAPTNTLWYKDFAYTGGIPANATRPSFIAPPL---------KTLRYFPLS 78

Query: 71  SK----YTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVS---TNDHVLLNNFS-VSSN 122
                 Y  +   +G + +R+ F+  V +    S   F VS   T    L + +S     
Sbjct: 79  DGPENCYNINRVPKGHYSVRV-FFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQ 137

Query: 123 VFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVVSVPDQLITDDASSISPPGKYQGLVFQ 182
           VF E  V +T  S  + F  + +    I ++E++ V      D A +  P    QG++ +
Sbjct: 138 VFAEALVFLTDGSASICFHSTGHGDPAILSIEILQV-----DDKAYNFGPSWG-QGVILR 191

Query: 183 TFETVHRVNMGGPLVTPEND---TLW---RTWVPDQSFLVNRNLAKSVSNIPAVKYVQGG 236
              T  R++ G      + D     W   R W   Q+F    + A S  N+      +  
Sbjct: 192 ---TAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIK----KAS 244

Query: 237 ATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVS--DGLNQL 294
                 P ++Y +A  +++D  P    ++++  DVD    Y V  HF +I +      + 
Sbjct: 245 NAPNFYPESLYQSAL-VSTDTQP----DLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKR 299

Query: 295 YFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTY-PDA 353
            F+V I+   A +D+D+   S     A      V V  +   L I      L       A
Sbjct: 300 VFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAV--SGRTLTI-----VLQPKKGTHA 352

Query: 354 ILNGLEIMKM 363
           I+N +E+ ++
Sbjct: 353 IINAIEVFEI 362

Length = 623

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 38/208 (18%)

Query: 469 IGIGGFGKV---YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
           +G G +G V   Y   L    KVAVK+ +   Q  +   +T  E+ +L   +H +++ L+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARG 571
                    +  NE+ L+   M          G+ L ++   Q+L       +     RG
Sbjct: 81  DVFTPATSIENFNEVYLVTNLM----------GADLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L Y+H+     +IHRD+K +N+ ++E+   ++ DFGL++   +    +V+T       Y 
Sbjct: 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYR 182

Query: 632 DPE-YFRRQQLTEKSDVYSFGVVLFEVL 658
            PE         +  D++S G ++ E+L
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRH 516
           ++F+   VIG G FG+V   ++ +  +V A+K  N       AE   F+ E ++L     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 517 RHLVSL-IGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK---QRLEICIGSAR 570
           R + +L   + DE N + L+ +Y   G L   L  +   LP    +     + + I S  
Sbjct: 61  RWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            L Y         +HRD+K  N+LLD+N   ++ADFG S      D T  S    G+  Y
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDY 169

Query: 631 LDPEYFR-----RQQLTEKSDVYSFGVVLFEVL 658
           + PE  +     + +   + D +S GV ++E+L
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 54/232 (23%), Positives = 85/232 (36%), Gaps = 48/232 (20%)

Query: 468 VIGIGGFGKVYKGELNDGT------KVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++G G  G+V+   L  GT      KV  K+    R++       TE E+L+   H  L 
Sbjct: 8   LLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVL--TEQEILATLDHPFLP 64

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRL-EICIGSARGLHYLH 576
           +L      +  + L+ +Y   G L   L    G  L     +    E+ +     L YLH
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA----LEYLH 120

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG------- 629
                 +++RD+K  NILL E+    ++DF LSK              KGS         
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 630 --------------------YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
                               Y+ PE           D ++ G++L+E+L   
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)

Query: 469 IGIGGFGKVYKGELNDGT-------------KVAVKRGNPRSQQ-GLAEFQTEIEMLSQF 514
           +G G   ++Y G LN                KV +K  +P  +   LA F+T   M+ Q 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETA-SMMRQV 61

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY-GSGLPSLSWKQRLEICIGSARGLH 573
            H+H+V L G C    E I++ E++E G L   ++  S + +  WK ++   + SA  L 
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASA--LS 119

Query: 574 YLHTGYAKAVIHRDVKSANILL-DENFMAKVADF-GLSKTGPEIDQTHVSTAVKGSFGYL 631
           YL     K ++H +V + NILL  E    +   F  LS  G  I        V+    ++
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-RIPWI 175

Query: 632 DPEYFR-RQQLTEKSDVYSFGVVLFEVLCAR---PVIDPTL 668
            PE     + L+  +D +SFG  L+E+ C     P+ D TL
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDKTL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 27/205 (13%)

Query: 468 VIGIGGFGKVYKGELNDGTKV----------AVKRGNPRSQQGLAEFQTEIEMLSQFRHR 517
           VIG G FG+V         KV           +KR +       A F  E ++++     
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSP 103

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
            +V L     +   + ++ EYM  G L   +    +P   W +       +A  +  L  
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FYTAEVVLALDA 157

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
            ++   IHRDVK  N+LLD++   K+ADFG      +       TAV G+  Y+ PE  +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 216

Query: 638 RQ----QLTEKSDVYSFGVVLFEVL 658
            Q        + D +S GV L+E+L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.2 bits (117), Expect = 5e-06
 Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 10/108 (9%)

Query: 556 LSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS 609
           L+ K+ + IC   A      R + YLH      +IHRD+K+ NI ++      + DFG +
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAA 229

Query: 610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
               +I+         G+     PE   R       D++S G+VLFE+
Sbjct: 230 CFPVDINANKY-YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 25/191 (13%)

Query: 480 GELNDGT---KVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI 535
            E N+     +V +K  +P  +   LA F+T   ++SQ  H HL  + G C   +E I++
Sbjct: 36  VEGNNNGRELRVVLKVLDPSHRDIALAFFETA-SLMSQVSHIHLAFVHGVCVRGSENIMV 94

Query: 536 YEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
            E++E+G L       KG +       ++WK  +   + SA  L YL     K ++H +V
Sbjct: 95  EEFVEHGPLDVCLRKEKGRV------PVAWKITVAQQLASA--LSYLED---KNLVHGNV 143

Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK-GSFGYLDPEYFRR-QQLTEKSD 646
            + NILL    +A+     +  + P +  T +S   +     ++ PE       L+  +D
Sbjct: 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAAD 203

Query: 647 VYSFGVVLFEV 657
            +SFG  L E+
Sbjct: 204 KWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 33/126 (26%), Positives = 51/126 (40%), Gaps = 20/126 (15%)

Query: 556 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI 615
           L+ ++   +C+     L  LH         R  KS NILL  + + K  D  ++   PE 
Sbjct: 14  LNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLLK-LDGSVAFKTPEQ 63

Query: 616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
            +          F    PE  + Q  TEK+D+YS G+ L+E L           RE+  +
Sbjct: 64  SR------PDPYFM--APEVIQGQSYTEKADIYSLGITLYEALDYEL--PYNEERELSAI 113

Query: 676 AEWAMK 681
            E  + 
Sbjct: 114 LEILLN 119

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 462 NFDESWVIGIGGFGKV----YKGELNDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF 514
           +F+    +G G FG+V    YK E  D   VA+KR        Q+ +    +E ++L+  
Sbjct: 31  DFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI 88

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI---CIGSARG 571
            H   V+L G   +++ + L+ E++  G             L   +R      C  +A+ 
Sbjct: 89  NHPFCVNLYGSFKDESYLYLVLEFVIGGEF--------FTFLRRNKRFPNDVGCFYAAQI 140

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           +       +  +++RD+K  N+LLD++   K+ DFG +K    +  T   T + G+  Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK----VVDTRTYT-LCGTPEYI 195

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE        + +D ++ G+ ++E+L   P
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 8e-06
 Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 29/199 (14%)

Query: 485 GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
           GT V V+  +    +++ L   Q E+ +   FRH ++++        + + +I  +M  G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 543 TLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLH-TGYAKAVIHRDVKSANILLDENFM 600
           +    L  +  P  +S      I  G+ RGL+YLH  GY    IHR++K+++IL+  + +
Sbjct: 85  SAN-SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISGDGL 139

Query: 601 AKVADFGLS----------KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL---TEKSDV 647
             ++  GLS          K     D    ST+V     +L PE   RQ L     KSD+
Sbjct: 140 VSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELL-RQDLYGYNVKSDI 193

Query: 648 YSFGVVLFEVLCAR-PVID 665
           YS G+   E+   R P  D
Sbjct: 194 YSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 46/220 (20%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR--GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +IG G FG VY+   ++   KVA+K+   +P+ +        E+ ++    H +++ L  
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKD 126

Query: 525 Y----CDEKNE----MILIYEYMENGTLKGHLYGS----GLPSLSWK-QRLEICIGSARG 571
           Y    C +KNE    + ++ E++     K   + +     LP    K    ++C    R 
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC----RA 182

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           L Y+H+   K + HRD+K  N+L+D N    K+ DFG +K            A + S  Y
Sbjct: 183 LAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN---------LLAGQRSVSY 230

Query: 631 LDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
           +   ++R  +L       T   D++S G ++ E++   P+
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPI 270

Length = 440

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/271 (19%), Positives = 105/271 (38%), Gaps = 59/271 (21%)

Query: 463 FDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           F +   +GIG FG+V      D   +     +++ +   +  +A  + E ++L++  +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYLHT 577
           +V L     +K+ +  + +Y+  G +   L   G+      +  +     +   +H +  
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM-- 120

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLS------------KTGPEIDQTH------ 619
                 IHRD+K  NIL+D +   K+ DFGL             ++G  + Q        
Sbjct: 121 ----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 620 ---------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 652
                                      ++ ++ G+  Y+ PE   R   T+  D +S GV
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 653 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 683
           +L+E+L  +P   P L +  +      + WQ
Sbjct: 237 ILYEMLVGQP---PFLAQTPLETQMKVINWQ 264

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 53/248 (21%), Positives = 99/248 (39%), Gaps = 44/248 (17%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHR 517
           +F+   VIG G FG+V   +  D   V     +++ +   ++ +   + E ++L +    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ-RLEICIGSARGLHYLH 576
            +V +     +K  + LI E++  G +   L      +    Q  +   + +   +H L 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL- 120

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGL---------------------------- 608
                  IHRD+K  N+LLD     K++DFGL                            
Sbjct: 121 -----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 609 --SKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             SK   E    ++  ++ +  G+  Y+ PE F +    +  D +S GV+++E+L   P 
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 664 IDPTLPRE 671
                P+E
Sbjct: 236 FCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 3e-05
 Identities = 56/264 (21%), Positives = 107/264 (40%), Gaps = 63/264 (23%)

Query: 469 IGIGGFGKV-YKGELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +GIG FG+V    +++     A+K   + +  ++  +A  + E ++L++  +  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGL-P---SLSWKQRLEICIGSARGLHYLHTGYA 580
              +K+ +  + +Y+  G +   L    + P   +  +   L + I S   + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLS------------KTGPEIDQTH--------- 619
              IHRD+K  NIL+D +   K+ DFGL             + G  I Q           
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 620 ------------------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 655
                                   ++ ++ G+  Y+ PE   R+  T+  D +S GV+LF
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239

Query: 656 EVLCAR-PVIDPTLPREMVNLAEW 678
           E+L  + P + PT     + +  W
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 3e-05
 Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 22/150 (14%)

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENG----TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           + + + L          +LI +Y+++G     LK          LS  +  +I       
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE------GKLSEAEVKKIIRQLVEA 121

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSKTGPEIDQTHVSTAVKGSFG 629
           L+ LH      +IH D+K  N+L D     ++   D+GL K           +   G+  
Sbjct: 122 LNDLH---KHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKI------IGTPSCYDGTLD 171

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           Y  PE  +        D ++ GV+ +E+L 
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 4e-05
 Identities = 57/247 (23%), Positives = 98/247 (39%), Gaps = 55/247 (22%)

Query: 461 NNFDESWVIGIGGFGKV---YKGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           ++F+   VIG G FG+V    K +       K   K      +Q +A  + E ++L++  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           +  +V L  Y    DE   + LI EY+  G +   L      + + ++       +   +
Sbjct: 60  NPWVVKL--YYSFQDENY-LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAI 114

Query: 573 HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSK--------------------T 611
             +H  GY    IHRD+K  N+LLD     K++DFGL                       
Sbjct: 115 DSIHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 612 GPEIDQTHVSTAVK----------------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLF 655
             +     +S+  K                G+  Y+ PE F +    ++ D +S GV+++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 656 EVLCARP 662
           E+L   P
Sbjct: 231 EMLVGYP 237

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.0 bits (109), Expect = 4e-05
 Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 55/216 (25%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQTEI---------EMLSQFRHR 517
           +G G +G V    +   G KVA+K+   P        FQ+EI          +L   +H 
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRP--------FQSEIFAKRAYRELTLLKHMQHE 74

Query: 518 HLVSLIGY------CDEKNEMILIYEYMENGTLK--GHLYGSGLPSLSWKQRLEICIGSA 569
           +++ L+         DE  +  L+  YM+    K  GH        LS  +   +     
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-------PLSEDKVQYLVYQML 127

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            GL Y+H   +  +IHRD+K  N+ ++E+   K+ DFGL++   + + T          G
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMT----------G 173

Query: 630 YLDPEYFRRQQL-------TEKSDVYSFGVVLFEVL 658
           Y+   ++R  ++        +  D++S G ++ E+L
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 25/89 (28%), Positives = 46/89 (51%), Gaps = 6/89 (6%)

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
             PE        E  D++S G ++ E++ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 58/254 (22%), Positives = 103/254 (40%), Gaps = 69/254 (27%)

Query: 469 IGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           IGIG FG+V      D   + A+K   + +   +   A  + E ++L++  +  +V L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 576
              +K+ +  + +Y+  G +   L   G+    +++ L      AR         +  +H
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRLGI----FEEDL------ARFYIAELTCAIESVH 118

Query: 577 -TGYAKAVIHRDVKSANILLDENFMAKVADFGL--------------------------S 609
             G+    IHRD+K  NIL+D +   K+ DFGL                          S
Sbjct: 119 KMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 610 KTGPEIDQTHVST---------------AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           +   EID+  +                 ++ G+  Y+ PE   R   T+  D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 655 FEVLCAR-PVIDPT 667
           +E+L  + P +  T
Sbjct: 235 YEMLVGQPPFLADT 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 35/144 (24%), Positives = 61/144 (42%), Gaps = 16/144 (11%)

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG--SARGLHYL 575
           ++V L  Y   ++ + L+ ++ E G L  H+         +    E C+   +A  +  L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVAL 98

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPE 634
              + + ++ RD+   NILLD+    ++  F   S+     D   V         Y  PE
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL 658
                + TE  D +S G +LFE+L
Sbjct: 153 VGGISEETEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 19/182 (10%)

Query: 485 GTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY------CDEKNEMILIY 536
           G  VAVK+   P   Q  A+    E+ +L    H++++SL+         +E  ++ L+ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
           E M+    +          +S+     +C     G+ +LH+     +IHRD+K +NI++ 
Sbjct: 106 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 157

Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
            +   K+ DFGL++T        + T    +  Y  PE        E  D++S G ++ E
Sbjct: 158 SDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 657 VL 658
           ++
Sbjct: 215 LV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 31/154 (20%), Positives = 59/154 (38%), Gaps = 15/154 (9%)

Query: 463 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS- 521
                + G G   +VY     D     +K    R +   A+ + E+ +L     + L   
Sbjct: 1   SSIKLLKG-GLTNRVYLLGTKDE-DYVLKINPSREKG--ADREREVAILQLLARKGLPVP 56

Query: 522 -LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            ++   +      L+ E++E         G  L  +S +++ +I    A  L  LH    
Sbjct: 57  KVLASGESDGWSYLLMEWIE---------GETLDEVSEEEKEDIAEQLAELLAKLHQLPL 107

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE 614
             + H D+   NIL+D+  +  + D+  +  GP 
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 25/88 (28%), Positives = 46/88 (52%), Gaps = 6/88 (6%)

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             PE        E  D++S G ++ E++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 32/121 (26%), Positives = 56/121 (46%), Gaps = 15/121 (12%)

Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        +N      +G G FGKV +      G+ ++ 
Sbjct: 16  GNNYTFIDPTQLPYNEKWEFP-------RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNV 68

Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            +VAVK     +     E   +E+++LS   +H+++V+L+G C     +++I EY   G 
Sbjct: 69  LRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGD 128

Query: 544 L 544
           L
Sbjct: 129 L 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.8 bits (100), Expect = 7e-04
 Identities = 62/265 (23%), Positives = 98/265 (36%), Gaps = 40/265 (15%)

Query: 425 GGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQ-EATNNFDESW-VIGI---GGFGKVYK 479
            G S    S  SH     A  ++    P    + +  + F   + VI     G FGK++ 
Sbjct: 107 DGPSGAEDSDASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFI 166

Query: 480 GELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN- 530
             L   T+ A  R        G P+ ++ +A+        +      +++L G  + +N 
Sbjct: 167 CALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL-GRLNHENI 225

Query: 531 ---EMILIYE---YMENGTLKGHLYGSGLP-SLSWK------QRLEICIGSARGLHYLHT 577
              E IL  E   YM        LY      +  WK      Q   I       + Y+H 
Sbjct: 226 LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEI--DQTHVSTAVKGSFGYLDP 633
              K +IHRD+K  NI L+ +    + DFG +          D   V T    S     P
Sbjct: 286 ---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS-----P 337

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E        E +D++S G++L ++L
Sbjct: 338 EILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 9e-04
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQT-HVSTAVKGSF 628
           G+ +LH   +  +IHRD+K +NI++  +   K+ DFGL++T G     T +V T      
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            Y  PE        E  D++S G ++ E++   
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	805
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
PLN03150	623	hypothetical protein; Provisional	99.45
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.44
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.37
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.21
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.13
KOG1243	690	consensus Protein kinase [General function predict	99.1
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.94
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.93
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.77
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.7
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.51
PRK09902	216	hypothetical protein; Provisional	98.5
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.47
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.45
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.43
COG4248	637	Uncharacterized protein with protein kinase and he	98.41
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.34
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.12
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.08
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.04
PF01636	239	APH: Phosphotransferase enzyme family This family	98.02
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.95
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.94
PLN02876	822	acyl-CoA dehydrogenase	97.84
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.82
PRK10593	297	hypothetical protein; Provisional	97.69
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.67
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.6
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.6
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.5
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.39
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.38
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.31
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.2
PRK05231	319	homoserine kinase; Provisional	97.17
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.04
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.03
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.93
PLN02236	344	choline kinase	96.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.39
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.38
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.14
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.13
COG2334	331	Putative homoserine kinase type II (protein kinase	95.8
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	95.7
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.7
PLN02756	418	S-methyl-5-thioribose kinase	95.66
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.54
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.51
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.32
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.01
PRK06148	1013	hypothetical protein; Provisional	94.87
PRK11768	325	serine/threonine protein kinase; Provisional	94.82
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.75

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=3.7e-62  Score=530.63  Aligned_cols=326  Identities=35%  Similarity=0.517  Sum_probs=260.3

Q ss_pred             EecCCCce-e-eeCCeeeEecCCCCccc--cCCCCcccccccccCCCCCccccceeeeeecCceeEEee--c--CCceEE
Q 003659           13 IDCGSRTN-T-TVGNRVFVADNSASKFL--STPQNVVANISESVTSSNDSQLYQTARIFTGSSKYTFSI--S--GRGRHW   84 (805)
Q Consensus        13 idCG~~~~-~-~~~~~~~~~~~~d~~~~--~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~~~~~y~~--~--~~~~yl   84 (805)
                      ||||++.+ + |.|+.+++.|++|..|.  |.++.++..  .........++|+|||+||.|.|+||++  .  +++|||
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~--~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~~yl   78 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQ--PDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGGKYL   78 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccc--cCCcCCccccccceEEEcCCCCccEEEeeccCCCCceEE
Confidence            89999644 4 67888999999999994  444455211  1112345788999999999999999998  3  456999


Q ss_pred             EEEEeeccCCCCcC----cccceEEEE--eCcEEEEeecCC-CCcEEEEEEEecc-CCcEEEEEecCCCCc-ceeeeeee
Q 003659           85 IRLYFYPFVYQSYN----MSRASFSVS--TNDHVLLNNFSV-SSNVFKEFSVNVT-SDSLDVIFSPSNNSF-AFINALEV  155 (805)
Q Consensus        85 vR~~F~~~~y~~~~----~~~~~F~~~--~~~~~~v~~~~~-~~~~~~E~i~~~~-~~~~~vc~~~~~~~~-pfi~~iE~  155 (805)
                      ||+||+|||||+++    .+.+.|||+  +|.|++|+..+. ..++++|+|+.+. +++++|||+|+++|+ ||||+|||
T Consensus        79 iRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl  158 (347)
T PF12819_consen   79 IRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIEL  158 (347)
T ss_pred             EEEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEE
Confidence            99999999999885    123779999  566999998772 2579999888777 799999999999887 99999999


Q ss_pred             EEeCCcccccCCCcCCCCCCCCCccceeEEEEEEEecCCCC--CCCCCCcccccccCCCcceecccCCcccccCCccccc
Q 003659          156 VSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPL--VTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYV  233 (805)
Q Consensus       156 ~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--~~~~~D~~~R~W~~d~~~~~~~~~~~~~s~~~~i~~~  233 (805)
                      ||||+++|++....          .+.+|++++|+||||+.  +|||+|++||+|.|..    ....|.++++..+++ .
T Consensus       159 ~~lp~~ly~~~~~~----------~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~----~~~~~~~ist~~~i~-~  223 (347)
T PF12819_consen  159 RPLPDSLYPDTDAN----------SSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYS----SSPGWSNISTTSNIN-I  223 (347)
T ss_pred             EECCccceeccccC----------CCceeEEEEeecCCCcccccCCCCCcceeeccccc----cCccccccccceeee-c
Confidence            99999999643222          23569999999999998  9999999999999642    255678888766665 2


Q ss_pred             cCCCCcccCchhHHhhccccccCCCCCCcceEEEEeecCCCCceEEEEEecceecc--CCCceEEEEEeccccccccccc
Q 003659          234 QGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSD--GLNQLYFNVYIDSWIAVRDLDL  311 (805)
Q Consensus       234 ~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~ltw~~~~~~~~~ylv~LhFae~~~~--~~~~r~F~v~in~~~~~~~~d~  311 (805)
                      ...++.+.+|..||+||+++....   .+++++|.+ ++++..|+|+||||||+..  ..++|+|||||||+.+.+++++
T Consensus       224 ~~~~~~~~~P~~V~~TA~~~~~~s---~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~  299 (347)
T PF12819_consen  224 NSSNNPYDAPSAVYQTARTPSNSS---DPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSP  299 (347)
T ss_pred             ccCCccCcChHHHHHhhhcccccc---cceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCc
Confidence            345677899999999999998544   349999999 9999999999999999864  4557999999999998864444


Q ss_pred             cccccCcccceEEEeeEEEecCCCcEEEEeccCCCCCCCCccccccceeeec
Q 003659          312 STYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKM  363 (805)
Q Consensus       312 ~~~s~~~~~~~~~~~~~~~~~~~~~~~i~l~~s~~~~~~~~pilng~Ei~~~  363 (805)
                      ..  ......+++.++.+.+...+.++|+|++...+ .. ||||||+|||++
T Consensus       300 ~~--~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S-~l-ppiLNalEIy~v  347 (347)
T PF12819_consen  300 PY--LGADTVPYYSDYVVNVPDSGFLNISLGPTPDS-TL-PPILNALEIYKV  347 (347)
T ss_pred             cc--ccCcceEeecceEEEecCCCEEEEEEEeCCCC-Cc-CceeEeeeeEeC
Confidence            22  33456788999998888777788999877554 23 899999999985

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-58  Score=504.53  Aligned_cols=290  Identities=51%  Similarity=0.842  Sum_probs=260.8

Q ss_pred             CCcccCHHHHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEE
Q 003659          447 SGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC  526 (805)
Q Consensus       447 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  526 (805)
                      ....|++.+++.||++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|+++|.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999999999999999999999999999999999999988876543146699999999999999999999999


Q ss_pred             ccCC-eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEee
Q 003659          527 DEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD  605 (805)
Q Consensus       527 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~D  605 (805)
                      .+.+ +++||||||++|+|.++|+.....+|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999886544899999999999999999999999989999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      ||||+..+.. .....+...||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+....++..|++....+
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999876541 222222228999999999999999999999999999999999999999877666777799999999999


Q ss_pred             CCcccccCcccc-CCCCh-hHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          686 GQLDQIIDPTLA-GKIRP-DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       686 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      +.+.+++|+.+. +.+.. +++.++.+++.+|++.+|.+||+|.||+++|+.+.
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            999999999987 56654 68999999999999999999999999999996544

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-55  Score=511.90  Aligned_cols=331  Identities=19%  Similarity=0.247  Sum_probs=259.4

Q ss_pred             ccCCCCcEEEecCCCceeeeCCeeeEecCCCCccccCCCCcccccccccCCCCCccccceeeeeec--CceeEEee--cC
Q 003659            4 KFDPADNYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTG--SSKYTFSI--SG   79 (805)
Q Consensus         4 ~~~p~~~~~idCG~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~--~~~~~y~~--~~   79 (805)
                      +...+|+|+||||++.+..+ +.+++.|++|..|++...... .    .+ ....++|+|||+||.  |.+|||++  ++
T Consensus        19 ~~~~~~~~~I~CGs~~~~~~-d~~~~~w~~D~~~~~~~~~~~-~----~~-~~~~~~~~t~R~F~~~~g~~~cY~~~~~~   91 (623)
T PLN03150         19 ASPEPFTMRISCGARVNVRT-APTNTLWYKDFAYTGGIPANA-T----RP-SFIAPPLKTLRYFPLSDGPENCYNINRVP   91 (623)
T ss_pred             ccCCCccEEEeCCCCCCccc-CCCCCEEcCCcccccCccccc-c----Cc-ccccchhhccccCCcccccccceEeeecC
Confidence            34458899999999765532 224555556655654221111 1    11 235678999999995  56889988  67


Q ss_pred             CceEEEEEEeeccCCCCcCcccceEEEEeCc--EEEEee-c-CCCCcEEEEEEEeccCCcEEEEEecCCCCcceeeeeee
Q 003659           80 RGRHWIRLYFYPFVYQSYNMSRASFSVSTND--HVLLNN-F-SVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEV  155 (805)
Q Consensus        80 ~~~ylvR~~F~~~~y~~~~~~~~~F~~~~~~--~~~v~~-~-~~~~~~~~E~i~~~~~~~~~vc~~~~~~~~pfi~~iE~  155 (805)
                      +||||||+||+|||||+++.+ |.|||++++  |.+|.. + .+...+++|+|+++++++++|||+|+++|+||||+|||
T Consensus        92 ~g~ylVRl~F~~~~y~~~~~~-~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFIs~iEv  170 (623)
T PLN03150         92 KGHYSVRVFFGLVAEPNFDSE-PLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAILSIEI  170 (623)
T ss_pred             CCcEEEEEEeecCCcCCCCCC-CceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCceeEEEE
Confidence            899999999999999999955 999999877  888864 2 23467899999999999999999999999999999999


Q ss_pred             EEeCCcccccCCCcCCCCCCCCCccceeEEEEEEEecCCCC----CCCCCCcc--cccccCCCcceecccCCcccccCCc
Q 003659          156 VSVPDQLITDDASSISPPGKYQGLVFQTFETVHRVNMGGPL----VTPENDTL--WRTWVPDQSFLVNRNLAKSVSNIPA  229 (805)
Q Consensus       156 ~~~~~~~y~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~----~~~~~D~~--~R~W~~d~~~~~~~~~~~~~s~~~~  229 (805)
                      |+||+.+|..... ..        .+.+|++++|+||||++    +++|+|.+  ||+|.+|+.|+  ...+.++++...
T Consensus       171 ~~l~~~~y~~~~~-~~--------~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~--~~~~~~~st~~~  239 (623)
T PLN03150        171 LQVDDKAYNFGPS-WG--------QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFG--SGSDQAISTENV  239 (623)
T ss_pred             EEcCccccccccc-cc--------CceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccC--CCcccccccccc
Confidence            9999999953210 11        13569999999999864    67999998  99999999876  333566666666


Q ss_pred             cccccCCCCcccCchhHHhhccccccCCCCCCcceEEEEeecCCCCceEEEEEecceecc--CCCceEEEEEeccccccc
Q 003659          230 VKYVQGGATKESAPNTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSD--GLNQLYFNVYIDSWIAVR  307 (805)
Q Consensus       230 i~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~ltw~~~~~~~~~ylv~LhFae~~~~--~~~~r~F~v~in~~~~~~  307 (805)
                      |++.  +++.+.+|+.|||||+++...     ..+++|.++++++..|+|+|||||++..  ..++|+|||||||+.+.+
T Consensus       240 I~~~--~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~  312 (623)
T PLN03150        240 IKKA--SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFK  312 (623)
T ss_pred             cccc--cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeec
Confidence            6544  346778999999999988642     2578999999999999999999999742  457799999999999999


Q ss_pred             cccccccccCcccceEEEeeEEEecCCCcEEEEeccCCCCCCCCccccccceeeecccC
Q 003659          308 DLDLSTYSTNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNL  366 (805)
Q Consensus       308 ~~d~~~~s~~~~~~~~~~~~~~~~~~~~~~~i~l~~s~~~~~~~~pilng~Ei~~~~~~  366 (805)
                      ++|+..+ .++...+++.++.+.+.. +.++|+++|...    .+|||||+|||++.+.
T Consensus       313 ~~di~~~-~g~~~~~~~~~~~v~~~~-g~l~isl~p~~~----s~pilNaiEI~~~~~~  365 (623)
T PLN03150        313 DVDIVKM-SGERYTALVLNKTVAVSG-RTLTIVLQPKKG----THAIINAIEVFEIITA  365 (623)
T ss_pred             ccChhhh-cCCcccceEEEeEEeecC-CeEEEEEeeCCC----Ccceeeeeeeeecccc
Confidence            9999887 445567899888887664 778999988642    2699999999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=403.49  Aligned_cols=256  Identities=34%  Similarity=0.516  Sum_probs=213.8

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchh--HHHHHHHHHHHhcCCCCceEEEEEEEccCC-eEEEEEEeccCC
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-EMILIYEYMENG  542 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~g  542 (805)
                      .+.||+|+||+||+|.++....||||++.......  .++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||++|
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G  125 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG  125 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence            34699999999999999854459999988754322  569999999999999999999999998887 899999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC-eEeeccCCCcEEeCCCC-cEEEeecCCCCCCCCCCCcce
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~NILld~~~-~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|.++|+......++|..+++||.+||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++......  ..
T Consensus       126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~  200 (362)
T KOG0192|consen  126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS  200 (362)
T ss_pred             cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence            99999988555689999999999999999999999   66 99999999999999998 99999999998754321  22


Q ss_pred             eecccccccccChhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          621 STAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~--~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .+...||+.|||||++.  ...++.|+|||||||+||||+||+.||....+...   ...+.            ......
T Consensus       201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~~v~------------~~~~Rp  265 (362)
T KOG0192|consen  201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---ASAVV------------VGGLRP  265 (362)
T ss_pred             ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HHHHH------------hcCCCC
Confidence            34478999999999999  66999999999999999999999999986654221   11111            111222


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhh
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE  741 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~  741 (805)
                      .++..+...+..++.+||+.+|.+||++.+++..|+.++....
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            3333466778999999999999999999999999998876543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-44  Score=385.85  Aligned_cols=262  Identities=29%  Similarity=0.438  Sum_probs=221.8

Q ss_pred             CcccCHHHHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEc
Q 003659          448 GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD  527 (805)
Q Consensus       448 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  527 (805)
                      ...++.+++...       +.||+|.||.||+|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+++|+|.
T Consensus       200 ~wei~r~~l~l~-------~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  200 PWEIPREELKLI-------RELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             CeeecHHHHHHH-------HHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            356666666654       47999999999999999888999999887643 3578999999999999999999999999


Q ss_pred             cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       528 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      .++.++||||||++|+|.++|.......+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccc
Confidence            98899999999999999999987666789999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKG  686 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (805)
                      |||.... +.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+....+          
T Consensus       349 LAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l----------  417 (468)
T KOG0197|consen  349 LARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL----------  417 (468)
T ss_pred             cccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH----------
Confidence            9995443 33444455566778999999999999999999999999999999 78888766544432221          


Q ss_pred             CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          687 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       687 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                            +....-..+..|+..+.+++..||+.+|++|||.+.+.+.|+...
T Consensus       418 ------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  418 ------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             ------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                  121222334567888999999999999999999998888887754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=369.88  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=210.7

Q ss_pred             ccCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEc
Q 003659          450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD  527 (805)
Q Consensus       450 ~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  527 (805)
                      .+++.+++.       .+.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||.++|.|.
T Consensus        75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            355555554       348999999999999887 6889999988543 4455788999999999999999999999998


Q ss_pred             cCC-eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          528 EKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       528 ~~~-~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                      ... +..++||||++|+|++++...  +.+++...-+|+.++++||.|||+.  ++||||||||+|||++..|++|||||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF  223 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF  223 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence            888 599999999999999999654  4689999999999999999999962  89999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhHHHHHHHHhh
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP--REMVNLAEWAMKWQN  684 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~  684 (805)
                      |.++.+-..    .....+||..|||||.+++..|+.++||||||++++|+.+|+.|+....+  .....+..       
T Consensus       224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-------  292 (364)
T KOG0581|consen  224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-------  292 (364)
T ss_pred             cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-------
Confidence            999876432    45678899999999999999999999999999999999999999976411  11122221       


Q ss_pred             cCCcccccCccccCCCCh-hHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          685 KGQLDQIIDPTLAGKIRP-DSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       685 ~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                           .+++..- ...+. .+..++..++..||+++|.+||++.|++++
T Consensus       293 -----~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  293 -----AIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -----HHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 2222111 11222 366779999999999999999999999863

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=368.01  Aligned_cols=205  Identities=30%  Similarity=0.535  Sum_probs=184.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .+|...+.||+|.||+||+|+++ ++..||||.+...  ..+..+.+..|+++|++++|||||.|++++..++.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            45777778999999999999876 5899999988766  55667778899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC------CcEEEeecCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN------FMAKVADFGLSKT  611 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~------~~~kl~DFGla~~  611 (805)
                      ||.+|+|.+||+..+  .+++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+||.
T Consensus        90 yC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             eCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            999999999997665  69999999999999999999999   999999999999999765      5689999999998


Q ss_pred             CCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV  673 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  673 (805)
                      +..   .....+.+|++-|||||+++.++|+.|+|+||.|++||++++|++||+...+.+..
T Consensus       165 L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~  223 (429)
T KOG0595|consen  165 LQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL  223 (429)
T ss_pred             CCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            753   44456789999999999999999999999999999999999999999977665543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-43  Score=398.95  Aligned_cols=259  Identities=29%  Similarity=0.457  Sum_probs=219.6

Q ss_pred             CCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +....+.||+|.||+||+|+..      +.+.||||.++..... ..++|++|+++|..|+|||||+|+|+|.+++.++|
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3344458999999999999753      3568999999987654 78999999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEE
Q 003659          535 IYEYMENGTLKGHLYGSG------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK  602 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~k  602 (805)
                      |+|||..|+|.+||....            ..+|+..+.+.||.|||.||+||-+   ..+|||||..+|+|+.++..+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence            999999999999996321            2349999999999999999999999   9999999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 003659          603 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      |+||||+|..-..+..+......-..+||+||.+..+++|.+||||||||||||++| |+.|+......+.+.       
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe-------  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE-------  716 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-------
Confidence            999999997655455544434455789999999999999999999999999999998 888988665554433       


Q ss_pred             HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHh
Q 003659          682 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~  739 (805)
                      ..+.+++         -..++.++.++.+|+..||+.+|.+||+++||-..|+...+.
T Consensus       717 ~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            2333332         134567888999999999999999999999999999876543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-42  Score=377.05  Aligned_cols=247  Identities=24%  Similarity=0.412  Sum_probs=210.8

Q ss_pred             cCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..|...++||+|||+.||.++. ..|+.||+|++...   .....+...+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4688889999999999999987 78999999987663   3344677889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      |+|++++|.+++.  .++++++.++..+..||+.||.|||+   .+|+|||||-.|+||++++++||+|||||..+...+
T Consensus        98 ELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            9999999999985  45689999999999999999999999   999999999999999999999999999998765322


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                        ....+.+||+.|+|||++.....+..+||||+|||||.||+|++||+...-.+..+-+.      ..    +.     
T Consensus       173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik------~~----~Y-----  235 (592)
T KOG0575|consen  173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK------LN----EY-----  235 (592)
T ss_pred             --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH------hc----Cc-----
Confidence              33567899999999999999999999999999999999999999998654333222111      00    11     


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        .++........+++.++|+.+|.+|||+++|+.
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              112233455788999999999999999999985

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=378.60  Aligned_cols=274  Identities=26%  Similarity=0.400  Sum_probs=228.3

Q ss_pred             CHHHHHHHhcCC-----cccceEeeeCceEEEEEEecC----CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEE
Q 003659          452 PFVAVQEATNNF-----DESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVS  521 (805)
Q Consensus       452 ~~~el~~at~~f-----~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~  521 (805)
                      |...+.+.+...     .++++||.|.||.||+|+++-    ...||||.++... ++...+|+.|+.+|.++.||||++
T Consensus       615 PnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIr  694 (996)
T KOG0196|consen  615 PNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIR  694 (996)
T ss_pred             ccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEE
Confidence            344444444433     467899999999999998862    4579999998764 556789999999999999999999


Q ss_pred             EEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       522 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      |.|+....+..++|.|||+||+|+.||+.+. ..+++.++.-+.++||.||.||-+   .++|||||.++|||++.+..+
T Consensus       695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvC  770 (996)
T KOG0196|consen  695 LEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVC  770 (996)
T ss_pred             EEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEE
Confidence            9999999999999999999999999998776 459999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCc-ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 003659          602 KVADFGLSKTGPEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (805)
                      |++||||+|.+.+.... ..+...+-...|.|||.+..+++|.+||||||||||||.++ |.+|+-.+...+.++-    
T Consensus       771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka----  846 (996)
T KOG0196|consen  771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA----  846 (996)
T ss_pred             EeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH----
Confidence            99999999976542211 11222334578999999999999999999999999999887 8888876554443322    


Q ss_pred             HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 003659          680 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH  745 (805)
Q Consensus       680 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~~~  745 (805)
                                  ++....-..+.+++..+.+|++.||+++-.+||...+++..|.+++.....++.
T Consensus       847 ------------Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  847 ------------IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             ------------HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                        223333345678999999999999999999999999999999999877766654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-42  Score=357.96  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCch-------hHHHHHHHHHHHhcCCCCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ-------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      .+.|...+.||+|+||.|-+|..+ +|+.||||+++.....       .....++|+++|++|+|||||++.++++..+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            455777889999999999999654 7999999987754211       12234699999999999999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC---CcEEEeecCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGL  608 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~---~~~kl~DFGl  608 (805)
                      .|||||||++|+|.+++..++  .+.+..-..++.|++.|+.|||+   .||+||||||+|||+..+   ..+||+||||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999997765  57778889999999999999999   999999999999999766   8899999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      |+..++   .....+.+||+.|.|||++.+..   +..|.|+||+||+||-+|||.+||.......  ++.+-    ...
T Consensus       326 AK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----I~~  396 (475)
T KOG0615|consen  326 AKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----ILK  396 (475)
T ss_pred             hhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----Hhc
Confidence            998653   33456789999999999997653   3348899999999999999999997543221  11110    111


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      |...      .....-.+..++..+++.++|..||++||++.|++++
T Consensus       397 G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 GRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             Cccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            1100      0001113456778899999999999999999999863

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-42  Score=341.94  Aligned_cols=256  Identities=26%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             CCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEE-EEccCCe-EEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG-YCDEKNE-MILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~  536 (805)
                      +|.+.++||+|.||.|||+. +.+|..+|.|.+.-.  +.+..+.+..|+.+|++|+|||||++++ -+.++++ +.+||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            45566789999999999995 458999999987643  4556778899999999999999999999 4566666 89999


Q ss_pred             EeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          537 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       537 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      |||..|+|.+.+..  +..+.++++.+|++..|+++||..+|....+ -|+||||||.||+|+.+|.+||+||||++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999853  4456799999999999999999999985543 38999999999999999999999999999875


Q ss_pred             CCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      .  ........+|||.||+||.+.+..|+.||||||+||++|||+.-++||...      ++.+.... ...+..     
T Consensus       180 s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd~-----  245 (375)
T KOG0591|consen  180 S--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGDY-----  245 (375)
T ss_pred             c--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCCC-----
Confidence            4  333456789999999999999999999999999999999999999999865      22222111 111111     


Q ss_pred             ccccCCCC-hhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          694 PTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       694 ~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                          ...+ ...+.++.+++..|+..||..||+.-.++..+..
T Consensus       246 ----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 ----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                1122 3457789999999999999999997666555543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-40  Score=362.01  Aligned_cols=261  Identities=24%  Similarity=0.384  Sum_probs=205.7

Q ss_pred             hcCCcccceEeeeCceEEEEEEe------cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccC-C
Q 003659          460 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK-N  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~  530 (805)
                      .++|...++||+|+||.||+|..      .+++.||||++.... ....+.+.+|++++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            45688888999999999999964      235689999987543 23456789999999999 899999999998654 4


Q ss_pred             eEEEEEEeccCCcccccccCCC----------------------------------------------------------
Q 003659          531 EMILIYEYMENGTLKGHLYGSG----------------------------------------------------------  552 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------  552 (805)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999886421                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccc
Q 003659          553 --LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY  630 (805)
Q Consensus       553 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (805)
                        ..++++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              1358899999999999999999999   99999999999999999999999999999864322211122234567889


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHH
Q 003659          631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFG  709 (805)
Q Consensus       631 ~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  709 (805)
                      +|||++.+..++.++|||||||+||||++ |+.||......+.     .. .....+..     .    ..+......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~-~~~~~~~~-----~----~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FC-QRLKDGTR-----M----RAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HH-HHHhcCCC-----C----CCCCCCCHHHH
Confidence            99999999999999999999999999997 9999975432211     01 11111110     0    11123345688


Q ss_pred             HHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          710 ETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       710 ~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      +++.+||+.+|.+||++.|+++.|+.+++
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=340.71  Aligned_cols=242  Identities=26%  Similarity=0.361  Sum_probs=202.1

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .+.|+..++||+|+||+||.++.+ +++.+|+|.++...   ....+...+|..+|.+++||.||+++-.|.+...++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            457888999999999999999765 58999999887653   34567788999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      +||+.||.|..+|.+.+  .+++....=.+..|+.||.|||+   .+||||||||+|||||++|+++|+||||++..-. 
T Consensus       104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            99999999999997654  58888888899999999999999   9999999999999999999999999999996432 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                       ....+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||.......      +........         
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k---------  241 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGK---------  241 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCc---------
Confidence             2233556899999999999999999999999999999999999999998553322      222211111         


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCC
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRP  724 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  724 (805)
                      + ...+.-......+++.+.|+.+|.+|-
T Consensus       242 ~-~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 L-PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            0 011122355678889999999999995

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.9e-39  Score=400.64  Aligned_cols=262  Identities=31%  Similarity=0.467  Sum_probs=217.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ...+...++||+|+||.||+|+.. ++..||||++......    ...|++.+++++||||++++|+|.+.+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            345777889999999999999874 6899999998654332    23568899999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++|+|.++++     .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.......    
T Consensus       765 ~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        765 IEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             CCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            99999999994     38999999999999999999997666899999999999999999988876 666543221    


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                        .....||..|+|||++.+..++.|+|||||||++|||+||+.|++.... ....+.+|+...........++|+.+..
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence              1223688999999999999999999999999999999999999964332 2345677877655555566667776644


Q ss_pred             C--CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          699 K--IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       699 ~--~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      .  ...++..++.+++.+|++.+|++||+|+||++.|+.+.+
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3  345667788999999999999999999999999988654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=349.19  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=204.6

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC--eEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~  538 (805)
                      ++...+.||+|.||.||++...+ |+..|||..........+.+.+|+++|++++|||||+.+|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            45556799999999999998764 8999999876654333677899999999999999999999854444  69999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCCCCC-CC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPE-ID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~~~~-~~  616 (805)
                      +++|+|.+++.+.+. .|++..+...+.||++||+|||+   ++|+||||||+|||++. ++.+||+|||+++.... ..
T Consensus        98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999987765 79999999999999999999998   99999999999999999 79999999999987542 11


Q ss_pred             CcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                      .........||+.|||||++..+ ....++|||||||+++||+||++||...     .....+........         
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~---------  239 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED---------  239 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC---------
Confidence            22223457899999999999854 3345999999999999999999999753     11112222211111         


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ....++...+....+++.+|++.+|.+|||+.++++..-
T Consensus       240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            111344455667889999999999999999999986553

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=351.35  Aligned_cols=262  Identities=29%  Similarity=0.429  Sum_probs=217.0

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchh-HHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      .....++||+|-||.|.++....+..||||.++...... .++|.+|+++|.+|+||||+.|+|+|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            344567899999999999999988999999999876654 4899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+||..+..+.+.-....+||.|||.||+||.+   .++|||||.++|||+|.++++||+|||+++.+-..+..+.
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            9999999988766666777888999999999999999   9999999999999999999999999999996655455555


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHH--hCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ....+-...|||+|.+.-+++|.++|||+||++|||++  |...||.....++...-   ...+.+.....      ..-
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven---~~~~~~~~~~~------~~l  766 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN---AGEFFRDQGRQ------VVL  766 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh---hhhhcCCCCcc------eec
Confidence            55566778999999999999999999999999999985  56788875544332211   11111111110      111


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .-+.-++..+.+++++|+..+-.+||+.+++...|.+
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            2234567788999999999999999999999887765

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=356.77  Aligned_cols=266  Identities=28%  Similarity=0.464  Sum_probs=212.6

Q ss_pred             HHHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe
Q 003659          454 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       454 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      .+.....+.+.....||+|.||+||+|++..  .||||+++...  .+..+.|++|+.++++-+|.||+-++|||.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            3333334444455689999999999999973  69999988653  4568899999999999999999999999988877


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                       .+|..+|++.+|..+||-.+ ..++..+.+.||+|||+|+.|||.   ++|||||||+.||+|.+++.|||+||||+..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceee
Confidence             99999999999999998765 569999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCCCcceeecccccccccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ........-.....|...|||||+++.   .++++.+||||||+|+|||+||..||.....+...    |   .+..|- 
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----f---mVGrG~-  609 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----F---MVGRGY-  609 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----E---Eecccc-
Confidence            433222222334567889999999974   36899999999999999999999999832222111    0   001110 


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                         +.+.+. .....+.+++.+|+..||..++++||...+++..|+.++.
T Consensus       610 ---l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  610 ---LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               111111 2234667889999999999999999999999998887664

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=381.06  Aligned_cols=260  Identities=31%  Similarity=0.471  Sum_probs=216.7

Q ss_pred             CCcccceEeeeCceEEEEEEecC--Cc----EEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND--GT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +.+..+.||+|.||.||.|...+  |.    .||||.+... +.+...+|.+|..+|+.++|||||+++|+|......++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            34455789999999999997653  33    4899988775 56778899999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCC-----CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          535 IYEYMENGTLKGHLYGSG-----LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ++|||++|+|..||++.+     ...|+..+.+.+|.+||+|+.|||+   +++|||||.++|+||+....+||+|||||
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998752     3569999999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      +.....+.........-...|||||.++.+.++.|+|||||||+|||++| |..||......+...      .+.+.+++
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggRL  923 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGRL  923 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCcc
Confidence            95443333332222344578999999999999999999999999999999 678887665444321      12233321


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                                +.+..++.++.+++..||+.+|++||+...+++.+..+++..
T Consensus       924 ----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  924 ----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                      234677888999999999999999999999999888877654

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=329.79  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=208.0

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      .|+...++|+|+||.|||++.++ |+.||||++.....  ...+-..+|+++|++|+|+|+|.|+.+|..+..+.||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            45666689999999999998874 99999999876543  3345678999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      |+.--|.+.- ... ..++.+.+.+++.|+++|+.|+|+   .++|||||||+|||++.++.+||||||+|+.+..  ..
T Consensus        83 ~dhTvL~eLe-~~p-~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg  155 (396)
T KOG0593|consen   83 CDHTVLHELE-RYP-NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG  155 (396)
T ss_pred             cchHHHHHHH-hcc-CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence            9874444432 222 358899999999999999999999   9999999999999999999999999999998764  33


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH--------HHhhc-CCc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KWQNK-GQL  688 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~-~~~  688 (805)
                      ...+..+.|..|.|||.+-+ .+|....|||+.||++.||++|.+.|....+.+...++....        ..... +..
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            34567789999999999877 799999999999999999999999998776666554443322        11111 111


Q ss_pred             ccc-----cCcc-ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQI-----IDPT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~-----~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+     -++. +...+ +....-+.+++..||+.||++|++.++++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111     1111 11111 233456889999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=351.98  Aligned_cols=250  Identities=28%  Similarity=0.488  Sum_probs=211.8

Q ss_pred             cccCHHHHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEcc
Q 003659          449 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE  528 (805)
Q Consensus       449 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  528 (805)
                      +.++++++.+.       +-||.|+.|.||.|+++ ++.||||+.+...       ..+|+-|++|+|+||+.+.|+|..
T Consensus       119 WeiPFe~IsEL-------eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEISEL-------EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhhhh-------hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            67788877654       47999999999999998 6889999875432       367889999999999999999999


Q ss_pred             CCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       529 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                      ...+++|||||..|-|...|...+  .++......|..+||.||+|||.   +.|||||||+-||||..+-.+||+|||-
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence            999999999999999999996554  78889999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ++.....   .......||..|||||+++....++|.|||||||||||||||..||......-.    -|          
T Consensus       259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw----------  321 (904)
T KOG4721|consen  259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW----------  321 (904)
T ss_pred             hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE----------
Confidence            9876542   223457899999999999999999999999999999999999999974322110    11          


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                       .+-...|.-..+..++..|.-++++||+..|..||+.++++.+|+-+
T Consensus       322 -GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  322 -GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence             11112233345567888899999999999999999999999998754

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=359.05  Aligned_cols=257  Identities=29%  Similarity=0.457  Sum_probs=210.2

Q ss_pred             cccceEeeeCceEEEEEEecC--C---cEEEEEEcCC---CCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          464 DESWVIGIGGFGKVYKGELND--G---TKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~--g---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ...++||+|+||.||+|+++.  +   ..||||....   .......+|.+|++++++++|||||+++|++..+..+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            334699999999999998753  2   2389998775   3466789999999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      ||+|.||+|.++|..... .++..++++++.++|+||+|||+   .+++||||.++|+|++.+..+||+||||++.... 
T Consensus       240 mEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-  314 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-  314 (474)
T ss_pred             EEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc-
Confidence            999999999999976653 69999999999999999999999   9999999999999999999999999999987541 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                       .........-...|+|||.+..+.++.++|||||||++||+++ |..|+......+..   .++   ...+        
T Consensus       315 -~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI---~~~~--------  379 (474)
T KOG0194|consen  315 -YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKI---VKNG--------  379 (474)
T ss_pred             -eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHH---HhcC--------
Confidence             1111112245678999999999999999999999999999999 78899866544321   111   0111        


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhh
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE  741 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~  741 (805)
                       ..-..+...+..+..+..+|+..+|++||+|.++.+.|+.+.+..+
T Consensus       380 -~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  380 -YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             -ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             1112223446667788889999999999999999999998776543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.5e-39  Score=342.44  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=201.3

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchh---HHHHHHHHHHHhcCCCCceEEEEEEEcc----CCeEEEEEEe
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILIYEY  538 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~  538 (805)
                      ...||+|++|.||+|++ +|+.||||++.......   .+.|.+|+++|++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35899999999999998 48899999987653322   5778899999999999999999999866    4578999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++|+|.+++...  ..++|...++++.+++.||+|||+.  .+++||||||+|||+++++.+||+|||+++.....   
T Consensus       104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---  176 (283)
T PHA02988        104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---  176 (283)
T ss_pred             CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---
Confidence            9999999999654  4689999999999999999999971  37889999999999999999999999999864321   


Q ss_pred             ceeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                        .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+..   .   .....+.         
T Consensus       177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~---~i~~~~~---------  239 (283)
T PHA02988        177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---D---LIINKNN---------  239 (283)
T ss_pred             --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---H---HHHhcCC---------
Confidence              123467899999999976  68999999999999999999999999865433221   1   1111110         


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      ....+..+...+.+++.+||+.+|.+||++.|+++.|+...
T Consensus       240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            01122234567899999999999999999999999998764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=351.30  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=211.8

Q ss_pred             cCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ..|..-.+||+|..|.||.++. ..++.||||++....+...+-+.+|+.+|+..+|+|||+++..+..++++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            3466667899999999999964 468899999998887777788899999999999999999999998889999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+.+....   +++.++..||.++++||+|||.   ++|+|||||.+||||+.++.+||+|||++....... . 
T Consensus       353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-~-  424 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-S-  424 (550)
T ss_pred             CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc-C-
Confidence            9999999986553   9999999999999999999999   999999999999999999999999999998765422 2 


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....+||+.|||||++....|.+|.||||||++++||+-|.+||-...+.....++.      ..+      .+.+  .
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng------~P~l--k  490 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG------TPKL--K  490 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcC------CCCc--C
Confidence            3467889999999999999999999999999999999999999997544433222211      111      1222  1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .++.....+.++..+||+.|+++||++.|+|++
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            223446678999999999999999999999973

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-38  Score=343.43  Aligned_cols=262  Identities=27%  Similarity=0.398  Sum_probs=204.1

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-----------------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-----------------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL  522 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  522 (805)
                      ++|...+.||+|+||.||++.+++                 +..||+|.+.... .....+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            457778899999999999997532                 3479999887643 3345679999999999999999999


Q ss_pred             EEEEccCCeEEEEEEeccCCcccccccCCC-----------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEe
Q 003659          523 IGYCDEKNEMILIYEYMENGTLKGHLYGSG-----------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH  585 (805)
Q Consensus       523 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH  585 (805)
                      ++++...+..++||||+++|+|.+++....                 ...++|.++++++.|++.||+|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            999999999999999999999999885321                 1357899999999999999999999   89999


Q ss_pred             eccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCC
Q 003659          586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPV  663 (805)
Q Consensus       586 ~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p  663 (805)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986433222222233456788999999998899999999999999999987  4566


Q ss_pred             CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          664 IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      +......+   ...............      .....++.++..+.+++.+|++.+|.+||++.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            76443222   222222221111100      000112234567899999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.8e-39  Score=337.76  Aligned_cols=249  Identities=35%  Similarity=0.538  Sum_probs=198.4

Q ss_pred             cceEeeeCceEEEEEEec-----CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          466 SWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .+.||.|.||.||+|.+.     .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++||||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            468999999999999877     25789999997643 344789999999999999999999999999888899999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.++|.......+++.++++|+.|+|+||+|||+   .+++|+||+++|||+++++.+||+|||+++.........
T Consensus        84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999988755679999999999999999999999   899999999999999999999999999998763322333


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......+...|+|||.+....++.++||||||+++|||++ |+.|+......+      +.... .++..         .
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~~---------~  224 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQR---------L  224 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTEE---------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-ccccc---------c
Confidence            3344567789999999999999999999999999999999 678886543322      11111 11110         1


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ..+..+...+.+++.+||+.+|.+||++.++++.|
T Consensus       225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            12223456688999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8e-39  Score=355.96  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=204.1

Q ss_pred             hcCCcccceEeeeCceEEEEEEe------cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      .++|...+.||+|+||.||+|+.      +.+..||||++.... ....+.+.+|+++|..+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34577788999999999999963      235689999987543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003659          532 MILIYEYMENGTLKGHLYGSG-----------------------------------------------------------  552 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  552 (805)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999998885421                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          553 --------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       553 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                                    ...++|..+++++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          1258899999999999999999999   89999999999999999999999999999865432221


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....+    ...+..         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~----~~~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKM----IKEGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHH----HHhCcc---------
Confidence            12223345678999999999999999999999999999998 888886442221  11111    111110         


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ...+.....++.+++.+|++.+|.+||++.||++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            001111245688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-39  Score=339.48  Aligned_cols=264  Identities=26%  Similarity=0.345  Sum_probs=207.6

Q ss_pred             cCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  535 (805)
                      +.|+..++||+|.||.||||+. .+|+.||+|++....  ........+||.+|++|.||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4466667999999999999965 579999999876554  44456667999999999999999999988766  789999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      +|||+. +|..++.... -.++..++..++.|++.||+|+|.   ++|+|||||.+|||||.+|.+||+|||||+.+.. 
T Consensus       197 FeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~-  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP-  270 (560)
T ss_pred             Eecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccC-
Confidence            999987 8888886543 469999999999999999999999   9999999999999999999999999999997654 


Q ss_pred             CCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc-----CCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK-----GQLD  689 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----~~~~  689 (805)
                      ......+..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.+....+.++...+-....-..+     ..+.
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            23333567788999999999876 58999999999999999999999999887766654443322111111     0111


Q ss_pred             --cccCcc------ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          690 --QIIDPT------LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       690 --~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ..+.+.      +.+. -.......++++..+|..||.+|.|+.++++
T Consensus       351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence              111111      1111 1122345678899999999999999999985

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-38  Score=354.44  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             hcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      .++|...+.||+|+||.||+|+..      ++..||||++.... ....+.+.+|+++++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346778889999999999998742      34589999987543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003659          532 MILIYEYMENGTLKGHLYGSG-----------------------------------------------------------  552 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  552 (805)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeec
Q 003659          553 ---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA  623 (805)
Q Consensus       553 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~  623 (805)
                               ..++++.++++++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     1348899999999999999999999   9999999999999999999999999999976433221112223


Q ss_pred             ccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       624 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........  ..    .....+     ..+    ..+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~-----~~~----~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG-----YQM----SRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc-----cCc----cCCC
Confidence            345678999999998999999999999999999997 9999875432211  00    011111     000    0111


Q ss_pred             hHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      ..+..+.+++.+|++.+|.+||++.+|++.|++++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            12456889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=330.87  Aligned_cols=260  Identities=23%  Similarity=0.331  Sum_probs=208.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .+.|+..+.||.|..++||+|+. ..++.||||++.... ....+.+.+|+..|+.++||||++.+..|..+..+++||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            35677888999999999999965 467999999988653 3447889999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      ||.+|++.+.+...-...+++..+..|.+++++||.|||+   +|.||||||+.||||+++|.+||+|||.+..+-....
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999976555669999999999999999999999   9999999999999999999999999998765433221


Q ss_pred             c-cee-ecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc--ccc
Q 003659          618 T-HVS-TAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL--DQI  691 (805)
Q Consensus       618 ~-~~~-~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~~~  691 (805)
                      . ... ...+||+.|||||+++.  ..|+.|+||||||++.+||.+|..||....+....     .+.+......  ...
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLLTSG  256 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCccccc
Confidence            1 111 56789999999999654  46999999999999999999999999865543321     1111111110  001


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+...    .......+.+++..||+.||.+|||++++++
T Consensus       257 ~~~d~----~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDE----DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHH----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11111    1223346889999999999999999999986

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.1e-38  Score=332.77  Aligned_cols=255  Identities=21%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec----CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...+.||+|+||.||+|.++    .+..||+|.+.... ......|.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45778889999999999999764    35789999887653 33456789999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++|+|.+++.... ..++|.+++.++.|++.||+|||+   .+++||||||+|||++.++.+|++|||.+..... 
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~-  159 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS-  159 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence            99999999999986543 468999999999999999999999   9999999999999999999999999998765322 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ..........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+.   ...    ...+.       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~~-------  225 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDGF-------  225 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCCC-------
Confidence            11111122345678999999999999999999999999999875 9999975543321   111    11110       


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                        ....+..++..+.+++.+|++.+|.+||++.++.+.|+++
T Consensus       226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              0112234456788999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=342.95  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=210.5

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHH--HHHHHHHhcCC-CCceEEEEEEEccCC-eEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEF--QTEIEMLSQFR-HRHLVSLIGYCDEKN-EMI  533 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~  533 (805)
                      ..++|...+.||.|.||.||+|+-. .|..||||+++..-.. ++++  ++|++.|++|+ ||||++|..++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3456777889999999999999765 5899999998875433 3333  58999999998 999999999997777 999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +|||||+. +|.+++.+. .+.+++..+..|+.||++||+|+|+   +|+.|||+||+|||+..+..+||+||||||...
T Consensus        87 fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            99999975 999999776 5789999999999999999999999   999999999999999999999999999999753


Q ss_pred             CCCCcceeecccccccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCC-----
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ-----  687 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  687 (805)
                      .   ....+..+.|..|.|||++ +.+.|+.+.|+|++|||++||.+-++.|.+..+.++..-+.-+..-..+..     
T Consensus       162 S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 S---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             c---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            3   2234667889999999986 578899999999999999999999999987766554433222111111100     


Q ss_pred             -c--------ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          688 -L--------DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       688 -~--------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                       +        .+..-..+..-. +.+..+..+++.+|++.||.+|||+.+.+++-
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             0        011111111111 33677889999999999999999999998743

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-38  Score=311.86  Aligned_cols=264  Identities=22%  Similarity=0.303  Sum_probs=209.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCch--hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...++||+|.||.||+|+.. +|+.||||+++.....  ......+|++.|++++|+||+.|++++...+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            4666789999999999999754 6999999988765432  245678999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      |+. +|...+..+. ..|+..++..++.++++||+|||.   +.|+||||||.|+|+++++.+||+|||+++.....+..
T Consensus        83 m~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            986 8998887655 579999999999999999999999   99999999999999999999999999999987654433


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc---cccC-
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD---QIID-  693 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d-  693 (805)
                        .+..+-|..|.|||.+.+ ++|+...|+||.||++.||+-|.+.|.+..+-++...+-.+..-..+++..   .+-| 
T Consensus       158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence              233478899999999875 679999999999999999999998887766555443332222111111111   1111 


Q ss_pred             ------c-cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 ------P-TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ------~-~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                            | ......-+.+.....+++..++..+|.+|++++|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                  0 01111223455667999999999999999999999753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-38  Score=335.84  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=201.7

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |...+.||+|+||.||+|... +++.||+|.+....   ......+.+|++++++++|+||+++.+++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            667789999999999999764 68999999876432   22345678999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++|+|.+++.......+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....   
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~---  155 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG---  155 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC---
Confidence            999999988865554579999999999999999999999   99999999999999999999999999999764321   


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||..........  ..... ....          ..
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~-~~~~----------~~  222 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRR-VKED----------QE  222 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHH-hhcc----------cc
Confidence            11234578999999999999999999999999999999999999997543321111  00000 0000          01


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~  731 (805)
                      .++......+.+++.+||+.+|.+||+     ++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            122233556889999999999999997     677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.2e-38  Score=329.87  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            46778889999999999999988888999998765433 35788999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++.+++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++...... ...
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~  160 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTA  160 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc-eec
Confidence            9999999976555678999999999999999999999   899999999999999999999999999998654311 111


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++....++.++|||||||++|||+| |+.||......+.   ..+.    ..+.     ..    .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~-----~~----~  224 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRGY-----RM----P  224 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCC-----CC----C
Confidence            223346678999999998899999999999999999998 9999875433221   1111    1110     00    0


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ........+.+++.+|++.+|++||+++++.+.|++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111234568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=338.79  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=209.2

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  533 (805)
                      ..++|...+.||+|.|++|++|+.. .++.+|||++...   .+...+-...|-+.|.+| .||.|++|+--|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3467888899999999999999765 5899999987654   223345567888999999 8999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +|+||+++|+|.++|...+  .+++....-.+.+|+.||+|||+   .|||||||||+|||||+|+++||+|||-|+.++
T Consensus       151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999997654  68999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCc---------cee--ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 003659          614 EIDQT---------HVS--TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       614 ~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      .....         ...  ...+||..|.+||++.....+..+|+|+|||+||.|+.|++||....+.-..   +     
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---q-----  297 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---Q-----  297 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH---H-----
Confidence            42221         111  4578999999999999999999999999999999999999999865443211   1     


Q ss_pred             hhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       683 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                             ++++  +.-++++..++.+.+|+.+.|..+|.+|++..++-++
T Consensus       298 -------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 -------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                   1111  1123445555778899999999999999999888764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.6e-39  Score=340.84  Aligned_cols=246  Identities=27%  Similarity=0.431  Sum_probs=211.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...+.||+|.||.||||+.+ +.+.||+|.+.+..  ++..+.+.+|++++++|+||||+.++++++...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778889999999999999766 58899999876543  4557788999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+.+ +|..+|...+  .|+++++..|+.++..||.|||+   .+|+|||+||.||||+.++.+|++|||+|+....  .
T Consensus        82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9986 9999996544  69999999999999999999999   9999999999999999999999999999998654  5


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      +.+.+.++||+-|||||.+.++.|+..+|+||+||+|||+++|++||....   ...+++   ....        |+.  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~Lv~---~I~~--------d~v--  217 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQLVK---SILK--------DPV--  217 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHHHH---HHhc--------CCC--
Confidence            667788999999999999999999999999999999999999999996432   112221   1111        111  


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ..+......+..++...|.+||.+|.+-.+++.
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             123456777899999999999999999998886

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1e-37  Score=333.27  Aligned_cols=255  Identities=29%  Similarity=0.462  Sum_probs=207.2

Q ss_pred             CCcccceEeeeCceEEEEEEecC------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +|...+.||+|+||.||+|....      ...||+|.+.... .....+|.+|++++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   85 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM   85 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence            56677899999999999997643      2579999887543 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCC--------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          535 IYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      +|||+++|+|.+++.....              ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence            9999999999999864321              458899999999999999999999   89999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (805)
                      +||+|||+++.....+.........++..|+|||++.+..++.++|||||||++|||++ |..||......+..   .+ 
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~---~~-  238 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---EM-  238 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH-
Confidence            99999999976433222222334456889999999998899999999999999999998 99998755433221   11 


Q ss_pred             HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          680 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       680 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                         ...+..         ...+...+..+.+++.+||+.+|.+||++.||++.|+.
T Consensus       239 ---i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 ---IRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               111111         11223456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.5e-37  Score=328.36  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +|...+.||+|++|.||+|..+ .++.||+|.+... ....+++.+|++++++++|+||++++++|...+..++||||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            4667789999999999999876 4889999987754 3346789999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++..++.++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++....... ..
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~  161 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA  161 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence            9999999976555679999999999999999999999   8999999999999999999999999999986543111 11


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..|+......+.      .... ..+         ....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~-~~~---------~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELL-EKG---------YRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHH-HCC---------CCCC
Confidence            112234668999999999999999999999999999998 8899865432221      1111 110         1111


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2223356688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-37  Score=333.02  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=210.9

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...+.||+|+||.||+|+..      ++..+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34667789999999999999742      356799999887766666789999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          535 IYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      ||||+++++|.+++....              ...++|.++++++.|++.||+|||+   .+++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            999999999999986432              2348999999999999999999999   99999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (805)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||+++||+| |+.||......+..   +  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---E--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H--
Confidence            99999999976543222222334556788999999999999999999999999999999 99998755433211   1  


Q ss_pred             HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          680 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       680 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                        ....+....         .....+..+.+++.+|++.+|.+||++.+|+++|+.+..
T Consensus       237 --~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 --CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              111111111         112234568899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-37  Score=348.59  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             hcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  531 (805)
                      .++|...++||+|+||.||+|+..      .+..||||++..... ...+.|.+|+++|+++. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            456777889999999999999753      235799999875433 33567899999999996 9999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003659          532 MILIYEYMENGTLKGHLYGSG-----------------------------------------------------------  552 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  552 (805)
                      .++||||+++|+|.++|+...                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999998875421                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC
Q 003659          553 -----------------------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE  597 (805)
Q Consensus       553 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~  597 (805)
                                                         ...+++.+++.++.|+++||+|||+   .+|+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                               1348899999999999999999999   89999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHH
Q 003659          598 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA  676 (805)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  676 (805)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+.........  .
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence            99999999999986433222112223456788999999998899999999999999999997 88888754322111  0


Q ss_pred             HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          677 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       677 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                          .....+.         ....+......+.+++.+||+.+|++||++.+|.+.|+.++
T Consensus       351 ----~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 ----NKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ----HHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                0111110         00112234567889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-37  Score=337.53  Aligned_cols=257  Identities=24%  Similarity=0.364  Sum_probs=204.9

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCc----EEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      .+|+..+.||+|+||.||+|++. +++    .||+|.+.... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            45888899999999999999864 333    48999987543 34567899999999999999999999999765 5679


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      |+||+++|+|.+++.... ..+++..+++++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999997543 458999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |+.|++.....+..   .    ....+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~----~~~~~~~-----  229 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---S----ILEKGER-----  229 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHhCCCC-----
Confidence            222211223345678999999999999999999999999999998 99998754332211   1    1111100     


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                          ...+..+...+.+++.+|++.+|.+||++.+++..|..+.+
T Consensus       230 ----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         230 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                01112234568899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-37  Score=327.32  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=207.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .++|...+.||+|++|.||+|..++++.||+|.+.... ...++|.+|++++++++|+||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            35678889999999999999998878899999987543 23577899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.......++|.++..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...... ..
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YE  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-cc
Confidence            99999999976555579999999999999999999999   899999999999999999999999999998654211 11


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......+..|+|||++.+..++.++||||||++++||+| |+.||.........   .   .......          .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~---~~~~~~~----------~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---Q---QVDQGYR----------M  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---H---HHHcCCC----------C
Confidence            1112223457999999999999999999999999999999 99998754322211   1   1111100          0


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .........+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1122335678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-38  Score=327.85  Aligned_cols=283  Identities=24%  Similarity=0.376  Sum_probs=216.6

Q ss_pred             CCCCCcccCHHHHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHh--cCCCCceEE
Q 003659          444 NSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLS--QFRHRHLVS  521 (805)
Q Consensus       444 ~~~~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~  521 (805)
                      .+.++...|+...+...++....+.||+|.||.||+|+++ |+.||||++...++.   .+.+|.++.+  .|+|+||+.
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhh
Confidence            4455677889999999999999999999999999999998 889999999877654   4556666655  569999999


Q ss_pred             EEEEEccC----CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhcc-----CCCCeEeeccCCCc
Q 003659          522 LIGYCDEK----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-----YAKAVIHRDVKSAN  592 (805)
Q Consensus       522 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~Dikp~N  592 (805)
                      +++.-..+    .+++||.+|.++|||.|||..   ..++....++++..+|.||++||.+     .++.|.|||||++|
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            99986443    378999999999999999965   3699999999999999999999963     35789999999999


Q ss_pred             EEeCCCCcEEEeecCCCCCCCCCCC--cceeecccccccccChhhhccC------CCCchhhHHHHHHHHHHHHhC----
Q 003659          593 ILLDENFMAKVADFGLSKTGPEIDQ--THVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCA----  660 (805)
Q Consensus       593 ILld~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~elltG----  660 (805)
                      ||+.+++.+.|+|+|||........  .......+||.+|||||++...      +.-..+||||||.|+||++.+    
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g  426 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG  426 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence            9999999999999999976544211  1223567899999999999643      122579999999999999863    


Q ss_pred             ------CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC-CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          661 ------RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       661 ------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                            +.||....+.+.. ..+ .....    ..+-+.|.+... ...+.+..+.++++.||..+|.-|-|+-.+-+.|
T Consensus       427 gi~eey~~Pyyd~Vp~DPs-~ee-MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  427 GIVEEYQLPYYDVVPSDPS-FEE-MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             CEehhhcCCcccCCCCCCC-HHH-Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence                  2566543332211 000 01111    111122222222 2346788999999999999999999999998888


Q ss_pred             HHHHHh
Q 003659          734 EYALQL  739 (805)
Q Consensus       734 ~~~~~~  739 (805)
                      .++.+.
T Consensus       501 ~~l~~~  506 (513)
T KOG2052|consen  501 AKLSNS  506 (513)
T ss_pred             HHHhcC
Confidence            776643

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-37  Score=325.53  Aligned_cols=251  Identities=27%  Similarity=0.433  Sum_probs=203.1

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|+..+.||+|+||.||+++++++..+|+|.+.... ...++|.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            3467778999999999999999888899999876443 335678999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++.... ..++|..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++...... ...
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS  157 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eec
Confidence            999999986543 358999999999999999999999   999999999999999999999999999987643211 111


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   ..+.   .. +.  ....+     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i---~~-~~--~~~~~-----  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI---SR-GF--RLYRP-----  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---HC-CC--CCCCC-----
Confidence            123345668999999998899999999999999999999 8999875433221   1111   11 11  00111     


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                        ......+.+++.+|++.+|.+||++.++++.|
T Consensus       224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence              11235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-37  Score=328.88  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=212.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ..+|...++||.|+||.||+|...++..+|+|.+.........++..|+++++.++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45677788999999999999998889999999988776656778999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++......  ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~~  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--VY  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc--cc
Confidence            99999999977655679999999999999999999999   89999999999999999999999999999765331  11


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......++..|+|||.+....++.++||||||++++||++ |+.||......+.   .....    .+         ...
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~---------~~~  223 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AG---------YRM  223 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hC---------CcC
Confidence            1223446778999999998899999999999999999998 8999975432221   11111    10         001


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            1123345668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3e-37  Score=326.59  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=208.0

Q ss_pred             cCCcccceEeeeCceEEEEEEecC----CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|+..+.||+|+||.||+|+++.    ...||||.+.... .....+|.+|+.++++++|+||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            568888999999999999998752    4589999887543 33456789999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++.... ..+++.++++++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999986543 368999999999999999999999   99999999999999999999999999999876422


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ..........++..|+|||.+.+..++.++||||||++++||++ |..|+......+.   ....    ..+...     
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~-----  227 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAV----EDGYRL-----  227 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCCCC-----
Confidence            22222223445678999999998999999999999999999998 9999865432221   1111    111000     


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                          ..+...+..+.+++.+|++.+|++||++.||++.|+++
T Consensus       228 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ----PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                11123356688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=339.23  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC----Cc-hhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCe
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR----SQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE  531 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~  531 (805)
                      ..++|...+.||+|.||+|+.|... +++.||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3567888899999999999999664 6899999976653    12 23456678999999999 9999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSK  610 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~  610 (805)
                      .++||||+.+|+|.+++...  .++.+.+...++.|++.|++|||+   ++|+||||||+|||+|.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999773  478899999999999999999999   999999999999999999 999999999998


Q ss_pred             CCCCCCCcceeecccccccccChhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ-LT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......   +..   . ...+. 
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~~---k-i~~~~-  239 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LYR---K-IRKGE-  239 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HHH---H-HhcCC-
Confidence            763  1223356789999999999999877 76 89999999999999999999998632211   111   1 11111 


Q ss_pred             ccccCccccCCCChhH-HHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          689 DQIIDPTLAGKIRPDS-LRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                             .  .++... ...+..++.+|+..+|.+|+++.+++
T Consensus       240 -------~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 -------F--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -------c--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                   0  112222 56688999999999999999999998

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.1e-37  Score=330.71  Aligned_cols=259  Identities=28%  Similarity=0.437  Sum_probs=209.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46778889999999999999742      346789999887666667789999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEE
Q 003659          535 IYEYMENGTLKGHLYGSG-----------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV  603 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl  603 (805)
                      ||||+++++|.+++....           ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432           2359999999999999999999999   99999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 003659          604 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      +|||+++...............++..|+|||++.+..++.++|||||||+++||++ |++||......+..   .   . 
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~---~-  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---E---C-  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---H-
Confidence            99999986533222222233446778999999998999999999999999999999 89998754432211   1   1 


Q ss_pred             hhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       683 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      ...+....     .    .......+.+++.+|++.+|.+||++.+|++.|+.+.+
T Consensus       235 i~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         235 ITQGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHcCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111110     1    11234568999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-37  Score=341.85  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=204.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEc-cCCe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD-EKNE  531 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-~~~~  531 (805)
                      ++|...++||+|+||.||+|...      .++.||+|++.... ....+.+..|++++.++ +|+||++++++|. .+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            45777889999999999999642      24789999887543 33356788999999999 8999999999885 4567


Q ss_pred             EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003659          532 MILIYEYMENGTLKGHLYGSG-----------------------------------------------------------  552 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  552 (805)
                      .+++|||+++++|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999998885321                                                           


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccC
Q 003659          553 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD  632 (805)
Q Consensus       553 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  632 (805)
                      ..+++|..+.+++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            1268999999999999999999999   8999999999999999999999999999986533222122233456778999


Q ss_pred             hhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHH
Q 003659          633 PEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGET  711 (805)
Q Consensus       633 PE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  711 (805)
                      ||++.+..++.++|||||||+|+||++ |+.||......+.  +.    .....+..         ...+......+.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~---------~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTR---------MRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCC---------CCCCccCCHHHHHH
Confidence            999999999999999999999999998 9999865432221  11    11111110         01112234568899


Q ss_pred             HHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          712 AEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       712 ~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      +.+|++.+|++||++.|++++|+++++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.6e-37  Score=329.21  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=205.0

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      ++++|+..+.||+|+||.||+|...      .+..||+|++.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567888999999999999999753      25679999876432 2345678999999999999999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEE
Q 003659          532 MILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV  603 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl  603 (805)
                      .++||||+++|+|.+++....        ...++|..++.++.|+++||+|||+   .+++||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986422        2347899999999999999999999   89999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 003659          604 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      +|||+++...............++..|+|||++.++.++.++|||||||+++||++ |..||......+..   .+    
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~---~~----  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RF----  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH----
Confidence            99999976443222221223345788999999998899999999999999999999 68888654332211   11    


Q ss_pred             hhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       683 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .......         ..+......+.+++.+|++.+|.+||++.|+++.|+
T Consensus       234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111110         112233456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-37  Score=329.82  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=206.3

Q ss_pred             cCCcccceEeeeCceEEEEEEecC------CcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ++|...+.||+|+||.||+|+..+      ++.||||.+...... ..+.|.+|+++|++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            456777899999999999997643      478999998765443 4678999999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          534 LIYEYMENGTLKGHLYGSG------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      +||||+++++|.+++...+            ...+++.++..++.|++.||+|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999986432            2458999999999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |+.||......+.   .... 
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~-  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECI-  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-
Confidence            9999999975433222222233446788999999999999999999999999999999 9999865433221   1111 


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                         ..+...         ..+......+.+++.+||+.+|.+||++.||++.|+
T Consensus       238 ---~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 ---TQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               111111         111233466889999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=325.89  Aligned_cols=264  Identities=29%  Similarity=0.409  Sum_probs=199.6

Q ss_pred             ccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhc--CCCCceEEEEEEEccCC----eEEEEEEe
Q 003659          465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ--FRHRHLVSLIGYCDEKN----EMILIYEY  538 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV~e~  538 (805)
                      ..++||+|+||.||||+++ ++.||||++....   .+.|++|-++.+.  ++|+||++++++-..+.    +++||+||
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3458999999999999998 5899999987643   4677888777664  58999999999876655    89999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccC------CCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY------AKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      .++|+|.++|..+   .++|....+|+..+++||+|||++.      +++|+|||||++||||.+|+++.|+|||||..+
T Consensus       290 h~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  290 HPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             ccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            9999999999765   4999999999999999999999743      578999999999999999999999999999876


Q ss_pred             CCCCCcceeecccccccccChhhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCCCCC------Chhh--h---hhH
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLT-----EKSDVYSFGVVLFEVLCARPVIDPT------LPRE--M---VNL  675 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~ksDV~S~Gvvl~elltG~~p~~~~------~~~~--~---~~l  675 (805)
                      ............+||.+|||||++.+. .+.     .+.||||+|.|||||+++...++..      .+.+  .   -.+
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            543333334458899999999999763 222     4789999999999999976544311      1111  0   011


Q ss_pred             HHHHHHHhhcCCcccccCccccCCC-ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                      -+.-....++..     .|.+.... ....+..+.+.+..||..|++.|.|+.=|-+.+.++..+.
T Consensus       447 e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  447 EEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            111111111111     12221111 1134677899999999999999999999988887765444

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-37  Score=337.62  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=205.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .++|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            357888899999999999999876 58899999877542 3345679999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            99999999998654  368999999999999999999997  136999999999999999999999999998764321  


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--cCCc-------
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQL-------  688 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~-------  688 (805)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.......  ....  .+..       
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCccc
Confidence              12345689999999999999999999999999999999999999975443222111000  0000  0000       


Q ss_pred             --------------------ccccC----ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          689 --------------------DQIID----PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       689 --------------------~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                                          .+..+    .............++.+++.+||+.+|++||++.|++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                00000    0000000112345689999999999999999999998654

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=340.47  Aligned_cols=252  Identities=27%  Similarity=0.362  Sum_probs=205.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            35788899999999999999876 48899999876432   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999644  368999999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HHHHHHHHhhcCCcccccCcc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~  695 (805)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..|..      .+   ..+.
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------~~---~~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------TL---QRPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------cc---cCCC
Confidence               2345679999999999999999999999999999999999999997654433211 111110      00   0011


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      . ..........+.+++.+||+.+|.+||++.+++++
T Consensus       222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0 00012335567889999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.2e-37  Score=351.80  Aligned_cols=250  Identities=22%  Similarity=0.302  Sum_probs=204.7

Q ss_pred             CcccceEeeeCceEEEEEEec-C-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          463 FDESWVIGIGGFGKVYKGELN-D-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      |...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++|+.++||||++++++|..++..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            778889999999999999654 3 67899998766655556678899999999999999999999999999999999999


Q ss_pred             CCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          541 NGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       541 ~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +|+|.++|...  ...++++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988542  33468999999999999999999999   99999999999999999999999999999865432222


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      ..... +..    +     
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~------~~~~~-~~~----~-----  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM------QQVLY-GKY----D-----  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCC----C-----
Confidence            2334567999999999999999999999999999999999999999754332211      11111 110    0     


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+......+.+++.+||+.+|.+||++.+++.
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            111223456889999999999999999999975

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.2e-37  Score=327.36  Aligned_cols=258  Identities=27%  Similarity=0.398  Sum_probs=205.8

Q ss_pred             CCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +|...+.||+|+||.||+|+..      ....+++|.+.... .....++.+|+.+++.++||||++++++|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            3666789999999999999753      23578999877543 3345678999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCC----------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCc
Q 003659          535 IYEYMENGTLKGHLYGS----------------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN  592 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~----------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  592 (805)
                      |+||+.+|+|.+++...                      ....+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            99999999999987532                      12358999999999999999999999   999999999999


Q ss_pred             EEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 003659          593 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPRE  671 (805)
Q Consensus       593 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  671 (805)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||....+.+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999976432221111223456778999999988899999999999999999999 999987554332


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      ...   +    ....         .....+......+.+++.+|++.+|.+||++.++++.|++++.
T Consensus       238 ~~~---~----~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 LFN---L----LKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHH---H----HhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            211   1    1111         0111112334568899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-37  Score=330.07  Aligned_cols=265  Identities=19%  Similarity=0.235  Sum_probs=202.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...+.||+|+||.||+++.+ +++.||+|++....  ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888899999999999999886 58899999876532  2335678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |++++.|..+...  ...+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  154 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-  154 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-
Confidence            9998777655432  2468999999999999999999999   999999999999999999999999999998754311 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHH---------HHHhhcCCc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA---------MKWQNKGQL  688 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~  688 (805)
                      ........||..|+|||++.+..++.++|||||||++|||++|++||......+........         ..+......
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            11223456899999999999889999999999999999999999999765433221111110         000111111


Q ss_pred             ccccCccccC------CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAG------KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .....+....      .........+.+++.+||+.+|.+||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111111100      011123456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.9e-37  Score=327.03  Aligned_cols=254  Identities=27%  Similarity=0.426  Sum_probs=203.4

Q ss_pred             CCcccceEeeeCceEEEEEEe-----cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .|+..+.||+|+||.||+|..     ..+..|++|.+.... .....+|.+|++++++++||||+++++++..+...++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            466678999999999999974     246789999887533 34457889999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          536 YEYMENGTLKGHLYGSG---------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      |||+++++|.+++....               ...+++.+.+.++.|++.||+|||+   .+++||||||+|||+++++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCc
Confidence            99999999999885321               2358899999999999999999999   89999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (805)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..||....+.+..   +. 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~---~~-  238 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI---EM-  238 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HH-
Confidence            99999999976533222222334456778999999988889999999999999999998 88888654332211   11 


Q ss_pred             HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          680 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       680 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                         .......         ..+......+.+++.+|++.+|.+||++.++.+.|+
T Consensus       239 ---~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         239 ---VRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence               1111110         111233456888999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.8e-37  Score=325.71  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=203.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCc----EEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...+.||+|+||.||+|++. +++    .+++|...... .....++..|+.+++++.||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            35667789999999999999874 344    47888876443 2345678889999999999999999999864 45788


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ++||+++|+|.+++.... ..++|..++.|+.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999996543 468999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||++.++.++.++|||||||++|||++ |+.|+....+.....+       ...+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~--~~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGERL--AQ  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCcC--CC
Confidence            222222334567789999999998999999999999999999998 9999976543322111       1111110  01


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      +       ..+...+.+++.+|+..+|.+||++.|+++.|..+.+
T Consensus       233 ~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         233 P-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1       1123456788999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.1e-37  Score=322.60  Aligned_cols=251  Identities=28%  Similarity=0.395  Sum_probs=202.6

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +|...+.||+|+||.||+|+.+++..+|+|.+..... ..++|.+|+.++++++||||+++++++.+....++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN   83 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence            4666779999999999999888777899998775432 356799999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++.... ..+++.++++++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++...... ....
T Consensus        84 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          84 GCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999986543 368999999999999999999999   999999999999999999999999999987643311 1112


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+.   ...   ......      .    ..
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~---~~~~~~------~----~~  222 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEK---VSQGLR------L----YR  222 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH---HhcCCC------C----CC
Confidence            22345678999999998889999999999999999999 9999875443221   111   111100      0    01


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .......+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1122467889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.5e-37  Score=330.45  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             CCcccceEeeeCceEEEEEEec--CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcC---CCCceEEEEEEEc-----cC
Q 003659          462 NFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCD-----EK  529 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----~~  529 (805)
                      +|...+.||+|+||.||+|+..  +++.||+|++....  ......+.+|+.+++.+   +||||++++++|.     ..
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            5778889999999999999763  46889999876432  22234566777777665   6999999999984     34


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||++ ++|.+++.......+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999996 699999876555679999999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      +.....   .......||..|+|||.+.+..++.++|||||||++|||++|++||......+..................
T Consensus       158 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         158 RIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             EeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            764331   22345578999999999998899999999999999999999999998654433221110000000000000


Q ss_pred             -------cccCcccc---CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          690 -------QIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       690 -------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                             ..+.+...   ....+.....+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                   00000000   0011223456789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-37  Score=338.36  Aligned_cols=241  Identities=24%  Similarity=0.298  Sum_probs=197.2

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      ++||+|+||.||+++.+ +|+.||+|.+...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            37999999999999775 6899999987643   2234567789999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceee
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST  622 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  622 (805)
                      +|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~  153 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK  153 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence            999998654  368999999999999999999999   9999999999999999999999999999875322  111223


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ...    ..+.      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~---~~~----~~~~------~----~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELI----LMEE------I----RFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH---HHH----HcCC------C----CCCC
Confidence            457999999999999999999999999999999999999999754322211   110    0110      1    1122


Q ss_pred             hHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3345688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.4e-37  Score=330.13  Aligned_cols=260  Identities=25%  Similarity=0.463  Sum_probs=208.6

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      ..++|+..+.||+|+||.||++...      ....+|+|.+... ......++.+|++++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3456778889999999999999764      2368999987754 334456788999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          531 EMILIYEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                      ..+++|||+++|+|.+++...              ....+++..+++++.|++.||+|||+   .+|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence            999999999999999998542              23569999999999999999999999   9999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+... 
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-  245 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-  245 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH-
Confidence            999999999999987543222222233345678999999998999999999999999999998 888886543322111 


Q ss_pred             HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                            ....+.         ....+......+.+++.+|++.+|.+|||+.|+++.|+.++
T Consensus       246 ------~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 ------LLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------HHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                  111111         01122233556889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=333.39  Aligned_cols=244  Identities=23%  Similarity=0.278  Sum_probs=200.4

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      +|...+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            5778889999999999999876 58999999876432   2335678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          82 YVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            99999999998654  368999999999999999999999   99999999999999999999999999999864321  


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .... .+.      .   
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i~-~~~------~---  215 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKIL-AGK------L---  215 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCC------c---
Confidence               22356899999999999989999999999999999999999999765432211      1111 111      0   


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCC-----HHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLWN  732 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~~  732 (805)
                       .++......+.+++.+||+.+|.+||+     +.|++++
T Consensus       216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             111222445789999999999999995     7776643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.7e-37  Score=330.08  Aligned_cols=261  Identities=27%  Similarity=0.444  Sum_probs=208.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec--------CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      ++|...+.||+|+||.||+++..        +...+|+|.+... ......++..|+++++++ +|+||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            46888899999999999999752        2357999988754 234456788999999999 7999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                      ..++||||+++|+|.+++....              ...++|.++++++.|++.||+|||+   .+++||||||+|||++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence            9999999999999999996532              1358999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.|+......+... 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-
Confidence            999999999999976543222111222334578999999998899999999999999999998 888886443222111 


Q ss_pred             HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                           . ......         ...+......+.+++.+|++.+|.+||+|.+|++.|+++++..
T Consensus       254 -----~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         254 -----L-LKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -----H-HHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                 1 111110         1112234567888999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.1e-37  Score=320.13  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=198.5

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      +.||+|+||.||+|+.. +++.+|+|..... .......|.+|++++++++||||++++++|......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999875 6899999987643 334457799999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++.... ..+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..............
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99986543 468999999999999999999999   89999999999999999999999999998764321111111112


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChh
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD  703 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  703 (805)
                      .++..|+|||.+.++.++.++||||||+++|||++ |..|+...........       ....         .....+..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-------~~~~---------~~~~~~~~  220 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-------IEQG---------VRLPCPEL  220 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-------HHcC---------CCCCCccc
Confidence            23457999999999999999999999999999998 8888865433221111       0000         01111223


Q ss_pred             HHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          704 SLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       704 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .+..+.+++.+|++.+|++||++.++.++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3557889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-37  Score=330.84  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=207.3

Q ss_pred             hcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      .++|...+.||+|+||.||++...      .+..||||++.... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888899999999999999641      35689999887543 33456789999999999 79999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++||||+++|+|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999976554458999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+.  ....    ...+.   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~----~~~~~---  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL----IKEGY---  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH----HHcCC---
Confidence            543222112223346778999999999999999999999999999998 9999865432221  1111    11110   


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                            ....+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  0001112245688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=338.07  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=217.4

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +.....+||-|.||.||.|.|+. ...||||.++.... ..++|+.|..+|+.++|||+|+|+|+|..+..+|+|.|||.
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34455689999999999999985 67899999887644 47899999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      .|+|.++|++.++..++-...+.+|.||+.||+||..   +++|||||.++|+|+.++..+||+||||++++.. +....
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTYTA  422 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTYTA  422 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC-Cceec
Confidence            9999999998888888999999999999999999999   9999999999999999999999999999998754 22222


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....-...|.|||-+....++.|+|||+|||+||||.| |..|+....-...                .++++....-+
T Consensus       423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV----------------Y~LLEkgyRM~  486 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YGLLEKGYRMD  486 (1157)
T ss_pred             ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH----------------HHHHhcccccc
Confidence            233344678999999999999999999999999999998 6777764322111                12233333334


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      -++.|+.++.+++++||+.+|.+||+.+|+-+.++.+.+
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            456788899999999999999999999999999998764

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.2e-36  Score=320.91  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|+||.||+|..+++..+|+|.+..... ..+.|.+|+.++++++|+|++++++++.+ ...+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            35677789999999999999988888899998876443 34678999999999999999999998854 56889999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++.+++.++.+++.||+|||+   .+++||||||+||++++++.+||+|||++....... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-ccc
Confidence            9999999976555678999999999999999999999   899999999999999999999999999997653311 111


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++.+..++.++||||||++++||++ |+.||......+.   ..+   .....          ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~---~~~~~----------~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ---VERGY----------RMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH---HHcCC----------CCC
Confidence            122345678999999988899999999999999999999 8889865432221   111   11100          011


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .+......+.+++.+|++.+|.+|||+.++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            122335568999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.2e-37  Score=330.46  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ..++|+...+||+|+||.||+++.+ +|..+|+|+++...   ....+....|-.+|....++.||+|+..|.+...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            3567888999999999999999776 59999999988764   3446778899999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||||++||++..+|...+  .|+.....-.+.+++.|++.||+   .|+|||||||+|+|||..|++||+||||+.-...
T Consensus       219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999996655  79999999999999999999999   9999999999999999999999999999842100


Q ss_pred             ----------------------CCCcc----e-------------------eecccccccccChhhhccCCCCchhhHHH
Q 003659          615 ----------------------IDQTH----V-------------------STAVKGSFGYLDPEYFRRQQLTEKSDVYS  649 (805)
Q Consensus       615 ----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~s~ksDV~S  649 (805)
                                            .+...    .                   ....+|||.|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                  00000    0                   12357999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhh-hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC
Q 003659          650 FGVVLFEVLCARPVIDPTLPRE-MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS  725 (805)
Q Consensus       650 ~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  725 (805)
                      +||||||||.|.+||....+.+ ...+..|...+.....              .....+..++|.+|+. +|.+|-.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999877765 3466677655433321              1223567889999998 9999965

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.4e-36  Score=321.08  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=205.7

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|+||.||+|+.++...||+|++..... ..++|.+|++++++++|+||+++++++.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            45788889999999999999887777899999875432 34678999999999999999999998754 56789999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++.......++|..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence            9999999976544568999999999999999999999   9999999999999999999999999999976543221 11


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||+..+..++.++||||||++++||+| |+.||......+...      . ...+.         ...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~-~~~~~---------~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------Q-VERGY---------RMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------H-HhcCC---------CCC
Confidence            223446778999999988899999999999999999999 788887543322111      0 00000         001


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ...+.+..+.+++.+|++.+|++||++.++++.|+..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1234456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-36  Score=321.87  Aligned_cols=254  Identities=30%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             cccceEeeeCceEEEEEEecC-Cc--EEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------CeE
Q 003659          464 DESWVIGIGGFGKVYKGELND-GT--KVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEM  532 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~  532 (805)
                      ...++||+|+||.||+|+..+ +.  .+|+|.+...  +....+.|..|++++++++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            455789999999999998764 32  6899987653  344567889999999999999999999987432      256


Q ss_pred             EEEEEeccCCcccccccC----CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          533 ILIYEYMENGTLKGHLYG----SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                      +++|||+++|+|.+++..    .....+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999988742    123458999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      ++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   .    .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~----~~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---Y----DYLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHHcCC
Confidence            986543221111223346678999999999999999999999999999999 7888865432211   1    1111111


Q ss_pred             cccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ..         .........+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10         11223455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1e-36  Score=324.68  Aligned_cols=256  Identities=27%  Similarity=0.384  Sum_probs=203.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  532 (805)
                      +++|...+.||+|++|.||+|.+.+      +..||+|...... ......|..|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4678888999999999999998753      5688999876543 33456799999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccCCCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC---cEEEe
Q 003659          533 ILIYEYMENGTLKGHLYGSGL-----PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVA  604 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~---~~kl~  604 (805)
                      ++||||+++++|.+++.....     ..++|.++++++.||+.||+|||+   .+++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999865431     358999999999999999999999   8999999999999998754   69999


Q ss_pred             ecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHh
Q 003659          605 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQ  683 (805)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  683 (805)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+...      ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~------~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME------FVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HHH
Confidence            9999986532111111112234568999999999999999999999999999997 999987543322111      111


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ....          ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       236 ~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1110          1112233567889999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-37  Score=337.46  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=200.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46788889999999999999876 58899999876432   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            999999999998654  368899999999999999999999   99999999999999999999999999999865331 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+..      .. ...+..        
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~-i~~~~~--------  232 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EK-ILAGRL--------  232 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HH-HhcCCc--------
Confidence                12357899999999999999999999999999999999999999754332211      11 111110        


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCC-----HHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~  731 (805)
                        .++......+.+++.+||+.+|.+||+     +.+++.
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              111122345789999999999999997     566654

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-36  Score=320.07  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=201.5

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +|...+.||+|+||.||+|..+++..+|+|.+..... ...+|.+|++++++++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4667789999999999999888777899998765432 345788999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|.+++.... ..++|..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++..... .....
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~  158 (256)
T cd05059          84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSS  158 (256)
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc-ccccc
Confidence            99999986543 368999999999999999999999   89999999999999999999999999999764321 11111


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   .   .. ..+     ...    ..
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~-~~~-----~~~----~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E---SV-SAG-----YRL----YR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H---HH-HcC-----CcC----CC
Confidence            12234457999999999999999999999999999999 78988754332211   1   11 110     001    11


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      +...+..+.+++.+|++.+|++||+|.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            122455789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-36  Score=328.43  Aligned_cols=262  Identities=25%  Similarity=0.438  Sum_probs=209.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEec--------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccC
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK  529 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  529 (805)
                      ..+|...+.||+|+||.||+|+..        ++..||+|...... ....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            455777789999999999999641        24579999886542 34467889999999999 899999999999999


Q ss_pred             CeEEEEEEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe
Q 003659          530 NEMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL  595 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  595 (805)
                      ...++||||+++|+|.+++....              ...++|.+++.++.|+++||+|||+   .+++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            99999999999999999986532              2358899999999999999999999   899999999999999


Q ss_pred             CCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhh
Q 003659          596 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN  674 (805)
Q Consensus       596 d~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (805)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+.  
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence            9999999999999987644332222333456778999999998889999999999999999998 7788764432221  


Q ss_pred             HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          675 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       675 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                          ..... .+..         ...+......+.+++.+||+.+|.+||+|.|+++.|++++.+.
T Consensus       249 ----~~~~~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         249 ----FKLLK-EGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ----HHHHH-cCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                11111 1110         0111234566888999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.2e-37  Score=327.54  Aligned_cols=264  Identities=21%  Similarity=0.312  Sum_probs=200.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            45788889999999999999876 58899999876443 22345678999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++ +|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++......  
T Consensus        85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            974 8998885443 357899999999999999999999   999999999999999999999999999997643211  


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH---------HhhcCCc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK---------WQNKGQL  688 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~  688 (805)
                      .......|++.|+|||++.+ ..++.++|||||||++|||+||++||......+..........         .......
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            11234568899999999865 5689999999999999999999999976544333221110000         0000000


Q ss_pred             ccccCccccC----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .....+....    ...+.....+.+++.+||+.+|.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111000    001122355789999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.8e-36  Score=323.26  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=209.2

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC-----CcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc-CCeE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~  532 (805)
                      .++|...++||+|+||.||+|...+     +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4567888899999999999998765     688999987754 33446778899999999999999999998865 5778


Q ss_pred             EEEEEeccCCcccccccCCCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          533 ILIYEYMENGTLKGHLYGSGL------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                      ++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence            999999999999999865321      469999999999999999999999   89999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      |+++.....+.........++..|+|||++.+..++.++|||||||++||+++ |+.||....+.+   +..+..   ..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLK---DG  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHH---cC
Confidence            99986543222222233456778999999998899999999999999999999 999997544322   111111   11


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      ...          .....++..+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus       236 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 YRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            000          0112234568899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.8e-36  Score=318.12  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=204.0

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|++|.||+|..+.+..+|+|++..... ..+.|.+|++++++++|+|++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            34677789999999999999988777899998765432 34678899999999999999999998854 56889999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......++|..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            9999999976555568999999999999999999999   8999999999999999999999999999976433111 11


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++.+..++.++||||||+++|||+| |+.|+......+.   ..+.    ..+.         ...
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~---------~~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----ERGY---------RMP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCC---------CCC
Confidence            223346778999999998999999999999999999999 8999875433221   1111    1110         001


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .+...+..+.+++.+|++.+|.+||++++|++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.1e-37  Score=327.01  Aligned_cols=265  Identities=25%  Similarity=0.404  Sum_probs=203.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-----CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  533 (805)
                      +.|...+.||+|+||.||++..+     ++..||+|++........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            45677789999999999999742     578999999887766667889999999999999999999998743  45689


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+++|+|.+++.... ..++|..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999996543 358999999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCcc-eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCC-----
Q 003659          614 EIDQTH-VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ-----  687 (805)
Q Consensus       614 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  687 (805)
                      ...... ......++..|+|||++.+..++.++|||||||+++||++|..+.......       +.........     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhhcccccccccch
Confidence            322111 111223345699999999889999999999999999999987665322110       0000000000     


Q ss_pred             --cccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          688 --LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       688 --~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                        +.+.+...............+.+++.+|++.+|++|||+.||++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0000110000111223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-37  Score=333.62  Aligned_cols=236  Identities=24%  Similarity=0.254  Sum_probs=192.8

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||.||+|+.. +++.||+|++...   .......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999876 5889999987642   234456788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++...  ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  153 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF  153 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence            9999654  368999999999999999999999   99999999999999999999999999999863221  1223456


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      .||+.|+|||++.+..++.++|||||||+++||++|+.||......+      ........ .      .    .++...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~-~------~----~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE-P------L----RFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC-C------C----CCCCcC
Confidence            79999999999999999999999999999999999999997543221      11111111 0      0    112233


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      ...+.+++.+||+.+|.+||+...
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCC
Confidence            456789999999999999986433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=330.26  Aligned_cols=247  Identities=28%  Similarity=0.391  Sum_probs=208.3

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .|...++||+|.||.||||... .++.||+|.+.... ....++.++|+.+|.+++|+||.+.+|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3455568999999999999775 58899999987653 445788999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      .+|++.+.|....  .+++..+.-|.++++.||.|||.   .+.+|||||+.|||+..++.+||+|||.+-.......  
T Consensus        94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            9999999995543  45888888899999999999999   9999999999999999999999999999987654222  


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ...+.+||+.|||||+++...|+.|+||||||++.+||++|.+|+....+....-+            +.+-.-|.+.  
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~--  232 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD--  232 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc--
Confidence            23678899999999999988999999999999999999999999986655322111            1111123333  


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ..+...+.+++..||..+|+.||++.++++
T Consensus       233 --~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 --GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             --cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence              355667999999999999999999999986

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-38  Score=303.56  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=210.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .++|+..+.||+|.||.||.|+.+ ++-.||+|++....   .+...++.+|+++-+.|+||||+++++++.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            456889999999999999999876 57889999876542   23356788999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      +||.++|.|...|.+.....++......+..|+|.||.|+|.   ++|+||||||+|+|++.++..||+|||-+...+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999987777789999999999999999999999   999999999999999999999999999987643  


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                        .......+||..|++||...+...+.+.|+|++|++.+|++.|.+||+.....+...-   ...       .++.   
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkr---I~k-------~~~~---  240 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKR---IRK-------VDLK---  240 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHH---HHH-------cccc---
Confidence              2234568899999999999999999999999999999999999999986543222110   000       1111   


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                          ++........+++.+|+..+|.+|.+..||+..
T Consensus       241 ----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 ----FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                223345567889999999999999999999754

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=321.13  Aligned_cols=255  Identities=28%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             CcccceEeeeCceEEEEEEecC----CcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe-----
Q 003659          463 FDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE-----  531 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  531 (805)
                      |...+.||+|+||.||+|+...    +..||+|++...  ......++.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4556799999999999998652    367999988754  23445789999999999999999999999866554     


Q ss_pred             -EEEEEEeccCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          532 -MILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       532 -~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                       .++|+||+++|+|.+++...    ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999988542    23468999999999999999999999   89999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      |+++...............++..|+|||++.+..++.++|||||||+++||++ |..|+......+   +..+.    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence            99986533222111222345678999999988899999999999999999999 888886543222   11111    11


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      +..         ...+......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus       231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         011233456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-36  Score=340.14  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  532 (805)
                      ++|...++||+|+||.||+|++.      .++.||+|++..... ...+.+.+|+++|.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            34666779999999999999853      346899999876432 33457889999999997 99999999999999999


Q ss_pred             EEEEEeccCCcccccccCCC------------------------------------------------------------
Q 003659          533 ILIYEYMENGTLKGHLYGSG------------------------------------------------------------  552 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~------------------------------------------------------------  552 (805)
                      ++||||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999886432                                                            


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          553 ------------------------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       553 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                                                          ...++|..+++++.|++.||+|||+   .+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence                                                1347888999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+......+.   
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---  350 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---  350 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence            999999999999986432111111223356788999999998889999999999999999998 8888864332211   


Q ss_pred             HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                         .......+.         ....+......+.+++.+|++.+|.+||+++||++.|+.++
T Consensus       351 ---~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 ---FYNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence               011111110         00112233567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.4e-36  Score=324.63  Aligned_cols=254  Identities=23%  Similarity=0.333  Sum_probs=203.0

Q ss_pred             CcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      |...+.||+|+||.||+|+..      .+..||+|++..... ...+.|.+|+.++++++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            455668999999999999763      257899999876543 2346788999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          536 YEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      +||+++++|.+++...              ....+++..++.++.|+++||+|||+   .+++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCce
Confidence            9999999999988421              12358899999999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..|+......+.      ..
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~  237 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------IE  237 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence            9999999886543222222334456789999999988889999999999999999998 7888865433221      11


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ... ....         ...+.+....+.+++..|++.+|.+||++.+|+..|+.
T Consensus       238 ~i~-~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIR-NRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHH-cCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111 1111         11223445668899999999999999999999988863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=306.55  Aligned_cols=236  Identities=25%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      .+|+..+.||.|.||.|.+++.+ +|..+|+|++....   .+..+...+|..+|+.+.||.++++++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            45777789999999999999887 58899999988653   234566779999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|.|..+|+..+  +++.....=+|.+|+.||+|||+   .+|++|||||+|||||.+|.+||+|||.|+....  
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999997654  68999999999999999999999   9999999999999999999999999999997543  


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                         .+-+.+||+.|+|||.+....+..++|.|+|||++|||+.|.+||....+...-.               +++.-.+
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~---------------KI~~~~v  258 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE---------------KILEGKV  258 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH---------------HHHhCcc
Confidence               2567899999999999999999999999999999999999999998766522211               1111111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCC
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDR  723 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~R  723 (805)
                        .++.-....+.+++...|+.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              2344445567888889999888888

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=330.99  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=192.9

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      |+..+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  155 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD  155 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence            444568999999999999875 68999999886543 3345678999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+..      .+.+..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus       156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  224 (353)
T PLN00034        156 GGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP  224 (353)
T ss_pred             CCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence            99987643      35677888999999999999999   899999999999999999999999999998643211  11


Q ss_pred             eecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          621 STAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                      .....||..|+|||++..     ...+.++|||||||+||||++|+.||......+...+....   ... .        
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~-~--------  292 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMS-Q--------  292 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hcc-C--------
Confidence            234579999999998743     23456999999999999999999999733222211111100   000 0        


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       ...........+.+++.+||+.+|++||++.|++++
T Consensus       293 -~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 -PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011122345568899999999999999999999853

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-36  Score=349.69  Aligned_cols=259  Identities=27%  Similarity=0.356  Sum_probs=207.2

Q ss_pred             HHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC-
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-  530 (805)
Q Consensus       455 el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-  530 (805)
                      +.....++|...++||+|+||+||+|+.. +++.||||++...  .......+.+|+..+..++|+|++++...+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34445578999999999999999999764 6899999987653  3445667889999999999999999987764322 


Q ss_pred             -------eEEEEEEeccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          531 -------EMILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       531 -------~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                             .+++||||+++|+|.+++...  ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence                   368999999999999998642  23568999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||+||||++|+.||......+.      ...
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~  256 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK  256 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH
Confidence            99999999865432222233456799999999999999999999999999999999999999975432221      111


Q ss_pred             HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .. .+..    +     ..+......+.+++.+||+.+|.+||++.+++.+
T Consensus       257 ~~-~~~~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TL-AGRY----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             Hh-cCCC----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11 1110    1     1223345668899999999999999999999864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.7e-37  Score=334.46  Aligned_cols=242  Identities=24%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      ++||+|+||.||+++.+ +++.||+|++...   .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            37999999999999865 5899999987653   2334567889999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceee
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST  622 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  622 (805)
                      +|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            999888554  368999999999999999999999   99999999999999999999999999998753221  11123


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      .... +      +.    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~~-~------~~----~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LILM-E------DI----KFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------Hhcc-C------Cc----cCCC
Confidence            4579999999999999999999999999999999999999997543322111      1000 0      01    1122


Q ss_pred             hHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRP-----SMGDVLWN  732 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~  732 (805)
                      .....+.+++.+||+.+|.+||     ++.|++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3345678899999999999997     78888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.9e-36  Score=326.09  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=206.3

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-C--cEEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-G--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...++||+|+||.||+|..++ +  ..+++|.+... .....+.|.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888899999999999998753 3  35788887743 334467789999999999 799999999999999999999


Q ss_pred             EEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          536 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      +||+++|+|.+++....              ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999986432              1358899999999999999999999   999999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||+++||++ |+.||......+..      .
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------E  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H
Confidence            99999998643211   01111223557999999998899999999999999999998 99999755432211      1


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhhh
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA  742 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~  742 (805)
                      .... +         .....+......+.+++.+|++.+|.+||++.++++.|+.+++..+.
T Consensus       230 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         230 KLPQ-G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             HHhc-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111 0         11111223345688999999999999999999999999988866543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-36  Score=324.48  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=205.2

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +++...+.||+|+||.||++...      ++..+|+|.+........+.|.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45666789999999999999642      356899999887776667889999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          535 IYEYMENGTLKGHLYGSGL-------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      ||||+++++|.+++.....             ..+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999865321             358999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |++||......+...      
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH------
Confidence            9999999875433221111223345678999999999999999999999999999998 899986543322211      


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .. ..+..     .    ..+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       236 ~~-~~~~~-----~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CI-TQGRE-----L----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HH-HcCcc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11 11100     0    111223456889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-36  Score=318.76  Aligned_cols=253  Identities=28%  Similarity=0.405  Sum_probs=205.8

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +.|...++||+|+||.||+|..++++.||+|.+..... ....|.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            46777889999999999999988899999998875543 3568899999999999999999999874 457899999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++....... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-ccc
Confidence            9999999876655679999999999999999999999   899999999999999999999999999997654211 111


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++....++.++||||||++++||++ |+.||......+.   ..   .. ..+.     ..    .
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~-~~~~-----~~----~  223 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ---NL-ERGY-----RM----P  223 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HH-HcCC-----CC----C
Confidence            223446778999999998899999999999999999999 9999975433221   11   11 0100     00    1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ........+.+++.+|++.+|++||++++++..|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=325.03  Aligned_cols=267  Identities=26%  Similarity=0.365  Sum_probs=203.2

Q ss_pred             cccceEeeeCceEEEEEEe-----cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeEEEE
Q 003659          464 DESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILI  535 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV  535 (805)
                      ...+.||+|+||.||++..     .++..||+|.+.... ......|.+|+++|++++||||+++++++..  ....++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            6678999999999988653     357889999887543 2346778899999999999999999998855  3468899


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++...   .+++.+++.++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++.....
T Consensus        87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            9999999999998653   49999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCc-ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ... .......++..|+|||.+....++.++||||||++++||+||+.|+...... ......+.........+.+.++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhhc
Confidence            111 1112234566799999999889999999999999999999999988643211 11111110000000011111222


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      ......+...+..+.+++.+|++.+|++||+++++++.|+.+.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2211223344577999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.9e-36  Score=315.78  Aligned_cols=247  Identities=26%  Similarity=0.423  Sum_probs=200.3

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      ++||+|+||.||+|..+++..+|+|++..... .....|.+|++++++++||||++++++|...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            37999999999999988889999998876543 33457889999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      +++.... ..+++.+++.++.+++.+|.|||+   .+++||||||+||++++++.+||+|||++....... ........
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~  155 (250)
T cd05085          81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQ  155 (250)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCC
Confidence            9986543 468999999999999999999999   899999999999999999999999999987533211 11112234


Q ss_pred             ccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       626 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      ++..|+|||++.+..++.++||||||+++|||++ |..||..........      . ...+.         ....+...
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~------~-~~~~~---------~~~~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE------Q-VEKGY---------RMSCPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH------H-HHcCC---------CCCCCCCC
Confidence            4677999999999999999999999999999999 999987543322111      1 11110         01112234


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      +..+.+++.+|++.+|++||++.|++++|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.1e-36  Score=319.13  Aligned_cols=256  Identities=28%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-C---cEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-G---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|+..+.||+|+||.||+|+... +   ..+|+|.+.... ....+++.+|++++++++|+|++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            467788899999999999998752 3   379999887553 34467799999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++.... ..+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++......
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999986543 468999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CCcce-eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          616 DQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       616 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ..... ......+..|+|||++....++.++|||||||++|||++ |+.||......+.      ..... .+.      
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~i~-~~~------  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKAIN-DGF------  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHh-cCC------
Confidence            21111 112223457999999998899999999999999999998 9999865433221      11111 110      


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                         ......+....+.+++.+|++.+|++||+|.+|++.|+++
T Consensus       228 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0011123356688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.6e-37  Score=333.33  Aligned_cols=241  Identities=24%  Similarity=0.305  Sum_probs=196.4

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      +.||+|+||.||+++.. +|..||+|.+...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            37999999999999865 6899999987653   2334567788999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceee
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST  622 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  622 (805)
                      +|..++...  ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  153 (323)
T cd05595          81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK  153 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence            999888544  368999999999999999999999   899999999999999999999999999987532211  1123


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...........      ... +.      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------~~~-~~------~----~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILM-EE------I----RFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------Hhc-CC------C----CCCC
Confidence            45699999999999999999999999999999999999999975433221110      000 00      0    1122


Q ss_pred             hHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .....+.+++.+||+.+|.+||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            3345678999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.3e-37  Score=334.98  Aligned_cols=264  Identities=24%  Similarity=0.322  Sum_probs=196.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC-----CeEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~  533 (805)
                      +|...++||+|+||.||+|+.. +++.||||++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4677889999999999999865 6899999987643  223456788999999999999999999987432     3589


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+. ++|.+++...  ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999996 6898888544  368999999999999999999999   899999999999999999999999999998643


Q ss_pred             CCCC-cceeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH--------HH
Q 003659          614 EIDQ-THVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KW  682 (805)
Q Consensus       614 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~  682 (805)
                      .... ........||..|+|||++.+  ..++.++|||||||++|||+||++||.............-..        ..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2111 111234579999999999876  678999999999999999999999997543322111100000        00


Q ss_pred             hhcCCccccc---Ccc----ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          683 QNKGQLDQII---DPT----LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       683 ~~~~~~~~~~---d~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .......+.+   .+.    +...+ +.....+.+++.+||+.+|++||+++|++++
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000   000    00000 1223457899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-37  Score=336.90  Aligned_cols=246  Identities=25%  Similarity=0.334  Sum_probs=205.4

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |..++.||+|+.|.|-.|+.. +|+.+|||++....   ......+.+|+-+|+-+.|||+++|+++++++.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            556678999999999999765 69999999887652   22345577999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++|-|.++|..++  +|.+.+..+.+.||+.|+.|+|.   .+|+|||+||+|+|||...++||+|||||.+...   .
T Consensus        94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---G  165 (786)
T ss_pred             cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC---C
Confidence            99999999997665  79999999999999999999999   9999999999999999999999999999987432   2


Q ss_pred             ceeecccccccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      ....+-+|+++|.|||++++..|. .++||||.||||+.||||+.||+...-.   .|..   . ++.|..         
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLl---K-V~~G~f---------  229 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLL---K-VQRGVF---------  229 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHH---H-HHcCcc---------
Confidence            334567899999999999998875 7999999999999999999999843222   2211   1 122211         


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                       +.+...+.+..+++.+|+..||+.|.|++||+++-
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence             12233455678899999999999999999998643

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.1e-36  Score=316.45  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||+|+.+ +++.|++|.+...  ......++.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            3667789999999999999876 5899999987643  344567899999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            999999999976545679999999999999999999999   899999999999999999999999999988654321  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......|+..|+|||++.+..++.++||||||++++||++|+.||......+.   ...    ...+..         .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~---------~  219 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILK----IIRGVF---------P  219 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HHcCCC---------C
Confidence            112345688899999999999999999999999999999999999975542211   111    111111         1


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .........+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1112334568999999999999999999999753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-36  Score=316.19  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=206.6

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            45777789999999999999876 78999999876654 56789999999999999999999999998999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......++|..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----  156 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence            9999999976554579999999999999999999999   999999999999999999999999999998653211    


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                       ....++..|+|||++..+.++.++||||||++++||++ |+.||......+..   ..    ...+.         ...
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~~---------~~~  219 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PH----VEKGY---------RME  219 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HhcCC---------CCC
Confidence             12345668999999998899999999999999999998 99998754332211   11    11110         011


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .+...+..+.+++.+|+..+|++||++.|++++|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            112335668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=326.14  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=202.1

Q ss_pred             cCCcccceEeeeCceEEEEEEecC---------------CcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND---------------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIG  524 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g  524 (805)
                      ++|...+.||+|+||.||++...+               ...||+|..... .......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            467788899999999999986532               235899988764 3344567999999999999999999999


Q ss_pred             EEccCCeEEEEEEeccCCcccccccCCC----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEE
Q 003659          525 YCDEKNEMILIYEYMENGTLKGHLYGSG----------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL  594 (805)
Q Consensus       525 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NIL  594 (805)
                      ++...+..++||||+++++|.+++....          ...++|..++.++.|+++||+|||+   .+++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            9999999999999999999999885422          1347899999999999999999999   89999999999999


Q ss_pred             eCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChhhh
Q 003659          595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREM  672 (805)
Q Consensus       595 ld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~  672 (805)
                      +++++.+||+|||+++...............++..|+|||++..+.++.++|||||||+++||++  |..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999976433222222223445778999999998899999999999999999998  5567764433221


Q ss_pred             hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          673 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .   ...........      .......++..+..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus       242 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 I---ENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H---HHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1   11111111100      00000111223457899999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-36  Score=322.85  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      ..++|...+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567888899999999999999653      24589999876543 2334568899999999999999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEE
Q 003659          532 MILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV  603 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl  603 (805)
                      .++||||+++|+|.+++....        ...+++..+++++.|++.||+|||+   ++|+||||||+|||+++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996421        2456788999999999999999999   99999999999999999999999


Q ss_pred             eecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHH
Q 003659          604 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       604 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      +|||+++...............++..|+|||.+.++.++.++|||||||+++||++ |..|+......+..   .   ..
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~---~~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---K---FV  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH
Confidence            99999986543222221223345678999999999999999999999999999999 78888654332211   1   11


Q ss_pred             hhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       683 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      . .+...         ..+......+.+++.+|++.+|.+||++.++++.|+..+
T Consensus       235 ~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 M-DGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             H-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1 11100         111223457899999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=342.81  Aligned_cols=261  Identities=22%  Similarity=0.307  Sum_probs=214.8

Q ss_pred             hcCCcccceEeeeCceEEEEEEecCC-cEEEEEEcCCCCchhHHHHHHHHHHHhcCC-CCceEEEEEEE-c-----c-CC
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDG-TKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYC-D-----E-KN  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~-~-----~-~~  530 (805)
                      ..+..+++.|.+|||+.||.|....+ ..+|+|++...++...+...+|+++|++|+ |+|||.+++.. .     . ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45567788999999999999988765 999999998888888999999999999997 99999999932 1     1 35


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      +.+|.||||++|.|-+++.......|++.++++|+.++++|+++||. ++++|||||||-+||||+.+++.||||||.+.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            78999999999999999976555569999999999999999999997 55789999999999999999999999999986


Q ss_pred             CCCCCC-Ccc-e-----eecccccccccChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 003659          611 TGPEID-QTH-V-----STAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       611 ~~~~~~-~~~-~-----~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (805)
                      -....- ... +     .-...-|+.|+|||++   .+..+++|+|||+|||+||-|+....||+....           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            422111 100 0     0123468899999987   467899999999999999999999999985422           


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                              ..|++-...-.-.+.....|..||..||+.+|.+||++-+|++.+.++...+
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                    1233333322223567889999999999999999999999999988877554

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.1e-36  Score=329.00  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=202.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .++|+..+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++|+||++++++|..++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367888899999999999999876 5888999987654 23345678999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++...  ..+++..+..++.|+++||+|||+  ..+++||||||+|||+++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            99999999999654  358899999999999999999997  136999999999999999999999999998754321  


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc---------
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL---------  688 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---------  688 (805)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.....    .....+..         
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAESETSPRP  231 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCccccccCccc
Confidence              123456899999999999989999999999999999999999999754332211100    00000000         


Q ss_pred             --------------------ccccCccccC---CCC-hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          689 --------------------DQIIDPTLAG---KIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       689 --------------------~~~~d~~l~~---~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                                          ..+.+.....   ... ......+.+++.+||+.+|.+||++.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                0000000000   000 0123568899999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=9.3e-37  Score=334.67  Aligned_cols=246  Identities=21%  Similarity=0.286  Sum_probs=200.1

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC--CcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND--GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      .++|...+.||+|+||.||+|+.+.  +..||+|++...   .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3468888999999999999997653  368999987542   22345678899999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||||+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       109 v~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999999654  368999999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.....      .. ..+..      
T Consensus       184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i-~~~~~------  245 (340)
T PTZ00426        184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KI-LEGII------  245 (340)
T ss_pred             C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HH-hcCCC------
Confidence            1     234579999999999999889999999999999999999999997543321111      11 11110      


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLWN  732 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~  732 (805)
                          .++......+.+++.+|++.+|.+|+     ++++++++
T Consensus       246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                11222234578899999999999995     77777643

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=320.80  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=205.9

Q ss_pred             cCCcccceEeeeCceEEEEEEecC------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ++|...+.||+|+||.||+|..++      +..||+|.+.... ......+.+|+.+++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            467778899999999999997642      3689999986553 344567889999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEee
Q 003659          534 LIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD  605 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~D  605 (805)
                      +||||+++|+|.+++....        ...++|..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence            9999999999999986422        2347899999999999999999999   9999999999999999999999999


Q ss_pred             cCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhh
Q 003659          606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQN  684 (805)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  684 (805)
                      ||+++...............++..|+|||.+.++.++.++|||||||++|||+| |+.|+......+..   .+.    .
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~~~----~  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---KFV----I  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---HHH----h
Confidence            999976543222222234456789999999998899999999999999999998 89998654433221   111    1


Q ss_pred             cCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       685 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .+...         ..+......+.+++.+|++.+|.+||++.++++.|+
T Consensus       236 ~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11110         112233567889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.7e-36  Score=315.87  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=196.9

Q ss_pred             eEeeeCceEEEEEEec---CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          468 VIGIGGFGKVYKGELN---DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      .||+|+||.||+|.++   ++..+|+|++....  ....+++.+|+.+++.+.|+||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999653   57899999876543  3346789999999999999999999999854 5678999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc-ee
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VS  621 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~  621 (805)
                      +|.+++...  ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999998644  368999999999999999999999   899999999999999999999999999998654322111 11


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......+..      .. .+.+..         ...
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~-i~~~~~---------~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------QM-IESGER---------MEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HH-HHCCCC---------CCC
Confidence            22334678999999988889999999999999999998 99999754332211      11 111111         112


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      +......+.+++.+|++.+|++||++.+|.+.|++
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            22345668899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-36  Score=322.79  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=201.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      +|+..++||+|+||.||++... +++.||+|.+....   ......+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3677789999999999999865 68999999886532   2223557889999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++.......+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            9999999998866554579999999999999999999999   899999999999999999999999999997643211 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||..........  . ........          .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~-~~~~~~~~----------~  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--E-VERRVKED----------Q  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--H-HHHHhhhc----------c
Confidence              1234568999999999998899999999999999999999999997543221111  0 11101110          0


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      ..++......+.+++.+|++.+|.+||     ++.+++.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            112223455688999999999999999     6777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-36  Score=315.91  Aligned_cols=255  Identities=29%  Similarity=0.438  Sum_probs=207.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .++|...+.||+|+||.||+|..++++.+|||.+..... ..+++.+|++++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            456888889999999999999988888999998875433 3577999999999999999999999999989999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.......+++.+++.++.+++.||+|||+   .+++|+||||+||++++++.+||+|||+++...... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            99999999977655679999999999999999999999   899999999999999999999999999987654311 11


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......++..|+|||.+.+..++.++||||||++++||++ |+.||.........   ..   ....          ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~---~~~~----------~~~  223 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL---EQ---VERG----------YRM  223 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH---HHcC----------CCC
Confidence            1122334568999999998899999999999999999999 99998654322211   11   1100          000


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ..+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1112234568899999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4e-36  Score=335.26  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|...+.||+|+||+||+|+.. +++.||||++....   ....+.+.+|++++++++|+||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            4777889999999999999765 58899999886532   3345678999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999986543  68899999999999999999999   9999999999999999999999999999753211000


Q ss_pred             ---------------------------------------------cceeecccccccccChhhhccCCCCchhhHHHHHH
Q 003659          618 ---------------------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV  652 (805)
Q Consensus       618 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gv  652 (805)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00112357999999999999889999999999999


Q ss_pred             HHHHHHhCCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHh--chhcCCCCCCCHHHH
Q 003659          653 VLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK--CLADFGVDRPSMGDV  729 (805)
Q Consensus       653 vl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPsm~ev  729 (805)
                      ++|||++|+.||....+.+.. ....|      ...+      ...  ........+.+++.+  |+..++..||++.|+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~~--~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENTL------HIP--PQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc------CCC--CCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999765433211 11111      0000      000  001123345566665  667777789999999


Q ss_pred             HHH
Q 003659          730 LWN  732 (805)
Q Consensus       730 l~~  732 (805)
                      +.+
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-36  Score=323.44  Aligned_cols=262  Identities=27%  Similarity=0.383  Sum_probs=205.7

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-----------------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-----------------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSL  522 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l  522 (805)
                      .+|+..+.||+|+||.||+++..+                 +..||+|++.... ....+++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            467788899999999999987542                 2468999887653 3456789999999999999999999


Q ss_pred             EEEEccCCeEEEEEEeccCCcccccccCCC---------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcE
Q 003659          523 IGYCDEKNEMILIYEYMENGTLKGHLYGSG---------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI  593 (805)
Q Consensus       523 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  593 (805)
                      +++|..+...++||||+++++|.+++....         ...+++..++.++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence            999999999999999999999999986533         2368999999999999999999999   8999999999999


Q ss_pred             EeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChhh
Q 003659          594 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPRE  671 (805)
Q Consensus       594 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  671 (805)
                      ++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999976543222222334556789999999998899999999999999999998  667775433221


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                         .................      ...+...+..+.+++.+|++.+|.+||++.||++.|+
T Consensus       242 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 ---VIENAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               11222211111111000      0111223467899999999999999999999998885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.2e-36  Score=319.57  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=203.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCc----EEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...++||+|+||.||+|++. +++    .||+|.+.... ....+++.+|+.+++.++|+||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            45777889999999999999754 444    48999886543 34467789999999999999999999999754 5679


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ++||+++|+|.+++.... ..+++.+++.++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999986543 468999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |..|+........   ..+..    .+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~~~~-----  229 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLE----KGER-----  229 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH----CCCc-----
Confidence            222111222345678999999998999999999999999999998 8999875433221   12111    1110     


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                          ..........+.+++.+|++.+|++||++.++++.|+.+.
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                0111223456889999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7e-36  Score=324.43  Aligned_cols=259  Identities=25%  Similarity=0.454  Sum_probs=205.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec--------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      ++|...+.||+|+||.||+++..        ....+|+|++.... .....++.+|+++++++ +||||++++++|...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45777889999999999999642        24579999877543 34467789999999999 6999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                      ..++||||+++|+|.+++....              ...++|.++++++.|++.||+|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            9999999999999999985432              2458999999999999999999999   9999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+....
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999986543222111222334567999999999999999999999999999999 8888865433222111


Q ss_pred             HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                             ...+..         ...+......+.+++.+|++.+|.+||++.|+++.|+.+..
T Consensus       249 -------~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         249 -------LREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -------HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                   111110         01122334568899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-36  Score=318.17  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=203.7

Q ss_pred             CCcccceEeeeCceEEEEEEecC-C---cEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-G---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      .|...+.||+|+||.||+|.... +   ..||||.+... .....++|..|+.++++++||||+++.+++..+...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            36677899999999999998753 3   36999998764 3445678999999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++.... ..+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999986543 468999999999999999999999   999999999999999999999999999987654322


Q ss_pred             Ccceee-cc--cccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003659          617 QTHVST-AV--KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       617 ~~~~~~-~~--~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      ...... ..  ..+..|+|||++.+..++.++|||||||+++||++ |+.||......+   ...+..    ...     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~----~~~-----  228 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE----QDY-----  228 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH----cCC-----
Confidence            111111 11  12457999999999999999999999999999986 999987543322   222211    100     


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .    -....+.+..+.+++.+|++.+|.+||+|.+++..|+.+
T Consensus       229 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 R----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             c----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0    011123345688999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.9e-36  Score=324.75  Aligned_cols=259  Identities=31%  Similarity=0.472  Sum_probs=204.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCc--EEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...+.||+|+||.||+|..+ ++.  .+|+|++... ......+|.+|++++.++ +|+||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            46777889999999999999865 344  4688876653 334567889999999999 899999999999999999999


Q ss_pred             EEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          536 YEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      |||+++|+|.+++....              ...+++.+++.++.|+++||+|||+   .+++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            99999999999986432              2358999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||+++....   ........++..|+|||++.+..++.++|||||||+++||+| |..||......+.   ..   
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~---  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE---  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH---
Confidence            9999999864221   111112234667999999988889999999999999999998 9999865433221   11   


Q ss_pred             HHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhh
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE  741 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~  741 (805)
                      ... .+         .....+......+.+++.+|++.+|++||++.++++.|+.+++...
T Consensus       235 ~~~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 KLP-QG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHh-cC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            110 00         0001111234567899999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.7e-36  Score=321.41  Aligned_cols=256  Identities=29%  Similarity=0.436  Sum_probs=204.8

Q ss_pred             hcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  532 (805)
                      .++|+..+.||+|+||.||+++.+      ++..||+|++.... ....++|.+|+.++++++||||++++++|..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            456888899999999999999763      46789999887543 34457799999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCc
Q 003659          533 ILIYEYMENGTLKGHLYGSG--------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN  592 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~N  592 (805)
                      ++||||+++|+|.+++....                    ...+++.+++.++.|++.||+|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            99999999999999986321                    2358899999999999999999999   899999999999


Q ss_pred             EEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhh
Q 003659          593 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPRE  671 (805)
Q Consensus       593 ILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  671 (805)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875432221111223345678999999998999999999999999999998 888886443322


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .      ... ...+...         ..+......+.+++.+|++.+|.+||++.|+++.|+
T Consensus       241 ~------~~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 V------IYY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H------HHH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1      111 1111111         111233466889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.4e-36  Score=313.82  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=197.5

Q ss_pred             eEeeeCceEEEEEEec---CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          468 VIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      .||+|+||.||+|.+.   .+..||+|.+..... ...++|.+|++++++++|+||++++++|.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   356799998876543 335679999999999999999999999864 57899999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc-eee
Q 003659          544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VST  622 (805)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~-~~~  622 (805)
                      |.+++.... ..+++.++++++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++......... ...
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999986533 468999999999999999999999   899999999999999999999999999997543322111 112


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ...++..|+|||++....++.++|||||||++|||++ |+.||......+..   .    ....+.         ....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~----~~~~~~---------~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---S----FIEQGK---------RLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---H----HHHCCC---------CCCCC
Confidence            2234578999999988889999999999999999996 99999755433211   1    111111         01122


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ..+...+.+++.+|++.+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            33456788999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-36  Score=332.92  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=202.2

Q ss_pred             cCCcccceEeeeCceEEEEEEe------cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEcc-CCe
Q 003659          461 NNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE-KNE  531 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~~  531 (805)
                      ++|...++||+|+||.||+|..      .+++.||||++.... ......+.+|+.++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4688888999999999999963      346889999987543 33456788999999999 68999999998854 456


Q ss_pred             EEEEEEeccCCcccccccCCC-----------------------------------------------------------
Q 003659          532 MILIYEYMENGTLKGHLYGSG-----------------------------------------------------------  552 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------------  552 (805)
                      .++||||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            889999999999999885421                                                           


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccc
Q 003659          553 ------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG  626 (805)
Q Consensus       553 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  626 (805)
                            ...++|.+++.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  1247889999999999999999999   9999999999999999999999999999976432111111223345


Q ss_pred             cccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003659          627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL  705 (805)
Q Consensus       627 t~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  705 (805)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+........  .    ......+...         ..+....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~---------~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRM---------RAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCC---------CCCCCCC
Confidence            678999999998899999999999999999997 8888864322111  0    1111111100         0011123


Q ss_pred             HHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          706 RKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       706 ~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      ..+.+++.+|++.+|.+||++.|+++.|+.+++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            457899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.2e-36  Score=327.66  Aligned_cols=239  Identities=25%  Similarity=0.350  Sum_probs=191.2

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHH---hcCCCCceEEEEEEEccCCeEEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEML---SQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      |...+.||+|+||.||+|..+ +++.||||++....   ....+.+..|++++   +.++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456679999999999999876 58999999876432   22345566666654   567899999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++|+|..++..   ..+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999988854   359999999999999999999999   99999999999999999999999999998753221


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                        ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+...      ..... .      . 
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~~-~------~-  218 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVND-E------V-  218 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC-C------C-
Confidence              112334679999999999999999999999999999999999999997554332211      11111 0      0 


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                         ..+......+.+++.+||+.+|.+||++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~  246 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGS  246 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence               1122234567889999999999999954

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.8e-36  Score=322.83  Aligned_cols=262  Identities=21%  Similarity=0.291  Sum_probs=198.1

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .++|...+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367888899999999999999876 688999998765432 223467889999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |++ ++|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--  156 (303)
T cd07869          84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--  156 (303)
T ss_pred             CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--
Confidence            996 58887775432 458899999999999999999999   99999999999999999999999999998753321  


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC---------C
Q 003659          618 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG---------Q  687 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~  687 (805)
                      ........||+.|+|||++.+ ..++.++|||||||+++||++|+.||.......  .............         .
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence            112234568899999999865 468899999999999999999999997543211  1111111100000         0


Q ss_pred             cccccCcc-ccCCCC---------hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          688 LDQIIDPT-LAGKIR---------PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~~~~~d~~-l~~~~~---------~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ... .++. .....+         ......+.+++.+||+.+|.+|||+.|+++
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPH-FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccc-cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000 0000 000000         011245778999999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.7e-36  Score=314.41  Aligned_cols=248  Identities=29%  Similarity=0.444  Sum_probs=201.6

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEE-ccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||++..+ |..+|+|......  ..+.|.+|+.++++++|+|++++++++ ..++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            35777889999999999999776 7889999876543  346789999999999999999999976 4556789999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.......+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----  155 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence            99999999976655568999999999999999999999   89999999999999999999999999998754321    


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                       .....++..|+|||++....++.++|||||||++|||++ |+.|+......+   +..+   . ..+.         ..
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~---~-~~~~---------~~  218 (256)
T cd05082         156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR---V-EKGY---------KM  218 (256)
T ss_pred             -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---H-hcCC---------CC
Confidence             122344568999999999899999999999999999998 898886432221   1111   1 1111         01


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1122335568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.5e-36  Score=315.45  Aligned_cols=258  Identities=22%  Similarity=0.315  Sum_probs=206.9

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...   .......+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46788889999999999999875 6899999976542   2344567899999999999999999999999999999999


Q ss_pred             EeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||+++|+|.+++..  .....+++.+++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753  223458899999999999999999999   9999999999999999999999999999886543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ..  .......|+..|+|||.+.+...+.++||||||+++|||++|+.|+.....    +...+.......+      .+
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~------~~  226 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCD------YP  226 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCC------CC
Confidence            11  112234688899999999988899999999999999999999999864321    1111111111110      11


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .   .........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1   11123346688999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=331.15  Aligned_cols=245  Identities=25%  Similarity=0.342  Sum_probs=207.2

Q ss_pred             HHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCe
Q 003659          457 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       457 ~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      ....++|...++||+|.||+|+++.++ +++.+|||.+++..   ....+....|.+++... +||.|+.|+.++..+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            344568999999999999999999887 58899999988763   45567788898888877 59999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      +++||||+.||++..+.+.   ..+++....=+|..++.||+|||+   ++||+||||-+|||||.+|++||+||||++.
T Consensus       444 l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999996555432   358999999999999999999999   9999999999999999999999999999997


Q ss_pred             CCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ...  ....+.+.+||+.|||||++.++.|+...|.|||||+|||||.|..||....+++..+-+.              
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--------------  581 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--------------  581 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------------
Confidence            532  3335678999999999999999999999999999999999999999999776655422110              


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                      .|..   .++...+.+...++.+.|..+|++|..+
T Consensus       582 ~d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 NDEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cCCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            0111   2345567778899999999999999877

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.7e-36  Score=332.55  Aligned_cols=204  Identities=25%  Similarity=0.396  Sum_probs=176.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|+..+.||+|+||+||+++.. +++.||+|++....   ......+..|+.++.+++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            36888899999999999999765 58899999886532   233466788999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999654  368999999999999999999999   999999999999999999999999999987543211


Q ss_pred             Cc---------------------------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003659          617 QT---------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV  663 (805)
Q Consensus       617 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  663 (805)
                      ..                                 .......||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 011235799999999999999999999999999999999999999


Q ss_pred             CCCCCh
Q 003659          664 IDPTLP  669 (805)
Q Consensus       664 ~~~~~~  669 (805)
                      |....+
T Consensus       236 f~~~~~  241 (363)
T cd05628         236 FCSETP  241 (363)
T ss_pred             CCCCCH
Confidence            976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=336.82  Aligned_cols=253  Identities=25%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36788899999999999999876 68999999876432   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++...  ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999655  468999999999999999999999   999999999999999999999999999998654322


Q ss_pred             ---------------------------CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 003659          617 ---------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP  669 (805)
Q Consensus       617 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~  669 (805)
                                                 .........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       01122345699999999999999999999999999999999999999976543


Q ss_pred             hhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC-HHHHHHH
Q 003659          670 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVLWN  732 (805)
Q Consensus       670 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~evl~~  732 (805)
                      .+..      ......  .     ..+.-.........+.+++.+|++ +|.+||+ +.++++.
T Consensus       236 ~~~~------~~i~~~--~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETY------NKIINW--K-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH------HHHhcc--C-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2211      111110  0     000000011134567888999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-36  Score=329.21  Aligned_cols=248  Identities=23%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+++.+ +++.||+|.+...   .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999876 5889999988753   233456688999999998 799999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~  153 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence            9999888544  369999999999999999999999   9999999999999999999999999999875321  11123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--hhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE--MVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+  ......+..........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence            34679999999999999999999999999999999999999996432111  11122222222222111          1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCC------HHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPS------MGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPs------m~evl~  731 (805)
                      ++......+.+++.+||+.+|.+||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            12233456789999999999999997      556653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.5e-36  Score=329.34  Aligned_cols=241  Identities=26%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             ceEeeeCceEEEEEEe----cCCcEEEEEEcCCC----CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          467 WVIGIGGFGKVYKGEL----NDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++||+|+||.||+++.    ..++.||+|.+...    .......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5899999999999975    35789999987642    223345678999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++|+|.+++...  ..+.+..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  ..
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  154 (323)
T cd05584          82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EG  154 (323)
T ss_pred             CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CC
Confidence            9999999998654  357889999999999999999999   9999999999999999999999999999875322  11


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......||+.|+|||++.+..++.++|||||||+||||++|+.||........      ..... .+.          .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~-~~~----------~  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKIL-KGK----------L  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHH-cCC----------C
Confidence            123345799999999999988899999999999999999999999975433221      11111 111          0


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .++......+.+++.+||+.+|.+||     ++.+++.
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11223345688999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-36  Score=330.18  Aligned_cols=251  Identities=24%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             CCcccceEeeeCceEEEEEEe----cCCcEEEEEEcCCC----CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  532 (805)
                      +|...+.||+|+||.||+++.    .+++.||+|++...    .....+.+..|++++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            467788999999999999875    35789999987542    223356678999999999 599999999999999999


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||+++|+|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999998654  368999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCCcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      .... ........||..|+|||++.+. .++.++|||||||+||||+||+.||..........  ........       
T Consensus       156 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~-------  225 (332)
T cd05614         156 LSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK-------  225 (332)
T ss_pred             cccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-------
Confidence            3211 1122345799999999999865 47899999999999999999999996432211111  11111111       


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .++.+    +......+.+++.+||+.+|.+||     +++++++
T Consensus       226 ~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111    222345578899999999999999     6667764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-36  Score=316.31  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=197.5

Q ss_pred             ceEeeeCceEEEEEEecC-Cc--EEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELND-GT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|++++ +.  .+++|.+... .....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999998764 43  5788887753 334456889999999999 899999999999999999999999999


Q ss_pred             CcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          542 GTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       542 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      |+|.+++....              ...+++.+++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999986432              1358899999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKG  686 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (805)
                      +++....   .........+..|+|||++....++.++|||||||+++||++ |+.||......+.      ........
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~  228 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQGY  228 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHHhCCC
Confidence            9864221   111112234567999999988899999999999999999997 9999865432211      11111110


Q ss_pred             CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          687 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       687 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                      .          ...+......+.+++.+|++.+|.+||++.++++.|++++
T Consensus       229 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 R----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            0          0111223456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9e-36  Score=315.61  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=204.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec----CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .+|...+.||+|+||.||+|+..    .+..+|+|.+.... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            45777889999999999999764    23479999886543 33457889999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++.... ..+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999996543 468999999999999999999999   99999999999999999999999999999865432


Q ss_pred             CCcce-eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          616 DQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       616 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ..... .....++..|+|||++.+..++.++||||||++++|+++ |+.||......+.   ..+.    .++.     .
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~-----~  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGY-----R  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCC-----c
Confidence            21111 112234568999999998899999999999999999886 9999875433221   1111    1110     0


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .    ......+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0    11123345678999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-35  Score=314.89  Aligned_cols=252  Identities=26%  Similarity=0.353  Sum_probs=194.5

Q ss_pred             eEeeeCceEEEEEEecC---CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          468 VIGIGGFGKVYKGELND---GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      .||+|+||.||+|+..+   +..+|+|++.... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            69999999999997653   4579999877643 2334578899999999999999999999999999999999999999


Q ss_pred             ccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          544 LKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       544 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      |.+++....   ...+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999986532   2356788899999999999999999   9999999999999999999999999999976433222222


Q ss_pred             eecccccccccChhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003659          621 STAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      .....++..|+|||++...       .++.++||||||+++|||++ |+.||....+.+...   +    ...+......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y----TVREQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H----HhhcccCCCC
Confidence            2345578889999998642       35789999999999999996 999997544332211   1    1111111222


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ++.+..    .....+.+++..|+ .+|++||+++||++.|+
T Consensus       232 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222221    22345777889998 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-35  Score=325.23  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=206.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec--------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      .+|...+.||+|+||.||++...        .+..||+|.+.... ....+++.+|+++++++ +|+||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            35777889999999999999642        12478999877543 34467899999999999 8999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                      ..+++|||+++|+|.+++....              ...++|.+++.++.|+++||+|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            9999999999999999986421              2358999999999999999999999   9999999999999999


Q ss_pred             CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhH
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||......+.   
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  245 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  245 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---
Confidence            999999999999986543222222223345578999999999999999999999999999998 8888865432221   


Q ss_pred             HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                         ....... ..         ...+......+.+++.+|++.+|.+||++.|+++.|+.+....
T Consensus       246 ---~~~~~~~-~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         246 ---FKLLKEG-HR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ---HHHHHcC-CC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence               1111111 10         0112233456889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.1e-36  Score=329.36  Aligned_cols=243  Identities=24%  Similarity=0.339  Sum_probs=193.0

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+++.+ +++.+|+|.+...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999876 5789999987653   233456678899988877 899999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~~  153 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCcc
Confidence            9999888544  368999999999999999999999   89999999999999999999999999998753221  1122


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--hhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE--MVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            34679999999999999999999999999999999999999996322111  11112222222111111          1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                      ++......+.+++.+||+.+|.+||+.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            223334567899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.9e-36  Score=315.41  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=201.7

Q ss_pred             ceEeeeCceEEEEEEecC--C--cEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELND--G--TKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.|.+|++++++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998753  3  3699999887665 567789999999999999999999999988 899999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc-ce
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HV  620 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~-~~  620 (805)
                      ++|.+++.......++|..++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||+++........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            999999976543578999999999999999999999   99999999999999999999999999999875432211 11


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++.+..++.++|||||||+++||++ |+.|+......+..   .   .......  .     +  .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~---~~~~~~~--~-----~--~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---K---KIDKEGE--R-----L--E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHhcCC--c-----C--C
Confidence            123457789999999999999999999999999999999 99998754333211   1   1111110  0     0  0


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      .+...+..+.+++.+|++.+|.+||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11223456889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-36  Score=313.03  Aligned_cols=249  Identities=32%  Similarity=0.481  Sum_probs=205.1

Q ss_pred             ceEeeeCceEEEEEEecC----CcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|....    +..+++|.+...... ..+.+.+|+++++.++|+|++++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            379999999999998764    789999998765443 367899999999999999999999999999999999999999


Q ss_pred             CcccccccCCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          542 GTLKGHLYGSG-------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       542 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ++|.+++....       ...+++.++++++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997642       3579999999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.||......+.   ..   .... +.      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~~~~-~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LE---YLRK-GY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HH---HHHc-CC------
Confidence            332223345567889999999998899999999999999999999 5999976533221   11   1111 10      


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                         ....+......+.+++.+|++.+|.+||++.|++..|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               00112233567889999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.6e-36  Score=317.76  Aligned_cols=247  Identities=21%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||.||+++.+ +|+.+|+|.+....   ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999875 58999999876422   12234556799999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++.......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            998876655679999999999999999999999   99999999999999999999999999998764321   122345


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||........  ...........         .... .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~---------~~~~-~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED---------EVKF-EHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc---------cccc-ccccC
Confidence            689999999999988899999999999999999999999964332111  11111111110         0000 00123


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ...+.+++.+||+.+|.+||+++|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            44578999999999999999998876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.4e-36  Score=325.02  Aligned_cols=238  Identities=26%  Similarity=0.373  Sum_probs=190.7

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhc-CCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.+ +++.||+|.+...   .....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999876 5789999987643   12334556667777765 4899999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            9999988654  368999999999999999999999   999999999999999999999999999997543211  223


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      .....       .+    .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~-------~~----~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILND-------RP----HFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcC-------CC----CCC
Confidence            45679999999999999999999999999999999999999997554322111      11110       01    112


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      ......+.+++.+||+.+|.+||++.+
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence            223455788999999999999999853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.3e-36  Score=326.29  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCC-ceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHR-HLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~  536 (805)
                      +|...+.||+|+||.||+|+.+ +++.||||++...   .....+.+..|.+++..+.|+ +|+++.+++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4677889999999999999876 4789999987643   233456788999999999765 5888999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            999999999988654  368999999999999999999999   99999999999999999999999999998753211 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                       ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+...   .   .. ...      .  
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~---~---i~-~~~------~--  218 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---S---IM-EHN------V--  218 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---H---HH-cCC------C--
Confidence             112334579999999999999999999999999999999999999997554332211   1   00 100      0  


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                        .++......+.+++.+||+.+|.+|++.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1122234567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.4e-36  Score=327.73  Aligned_cols=238  Identities=24%  Similarity=0.326  Sum_probs=193.1

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.+ +++.||||++...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999876 5889999987643   223456678899988876 699999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~  153 (320)
T cd05590          81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTT  153 (320)
T ss_pred             chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCcc
Confidence            9999988654  368999999999999999999999   9999999999999999999999999999875322  11123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      ..... +..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~-~~~----------~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAILN-DEV----------VYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHhc-CCC----------CCC
Confidence            4457999999999999999999999999999999999999999765433221      11111 110          111


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      ......+.+++.+||+.+|.+||++.+
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~  243 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLT  243 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            223456789999999999999999843

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.3e-35  Score=313.21  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=205.5

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|+||.||++..+++..+|+|.+.... ...+.|.+|++++++++|+|++++.+++.+ ...+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA   83 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence            5677888999999999999998778889999877543 335678999999999999999999999877 77899999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~  159 (260)
T cd05073          84 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTA  159 (260)
T ss_pred             CCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC-ccc
Confidence            9999999976555678999999999999999999999   899999999999999999999999999987643311 111


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||++....++.++|+|||||+++||+| |+.||......+.   ..+.    ..+..         ..
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~---------~~  223 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRAL----ERGYR---------MP  223 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----hCCCC---------CC
Confidence            223345678999999998889999999999999999999 8999875432221   1111    11100         01


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            112334568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-36  Score=330.72  Aligned_cols=243  Identities=24%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      +.||+|+||.||+++.. +++.||+|.+...   .......+..|++++..++||||+++.+++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999765 6899999987643   2234567788999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceee
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST  622 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  622 (805)
                      +|..++...  ..+++.++..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK  154 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence            999888544  368999999999999999999995  158999999999999999999999999998753221  11123


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ...||+.|+|||++.+..++.++|||||||+||||+||+.||......+.....       ..+.      ..    ++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~------~~----~p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE------IR----FPR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC------CC----CCC
Confidence            456999999999999999999999999999999999999999754332221111       0000      01    112


Q ss_pred             hHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRP-----SMGDVLWN  732 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~  732 (805)
                      .....+.+++.+||+.+|.+|+     ++.+++++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            2345678899999999999996     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-36  Score=330.19  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=201.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+++.. +++.||+|++....   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36788899999999999999875 68999999877532   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++.... ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCC-
Confidence            9999999999996542 469999999999999999999999   99999999999999999999999999999865432 


Q ss_pred             CcceeecccccccccChhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .........||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ............
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLK  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccC
Confidence            222233457999999999986      45678999999999999999999999975433221      111111111000


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .       .........+.+++..|++ +|.+||++.+++.
T Consensus       230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0       0011234567888999997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-36  Score=316.18  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=206.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|... +++.+|||.+...   ......++.+|+++++.++|+||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            35777789999999999999864 7899999976543   2334568899999999999999999999999999999999


Q ss_pred             EeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||+++++|.+++..  .....+++.+++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998853  223468999999999999999999999   9999999999999999999999999999876533


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ..  .......|+..|+|||++.+..++.++||||||+++|||++|..||......    ...+.....      ....+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~------~~~~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE------QCDYP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh------cCCCC
Confidence            11  1123456889999999999889999999999999999999999998643211    111111110      11111


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .+   ........+.+++.+|++.+|.+||+|.+|++.++++
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11   1123456788999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-36  Score=334.83  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=198.9

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...++||+|+||.||+|+.. +++.||||++...   .......+.+|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888899999999999999876 5899999988643   1233566889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999986543  68999999999999999999999   999999999999999999999999999987532211


Q ss_pred             Cc------------------------------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhC
Q 003659          617 QT------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA  660 (805)
Q Consensus       617 ~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG  660 (805)
                      ..                                    .......||+.|+|||++....++.++|||||||+++||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                    001124699999999999999999999999999999999999


Q ss_pred             CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC---HHHHHH
Q 003659          661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS---MGDVLW  731 (805)
Q Consensus       661 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~evl~  731 (805)
                      +.||....+.+..   .....+  ...+ .     ...  .......+.+++.+|+. +|.+|++   +.|+++
T Consensus       236 ~~Pf~~~~~~~~~---~~i~~~--~~~~-~-----~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQETY---RKIINW--KETL-Q-----FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHHH---HHHHcC--CCcc-C-----CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999765433211   111100  0000 0     000  01123456788888886 8999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-35  Score=320.28  Aligned_cols=262  Identities=23%  Similarity=0.336  Sum_probs=202.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-----------------CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-----------------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL  522 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l  522 (805)
                      ++|+..+.||+|+||.||++...                 ++..+|+|++... .....++|.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788889999999999998532                 2346899998754 33446789999999999999999999


Q ss_pred             EEEEccCCeEEEEEEeccCCcccccccCCCC---------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcE
Q 003659          523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL---------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI  593 (805)
Q Consensus       523 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  593 (805)
                      ++++...+..++||||+++|+|.+++.....         ..+++.+++.++.|++.||+|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            9999999999999999999999999865321         247889999999999999999999   8999999999999


Q ss_pred             EeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCChhh
Q 003659          594 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPRE  671 (805)
Q Consensus       594 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  671 (805)
                      |+++++.+||+|||+++...............++..|+|||....+.++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999976433221111222344678999999888899999999999999999998  667776443322


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ...   ........... ....     ..+..++..+.+++.+|++.+|.+||+|.+|++.|+
T Consensus       242 ~~~---~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIE---NTGEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHH---HHHHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            211   11111111100 0000     111233467889999999999999999999998885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-35  Score=320.54  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=203.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCc----EEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...+.||+|+||.||+|... ++.    .||+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45677789999999999999764 343    578998775433 3345788999999999999999999999754 4679


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999986543 358999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |+.|+......+..   .+.    ..+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~---~~~----~~~~~-----  229 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP---DLL----EKGER-----  229 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HCCCC-----
Confidence            222211223445778999999999999999999999999999997 88998654332221   111    11110     


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                        .  .....+...+.+++..|+..+|++||++.++++.|+.+.+..
T Consensus       230 --~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         230 --L--PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             --C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence              0  011223456889999999999999999999999998865443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.3e-36  Score=317.36  Aligned_cols=253  Identities=26%  Similarity=0.404  Sum_probs=201.0

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEcc------C
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE------K  529 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~------~  529 (805)
                      .+++.|...+.||+|+||.||+|... +++.||+|++.... ....++.+|+.++.++ +|+||+++++++..      .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888889999999999999875 58899999876543 3356788999999998 79999999999864      2


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||+++++|.+++.......++|..+..++.|++.||+|||+   .+|+|+||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            468999999999999999976555579999999999999999999999   89999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN  684 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  684 (805)
                      +......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.|+....+.....     .  ..
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~--~~  229 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L--IP  229 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H--Hh
Confidence            7643211  1223456899999999986     3457889999999999999999999996443221111     0  00


Q ss_pred             cCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       685 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...     .+.+   ........+.+++.+||+.+|.+||++.|+++
T Consensus       230 ~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            110     0111   11123456889999999999999999999974

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-35  Score=311.10  Aligned_cols=248  Identities=26%  Similarity=0.361  Sum_probs=198.5

Q ss_pred             ceEeeeCceEEEEEEecC----CcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|++..    +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            379999999999997532    26899998876543 34567899999999999999999999876 4568999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc-e
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-V  620 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~-~  620 (805)
                      |+|.+++....  .+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999996543  68999999999999999999999   899999999999999999999999999998653322111 1


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   +..+...    ...         ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~~----~~~---------~~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLES----GER---------LP  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc----CCc---------CC
Confidence            122234568999999999999999999999999999998 999997554322   2222111    110         01


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      .+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1223346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-36  Score=328.03  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=213.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe-EEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE-MILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~  536 (805)
                      ++|...+++|+|+||.++..+.+ ++..+++|.+....  ....+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            45777789999999999998766 57899999776543  3345577899999999999999999999999988 99999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      +|++||+|.+.+...+...++++.+++++.|++.|+.|||+   ..|+|||||+.|||++.+..+||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999999987776779999999999999999999998   999999999999999999999999999999876532


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                        .......||+.||.||.+.+.+|..|+|||||||++|||++-+++|.......   ++.   .         ++ +..
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---k---------i~-~~~  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---K---------IN-RGL  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH---H---------Hh-hcc
Confidence              24567889999999999999999999999999999999999999998653322   221   1         11 111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ....+......+..++..|++.+|..||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            223345567789999999999999999999999986

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2e-36  Score=336.06  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=200.7

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ..++|...++||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567888999999999999999876 5889999987542   22334567899999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||||+++|+|.+++...   .++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999998543   47888899999999999999999   9999999999999999999999999999976432


Q ss_pred             CCCcceeecccccccccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .. ........||+.|+|||++.+.    .++.++|||||||+||||++|+.||.........      ........  .
T Consensus       195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~--~  265 (370)
T cd05596         195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN--S  265 (370)
T ss_pred             CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC--c
Confidence            11 1122345799999999998653    4789999999999999999999999754332211      11111000  0


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCC--CCCHHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLWN  732 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~  732 (805)
                      +   ...  ........+.+++.+||+.+|.+  ||++.|++.+
T Consensus       266 ~---~~~--~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 L---TFP--DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C---CCC--CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0   000  01123456788999999988987  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-35  Score=348.90  Aligned_cols=262  Identities=24%  Similarity=0.304  Sum_probs=205.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...++||+|+||.||+|+.. +++.||+|++....   ....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888899999999999999875 58999999886532   233567999999999999999999999999999999999


Q ss_pred             EeccCCcccccccCC---------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          537 EYMENGTLKGHLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       537 e~~~~gsL~~~l~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      ||+++|+|.+++...         ....+++..+++++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988531         12346788899999999999999999   899999999999999999999999999


Q ss_pred             CCCCCCCCCCc----------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Q 003659          608 LSKTGPEIDQT----------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE  671 (805)
Q Consensus       608 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (805)
                      +++........                .......||+.|+|||++.+..++.++|||||||+++||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99764211100                01123469999999999999999999999999999999999999997533221


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCC-CHHHHHHHHHHHHHh
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYALQL  739 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-sm~evl~~L~~~~~~  739 (805)
                      ...    .      .   .+.++.-... ..+.+..+.+++.+|++.+|.+|| +++++++.|+..++.
T Consensus       239 i~~----~------~---~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 ISY----R------D---VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hhh----h------h---hccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            100    0      0   0011110000 012345678899999999999995 677787888877653

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=315.88  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=204.2

Q ss_pred             HHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--------------hhHHHHHHHHHHHhcCCCCceEE
Q 003659          457 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------------QGLAEFQTEIEMLSQFRHRHLVS  521 (805)
Q Consensus       457 ~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~  521 (805)
                      ....++|...+.||+|.||.|-+|+.. +++.||||++.....              ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344678888999999999999999765 689999998764321              12457889999999999999999


Q ss_pred             EEEEEcc--CCeEEEEEEeccCCcccccccCCCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC
Q 003659          522 LIGYCDE--KNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN  598 (805)
Q Consensus       522 l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~  598 (805)
                      |+.+..+  .+.+|||+|||..|.+...-   ..++ |+..+.+++++++..||+|||.   ++||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence            9999854  56899999999988876543   2234 9999999999999999999999   999999999999999999


Q ss_pred             CcEEEeecCCCCCCCCC---CCcceeecccccccccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Q 003659          599 FMAKVADFGLSKTGPEI---DQTHVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVIDPTLPRE  671 (805)
Q Consensus       599 ~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (805)
                      +++||+|||.+...+..   +.........||+.|+|||...++.    .+.+.||||+||+||-|+.|+.||-.....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999999764221   1111123468999999999987632    4578999999999999999999997543322


Q ss_pred             hhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       672 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ..               ++++...+.-...++..+.+.++++++|++||++|.+..+|..+.-
T Consensus       327 l~---------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  327 LF---------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             HH---------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            21               2333344433333456778999999999999999999999976543

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.1e-36  Score=327.35  Aligned_cols=241  Identities=23%  Similarity=0.312  Sum_probs=194.6

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.+ +++.||+|.+...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999876 4789999987653   233456678899998866 799999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GVTT  153 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccC--Cccc
Confidence            9999888654  368999999999999999999999   89999999999999999999999999998753221  1123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   .   ..... .   .       ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~---~i~~~-~---~-------~~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---E---SILHD-D---V-------LYP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---H---HHHcC-C---C-------CCC
Confidence            3457999999999999999999999999999999999999999865433221   1   11111 0   0       011


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCC-------CHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRP-------SMGDVLW  731 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RP-------sm~evl~  731 (805)
                      ......+.+++.+||+.+|.+||       ++.++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            12245678899999999999999       6666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7e-36  Score=325.82  Aligned_cols=241  Identities=22%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +|...+.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|.+++..+ +|++|+++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4677889999999999999876 57899999876532   23345567788888877 5899999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....  
T Consensus        81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--  153 (323)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC--
Confidence            999999999988554  368999999999999999999999   8999999999999999999999999999975322  


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      .........||+.|+|||++.+..++.++|||||||++|||+||+.||......+..   ..   ... ..         
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---~~---i~~-~~---------  217 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---QS---IME-HN---------  217 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH---HH---HHh-CC---------
Confidence            111233567999999999999999999999999999999999999999765433221   11   111 10         


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                       ..++......+.+++.+|++.+|.+|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             01122334567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-35  Score=314.10  Aligned_cols=239  Identities=24%  Similarity=0.359  Sum_probs=191.0

Q ss_pred             ceEeeeCceEEEEEEecC-------------CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          467 WVIGIGGFGKVYKGELND-------------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      +.||+|+||.||+|++..             ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997532             2358999887665555678899999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc-------EEEeec
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM-------AKVADF  606 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~-------~kl~DF  606 (805)
                      +||||+++|+|..++.... ..+++..+++++.|+++||+|||+   .+|+||||||+|||++.++.       +|++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999998886543 458999999999999999999999   99999999999999987664       899999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhhhhhHHHHHHHHhh
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL-CARPVIDPTLPREMVNLAEWAMKWQN  684 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~  684 (805)
                      |++.....      .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+...       ...
T Consensus       157 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~~  223 (262)
T cd05077         157 GIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FYE  223 (262)
T ss_pred             CCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HHh
Confidence            99875432      12345788899999986 567899999999999999998 5788876433221111       000


Q ss_pred             cCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       685 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                       ... .         ........+.+++.+||+.+|.+||++.++++.|
T Consensus       224 -~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 -GQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -cCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             000 0         0111235688999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-35  Score=314.54  Aligned_cols=257  Identities=22%  Similarity=0.342  Sum_probs=205.3

Q ss_pred             HHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       455 el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      |++.+++++....+||+|+||.||+|+.. ++..|++|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45667788888889999999999999865 57889999887776666778999999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSL--SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSK  610 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~  610 (805)
                      +|+||+++++|.+++.... ..+  ++..+..++.|+++||+|||+   .+|+||||||+||+++. ++.+||+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999996542 234  888999999999999999999   99999999999999986 6799999999987


Q ss_pred             CCCCCCCcceeecccccccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      .......  ......|+..|+|||++...  .++.++||||||+++|||++|+.|+........   ..|......    
T Consensus       158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~----  228 (268)
T cd06624         158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK----  228 (268)
T ss_pred             ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc----
Confidence            6432111  12234578999999998654  378999999999999999999999864322111   111111000    


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                             ....++......+.+++.+|++.+|.+||++.|+++
T Consensus       229 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 -------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                   011122334456889999999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-35  Score=315.00  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46788889999999999999864 68899999887655555667889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...  ..+++.++..++.|+++||+|||+   .+|+||||||+||++++++.+||+|||+++......  .
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            999999988644  368999999999999999999999   899999999999999999999999999998643211  1


Q ss_pred             eeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          620 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ......|+..|+|||.+.   ...++.++|||||||+++||++|+.|+....+.+...  .     ....   ....+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~---~~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKS---NFQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecC---CCCCCCC
Confidence            123346888999999884   4457889999999999999999999986433221100  0     0000   0001111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ..  .......+.+++.+||+.+|++||+++++++.|
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            10  112345788999999999999999999998653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-35  Score=312.22  Aligned_cols=257  Identities=23%  Similarity=0.335  Sum_probs=208.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|+..+.||+|+||.||+|... +|+.||+|.+...   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            56888899999999999999887 7899999977532   2333678899999999999999999999999999999999


Q ss_pred             EeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||+++|+|.+++..  .....+++.+++.++.++++||+|||+   .+++||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999998854  223568999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++|+.|+....    .++.+...... .+.       
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~-------  224 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCD-------  224 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCC-------
Confidence            11  11233468889999999998889999999999999999999999985432    11112111111 110       


Q ss_pred             cccCCCC-hhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          695 TLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       695 ~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                        ....+ ......+.+++.+|+..+|++||++.+|+++|+.+
T Consensus       225 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         225 --YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              01111 13345688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.6e-36  Score=317.92  Aligned_cols=245  Identities=23%  Similarity=0.351  Sum_probs=194.5

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999765 68899999876432   22346678899999999999999999999999999999999999999


Q ss_pred             cccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceee
Q 003659          545 KGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST  622 (805)
Q Consensus       545 ~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~  622 (805)
                      .+++..  .....+++.+++.++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            988753  233569999999999999999999999   999999999999999999999999999997643311  1123


Q ss_pred             cccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCCh
Q 003659          623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP  702 (805)
Q Consensus       623 ~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  702 (805)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........  .......         +.....  .++.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~---------~~~~~~--~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR---------ILNDSV--TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHh---------hcccCC--CCcc
Confidence            45789999999999999999999999999999999999999975432111  0010000         001100  1222


Q ss_pred             hHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          703 DSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       703 ~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .....+.+++.+||+.+|++||     ++++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3455688999999999999999     5566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-36  Score=317.87  Aligned_cols=238  Identities=25%  Similarity=0.368  Sum_probs=189.7

Q ss_pred             eEeeeCceEEEEEEecC-------------------------CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEE
Q 003659          468 VIGIGGFGKVYKGELND-------------------------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL  522 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  522 (805)
                      +||+|+||.||+|.+..                         ...|++|++.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         23589998876555556778999999999999999999


Q ss_pred             EEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC---
Q 003659          523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---  599 (805)
Q Consensus       523 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~---  599 (805)
                      +++|......++||||+++|+|..++.... ..+++..+++++.|+++||+|||+   .+|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            999999999999999999999999886533 468999999999999999999999   8999999999999997643   


Q ss_pred             ----cEEEeecCCCCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhhhh
Q 003659          600 ----MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVL-CARPVIDPTLPREMV  673 (805)
Q Consensus       600 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~  673 (805)
                          .+|++|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.|+....+.+..
T Consensus       158 ~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                489999999864322      122356788999998865 56899999999999999995 789988754433221


Q ss_pred             hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          674 NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       674 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ..       ....       ..+    +......+.+++.+||+.+|++||++.+|++.|
T Consensus       232 ~~-------~~~~-------~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RF-------YEKK-------HRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HH-------HHhc-------cCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            11       0000       001    111224588999999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-35  Score=308.84  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=200.0

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      ++||+|+||.||++..++++.||+|+....... ....|.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            379999999999998877999999987765433 5678999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      +++.... ..+++..++.++.+++.||+|||+   .+++||||||+|||++.++.+||+|||+++...............
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9986543 368999999999999999999999   899999999999999999999999999997643211111111223


Q ss_pred             ccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       626 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      ++..|+|||.+.++.++.++|||||||+++||+| |..|+...........      . ....         ....+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~------~-~~~~---------~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------I-ESGY---------RMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH------H-hcCC---------CCCCCccC
Confidence            4567999999998899999999999999999999 7888865433221111      0 0000         00112233


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      +..+.+++.+|++.+|.+||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-35  Score=330.87  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC-----eEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  533 (805)
                      +|+..+.||+|+||.||++... +++.||||++...  .....+++.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4677889999999999999864 6899999988653  2234567889999999999999999999997766     789


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +|+||+. ++|.+.+...  ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 5788777443  369999999999999999999999   899999999999999999999999999998643


Q ss_pred             CCCCcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHH--------------
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW--------------  678 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------------  678 (805)
                      ... ........++..|+|||++.+. .++.++|||||||+++||++|+.||....+.+.......              
T Consensus       155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            211 1122344678999999998764 579999999999999999999999976554332221110              


Q ss_pred             --HHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          679 --AMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       679 --~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                        ............-..+.+ .....+....+.+++.+||+.+|.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              000000000000000000 01112234567899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-35  Score=323.38  Aligned_cols=240  Identities=25%  Similarity=0.357  Sum_probs=192.5

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhc-CCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +.||+|+||.||+|+.. +++.||||.+....   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            37999999999999876 47899999876531   2334556778888876 4899999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence            9999998643  368999999999999999999999   999999999999999999999999999987532211  122


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   ...    ...      .+.    ++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~i----~~~------~~~----~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QSI----RMD------NPC----YP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhC------CCC----CC
Confidence            3457999999999999999999999999999999999999999755432221   111    100      011    11


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMG-DVL  730 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~-evl  730 (805)
                      ......+.+++.+||+.+|.+||++. ++.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            12334578899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=313.13  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=202.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-----chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ++|...+.||+|++|.||++... +++.+|+|.+....     ....+.+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888899999999999999764 58999999865432     2234578899999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      |+||+++++|.+++...  ..+++..+.+++.|++.||+|||+   .+++||||||+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999999998654  358899999999999999999999   8999999999999999999999999999976433


Q ss_pred             CCCcce-eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHV-STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...... .....|+..|+|||++.+..++.++||||||+++|||++|+.||.........   .+   ....        
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~---~~~~--------  222 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FK---IATQ--------  222 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HH---Hhcc--------
Confidence            211111 12345788999999999988999999999999999999999998643222111   00   0000        


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       ......+......+.+++.+|+..+|.+||++.++++.
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 -PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             01111223345568899999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.9e-36  Score=333.54  Aligned_cols=255  Identities=22%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ...++|...+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34567899999999999999999876 5789999987542   2233456889999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999998543   47889999999999999999999   999999999999999999999999999998653


Q ss_pred             CCCCcceeecccccccccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      ... ........||+.|+|||++.+.    .++.++|||||||+||||++|+.||......+..      ......... 
T Consensus       194 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~-  265 (370)
T cd05621         194 ETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNS-  265 (370)
T ss_pred             cCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcc-
Confidence            211 1122356799999999998754    3789999999999999999999999754332211      111111000 


Q ss_pred             cccCccccCCCChhHHHHHHHHHHhchhcCCC--CCCCHHHHHHH
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGV--DRPSMGDVLWN  732 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPsm~evl~~  732 (805)
                          ..+.  ........+.+++..|++..+.  .||++.|++++
T Consensus       266 ----~~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 ----LNFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----cCCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                0000  0112345577788888875544  38899888754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-35  Score=331.58  Aligned_cols=258  Identities=22%  Similarity=0.223  Sum_probs=195.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||++... .++.||+|...      ...+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            57999999999999999999765 58899999753      235678999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      . ++|.+++...  ..+++.+++.++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus       166 ~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        166 K-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             C-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            5 6888887544  368999999999999999999999   899999999999999999999999999997533211 11


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----hhHHHHHHHHhhc----------
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----VNLAEWAMKWQNK----------  685 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----~~l~~~~~~~~~~----------  685 (805)
                      ......||+.|+|||++.+..++.++|||||||+||||++|+.|+......+.    .............          
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            22345799999999999999999999999999999999999977643211100    0000000000000          


Q ss_pred             CCccccc---------CccccCCC--ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          686 GQLDQII---------DPTLAGKI--RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 ~~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+.+..         .+......  .......+.+++.+||+.+|.+|||+.|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000         00000000  0123456889999999999999999999984

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=333.91  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=197.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+++.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36788899999999999999765 6899999987543   2234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999998654  468899999999999999999999   999999999999999999999999999996321100


Q ss_pred             Cc---------------------------------------------ceeecccccccccChhhhccCCCCchhhHHHHH
Q 003659          617 QT---------------------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG  651 (805)
Q Consensus       617 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~G  651 (805)
                      ..                                             .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                             000124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCChhhhhh-HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCC---CCHH
Q 003659          652 VVLFEVLCARPVIDPTLPREMVN-LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR---PSMG  727 (805)
Q Consensus       652 vvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Psm~  727 (805)
                      |+||||++|+.||....+.+... ...|      ...+      .+...  ......+.+++.+|++ +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~------~~~~------~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINW------RETL------YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHcc------CCcc------CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999997654332211 1111      0000      00000  1123457788999997 66665   6999


Q ss_pred             HHHHH
Q 003659          728 DVLWN  732 (805)
Q Consensus       728 evl~~  732 (805)
                      |++++
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=9.8e-36  Score=325.16  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=194.8

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+++.. +++.||+|++...   .....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999875 5789999988753   223456688999999888 699999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            9999888544  369999999999999999999999   99999999999999999999999999998753221  1123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||+||||++|+.||.............+..........          .++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence            4567999999999999999999999999999999999999999643322222222222222111110          112


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      ......+.+++.+||+.+|.+|+++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            22345578899999999999999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.5e-35  Score=309.85  Aligned_cols=250  Identities=30%  Similarity=0.487  Sum_probs=201.9

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +|...+.||+|+||.||+|.+.++..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||+++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH   83 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence            4666789999999999999887788999998765432 346789999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|.+++.... ..+++..++.++.+++.||+|||+   .+++||||||+||+++.++.+||+|||+++...... ....
T Consensus        84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999986543 358999999999999999999999   899999999999999999999999999987643211 1111


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ....++.+|+|||++.++.++.++||||||+++|||++ |+.|+......+..      ... .++  .....+.     
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~~-~~~--~~~~~~~-----  224 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------ETI-NAG--FRLYKPR-----  224 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH------HHH-hCC--CCCCCCC-----
Confidence            22335678999999998999999999999999999998 89998754322211      111 111  0111111     


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                        .....+.+++.+||+.+|++||++.|+++.|
T Consensus       225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              1245688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=298.78  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=209.8

Q ss_pred             hcCCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEcc-----CCeEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNEMI  533 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~  533 (805)
                      .++|.+.+.||+|||+.||.++ +.++..+|+|++...+.++.+..++|++.-++++|||++++++++..     +.+.+
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4678888999999999999996 45789999999988888888999999999999999999999998743     34589


Q ss_pred             EEEEeccCCcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ++++|...|+|.+.+....  ...+++.+++.|+.++++||++||+.. ++++||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999986532  346999999999999999999999832 3599999999999999999999999999875


Q ss_pred             CCCCCCcc-------eeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 003659          612 GPEIDQTH-------VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       612 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      ..-.-...       .......|..|.|||.+.   +...++++|||||||+||+|+.|..||+.....           
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----------  247 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----------  247 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence            43211100       012345788999999985   456889999999999999999999999744321           


Q ss_pred             HhhcCCcc-cccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          682 WQNKGQLD-QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       682 ~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                         .+.+. .+....+.-.-....++.+.+++.+|++.||.+||++.+++..++.++
T Consensus       248 ---GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ---GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence               11111 112222221112235778999999999999999999999998887653

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.2e-35  Score=315.99  Aligned_cols=246  Identities=24%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |...++||+|+||+||+|... +++.+|+|.+....   ......+.+|++++++++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556679999999999999875 68899999876542   22345578899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++.......+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            999999998876555579999999999999999999999   999999999999999999999999999987643211  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                       ......|+..|+|||++.+..++.++|||||||+++||++|+.||..........  .+........       .    
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~~~~~-------~----  222 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRVLETE-------E----  222 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhhccc-------c----
Confidence             1234568999999999998899999999999999999999999997543322111  1111110000       0    


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      .+.......+.+++..|++.+|.+||++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence            11223345578899999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-35  Score=323.80  Aligned_cols=241  Identities=24%  Similarity=0.320  Sum_probs=195.1

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.+ +++.||||.+...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999876 4789999987643   223456677899999888 799999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++.++..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTT  153 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCcc
Confidence            9999888654  369999999999999999999999   99999999999999999999999999998753221  1112


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.........      ..... ..      .    .++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~------~~i~~-~~------~----~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF------QSILE-DE------V----RYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH------HHHHc-CC------C----CCC
Confidence            3456899999999999999999999999999999999999999754432211      11111 10      0    111


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCH-----HHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSM-----GDVLW  731 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm-----~evl~  731 (805)
                      ......+.+++.+||+.+|.+||++     .+++.
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            2234568899999999999999999     66654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-36  Score=328.43  Aligned_cols=238  Identities=25%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             ceEeeeCceEEEEEEe----cCCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          467 WVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +.||+|+||.||+++.    .+|+.+|+|++....  ......+..|+++|++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    357899999876532  2234567789999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++...  ..+++.+++.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            99999998543  368999999999999999999999   999999999999999999999999999997643211  12


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+...      ... ....          .+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~i~-~~~~----------~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT------MIL-KAKL----------GM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH------HHH-cCCC----------CC
Confidence            334679999999999998889999999999999999999999997543322111      111 1100          11


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      +......+.+++.+||+.+|.+||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2223456788999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-37  Score=313.82  Aligned_cols=266  Identities=24%  Similarity=0.315  Sum_probs=205.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcC--CCCchhHHHHHHHHHHHhcCCCCceEEEEEEEcc-----CCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~  531 (805)
                      ...|...+.||+|++|.|+.+..+ +|+.||||++.  -......++-.+|+++|+.++|+||+.+.+.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            344555678999999999999775 68999999987  3455567888999999999999999999998744     467


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++|+|+|+ -+|...++.+  +.|+.....-+..|+++||.|+|+   .+|+||||||+|+|++.+...||+|||||+.
T Consensus       101 vYiV~elMe-tDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceee
Confidence            899999995 4899988544  359999999999999999999999   9999999999999999999999999999998


Q ss_pred             CCCCCCcceeecccccccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      ..........+..+.|..|.|||.+. ...|+.+.||||.||+|.||++|++.|.+....++..++--......++.+..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            65432333346778899999999875 57899999999999999999999999977654444333322111111111111


Q ss_pred             cc--------C-------ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          691 II--------D-------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       691 ~~--------d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      +-        .       ..+...+ +.......+++.++|..||.+|+|++|.+++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIF-PNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHc-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11        0       0000111 1333457789999999999999999999754

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-35  Score=310.48  Aligned_cols=251  Identities=28%  Similarity=0.447  Sum_probs=195.3

Q ss_pred             ceEeeeCceEEEEEEec----CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEc-cCCeEEEEEEecc
Q 003659          467 WVIGIGGFGKVYKGELN----DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD-EKNEMILIYEYME  540 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~~  540 (805)
                      +.||+|+||.||+|...    ++..||+|++... .....+.+.+|+.+++.++||||++++++|. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36999999999999753    2457999987643 3344678889999999999999999999875 4556889999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc--
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--  618 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~--  618 (805)
                      +|+|.+++.... ..+++..++.++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999986543 357888999999999999999999   89999999999999999999999999999754321110  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      .......++..|+|||++.+..++.++|||||||++|||++| .+|+......+   +....   .. +.     .+.  
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~-~~-----~~~--  222 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQ-GR-----RLL--  222 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hc-CC-----CCC--
Confidence            111234467789999999988999999999999999999995 55665432221   11111   11 10     000  


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~  737 (805)
                        .+...+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus       223 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         223 --QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              01122456889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=313.43  Aligned_cols=257  Identities=25%  Similarity=0.369  Sum_probs=205.2

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-Cc----EEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-GT----KVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      .+|...+.||+|+||.||+|..++ |+    .+|+|.+.... .....++.+|+.++++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            456677899999999999998652 33    68999877654 3446788999999999999999999999987 78999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997543 358999999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.|+......+..   .   .. ..+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~---~~-~~~~~-----  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP---D---LL-EKGER-----  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH---H---HH-hCCCC-----
Confidence            222111122334568999999988899999999999999999999 99999765433211   1   11 11110     


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                          ...+..+...+.+++.+|+..+|.+||++.++++.|+.+.+
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                01112233467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-36  Score=303.08  Aligned_cols=263  Identities=21%  Similarity=0.255  Sum_probs=204.0

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchh--HHHHHHHHHHHhcCCCCceEEEEEEE--ccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIGYC--DEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~  536 (805)
                      +|...+.|++|.||.||+|+.+ +++.||+|+++...+..  --...+|+.+|.+++|||||.+-.+.  .+-+..+|||
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            4555678999999999999876 68999999987654321  22457999999999999999998776  4456799999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      |||+. +|...+.... +++...++.-+..|+++||+|||.   .-|+|||||++|+|+.+.|.+||+||||||.++.. 
T Consensus       157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            99987 8999887655 578999999999999999999999   99999999999999999999999999999987653 


Q ss_pred             CcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc-
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP-  694 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-  694 (805)
                       ....+..+-|..|.|||.+.+ ..|+...|+||+|||+.||+++++.|....+.++.+.+-.......+.....+.+. 
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence             233567788999999999876 57999999999999999999999999877665554433222211111111111110 


Q ss_pred             -------------cccCCCChh-HHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 -------------TLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 -------------~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                                   .+.+.+... ..+.-.++....|..||.+|-|+.|.++
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                         111222211 2345578889999999999999999874

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.4e-36  Score=324.10  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=192.5

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.+ +|+.||+|.+....   ....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999876 58899999876531   23345667788888754 899999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++.++..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence            9999988654  368999999999999999999999   9999999999999999999999999999875321  11123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   +   .. ..+      .+.+    +
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~---~~-~~~------~~~~----~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---E---SI-RVD------TPHY----P  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HH-HhC------CCCC----C
Confidence            4567999999999999999999999999999999999999999754432211   1   11 000      1111    1


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHH-HHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMG-DVL  730 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~-evl  730 (805)
                      ......+.+++.+||+.+|.+||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12345678899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-35  Score=314.71  Aligned_cols=249  Identities=30%  Similarity=0.463  Sum_probs=198.2

Q ss_pred             ceEeeeCceEEEEEEecC-------CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          467 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... .....+|.+|+++++.++||||++++++|......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999997642       2579999876543 24467889999999999999999999999999999999999


Q ss_pred             ccCCcccccccCC-----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-----cEEEeecCC
Q 003659          539 MENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-----MAKVADFGL  608 (805)
Q Consensus       539 ~~~gsL~~~l~~~-----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-----~~kl~DFGl  608 (805)
                      +++++|.+++...     ....++|.+++.++.|++.||+|||+   .+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999643     22358999999999999999999998   8999999999999999877     899999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      ++...............++..|+|||++.++.++.++|||||||++|||+| |+.||......+.   ....    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHH----hcCC
Confidence            976433222111223345678999999999999999999999999999998 9999864433221   1111    1110


Q ss_pred             cccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                               ........+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                     00112234567889999999999999999999998885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-35  Score=332.32  Aligned_cols=259  Identities=19%  Similarity=0.201  Sum_probs=195.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .+|...+.||+|+||.||++... .++.||||....      ..+.+|+++|++|+|+||+++++++..++..++|||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            35888899999999999999876 478999996432      34578999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      . ++|.+++.... ..++|.+++.|+.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       243 ~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        243 R-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            5 68888875433 369999999999999999999999   899999999999999999999999999998654322222


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhHHHHHHHHhhcCCcccc
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP--------REMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~--------~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ......||..|+|||++.+..++.++|||||||+||||++|..++.....        ......+.+.....  ......
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~--~~~~~~  395 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV--DEFPQH  395 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc--ccCCCC
Confidence            23346799999999999999999999999999999999998865532211        11111111111000  000000


Q ss_pred             cCccc------------cCCCC-------hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          692 IDPTL------------AGKIR-------PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       692 ~d~~l------------~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ....+            .....       ......+.+++.+||+.||.+|||+.|++++
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000            00000       0112357889999999999999999999864

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-35  Score=309.49  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=203.3

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|...+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            3667789999999999999876 5889999987543 3344677889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++.......+++...+.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++.....  ..
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GA  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc--cc
Confidence            99999998865555568999999999999999999999   99999999999999999999999999998764321  11


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||++.+..++.++|+||||+++++|++|+.||........      .... ..+...         .
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~---------~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKV-CQGSYK---------P  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHH-hcCCCC---------C
Confidence            22345688999999999998999999999999999999999999975432211      1111 111111         1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+......+.+++.+||+.+|.+||++.+++.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  251 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILS  251 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence            11223456789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-35  Score=324.55  Aligned_cols=240  Identities=28%  Similarity=0.366  Sum_probs=191.3

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHH-HHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.. +|+.+|+|++...   ......++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            37999999999999765 6899999987643   2233445566655 56789999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++.++..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+++....  .....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~  153 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT  153 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence            9999888543  468999999999999999999999   9999999999999999999999999999875322  11123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..      ...... .        +  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~-~--------~--~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHK-P--------L--VLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcC-C--------c--cCC
Confidence            4567999999999999999999999999999999999999999754332211      111111 0        0  111


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            22345678899999999999999986443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=322.40  Aligned_cols=258  Identities=28%  Similarity=0.416  Sum_probs=215.5

Q ss_pred             cCCcccceEeeeCceEEEEEEecC---C--cEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND---G--TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~---g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +.....++||+|-||.||+|.+.+   |  -.||||..+.. .....+.|..|..+|+.++||||++|+|+|.+. ..++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            334455789999999999997542   3  46899988874 445578899999999999999999999999764 7899


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      |||.++.|.|+.+|..+. ..|+.......+.||..+|+|||+   ..+|||||..+|||+.+.--+||+||||+|....
T Consensus       468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999997654 469999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ....+ .+...-...|||||.+.-.+++.+||||.|||+|||++. |..||......+...                .++
T Consensus       544 ~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----------------~iE  606 (974)
T KOG4257|consen  544 DAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----------------HIE  606 (974)
T ss_pred             cchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE----------------Eec
Confidence            44333 334556778999999999999999999999999999986 889997554333211                112


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                      ..-.-..++.|+..+..+..+||+.+|.+||...++...|+.+++..
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee  653 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE  653 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence            22222456788888999999999999999999999999999998854

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.8e-35  Score=316.98  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=203.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .+|...+.||+|++|.||+|+.. +++.||+|.+........+.+.+|+.+++++.|+|++++++++..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46777889999999999999864 68899999887665555678899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...   .+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......  .
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            999999998543   48999999999999999999999   899999999999999999999999999987643211  1


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||.+.+...+.++|||||||+++||++|+.||....+.+.  +..   . ...+ .     +.+  .
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~---~-~~~~-~-----~~~--~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL---I-ATNG-T-----PEL--Q  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH---H-hcCC-C-----CCC--C
Confidence            12334688999999999988899999999999999999999999975433211  111   0 0000 0     000  1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+......+.+++.+|+..+|++||++.|++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            11233456888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.6e-36  Score=333.79  Aligned_cols=203  Identities=24%  Similarity=0.366  Sum_probs=173.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|...++||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            4778899999999999999865 58899999876532   2345678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC-
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID-  616 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~-  616 (805)
                      |+++|+|.+++...  ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999998654  358889999999999999999999   899999999999999999999999999975321000 


Q ss_pred             --------------------------------------------CcceeecccccccccChhhhccCCCCchhhHHHHHH
Q 003659          617 --------------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV  652 (805)
Q Consensus       617 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gv  652 (805)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000112346999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCh
Q 003659          653 VLFEVLCARPVIDPTLP  669 (805)
Q Consensus       653 vl~elltG~~p~~~~~~  669 (805)
                      +||||++|++||....+
T Consensus       237 il~elltG~~Pf~~~~~  253 (382)
T cd05625         237 ILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             HHHHHHhCCCCCCCCCH
Confidence            99999999999976544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3e-35  Score=312.07  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=204.4

Q ss_pred             cCCcccceEeeeCceEEEEEEecC----CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...++||+|+||.||+|...+    ...||||...... ....+.|.+|+.++++++|+||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            346777899999999999997643    2478999877654 4456789999999999999999999999875 457899


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++|+|.+++.... ..+++.+++.++.+++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999996543 358999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      . ....+...++..|+|||.+....++.++||||||++++||++ |+.||......+..   .+   .......      
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~---~~~~~~~------  227 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GR---IENGERL------  227 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HH---HHcCCcC------
Confidence            1 111223334568999999988889999999999999999996 99999755432211   11   1111110      


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                          ..+...+..+.+++.+|+..+|.+||++.+++..|++++.
T Consensus       228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                1122334578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-35  Score=317.01  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=195.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcC---CCCceEEEEEEEcc-----CC
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCDE-----KN  530 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~  530 (805)
                      +|...+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4677789999999999999876 58899999876532  12233456677777665   79999999998854     34


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ..++||||+++ +|.+++.......+++.++..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            68999999984 89888876555569999999999999999999999   899999999999999999999999999998


Q ss_pred             CCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHhhcCCc-
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQL-  688 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~-  688 (805)
                      .....   .......||..|+|||++.+..++.++|||||||+++||++|++||......+.. ....+.......... 
T Consensus       157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            65321   1123456889999999999889999999999999999999999999754432211 111110000000000 


Q ss_pred             -----ccccCccc---cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 -----DQIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 -----~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                           .....+..   .....++....+.+++.+||+.+|.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                 00000000   00111234556789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.9e-35  Score=312.95  Aligned_cols=249  Identities=22%  Similarity=0.299  Sum_probs=198.0

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|...++||+|+||.||+|... +++.||+|.+... .....++|.+|++++++++||||+++++++...+..++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5667789999999999999764 6889999987654 3344567899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|..+.      .+++..+..++.|++.||+|||+   .+|+|+||||+|||++.++.+||+|||++......    
T Consensus        82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            999987552      47888999999999999999999   99999999999999999999999999999764321    


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......||..|+|||++.+..++.++||||||+++|||++|+.||......... ....+........      .+.+. 
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-  221 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVLP-  221 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCCC-
Confidence            123457899999999999989999999999999999999999999653322111 1111111111110      01111 


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                        .......+.+++.+|++.+|.+||+++|+++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              11223467899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.8e-36  Score=334.17  Aligned_cols=252  Identities=23%  Similarity=0.288  Sum_probs=196.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      +|...+.||+|+||.||+++.. +++.||||.+....   ......+.+|+++|++++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            5788899999999999999865 58999999876432   2235668899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC-
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID-  616 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~-  616 (805)
                      |+++|+|.+++...+  .+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999996543  58889999999999999999999   999999999999999999999999999975321000 


Q ss_pred             ----------------------------------------CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHH
Q 003659          617 ----------------------------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE  656 (805)
Q Consensus       617 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~e  656 (805)
                                                              .........||+.|+|||++.+..++.++|||||||+|||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123579999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCC---CHHHHHHH
Q 003659          657 VLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP---SMGDVLWN  732 (805)
Q Consensus       657 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---sm~evl~~  732 (805)
                      |++|+.||....+.+...      ......       ..+...........+.+++.+|+ .+|.+|+   ++.+++.+
T Consensus       237 ll~G~~Pf~~~~~~~~~~------~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQL------KVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHH------HHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999997654432211      100000       00000001122344666777765 4999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-35  Score=323.85  Aligned_cols=237  Identities=26%  Similarity=0.338  Sum_probs=189.1

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHH-HHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999875 58899999876432   222344555554 67889999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++.++..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            9999888543  368889999999999999999999   89999999999999999999999999998753221  1123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..   .....         .  ..++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~---~i~~~---------~--~~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---YD---NILHK---------P--LQLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---HH---HHhcC---------C--CCCC
Confidence            445789999999999998999999999999999999999999975432211   11   11110         0  0122


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      ......+.+++.+||+.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            23355688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-35  Score=316.60  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=200.5

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |+..++||+|+||.||++... +++.+|+|.+....   ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            566789999999999999776 58899999876432   22345678899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            999999999866555579999999999999999999999   999999999999999999999999999987643211  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||.............   .....      ...    
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~------~~~----  222 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE------VQE----  222 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh------hhh----
Confidence             1123468999999999999999999999999999999999999997543211100000   00000      000    


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCC-----HHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLWN  732 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----m~evl~~  732 (805)
                      .........+.+++.+||+.+|.+||+     +.|++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            111223445789999999999999999     7788753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=8e-36  Score=325.34  Aligned_cols=237  Identities=29%  Similarity=0.383  Sum_probs=190.2

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHH-HHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIE-MLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|+||.||+|+.. +|+.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            37999999999999876 68999999876432   222344555555 56789999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|..++...  ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~  153 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT  153 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence            9999988654  368999999999999999999999   9999999999999999999999999999875322  11223


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ....... .      .    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~-~------~----~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILNK-P------L----RLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHcC-C------C----CCC
Confidence            445799999999999999999999999999999999999999975433221      1111110 0      0    111


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      +.....+.+++.+||+.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23355688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-35  Score=318.22  Aligned_cols=261  Identities=26%  Similarity=0.422  Sum_probs=203.1

Q ss_pred             CCcccceEeeeCceEEEEEEe-----cCCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  533 (805)
                      .|...+.||+|+||.||+++.     .++..||+|.+.... ......+.+|++++++++|+|++++.+++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            466778999999999999974     347889999987553 34457799999999999999999999998764  5689


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+++++|.+++.... ..++|.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999985543 368999999999999999999999   999999999999999999999999999998654


Q ss_pred             CCCCc-ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---------hhhhHHHHHHHHh
Q 003659          614 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR---------EMVNLAEWAMKWQ  683 (805)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~~~~~  683 (805)
                      ..... .......++..|+|||++.+..++.++|||||||+++||+|++.|.......         .......+.. ..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL  239 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence            32211 1122345677899999998888999999999999999999987664321110         0011111111 11


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ..+.         ........+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111         0011223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-36  Score=312.55  Aligned_cols=259  Identities=22%  Similarity=0.293  Sum_probs=197.3

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC-----eEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMILI  535 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV  535 (805)
                      .|...+++|.|.||.||+|++.. ++.||||+.....+-    -.+|+++|+++.|||||+|+-++....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            45566799999999999998764 789999987665432    237999999999999999999884322     34689


Q ss_pred             EEeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCCCC
Q 003659          536 YEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTG  612 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~~~  612 (805)
                      ||||+. +|.+.++.  ..+..++...+.-+..||.+||+|||+   .+|+||||||+|+|+|.+ +.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 99998864  223568888888999999999999999   999999999999999977 89999999999986


Q ss_pred             CCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc--
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD--  689 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  689 (805)
                      ...+.   ......|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....++..++--+.....++.+.  
T Consensus       177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            44222   244557889999999875 589999999999999999999999998765544433322222111111111  


Q ss_pred             -----cccCcccc-----CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          690 -----QIIDPTLA-----GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       690 -----~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                           +.-.+.+.     .-+......+..+++.+||+.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 11111111     1123344566889999999999999999999985

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.1e-35  Score=310.83  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             eEeeeCceEEEEEEecC---CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          468 VIGIGGFGKVYKGELND---GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      .||+|+||.||+|+..+   ...+++|.+.... ......|.+|++.++.++|+||++++++|......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997543   4578899776543 3345678899999999999999999999999999999999999999


Q ss_pred             ccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          544 LKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       544 L~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      |.+++....   ....++...+.++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999996543   2335788899999999999999999   8999999999999999999999999999875332111111


Q ss_pred             eecccccccccChhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003659          621 STAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |+.||....+.+.  + .   ..... ....+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~-~---~~~~~-~~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--L-K---QVVRE-QDIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--H-H---HHhhc-cCccCC
Confidence            223346678999999753       456889999999999999999 7788865433221  1 1   11111 111122


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ++.+.    ......+.+++..|+ .+|++||++++|++.|
T Consensus       232 ~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 KPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            22222    233455677888888 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-35  Score=321.10  Aligned_cols=264  Identities=21%  Similarity=0.315  Sum_probs=199.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            45778889999999999999876 57889999876543 22345678899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++ +|.+++.... ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++......  
T Consensus        86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            975 8888775543 358899999999999999999999   999999999999999999999999999997543211  


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH---------HhhcCCc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK---------WQNKGQL  688 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~~  688 (805)
                      .......+|..|+|||.+.+ ..++.++|||||||+++||+||++||......+..........         .......
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            11233467899999999865 5689999999999999999999999976544333222211100         0000000


Q ss_pred             ccccCccccC----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...-.+....    ...+.....+.+++.+||+.+|.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000000000    001123456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.5e-36  Score=317.80  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=204.4

Q ss_pred             CCcccceEeeeCceEEEEEEec-----CCcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-----DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~  533 (805)
                      .|...+.||+|+||.||+|++.     .+..+|||.+...... ..++|.+|++++++++|+||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4555679999999999999864     3689999998765443 56789999999999999999999999877  66789


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+++++|.+++.... ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999996543 359999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCc-ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh---------hHHHHHHHHh
Q 003659          614 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV---------NLAEWAMKWQ  683 (805)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---------~l~~~~~~~~  683 (805)
                      ..... .......++..|+|||.+.+..++.++||||||++++||+||+.|+.........         ....+.. ..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HH
Confidence            22111 1112234556799999998889999999999999999999999887543221100         0111111 11


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ..+         .....+..+...+.+++.+|++.+|.+||+|.||+++|+.+
T Consensus       240 ~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            110         01111123346788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-36  Score=314.92  Aligned_cols=239  Identities=24%  Similarity=0.379  Sum_probs=191.7

Q ss_pred             ceEeeeCceEEEEEEecC--------CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          467 WVIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +.||+|+||.||+|..+.        ...+++|.+........+++.+|+.+++.++|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999997642        234888887665555567889999999999999999999999998999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc--------EEEeecCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--------AKVADFGLSK  610 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~--------~kl~DFGla~  610 (805)
                      +++|+|.+++.... ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.        ++++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999997654 368999999999999999999999   99999999999999987765        6999999986


Q ss_pred             CCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCC-CCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ....      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....+......      ....   
T Consensus       157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------~~~~---  221 (258)
T cd05078         157 TVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------YEDR---  221 (258)
T ss_pred             ccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------HHcc---
Confidence            5432      123467889999999976 45899999999999999999995 55543322221110      0000   


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                               ...+.....++.+++.+||+.+|++||+++++++.|
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                     011222235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.6e-35  Score=308.30  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=204.2

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|+..+.||+|+||.||+|+..+ ++.+++|.+.....  .+++.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            567888899999999999998875 78999998865533  678999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.... ..+++..++.++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++........  
T Consensus        81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999986433 468999999999999999999999   8999999999999999999999999999986543221  


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||++.+..++.++||||||++++||++|+.|+....+......       ...     ...+.+  .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~-----~~~~~~--~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPN-----KPPPTL--S  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hcc-----CCCCCC--C
Confidence            22344578899999999999999999999999999999999999975433221100       000     000011  1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+......+.+++.+|++.+|.+||++.||++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11223456889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.7e-35  Score=312.68  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=200.0

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      |+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+|++++++++..++..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455568999999999999876 4788899998776666678899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|..++.... .++++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++.....  ....
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~  160 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  160 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence            99998876533 469999999999999999999999   89999999999999999999999999998764321  1122


Q ss_pred             ecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          622 TAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ....|+..|+|||++.     ...++.++|||||||++|||++|++|+....+.+..  .    ..... .     .+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~----~~~~~-~-----~~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--L----KIAKS-E-----PPTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--H----HHhhc-C-----CCCC
Confidence            3456889999999984     345788999999999999999999998754332211  1    11110 0     0000


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ..+......+.+++.+||+.+|.+||++.++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              011123456889999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=305.83  Aligned_cols=265  Identities=22%  Similarity=0.287  Sum_probs=202.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCc-eEEEEEEEccCC------e
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKN------E  531 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~  531 (805)
                      .|...++||+|.||+||+|+.+ +|+.||+|++.....  ..-....+|+.+|++|+|+| |++|.+++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            3445567999999999999765 689999998776543  23345679999999999999 999999997776      7


Q ss_pred             EEEEEEeccCCcccccccCCCC--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      +++|+||++. +|..++.....  ..++...+..+..||++||+|||+   ++|+||||||+|||+++++.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence            8999999975 99999866443  357778999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      +...-  .....+..++|..|.|||++.+. .|+...||||+||++.||+++++.|....+.+....+--......+...
T Consensus       168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            96542  12224567889999999999876 7999999999999999999999999876654332221111111111111


Q ss_pred             ---ccccCcc--ccCC-----CC---hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          689 ---DQIIDPT--LAGK-----IR---PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       689 ---~~~~d~~--l~~~-----~~---~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                         ....+-.  ....     ..   +.......+++.+||+.+|.+|.|+..++++
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence               1111100  0000     00   1111367899999999999999999998864

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-35  Score=334.79  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=193.2

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccC--------C
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--------N  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~  530 (805)
                      .++|...++||+|+||.||+|... +++.||||++....    ....+|+.+|++++|+||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457899999999999999999875 58899999875432    2335799999999999999998876321        2


Q ss_pred             eEEEEEEeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-cEEEeecC
Q 003659          531 EMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFG  607 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-~~kl~DFG  607 (805)
                      .+++||||+++ +|.+++..  .....+++..+..++.|+++||+|||+   .+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46789999985 67666642  233569999999999999999999999   9999999999999999665 79999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--  684 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--  684 (805)
                      +++......   ......||+.|+|||++.+ ..++.++|||||||+||||++|++||......+...  ........  
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~~~~~~p~  291 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RIIQVLGTPT  291 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCC
Confidence            998653311   1234568999999999865 468999999999999999999999997654332211  11100000  


Q ss_pred             -------cC-----CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          685 -------KG-----QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       685 -------~~-----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                             ..     ....+....+...++.....++.+++.+||+.+|.+||++.|++++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                   00     0000111111111222334568899999999999999999999864

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.1e-35  Score=316.79  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|...+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|++++++++||||++++++|..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999875 57889999876542 33456788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++...  ..+++..+..++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999654  468999999999999999999997  147999999999999999999999999998754321   


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCC-----------
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ-----------  687 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----------  687 (805)
                       ......|+..|+|||++.+..++.++||||||++++||++|+.|+........   ..+.........           
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCC
Confidence             12345688999999999888899999999999999999999999864332211   111100000000           


Q ss_pred             ---------cccccCcccc---CCCC-hhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          688 ---------LDQIIDPTLA---GKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       688 ---------~~~~~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                               ..+..+....   ...+ ......+.+++.+|++.+|++||++.++++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                     0000000000   0000 11234588999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3e-35  Score=320.76  Aligned_cols=242  Identities=22%  Similarity=0.313  Sum_probs=194.3

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +|+..++||+|+||.||+|+.. +++.||+|++...   .....+.+..|.+++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999865 5889999987643   2234566788999998885 577888999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++.+++.++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-  154 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence            999999999998554  369999999999999999999999   99999999999999999999999999998753221 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...   ... ...        
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~---i~~-~~~--------  218 (323)
T cd05615         155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQS---IME-HNV--------  218 (323)
T ss_pred             -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHH---HHh-CCC--------
Confidence             1122345699999999999999999999999999999999999999976543221   111   111 100        


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                        .++......+.+++.+||+.+|.+|++..
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence              11222345678899999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-36  Score=309.06  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=208.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ..+|+..+.||+|.||+|-+|.. ..|+.||||.+...   ++++.-.+.+|+++|+.|+||||+.++.+|+.++.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            34566777999999999999965 57999999977654   455667788999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||..+|.|.+++...  ..|++.+...+++||..|+.|+|+   .+++|||||-+|||||.++++||+||||+.++.. 
T Consensus       132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-  205 (668)
T ss_pred             EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc-
Confidence            9999999999999554  479999999999999999999999   9999999999999999999999999999987532 


Q ss_pred             CCcceeecccccccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                        ....++.+|++-|.+||.+.+..|. +..|-|||||+||.|+.|..||+....   ..++.   +. ..|..      
T Consensus       206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvr---QI-s~GaY------  270 (668)
T KOG0611|consen  206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVR---QI-SRGAY------  270 (668)
T ss_pred             --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHH---Hh-hcccc------
Confidence              3445788999999999999988875 789999999999999999999986532   22222   11 11111      


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                           ..++.+....-+++++|..+|++|.|+.||..+.
T Consensus       271 -----rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 -----REPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                 1133345567789999999999999999998643

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-35  Score=328.07  Aligned_cols=260  Identities=22%  Similarity=0.235  Sum_probs=201.4

Q ss_pred             HHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC
Q 003659          454 VAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK  529 (805)
Q Consensus       454 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  529 (805)
                      .++....++|...+.||+|+||.||+++.+ +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++..+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999876 5889999987542   223345678999999999999999999999999


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      +..++||||+++|+|.+++...   .++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            9999999999999999998543   47888999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      +..... .........||+.|+|||++...    .++.++|||||||+||||++|+.||........      .......
T Consensus       190 ~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~  262 (371)
T cd05622         190 MKMNKE-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH  262 (371)
T ss_pred             eEcCcC-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence            865431 11122356799999999998754    378999999999999999999999975433211      1111111


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCC--CCCHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLWNL  733 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~L  733 (805)
                      ......       .........+.+++.+|+...+.+  ||++.|++++.
T Consensus       263 ~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         263 KNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            110000       011233456788899999844432  67888887654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-35  Score=309.45  Aligned_cols=252  Identities=29%  Similarity=0.465  Sum_probs=201.2

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhH--HHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGL--AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |+..+.||+|+||+||+++.. +++.+|+|.+........  ....+|+.++++++|+||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            455689999999999999877 467899999887754432  23456999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.  ....+++.+++.++.|+++||++||+   .+++|+||||+||++++++.++|+|||.+....  ....
T Consensus        81 ~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE  153 (260)
T ss_dssp             TTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred             cccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--cccc
Confidence            9999999997  23468999999999999999999999   899999999999999999999999999987531  1222


Q ss_pred             eeecccccccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......++..|+|||++. +...+.++||||+|+++++|++|+.|+......+............    .    ....  
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~----~~~~--  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----L----PSSS--  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----H----HHHT--
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----c----cccc--
Confidence            344567899999999998 8899999999999999999999999998653222222211111000    0    0000  


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000111367899999999999999999999974

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.3e-35  Score=309.82  Aligned_cols=255  Identities=27%  Similarity=0.428  Sum_probs=203.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ++|...+.||+|+||.||+|+.+      +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            46777889999999999999864      2467999988765443 4678999999999999999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCC-------CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          534 LIYEYMENGTLKGHLYGSGL-------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                      +||||+++|+|.+++.....       ..+++..++.++.|+++||+|||+   .+|+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999965431       268999999999999999999999   89999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      |+++...... ........++..|+|||.+.+...+.++||||||++++||++ |..||........   ..   . ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~---~-~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN---R-LQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH---H-HHc
Confidence            9987532211 111223456778999999988889999999999999999999 7788854322211   11   1 111


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      +...        .......+..+.+++.+|++.+|.+||++.|++..|+
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1110        0111233457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=326.51  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=209.2

Q ss_pred             ceEeeeCceEEEEEEecC--C--cEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELND--G--TKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ++||+|.||.|++|.|..  |  ..||||.+...... ...+|.+|+.+|.+|+|+|+++|+|+..+ ..+.||+|.++.
T Consensus       116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl  194 (1039)
T KOG0199|consen  116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL  194 (1039)
T ss_pred             HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence            489999999999998863  4  46899999887654 67899999999999999999999999877 788999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+.|+......|-......+|.|||.||+||..   +++|||||..+|+||-....+||+||||.+.++..+.....
T Consensus       195 GSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm  271 (1039)
T KOG0199|consen  195 GSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVM  271 (1039)
T ss_pred             chHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEe
Confidence            999999988555678889999999999999999999   99999999999999999999999999999987764443332


Q ss_pred             -ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          622 -TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       622 -~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                       ....-.+.|+|||.++...++.++|||+|||++|||+| |..||........                .+.+|..-.-.
T Consensus       272 ~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI----------------L~~iD~~erLp  335 (1039)
T KOG0199|consen  272 APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI----------------LKNIDAGERLP  335 (1039)
T ss_pred             cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH----------------HHhccccccCC
Confidence             23445678999999999999999999999999999999 5678876544332                22333222223


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      -+..|.+++.++++.||..+|++||+..++.+.+-
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            35678999999999999999999999999986553

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8e-35  Score=306.02  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=205.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|+..++||+|+||.||.++.. +++.+++|.+...  .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4677789999999999998765 5889999986643  345567889999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++.......+++.++..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999999976544578999999999999999999999   8999999999999999999999999999976543221 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                       ......|+..|+|||++.+...+.++||||||++++||++|+.||......+.      ..... .+...         
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~---------  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYT---------  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCC---------
Confidence             22345689999999999888899999999999999999999999975433221      11111 11110         


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .........+.+++.+|++.+|.+||++.|+++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1112334568899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-35  Score=323.09  Aligned_cols=240  Identities=27%  Similarity=0.361  Sum_probs=190.4

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHH-HHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEI-EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +.||+|+||.||+|+.. +++.||+|++....   .....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            37999999999999876 57889999876432   12233444444 457889999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+.+.....++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++....  .....
T Consensus        81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~  153 (325)
T cd05602          81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTT  153 (325)
T ss_pred             CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCc
Confidence            9999998654  357888899999999999999999   9999999999999999999999999999975322  11123


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   .   ..... .        .  ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~~~-~--------~--~~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NILNK-P--------L--QLK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH---H---HHHhC-C--------c--CCC
Confidence            4567999999999999999999999999999999999999999754432211   1   11111 0        0  112


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            23345688999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.6e-35  Score=305.82  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=201.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc-CCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~e  537 (805)
                      +|...+.||+|++|.||+++.+ +++.+|+|++...  .....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            3677889999999999999865 4789999987643  23445678899999999999999999998764 446889999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++++|.+++.......+++.+++.++.+++.||++||+   .+++||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            9999999999976555579999999999999999999999   899999999999999999999999999997653211 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                       .......|++.|+|||++.+..++.++||||||++++||++|+.||........      ..... .+.+         
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~---------  219 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKL---------  219 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCC---------
Confidence             122345688999999999999999999999999999999999999875432211      11111 1111         


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...+......+.+++.+|++.+|.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0112234466889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.7e-35  Score=313.71  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=200.6

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      |...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445568999999999999865 57899999876443 3446678999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++..   ..+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++.......  ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999998854   358999999999999999999999   899999999999999999999999999997654311  11


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      .....|+..|+|||++.+..++.++|||||||+++||++|+.|+....+....      .. ....     ..+.    .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~-~~~~-----~~~~----~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL------FL-IPKN-----SPPT----L  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH------hh-hhcC-----CCCC----C
Confidence            22346788999999999989999999999999999999999998644332211      00 0010     0111    1


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .......+.+++.+|++.+|.+||+|.+++.+
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            22345568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-35  Score=309.46  Aligned_cols=238  Identities=26%  Similarity=0.393  Sum_probs=190.6

Q ss_pred             ceEeeeCceEEEEEEecCC-----------cEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          467 WVIGIGGFGKVYKGELNDG-----------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g-----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      +.||+|+||.||+|...+.           ..+++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3799999999999987643           25788876655433 6788999999999999999999999988 788999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-------cEEEeecCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-------MAKVADFGL  608 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-------~~kl~DFGl  608 (805)
                      |||+++|+|.+++..... .+++..++.++.|++.||+|||+   .+|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999965432 68999999999999999999999   9999999999999999888       799999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      ++....      .....++..|+|||++...  .++.++|||||||++|||++ |..|+......+..      ..+...
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~------~~~~~~  222 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------RFYQDQ  222 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH------HHHhcC
Confidence            986432      1233466789999999876  78999999999999999999 46777544322111      111110


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ..            .+......+.+++.+|+..+|.+||++.+|++.|+
T Consensus       223 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00            00111267889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.3e-35  Score=307.64  Aligned_cols=251  Identities=23%  Similarity=0.400  Sum_probs=200.7

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCC------chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ......+.+|++++++++|+||++++++|.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            356678999999999999988889999999876432      22345688999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++...  .++++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.....
T Consensus        81 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999999654  368899999999999999999999   89999999999999999999999999998754221


Q ss_pred             C----CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          616 D----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       616 ~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      .    .........|+..|+|||++.+..++.++|||||||+++||++|+.||.........  .    .......    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~----~~~~~~~----  225 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--F----YIGAHRG----  225 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--H----HhhhccC----
Confidence            1    111123456889999999999988999999999999999999999999754322111  0    0000000    


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+.    .+......+.+++.+|++.+|.+||++.+++.
T Consensus       226 ~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 LMPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111    12233456788999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.2e-35  Score=320.02  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=196.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .......+.+|..++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999876 5789999987642   2233456788999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-
Confidence            9999999999996532 368999999999999999999999   99999999999999999999999999999765331 


Q ss_pred             CcceeecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      .........||+.|+|||++.+     +.++.++|||||||+||||++|+.||......+.      ...........  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~--  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERF--  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCcc--
Confidence            1112234579999999999875     5678999999999999999999999975433221      11111111000  


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCC--CCCHHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVD--RPSMGDVLWN  732 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPsm~evl~~  732 (805)
                         .+... ..+....+.+++.+|+...+.+  |+++++++++
T Consensus       228 ---~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 ---QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               00000 1123456778888888765443  4677777643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.6e-35  Score=314.06  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=203.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .+|...+.||.|++|.||+|... +++.|++|.+........+.+.+|+++++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            45788889999999999999764 68999999887665555678899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...   .+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            999999988543   58999999999999999999999   9999999999999999999999999999876433211  


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||.+.+..++.++|||||||++|||++|+.||....+.+...  .    ... ....     .+  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~--~----~~~-~~~~-----~~--~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----IAT-NGTP-----EL--Q  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHh-cCCc-----cc--C
Confidence            1234568889999999998889999999999999999999999997654332211  0    000 0000     00  0


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+......+.+++.+||+.+|.+||++.+++.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11223446788999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.6e-35  Score=318.09  Aligned_cols=255  Identities=23%  Similarity=0.270  Sum_probs=195.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...++||+|+||.||+++.+ +++.+|+|.+...   .......|..|+.++..++|+||+++.+++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36788899999999999999876 4788999987542   2223455888999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.... .
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~-~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-D  155 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc-C
Confidence            9999999999996532 368999999999999999999999   9999999999999999999999999999875432 1


Q ss_pred             CcceeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      .........||+.|+|||++.     ...++.++|||||||+||||++|+.||......+.      ............ 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~-  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQ-  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcccc-
Confidence            122233457999999999986     34688999999999999999999999975432221      111111110000 


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcC--CCCCCCHHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADF--GVDRPSMGDVLWN  732 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~--p~~RPsm~evl~~  732 (805)
                      + +.    ........+.+++.+|+..+  +..|+++.|++++
T Consensus       229 ~-p~----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 F-PA----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             C-CC----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0 00    01123445677788877543  4446889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-35  Score=310.17  Aligned_cols=247  Identities=29%  Similarity=0.397  Sum_probs=202.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|...+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|++++++++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5667789999999999999876 58899999876543 344577899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...   .+++..++.++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++......  .
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            999999998654   68999999999999999999999   899999999999999999999999999998754321  1


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||++.+..++.++||||||+++|||+||+.||....+....      .. .....     .+.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~-~~~~~-----~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FL-IPKNN-----PPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HH-hhhcC-----CCCCccc
Confidence            223456888999999999888999999999999999999999999754322211      00 01111     1111111


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                         .....+.+++.+|+..+|++||+++++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               13456888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.4e-35  Score=308.90  Aligned_cols=255  Identities=30%  Similarity=0.412  Sum_probs=199.4

Q ss_pred             CcccceEeeeCceEEEEEEec----CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC------
Q 003659          463 FDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------  530 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  530 (805)
                      |...++||+|+||.||+|.+.    .++.||||++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999753    3688999987654  3345677899999999999999999999885432      


Q ss_pred             eEEEEEEeccCCcccccccCC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          531 EMILIYEYMENGTLKGHLYGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                      ..++++||+.+|+|.+++...    ....+++...++++.|++.||+|||+   .+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            347889999999998887432    22358899999999999999999999   89999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |++|+......+   +..+..   ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~---~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI---KG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHH---cC
Confidence            99986543221111223345678999999998889999999999999999999 888886543322   222111   11


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ...          .........+.+++.+|++.+|++||++.++++.|+.+
T Consensus       232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            100          01123356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.6e-35  Score=315.30  Aligned_cols=261  Identities=22%  Similarity=0.353  Sum_probs=199.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            45778889999999999999876 57899999876443 23345678899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      ++ ++|.+++.... ..+++..+..++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++......  
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            97 58988886543 468999999999999999999999   999999999999999999999999999997643211  


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh---cCCcccccC-
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN---KGQLDQIID-  693 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-  693 (805)
                      .......++..|+|||.+.+ ..++.++|||||||+++||+||++||......+....   ......   ......+.+ 
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSN  235 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCChhhchhhhcc
Confidence            11223457889999999865 4578999999999999999999999976543322111   111100   000000000 


Q ss_pred             --------ccccC----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          694 --------PTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 --------~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                              +....    ...+.....+.+++.+||+.+|.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                    10000    011223456789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=317.14  Aligned_cols=255  Identities=23%  Similarity=0.264  Sum_probs=194.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.|.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36788899999999999999876 5899999987642   2233566889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-
Confidence            9999999999986432 468999999999999999999999   99999999999999999999999999998754321 


Q ss_pred             CcceeecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      .........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+.      ............+
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  229 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF  229 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence            1112233569999999999863     4578899999999999999999999975432221      1111111110010


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhc--CCCCCCCHHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLAD--FGVDRPSMGDVLWN  732 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPsm~evl~~  732 (805)
                       .+ .    .......+.+++.+|+..  ++..||++.+++..
T Consensus       230 -~~-~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 -PP-D----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -CC-c----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             00 0    011234566677776643  44447899888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.5e-35  Score=307.07  Aligned_cols=247  Identities=30%  Similarity=0.435  Sum_probs=199.5

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|...+.||+|+||.||+|.. .++.||+|......  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3467778999999999999975 47889999876543  346789999999999999999999998664 4789999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++.......+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++.....     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            9999999976655578999999999999999999999   99999999999999999999999999998754321     


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......+..|+|||++.+..++.++|||||||+++||++ |+.||......+..      .. ...+.         ...
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~-~~~~~---------~~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK------EC-VEKGY---------RME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH------HH-HhCCC---------CCC
Confidence            112234567999999998899999999999999999998 99998754432211      11 11111         001


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .....+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            112234567899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.7e-35  Score=305.74  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=203.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|+..+.||+|+||.||+++.. +++.+|+|++...  .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4677889999999999999765 5889999987643  233456889999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++.......+++.++++++.|++.||+|||+   .+++|+||+|+|||++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            999999999876554568999999999999999999999   8999999999999999999999999999976533111 


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                       ......|+..|+|||++.+...+.++|||||||+++||++|+.|+......+.      ...... +..         .
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~~---------~  219 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR-GSY---------P  219 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc-CCC---------C
Confidence             12234588899999999988999999999999999999999999875432221      111111 110         0


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+......+.+++.+|++.+|.+||+|.||++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            112233556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-34  Score=304.51  Aligned_cols=250  Identities=31%  Similarity=0.501  Sum_probs=201.9

Q ss_pred             cccceEeeeCceEEEEEEecC-----CcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          464 DESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ...+.||+|+||.||+++..+     +..||+|.+...... ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            455789999999999998764     388999998765443 56789999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++++|.+++.......+++.+++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999976543338999999999999999999999   8999999999999999999999999999986543211


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      .. .....++..|+|||.+.+..++.++||||||++++||++ |++|+........   ....    ..+..        
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~--------  222 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYL----KKGYR--------  222 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcCCC--------
Confidence            11 112347789999999988889999999999999999998 7888865322221   1111    11110        


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                       ..........+.+++.+|+..+|.+||++.|+++.|
T Consensus       223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 -LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             011122356688899999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.5e-34  Score=306.59  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=191.7

Q ss_pred             eEeeeCceEEEEEEecCC---cEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          468 VIGIGGFGKVYKGELNDG---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      .||+|+||.||+|+..++   ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            699999999999975433   356677766443 3456789999999999999999999999999999999999999999


Q ss_pred             ccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          544 LKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       544 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |.+++....  ...+++..++.++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997532  2456778889999999999999999   89999999999999999999999999998643221111122


Q ss_pred             ecccccccccChhhhcc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          622 TAVKGSFGYLDPEYFRR-------QQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~-------~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ....++..|+|||++..       ..++.++|||||||++|||+++ ..|+....+.+.      ...... +......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHh-hcccccCC
Confidence            34567889999999753       2457899999999999999974 667764433221      111111 12223334


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      +.+...    ....+.+++..|+ .+|++||++++|++.|.
T Consensus       232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            443322    2345777888999 57999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-36  Score=318.94  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|...+-||.|.||.||.|+.. +.+.||||++.-..   ...+.++..|++.|.+++|||++.+-||+......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3555667999999999999765 67899999987553   3447789999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      ||- |+-.+.|.-.+ ++|-..++..|+.+.+.||+|||+   .+.||||||+.||||++.+.+||+|||.|.....   
T Consensus       107 YCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            995 57777664332 578899999999999999999999   9999999999999999999999999999876543   


Q ss_pred             cceeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          618 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                         ....+||+.|||||++.   .++|+-|.||||||++..||.-.++|+..+..-..   .....   ..      -.|
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIA---QN------esP  243 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIA---QN------ESP  243 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHH---hc------CCC
Confidence               45678999999999974   58999999999999999999999999875543211   11111   11      112


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+.   .+++...|..++..||+.-|.+|||..+++.
T Consensus       244 tLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 TLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            332   4678889999999999999999999988764

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8e-35  Score=308.49  Aligned_cols=253  Identities=23%  Similarity=0.382  Sum_probs=201.0

Q ss_pred             CCcccceEeeeCceEEEEEEecC--CcEEEEEEcCCC----------CchhHHHHHHHHHHHhc-CCCCceEEEEEEEcc
Q 003659          462 NFDESWVIGIGGFGKVYKGELND--GTKVAVKRGNPR----------SQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDE  528 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  528 (805)
                      +|...+.||+|+||.||+|..+.  ++.+|+|.+...          ......++.+|+.++.+ ++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36677899999999999998765  688999976532          22345667889998875 799999999999999


Q ss_pred             CCeEEEEEEeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeec
Q 003659          529 KNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADF  606 (805)
Q Consensus       529 ~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DF  606 (805)
                      ++..++||||+++++|.+++..  .....+++..+++++.|++.||.|||+  ..+++|+||||+|||+++++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999988743  223468999999999999999999995  257999999999999999999999999


Q ss_pred             CCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003659          607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG  686 (805)
Q Consensus       607 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (805)
                      |++.......   ......|+..|+|||++.+..++.++||||||+++|||++|+.|+........      ...... +
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~-~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE-A  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh-c
Confidence            9998654322   23455688999999999988899999999999999999999999864432211      111111 1


Q ss_pred             CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          687 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       687 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                      ..    .+..    .......+.+++.+|++.+|++||++.||.++++
T Consensus       229 ~~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10    1111    1122456888999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-35  Score=326.58  Aligned_cols=261  Identities=23%  Similarity=0.219  Sum_probs=198.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEec---CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..+|...+.||+|+||.||++...   .+..||+|.+...     +.+.+|+++|++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            356889999999999999999653   3578999987643     23468999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      |++. ++|.+++..  ...+++.+++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9996 688888833  3479999999999999999999999   899999999999999999999999999997654322


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHhhcCCcc--c---
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQNKGQLD--Q---  690 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~--~---  690 (805)
                      .........||..|+|||++....++.++|||||||+||||++|+.||......... .+..... ........  .   
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccc
Confidence            222233567999999999999999999999999999999999999998654322111 1111111 00000000  0   


Q ss_pred             -----c---cCccccCCC--C-----hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          691 -----I---IDPTLAGKI--R-----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       691 -----~---~d~~l~~~~--~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                           .   ........+  +     ......+.+++.+||+.+|++||++.|++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 0   000000000  0     1123457788999999999999999999854

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-34  Score=312.67  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=203.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ..+|...+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            356888889999999999999864 6899999988765555567788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++..   ..+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++.......  
T Consensus        98 ~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--  169 (297)
T cd06656          98 LAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  169 (297)
T ss_pred             cCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence            999999999854   358899999999999999999999   899999999999999999999999999987643211  


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......+++.|+|||.+.+..++.++|||||||++++|++|+.||....+......       .....     .+.+  
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~~~-----~~~~--  235 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG-----TPEL--  235 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------eccCC-----CCCC--
Confidence            112345688899999999998899999999999999999999999965432211000       00000     0000  


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+......+.+++.+|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111223455788999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=323.02  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=203.5

Q ss_pred             eEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccc
Q 003659          468 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG  546 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  546 (805)
                      +||+|.||+||.|+..+ ...+|||.+........+-+..|+.+-++|+|+|||+.+|.|.+++.+-+.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            79999999999998764 66899999888777777788999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC-CCCcEEEeecCCCCCCCCCCCcceeec
Q 003659          547 HLYGSGLPSL--SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTA  623 (805)
Q Consensus       547 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld-~~~~~kl~DFGla~~~~~~~~~~~~~~  623 (805)
                      .|..+ ..+|  ++.++--...||++||.|||+   ..|||||||-+|||++ -.|.+||+|||-++.+...+  ..+.+
T Consensus       662 LLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  662 LLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            99653 3456  677788889999999999999   9999999999999995 57899999999998764322  23456


Q ss_pred             ccccccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          624 VKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       624 ~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ..||..|||||++..+  .|..++|||||||++.||.||++||..........        .+-|    +  -.....++
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVG----m--yKvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVG----M--YKVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhc----c--eecCCCCc
Confidence            7899999999999865  58899999999999999999999997543222110        0001    0  01123556


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+...+...++++|+..+|.+||++.++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            777888999999999999999999999985

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-34  Score=310.24  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=197.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||+|+.. +++.||+|++....  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            3667789999999999999875 58999999876432  23356788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      ++ ++|.+++.... ...+++.+++.++.|+++||+|||+   .+++||||||+|||+++++.+||+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 68888875432 3568999999999999999999999   99999999999999999999999999998754321  


Q ss_pred             cceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--------cC--
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--------KG--  686 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~~--  686 (805)
                      ........++..|+|||++.+. .++.++|||||||+++||+||++||......+..  ......+..        ..  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence            1112334578899999998654 5789999999999999999999999754332111  110000000        00  


Q ss_pred             -----CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          687 -----QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       687 -----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                           .........+. ........++.+++.+||+.+|.+||++.+|+.
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 00000000000 001123456789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-35  Score=326.21  Aligned_cols=251  Identities=22%  Similarity=0.335  Sum_probs=195.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|+..+.||+|+||.||+++.+ +++.||+|++...   .......+..|++++.+++|+||+++++++..++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            35788899999999999999876 5899999987643   2334567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999998654  368999999999999999999999   999999999999999999999999999987532111


Q ss_pred             C---------------------------------cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 003659          617 Q---------------------------------THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV  663 (805)
Q Consensus       617 ~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p  663 (805)
                      .                                 ........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                 0011235699999999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC---HHHHH
Q 003659          664 IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS---MGDVL  730 (805)
Q Consensus       664 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---m~evl  730 (805)
                      |....+.+...      .......  .+.   ....  ......+.+++.+|+ .+|.+|++   +.|++
T Consensus       236 f~~~~~~~~~~------~i~~~~~--~~~---~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         236 FCSETPQETYR------KVMNWKE--TLV---FPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             CCCCCHHHHHH------HHHcCCC--cee---cCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            97654432211      1110000  000   0000  012345666777766 49999986   45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.8e-35  Score=335.24  Aligned_cols=266  Identities=20%  Similarity=0.248  Sum_probs=195.7

Q ss_pred             HHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCC------CceEEEEEEEc
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH------RHLVSLIGYCD  527 (805)
Q Consensus       455 el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~  527 (805)
                      ++...+++|...++||+|+||+||+|... .++.||||++.... ....++..|++++.+++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445678999999999999999999875 57899999986432 223455677777777754      45899999886


Q ss_pred             cC-CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-------
Q 003659          528 EK-NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-------  599 (805)
Q Consensus       528 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-------  599 (805)
                      .. ...++|||++ +++|.+++...  ..+++.++..|+.||+.||+|||+  ..+||||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence            54 5789999988 67888888654  369999999999999999999996  14899999999999998765       


Q ss_pred             ---------cEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 003659          600 ---------MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR  670 (805)
Q Consensus       600 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (805)
                               .+||+|||++.....     ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||+.....
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998864221     234567999999999999999999999999999999999999999865543


Q ss_pred             hhhhHHHHH---------HHH--------h-hcCCcccccCccc----cC-C-C-ChhHHHHHHHHHHhchhcCCCCCCC
Q 003659          671 EMVNLAEWA---------MKW--------Q-NKGQLDQIIDPTL----AG-K-I-RPDSLRKFGETAEKCLADFGVDRPS  725 (805)
Q Consensus       671 ~~~~l~~~~---------~~~--------~-~~~~~~~~~d~~l----~~-~-~-~~~~~~~l~~l~~~Cl~~~p~~RPs  725 (805)
                      +...+....         ..+        . ..+.+....++..    .. . . .......+.+++.+||+.||.+|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            333222111         000        0 0000000011100    00 0 0 0011345789999999999999999


Q ss_pred             HHHHHH
Q 003659          726 MGDVLW  731 (805)
Q Consensus       726 m~evl~  731 (805)
                      +.|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999985

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-35  Score=322.09  Aligned_cols=192  Identities=23%  Similarity=0.318  Sum_probs=165.2

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ...+|...+.||+|+||.||+|+.. +++.||+|.....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            3457999999999999999999876 4788999975432      23569999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      ++. ++|.+++.... ..++|.+++.|+.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....   
T Consensus       138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  209 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---  209 (357)
T ss_pred             ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence            995 68888885433 469999999999999999999999   8999999999999999999999999999975322   


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI  664 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~  664 (805)
                      ........||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            11123456899999999999999999999999999999999976554

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-34  Score=306.54  Aligned_cols=250  Identities=25%  Similarity=0.407  Sum_probs=194.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-----chhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM  532 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  532 (805)
                      .+|...++||+|+||.||+|... .+..||+|++....     .+..+.+.+|+.++++++|+||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36788899999999999999765 58899999875432     2335678899999999999999999998864  4678


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++++||+++++|.+++....  .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999986543  58999999999999999999998   89999999999999999999999999998764


Q ss_pred             CCCCC-cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          613 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ..... ........++..|+|||++.+..++.++|||||||++|||++|+.||.........      .......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----
Confidence            32111 11112345888999999999989999999999999999999999999754221111      1110000     


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+    .++......+.+++ +|+..+|++||+++||+.
T Consensus       226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111    11222234455555 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-34  Score=307.63  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++++.|+||+++++++......++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4556678999999999999875 58899999876442 345678899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++..   .++++.+...++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          85 GGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            99999999854   358899999999999999999999   899999999999999999999999999997653321  1


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......++..|+|||++.+...+.++|||||||+++||+||+.|+....+......                +.......
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----------------~~~~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL----------------IPKNNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------hhcCCCCC
Confidence            12334678899999999988899999999999999999999999875443221110                00011112


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ........+.+++.+||+.+|.+||++.+++..
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            234556778999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.4e-35  Score=310.65  Aligned_cols=261  Identities=27%  Similarity=0.394  Sum_probs=206.8

Q ss_pred             ccCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEc
Q 003659          450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD  527 (805)
Q Consensus       450 ~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  527 (805)
                      +.++.++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|...... ....++..|+.++.++ +|+||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            4566777778889999999999999999999875 58899999876543 3346788999999998 6999999999984


Q ss_pred             ------cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          528 ------EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       528 ------~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                            .....+++|||+++|+|.+++.......+++..++.++.|+++||+|||+   .+++|+||||+||++++++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCE
Confidence                  34678999999999999999876555568899999999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA  676 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  676 (805)
                      +|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....+...... 
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-  237 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence            9999999875432111  123456889999999975     34678899999999999999999999965432221110 


Q ss_pred             HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          677 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       677 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                           . ..     ...+.+   ........+.+++.+||+.+|.+||++.|+++
T Consensus       238 -----~-~~-----~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 -----I-PR-----NPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -----H-hh-----CCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                 0 00     001111   11233457899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-34  Score=310.14  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=202.2

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +.|...+.||+|+||.||+|+.. +++.+++|.+........+.+.+|++++++++|+|++++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            45677789999999999999876 48899999988777667788999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|..++.... ..+++.+++.++.|++++|+|||+   .+++||||||+||+++.++.+||+|||++......  ..
T Consensus        92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999988875443 468999999999999999999999   89999999999999999999999999998753221  11


Q ss_pred             eeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          620 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ......++..|+|||++.     ...++.++|||||||++|||++|++|+....+...      ........      .+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~------~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCC------Cc
Confidence            123456888999999984     34568899999999999999999999865432211      11111110      01


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..  ..+......+.+++.+|++.+|++||++.++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11  111233456889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-34  Score=305.00  Aligned_cols=248  Identities=26%  Similarity=0.401  Sum_probs=198.8

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc---------hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  532 (805)
                      |.....||+|++|.||+|... +++.+|+|.+.....         +..+.+.+|++++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            556679999999999999765 578999997764322         1235688999999999999999999999999999


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999654  468999999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCC----cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          613 PEIDQ----THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       613 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      .....    ........|+..|+|||.+.+..++.++|||||||+++||++|+.||........  ..    ...     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~-----  225 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IF----KIG-----  225 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--HH----HHh-----
Confidence            42111    1111234588899999999988899999999999999999999999975422111  00    000     


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ....+.    .+......+.+++.+||+.+|.+||++.|+++
T Consensus       226 -~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 -ENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -ccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             011111    22233566888999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.3e-35  Score=308.42  Aligned_cols=252  Identities=25%  Similarity=0.353  Sum_probs=200.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45667779999999999999765 58899999887665555667889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...  ..+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          89 GGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            999999988544  368999999999999999999999   89999999999999999999999999998754321  11


Q ss_pred             eeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          620 VSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.|+....+.....      .... ..   ...+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~-~~---~~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTK-SN---FQPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhc-cC---CCCCcc
Confidence            123456899999999974   4568899999999999999999999986443322110      0000 00   001111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...  ......+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            110  122345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-34  Score=304.85  Aligned_cols=246  Identities=28%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-----chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      |...+.||+|++|.||+|... +++.|++|.+....     .+..+.+.+|+++++.++|+||+++++++..+...++||
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            566789999999999999876 78999999865433     234678899999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++...  ..+++..++.++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          82 ELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            999999999998654  368999999999999999999999   899999999999999999999999999987643322


Q ss_pred             CcceeecccccccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                         ......|+..|+|||.+.... ++.++|+||||++++||++|+.||......+..      .........       
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~-------  220 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKEL-------  220 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccC-------
Confidence               223456889999999987766 899999999999999999999999754322111      111110111       


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ..++......+.+++.+|++.+|.+||++.+++.
T Consensus       221 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 --PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              1112233456788999999999999999999974

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-34  Score=315.45  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=195.0

Q ss_pred             cceEeee--CceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          466 SWVIGIG--GFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       466 ~~~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      .++||+|  +|++||+++.+ +|+.||+|++....  ....+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4589999  78999999775 68999999987542  3334567789999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc--
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--  618 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~--  618 (805)
                      +|+|.+++.......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.++++||+...........  
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            9999999965544569999999999999999999999   89999999999999999999999999865432111100  


Q ss_pred             ---ceeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          619 ---HVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       619 ---~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                         .......++..|+|||++.+  ..++.++|||||||+++||++|+.||........  .....     .+.+...++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~~  232 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLLD  232 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCcccccc
Confidence               01122346778999999975  4689999999999999999999999975332111  00000     000000000


Q ss_pred             -------------------ccc-----------------cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 -------------------PTL-----------------AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                                         ...                 ...........+.+++.+||+.+|.+|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                               000                 001112234568899999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-34  Score=319.89  Aligned_cols=263  Identities=19%  Similarity=0.240  Sum_probs=198.6

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------  529 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  529 (805)
                      ..++|...+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568989999999999999999765 5889999988753  233456788999999999999999999987543      


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999975 6666653    248899999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH-------------
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-------------  676 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-------------  676 (805)
                      +....   ........||..|+|||++.+..++.++|||||||+++||++|+.||......+.....             
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            86432   12223457899999999999999999999999999999999999999754322211100             


Q ss_pred             ---HHHHHHhhc-CCcccccCccc--------cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          677 ---EWAMKWQNK-GQLDQIIDPTL--------AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       677 ---~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                         .....+... .....+..+..        ...........+.+++.+||+.+|.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               000011100 00000000000        001111234567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.2e-35  Score=311.28  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=204.7

Q ss_pred             cCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEc-
Q 003659          451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD-  527 (805)
Q Consensus       451 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~-  527 (805)
                      +.+..+..+.++|...+.||+|+||.||+++.. +++.+|+|.+..... ...++.+|+.+++++ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445666778889999999999999999999775 578999998765332 245688999999999 6999999999883 


Q ss_pred             ----cCCeEEEEEEeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          528 ----EKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       528 ----~~~~~~lV~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                          .++..++||||+++++|.+++..  .....+++..+..++.|+++||.|||+   .+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                44678999999999999998753  223468999999999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA  676 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  676 (805)
                      ||+|||+++......  .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+....+...  +.
T Consensus       164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF  239 (286)
T ss_pred             EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh
Confidence            999999987643211  11234468999999999853     4578999999999999999999999875432211  00


Q ss_pred             HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          677 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       677 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      .    . .........++       ......+.+++.+|++.+|++||++.|+++.+
T Consensus       240 ~----~-~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 K----I-PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             h----c-cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0    0 00000011111       11234688999999999999999999998653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-34  Score=305.83  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=200.0

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC----------chhHHHHHHHHHHHhcCCCCceEEEEEEEccCC
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS----------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN  530 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  530 (805)
                      +|...+.||+|+||.||+|... +++.+|+|.+....          ....+.+.+|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566789999999999999765 58899999765321          112356788999999999999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998665  368999999999999999999999   899999999999999999999999999997


Q ss_pred             CCCCCCCcceeecccccccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ...............|+..|+|||.+....  ++.++||||||++++||++|+.|+......+     .+ ...... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~~~-~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKLGNK-RS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHhhcc-cc
Confidence            654322222234456889999999987654  8899999999999999999999986432211     11 010000 01


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ...+.+    ....+....+.+++.+|++.+|.+||++.+|++.
T Consensus       230 ~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111    1222345678889999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-34  Score=310.47  Aligned_cols=261  Identities=26%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             cCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEcc
Q 003659          451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE  528 (805)
Q Consensus       451 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  528 (805)
                      +++.++..++++|...+.||+|+||.||++... +++.+|+|.+..... ...++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455667778899999999999999999999875 588999998865432 245678899999999 89999999999864


Q ss_pred             C-----CeEEEEEEeccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          529 K-----NEMILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       529 ~-----~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      .     +..++||||+++++|.+++...  ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence            3     4689999999999999988532  23468999999999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA  676 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  676 (805)
                      ||+|||+++.......  ......|+..|+|||++...     .++.++|||||||++|||++|+.|+....+.+.  +.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            9999999886443111  12335688999999998643     368999999999999999999999975433221  11


Q ss_pred             HHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          677 EWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       677 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+    . ......+.+       .......+.+++.+|++.+|++||++.|+++
T Consensus       244 ~~----~-~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 KI----P-RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HH----h-cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            11    1 111111111       1223456889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=309.37  Aligned_cols=252  Identities=28%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||+|+.. ++..+|+|..........+.|.+|++++++++|+||+++++++..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45777789999999999999875 58899999987776666788999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.... ..+++.++..++.|++.||+|||+   .+|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999886543 469999999999999999999999   899999999999999999999999999987643211  1


Q ss_pred             eeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          620 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+......+.  .    ..... ..     .+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~-~~-----~~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--L----LKILK-SE-----PP  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--H----HHHhc-CC-----CC
Confidence            223456889999999975     34577899999999999999999999975433221  1    11111 10     01


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .+  ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11  0112234567889999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.3e-34  Score=318.68  Aligned_cols=263  Identities=21%  Similarity=0.250  Sum_probs=197.5

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------  529 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  529 (805)
                      ..++|...+.||+|+||.||+++.. .|+.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3577889999999999999999865 5899999988643  234456788999999999999999999998543      


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            357999999975 5666553    247889999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh---------------
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN---------------  674 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~---------------  674 (805)
                      +....   ........||..|+|||++.+..++.++|||||||++|||++|+.||......+...               
T Consensus       171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            76422   112334578999999999999999999999999999999999999997543221100               


Q ss_pred             -HHHHHHHHhhc-CCcc-----cccCcccc---CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          675 -LAEWAMKWQNK-GQLD-----QIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       675 -l~~~~~~~~~~-~~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       +......+... ....     +.......   ..........+.+++.+||+.+|.+|||+.|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence             00000001000 0000     00000000   00011123567899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=303.44  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++|...+.||+|+||.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            46788889999999999999875 57889999887665556788999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.... ..+++.++..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.......  .
T Consensus        83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999886542 468999999999999999999999   899999999999999999999999999987643311  1


Q ss_pred             eeecccccccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          620 VSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ......++..|+|||.+...   .++.++||||||++++||+||+.|+....+.....  .     ......   ..+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~-----~~~~~~---~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--L-----ISKSNF---PPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HHhccC---CCccc
Confidence            12345688899999999776   88999999999999999999999997544322211  0     000000   00111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        .........+.+++.+|++.+|.+||++.+|+.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112234567899999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-34  Score=310.14  Aligned_cols=256  Identities=21%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45666779999999999999865 58899999766543 34467899999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++...  ..+++..+..++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999988653  368999999999999999999996  247999999999999999999999999998654221   


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhHHHHHHHHhhcCCcccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-----MVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                       ......|+..|+|||++.+..++.++|||||||+++||++|+.||......+     ...+..+........      .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence             1224568999999999988899999999999999999999999997544321     111222222211110      0


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      +.+.   ..+....+.+++.+|++.+|.+||++.|++++.
T Consensus       231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1110   112345688999999999999999999998654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4e-34  Score=305.74  Aligned_cols=264  Identities=23%  Similarity=0.276  Sum_probs=200.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|+..+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            35777889999999999999876 58999999876432  2234568899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |++++.|..++...  ..+++.+++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876443  358999999999999999999999   9999999999999999999999999999987543221


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH-HHHHHH-------h-hcCC
Q 003659          618 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EWAMKW-------Q-NKGQ  687 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~-------~-~~~~  687 (805)
                        ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+..... ......       . ....
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457889999999876 56789999999999999999999999755433221110 000000       0 0000


Q ss_pred             cccccCccccCCCC-----hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          688 LDQIIDPTLAGKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......+......+     +.....+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00000111000000     122456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-34  Score=302.51  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-----chhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-----QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM  532 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  532 (805)
                      ++|...++||+|+||.||+|... ++..||+|.+....     ....+.+.+|++++++++|+||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46788899999999999999875 58999999865321     2335678899999999999999999998865  3567


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||+++++|.+++...  ..+++...++++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            8999999999999998644  358899999999999999999999   89999999999999999999999999998754


Q ss_pred             CCCCCc-ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          613 PEIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       613 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........  ..    .....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~------  224 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQ------  224 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcC------
Confidence            321111 112234688999999999888899999999999999999999999864322111  10    00000      


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                         ......+......+.+++.+|+. +|.+||+++|+++
T Consensus       225 ---~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 ---PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence               00112233445567788889985 8999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.4e-34  Score=302.06  Aligned_cols=248  Identities=23%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||++... +++.+|+|.+...  .....+.+.+|++++++++|+|++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4677789999999999999765 5889999987654  234467889999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~~~~~~~~  617 (805)
                      +++++|.+++.......+++..+++++.++++||+|||+   .+++|+||||+||+++++ ..+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            999999999976555668999999999999999999999   899999999999999855 468999999998654321 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                        ......|+..|+|||.+.+..++.++||||||++++||++|+.|+.......      ........ ..         
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~~-~~---------  218 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMSG-TF---------  218 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHhc-CC---------
Confidence              1223568889999999998889999999999999999999999987543221      11111111 00         


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..........+.+++.+|++.+|.+||++.|++.
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0111223556889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=339.90  Aligned_cols=255  Identities=20%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeE
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEM  532 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~  532 (805)
                      ...++|...+.||+|+||.||+++.. .+..+|+|.+...  .......|..|+.+|++|+||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34567889999999999999999876 4778999987643  33446778999999999999999999998743  4578


Q ss_pred             EEEEEeccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccC----CCCeEeeccCCCcEEeCC---------
Q 003659          533 ILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY----AKAVIHRDVKSANILLDE---------  597 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~Dikp~NILld~---------  597 (805)
                      +|||||+++|+|.++|...  ....+++..++.|+.||+.||+|||+..    ..+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999998642  2246999999999999999999999832    145999999999999964         


Q ss_pred             --------CCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003659          598 --------NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPT  667 (805)
Q Consensus       598 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~  667 (805)
                              ...+||+|||+++.....   .......||+.|+|||++.+  ..++.++|||||||+||||+||+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    335899999999865321   12234579999999999854  46899999999999999999999999743


Q ss_pred             ChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          668 LPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       668 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ....     .....+...        +.+.   .......+.+++..||+.+|.+||++.|++.
T Consensus       247 ~~~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            2211     111111111        1110   0122456889999999999999999999985

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-34  Score=319.37  Aligned_cols=263  Identities=19%  Similarity=0.258  Sum_probs=197.9

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------  529 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  529 (805)
                      ..++|...+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3567888999999999999999765 5889999988653  234456788999999999999999999987543      


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999975 6777663    248899999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH---------HHH-
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA---------EWA-  679 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~-  679 (805)
                      +....   ........||..|+|||++.+..++.++|||||||+||||++|+.||......+.....         ++. 
T Consensus       174 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            86432   11223457899999999999999999999999999999999999999755432221110         000 


Q ss_pred             ------HHHh-hcCCcc-----cccCccc---cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          680 ------MKWQ-NKGQLD-----QIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       680 ------~~~~-~~~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                            ..+. ......     +.....+   ...........+.+++.+||+.+|.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  0000 000000     0000000   000111123467899999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.8e-34  Score=312.22  Aligned_cols=196  Identities=26%  Similarity=0.371  Sum_probs=159.9

Q ss_pred             cceEeeeCceEEEEEEec---CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeEEEEEEecc
Q 003659          466 SWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILIYEYME  540 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~  540 (805)
                      .++||+|+||.||+|+..   +++.+|+|.+.....  ...+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999864   467899998865432  3457889999999999999999998843  456899999986


Q ss_pred             CCcccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe----CCCCcEEEeecCCC
Q 003659          541 NGTLKGHLYGS-------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLS  609 (805)
Q Consensus       541 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----d~~~~~kl~DFGla  609 (805)
                      + +|.+++...       ....+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 777766421       12358999999999999999999999   899999999999999    46679999999999


Q ss_pred             CCCCCCCC-cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003659          610 KTGPEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPT  667 (805)
Q Consensus       610 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~  667 (805)
                      +....... ........||+.|+|||++.+ ..++.++||||+||+++||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            86543211 112234678999999999876 46899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.4e-34  Score=311.32  Aligned_cols=195  Identities=25%  Similarity=0.374  Sum_probs=159.7

Q ss_pred             ceEeeeCceEEEEEEec---CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEc--cCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN---DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD--EKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~  541 (805)
                      .+||+|+||.||+|+.+   ++..||+|.+.....  ...+.+|++++++++||||+++++++.  .+...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999865   357899998865432  346789999999999999999999884  45678999999875


Q ss_pred             CcccccccCC-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe----CCCCcEEEeecCCCC
Q 003659          542 GTLKGHLYGS-------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK  610 (805)
Q Consensus       542 gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl----d~~~~~kl~DFGla~  610 (805)
                       +|.+++...       ....+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             776665321       12358899999999999999999999   899999999999999    567799999999998


Q ss_pred             CCCCCCCc-ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003659          611 TGPEIDQT-HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPT  667 (805)
Q Consensus       611 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~  667 (805)
                      ........ .......||..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            65432211 11234578999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1e-34  Score=310.38  Aligned_cols=264  Identities=24%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...++||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            35777889999999999999886 589999998764322  235678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++++|.++....  ..++|.+++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998876443  358999999999999999999999   899999999999999999999999999987643322 


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh-hHHHHHHHHh-------hcCC-
Q 003659          618 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLAEWAMKWQ-------NKGQ-  687 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~-------~~~~-  687 (805)
                       .......++..|+|||++.+ ..++.++||||||++++||++|++|+......+.. .+..+...+.       .... 
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             12234567889999999875 45788999999999999999999998754332211 1111100000       0000 


Q ss_pred             cccccCccccC-----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          688 LDQIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......+....     ...+.....+.+++.+|++.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00000000000     011233566899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=308.19  Aligned_cols=264  Identities=21%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|+..+.||+|+||.||+|..+ +++.||+|++...  .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            5778889999999999999876 5889999987653  233457789999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      ++++.|..++...  ..+++.+++.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            9987776655332  458999999999999999999999   8999999999999999999999999999987544222 


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH---------HHhhcCC-
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM---------KWQNKGQ-  687 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~-  687 (805)
                      .......++..|+|||++.+. .++.++||||||+++|||++|++|+......+.........         .+..... 
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122345678899999999887 88999999999999999999999997543322211111100         0000000 


Q ss_pred             ----cccccCcc-ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          688 ----LDQIIDPT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ----~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                          ..+..++. +...++......+.+++.+||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                00000000 000112223577899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.5e-34  Score=308.24  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=201.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36778889999999999999876 47899999876543   233567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999654  368999999999999999999999   899999999999999999999999999987421100


Q ss_pred             -------------CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 003659          617 -------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ  683 (805)
Q Consensus       617 -------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (805)
                                   .........|+..|+|||.+....++.++|||||||++|||++|+.||......+.      .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------~~~~~  229 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVI  229 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence                         00011234578899999999888899999999999999999999999975433221      11111


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .. .   ...+...    ......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       230 ~~-~---~~~~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SD-D---IEWPEGD----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hc-c---cCCCCcc----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11 0   0011111    1234557899999999999999997666655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-34  Score=311.23  Aligned_cols=250  Identities=22%  Similarity=0.263  Sum_probs=200.4

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc---hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      +|...+.||+|++|.||+|... +++.+|+|.+.....   ...+.+..|+++++.++|+||+++++++......++|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            5778889999999999999876 489999998775432   245678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+.+++|.+++.......+++..+..++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            9999999999876555679999999999999999999999   8999999999999999999999999999875432111


Q ss_pred             c---------------------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh
Q 003659          618 T---------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR  670 (805)
Q Consensus       618 ~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~  670 (805)
                      .                           .......||..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                           0111346888999999999888999999999999999999999999754332


Q ss_pred             hhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHH
Q 003659          671 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV  729 (805)
Q Consensus       671 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ev  729 (805)
                      ...     .. .         .+....-.........+.+++.+|++.+|++||++...
T Consensus       239 ~~~-----~~-~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~  282 (316)
T cd05574         239 ETF-----SN-I---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRG  282 (316)
T ss_pred             HHH-----HH-H---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhh
Confidence            111     00 0         01111000111145678999999999999999994444

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=329.28  Aligned_cols=253  Identities=26%  Similarity=0.374  Sum_probs=212.5

Q ss_pred             ccceEeeeCceEEEEEEe-cCC----cEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          465 ESWVIGIGGFGKVYKGEL-NDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ..++||+|+||+||||.+ ..|    .+||+|++... ..+...++++|+-.|.+|.||||++|+|+|.... +.||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            346999999999999965 233    47899977654 4556789999999999999999999999998765 8899999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      |+.|+|.+|++.++ ..+--+..+.|+.|||+||.|||+   +.++||||..+|||+.+...+||.|||+++.+...+..
T Consensus       779 mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             cccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999998754 468889999999999999999999   99999999999999999999999999999987764444


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      .......-.+.|||-|.+....++.++|||||||++||++| |..|++.....+..++.+       .+         .+
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g---------eR  918 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG---------ER  918 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc---------cc
Confidence            43444455678999999999999999999999999999998 889998776655544332       11         11


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      -..++-+..++..++.+||..|+..||+++++...+.+..+
T Consensus       919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            12346677889999999999999999999999988876654

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-34  Score=301.00  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=202.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEc--cCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD--EKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~  536 (805)
                      +|+..+.||.|+||.||++... +++.+|+|.+...  .....+++..|++++++++|+||+++++++.  .+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3667789999999999999765 6789999987643  3344667889999999999999999999874  345689999


Q ss_pred             EeccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccC--CCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          537 EYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       537 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ||+++++|.+++...  ....+++.+++.++.|++.||+|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998542  2357999999999999999999999322  289999999999999999999999999999875


Q ss_pred             CCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      .....  ......|+..|+|||.+.+..++.++||||||+++++|++|+.|+.......   +...    ...+.     
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~-----  226 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGK-----  226 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCC-----
Confidence            43221  1234568999999999998889999999999999999999999997543221   1111    11111     


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                          ....+......+.+++.+|++.+|.+||++.+|+++
T Consensus       227 ----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 ----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                112223445678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=301.91  Aligned_cols=248  Identities=24%  Similarity=0.374  Sum_probs=208.8

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      -|++..+||+|.||.|||+.++ .|+.+|||.....+  +.+++..|+.++++...|++|+.+|.+.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3566679999999999999776 59999999987654  47889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      -|+..+.++..+ ++|++.++..+.+..++||+|||.   ..-+|||||+.||||+-+|.+||+|||.+-.+..  .-..
T Consensus       112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK  185 (502)
T KOG0574|consen  112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK  185 (502)
T ss_pred             CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence            999999986544 689999999999999999999999   8889999999999999999999999999976532  2223


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ...+.||+.|||||++..-.|..++||||||++..||..|++|+....+-...-.            +.  ..|.-.-..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM------------IP--T~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM------------IP--TKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe------------cc--CCCCCCCCC
Confidence            4567899999999999999999999999999999999999999975443221100            00  011111123


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ++++...+.++++.||-..|++|-|+.++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            4677889999999999999999999988876

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.3e-34  Score=301.28  Aligned_cols=256  Identities=26%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+..++..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            36788889999999999999865 57899999886532 33567899999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      +++++|.+++..... ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999965432 568999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             c--ceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          618 T--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      .  .......|+..|+|||++... ..+.++|+|||||+++||++|+.||......+.  ...    .....      .+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~~------~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQND------PP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcCC------CC
Confidence            2  122345688999999998877 789999999999999999999999975433211  111    11110      01


Q ss_pred             cccCCC-ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+.... .......+.+++.+|++.+|++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111110 1234567889999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1e-34  Score=311.88  Aligned_cols=244  Identities=23%  Similarity=0.363  Sum_probs=198.3

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      ..||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            47999999999999875 58899999987665566678899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      +++...   .+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++........  ......
T Consensus       108 ~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~  179 (292)
T cd06658         108 DIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLV  179 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceee
Confidence            988432   58999999999999999999999   8999999999999999999999999999875432111  123356


Q ss_pred             ccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003659          626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL  705 (805)
Q Consensus       626 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  705 (805)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||............       ..     .+.+.+..  .....
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~-------~~-----~~~~~~~~--~~~~~  245 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------RD-----NLPPRVKD--SHKVS  245 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------Hh-----cCCCcccc--ccccC
Confidence            889999999998888999999999999999999999998754332211110       00     11111111  11223


Q ss_pred             HHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          706 RKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       706 ~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ..+.+++.+|++.+|.+||++.|+++.
T Consensus       246 ~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         246 SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            457788999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.2e-34  Score=307.65  Aligned_cols=261  Identities=22%  Similarity=0.297  Sum_probs=198.9

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|+..+.||.|++|.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4777889999999999999875 58899999876442  22346788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +. ++|.+++.......+++..++.++.|+++||+|||+   .+++||||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 689988876555679999999999999999999999   8999999999999999999999999999876432111 


Q ss_pred             ceeecccccccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc------------
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK------------  685 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------------  685 (805)
                       ......++..|+|||++.+.. ++.++||||||++++||+||+.||......+  .+.+........            
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHH
Confidence             123345688999999887644 6899999999999999999999997543321  111111100000            


Q ss_pred             ---CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          686 ---GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                         ..........+. ...+.....+.+++.+|++.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               000000000000 001122345778999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-34  Score=310.62  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=199.2

Q ss_pred             ccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          465 ESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      ....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3447999999999999875 689999999876555556778899999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeec
Q 003659          544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA  623 (805)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~  623 (805)
                      |.+++..   ..+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......  .....
T Consensus       105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~  176 (297)
T cd06659         105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS  176 (297)
T ss_pred             HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence            9998744   358999999999999999999999   899999999999999999999999999987543211  11234


Q ss_pred             ccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChh
Q 003659          624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD  703 (805)
Q Consensus       624 ~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  703 (805)
                      ..|+..|+|||++.+..++.++|||||||+++||++|+.||....+.+...      .. .....     +...  ....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~-~~~~~-----~~~~--~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK------RL-RDSPP-----PKLK--NAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-hccCC-----CCcc--ccCC
Confidence            568899999999998899999999999999999999999997543322111      10 11100     0000  0112


Q ss_pred             HHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          704 SLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       704 ~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ....+.+++.+|++.+|.+||++.++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            23457889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-33  Score=288.29  Aligned_cols=263  Identities=23%  Similarity=0.299  Sum_probs=217.2

Q ss_pred             HHHHHhcCCcccceEeeeCceEEEEEEec------CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEc
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD  527 (805)
Q Consensus       455 el~~at~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  527 (805)
                      ++..-..++....++-+|.||.||.|.+.      +.+.|-||..+.. ++-....+..|.-+|..+.|||+.++.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            34444456777778999999999999554      3456778866543 5556778899999999999999999999985


Q ss_pred             c-CCeEEEEEEeccCCcccccccC------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          528 E-KNEMILIYEYMENGTLKGHLYG------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       528 ~-~~~~~lV~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      + ....+.+|.++.-|+|..||..      +..+.++..+...++.|++.|++|||+   .++||.||.++|+++|+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhee
Confidence            4 5567889999999999999972      234568889999999999999999999   99999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHH
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  679 (805)
                      +||+|=.|+|.+-..+..........+..||+||.+....++.++|||||||+||||+| |+.|+....|.+...     
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-----  509 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-----  509 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH-----
Confidence            99999999998766666666666667789999999999999999999999999999998 789998777766432     


Q ss_pred             HHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          680 MKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       680 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                        +..+|.       ++  .-+.+++.++..++..||+..|++||+.++++.-|.+-
T Consensus       510 --ylkdGy-------Rl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  510 --YLKDGY-------RL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             --HHhccc-------ee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence              222221       11  22346788899999999999999999999999988764

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.7e-34  Score=306.23  Aligned_cols=261  Identities=21%  Similarity=0.286  Sum_probs=199.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCch-----hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQ-----GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      +|...+.||+|++|.||+|... +++.||||++......     ....+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3667789999999999999875 5899999988654322     245677899999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+ +|+|.+++.... ..+++..++.++.|+++||+|||+   .+++|+||||+|||++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999996544 469999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH--------hhcC
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW--------QNKG  686 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~  686 (805)
                      ..  ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++....+.+..  .......        ....
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhhhcc
Confidence            21  1223456788999999865 46789999999999999999998887654332211  1100000        0000


Q ss_pred             CcccccCccccC-----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          687 QLDQIIDPTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       687 ~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+..........     .........+.+++.+||+.+|.+||++.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000000     011233567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-33  Score=301.62  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      -|...+.||+|+||.||+|... +++.+|+|...... ....+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3566678999999999999765 68899999876433 344567889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++..   ..+++..+..++.|++.+|+|||+   .+++|+||||+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06641          85 GGGSALDLLEP---GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--h
Confidence            99999999854   358999999999999999999999   999999999999999999999999999987643311  1


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......++..|+|||.+.+...+.++|||||||+++||++|+.|+....+...      .... ....     .+    .
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~-~~~~-----~~----~  220 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLI-PKNN-----PP----T  220 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHH-hcCC-----CC----C
Confidence            12334678899999999988899999999999999999999999875432211      1111 1110     01    1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ........+.+++.+|++.+|.+||++.+++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            122334568889999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-34  Score=306.77  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=199.4

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|+..+.||+|+||.||++..+ ++..+|+|.+... .......+.+|++++++++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            4667789999999999999876 6899999987653 3344578899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          540 ENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       540 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+  ..+++||||||+||+++.++.+||+|||++......   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            9999999886532 2368999999999999999999996  248999999999999999999999999998754321   


Q ss_pred             ceeecccccccccChhhhccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                       ......++..|+|||.+.+.      .++.++|||||||+++||++|+.||...........   ... ...+.     
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~-~~~~~-----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---LSA-IVDGD-----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---HHH-HhhcC-----
Confidence             12334578899999998554      358899999999999999999999965322111110   000 00000     


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                          ....+......+.+++.+|++.+|.+||++.+++.
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                01122334566889999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-34  Score=306.17  Aligned_cols=262  Identities=23%  Similarity=0.292  Sum_probs=202.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||+|+.. +|+.||+|++....  ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            3667789999999999999875 68999999876543  33456789999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      + +++|.+++.... ..+++.+++.++.|+++||+|||+   .+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999986544 569999999999999999999999   8999999999999999999999999999987543221 


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC-----------
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG-----------  686 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------  686 (805)
                      .......|+..|+|||.+.+. .++.++||||||++++||++|++++......+.   ..+........           
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence            122345688999999998654 468999999999999999999888865433221   11111111000           


Q ss_pred             -CcccccCccc----cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          687 -QLDQIIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       687 -~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       ....+..+..    .....++....+.+++.+|++.+|.+||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000    001112334778999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.7e-34  Score=301.51  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=201.0

Q ss_pred             CCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCCC------chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      +|...+.||+|++|.||+|+. .+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467778999999999999976 468999999876432      1235678999999999999999999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-cEEEeecCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGP  613 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-~~kl~DFGla~~~~  613 (805)
                      ||||+++++|.+++...  .++++..++.++.|++.||+|||+   .+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999998654  368999999999999999999999   8999999999999998776 59999999987654


Q ss_pred             CCCC--cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          614 EIDQ--THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       614 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ....  ........|+..|+|||.+.+..++.++||||+|++++||++|+.|+..........   .......       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~-------  225 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIAS-------  225 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhc-------
Confidence            3211  111223468889999999988889999999999999999999999986432211111   1111000       


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        .......+......+.+++.+|++.+|.+||++.+++.
T Consensus       226 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         226 --ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              00111223344567889999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-33  Score=302.20  Aligned_cols=257  Identities=25%  Similarity=0.299  Sum_probs=201.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEcc--CCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~  536 (805)
                      ++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|..  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35778889999999999999875 588999998775432 446778999999999999999999998854  44789999


Q ss_pred             EeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||+++++|.+++..  .....+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753  223468999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hhhhhHHHHHHHHhhcCCccccc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP--REMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      ..    .....++..|+|||.+.+..++.++|||||||++|||++|+.|+.....  .....+..|....    ....+.
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  229 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK  229 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence            11    1234578899999999999999999999999999999999999975422  1112222222210    101110


Q ss_pred             CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      + ..  .........+.+++.+|++.+|.+||++.|+++
T Consensus       230 ~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 D-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             c-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0 00  001224567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-34  Score=305.42  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=196.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++|...+.||+|++|.||+|+.+ +++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56788889999999999999876 689999998765432 2234577899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++ +|.+++.... ..+++.....++.|+++||.|||+   .+++||||||+|||+++++.+||+|||+++....... 
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            985 9999886544 368999999999999999999999   8999999999999999999999999999875322111 


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhHHHHHHHHhhcCC------ccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTL-PREMVNLAEWAMKWQNKGQ------LDQ  690 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~------~~~  690 (805)
                       ......++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ..+................      ...
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1223346789999999875 458899999999999999999999996443 1111111100000000000      000


Q ss_pred             c-------c-CccccCCC-ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          691 I-------I-DPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       691 ~-------~-d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .       . ...+.... .......+.+++.+||+.+|.+||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            0       0 00000000 0011256788999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.1e-34  Score=299.80  Aligned_cols=249  Identities=24%  Similarity=0.409  Sum_probs=201.9

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|+||.||+|..+ +|..+|+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677789999999999999876 48899999876532  23456788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-cEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-~~kl~DFGla~~~~~~~~  617 (805)
                      +++++|.+++.......+++..++.++.|+++||+|||+   .+++|+||||+||++++++ .+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            999999999976554568999999999999999999999   8999999999999999885 56999999987654311 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                       .......|+..|+|||++.+..++.++||||||++++||++|+.|+......      ++...... +...        
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~--------  220 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYFA--------  220 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccCC--------
Confidence             1223346889999999998888999999999999999999999998644322      22222111 1111        


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ...+.....+.+++.+|++.+|++||++.|++.
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence             111223456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.6e-33  Score=294.00  Aligned_cols=248  Identities=28%  Similarity=0.455  Sum_probs=204.6

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            566789999999999999886 6889999998876655678899999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|.+++.... ..+++..+..++.|++++|++||+   .+++||||+|+||++++++.++|+|||.+........   .
T Consensus        82 ~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          82 GSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999986643 469999999999999999999999   9999999999999999999999999999987544221   2


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....++..|+|||.+.+...+.++||||||++++||++|+.|+..........      .... ........       .
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~~~~~~~~-------~  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIAT-NGPPGLRN-------P  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHh-cCCCCcCc-------c
Confidence            34568899999999998889999999999999999999999987543222111      0000 11111110       1


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......+.+++.+|++.+|.+||++.|+++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            112456889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=318.19  Aligned_cols=259  Identities=21%  Similarity=0.270  Sum_probs=195.0

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------  529 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  529 (805)
                      ..++|...+.||+|+||.||+|... +++.||||++....  ....+.+.+|+++|++++|+||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4567888899999999999999764 68899999886532  23345678999999999999999999887432      


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++++|++ +++|.+++..   ..+++..+..++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence            4578999988 6788887743   359999999999999999999999   99999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh-----
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-----  683 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  683 (805)
                      +.....     .....||..|+|||++.+ ..++.++|||||||+++||++|+.||......+.  +..+.....     
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~  238 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPE  238 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            864321     234568999999999876 5789999999999999999999999965432211  111100000     


Q ss_pred             -----hcC-------CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          684 -----NKG-------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       684 -----~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                           ..+       .+...-...+...+ ......+.+++.+||+.+|.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000       00000000000000 0112346789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-34  Score=310.86  Aligned_cols=252  Identities=24%  Similarity=0.326  Sum_probs=210.8

Q ss_pred             HhcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCc---hhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  533 (805)
                      ....|...+.||+|.||.||+++.+. |+.+|+|.+.....   ...+.+.+|+++|+++. |||||.+.+.++.....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34567777899999999999998875 99999998776543   23468899999999998 999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC----CcEEEeecCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN----FMAKVADFGLS  609 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~----~~~kl~DFGla  609 (805)
                      +|||++.+|.|.+.+...   .+++.....++.|++.+++|||+   .+|+||||||+|+|+...    +.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999665   39999999999999999999999   999999999999999543    57999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      .....   .......+||+.|+|||++....++..+||||+||++|.|++|.+||......+...       ....+.. 
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-  255 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence            98654   344677899999999999999999999999999999999999999998665433221       1111111 


Q ss_pred             cccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                           ......-+.....+.+++..|+..+|.+|+++.+++++
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 12222223456778899999999999999999999873

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=304.19  Aligned_cols=253  Identities=29%  Similarity=0.405  Sum_probs=200.5

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN------  530 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------  530 (805)
                      ++++|...+.||+|++|.||+|+.+ +++.+++|.+..... ..+++.+|+++++++ .|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4678999999999999999999875 578999998776543 346789999999999 6999999999996543      


Q ss_pred             eEEEEEEeccCCcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                      ..++||||+++++|.+++....  ...+++..+..++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            5899999999999999886533  4578999999999999999999999   8999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ  683 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (805)
                      +.......  .......|+..|+|||++..     ..++.++|||||||+|+||++|+.||....+...  +..    ..
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~  231 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----IP  231 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----hh
Confidence            87643211  11234568899999998753     3467899999999999999999999964322211  111    00


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ....     +.+  .........+.+++.+||..+|.+||++.|+++
T Consensus       232 -~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 -RNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -ccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             1100     111  111224567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-33  Score=296.61  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|...+.||+|++|.||+|+.. +++.|++|++..... ...+++.+|++++.+++|+|++++++++...+..++||||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5777889999999999999887 489999998876644 45678999999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...  ..+++..++.++.|+++||+|||+.  .+++||||+|+||+++.++.++|+|||++......... 
T Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-  156 (264)
T cd06623          82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-  156 (264)
T ss_pred             CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence            999999999654  4689999999999999999999962  68999999999999999999999999998865432211 


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                       .....++..|+|||.+.+..++.++||||||+++|||+||+.|+..........+..+..    ....     +    .
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~----~  222 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----P----S  222 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----C----C
Confidence             124568889999999999999999999999999999999999997554212222222211    1110     1    1


Q ss_pred             CChh-HHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          700 IRPD-SLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       700 ~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .... .+..+.+++.+|++.+|++||++.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1122 45678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-35  Score=317.74  Aligned_cols=236  Identities=24%  Similarity=0.291  Sum_probs=184.7

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcC---CCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      ||+|+||.||+|+.. +++.||||++....   ......+..|..++..+   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999876 58999999876432   12234455677777665   699999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...  ..+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            9999988644  468999999999999999999999   999999999999999999999999999987532211  123


Q ss_pred             ecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ....||..|+|||++.+. .++.++|||||||++|||+||+.||......+..      ... ..+..      .+..  
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~------~~i-~~~~~------~~~~--  218 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY------RNI-AFGKV------RFPK--  218 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH------HHH-HcCCC------CCCC--
Confidence            346799999999998764 4899999999999999999999999754332211      111 11110      1110  


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                       ......+.+++.+||+.+|.+||++.
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~  244 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAH  244 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence             11234577899999999999998543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-35  Score=288.91  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=204.0

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--------hhHHHHHHHHHHHhcC-CCCceEEEEEEEc
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQF-RHRHLVSLIGYCD  527 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  527 (805)
                      ..-++|...+.||.|..+.|-++..+ +|...|+|++.....        .-.++-.+|+.+|+++ .||+|+++.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34566788889999999999988665 588899997654321        1134456899999998 6999999999999


Q ss_pred             cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       528 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      ....+++|+|.|+.|.|.++|...  -.++++...+|+.|+.+|++|||.   ..||||||||+|||+|++.++||+|||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            999999999999999999999654  379999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      ++..+..   .......+||++|+|||.+..      ..|+...|+|++||+||.||.|.+||-...   .+-    ...
T Consensus       169 Fa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---Qml----MLR  238 (411)
T KOG0599|consen  169 FACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QML----MLR  238 (411)
T ss_pred             eeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHH----HHH
Confidence            9987654   333567899999999999864      357889999999999999999999995321   111    112


Q ss_pred             HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ...+|+. +.-.|..     .+......+++.+||+.||.+|.|++|++.+
T Consensus       239 ~ImeGky-qF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 MIMEGKY-QFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHhccc-ccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            2222221 1112221     2345568899999999999999999999974

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.2e-34  Score=307.17  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=197.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +.|...+.||+|+||.||+|+.. +++.||+|.+....   ....+++.+|+++++.++||||+++.++|..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45777789999999999999875 58999999876432   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||++ |+|.+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++.....  
T Consensus        95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--  167 (307)
T cd06607          95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--  167 (307)
T ss_pred             HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence            9997 57777664433 369999999999999999999999   8999999999999999999999999999876432  


Q ss_pred             CcceeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          617 QTHVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                          .....++..|+|||++.   ...++.++||||||+++|||+||++|+.........      ......+      .
T Consensus       168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~~~------~  231 (307)
T cd06607         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND------S  231 (307)
T ss_pred             ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhcCC------C
Confidence                12346788999999874   456889999999999999999999998654322211      0100000      0


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      +.+   ........+.+++.+||+.+|.+||++.+++.+
T Consensus       232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            111   112345678999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-34  Score=298.12  Aligned_cols=252  Identities=25%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|+..+.||+|.-|+||++++++ +...|+|++....   .+...+.+.|-+||+.+.||.++.|++.++.++..+||||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            34555689999999999999885 5899999987653   3445677889999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC---
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE---  614 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~---  614 (805)
                      ||+||+|...++.+..+.++...+.=.+..++-||+|||-   .|||.|||||+||||.++|++.|+||.|+..+..   
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            9999999999988888889999999999999999999999   9999999999999999999999999999753211   


Q ss_pred             ------------------------------CCCc---------------------ceeecccccccccChhhhccCCCCc
Q 003659          615 ------------------------------IDQT---------------------HVSTAVKGSFGYLDPEYFRRQQLTE  643 (805)
Q Consensus       615 ------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s~  643 (805)
                                                    ....                     ..+...+||-.|+|||++.+...+.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0000                     1123457999999999999999999


Q ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCC
Q 003659          644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR  723 (805)
Q Consensus       644 ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  723 (805)
                      +.|.|+|||+|||||.|+.||......+..               ..++-..+.-.-.++.+..+.++|++.|.+||.+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence            999999999999999999999876543321               12222222111123556778999999999999999


Q ss_pred             CC----HHHHHH
Q 003659          724 PS----MGDVLW  731 (805)
Q Consensus       724 Ps----m~evl~  731 (805)
                      ..    +.||-+
T Consensus       380 lg~~rGA~eIK~  391 (459)
T KOG0610|consen  380 LGSKRGAAEIKR  391 (459)
T ss_pred             hccccchHHhhc
Confidence            87    666643

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=300.74  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=198.9

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCC---CCceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  536 (805)
                      .|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            3666779999999999999864 6899999987654 3344677889999999997   999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++...   .+++..++.++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999988543   68999999999999999999999   999999999999999999999999999997654322


Q ss_pred             CcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                        .......|+..|+|||.+.++ .++.++|||||||++|||++|+.||.........      .. ..     ....+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~~-~~-----~~~~~~  221 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------ML-IP-----KSKPPR  221 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------hc-cc-----cCCCCC
Confidence              112334688999999998754 5689999999999999999999999754322111      00 00     001111


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +...   .....+.+++.+|++.+|++||++.|++.
T Consensus       222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1111   13456889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-33  Score=301.69  Aligned_cols=266  Identities=22%  Similarity=0.284  Sum_probs=197.0

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++++|...+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++|+||+++.+++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567888899999999999999765 588999998765432 22346789999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+. ++|.+++.... ..+.+.++..++.|++.||+|||+   .+++|+||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 67777665433 458899999999999999999999   899999999999999999999999999997643211


Q ss_pred             CcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH----------Hhhc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK----------WQNK  685 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~~  685 (805)
                      .  ......++..|+|||++.+ ..++.++|||||||+++||++|+.||+........-...|...          ....
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            1  1233457889999999875 4578999999999999999999999975432211100111100          0000


Q ss_pred             -CCcccccCccccCCC-----ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          686 -GQLDQIIDPTLAGKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 -~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ...............     .......+.+++.+|++.+|.+|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000000000000000     0011346788999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-33  Score=297.34  Aligned_cols=252  Identities=25%  Similarity=0.371  Sum_probs=200.9

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|+||.||+|... +++.|++|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4667789999999999999865 688999998765543  3678899999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++...  ..+++..+..++.++++||+|||+   .+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999998654  358899999999999999999999   99999999999999999999999999998865432221


Q ss_pred             ce--eecccccccccChhhhccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          619 HV--STAVKGSFGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       619 ~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ..  .....++..|+|||++.+..   .+.++||||||++++||++|+.||........  .   ...... +.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~-~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA-GH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc-CC-----C
Confidence            11  12356788999999998766   89999999999999999999999974421111  0   111000 10     1


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +.+..  .......+.+++.+|++.+|.+||++.|++.
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11110  1122456778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-33  Score=295.00  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=205.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~  536 (805)
                      +|...+.||+|++|.||+|... +++.|++|+......  ...+.+.+|++++++++|+||+++++++...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3667789999999999999887 689999998766542  4567899999999999999999999999888  8999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++....  .+++.+++.++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999986554  79999999999999999999999   999999999999999999999999999998754422


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      .........++..|+|||.+.....+.++||||||+++++|++|+.|+......     ..-.....         ....
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~---------~~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIG---------SSGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhcc---------ccCC
Confidence            211123456888999999999888999999999999999999999999754311     01011111         1111


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ....+......+.+++.+|++.+|.+||++.|++.
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11222333567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-34  Score=316.66  Aligned_cols=261  Identities=22%  Similarity=0.274  Sum_probs=205.5

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-C-----CceEEEEEEEccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-H-----RHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l  534 (805)
                      +|.+.++||+|.||.|-||... +++.||||+++.... -..+...|+.+|..|+ |     -|+|++++|+...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888899999999999999654 699999999987643 3566688999999997 4     589999999999999999


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC--cEEEeecCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF--MAKVADFGLSKTG  612 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~--~~kl~DFGla~~~  612 (805)
                      |+|.+.. +|.++|..++...++...+..|+.||+.||.+||+   .+|||+||||+||||.+..  .+||+|||.+...
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999965 99999998888889999999999999999999999   9999999999999996543  7999999999874


Q ss_pred             CCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-----------
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK-----------  681 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----------  681 (805)
                      ...    .. ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|....+.+....+.-+..           
T Consensus       342 ~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            331    11 34456789999999999999999999999999999999988887766655433221110           


Q ss_pred             ----Hhhc-CCcccc----------------------cCccccC--------CCChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          682 ----WQNK-GQLDQI----------------------IDPTLAG--------KIRPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       682 ----~~~~-~~~~~~----------------------~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                          +... ......                      .+.....        ......-..+.+++++||+.||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                0011 000000                      0000000        0011234568999999999999999999


Q ss_pred             HHHHHH
Q 003659          727 GDVLWN  732 (805)
Q Consensus       727 ~evl~~  732 (805)
                      .+++++
T Consensus       497 ~qal~H  502 (586)
T KOG0667|consen  497 AQALNH  502 (586)
T ss_pred             HHHhcC
Confidence            999863

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-33  Score=301.53  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=200.4

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      |...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            444569999999999999864 6889999988765555567789999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|.+++..   ..+++.++..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++.......  ...
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~  172 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRR  172 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--ccc
Confidence            999999865   358999999999999999999999   899999999999999999999999999887543211  112


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....|+..|+|||.+.+..++.++|||||||+++||++|+.||....+....      .... .+.     .+.+.  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~-~~~-----~~~~~--~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIR-DNL-----PPKLK--NL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHH-hcC-----CCCCc--cc
Confidence            3346889999999998888999999999999999999999998654332211      1111 110     01111  01


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            123456889999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-33  Score=304.42  Aligned_cols=250  Identities=25%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .+|...+.||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            56778889999999999999764 57899999987655555678899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++...   .+++.++..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            999999998543   47899999999999999999999   9999999999999999999999999999875433221  


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......|+..|+|||.+....++.++||||||+++|||++|+.||......+....      ....+.      +..  .
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~------~~~--~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGT------PEL--Q  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCC------CCC--C
Confidence            12334688899999999888899999999999999999999999975433221100      000000      000  0


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ........+.+++.+||+.+|.+||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            112234568889999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-34  Score=303.84  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=195.3

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|+||.||+|+.. +|+.+|+|++....  ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            3667789999999999999876 58999999876432  22345678899999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      ++ ++|.+++.... ..+++..++.++.||++||.|||+   .+++||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            97 57888775433 458999999999999999999999   899999999999999999999999999998643211  


Q ss_pred             ceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC------Ccccc
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG------QLDQI  691 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  691 (805)
                      .......++..|+|||++.+. .++.++|||||||+++||+||+.|+........ .+ ..........      .+...
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HH-HHHHHHhCCCChHHhHHhhhc
Confidence            112334578899999998764 478999999999999999999988643322111 00 0000000000      00000


Q ss_pred             cCcc----cc-----CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPT----LA-----GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~----l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+..    ..     ....+.....+.+++.+||+.+|.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000    00     0111223466789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.7e-33  Score=306.21  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=197.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|...+.||+|+||.||+|+.. ++..+|+|++....   ....+++.+|++++++++|+|++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667779999999999999865 58899999876432   2335678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |++ |+|.+.+.... .+++|.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.....   
T Consensus       106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            997 57777765433 469999999999999999999999   8999999999999999999999999999875432   


Q ss_pred             cceeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          618 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                         .....|+..|+|||++.   .+.++.++|||||||+++||++|+.|+.........  ..+    ...+.      +
T Consensus       178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~----~~~~~------~  242 (317)
T cd06635         178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHI----AQNES------P  242 (317)
T ss_pred             ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHH----HhccC------C
Confidence               22346888999999974   467899999999999999999999998654322111  111    11110      0


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                      .   .........+.+++.+|++.+|.+||++.++++.+..
T Consensus       243 ~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         243 T---LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             C---CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            0   1112334568899999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.2e-34  Score=303.77  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=206.6

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..++.|...+.||+|++|.||+|..+ ++..+++|.+..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45667888889999999999999887 688999998876544 5677899999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++.... ..+++.+++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999997654 479999999999999999999999   999999999999999999999999999986543211


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      .  ......++..|+|||.+.+..++.++|||||||++|||++|+.|+....+....  ..    ... .......    
T Consensus       171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~----~~~-~~~~~~~----  237 (286)
T cd06614         171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FL----ITT-KGIPPLK----  237 (286)
T ss_pred             h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HH----HHh-cCCCCCc----
Confidence            1  123345788999999998888999999999999999999999998754332211  11    001 1111100    


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                         ........+.+++.+|++.+|.+||++.++++.
T Consensus       238 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 ---NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ---chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               011134568899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-33  Score=302.25  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|++|.||++... +++.+|+|.+....   ....+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            35777889999999999999876 58999999876432   234567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      ||+++++|.+++...  ..+++..+..++.|+++||+|||+   .+++|+||+|+|||+++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998654  468999999999999999999999   99999999999999999999999999999875432 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                          .....|++.|+|||.+.+...+.++||||||++++||++|+.||.........   .   . ...+.      .  
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-~~~~~------~--  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---E---K-ILEGK------V--  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HhcCC------c--
Confidence                23456889999999998888999999999999999999999999754321110   0   0 00111      0  


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVL  730 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl  730 (805)
                        .++......+.+++.+||+.+|.+||     +++|++
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence              11122345678999999999999998     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-33  Score=301.28  Aligned_cols=263  Identities=23%  Similarity=0.305  Sum_probs=198.9

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEEEEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILIYE  537 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~e  537 (805)
                      |+..+.||+|++|.||+|+.. +++.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456678999999999999876 48899999887653  33456788999999999999999999999877  89999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++ +|.+++.... ..+++.+++.++.|+++||+|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8888886543 469999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCC---c-----
Q 003659          618 THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ---L-----  688 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~-----  688 (805)
                       ...+...++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......................   .     
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence             11233456788999998764 4678999999999999999999999976543322111110000000000   0     


Q ss_pred             ------ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 ------DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                            .......+...+...+...+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  0000000101111112567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-33  Score=301.99  Aligned_cols=250  Identities=25%  Similarity=0.339  Sum_probs=192.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHH-HhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEM-LSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...+.||+|+||.||+++.+ +|+.||+|++.... .....++..|+.. ++.++|+||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36778889999999999999876 58999999876542 2234455666665 666789999999999999999999999


Q ss_pred             eccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCC-CeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          538 YMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       538 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      |++ |+|.+++...  ....+++..++.++.|++.||+|||+   . +++||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6887777532  23568999999999999999999998   5 899999999999999999999999999986432


Q ss_pred             CCCcceeecccccccccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .   ...+...|+..|+|||.+.+    ..++.++|+|||||++|||++|+.|+...... ...+..    ... +.   
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~-~~---  224 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE-EP---  224 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh-cC---
Confidence            1   11233568889999998864    45689999999999999999999998642211 111111    111 00   


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        .+.+.   ....+..+.+++.+|++.+|.+||++.++++
T Consensus       225 --~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 --SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              01110   0122456889999999999999999999985

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-33  Score=302.51  Aligned_cols=264  Identities=20%  Similarity=0.261  Sum_probs=199.3

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV  535 (805)
                      ++|...+.||+|+||.||+|+.+ +++.+|+|.+....  ......+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            45777789999999999999886 58899999876543  22234577899999999999999999998776  899999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||++ ++|.+++.... ..+++.+++.++.|++.||+|||+   .+++|+||||+|||+++++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 48988886543 369999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhH-HH---------HHHH---
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL-AE---------WAMK---  681 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~---------~~~~---  681 (805)
                      ..  ......++..|+|||.+.+. .++.++|+||||++++||++|++||......+.... ..         |...   
T Consensus       160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            11  12334578899999998754 468999999999999999999999975443221110 00         1000   


Q ss_pred             -HhhcCCcccccCccccCCCChh-HHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          682 -WQNKGQLDQIIDPTLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       682 -~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ..............+...++.. ....+.+++.+||+.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0000001111111111222222 3566889999999999999999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=302.28  Aligned_cols=260  Identities=24%  Similarity=0.307  Sum_probs=198.3

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |+..+.||.|++|.||+|... +|+.||+|++....  ....+.+.+|++++++++|+|++++++++..++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            455679999999999999875 68999999876543  233467889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      + ++|.+++.......+++..+++++.|+++||+|||+   .+++||||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 689999866554579999999999999999999999   8999999999999999999999999999976432111  


Q ss_pred             eeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC--------Cc--
Q 003659          620 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG--------QL--  688 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~--  688 (805)
                      ......++..|+|||++.+. .++.++||||||+++|||++|++||........  +...........        .+  
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence            12233568899999988654 578999999999999999999999975433221  111111000000        00  


Q ss_pred             -----ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 -----DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 -----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                           ........ ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                 00000000 0111223456889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-34  Score=316.27  Aligned_cols=243  Identities=27%  Similarity=0.434  Sum_probs=189.7

Q ss_pred             cceEeeeCceEEEEEEec-CCcEEEEEEcC----CCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC--eEEEEEEe
Q 003659          466 SWVIGIGGFGKVYKGELN-DGTKVAVKRGN----PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN--EMILIYEY  538 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~e~  538 (805)
                      ..+||+|.|-+||||... +|..||--.++    ..+....+.|..|+.+|+.|+|+||++++.++.+..  ...+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            348999999999999765 47777633211    123455689999999999999999999999996544  48899999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~~~~~~~~  617 (805)
                      |..|+|+.|+.+.+  .++.+.+..||+||++||.|||+.. ++|||||||.+||+|+.+ |.+||+|+|||.....   
T Consensus       125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---  198 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---  198 (632)
T ss_pred             ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence            99999999996554  6889999999999999999999844 799999999999999765 7999999999987543   


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      .+ ...+.|||.|||||.+. ..|.+..||||||++|+||+|+..||....     +-++.-... ..|.     .|.-.
T Consensus       199 s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV-~SGi-----KP~sl  265 (632)
T KOG0584|consen  199 SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKV-TSGI-----KPAAL  265 (632)
T ss_pred             cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHH-HcCC-----CHHHh
Confidence            22 23478999999999987 889999999999999999999999996432     222211111 1111     11111


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ....   -..+.++|.+|+.. ..+|||+.|++.
T Consensus       266 ~kV~---dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  266 SKVK---DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             hccC---CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1111   12367889999998 999999999986

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-34  Score=305.89  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcC--CCCchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ..|+..++||+||.+.||++...+.+.+|+|+..  ..+.+...-|.+|+..|.+|+ |.+|++|++|-..++.++||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            4577778999999999999998888889998654  345667888999999999995 9999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |=+ .+|..+|.........| .+..+..|++.++.++|+   .+|||.||||.|+|+-. |.+||+|||+|........
T Consensus       441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence            864 49999998766555667 777899999999999999   99999999999999976 5999999999998776555


Q ss_pred             cceeecccccccccChhhhccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG  686 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (805)
                      .......+||+.||+||.+...           +.+.++||||+||+||+|+.|++||...     .+.  |+       
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~--~a-------  580 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQ--IA-------  580 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHH--HH-------
Confidence            5556678899999999998543           2568999999999999999999999632     111  11       


Q ss_pred             CcccccCccccCCCChh-HHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          687 QLDQIIDPTLAGKIRPD-SLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       687 ~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+..+.||.-.-+++.- ....+.++++.||+.||.+||++.|+++
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            23455666443333211 1222889999999999999999999985

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.3e-34  Score=299.37  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=202.0

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|+..+.||+|++|.||++..+ +++.+|+|++.... ....+++.+|++++++++||||+++++++..++..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            4666779999999999999876 58899999877653 344677899999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++++|.+++.... ..+++..+.+++.|+++||+|||+  ..+++|+||||+||++++++.+||+|||++.......   
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~---  155 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---  155 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence            9999999986543 578999999999999999999997  3689999999999999999999999999987542211   


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                       .....++..|+|||++.+..++.++||||||++++||++|+.|+...... ...............      .+.+.. 
T Consensus       156 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~~~~-  226 (265)
T cd06605         156 -AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP------PPRLPS-  226 (265)
T ss_pred             -hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC------CCCCCh-
Confidence             11266888999999999999999999999999999999999998644211 011111111111110      011110 


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ......+.+++.+|+..+|.+||++.+++.
T Consensus       227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              114556889999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.3e-33  Score=300.35  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=197.4

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|++++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46788889999999999999876 68899999876432  2334678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~~~~~~  616 (805)
                      |++ ++|.+++.......+++.....++.|++.||+|||+   .+++||||||+||+++. ++.+||+|||+++..... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            996 588887755444457888999999999999999999   89999999999999985 567999999999764321 


Q ss_pred             CcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC--C------
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG--Q------  687 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~------  687 (805)
                       ........++..|+|||++.+ ..++.++|||||||++|||+||++||....+.+.....   .......  .      
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---FRILGTPNEETWPGVT  232 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChhhccccc
Confidence             111233457889999999866 45789999999999999999999999755432221110   0000000  0      


Q ss_pred             -cccccC--ccccC----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          688 -LDQIID--PTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 -~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       +.....  +....    ...+.....+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000000  00000    011223456889999999999999999999985

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.1e-33  Score=301.87  Aligned_cols=263  Identities=22%  Similarity=0.261  Sum_probs=194.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCe-----
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNE-----  531 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~-----  531 (805)
                      ++|+..+.||+|+||.||+|... +++.||+|......  ......+.+|+.+++.++ |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36788889999999999999875 58999999866542  223467889999999995 6999999999876555     


Q ss_pred             EEEEEEeccCCcccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-CCcEEEeecC
Q 003659          532 MILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFG  607 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-~~~~kl~DFG  607 (805)
                      .++||||+++ +|.+++....   ...+++..++.++.|+++||+|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8888875432   2468999999999999999999999   89999999999999998 8899999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG  686 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  686 (805)
                      +++......  .......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+....  ...........
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence            987543211  11223356788999998865 45799999999999999999999999754322211  00000000000


Q ss_pred             --Ccccc---c--------CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          687 --QLDQI---I--------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       687 --~~~~~---~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        .....   .        .+.......+.....+.+++.+||+.+|.+||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              00000   0        000000111234566889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.3e-33  Score=302.54  Aligned_cols=253  Identities=25%  Similarity=0.314  Sum_probs=194.3

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            445568999999999999875 58999999876543 344567889999999996 999999999999999999999998


Q ss_pred             cCCcccc---cccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          540 ENGTLKG---HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       540 ~~gsL~~---~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      .. +|.+   .+.......+++..+..++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            64 4444   3333333579999999999999999999997  1489999999999999999999999999987543211


Q ss_pred             CcceeecccccccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                         ......|+..|+|||++.+.   .++.++|||||||+++||++|+.||.....     ...-...... +     ..
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~~  228 (288)
T cd06616         163 ---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----DP  228 (288)
T ss_pred             ---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----CC
Confidence               12334688899999999765   689999999999999999999999864321     1111111110 0     01


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      +.+...........+.+++.+|++.+|.+||++.+|+..
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122222222345678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.7e-33  Score=298.02  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=199.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +|+..+.||+|++|.||+|+.. +|+.||||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4777889999999999999886 588999998775432 23466788999999999999999999999999999999999


Q ss_pred             cCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          540 ENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       540 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      ++ +|.+++.... ...+++.+++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++.....  .
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--V  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--c
Confidence            85 8888875433 3468999999999999999999999   89999999999999999999999999999754321  1


Q ss_pred             ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HHHHH--------HHHhhcCCc
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWA--------MKWQNKGQL  688 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~--------~~~~~~~~~  688 (805)
                      .......++..|++||++.+ ..++.++|||||||+++||++|+.||......+... ..+..        ..+......
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            11233457889999999865 457899999999999999999999997554332211 11100        000000000


Q ss_pred             cc----ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQ----IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..    ..+... ....+.....+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00    000000 0111223456789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=302.86  Aligned_cols=266  Identities=22%  Similarity=0.266  Sum_probs=196.5

Q ss_pred             CCcccceEeeeCceEEEEEEec---CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN---DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~  533 (805)
                      +|...+.||+|+||.||+|+..   +++.||+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677789999999999999875   37899999887632   33346778999999999999999999999877  8899


Q ss_pred             EEEEeccCCcccccccCC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC----CCcEEEeec
Q 003659          534 LIYEYMENGTLKGHLYGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE----NFMAKVADF  606 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~----~~~~kl~DF  606 (805)
                      +||||+++ +|.+++...   ....+++..++.++.|++.||+|||+   .+++||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 666655322   22368999999999999999999999   89999999999999999    999999999


Q ss_pred             CCCCCCCCCCC-cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------hhhHHH
Q 003659          607 GLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-------MVNLAE  677 (805)
Q Consensus       607 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~  677 (805)
                      |+++....... ........++..|+|||++.+ ..++.++|||||||+|+||++|++||.......       ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543222 111234567889999998876 457899999999999999999999997543322       111111


Q ss_pred             HHHHHhh-----------cCCcccccCccccCCCC---------h--hHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          678 WAMKWQN-----------KGQLDQIIDPTLAGKIR---------P--DSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       678 ~~~~~~~-----------~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ....+..           ........+......++         .  .....+.+++.+||+.+|++||++.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111000           00000000000000011         0  23356889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.3e-33  Score=309.78  Aligned_cols=267  Identities=23%  Similarity=0.313  Sum_probs=199.0

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcC-CCCceEEEEEEEcc--CCeE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE--KNEM  532 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~--~~~~  532 (805)
                      ..++|...+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +|+||++++++|..  ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567888889999999999999876 5889999987542  233455678899999999 99999999999854  3468


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||++ ++|.+++...   .++|..++.++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5998888543   68899999999999999999999   89999999999999999999999999999865


Q ss_pred             CCCCCc---ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH-------
Q 003659          613 PEIDQT---HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK-------  681 (805)
Q Consensus       613 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-------  681 (805)
                      ......   .......|+..|+|||.+.+ ...+.++||||||+++|||+||+.||......+..........       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211   12234568999999998764 5678999999999999999999999975443322111100000       


Q ss_pred             -HhhcCCcccccC----ccc--cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 -WQNKGQLDQIID----PTL--AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 -~~~~~~~~~~~d----~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       .........+++    ...  .....+.....+.+++.+|++.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             000000000110    000  001111235668899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-33  Score=297.67  Aligned_cols=247  Identities=26%  Similarity=0.298  Sum_probs=202.3

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      +|...+.||.|+||.||+|+.+ +++.+|+|.+....   ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4677889999999999999876 58999999876532   2446789999999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+++++|.+++...  .++++.++..++.|+++||.|||+   .+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998654  478999999999999999999999   899999999999999999999999999987654321 


Q ss_pred             cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcccc
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                        ......|+..|+|||.+.+..++.++|+||||+++++|++|+.|+........    .+.......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence              22345688899999999988899999999999999999999999975543211    111111110          01


Q ss_pred             CCCChhHHHHHHHHHHhchhcCCCCCCCH--HHHH
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSM--GDVL  730 (805)
Q Consensus       698 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm--~evl  730 (805)
                      ...+......+.+++.+|++.+|.+||+.  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11223345678899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.6e-33  Score=300.18  Aligned_cols=264  Identities=25%  Similarity=0.333  Sum_probs=197.9

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCC----
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----  530 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  530 (805)
                      .+.++|+..+.||+|+||.||+|..+ +++.||+|++....  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34567888899999999999999886 58899999876542  233456788999999999999999999986654    


Q ss_pred             ------eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEe
Q 003659          531 ------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA  604 (805)
Q Consensus       531 ------~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~  604 (805)
                            ..++|+||+++ +|.+.+... ...+++.+++.++.|++.||+|||+   .+|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999986 676666543 3468999999999999999999999   899999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh
Q 003659          605 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ  683 (805)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  683 (805)
                      |||++........ .......++..|+|||.+.+ ...+.++|||||||+++||++|++||......+...  . .....
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~--~-~~~~~  234 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE--L-ISRLC  234 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHh
Confidence            9999986543221 11223346778999998865 457899999999999999999999997543322111  1 11110


Q ss_pred             hcC---Ccccc--------cCc------cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          684 NKG---QLDQI--------IDP------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       684 ~~~---~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...   ....+        .++      ...... ...+..+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000   00000        000      000000 122456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=309.84  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=196.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccC-----CeE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  532 (805)
                      +++|...++||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467888999999999999999765 68999999886532 23456788999999999999999999887543     358


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++|+||+.+ +|.+++..   ..+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999974 78777643   358999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCC-cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcC---C
Q 003659          613 PEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG---Q  687 (805)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~  687 (805)
                      ..... ........|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........   ..+........   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence            32111 111233568899999998754 5689999999999999999999999965432111   11111111100   0


Q ss_pred             cccccCccc---------cCC-----CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          688 LDQIIDPTL---------AGK-----IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       688 ~~~~~d~~l---------~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ...+.+...         ...     ..+.....+.+++.+||+.+|.+||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000         000     001224568899999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-33  Score=302.05  Aligned_cols=267  Identities=21%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCC------
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  530 (805)
                      -++|...+.||+|+||.||+|+.. +++.||||.+....  ......+.+|++++++++||||++++++|....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346888899999999999999876 58999999875432  222345678999999999999999999986543      


Q ss_pred             --eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          531 --EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       531 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                        ..++||||+.+ +|.+.+.... ..+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              45999999974 7887775433 368999999999999999999999   8999999999999999999999999999


Q ss_pred             CCCCCCCCCc--ceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          609 SKTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       609 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      +.........  .......++..|+|||.+.+. .++.++||||||++++||++|++|+....+................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9765332211  112334578899999998664 4789999999999999999999999765443322222211100000


Q ss_pred             CCcccc-----cCc-cccCCC---------ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          686 GQLDQI-----IDP-TLAGKI---------RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 ~~~~~~-----~d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +.....     .+. .+....         .......+.+++.+||+.+|.+||+++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000     000 000000         0001245678999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.7e-33  Score=297.87  Aligned_cols=242  Identities=24%  Similarity=0.318  Sum_probs=186.8

Q ss_pred             eEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHh---cCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLS---QFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +||+|+||.||++... +++.+|+|.+....   ......+.+|..++.   ..+|+|++.+.+++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58899999875432   122233445544443   4479999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++...  ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++......    .
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            99999988644  369999999999999999999999   89999999999999999999999999998754321    1


Q ss_pred             eecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....|+..|+|||.+.+ ..++.++|||||||+++||++|+.||..........+...    ..      ....    .
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~------~~~~----~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL------TVNV----E  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh------cCCc----C
Confidence            223468999999999864 5689999999999999999999999975432221111110    00      0111    1


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLWN  732 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~~  732 (805)
                      .+......+.+++.+||+.+|.+||     +++|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2233455688999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.3e-33  Score=290.45  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=205.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||++... ++..+++|++.....  ...+++.+|++++++++|+|++++.+.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677789999999999999876 588999998876532  4567789999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      +++++|.+++....  ...+++.+++.++.+++.||+|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999986643  3679999999999999999999999   899999999999999999999999999997654322


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                        .......|++.|+|||.+.+..++.++||||||+++++|++|+.|+......+.      ....... ..        
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~-~~--------  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILKG-QY--------  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHHHhcC-CC--------
Confidence              123345688899999999988999999999999999999999999875432211      1111111 11        


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ...+......+.+++.+||..+|++||++.|+++
T Consensus       221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             1122234566889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=284.94  Aligned_cols=251  Identities=22%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +++|+.-+.||+|.|+.||+.... .|+.+|+|.++..  +..+.+++.+|+++.+.|+|||||+|.....+....+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            455666678999999999998544 6888998876543  3346788899999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC---CCCcEEEeecCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGP  613 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld---~~~~~kl~DFGla~~~~  613 (805)
                      |+|.+++|..-+-..  .-.++...-...+||+++|.|+|.   ++|||||+||.|+||-   ..--+||+|||+|...+
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999997765433  346777888899999999999999   9999999999999994   34468999999998765


Q ss_pred             CCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                         .........||++|||||+++..+++..+|||+.||+|+-||.|++||.......   +.+-..    .+..  -++
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye~I~----~g~y--d~~  232 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYEQIK----AGAY--DYP  232 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHHHHh----cccc--CCC
Confidence               3344567889999999999999999999999999999999999999997532221   211111    1110  011


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +...    +...+...+++++||..+|.+|.|+.|.+.
T Consensus       233 ~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  233 SPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             Cccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1111    233455788899999999999999999874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=288.85  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=202.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|...+.||+|++|.||+++.. +++.+++|.+.....  ...+.+.+|++++++++|+|++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            3667789999999999999776 578999998876643  4567899999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998654  469999999999999999999999   89999999999999999999999999999865432221


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                        .....++..|+|||...+...+.++||||||++++||++|+.|+........    .|...  . ..     .+    
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~--~-~~-----~~----  217 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV--Q-DD-----HP----  217 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh--c-cC-----CC----
Confidence              2345688899999999888899999999999999999999999874432111    11111  0 00     01    


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+......+.+++.+||..+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            112223456789999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6e-33  Score=296.01  Aligned_cols=257  Identities=23%  Similarity=0.262  Sum_probs=193.3

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCC-CCceEEEEEEEccC--CeEEEEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEK--NEMILIYE  537 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e  537 (805)
                      |...+.||+|+||.||+|+.. +++.+|+|++.... .........|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            455678999999999999865 58899999876542 222234457899999885 99999999999877  88999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |++ |+|.+++.... ..++|.+++.++.|++.||+|||+   .+++||||||+||+++. +.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            997 58888775533 468999999999999999999999   89999999999999999 9999999999986532111


Q ss_pred             cceeecccccccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh-----------hc
Q 003659          618 THVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-----------NK  685 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~~  685 (805)
                         .....++..|+|||++. +..++.++|||||||+++||++|++||....+.+.   ..+.....           ..
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence               12345788999999764 45678999999999999999999999976543321   11111111           00


Q ss_pred             CCcccccCccccC----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          686 GQLDQIIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 ~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ........+...+    ...+..+..+.+++.+||+.+|.+||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000000    011234677899999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-33  Score=292.40  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=197.6

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-----CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEM  532 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~  532 (805)
                      .+|...+.||+|+||.||+|... +++.||+|.+...     ..+....+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46788899999999999999865 5899999986432     233456788999999999999999999998653  568


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++|+||+++++|.+++....  .+++...++++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999986443  58899999999999999999999   89999999999999999999999999999864


Q ss_pred             CCCCC-cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          613 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ..... ........|+..|+|||++.+...+.++|||||||+++||++|+.||........  ...    ..        
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~--------  222 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK----IA--------  222 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH----HH--------
Confidence            32111 1111235688999999999988899999999999999999999999974422211  110    00        


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ........+......+.+++.+|++ +|..||+..+++.
T Consensus       223 -~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 -TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             0011112333445678899999998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-33  Score=321.79  Aligned_cols=270  Identities=20%  Similarity=0.226  Sum_probs=190.0

Q ss_pred             HHHhcCCcccceEeeeCceEEEEEEecC--CcEEEEE------------------EcCCCCchhHHHHHHHHHHHhcCCC
Q 003659          457 QEATNNFDESWVIGIGGFGKVYKGELND--GTKVAVK------------------RGNPRSQQGLAEFQTEIEMLSQFRH  516 (805)
Q Consensus       457 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H  516 (805)
                      ....++|...+.||+|+||+||++.++.  +...++|                  +.. ........+.+|+++|++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            3345789999999999999999986542  2222222                  111 112234568899999999999


Q ss_pred             CceEEEEEEEccCCeEEEEEEeccCCcccccccCCC---CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcE
Q 003659          517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG---LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANI  593 (805)
Q Consensus       517 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NI  593 (805)
                      +||+++++++...+..++|+|++. ++|.+++....   .......+...|+.|++.||+|||+   .+|+||||||+||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NI  298 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENI  298 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHE
Confidence            999999999999999999999985 57777764432   1223456778899999999999999   8999999999999


Q ss_pred             EeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCChhhh
Q 003659          594 LLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP-VIDPTLPREM  672 (805)
Q Consensus       594 Lld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~  672 (805)
                      |++.++.+||+|||+++..... .........||..|+|||++.+..++.++|||||||+||||++|+. |+........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999865431 1222234579999999999999999999999999999999999874 4443322222


Q ss_pred             hhHHHHHHHHh--hcC------CcccccCcc-c---cCCCC-----hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          673 VNLAEWAMKWQ--NKG------QLDQIIDPT-L---AGKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       673 ~~l~~~~~~~~--~~~------~~~~~~d~~-l---~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ..+........  .++      .+.+.++.. +   ...+.     ......+.+++.+||+.||.+||++.|++.+
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22222111100  000      000000000 0   00000     0112346778999999999999999999864

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.2e-33  Score=293.41  Aligned_cols=237  Identities=22%  Similarity=0.273  Sum_probs=192.7

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||.|++|.||+++.. +++.+|+|.+....   ....+.+.+|++++++++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999876 48899999876432   23456789999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++...  ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++......   .....
T Consensus        81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            9999654  358999999999999999999999   999999999999999999999999999998754321   12334


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      .|+..|++||.+....++.++|+||||+++|||++|+.|+.......    ........         +......++...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCccc
Confidence            68889999999988889999999999999999999999997554211    11111111         000111222233


Q ss_pred             HHHHHHHHHhchhcCCCCCCCH
Q 003659          705 LRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                      ...+.+++.+||+.+|.+||++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~  241 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGN  241 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCC
Confidence            5678999999999999999993

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2e-33  Score=296.06  Aligned_cols=245  Identities=27%  Similarity=0.359  Sum_probs=196.8

Q ss_pred             EeeeCceEEEEEEecC-CcEEEEEEcCCCCc---hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||.||+++... |+.+++|.+.....   ...+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999998874 89999998865433   4567788999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC------c
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ------T  618 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~------~  618 (805)
                      .+++....  .+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99986543  68999999999999999999999   9999999999999999999999999999876433211      1


Q ss_pred             ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......++..|+|||.+.....+.++||||||++++||++|+.||......+..      ..... +...      ...
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~------~~~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILN-GKIE------WPE  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-CCcC------CCc
Confidence            1223456788999999998888999999999999999999999999755433211      11111 1100      000


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                        .......+.+++.+|++.+|.+||++.++.+.|
T Consensus       223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              001246688999999999999999996665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-33  Score=296.50  Aligned_cols=241  Identities=23%  Similarity=0.362  Sum_probs=191.5

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||+||++..+ +|+.+|+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999765 58899999876432   22345677899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++.......+++.+++.++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            999976555579999999999999999999999   8999999999999999999999999999876432   1112334


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      .++..|+|||++.+..++.++|||||||+++||++|+.||..........  .....     .    ..  .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~-----~----~~--~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRR-----T----LE--MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhc-----c----cc--ccccCCccC
Confidence            57889999999988889999999999999999999999997543211100  00000     0    00  000112223


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      ...+.+++.+||+.+|.+||+.++
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCc
Confidence            456789999999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-33  Score=291.59  Aligned_cols=247  Identities=26%  Similarity=0.375  Sum_probs=203.1

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +|+..+.||+|++|.||+++.+ +++.+++|.+...  ......++.+|++++++++|+||+++.+++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677789999999999999765 6889999987653  234456788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      +++++|.+++...  ....+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998552  23568999999999999999999999   89999999999999999999999999999875432 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                         ......++..|++||.+.+..++.++|+||||++++||++|+.|+......+..   .   . ...+..        
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~---~-~~~~~~--------  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---Y---K-VQRGKY--------  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H-HhcCCC--------
Confidence               223345788999999999999999999999999999999999999755432211   1   0 011111        


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                       ..........+.+++.+|++.+|.+||++.|+++
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 -PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             1122244567899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.4e-33  Score=305.37  Aligned_cols=262  Identities=20%  Similarity=0.265  Sum_probs=198.2

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------  529 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------  529 (805)
                      ..++|...+.||+|+||.||+|+.. +++.||+|.+...  ......++.+|+.++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4577999999999999999999865 6899999987642  333456778899999999999999999988543      


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      ...++||||+. ++|.+.+..    .+++.++..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999996 488887743    28899999999999999999999   89999999999999999999999999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HH--------HHHH
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LA--------EWAM  680 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~--------~~~~  680 (805)
                      +......   ......++..|+|||.+.+..++.++|||||||++++|++|+.||......+... +.        ++..
T Consensus       166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8654311   1234467889999999999999999999999999999999999997543221110 00        0000


Q ss_pred             -------HHhhc-C-----CcccccCccc----cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          681 -------KWQNK-G-----QLDQIIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       681 -------~~~~~-~-----~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                             .+... .     ...+++...+    ...........+.+++.+||+.+|.+||++.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                   00000 0     0001111110    00111123556789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5e-33  Score=301.26  Aligned_cols=262  Identities=25%  Similarity=0.302  Sum_probs=195.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC--CeEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK--NEMIL  534 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l  534 (805)
                      .++|...+.||+|+||.||+|... +|+.||+|.+....  ......+.+|++++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            356888899999999999999875 58999999876432  22233567899999999999999999998654  56899


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ||||+.+ +|.+++.... ..+++.+++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            9999974 8888875433 469999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc--CCc---
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK--GQL---  688 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~---  688 (805)
                      ...  ..+...++..|+|||.+.+ ..++.++|||||||++|||++|++||....+.+......   .....  ...   
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWPG  235 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhchh
Confidence            211  1223345788999999865 567899999999999999999999997654433211111   10000  000   


Q ss_pred             -------ccc-cCccccCCC---ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 -------DQI-IDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 -------~~~-~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                             ... +........   .......+.+++.+|++.+|.+||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   000 000000000   0112456788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-33  Score=296.16  Aligned_cols=260  Identities=24%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             CcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCC--chhHHHHHHHHHHHhcC---CCCceEEEEEEEccCCe-----
Q 003659          463 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS--QQGLAEFQTEIEMLSQF---RHRHLVSLIGYCDEKNE-----  531 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~-----  531 (805)
                      |+..+.||+|+||.||+|+.+. ++.+|+|++....  ......+.+|+.++.++   +|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            4567799999999999999874 8999999886432  22234566788777666   59999999999987766     


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .+++|||+.+ +|.+++.......+++.+++.++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999999974 89888865444469999999999999999999999   8999999999999999999999999999976


Q ss_pred             CCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc---
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL---  688 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  688 (805)
                      ......   .....++..|+|||++.+..++.++|||||||+++||++|++|+......+.  +..+..........   
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhcC
Confidence            543211   1233578899999999999999999999999999999999999875443221  11111111000000   


Q ss_pred             ------ccccCcccc---CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 ------DQIIDPTLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                            .........   ....++....+.+++.+||+.+|.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  000000000   1111233466789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.9e-33  Score=302.41  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=194.5

Q ss_pred             eEeee--CceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          468 VIGIG--GFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       468 ~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      .||+|  +||+||+++.. +|+.||+|......  ....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56666  89999999875 68999999876532  334577889999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc---
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH---  619 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~---  619 (805)
                      +|.+++.......+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+|++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            99999876554568999999999999999999999   899999999999999999999999998653321111000   


Q ss_pred             --eeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--------------
Q 003659          620 --VSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK--------------  681 (805)
Q Consensus       620 --~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------------  681 (805)
                        ......++..|+|||++.+  ..++.++|||||||+++||++|+.||........  .......              
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccchh
Confidence              0111234567999999976  3578999999999999999999999975432211  0000000              


Q ss_pred             ------------------HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 ------------------WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 ------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                                        .........+.+..+.......+...+.+++.+||+.+|.+|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                              000000001111111112223456778999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.4e-33  Score=297.99  Aligned_cols=243  Identities=23%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      .+||+|+||.||++..+ +++.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            47999999999999875 68999999887655556677999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      +++..   ..+++.....++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......  .......
T Consensus       106 ~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTH---TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            98743   258999999999999999999999   899999999999999999999999999987543211  1123356


Q ss_pred             ccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHH
Q 003659          626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL  705 (805)
Q Consensus       626 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  705 (805)
                      |+..|+|||.+.+..++.++||||||++++||++|+.||......+.....   ..         ...+.+..  .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~---------~~~~~~~~--~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RD---------NLPPKLKN--LHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---------hCCcccCC--cccCC
Confidence            889999999998888999999999999999999999998754332221111   00         00111100  01223


Q ss_pred             HHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          706 RKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       706 ~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+.+++.+||+.+|.+||++.+++.
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            45778899999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=296.78  Aligned_cols=260  Identities=21%  Similarity=0.273  Sum_probs=200.1

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |...+.||+|++|.||+|+.. +++.+++|++.....  .....+..|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            445678999999999999875 688999998765432  24567889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      ++ +|.+++.... ..+++.+++.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            75 8888876543 479999999999999999999999   899999999999999999999999999997654422  1


Q ss_pred             eeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh--cCCcccccC---
Q 003659          620 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN--KGQLDQIID---  693 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~d---  693 (805)
                      ......++..|+|||.+.+. .++.++||||||+++++|+||+.||......+......  .....  ........+   
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF--RTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHcCCCchHhcccchhhhh
Confidence            12334578889999998876 78999999999999999999999997554322211100  00000  000000000   


Q ss_pred             --------cc--ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          694 --------PT--LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 --------~~--l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                              ..  ......+.....+.+++.+|++.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                    00  000112234567899999999999999999999974

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-33  Score=307.13  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC-----Ce
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  531 (805)
                      .++|...+.||+|+||.||+|+.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            456888899999999999999765 5899999987653  233356678899999999999999999987543     35


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            899999996 6888888543  469999999999999999999999   8999999999999999999999999999986


Q ss_pred             CCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--------H
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK--------W  682 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~  682 (805)
                      .....  .......++..|+|||.+.. ..++.++|||||||+++||++|++||.............-...        .
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            54321  12234467889999998865 5689999999999999999999999965432211111000000        0


Q ss_pred             hhcCCccc-------ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          683 QNKGQLDQ-------IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       683 ~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ...+....       ..++.+. ...+.....+.+++.+||+.+|.+||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000       0001000 0112345668899999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=295.84  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=207.7

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..-|+.++.||+|.|..|-+|+.- .|+.||||++....-  .....+.+|++.|+.++|||||+|+.+......+|||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            345777789999999999999653 799999999876543  33567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe-CCCCcEEEeecCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-d~~~~~kl~DFGla~~~~~~  615 (805)
                      |.=++|+|.+||.... ..|.+....+.+.||+.|+.|+|+   ..+|||||||+||.+ .+-|-+||.|||++..... 
T Consensus        97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            9999999999997654 469999999999999999999999   999999999999776 5678999999999976433 


Q ss_pred             CCcceeecccccccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                        ....+..+|+..|-|||.+.+..|+ ++.|||||||+||-|+||++||+.....+..               ..++|=
T Consensus       172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDC  234 (864)
T KOG4717|consen  172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDC  234 (864)
T ss_pred             --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcc
Confidence              2334677899999999999988876 6899999999999999999999865544332               222332


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..  ..+.....+..++|..||..+|.+|.+.+||+.
T Consensus       235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            21  344566788999999999999999999998863

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.5e-33  Score=307.22  Aligned_cols=267  Identities=20%  Similarity=0.283  Sum_probs=199.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEc----cCCeE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----EKNEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~  532 (805)
                      ..+|...+.||+|++|.||+|... +++.||+|++....  ....+.+.+|+.+|++++|+||+++.+++.    .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888899999999999999865 58999999877542  234567788999999999999999998874    34568


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||+. ++|.+++...  ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999996 6899988654  359999999999999999999999   89999999999999999999999999999764


Q ss_pred             CCCCC--cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH--------
Q 003659          613 PEIDQ--THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK--------  681 (805)
Q Consensus       613 ~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------  681 (805)
                      .....  ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-...        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            32111  111234578899999999865 5689999999999999999999999975543222111100000        


Q ss_pred             HhhcCCcccccCc---ccc---CCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 WQNKGQLDQIIDP---TLA---GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 ~~~~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ......+.+..+.   ...   ....+.....+.+++.+||+.+|.+||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000000000000   000   00112235678999999999999999999998764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.2e-32  Score=289.84  Aligned_cols=249  Identities=19%  Similarity=0.229  Sum_probs=192.4

Q ss_pred             HHHHHHhcCCcccceE--eeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEccC
Q 003659          454 VAVQEATNNFDESWVI--GIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK  529 (805)
Q Consensus       454 ~el~~at~~f~~~~~L--G~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  529 (805)
                      .+.....++|+..+.+  |+|+||.||+++.+ ++..+|+|..........     |+.....+ +|+|++++++++...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3444555677766666  99999999999865 578899998765322111     22222222 799999999999999


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-cEEEeecCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGL  608 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-~~kl~DFGl  608 (805)
                      +..++||||+++++|.+++....  .++|.+++.++.|+++||+|||+   .+++||||||+||+++.++ .++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            99999999999999999996543  79999999999999999999999   8999999999999999998 999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      ++....      .....|+..|+|||++.+..++.++||||||++++||++|+.||...... ......|........  
T Consensus       157 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--  227 (267)
T PHA03390        157 CKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQQKKL--  227 (267)
T ss_pred             ceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhhcccC--
Confidence            876432      12346889999999999989999999999999999999999999744322 222223322211000  


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC-HHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-MGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-m~evl~  731 (805)
                                .........+.+++.+||+.+|.+||+ ++++++
T Consensus       228 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 ----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                      111134456889999999999999996 588763

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.5e-33  Score=299.05  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=195.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      .|...+.||+|+||.||+|+.. +++.+|+|.+...   .....+++.+|+++++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3556678999999999999875 5789999987532   23345678899999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+. |+|.+.+.... ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....   
T Consensus        96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---  167 (308)
T cd06634          96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (308)
T ss_pred             ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence            996 68877765433 458999999999999999999999   8999999999999999999999999999876432   


Q ss_pred             cceeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          618 THVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                         .....|+..|+|||.+.   ...++.++|||||||+++||++|+.|+......+..      ...... ..     +
T Consensus       168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~-~~-----~  232 (308)
T cd06634         168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-ES-----P  232 (308)
T ss_pred             ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHhhc-CC-----C
Confidence               12345788999999974   356889999999999999999999998644322111      111111 00     1


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      ..   ........+.+++.+||+.+|.+||++.+++...
T Consensus       233 ~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             Cc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            11   1123345688999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=308.51  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=205.1

Q ss_pred             CcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          463 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      |.+..-||.|+||.||||..++ +-..|.|.+...+....++|.-|+++|....||+||+|++.+...+.+++..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            4444579999999999998775 445677888888888899999999999999999999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |-....+..-+ ..|+..++.-+|.|++.||.|||+   ..|||||||+.|||++-+|.++|+|||.+.....  .....
T Consensus       114 GAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR  187 (1187)
T KOG0579|consen  114 GAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR  187 (1187)
T ss_pred             chHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence            99988776544 479999999999999999999999   9999999999999999999999999999865322  12223


Q ss_pred             ecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          622 TAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ....||+.|||||+.+     ..+|+.++||||||++|.||..+.+|.....+-..      .......+      -|.|
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSe------PPTL  255 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PPTL  255 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcC------CCcc
Confidence            4678999999999875     46899999999999999999999999865443221      11111111      1112


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .  -+..+...|.++..+||..+|..||++.++++
T Consensus       256 l--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 L--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             c--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1  23467788999999999999999999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=289.99  Aligned_cols=242  Identities=22%  Similarity=0.298  Sum_probs=189.3

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc---hhHHHHHHHHHH-HhcCCCCceEEEEEEEccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEM-LSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      +.||+|+||.||+|+.. +++.||+|.+.....   .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999875 588999998765432   222334455544 4456899999999999999999999999999


Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      ++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            9999998654  368899999999999999999999   8999999999999999999999999999876432      2


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                      ....|+..|+|||.+.+..++.++||||||++++||++|+.||..........      ... .....      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD------NIL-SRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-hcccC------CCCccc
Confidence            23467889999999988889999999999999999999999997544322111      110 11000      000111


Q ss_pred             hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          702 PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       702 ~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ......+.+++.+||+.+|++||++.++.+.
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            2334668899999999999999987666443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=294.30  Aligned_cols=255  Identities=15%  Similarity=0.175  Sum_probs=183.1

Q ss_pred             cCCcccceEeeeCceEEEEEEecC----CcEEEEEEcCCCCchhH-----------HHHHHHHHHHhcCCCCceEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQGL-----------AEFQTEIEMLSQFRHRHLVSLIGY  525 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~g~  525 (805)
                      ++|...++||+|+||.||+|...+    +..+|+|..........           .....+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            568888999999999999998764    34567775433222111           112234445667789999999998


Q ss_pred             EccCC----eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          526 CDEKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       526 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                      +....    ..++++|++.. ++.+.+...  ...++..+..|+.|+++||+|||+   .+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcE
Confidence            75443    34667777643 555555332  235788899999999999999999   899999999999999999999


Q ss_pred             EEeecCCCCCCCCCCCc-----ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-hhhH
Q 003659          602 KVADFGLSKTGPEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNL  675 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l  675 (805)
                      ||+|||+++........     .......||+.|+|||++.+..++.++|||||||+|+||++|+.||....... ....
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999764321111     11223469999999999999999999999999999999999999997552221 1111


Q ss_pred             --HHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          676 --AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       676 --~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                        ..+....         ....+.   .......+.+++..|++.+|++||++.++++.|
T Consensus       246 ~~~~~~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRL---------HEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHh---------hhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence              1111111         111110   122346688999999999999999999998765

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=308.65  Aligned_cols=270  Identities=24%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCCCCceEEEEEEEccC------CeEEE
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------NEMIL  534 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l  534 (805)
                      +...+.||+|+||.||+|+.+ .|+.||||.++... ....+...+|+++|++|+|+|||++++.-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344568999999999999855 69999999887753 33456678999999999999999999986544      36789


Q ss_pred             EEEeccCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC----CCCcEEEeecCCC
Q 003659          535 IYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD----ENFMAKVADFGLS  609 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld----~~~~~kl~DFGla  609 (805)
                      |||||.+|+|+..|... +...|+..+.+.+..+++.||.|||+   .+|+||||||.||++-    ....-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            99999999999999763 34679999999999999999999999   9999999999999992    3335799999999


Q ss_pred             CCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      +....   ....+..+||..|++||.+.. +.++...|.|||||++||.+||..||.+........-..|.........+
T Consensus       172 rel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            98654   335678899999999999984 88999999999999999999999999866443222223333332222222


Q ss_pred             ccccCccccCC------------CChhHHHHHHHHHHhchhcCCCCCC--CHHHHHHHHHHHHH
Q 003659          689 DQIIDPTLAGK------------IRPDSLRKFGETAEKCLADFGVDRP--SMGDVLWNLEYALQ  738 (805)
Q Consensus       689 ~~~~d~~l~~~------------~~~~~~~~l~~l~~~Cl~~~p~~RP--sm~evl~~L~~~~~  738 (805)
                      .-.+++...+.            ........+..+....|..+|.+|-  ...+.-..+..+++
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            22222222211            1123334455556666666777776  55555555555554

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-33  Score=294.95  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=197.4

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |...+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456679999999999999886 478999998765432 22334567999999999 999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                       +|+|.+++.......+++.+++.++.|++++|+|||+   .+++|+||+|+||++++++.++|+|||++.......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             7899998876554578999999999999999999999   899999999999999999999999999997643211   


Q ss_pred             eeecccccccccChhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HH---------HHHHHHhhcCCc
Q 003659          620 VSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LA---------EWAMKWQNKGQL  688 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~---------~~~~~~~~~~~~  688 (805)
                      ......++..|+|||++. ...++.++|+||||++++||++|++||......+... ..         .|..........
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            123345788999999875 4568999999999999999999999986543322111 00         011111000011


Q ss_pred             ccccCccc---cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...+....   .....+.....+.+++.+|++.+|.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000   00011112466889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=293.15  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=206.5

Q ss_pred             HHHHHHHh-cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEc
Q 003659          453 FVAVQEAT-NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD  527 (805)
Q Consensus       453 ~~el~~at-~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  527 (805)
                      ..|.+..| +.|..-++||+||||.||-++.+ +|+.+|.|++....   .++..-.++|-.+|.+++.+.||.+--.++
T Consensus       176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            34444444 45888899999999999999776 58999999765432   344556789999999999999999999999


Q ss_pred             cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       528 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      .++.++||+..|.+|+|.-||.+.+.+.+++...+-.|.+|+.||++||+   ..||.||+||+|||||+.|+++|+|+|
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccc
Confidence            99999999999999999999999888899999999999999999999999   999999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCC
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      ||...+.   ....+..+||.+|||||+++++.|+...|.||+||+||||+.|+.||....+.....-   +.+....  
T Consensus       333 LAvei~~---g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdrr~~~--  404 (591)
T KOG0986|consen  333 LAVEIPE---GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDRRTLE--  404 (591)
T ss_pred             eEEecCC---CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHHHHhc--
Confidence            9987654   2223455899999999999999999999999999999999999999964332211100   0000000  


Q ss_pred             cccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                           |+   .+++....++...+....|+.+|.+|...+
T Consensus       405 -----~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 -----DP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             -----ch---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                 11   123344456677778888999999996543

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-32  Score=299.46  Aligned_cols=259  Identities=22%  Similarity=0.228  Sum_probs=193.1

Q ss_pred             eEeeeCceEEEEEEecCCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      .+|.|+++.||+++. +++.||||++...  .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            445555666666654 5899999987654  3455678999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC-----cce
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-----THV  620 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~-----~~~  620 (805)
                      +++.......+++.....++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+........     ...
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            99976544568999999999999999999999   8999999999999999999999999998865432111     111


Q ss_pred             eecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHh----h-------cCC
Q 003659          621 STAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ----N-------KGQ  687 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~-------~~~  687 (805)
                      .....++..|+|||++..  ..++.++|||||||+++||++|+.||........  +.+......    .       ...
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence            233457788999999876  4588999999999999999999999975432211  111000000    0       000


Q ss_pred             ccc----ccCccc----cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          688 LDQ----IIDPTL----AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       688 ~~~----~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ...    ..++..    ...........+.+++.+||+.+|++||++.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            000    001100    001112334568899999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-32  Score=296.04  Aligned_cols=244  Identities=26%  Similarity=0.378  Sum_probs=193.7

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |...+.||+|+||.||+|+.. +++.|++|++....   ....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            444567999999999999875 58899999876432   23346788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      +. |+|.+++.... .++++.+++.++.|++.+|+|||+   .+++|+||||+||++++++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 57777775433 468999999999999999999999   8999999999999999999999999999865322    


Q ss_pred             ceeecccccccccChhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          619 HVSTAVKGSFGYLDPEYFR---RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                        .....|+..|+|||++.   ...++.++|||||||+++||++|+.|+.........   .   ..... ....     
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~---~~~~~-~~~~-----  239 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y---HIAQN-DSPT-----  239 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H---HHHhc-CCCC-----
Confidence              22456888999999984   466889999999999999999999998654322211   1   11111 1111     


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .   ........+.+++.+||+.+|.+||++.+++..
T Consensus       240 ~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 L---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1   111223457889999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=322.15  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=207.4

Q ss_pred             CCcccceEeeeCceEEEEEEec--------CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN--------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      +....+.||+|.||.|++|...        ....||||.++... ....+.+..|+++|+.+ +|+||+.++|+|..++.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            3344459999999999999743        14579999987653 35678899999999999 69999999999999999


Q ss_pred             EEEEEEeccCCcccccccCCC------------C--CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC
Q 003659          532 MILIYEYMENGTLKGHLYGSG------------L--PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE  597 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~  597 (805)
                      .++|+||+..|+|..+|+.++            .  ..|+..+.+.++.|||.|++||++   .++|||||.++|||+.+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence            999999999999999997655            0  138999999999999999999999   99999999999999999


Q ss_pred             CCcEEEeecCCCCCCCCCCCcceeeccc--ccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhh
Q 003659          598 NFMAKVADFGLSKTGPEIDQTHVSTAVK--GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVN  674 (805)
Q Consensus       598 ~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  674 (805)
                      +..+||+|||+++.....+.... ....  -...|||||.+....++.|+|||||||+||||+| |..|+........  
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~--  530 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE--  530 (609)
T ss_pred             CCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH--
Confidence            99999999999996544232221 1122  3456999999999999999999999999999999 6788865321111  


Q ss_pred             HHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          675 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       675 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      +.    .+.++|..         -+.+..+..++.++++.||+.+|++||+..++++.++..++
T Consensus       531 l~----~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  531 LL----EFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HH----HHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            11    12333321         12234556778899999999999999999999999998544

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3e-32  Score=290.58  Aligned_cols=241  Identities=23%  Similarity=0.296  Sum_probs=186.6

Q ss_pred             eEeeeCceEEEEEEec-CCcEEEEEEcCCCCc---hhHHHHHHHHH---HHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIE---MLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      +||+|+||.||++... +++.||+|.+.....   .....+..|..   +++...||||+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999765 588999998765321   11223444443   4455689999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++...  ..+++..+..++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++......    
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence            99999988543  469999999999999999999999   899999999999999999999999999987543211    


Q ss_pred             eecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          621 STAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....|+..|+|||++.++ .++.++|||||||+++||++|+.||............    ....      .....    
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~----  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVE----  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCC----
Confidence            2234689999999998754 6899999999999999999999999754322111110    0000      00111    


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCC-----CHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl~  731 (805)
                      .+......+.+++.+|+..+|.+||     ++.++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1222346688999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-32  Score=302.94  Aligned_cols=259  Identities=20%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC------C
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK------N  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~  530 (805)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .......+.+|++++++++|+||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378888899999999999999865 6899999987643  223345688999999999999999999998644      3


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ..++|+||+.. +|.+++.    ..+++..+..++.|+++||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            56999999964 6766541    358999999999999999999999   899999999999999999999999999998


Q ss_pred             CCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH--------H
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------K  681 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~  681 (805)
                      .....     .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||................        .
T Consensus       166 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            64321     223467889999999876 568999999999999999999999997543322111110000        0


Q ss_pred             HhhcCCcccc-------cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          682 WQNKGQLDQI-------IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 ~~~~~~~~~~-------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      ..........       ....+.. ..+.....+.+++.+||+.+|.+||++.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000000       0000000 001223457899999999999999999999853

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.3e-32  Score=292.85  Aligned_cols=254  Identities=24%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             CcccceEeeeCceEEEEEEe----cCCcEEEEEEcCCCC----chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEE
Q 003659          463 FDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  533 (805)
                      |...+.||+|++|.||+++.    .+++.||||.+....    ....+.+.+|++++.++ +|+||+++.+.+..+...+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56678999999999999974    257889999876432    22346688999999999 5999999999999999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||+++|+|.+++...  ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++|+|||+++...
T Consensus        82 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          82 LILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999999998643  368999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCcceeecccccccccChhhhccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ... ........|+..|+|||.+.+..  .+.++||||||++++||++|+.|+.......  ............      
T Consensus       157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~------  227 (288)
T cd05583         157 AEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS------  227 (288)
T ss_pred             ccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc------
Confidence            321 11123356889999999987655  7899999999999999999999986322111  111111111110      


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                       .+    ..+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       228 -~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 -KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             -CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence             01    1112233457889999999999999999988766543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-33  Score=303.13  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCC-----eEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-----EMI  533 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~  533 (805)
                      +|...+.||.|++|.||+|+.. +++.+|+|++....  ....+.+.+|+++++.++|+||+++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4677789999999999999876 48999999887643  344577899999999999999999999987765     789


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      +||||++ ++|.+++....  .+++..++.++.|+++||+|||+   .+++||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999998 48988886543  79999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCC-cceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhh-------
Q 003659          614 EIDQ-THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN-------  684 (805)
Q Consensus       614 ~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------  684 (805)
                      .... ........++..|+|||.+.+. .++.++||||||+++++|++|++||......+.....   .....       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI---VEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHhcCCCChhHh
Confidence            3211 0112345678899999999887 8999999999999999999999999765433221111   11000       


Q ss_pred             ----cCCcccccC---ccc---cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          685 ----KGQLDQIID---PTL---AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       685 ----~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                          .......+.   ...   .....+.....+.+++.+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                000000000   000   000112235668899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-32  Score=295.81  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=192.9

Q ss_pred             cCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCC-chhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++|...+.||+|++|.||+|+.++ ++.||||++.... .....++..|+.++.+.. |+||++++++|..+...++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            456777899999999999999875 8999999986543 233456777888777775 9999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      |+.+ +|.+++.... ..+++..+..++.|+++||+|||+  ..+|+||||+|+||++++++.+||+|||++....... 
T Consensus        95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-  169 (296)
T cd06618          95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-  169 (296)
T ss_pred             ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence            9854 6666654432 379999999999999999999996  1489999999999999999999999999987643211 


Q ss_pred             cceeecccccccccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQ----LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                        ......++..|+|||.+.+..    ++.++||||||+++|||++|+.||...... ...+    ....... .     
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~~~-~-----  236 (296)
T cd06618         170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVL----TKILQEE-P-----  236 (296)
T ss_pred             --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHH----HHHhcCC-C-----
Confidence              122345788999999987553    789999999999999999999999643211 1111    1111110 0     


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      +.+.  ........+.+++.+|++.+|.+||++.+++++
T Consensus       237 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 PSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000  001234568899999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-32  Score=302.05  Aligned_cols=270  Identities=21%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             ccCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEE
Q 003659          450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYC  526 (805)
Q Consensus       450 ~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~  526 (805)
                      .....++..++++|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++|+||+++.+++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3445677788899999999999999999999764 68999999886532  23356788999999999999999999987


Q ss_pred             ccC------CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          527 DEK------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       527 ~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      ...      ...+++++++ +++|.+++...   .+++..++.++.|+++||+|||+   .+++||||||+||++++++.
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~  158 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE  158 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence            532      3467888876 67898877432   58999999999999999999999   99999999999999999999


Q ss_pred             EEEeecCCCCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHH-HH
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLA-EW  678 (805)
Q Consensus       601 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~  678 (805)
                      +||+|||+++....     ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||............ .+
T Consensus       159 ~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  233 (345)
T cd07877         159 LKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  233 (345)
T ss_pred             EEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            99999999876432     1234567889999999866 56889999999999999999999999654332211110 00


Q ss_pred             H-------HHHhhcCC-------cccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          679 A-------MKWQNKGQ-------LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       679 ~-------~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      .       ........       +.......... ........+.+++.+|++.+|.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0       00000000       00000000000 000123457899999999999999999999754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.8e-32  Score=291.64  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...+.||+|++|.||+|+.. +++.||+|.+...   .....+.+..|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36777889999999999999876 6899999987653   2334567889999999998 99999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+++++|.+++....  .+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999996543  69999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCc------------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 003659          616 DQT------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE  677 (805)
Q Consensus       616 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (805)
                      ...                  .......|+..|+|||.+....++.++||||||++++|+++|+.|+........   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence            211                  112334578899999999888899999999999999999999999975432111   11


Q ss_pred             HHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCH----HHHHH
Q 003659          678 WAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSM----GDVLW  731 (805)
Q Consensus       678 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm----~evl~  731 (805)
                      ...   .           .....+......+.+++.+||+.+|.+||++    ++++.
T Consensus       233 ~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KIL---K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH---h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            100   0           0111222335668899999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-32  Score=297.95  Aligned_cols=256  Identities=21%  Similarity=0.257  Sum_probs=192.9

Q ss_pred             cceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchh--------------HHHHHHHHHHHhcCCCCceEEEEEEEccCC
Q 003659          466 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--------------LAEFQTEIEMLSQFRHRHLVSLIGYCDEKN  530 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  530 (805)
                      .+.||+|+||.||+|... +++.||||.+.......              ...+.+|++++++++|+||+++++++..++
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999865 68999999875432211              124778999999999999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ..++||||+. |+|.+++...  ..+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcccee
Confidence            9999999997 6899888543  358999999999999999999999   999999999999999999999999999997


Q ss_pred             CCCCCC------------CcceeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHH
Q 003659          611 TGPEID------------QTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE  677 (805)
Q Consensus       611 ~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~  677 (805)
                      ......            .........++..|+|||++.+. .++.++|||||||+++||++|++||....+.+..   .
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~  244 (335)
T PTZ00024        168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL---G  244 (335)
T ss_pred             ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence            644100            01111233567889999998764 4789999999999999999999999755433221   1


Q ss_pred             HHHHHhhcCC---cccc------------cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          678 WAMKWQNKGQ---LDQI------------IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       678 ~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..........   ..+.            ..+... .........+.+++.+|++.+|++||++.|++.
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1111111000   0000            000000 001123456889999999999999999999974

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.9e-32  Score=290.64  Aligned_cols=250  Identities=24%  Similarity=0.299  Sum_probs=194.1

Q ss_pred             CCcccceEeeeCceEEEEEEe----cCCcEEEEEEcCCCC----chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  532 (805)
                      +|...+.||+|+||.||+++.    .+|..||+|++....    ....+.+.+|++++.++ +|+||+++.+++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            366778999999999999976    368899999876532    22346788999999999 599999999999999999


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++||||+++++|.+++...  ..+++..+..++.|+++||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999998654  368899999999999999999999   99999999999999999999999999999764


Q ss_pred             CCCCCcceeecccccccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .... ........|+..|+|||.+...  .++.++||||||++++||++|+.|+......  .....+........    
T Consensus       156 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~----  228 (290)
T cd05613         156 HEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE----  228 (290)
T ss_pred             cccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC----
Confidence            3311 1112235688999999998753  4688999999999999999999998643211  11111111111110    


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCC-----CHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVL  730 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----sm~evl  730 (805)
                         +    .++......+.+++.+|++.+|.+||     ++.+++
T Consensus       229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence               1    11222345678999999999999997     555554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.2e-32  Score=295.92  Aligned_cols=266  Identities=24%  Similarity=0.301  Sum_probs=195.0

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccC-------
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-------  529 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------  529 (805)
                      .++|...+.||+|+||.||+|+.+ +++.+|+|++.....  .....+.+|++++++++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467889999999999999999876 588999998754322  2234567899999999999999999887433       


Q ss_pred             -CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          530 -NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       530 -~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                       ..+++|+||+.. +|...+... ...+++.++..++.|+++||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999975 677766543 2469999999999999999999999   8999999999999999999999999999


Q ss_pred             CCCCCCCCCc---------ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHH
Q 003659          609 SKTGPEIDQT---------HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW  678 (805)
Q Consensus       609 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  678 (805)
                      ++........         ...+...|+..|+|||.+.+ ..++.++|||||||+++||++|++||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9754321111         11234467888999998765 4589999999999999999999999975544322111110


Q ss_pred             HHHHhh------cCCccccc--------CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          679 AMKWQN------KGQLDQII--------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       679 ~~~~~~------~~~~~~~~--------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......      ...+....        .+.+.... ......+.+++.+||+.+|.+||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000000      00000100        00110000 112356889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.5e-32  Score=295.13  Aligned_cols=264  Identities=23%  Similarity=0.293  Sum_probs=198.2

Q ss_pred             HHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc-CCe
Q 003659          456 VQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNE  531 (805)
Q Consensus       456 l~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  531 (805)
                      +..++++|...+.||+|+||.||++... +++.||+|++...  .....+.+..|++++++++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999765 6899999987542  22335678899999999999999999998855 567


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++|+||+ +++|.+++...   ++++.....++.|+++||+|||+   .+++||||||+|||+++++.+||+|||++..
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            89999998 46888887533   47888999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HHH--------HHHH
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAE--------WAMK  681 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~~~~  681 (805)
                      ....     .....++..|+|||.+.+ ..++.++|||||||+++||+||+.||.......... +.+        |...
T Consensus       158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4321     123457889999998765 578999999999999999999999997544322111 111        1110


Q ss_pred             HhhcCCcccccCccccCCCC-----hhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          682 WQNKGQLDQIIDPTLAGKIR-----PDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ........-+..-......+     +.....+.+++.+|++.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000000000000011     123467889999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=2.1e-32  Score=300.89  Aligned_cols=264  Identities=21%  Similarity=0.297  Sum_probs=194.8

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccC----------
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK----------  529 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----------  529 (805)
                      .+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            56888899999999999999875 5899999988776656677889999999999999999999776443          


Q ss_pred             ----CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC-CCCcEEEe
Q 003659          530 ----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVA  604 (805)
Q Consensus       530 ----~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld-~~~~~kl~  604 (805)
                          ...++||||++ ++|.+++...   .+++..++.++.|+++||+|||+   .+++||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 5888887432   58899999999999999999999   8999999999999997 45678999


Q ss_pred             ecCCCCCCCCCCC-cceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH
Q 003659          605 DFGLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       605 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      |||+++....... ........++..|+|||.+.. ..++.++|||||||+++||++|+.||....+.+...........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999976432111 111123457889999998754 56889999999999999999999999765443221111000000


Q ss_pred             hhc---CC----cccccC-ccccC-----CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          683 QNK---GQ----LDQIID-PTLAG-----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       683 ~~~---~~----~~~~~d-~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...   ..    +..... .....     ...+.....+.+++.+|++.+|.+||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000   00    000000 00000     001123456789999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.1e-32  Score=318.25  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=190.1

Q ss_pred             HHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC-----
Q 003659          457 QEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----  529 (805)
Q Consensus       457 ~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  529 (805)
                      .+-..+|++.++||+||||.|||++.+ ||+.+|||++... +........+|++.|++|+|||||+++..+.+.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345567888889999999999999887 8999999988765 344466788999999999999999987654220     


Q ss_pred             --------------------------------------------------------------------------------
Q 003659          530 --------------------------------------------------------------------------------  529 (805)
Q Consensus       530 --------------------------------------------------------------------------------  529 (805)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------------CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003659          530 ----------------------------------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL  575 (805)
Q Consensus       530 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL  575 (805)
                                                        ..+|+-||||+.-.|+++++.+.... .-...++++++|++||+|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                              12356678887766666665443211 3567899999999999999


Q ss_pred             hccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC----C------------CCCcceeecccccccccChhhhccC
Q 003659          576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP----E------------IDQTHVSTAVKGSFGYLDPEYFRRQ  639 (805)
Q Consensus       576 H~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~  639 (805)
                      |+   .+||||||||.||+||++..+||+|||+|....    .            .......+...||.-|+|||.+.+.
T Consensus       714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            99   999999999999999999999999999997511    0            0011124667899999999999764


Q ss_pred             ---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhch
Q 003659          640 ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL  716 (805)
Q Consensus       640 ---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  716 (805)
                         .|+.|.|+||+||||+||+.   ||....+.-     . +..-.+.+.+..-      ..+..+....-..++.+++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa-----~-iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA-----S-ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHH-----H-HHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               59999999999999999984   465432211     1 1111233433322      1111223334468899999


Q ss_pred             hcCCCCCCCHHHHHH
Q 003659          717 ADFGVDRPSMGDVLW  731 (805)
Q Consensus       717 ~~~p~~RPsm~evl~  731 (805)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999984

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=5e-32  Score=296.62  Aligned_cols=263  Identities=24%  Similarity=0.274  Sum_probs=192.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-C--CcEEEEEEcCCC--CchhHHHHHHHHHHHhcC-CCCceEEEEEEEcc----CCe
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-D--GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE----KNE  531 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~  531 (805)
                      +|...+.||+|+||.||+++.. .  +..||+|++...  .....+.+.+|+++++++ +|+||+++++++..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999875 3  778999987643  222356788999999999 59999999997533    245


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++++||+. ++|.+++...  ..+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788888886 6898888543  468999999999999999999999   8999999999999999999999999999976


Q ss_pred             CCCCCCc--ceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHH---------HH
Q 003659          612 GPEIDQT--HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE---------WA  679 (805)
Q Consensus       612 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~  679 (805)
                      .......  .......||..|+|||++.+ ..++.++|||||||+++||++|++||.............         +.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            4321111  11234568999999998765 468999999999999999999999997544322111000         00


Q ss_pred             HHHhhcC------CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          680 MKWQNKG------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       680 ~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ..+....      .....-...+. ...+.....+.+++.+|++.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000      00000000000 011122456889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=2.4e-32  Score=297.90  Aligned_cols=246  Identities=25%  Similarity=0.338  Sum_probs=206.5

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      -...|.....||+|.|++|.+|+.. .+..||||.+....-  ...+.+.+|+++|+.|+|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3567888899999999999999765 589999998876532  3345588999999999999999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+.+|.+.++|...+  .+.......+..|+.++++|||+   +.|||||||++||||+.++++||+|||++....  
T Consensus       134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec--
Confidence            99999999999997665  45668889999999999999999   999999999999999999999999999998753  


Q ss_pred             CCcceeecccccccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                       ........+|++.|.|||++.+.++ .+++|+||+|++||-|++|..||+...-.                   ++-++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r  266 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR  266 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence             3445567899999999999998765 58999999999999999999999854221                   11122


Q ss_pred             cccCCC--ChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKI--RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+.+.+  +.-...++.+++++.|-.+|.+|++++++.+
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            233322  2233456778899999999999999999876

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=5.3e-32  Score=288.53  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=198.6

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |...+.||+|++|.||+|+.. +++.+|+|.+....  ....+.+..|++++++++|+|++++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            345568999999999999876 48999999877653  333567889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      + ++|.+++.... ..+++..+++++.++++||+|||+   .+++||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            8 58999986543 469999999999999999999999   8999999999999999999999999999986543221  


Q ss_pred             eeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HHHHHH-----HHhhcCCc---c
Q 003659          620 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAEWAM-----KWQNKGQL---D  689 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~-----~~~~~~~~---~  689 (805)
                      ......++..|+|||.+.+. .++.++|||||||+++||++|++||......+... ......     .+..-..+   .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12234457789999998766 88999999999999999999999997543222111 100000     00000000   0


Q ss_pred             cccCcc---ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          690 QIIDPT---LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       690 ~~~d~~---l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ......   ......+.....+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000   000001122457899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=6.1e-32  Score=284.89  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=193.2

Q ss_pred             CCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCC-----CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      +|...+.||+|+||.||+++... +..+++|.++..     ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36677899999999999997653 444555544321     222344677899999999999999999999999999999


Q ss_pred             EEeccCCcccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          536 YEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      |||+++++|.+++..  .....+++.+++.++.|+++||.|||+   .+++|+||||+||++++ ..+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988854  233579999999999999999999999   99999999999999986 469999999987643


Q ss_pred             CCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccC
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ..  ........|+..|+|||.+.+..++.++|+||||+++++|++|+.|+.......      ....... +.     .
T Consensus       157 ~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~-~~-----~  222 (260)
T cd08222         157 GS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVE-GP-----T  222 (260)
T ss_pred             CC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHc-CC-----C
Confidence            21  112234568889999999988889999999999999999999999986432211      1111111 10     1


Q ss_pred             ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +    ..+......+.+++.+|++.+|++||++.|+++
T Consensus       223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1    112334567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=8.2e-32  Score=296.25  Aligned_cols=261  Identities=22%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCC----
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----  530 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  530 (805)
                      ...++|...+.||+|+||.||+|... ++..||||++...  .....+.+.+|++++++++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34677988999999999999999765 6899999987543  2233456889999999999999999999986543    


Q ss_pred             --eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          531 --EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       531 --~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                        ..++||||+ +++|.+++..   ..+++..++.++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              468999999 6788888753   358999999999999999999999   8999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh-hHH--------HH
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV-NLA--------EW  678 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~--------~~  678 (805)
                      +......     .....++..|+|||.+.+ ..++.++|||||||++++|++|+.||......... ...        .|
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9864321     123467889999999876 46889999999999999999999999754322110 000        01


Q ss_pred             HHHHhhcC------CcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          679 AMKWQNKG------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       679 ~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...+....      .+.......+ ....+.....+.+++.+|++.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000000      0000000000 0011223445789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-33  Score=327.65  Aligned_cols=250  Identities=26%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCC--CCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNP--RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +-++....+||.|.||.||.|.. ++|+..|+|.+..  ......+...+|+.+|..|+|||+|+.+|+-.+.+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            34566677999999999999965 4699999996543  33455677889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~  616 (805)
                      |||++|+|.+.+...+  -+++........|++.|++|||+   .+||||||||.||+|+.+|.+|++|||.|.......
T Consensus      1314 EyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            9999999999986543  35566667788999999999999   999999999999999999999999999998754421


Q ss_pred             --CcceeecccccccccChhhhccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHH-hhcCCccc
Q 003659          617 --QTHVSTAVKGSFGYLDPEYFRRQ---QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQ  690 (805)
Q Consensus       617 --~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~  690 (805)
                        .........||+.|||||++.+.   .-..++||||+|||++||+||++||.....       +|+.-+ +..|... 
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~P- 1460 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHKP- 1460 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCCC-
Confidence              11223467899999999999753   345789999999999999999999974422       233221 1222211 


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                              .++......-.+++.+||+.||.+|.++.|++
T Consensus      1461 --------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1461 --------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred             --------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence                    22333455567889999999999997766554

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=274.55  Aligned_cols=241  Identities=26%  Similarity=0.321  Sum_probs=197.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      -++|+..++||+|.||+|-+++-+ .++.+|+|+++..-   ......-..|-++|+..+||.+..|--.+...+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            357888899999999999999776 58999999887653   33445567899999999999999998889999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||..+|.|.-+|...  +.+++....-....|..||.|||+   .+||.||||-+|.|||.+|++||+||||++..-  
T Consensus       247 MeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--  319 (516)
T ss_pred             EEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence            9999999999999554  467887777888999999999999   999999999999999999999999999998643  


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                      .........+||+.|+|||++....|..+.|.|.+|||||||+||+.||..........++-             +-|- 
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-------------~ed~-  385 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-------------MEDL-  385 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-------------hhhc-
Confidence            23334567899999999999999999999999999999999999999997543332222211             0011 


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCC
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRP  724 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  724 (805)
                         .++.....+...+....|..+|.+|.
T Consensus       386 ---kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  386 ---KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ---cCCccCCHHHHHHHHHHhhcChHhhc
Confidence               12333344566778888999999994

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=269.11  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=192.0

Q ss_pred             ceEeeeCceEEEEEEec-CCcEEEEEEcCCCC-chhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          467 WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      ..||.|..|.|++++.+ .|..+|||.+.... .+..++++..++++.+-+ +|.||+.+|||..+....+.||.|.- .
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C  176 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C  176 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H
Confidence            36999999999999876 48999999877654 445677778888776664 89999999999999999999999853 4


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeec
Q 003659          544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA  623 (805)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~  623 (805)
                      +..+|.... .++++.-+-++...+.+||.||.+  +++|+|||+||+|||+|+.|++||+|||++-.+-.   ....+.
T Consensus       177 ~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkAhtr  250 (391)
T KOG0983|consen  177 AEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKAHTR  250 (391)
T ss_pred             HHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---cccccc
Confidence            455554433 468888888999999999999998  47899999999999999999999999999976432   334566


Q ss_pred             ccccccccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          624 VKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTL-PREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       624 ~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ..|.+.|||||.+.-   ..|+.++||||||+.|+||.||+.||.... +.+...      ....++      -|.|.+.
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt------kvln~e------PP~L~~~  318 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT------KVLNEE------PPLLPGH  318 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH------HHHhcC------CCCCCcc
Confidence            779999999999863   478999999999999999999999997532 222111      111111      1222221


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                        ......+.+++..||+.|+.+||...++++
T Consensus       319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              124667999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.6e-31  Score=278.01  Aligned_cols=236  Identities=27%  Similarity=0.339  Sum_probs=193.4

Q ss_pred             EeeeCceEEEEEEec-CCcEEEEEEcCCCCc---hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcc
Q 003659          469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL  544 (805)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999876 488999998765432   2456889999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecc
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV  624 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~  624 (805)
                      .+++....  .+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            99996543  68999999999999999999999   999999999999999999999999999997653321  123345


Q ss_pred             cccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       625 ~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      .++..|++||.+.+...+.++|+||||++++||++|+.||.......   ...   .... +.          ..++...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~-~~----------~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE---KILK-DP----------LRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHhc-CC----------CCCCCCC
Confidence            68889999999988889999999999999999999999997543211   111   1111 00          0122222


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGD  728 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~e  728 (805)
                      ...+.+++.+|+..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            456789999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.2e-32  Score=297.81  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=196.9

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe---
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE---  531 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---  531 (805)
                      ...++|...+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.++++++|+|++++.+++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34667888899999999999999876 5789999987643  23345667889999999999999999988765544   


Q ss_pred             ---EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          532 ---MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       532 ---~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                         .++|+||+ +++|.+++..   ..+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999998 5699988854   359999999999999999999999   8999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhh-HHH--------H
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN-LAE--------W  678 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~  678 (805)
                      +......     .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+... +..        +
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            9864321     233467889999999865 467899999999999999999999997543322110 000        0


Q ss_pred             HHHHhhcCCcccccC-------ccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          679 AMKWQNKGQLDQIID-------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       679 ~~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ...+.. ......+.       +.+.. ........+.+++.+||+.+|.+|||+.||+.
T Consensus       240 ~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISS-ESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             Hhhccc-hhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            000000 00000000       00000 00112567889999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=9.5e-31  Score=310.51  Aligned_cols=145  Identities=30%  Similarity=0.407  Sum_probs=130.7

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...++||+|+||.||+|... +++.||||++....   ......+..|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            56888899999999999999876 68999999876532   233567889999999999999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ||+.+++|.+++....  .+++..++.|+.||+.||+|||.   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999986543  58899999999999999999999   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=295.79  Aligned_cols=259  Identities=26%  Similarity=0.375  Sum_probs=213.7

Q ss_pred             CHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEc--
Q 003659          452 PFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD--  527 (805)
Q Consensus       452 ~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~--  527 (805)
                      .+..+..-+.-|++.+.||+|.+|.||+++.. +++.+|+|++...... .++...|.++|+.+ .|||++.++|++.  
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            34444455677888999999999999999754 6899999988776543 46678899999988 6999999999983  


Q ss_pred             ---cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEe
Q 003659          528 ---EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA  604 (805)
Q Consensus       528 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~  604 (805)
                         .+++++||||||.+|+..|++.+.....+.|..+..|+..+++||.+||.   ..++|||||-.||||+.++.+||+
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence               46799999999999999999987667789999999999999999999999   999999999999999999999999


Q ss_pred             ecCCCCCCCCCCCcceeecccccccccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 003659          605 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (805)
                      |||++..+..  ......+..||+.|||||++...     .|+.++|+||||++..||.-|.+|+..+.+....      
T Consensus       166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------  237 (953)
T KOG0587|consen  166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------  237 (953)
T ss_pred             eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence            9999987543  22334567899999999999643     4678999999999999999999999866543211      


Q ss_pred             HHHhhcCCccccc-CccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          680 MKWQNKGQLDQII-DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       680 ~~~~~~~~~~~~~-d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                               ..+. .|...-.-+..+.+++.+++..||..+-.+||++.++++
T Consensus       238 ---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 ---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     1111 122222334677899999999999999999999999986

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-33  Score=272.64  Aligned_cols=261  Identities=24%  Similarity=0.270  Sum_probs=199.7

Q ss_pred             cccCHHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc-hhHHHHHHHHHHHhc-CCCCceEEEEEE
Q 003659          449 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQ-FRHRHLVSLIGY  525 (805)
Q Consensus       449 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~H~niv~l~g~  525 (805)
                      +.|+-..|+...       .||.|.||+|+|-..+ .|+..|||++..... ...++++.|.+...+ -++||||+++|.
T Consensus        59 ~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   59 HTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccchHHHHH-------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            456666665543       6999999999999766 699999999876543 567788888886554 479999999999


Q ss_pred             EccCCeEEEEEEeccCCccccc---ccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEE
Q 003659          526 CDEKNEMILIYEYMENGTLKGH---LYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAK  602 (805)
Q Consensus       526 ~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~k  602 (805)
                      +..++.+++.||.|+- +|..+   .+.-....+++.-+-+|.....+||.||.+  ...|||||+||+|||||..|.+|
T Consensus       132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEe
Confidence            9999999999999964 55443   233334568888888999999999999998  36899999999999999999999


Q ss_pred             EeecCCCCCCCCCCCcceeecccccccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH
Q 003659          603 VADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       603 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  680 (805)
                      |||||++-.+..   ....+...|...|||||.+..  ..|+.+|||||||++|+|+.||+.|+.....     ..+...
T Consensus       209 LCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  209 LCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            999999876432   333456678899999999863  3589999999999999999999999975432     222222


Q ss_pred             HHhhcCCcccccCccccCC-CChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          681 KWQNKGQLDQIIDPTLAGK-IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      +... +.-     |.+... -..+....+..++..||..+-..||...++.++-
T Consensus       281 ~Vv~-gdp-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  281 QVVI-GDP-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             HHHc-CCC-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence            2211 111     111111 1123456789999999999999999999987643

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=270.14  Aligned_cols=263  Identities=22%  Similarity=0.310  Sum_probs=200.7

Q ss_pred             HHHHHHHhcCCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCC
Q 003659          453 FVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKN  530 (805)
Q Consensus       453 ~~el~~at~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  530 (805)
                      ++++-..|.     ++||+|+++.|-.++ +.+|..+|||++............+|++++.+.+ |+||+.|+.+|+++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455555554     489999999998884 5689999999998887777888999999999995 999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC---cEEEeecC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVADFG  607 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~---~~kl~DFG  607 (805)
                      ..|||||-|.+|+|.++|+...  .+++.+..++..+||.||.|||.   ++|.|||+||+|||..+..   -+||+||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999999999997654  68999999999999999999999   9999999999999997654   48999999


Q ss_pred             CCCCCCCCC-----CcceeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhh----
Q 003659          608 LSKTGPEID-----QTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV----  673 (805)
Q Consensus       608 la~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~----  673 (805)
                      |..-.....     .+....+.+|+..|||||+..     ...|+.++|.||||||||-||+|.+||...-..+..    
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            874321111     111123567899999999874     346889999999999999999999999765332210    


Q ss_pred             ----hHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          674 ----NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       674 ----~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                          ........-.++|. .+.-|+..     ...+....+++...+..++.+|-++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                00010111111111 11111111     123455677888888899999999888876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.5e-31  Score=273.00  Aligned_cols=222  Identities=19%  Similarity=0.168  Sum_probs=178.1

Q ss_pred             eCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccccccC
Q 003659          472 GGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG  550 (805)
Q Consensus       472 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  550 (805)
                      |.+|.||+++.. +++.+|+|++....     .+..|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            789999999875 68899999986543     234555666667899999999999999999999999999999999865


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccc
Q 003659          551 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY  630 (805)
Q Consensus       551 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (805)
                      .  ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.++++|||++......     .....++..|
T Consensus        79 ~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 F--LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             h--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            4  358999999999999999999999   99999999999999999999999999987654321     1233456789


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHH
Q 003659          631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE  710 (805)
Q Consensus       631 ~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  710 (805)
                      +|||.+....++.++||||+|++++||++|+.|+.......                 ......    ..+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTL----NIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------cccccc----CCcccCCHHHHH
Confidence            99999988889999999999999999999998765321100                 000000    112223456888


Q ss_pred             HHHhchhcCCCCCCCHHHH
Q 003659          711 TAEKCLADFGVDRPSMGDV  729 (805)
Q Consensus       711 l~~~Cl~~~p~~RPsm~ev  729 (805)
                      ++.+|++.+|.+||++.+.
T Consensus       208 li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         208 LLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHccCCHHHhcCCCcc
Confidence            9999999999999997544

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=266.33  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=196.6

Q ss_pred             HhcCCccc-ceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEc----cCCe
Q 003659          459 ATNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCD----EKNE  531 (805)
Q Consensus       459 at~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~----~~~~  531 (805)
                      .+++|.+. ++||-|-.|+|-.+..+ .|+.+|+|++....     ...+|+++--+. .|||||.++++++    ....
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34555543 58999999999999765 68999999987542     346788765554 6999999999874    3467


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC---CCcEEEeecCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGL  608 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~---~~~~kl~DFGl  608 (805)
                      +++|||.|+||.|...+...+...+++.+.-+|..||+.|+.|||+   .+|.||||||+|+|...   |...||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence            8899999999999999988888889999999999999999999999   99999999999999964   55799999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      |+....   .....+.+-|+.|.|||++...+|+..+|+||+||++|-||||.+||........   ..=.....+.++ 
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~gq-  283 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTGQ-  283 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhccC-
Confidence            997432   2234566789999999999999999999999999999999999999975432110   000000011111 


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .++-++..     ...++...++++..|..+|.+|.|+.+++.
T Consensus       284 y~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  284 YEFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             ccCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            01111111     234677889999999999999999999974

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=3.5e-30  Score=266.83  Aligned_cols=238  Identities=27%  Similarity=0.363  Sum_probs=193.8

Q ss_pred             CceEEEEEEecC-CcEEEEEEcCCCCchh-HHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccccccC
Q 003659          473 GFGKVYKGELND-GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG  550 (805)
Q Consensus       473 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  550 (805)
                      +||.||+|+..+ ++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999998874 8999999988765544 68899999999999999999999999999999999999999999999865


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccc
Q 003659          551 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY  630 (805)
Q Consensus       551 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (805)
                      ..  .+++..++.++.+++++|+|||+   .+++|+||+|+||++++++.++|+|||++.......   ......++..|
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            43  38999999999999999999999   899999999999999999999999999998754421   23345678899


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHH
Q 003659          631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGE  710 (805)
Q Consensus       631 ~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  710 (805)
                      ++||.+....++.++||||||++++||++|+.|+......  .....+.    ......    .   ..........+.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~~----~---~~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKPP----F---PPPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCCC----C---ccccccCCHHHHH
Confidence            9999999888999999999999999999999998753111  1111111    111000    0   0000003467889


Q ss_pred             HHHhchhcCCCCCCCHHHHHH
Q 003659          711 TAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       711 l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=3.5e-31  Score=265.13  Aligned_cols=203  Identities=27%  Similarity=0.362  Sum_probs=167.9

Q ss_pred             hcCCcccceEeeeCceEEEEEEec---C--CcEEEEEEcCCCCch--hHHHHHHHHHHHhcCCCCceEEEEEEEcc-CCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN---D--GTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~  531 (805)
                      ...|+....||+|.||.||||.-+   +  ...+|+|+++.....  .-....+|+.++++|+||||+.|..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346778889999999999999543   2  237899988765321  12456789999999999999999999866 788


Q ss_pred             EEEEEEeccCCcccccccC---CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC----CcEEEe
Q 003659          532 MILIYEYMENGTLKGHLYG---SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN----FMAKVA  604 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~----~~~kl~  604 (805)
                      .+|++||.+. +|.+.++-   ...+.++...+..|..||+.|++|||+   .=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999987 88887753   223578889999999999999999999   889999999999999877    899999


Q ss_pred             ecCCCCCCCCCCCcc-eeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003659          605 DFGLSKTGPEIDQTH-VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       605 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~  666 (805)
                      |||+++.....-... ....++-|..|.|||.+.+ ..||.+.|||+.||++.||+|-++.|..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999865433332 2345678999999999876 5799999999999999999998887754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=8.3e-30  Score=288.03  Aligned_cols=260  Identities=22%  Similarity=0.256  Sum_probs=182.6

Q ss_pred             HhcCCcccceEeeeCceEEEEEEe-----------------cCCcEEEEEEcCCCCchhHHHH--------------HHH
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGEL-----------------NDGTKVAVKRGNPRSQQGLAEF--------------QTE  507 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~E  507 (805)
                      ..++|...++||+|+||.||+|.+                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            366899999999999999999964                 2356899999876543333333              347


Q ss_pred             HHHHhcCCCCce-----EEEEEEEcc--------CCeEEEEEEeccCCcccccccCCC----------------------
Q 003659          508 IEMLSQFRHRHL-----VSLIGYCDE--------KNEMILIYEYMENGTLKGHLYGSG----------------------  552 (805)
Q Consensus       508 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~----------------------  552 (805)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777888877655     677888743        457899999999999999886421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccC
Q 003659          553 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD  632 (805)
Q Consensus       553 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  632 (805)
                      ...++|..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..... .........+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~-~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG-INFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccC-CccCccccCCCcceeC
Confidence            1235788899999999999999999   89999999999999999999999999999754321 1111122345789999


Q ss_pred             hhhhccCC----------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCChh--h----hhhHHHHHHHHh
Q 003659          633 PEYFRRQQ----------------------LTEKSDVYSFGVVLFEVLCARP-VIDPTLPR--E----MVNLAEWAMKWQ  683 (805)
Q Consensus       633 PE~~~~~~----------------------~s~ksDV~S~Gvvl~elltG~~-p~~~~~~~--~----~~~l~~~~~~~~  683 (805)
                      ||.+....                      ...+.||||+||+++||++|.. |+......  +    ...+..|...  
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence            99875432                      1235799999999999999975 55422111  0    0112222211  


Q ss_pred             hcCCcccccCccccCCCChhHHHHHHHHHHhchhcCC---CCCCCHHHHHHH
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG---VDRPSMGDVLWN  732 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPsm~evl~~  732 (805)
                      ....    .+-..    .........+++.+||..+|   .+|+|++|++++
T Consensus       457 ~~~~----~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        457 KGQK----YDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cccC----CCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1100    01001    11224557788999998765   689999999753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=8e-30  Score=295.40  Aligned_cols=259  Identities=20%  Similarity=0.242  Sum_probs=169.8

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-C----CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEE------Ec
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-D----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY------CD  527 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~  527 (805)
                      ..++|...++||+|+||.||+|++. +    +..||||++......  +.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999875 4    689999987653321  111111  1222222222222111      35


Q ss_pred             cCCeEEEEEEeccCCcccccccCCCCC------------------CCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccC
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLP------------------SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK  589 (805)
Q Consensus       528 ~~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik  589 (805)
                      .+.+.++||||+++++|.+++......                  ......+..++.|+++||+|||+   .+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            667899999999999999988643211                  11233456799999999999999   899999999


Q ss_pred             CCcEEeCC-CCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccC----------------------CCCchhh
Q 003659          590 SANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ----------------------QLTEKSD  646 (805)
Q Consensus       590 p~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD  646 (805)
                      |+|||+++ ++.+||+|||+++.... ..........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~-~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRV-GINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccc-ccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57999999999986432 122223456789999999965321                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChh-------hhhhHHHHHHHHhhcCCcccccCccccCCC--ChhHHHHHHHHHHhchh
Q 003659          647 VYSFGVVLFEVLCARPVIDPTLPR-------EMVNLAEWAMKWQNKGQLDQIIDPTLAGKI--RPDSLRKFGETAEKCLA  717 (805)
Q Consensus       647 V~S~Gvvl~elltG~~p~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~  717 (805)
                      ||||||+||||+++..+.+.....       ....+..|.......      ..+.+...+  .........+++.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999977654421100       001112222111100      000000000  00012235589999999


Q ss_pred             cCCCCCCCHHHHHH
Q 003659          718 DFGVDRPSMGDVLW  731 (805)
Q Consensus       718 ~~p~~RPsm~evl~  731 (805)
                      .+|.+|||+.|+++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999985

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-30  Score=298.85  Aligned_cols=208  Identities=25%  Similarity=0.309  Sum_probs=181.5

Q ss_pred             HHHHHHHhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc
Q 003659          453 FVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE  528 (805)
Q Consensus       453 ~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  528 (805)
                      ..+++-..++|.+.++||+|+||.|..++.+ .++.+|+|+++..   ......-|..|-.+|..-+.+=|++|.-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3455666788999999999999999999886 4889999998873   23445678899999999999999999999999


Q ss_pred             CCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       529 ~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                      .+.+|||||||+||+|-..+....  .++.....=.+..|.-||.-||+   .|+|||||||+|||||..|++||+|||-
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence            999999999999999999996554  68888888888999999999999   9999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-----QQLTEKSDVYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDV~S~Gvvl~elltG~~p~~~  666 (805)
                      +-.+.. +..-.....+|||-|++||+++.     +.|...+|.||+||++|||+.|..||..
T Consensus       222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            876654 44445667789999999999963     5789999999999999999999999964

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-30  Score=238.27  Aligned_cols=262  Identities=22%  Similarity=0.256  Sum_probs=193.3

Q ss_pred             CcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          463 FDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      |+.-++||+|.+|+|+||+.. .++.||+|+....  ++.......+|+.+|++++|+|||+++++...++.+-+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            445568999999999999765 5889999976543  3334566789999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      +. +|..+...- +..++.+....++.|+++||.++|+   +++.|||+||.|.|++.+|+.|++|||+++..+-.  ..
T Consensus        84 dq-dlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip--vr  156 (292)
T KOG0662|consen   84 DQ-DLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VR  156 (292)
T ss_pred             hH-HHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eE
Confidence            64 787776443 3568999999999999999999999   99999999999999999999999999999975431  12


Q ss_pred             eeecccccccccChhhhccC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhcCC---cccccCc
Q 003659          620 VSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQ---LDQIIDP  694 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d~  694 (805)
                      ..+..+-|..|.+|.++-+. -|+...|+||-||++.|+... ++.|....-.+....+-|......+++   +.++-|-
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            23455678999999998764 588999999999999999875 455554444444333444443333332   2222232


Q ss_pred             cccCCCCh---------hHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRP---------DSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~---------~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .....++.         .....=.++..+.+.-+|.+|.++++.++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            22222221         11111234455555567888888877653

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=274.22  Aligned_cols=242  Identities=23%  Similarity=0.324  Sum_probs=192.8

Q ss_pred             cceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          466 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      +++||.|.||+||-|+.+ +|+.||||++.+.  ..+...++.+|+.+|++++||.||.|.-.|+..+..++|||.+.+ 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            469999999999999765 6999999987653  234457889999999999999999999999999999999999965 


Q ss_pred             cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC---CcEEEeecCCCCCCCCCCCcc
Q 003659          543 TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       543 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~---~~~kl~DFGla~~~~~~~~~~  619 (805)
                      +..+++..+....|+...-.-++.||+.||.|||.   ++|+|+||||+||||.+.   -++||+|||.|+..++   ..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence            55555545555678888888899999999999999   999999999999999644   4799999999999765   23


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-hhhhHHHHHHHHhhcCCcccccCccccC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR-EMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ....++||+.|+|||+++.+.|...-|+||.||++|--|+|..||....+. +...-+.            -+.-+.-- 
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------FMyPp~PW-  788 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------FMYPPNPW-  788 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------cccCCCch-
Confidence            345789999999999999999999999999999999999999999754221 1111000            00011111 


Q ss_pred             CCChhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       699 ~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                         .+......++|...|+..-.+|-+...-+
T Consensus       789 ---~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 ---SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ---hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence               23345567888888888888888876654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=284.74  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=192.0

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ++.|.....+|.|.|+.|-++... +++..+||++.....    +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            556777778999999999988665 578899999876622    234677666555 79999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe-CCCCcEEEeecCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-d~~~~~kl~DFGla~~~~~~~  616 (805)
                      .+.++-|.+.+....  ... .++..|+.+|+.++.|||+   +++|||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999988888775543  222 7788899999999999999   999999999999999 69999999999999876542 


Q ss_pred             CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccc
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                          ....+-|..|.|||++....+++++|+||||++|||||||+.|+......  ..+    .....            
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~------------  527 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQ------------  527 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhc------------
Confidence                22345678999999999999999999999999999999999999754322  111    11111            


Q ss_pred             cCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+.+....+....+++.+||+.+|.+||+|.++..
T Consensus       528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            12222344566889999999999999999999964

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=267.97  Aligned_cols=264  Identities=20%  Similarity=0.254  Sum_probs=205.6

Q ss_pred             HhcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCC--C----ceEEEEEEEccCCe
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--R----HLVSLIGYCDEKNE  531 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~----niv~l~g~~~~~~~  531 (805)
                      .+++|.+..++|+|.||.|-++..+ .+..||||+++....- .+...-|+++|.++.+  |    -+|.+.+|++-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3778888899999999999999665 3789999998765432 4456789999999942  2    26888899999999


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC---------------
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---------------  596 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld---------------  596 (805)
                      .++|+|.| +-|+.++|..++..+++..++..|+.|+++++++||+   .+++|-||||+|||+-               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 4499999988888889999999999999999999999   9999999999999992               


Q ss_pred             -----CCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Q 003659          597 -----ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE  671 (805)
Q Consensus       597 -----~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~  671 (805)
                           .+..+||+|||-|....+.     .+.++.|..|.|||++.+-..+.++||||+||+|.|+.||...|......+
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                 2457999999999874331     256778999999999999999999999999999999999999998765544


Q ss_pred             hhhHHHHHH--------------HHhhcCCcc-----------cccCccc--c--CCCChhHHHHHHHHHHhchhcCCCC
Q 003659          672 MVNLAEWAM--------------KWQNKGQLD-----------QIIDPTL--A--GKIRPDSLRKFGETAEKCLADFGVD  722 (805)
Q Consensus       672 ~~~l~~~~~--------------~~~~~~~~~-----------~~~d~~l--~--~~~~~~~~~~l~~l~~~Cl~~~p~~  722 (805)
                      ...+.+.+.              .+...+.++           ...++..  .  -.....+...+.+++.++|..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            433222211              111111111           0011100  0  0112345667999999999999999


Q ss_pred             CCCHHHHHHH
Q 003659          723 RPSMGDVLWN  732 (805)
Q Consensus       723 RPsm~evl~~  732 (805)
                      |+|+.|++++
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999854

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7e-30  Score=265.54  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=191.1

Q ss_pred             CcccceEeeeCceEEEEEE-ecCCcEEEEEEcCC--CCch-----hHHHHHHHHHHHhcCCCCceEEEEEEEc-cCCeEE
Q 003659          463 FDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNP--RSQQ-----GLAEFQTEIEMLSQFRHRHLVSLIGYCD-EKNEMI  533 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~--~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~  533 (805)
                      |-...+||+|||+.||||. +...+.||||+-..  ....     -.+...+|.++-+.|.||.||++++|+. +.+.+|
T Consensus       465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC  544 (775)
T KOG1151|consen  465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC  544 (775)
T ss_pred             HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence            3445689999999999995 44678999996332  2111     1344668999999999999999999984 556789


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC---CCCcEEEeecCCCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSK  610 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld---~~~~~kl~DFGla~  610 (805)
                      -|+|||++.+|.-+|...  +.+++++...|+.||+.||.||.+ .+.+|||-||||.||||-   .-|.+||+||||++
T Consensus       545 TVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  545 TVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             eeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            999999999999999655  469999999999999999999997 457999999999999994   45789999999999


Q ss_pred             CCCCCCC-----cceeecccccccccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 003659          611 TGPEIDQ-----THVSTAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       611 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      .+.....     -..+....||..|++||++.-    .+++.|.||||.||++|..+.|++||.......  .+      
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI------  693 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI------  693 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH------
Confidence            7654222     233456789999999999853    367899999999999999999999998543221  11      


Q ss_pred             HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHH
Q 003659          682 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV  729 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ev  729 (805)
                       +.+..+....+-.+.  ..+....+...+|++||+...++|....++
T Consensus       694 -LqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  694 -LQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -HhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence             111112111111111  112334556788999999999998765554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=7.7e-30  Score=285.25  Aligned_cols=246  Identities=27%  Similarity=0.367  Sum_probs=190.2

Q ss_pred             CCcccceEeeeCceE-EEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEec
Q 003659          462 NFDESWVIGIGGFGK-VYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      -|...+++|.|+.|+ ||+|... |+.||||++-...   ..-.++|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            356667899999886 6999886 7899999986543   34557899999988 6999999999888889999999999


Q ss_pred             cCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-----CCcEEEeecCCCCCC
Q 003659          540 ENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTG  612 (805)
Q Consensus       540 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-----~~~~kl~DFGla~~~  612 (805)
                      .. +|.+++...  ......-...+.+..|++.||++||+   .+||||||||.||||+.     ...++|+|||+++..
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            65 999999764  11112224567889999999999999   99999999999999975     257999999999986


Q ss_pred             CCCCC-cceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          613 PEIDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       613 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      ..... -.......||-||+|||.+....-+.+.||||+|||+|..++| ..||......+. ++      +.....+..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI------l~~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI------LTGNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh------hcCccceee
Confidence            54221 1224567899999999999998888999999999999999997 899986544321 11      011111111


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +     .  ...++  ...++|.+++..+|..||++.+|+.
T Consensus       735 L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  735 L-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             e-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1     0  01122  6788999999999999999999983

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.6e-31  Score=256.49  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=194.1

Q ss_pred             cccceEeeeCceEEEEEEec-CCcEEEEEEcCC-C-CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc--------CCeE
Q 003659          464 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNP-R-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--------KNEM  532 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~-~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~~~~  532 (805)
                      ....+||+|.||.||+|+.+ .|+.||+|+..- . .+.--....+|+++|..|+|+|++.++..|..        ...+
T Consensus        20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~   99 (376)
T KOG0669|consen   20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF   99 (376)
T ss_pred             HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence            33458999999999999876 478899985432 2 22223456799999999999999999988843        2358


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      +||+++|+. +|...|... ...++..++.++..++..||.|+|.   ..|+|||+|+.|+|++.++.+||+|||+++..
T Consensus       100 ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen  100 YLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             eeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence            999999986 888887543 2568999999999999999999999   99999999999999999999999999999865


Q ss_pred             CCCC--CcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          613 PEID--QTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       613 ~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      ...+  .....+..+-|..|++||.+.+ .+++++.|||.-||+|.||+||.+-+....+.....++.-...-..++-..
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            4322  1222345667999999999875 679999999999999999999998887665554444443222111111111


Q ss_pred             --------ccc--CccccCCCC--hhHHH------HHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          690 --------QII--DPTLAGKIR--PDSLR------KFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       690 --------~~~--d~~l~~~~~--~~~~~------~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                              +.+  .|-..+.++  ++..+      ..++++..++..||.+|+.+.+++.
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                    111  110011110  11122      4678899999999999999988874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.7e-30  Score=263.81  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=194.0

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC---chhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .+|....+||+|.||+|.+|..+ ..+.+|||+++..-   ..+.+--..|-++|... +-|.+++|..++..-+++++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            35777789999999999999766 46789999887642   12222234566777766 568899999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      |||+.+|+|--++.+-+  .+.+....-.|..||-||-+||+   ++||.||||-.|||||.+|++||+|||+++..-. 
T Consensus       429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-  502 (683)
T ss_pred             EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence            99999999998886544  57778888899999999999999   9999999999999999999999999999987432 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCcc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                       ....+.+.+||+.|+|||.+..++|....|.|||||+||||+.|++||+...+.+....               +.+..
T Consensus       503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a---------------I~ehn  566 (683)
T KOG0696|consen  503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA---------------IMEHN  566 (683)
T ss_pred             -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------------HHHcc
Confidence             22335678999999999999999999999999999999999999999997765543221               11111


Q ss_pred             ccCCCChhHHHHHHHHHHhchhcCCCCCC
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRP  724 (805)
Q Consensus       696 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  724 (805)
                      .  .++...+.+...+....+...|.+|.
T Consensus       567 v--syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 V--SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence            1  23445566777888889999999993

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.4e-28  Score=262.64  Aligned_cols=206  Identities=25%  Similarity=0.390  Sum_probs=172.5

Q ss_pred             CCcccceEeeeCceEEEEEEe-cCCcEEEEEEcCCCC---chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      -|...+.||-|+||.|.+++. +....+|.|.+...+   .......+.|-.||.+...+=||+|+-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            477778999999999999954 446788999776653   3345567789999999999999999999999999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC------
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT------  611 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~------  611 (805)
                      |+++|++-.+|.+.+  -+.+....-.+..++.|+++.|.   .|+|||||||+|||||.+|++||+||||+.-      
T Consensus       710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccc
Confidence            999999999997765  46667777778899999999999   9999999999999999999999999999841      


Q ss_pred             ---CCCCCCc-------------------------------ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHH
Q 003659          612 ---GPEIDQT-------------------------------HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV  657 (805)
Q Consensus       612 ---~~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~el  657 (805)
                         +.+.+..                               ......+||..|+|||++....++.-+|.||.||||+||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence               1110000                               001245799999999999999999999999999999999


Q ss_pred             HhCCCCCCCCChhhh
Q 003659          658 LCARPVIDPTLPREM  672 (805)
Q Consensus       658 ltG~~p~~~~~~~~~  672 (805)
                      +.|++||-...+.+.
T Consensus       865 ~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGET  879 (1034)
T ss_pred             hhCCCCccCCCCCcc
Confidence            999999987665543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-28  Score=243.57  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=197.5

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC---CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEE
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|+..++||+|.|++|..++++ ..+.+|+|+++..   ..+.+.-.+.|-.+..+. +||.+|.|..++..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57888899999999999999876 4788999876543   334455667777777766 799999999999999999999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      .||+++|+|--++.+.  ..|+++...-....|.-||.|||+   ++||.||||-.|||||..+++||+|+|+++..-. 
T Consensus       330 ieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~-  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-  403 (593)
T ss_pred             EEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC-
Confidence            9999999998877554  468899988899999999999999   9999999999999999999999999999987432 


Q ss_pred             CCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTL-PREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                       ....+++.+||+.|.|||.+++..|....|.|++||+|+||+.|+.||+-.. .....+-..+..+..-+.++      
T Consensus       404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------  476 (593)
T KOG0695|consen  404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------  476 (593)
T ss_pred             -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence             3344677899999999999999999999999999999999999999997432 11222333333333222211      


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCC
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRP  724 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  724 (805)
                          .++.....+...+.+.-|..||.+|.
T Consensus       477 ----riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 ----RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ----cccceeehhhHHHHHHhhcCCcHHhc
Confidence                12233344566778888999999983

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1e-28  Score=234.61  Aligned_cols=196  Identities=25%  Similarity=0.335  Sum_probs=162.0

Q ss_pred             cceEeeeCceEEEEEEec-CCcEEEEEEcCCC-CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEEEEEEeccCC
Q 003659          466 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      ...||+|++|.|-+-++. +|+..|+|++... ..+..++.++|+.+..+- .+|.+|.++|........++.||.|+. 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            346999999999888664 7999999987754 234466778888876654 799999999999888999999999965 


Q ss_pred             cccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          543 TLKGHLYG--SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       543 sL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|..+-.+  .....+++.-+-+||..+.+||.|||+  +..++|||+||+|||++.+|++|+||||++-.+..   ...
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d---SiA  204 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD---SIA  204 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh---hhH
Confidence            77665432  233568889999999999999999998  46899999999999999999999999999976532   222


Q ss_pred             eecccccccccChhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 003659          621 STAVKGSFGYLDPEYFRR----QQLTEKSDVYSFGVVLFEVLCARPVIDPT  667 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~----~~~s~ksDV~S~Gvvl~elltG~~p~~~~  667 (805)
                      .+...|...|||||.+..    ..|+.|+||||||+++.||.+++.|++..
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            344568889999998853    37899999999999999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=5.1e-27  Score=236.81  Aligned_cols=210  Identities=37%  Similarity=0.577  Sum_probs=183.6

Q ss_pred             EeeeCceEEEEEEecC-CcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccc
Q 003659          469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKG  546 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  546 (805)
                      ||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998864 899999998776542 35678999999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          547 HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       547 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      ++.... ..+++..++.++.+++++|++||+   .+++|+||+|.||+++. +..++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            986542 468999999999999999999999   89999999999999999 89999999999986543211  123345


Q ss_pred             ccccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhH
Q 003659          626 GSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS  704 (805)
Q Consensus       626 gt~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  704 (805)
                      +...|++||.+... ..+.+.|+|++|+++++|                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            77889999999877 889999999999999999                                               


Q ss_pred             HHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          705 LRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       705 ~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                       ..+.+++..|++.+|.+||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             347889999999999999999999764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=246.50  Aligned_cols=263  Identities=26%  Similarity=0.354  Sum_probs=195.8

Q ss_pred             cccceEeeeCceEEEEEEec-CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccC-----CeEEEE
Q 003659          464 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK-----NEMILI  535 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~lV  535 (805)
                      ...+.||.|+||.||..+.. +|+.||.|++...-  -...+.+.+|+++|.-++|.|++..++...-.     .+++++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34568999999999999765 79999999876542  23457788999999999999999988765332     356788


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      .|.|.. +|...+...  ..|+-..+.-+..||++||.|||+   .+|.||||||.|.|+++|...||+||||++.-.. 
T Consensus       136 TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~-  208 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ-  208 (449)
T ss_pred             HHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch-
Confidence            898864 888877543  468888899999999999999999   9999999999999999999999999999997544 


Q ss_pred             CCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHH--------HHHHhhcC
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW--------AMKWQNKG  686 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~  686 (805)
                      +.....+..+-|..|.|||.+++ ..|+.+.||||.||++.||+..+..|....+.+...++.-        +++...+|
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            33333345567889999999987 5799999999999999999999988887766655444321        12222223


Q ss_pred             CcccccCccccC--------CCC-hhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          687 QLDQIIDPTLAG--------KIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       687 ~~~~~~d~~l~~--------~~~-~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                      .-..++....+.        -.. ...-.....+...++..+|++|.+..+.+..+
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            222222211110        000 11223345667778888999998887776543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.3e-29  Score=262.41  Aligned_cols=239  Identities=22%  Similarity=0.289  Sum_probs=196.2

Q ss_pred             cccceEeeeCceEEEEEEecCCc-EEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          464 DESWVIGIGGFGKVYKGELNDGT-KVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      .....||-||||.|=+.+.+... ..|+|.++..   +....+....|-++|.+.+.|.||+|+--+.+.+..|+.||-|
T Consensus       423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC  502 (732)
T KOG0614|consen  423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC  502 (732)
T ss_pred             hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence            33447999999999999877533 3788766653   3444667889999999999999999999999999999999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcc
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~  619 (805)
                      -+|.|...|...+  .++..+..-++..+.+|++|||.   ++||.|||||+|.|||.+|-+||.|||+|+....   ..
T Consensus       503 lGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g~  574 (732)
T KOG0614|consen  503 LGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---GR  574 (732)
T ss_pred             cCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc---CC
Confidence            9999999996654  67788888899999999999999   9999999999999999999999999999998654   33


Q ss_pred             eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCC
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .+-+.+||+.|.|||.+.+...+.+.|.||||++++|||+|++||....+-...+++--            -+|.   -.
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk------------Gid~---i~  639 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK------------GIDK---IE  639 (732)
T ss_pred             ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh------------hhhh---hh
Confidence            45678999999999999999999999999999999999999999987766544333211            0111   02


Q ss_pred             CChhHHHHHHHHHHhchhcCCCCCCC
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPS  725 (805)
Q Consensus       700 ~~~~~~~~l~~l~~~Cl~~~p~~RPs  725 (805)
                      ++....+...+++++.+..+|.+|..
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhc
Confidence            23333455678889989999999965

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=3.7e-26  Score=234.32  Aligned_cols=199  Identities=32%  Similarity=0.468  Sum_probs=173.2

Q ss_pred             CcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEecc
Q 003659          463 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      |...+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999998875 889999998876554 57889999999999999999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +++|.+++..... .+++..+..++.+++++|++||+   .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence            9999999865432 28999999999999999999999   8999999999999999999999999999987544221 11


Q ss_pred             eecccccccccChhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003659          621 STAVKGSFGYLDPEYF-RRQQLTEKSDVYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~-~~~~~s~ksDV~S~Gvvl~elltG~~p~~~  666 (805)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2345677889999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-26  Score=241.26  Aligned_cols=131  Identities=25%  Similarity=0.369  Sum_probs=112.9

Q ss_pred             cCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-----C---CceEEEEEEEc----
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----H---RHLVSLIGYCD----  527 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~----  527 (805)
                      .+|...++||.|.|++||++... +.+.||+|+.+... .-.+....||++|++++     |   .+||+|+++|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67889999999999999999654 57899999976543 22456689999999984     2   46999999984    


Q ss_pred             cCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL  595 (805)
Q Consensus       528 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl  595 (805)
                      .+.+.+||+|++ +-+|..+|.....+.++...+.+|++|++.||.|||..|  +|||-||||+||||
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            466899999999 558999998888888999999999999999999999965  79999999999999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=253.22  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=205.1

Q ss_pred             hcCCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ..+|+..+.+|.|.+|.|||++.. .++..|||.++........-.++|+-+++..+|+||+.++|.+.....++++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            356777789999999999999875 5899999988877666777788999999999999999999999999999999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                      |.+|+|++.-+...  +|++.++-.+++..++||+|||+   .+-+|||||-.|||+++.+.+|++|||.+......  -
T Consensus        94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i  166 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--I  166 (829)
T ss_pred             cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh--h
Confidence            99999999887665  79999999999999999999999   89999999999999999999999999998765431  1


Q ss_pred             ceeecccccccccChhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc-
Q 003659          619 HVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP-  694 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~---~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-  694 (805)
                      .......||+.|||||+.   +.+.|..++|||+.|+...|+---++|.....+....       .+..+    ...+| 
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~qpp  235 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQPP  235 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCCCC
Confidence            123456799999999986   4677899999999999999998888776543332211       11111    11111 


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .+..  .......|-++++.|+-.+|.+||+++.++.
T Consensus       236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1211  1244667888999999999999999988775

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=3.5e-26  Score=231.08  Aligned_cols=258  Identities=21%  Similarity=0.243  Sum_probs=190.2

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcCCCCceEEEEEEEcc------CCeE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------KNEM  532 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~  532 (805)
                      +|...+.+|.|.- .|..+... .+++||+|++...  .....+...+|..++..++|+|+++++.++.-      -.+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            4445557888877 55555433 4789999976543  23456778899999999999999999999843      3467


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++|||+|. ++|.+.++    -.++-+.+..|..|++.|++|||+   .+|+||||||+||++..+...||.|||+++..
T Consensus        97 y~v~e~m~-~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhh-hHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhccc
Confidence            99999996 58988886    247888999999999999999999   99999999999999999999999999999864


Q ss_pred             CCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh----------------hhHH
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM----------------VNLA  676 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----------------~~l~  676 (805)
                      ..   ....+..+.|..|.|||++-+..+.+..||||.||++.||++|+..|.+....+.                ..+.
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            32   2355677889999999999988899999999999999999999987764322111                1111


Q ss_pred             HHHHHHhhc-CC-----ccccc-CccccC--CCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          677 EWAMKWQNK-GQ-----LDQII-DPTLAG--KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       677 ~~~~~~~~~-~~-----~~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .-+..+.+. ++     ..+.+ |.....  +.++-......+++.++|-.+|++|-++++++.
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            111111110 00     00111 111111  111122445678899999999999999999974

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=3.7e-26  Score=245.59  Aligned_cols=195  Identities=21%  Similarity=0.366  Sum_probs=165.6

Q ss_pred             CCcccceEeeeCceEEEEEEec-CCcEEEEEEcCCCCc--------hhHHHHHHHHHHHhcCC---CCceEEEEEEEccC
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEK  529 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~  529 (805)
                      .|...+.+|+|+||.|+.+.++ +...|+||.+.+..-        ...-..-.|+.+|..|+   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4777889999999999999877 467899997765421        11122457999999997   99999999999999


Q ss_pred             CeEEEEEEec-cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCC
Q 003659          530 NEMILIYEYM-ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       530 ~~~~lV~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGl  608 (805)
                      +.++|+||-. ++-+|.+++..+  +.+++.+..-|+.|++.|+++||+   .+|||||||-+||.++.+|-+||+|||.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence            9999999986 556899998544  579999999999999999999999   9999999999999999999999999999


Q ss_pred             CCCCCCCCCcceeecccccccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCC
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVID  665 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~S~Gvvl~elltG~~p~~  665 (805)
                      +....    .......+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       717 aa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  717 AAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            87632    223456789999999999998776 466899999999999998887764

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=1e-25  Score=217.02  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=191.2

Q ss_pred             hcCCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-CCceEEEEEEEcc--CCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDE--KNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV  535 (805)
                      .++|+..+++|+|.++.|+.|. ..+.+.++||.+++...   +.+.+|+.+|..|+ ||||++|++...+  .....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3567788899999999999995 45688999999987643   56789999999997 9999999998744  4567899


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPE  614 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~~~~~  614 (805)
                      +||+.+-+.....     +.|+-..+.....+++.||.|+|+   .||.|||+||.|+++|.. ...+|+|+|||.....
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999987776654     457888899999999999999999   999999999999999965 4799999999987543


Q ss_pred             CCCcceeecccccccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHH--------HHhhc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM--------KWQNK  685 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~  685 (805)
                      ..   .-...+.+..|.-||.+-. +.++-.-|+|||||+|.+|+..+.||-..... ..+++..+.        .+..+
T Consensus       186 ~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Cc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHH
Confidence            11   1233455667889998865 56888999999999999999999998643221 112222211        11111


Q ss_pred             CCcccccCccccC---C---------CC----hhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          686 GQLDQIIDPTLAG---K---------IR----PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       686 ~~~~~~~d~~l~~---~---------~~----~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      -++.  +||.+..   .         ++    .-...+..+++.+.|..|.++|||+.|...+
T Consensus       262 Y~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  262 YQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1111  2222211   0         00    0112457788999999999999999998753

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-25  Score=217.28  Aligned_cols=253  Identities=20%  Similarity=0.308  Sum_probs=183.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEE-EccCCeEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGY-CDEKNEMILIY  536 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~  536 (805)
                      .+.|.+++.||+|.||.+-++.++. .+.+++|-.... ....++|.+|..---.| .|.||+.-++. +...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4568888999999999999998874 678888876543 33468899998866666 58999988765 56777889999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEe-C-CCCcEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL-D-ENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILl-d-~~~~~kl~DFGla~~~~~  614 (805)
                      ||++.|+|.+-+...   .+.+....+++.|++.|+.|+|+   .++||||||.+|||+ + +..++||||||+.+..+.
T Consensus       102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999988654   47788899999999999999999   999999999999999 3 345899999999886432


Q ss_pred             CCCcceeecccccccccChhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQ-----QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      .     .....-+..|.+||.....     ...+.+|||.||++++.++||+.|++.... ......+|..-..+..   
T Consensus       176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~---  246 (378)
T KOG1345|consen  176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKN---  246 (378)
T ss_pred             e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccC---
Confidence            1     1123345679999987432     456789999999999999999999983322 2223333322111111   


Q ss_pred             cccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHH
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL  733 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L  733 (805)
                          +.+...+. ....++.++-++-+..++.+|=-..++.++-
T Consensus       247 ----~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  247 ----PALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             ----ccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence                12222221 1233455566777788888885555554433

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=8.6e-26  Score=239.80  Aligned_cols=272  Identities=24%  Similarity=0.281  Sum_probs=204.7

Q ss_pred             cccCHHHHHHHhcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCC------CCceEE
Q 003659          449 YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR------HRHLVS  521 (805)
Q Consensus       449 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~  521 (805)
                      +++-+-|+.  ...|.+....|+|-|++|..|.... |..||||++...... .+.=+.|+++|++|+      -.|.++
T Consensus       422 Yrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  422 YRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             EEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            344444444  4678888889999999999998764 789999998876432 345578999999995      357889


Q ss_pred             EEEEEccCCeEEEEEEeccCCcccccccCCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-
Q 003659          522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-  599 (805)
Q Consensus       522 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-  599 (805)
                      |+-.|...+++|||+|-+. .+|++.|..-+ .-.|....+...+.|+.-||..|..   .+|+|+||||.|||+++.- 
T Consensus       499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN  574 (752)
T ss_pred             HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence            9999999999999999885 49999996532 3568889999999999999999999   8999999999999998764 


Q ss_pred             cEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHH
Q 003659          600 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA  679 (805)
Q Consensus       600 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  679 (805)
                      ..||||||.|......+.    +...-+..|.|||.+.+..|+...|+||.||+||||.||+..|.+.....+..+.--+
T Consensus       575 iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             eeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            679999999987554222    2333456799999999999999999999999999999999999776554443332111


Q ss_pred             -----HHHhhcCCc-cc--------------------------ccCc------cccC--CCC---hhHHHHHHHHHHhch
Q 003659          680 -----MKWQNKGQL-DQ--------------------------IIDP------TLAG--KIR---PDSLRKFGETAEKCL  716 (805)
Q Consensus       680 -----~~~~~~~~~-~~--------------------------~~d~------~l~~--~~~---~~~~~~l~~l~~~Cl  716 (805)
                           ..++++++. .+                          .+.|      .+.+  .++   +.....|.+|+..|+
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence                 112222221 00                          1111      0111  111   334567888999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 003659          717 ADFGVDRPSMGDVLW  731 (805)
Q Consensus       717 ~~~p~~RPsm~evl~  731 (805)
                      ..+|++|.+..+.++
T Consensus       731 ~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  731 ILDPEKRITVNQALK  745 (752)
T ss_pred             ccChhhcCCHHHHhc
Confidence            999999999888864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=2.5e-25  Score=270.61  Aligned_cols=196  Identities=17%  Similarity=0.225  Sum_probs=139.6

Q ss_pred             cCCC-CceEEEEEEE-------ccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeE
Q 003659          513 QFRH-RHLVSLIGYC-------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI  584 (805)
Q Consensus       513 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  584 (805)
                      .++| +||++++++|       .+...+++++|++ .++|.++|... ...+++.+++.++.||++||+|||+   .+|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            4556 6888888877       3334677888987 55999999643 3469999999999999999999999   9999


Q ss_pred             eeccCCCcEEeCC-------------------CCcEEEeecCCCCCCCCCCC--------------cceeeccccccccc
Q 003659          585 HRDVKSANILLDE-------------------NFMAKVADFGLSKTGPEIDQ--------------THVSTAVKGSFGYL  631 (805)
Q Consensus       585 H~Dikp~NILld~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  631 (805)
                      ||||||+||||+.                   ++.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999965                   44556666666653211000              00011245888999


Q ss_pred             ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHH
Q 003659          632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGET  711 (805)
Q Consensus       632 aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  711 (805)
                      |||++.+..++.++|||||||+||||++|.+|+.....    ....+...         .+.+...     ........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~~-----~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQIL-----LNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhhh-----hcCHHHHHH
Confidence            99999999999999999999999999999887642110    01111000         1111110     112335677


Q ss_pred             HHhchhcCCCCCCCHHHHHH
Q 003659          712 AEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       712 ~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +.+||+.+|.+||+|.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.2e-23  Score=208.21  Aligned_cols=169  Identities=22%  Similarity=0.238  Sum_probs=126.6

Q ss_pred             CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCccee
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS  621 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~  621 (805)
                      |+|.+++...+ ..++|.+++.|+.|+++||+|||+   .+      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc------
Confidence            68889886533 469999999999999999999999   44      999999999999999  9998864331      


Q ss_pred             ecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCC
Q 003659          622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR  701 (805)
Q Consensus       622 ~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  701 (805)
                       ...||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+..+.......       ++.. ....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~-------~~~~-~~~~  132 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPAD-------DPRD-RSNL  132 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccC-------Cccc-cccH
Confidence             1258899999999999999999999999999999999999986432211 1111111111000       0000 0011


Q ss_pred             hhHHH--HHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          702 PDSLR--KFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       702 ~~~~~--~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      .....  .+.+++.+|++.+|.+||++.|+++++.....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            12222  58999999999999999999999998877643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=3.5e-24  Score=224.68  Aligned_cols=201  Identities=24%  Similarity=0.349  Sum_probs=166.1

Q ss_pred             HHHHhcCCcccceEeeeCceEEEEEEec----CCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCC
Q 003659          456 VQEATNNFDESWVIGIGGFGKVYKGELN----DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       456 l~~at~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      +....+.|...++||+|.|++||++.+.    ..+.||+|.+...+.  .....+|+++|..+ -+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3345567888899999999999999654    367899999877654  35688999999999 5999999999999999


Q ss_pred             eEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLS  609 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla  609 (805)
                      ...+|+||++.....+++.     .++..++......+..||+++|.   .|||||||||+|+|.+.. ..-.|.|||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence            9999999999988888873     36688999999999999999999   999999999999999865 56789999998


Q ss_pred             CCCCC--------C------CC----------------------------cceeecccccccccChhhhcc-CCCCchhh
Q 003659          610 KTGPE--------I------DQ----------------------------THVSTAVKGSFGYLDPEYFRR-QQLTEKSD  646 (805)
Q Consensus       610 ~~~~~--------~------~~----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksD  646 (805)
                      .....        .      ..                            ........||+||.|||++.. ...+.+.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            61000        0      00                            000123469999999999864 56799999


Q ss_pred             HHHHHHHHHHHHhCCCCCCC
Q 003659          647 VYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       647 V~S~Gvvl~elltG~~p~~~  666 (805)
                      |||-||+++-+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999853

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.8e-22  Score=219.33  Aligned_cols=168  Identities=20%  Similarity=0.153  Sum_probs=130.2

Q ss_pred             HHHhcCCcccceEeeeCceEEEEEEec--CCcEEEEEEcCCC-----CchhHHHHHHHHHHHhcCCCCceEEEEEEEccC
Q 003659          457 QEATNNFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEK  529 (805)
Q Consensus       457 ~~at~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  529 (805)
                      ....++|...+.||+|+||+||+|..+  +++.||||++...     .....+.|.+|+++|++++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345577999999999999999999765  5778899986533     122356789999999999999998543322   


Q ss_pred             CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecc-CCCcEEeCCCCcEEEeecCC
Q 003659          530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV-KSANILLDENFMAKVADFGL  608 (805)
Q Consensus       530 ~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILld~~~~~kl~DFGl  608 (805)
                      +..++||||+++++|... . .    ..   ...++.+++++|+|||+   .+|+|||| ||+|||++.++.+||+|||+
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~-~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-R-P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-C-c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            457999999999999632 1 1    11   24678899999999999   99999999 99999999999999999999


Q ss_pred             CCCCCCCCCcc------eeecccccccccChhhhccC
Q 003659          609 SKTGPEIDQTH------VSTAVKGSFGYLDPEYFRRQ  639 (805)
Q Consensus       609 a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~  639 (805)
                      ++.........      ..+...+++.|+|||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            98654322111      11456788999999998643

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-23  Score=205.62  Aligned_cols=243  Identities=21%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             eEeeeCceEEEEEEecCCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCccc
Q 003659          468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      +|.+...|..|+|+++ |..+++|++....  ...-++|..|.-.|+-+.||||++++|.|.....+.++..||+.|+|.
T Consensus       197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            6888999999999998 4556677665432  223467899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEe--ecCCCCCCCCCCCcceeec
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA--DFGLSKTGPEIDQTHVSTA  623 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~  623 (805)
                      ..|++...--.+..+..+++.++|+|++|||+- .+-|.---|.+..|++|++.+++|+  |--++..         ...
T Consensus       276 nvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---------e~g  345 (448)
T KOG0195|consen  276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVG  345 (448)
T ss_pred             HHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---------ccc
Confidence            999988766788899999999999999999983 2334455688999999999998875  2222211         112


Q ss_pred             ccccccccChhhhccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          624 VKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       624 ~~gt~~y~aPE~~~~~~~s---~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                      ..-.+.||+||.++..+-+   .++|+|||.++||||.|...||....+-+....               +.=+.+.-.+
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------------ialeglrv~i  410 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------------IALEGLRVHI  410 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------------hhhccccccC
Confidence            2235789999999876543   689999999999999999999986655443211               1112344456


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~  736 (805)
                      ++.....+.+++.-|+..||.+||....|+-.||+.
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            677788899999999999999999999999888864

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.7e-21  Score=211.97  Aligned_cols=263  Identities=19%  Similarity=0.209  Sum_probs=196.4

Q ss_pred             CCcccceEeeeCceEEEEEEecCC--cEEEEEEcCCCCchhHHHHHHHHHHHhcCCC----CceEEEEEEE-ccCCeEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDG--TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH----RHLVSLIGYC-DEKNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l  534 (805)
                      +|...++||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            788999999999999999986643  5789997766533332367889999998873    6888999888 57778899


Q ss_pred             EEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-----CcEEEeecCCC
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-----FMAKVADFGLS  609 (805)
Q Consensus       535 V~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-----~~~kl~DFGla  609 (805)
                      ||+.+ +.+|.++........++..+.++|+.|++.+|++||+   .+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 5699997755555689999999999999999999999   999999999999999765     46999999999


Q ss_pred             C--CCCCCCC----cce--eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHH
Q 003659          610 K--TGPEIDQ----THV--STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       610 ~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      +  .......    ...  ....+||..|.++..+.+...+.+.|+||++.++.|++.|..|+.............   .
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---K  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---H
Confidence            8  3221111    111  234569999999999999999999999999999999999999986443222111100   0


Q ss_pred             HhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhh
Q 003659          682 WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       682 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~  740 (805)
                      ....    .....     .....+..+.++...+-..+..++|....+...|+.+....
T Consensus       252 ~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             Hhhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            0000    00000     11122344555566666688999999999999888776543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=6.8e-20  Score=197.37  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=197.1

Q ss_pred             CcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCch---hHHHHHHHHHHHhcCCCC-ceEEEEEEEccCCeEEEEEEe
Q 003659          463 FDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ---GLAEFQTEIEMLSQFRHR-HLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~  538 (805)
                      |...+.||.|+||.||++...  ..+++|.+......   ....|.+|+.++..+.|+ +++++.+++......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            456678999999999999877  78899987765432   477899999999999988 799999999777778999999


Q ss_pred             ccCCcccccccCCCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC-cEEEeecCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~-~~kl~DFGla~~~~~~~  616 (805)
                      +.+++|.+++..... ..+.......+..|++.++.|+|+   .+++||||||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966644321 268899999999999999999999   8899999999999999998 79999999998544322


Q ss_pred             Ccc----eeecccccccccChhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCChh-hhhhHHHHHHHHhhcCCc
Q 003659          617 QTH----VSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR-EMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       617 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  688 (805)
                      ...    ......||..|+|||.+..   ...+...|+||+|++++++++|..|+...... ..........    ....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL----ELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH----hcCC
Confidence            211    2456789999999999987   68899999999999999999999997644321 0111111111    1000


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHH
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~  732 (805)
                      . .................+.+++..|+..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000000000001223567889999999999999999887764

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=1.3e-19  Score=184.12  Aligned_cols=269  Identities=17%  Similarity=0.214  Sum_probs=199.0

Q ss_pred             cCCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEe
Q 003659          461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      -.|.+.++||+|.||.++.|+ +-+++.||||.....++  ..++..|.+..+.|. .++|...+-+..++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            358888999999999999996 34689999998766554  356778888888884 68999999888899899999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-----CcEEEeecCCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-----FMAKVADFGLSKTGP  613 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-----~~~kl~DFGla~~~~  613 (805)
                      + +-+|++++.-. ...++.+++..||.|++.-++|+|+   +.+|.|||||+|+||...     ..+.|+|||||+.+-
T Consensus       106 L-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            8 55888766433 3579999999999999999999999   999999999999999643     468999999999754


Q ss_pred             CCCCc-----ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCc
Q 003659          614 EIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL  688 (805)
Q Consensus       614 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  688 (805)
                      .....     .......||..||+-..+.+.+.+.+.|+-|+|-+++..|-|..||..........-.+   ..-+..+.
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe---KIGe~Kr~  257 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE---KIGETKRS  257 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH---Hhcccccc
Confidence            32221     11245679999999999999999999999999999999999999998654433222111   11111111


Q ss_pred             ccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHHhhhhhhc
Q 003659          689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH  745 (805)
Q Consensus       689 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~~~~~~~~  745 (805)
                      ..+  ..|...+ +++....++.++.   .+-.+-|..+-+...+..++.......+
T Consensus       258 T~i--~~Lc~g~-P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~D  308 (449)
T KOG1165|consen  258 TPI--EVLCEGF-PEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETDD  308 (449)
T ss_pred             CCH--HHHHhcC-HHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCccc
Confidence            100  1122222 3444455555554   4667789988887777777766544443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=6e-20  Score=178.85  Aligned_cols=260  Identities=18%  Similarity=0.205  Sum_probs=194.6

Q ss_pred             hcCCcccceEeeeCceEEEEEE-ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCC-CceEEEEEEEccCCeEEEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ..+|...++||.|.||.+|.|. ..+|+.||||.......  ..++..|.++...|+| ..|..+..|..++..-.||||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3568889999999999999995 46799999998765543  2467789999999976 677778888889999999999


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC---CcEEEeecCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSKTGPE  614 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~---~~~kl~DFGla~~~~~  614 (805)
                      .+ +-+|.+.+.-. ...++.++++-+|-|++.-++|+|.   +++|||||||+|+|+.-+   ..+.|+|||||+....
T Consensus        92 LL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            98 55888876433 3468999999999999999999999   999999999999999644   4688999999987543


Q ss_pred             CCCc-----ceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcc
Q 003659          615 IDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       615 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      ....     .......||..|.+-..+.+.+.+.+.|+-|+|.+|+...-|+.||+...+.....-.+........-.  
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~--  244 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP--  244 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC--
Confidence            2211     112456799999998888888889999999999999999999999987765544333222211111000  


Q ss_pred             cccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                         -..+...+    +.++.-.+.-|-..--++-|...-+.+..+-
T Consensus       245 ---ie~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  245 ---IEVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             ---HHHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence               01122223    3446666777877778888887655554443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=5.2e-20  Score=203.34  Aligned_cols=217  Identities=26%  Similarity=0.386  Sum_probs=164.8

Q ss_pred             HhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCe-EeeccC
Q 003659          511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV-IHRDVK  589 (805)
Q Consensus       511 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i-vH~Dik  589 (805)
                      |+.+.|.|+.+++|.|.++...+.|.+||..|+|.+.+... ...++|.-...+.++|++||+|||.   .+| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeeeec
Confidence            46789999999999999999999999999999999999763 3579999999999999999999998   444 999999


Q ss_pred             CCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccC-------CCCchhhHHHHHHHHHHHHhCCC
Q 003659          590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ-------QLTEKSDVYSFGVVLFEVLCARP  662 (805)
Q Consensus       590 p~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDV~S~Gvvl~elltG~~  662 (805)
                      ++|+++|..+.+||+|||+.................-..-|.|||.+...       ..+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998775421111222223344579999999763       25788999999999999999999


Q ss_pred             CCCCCChhhh-hhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHHHHH
Q 003659          663 VIDPTLPREM-VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       663 p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~~~~  738 (805)
                      ||+....... ..++.++..     .-...+.|.+....  +....+..++..||..+|.+||++.+|-..++.+..
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9975322221 223322221     11222333332111  333468899999999999999999999877766544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=6.7e-21  Score=218.72  Aligned_cols=250  Identities=23%  Similarity=0.260  Sum_probs=184.0

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCC-chhHHHHHHHHHH--HhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS-QQGLAEFQTEIEM--LSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ++...+.||.+.|=+|.+|+.++|. |+||++-... .-..+.|.++++-  ...++|||.+++.-+-...+..+||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677789999999999999999887 8899766554 3445556555444  4455899999998887777788899999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC--CCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~--~~~~~  616 (805)
                      ..+ +|.|.|  +.++-|...+..-|+.|++.||..+|.   .+|+|||||.+|||++.-.-+.|+||.--+.  +++.+
T Consensus       103 vkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            876 899988  445678888999999999999999999   9999999999999999999999999986653  23322


Q ss_pred             Cc---ceeecccccccccChhhhccC-----------CCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHH
Q 003659          617 QT---HVSTAVKGSFGYLDPEYFRRQ-----------QLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMK  681 (805)
Q Consensus       617 ~~---~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  681 (805)
                      ..   ....+...-.+|+|||.+...           .++++.||||+||++.||++ |+++|+.      .+|..+   
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY---  247 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY---  247 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH---
Confidence            21   111222333579999987531           26789999999999999988 5787752      222222   


Q ss_pred             HhhcCCcccccCcc-ccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHHH
Q 003659          682 WQNKGQLDQIIDPT-LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       682 ~~~~~~~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~~  735 (805)
                        +.+.   ..++. +.+.++   ...+..+++.|++.+|.+|-++++.++.-++
T Consensus       248 --r~~~---~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  248 --RSGN---ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             --hccC---ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence              1111   00110 111111   1247788999999999999999999987443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1e-20  Score=218.89  Aligned_cols=253  Identities=21%  Similarity=0.224  Sum_probs=185.9

Q ss_pred             ccceEeeeCceEEEEEEec-CCcEEEEEEcC----C-CCc-hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEE
Q 003659          465 ESWVIGIGGFGKVYKGELN-DGTKVAVKRGN----P-RSQ-QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~----~-~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e  537 (805)
                      ..+++|.|.+|.|+..... ..+..+.|...    . ... +....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4568999999977777433 33334444322    1 111 112226678888888999999888777777766666799


Q ss_pred             eccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      ||+. +|..++...  ..++-.++..+..|+.+|+.|||+   .+|.|||+|++|++++.++.+||+|||.+........
T Consensus       402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 999998554  358889999999999999999999   9999999999999999999999999999876443333


Q ss_pred             c--ceeecccccccccChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCc
Q 003659          618 T--HVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      .  .......|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.||......+...        .......+.-..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNIF  547 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhccccccccc
Confidence            3  5567889999999999999988875 5899999999999999999997543332211        000000000000


Q ss_pred             cccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      .-...+....+.....++.++|+.+|.+|-+|++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0011122344566788899999999999999999974

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=1.3e-19  Score=181.26  Aligned_cols=139  Identities=15%  Similarity=0.146  Sum_probs=107.3

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCch--h-------HHH-----------------HHHHHHHHhcCCCCce
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--G-------LAE-----------------FQTEIEMLSQFRHRHL  519 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  519 (805)
                      ...||+|+||.||+|...+|+.||||+++.....  .       ...                 ...|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3589999999999999888999999987654211  0       112                 2349999999987776


Q ss_pred             EEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEeeccCCCcEEeCCC
Q 003659          520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDEN  598 (805)
Q Consensus       520 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dikp~NILld~~  598 (805)
                      .....+..  ...+|||||+++++|...+...  ..+++.+..+++.|++.+|++| |+   .+|+||||||+|||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEEC-
Confidence            33322222  2238999999988776553222  3688999999999999999999 67   79999999999999984 


Q ss_pred             CcEEEeecCCCCCC
Q 003659          599 FMAKVADFGLSKTG  612 (805)
Q Consensus       599 ~~~kl~DFGla~~~  612 (805)
                      +.++|+|||++...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=8.1e-20  Score=184.87  Aligned_cols=171  Identities=16%  Similarity=0.157  Sum_probs=133.4

Q ss_pred             HhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhH---HH------HHHHHHHHhcCCCCceEEEEEEEcc-
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL---AE------FQTEIEMLSQFRHRHLVSLIGYCDE-  528 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---~~------~~~E~~~l~~l~H~niv~l~g~~~~-  528 (805)
                      ..++|...++||.|+||.||.... ++..+|||.+.+......   ..      |.+|++.+.+++|++|..+..++.. 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999765 567899999875432222   22      6799999999999999999888542 


Q ss_pred             -------CCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          529 -------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       529 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                             .+..+|||||+++.+|.++.      .++.    ....+++.+|..||+   .+++||||||+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-E
Confidence                   23578999999999998873      1222    345699999999999   9999999999999999988 9


Q ss_pred             EEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHH
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL  658 (805)
Q Consensus       602 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell  658 (805)
                      +|+|||...........              ..++....+..++|+|+||+++.-+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988754321100              11444555678999999999987664

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=2.5e-18  Score=172.41  Aligned_cols=140  Identities=16%  Similarity=0.154  Sum_probs=109.8

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCch---------------------h-----HHHHHHHHHHHhcCCCCceE
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ---------------------G-----LAEFQTEIEMLSQFRHRHLV  520 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~niv  520 (805)
                      ..||+|++|.||+|+..+|+.||||++......                     .     ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            589999999999998878999999987754211                     0     12245789999999999875


Q ss_pred             EEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       521 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      ....+...  ..+|||||++++++.......  ..++..+..+++.|++.+|.+||+  ..+|+||||||+|||++ ++.
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-CCC
Confidence            44433322  248999999988654432222  357788999999999999999997  36899999999999999 789


Q ss_pred             EEEeecCCCCCCC
Q 003659          601 AKVADFGLSKTGP  613 (805)
Q Consensus       601 ~kl~DFGla~~~~  613 (805)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.4e-18  Score=168.56  Aligned_cols=186  Identities=17%  Similarity=0.100  Sum_probs=140.5

Q ss_pred             cccceEeeeCceEEEEEEecCCcEEEEEEcCCCCch----hHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEe
Q 003659          464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ----GLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      .+...|++|+||+||.+.- .+.+++.+.+.....-    ....|.+|+++|++|. |+++.+++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3456899999999997765 5778887776654331    1225789999999995 5889999886    356999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeecc-CCCcEEeCCCCcEEEeecCCCCCCCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV-KSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Di-kp~NILld~~~~~kl~DFGla~~~~~~~~  617 (805)
                      +.+.+|.+.+..         ....++.|++++|+++|+   .+|+|||| ||.|||++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999888754311         124578899999999999   99999999 79999999999999999999986443221


Q ss_pred             c----ce-------eecccccccccChhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Q 003659          618 T----HV-------STAVKGSFGYLDPEYFRRQ-QLT-EKSDVYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       618 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~s-~ksDV~S~Gvvl~elltG~~p~~~  666 (805)
                      .    ..       ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            0    00       1123467888999865422 333 678999999999999999987643

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=1e-17  Score=174.66  Aligned_cols=231  Identities=19%  Similarity=0.263  Sum_probs=151.2

Q ss_pred             CcccceEeeeCceEEEEEEecC-CcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCC----------CceEEEEEEE--
Q 003659          463 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH----------RHLVSLIGYC--  526 (805)
Q Consensus       463 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~--  526 (805)
                      +...+.||.|+++.||.++..+ ++.+|||.....   .....+++.+|.-....+.+          -.++-.++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456799999999999998874 899999964432   23457778887766666433          1222222211  


Q ss_pred             -------ccC---C-----eEEEEEEeccCCcccccccC-----CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEee
Q 003659          527 -------DEK---N-----EMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR  586 (805)
Q Consensus       527 -------~~~---~-----~~~lV~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~  586 (805)
                             ..+   .     ..+++|+-+. ++|.+++..     .....+....++.+..|+.+.+++||.   .+++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence                   111   1     2366777774 588776531     122345667788889999999999999   999999


Q ss_pred             ccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccC--------CCCchhhHHHHHHHHHHHH
Q 003659          587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ--------QLTEKSDVYSFGVVLFEVL  658 (805)
Q Consensus       587 Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDV~S~Gvvl~ell  658 (805)
                      ||||+|++++.+|.++|+||+.....+.    . ......+..|.+||.....        .++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE----E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc----e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999988765432    1 1113455789999987442        5789999999999999999


Q ss_pred             hCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCC
Q 003659          659 CARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDR  723 (805)
Q Consensus       659 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R  723 (805)
                      ||+.||+...+.....                   ..+ ..+. +.++.+..++..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~-------------------~~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPE-------------------WDF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSG-------------------GGG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCcccccc-------------------ccc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999998654322111                   012 2334 667888999999999999887

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=173.23  Aligned_cols=195  Identities=21%  Similarity=0.234  Sum_probs=137.2

Q ss_pred             CCCceEEEEEEEcc---------------------------CCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHH
Q 003659          515 RHRHLVSLIGYCDE---------------------------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG  567 (805)
Q Consensus       515 ~H~niv~l~g~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  567 (805)
                      +|||||++.++|.+                           ...+++||.-.+. +|++++...   ..+.....-|..|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999887633                           3467899988865 999998544   3566777889999


Q ss_pred             HHHHHHHHhccCCCCeEeeccCCCcEEe--CCCC--cEEEeecCCCCCCCC----CCCcceeecccccccccChhhhccC
Q 003659          568 SARGLHYLHTGYAKAVIHRDVKSANILL--DENF--MAKVADFGLSKTGPE----IDQTHVSTAVKGSFGYLDPEYFRRQ  639 (805)
Q Consensus       568 ia~gL~yLH~~~~~~ivH~Dikp~NILl--d~~~--~~kl~DFGla~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~  639 (805)
                      +++|+.|||+   ++|.|||+|++|||+  |+|.  ...|+|||++-....    ..........-|...-||||+....
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999   999999999999999  4443  568999998753221    0111111234577789999998643


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHH
Q 003659          640 Q------LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAE  713 (805)
Q Consensus       640 ~------~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~  713 (805)
                      .      --.|+|.|+.|.+.||+++...||....+. ..+...     .++.++     |.+    +..++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qL-----Pal----p~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQL-----PAL----PSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhC-----CCC----cccCChHHHHHHH
Confidence            2      236999999999999999999999752211 111111     122222     222    2333455788999


Q ss_pred             hchhcCCCCCCCHHHHHH
Q 003659          714 KCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       714 ~Cl~~~p~~RPsm~evl~  731 (805)
                      ..|+.+|.+|++..=...
T Consensus       492 ~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             HHhcCCccccCCccHHHh
Confidence            999999999988654433

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=3.2e-17  Score=165.59  Aligned_cols=136  Identities=18%  Similarity=0.207  Sum_probs=106.7

Q ss_pred             cccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-----CCCceEEEEEEEccCC---e-EEE
Q 003659          464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-----RHRHLVSLIGYCDEKN---E-MIL  534 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l  534 (805)
                      ...++||+|+||.||. .-.++.. +||+.........+++.+|+++++++     .||||++++|++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3456999999999996 3334444 69987765444567899999999999     5799999999997763   3 347


Q ss_pred             EEEe--ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCCeEeeccCCCcEEeCC----CCcEEEeecC
Q 003659          535 IYEY--MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL-HYLHTGYAKAVIHRDVKSANILLDE----NFMAKVADFG  607 (805)
Q Consensus       535 V~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dikp~NILld~----~~~~kl~DFG  607 (805)
                      |+||  +++|+|.+++.+.   .+++.  ..++.+++.++ +|||+   .+|+||||||+|||++.    +..++|+||+
T Consensus        83 I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            8999  5689999999543   25544  35677888777 99999   99999999999999974    3489999955


Q ss_pred             CC
Q 003659          608 LS  609 (805)
Q Consensus       608 la  609 (805)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            44

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=4.1e-17  Score=192.22  Aligned_cols=198  Identities=21%  Similarity=0.228  Sum_probs=159.5

Q ss_pred             HHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC---CCceEEEEEEEccCCeE
Q 003659          456 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       456 l~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~  532 (805)
                      .+.-.+.|.+.+.||+|+||+||+|...+|+.||+|.-++...-   +|.--.+++.+|+   -+.|..+..++.-.+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            33445678888999999999999999888999999998776542   3333344555555   22333444444566788


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC-------CCCcEEEee
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-------ENFMAKVAD  605 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld-------~~~~~kl~D  605 (805)
                      +||+||.+.|+|.+++.  ..+.++|...+-++.|+++.++.||.   .+|||+||||+|+||.       +...++|+|
T Consensus       770 ~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEe
Confidence            99999999999999996  44579999999999999999999999   9999999999999993       344689999


Q ss_pred             cCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCC
Q 003659          606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR  661 (805)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~  661 (805)
                      ||.+-.+.-...........+|-++--+|...+...+-..|.|.|+-+++-||.|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            99986543222233456778999999999999999999999999999999999996

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=6.4e-18  Score=186.45  Aligned_cols=225  Identities=22%  Similarity=0.261  Sum_probs=174.0

Q ss_pred             eEeeeCceEEEEEE----ecCCcEEEEEEcCCCCch--hHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEecc
Q 003659          468 VIGIGGFGKVYKGE----LNDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ++|+|.||.|+..+    .+.|..+|+|.++.....  .......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37899999998763    234677888876654321  1124557888888887 9999999999999999999999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcce
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~  620 (805)
                      +|.|...+....  ..+..........+|-+++++|+   .+++|||+|++||+++.+|++|+.|||+++..-...    
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----  151 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence            999999885543  56667777778889999999999   999999999999999999999999999998743311    


Q ss_pred             eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCC
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI  700 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  700 (805)
                        ..+||..|||||++.  .....+|.||||++++||+||..||..    +...      .         +....  -..
T Consensus       152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~------~---------Il~~~--~~~  206 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMK------R---------ILKAE--LEM  206 (612)
T ss_pred             --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHH------H---------Hhhhc--cCC
Confidence              128999999999998  567899999999999999999999975    1111      0         11111  123


Q ss_pred             ChhHHHHHHHHHHhchhcCCCCCCCH
Q 003659          701 RPDSLRKFGETAEKCLADFGVDRPSM  726 (805)
Q Consensus       701 ~~~~~~~l~~l~~~Cl~~~p~~RPsm  726 (805)
                      +.+.......+...++..+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            34445556677778888888888654

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=1.7e-16  Score=164.10  Aligned_cols=141  Identities=16%  Similarity=0.135  Sum_probs=111.4

Q ss_pred             CCcccceEeeeCceEEEEEE--ecCCcEEEEEEcCCCCch------------------------hHHHHHHHHHHHhcCC
Q 003659          462 NFDESWVIGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQ------------------------GLAEFQTEIEMLSQFR  515 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  515 (805)
                      .|...+.||+|++|.||+|.  ..+|+.||+|.+......                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47778899999999999998  567999999987643210                        1123568999999997


Q ss_pred             CC--ceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC-eEeeccCCCc
Q 003659          516 HR--HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSAN  592 (805)
Q Consensus       516 H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~Dikp~N  592 (805)
                      +.  .+.+++++    ...++||||+++++|.......  ..+...+...++.|++.+|++||+   .+ ++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence            63  34455543    2348999999998887765322  245666778999999999999999   88 9999999999


Q ss_pred             EEeCCCCcEEEeecCCCCCC
Q 003659          593 ILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       593 ILld~~~~~kl~DFGla~~~  612 (805)
                      |+++ ++.++|+|||++...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.68  E-value=1.4e-16  Score=162.55  Aligned_cols=134  Identities=25%  Similarity=0.398  Sum_probs=113.6

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCch--------hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--------GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 5778999976543211        124578899999999999988777777777788999999


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      +++++|.+++....     + ++..++.+++.+|.+||+   .+++|||++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999885432     2 889999999999999999   9999999999999999 78999999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=4e-16  Score=157.58  Aligned_cols=143  Identities=19%  Similarity=0.158  Sum_probs=111.9

Q ss_pred             HHHHHhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCc----------------------hhHHHHHHHHHHHh
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----------------------QGLAEFQTEIEMLS  512 (805)
Q Consensus       455 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~  512 (805)
                      ++......|...+.||+|+||.||++..++|+.||||++.....                      .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            34444444677789999999999999988899999997554321                      01123677899999


Q ss_pred             cCCCC--ceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCC
Q 003659          513 QFRHR--HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS  590 (805)
Q Consensus       513 ~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp  590 (805)
                      .+.|+  .+...++.    ...++||||+++++|......        .....++.++++++.++|+   .+++||||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p  153 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLSE  153 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCc
Confidence            99887  44455543    345899999999998776421        3456789999999999999   9999999999


Q ss_pred             CcEEeCCCCcEEEeecCCCCCC
Q 003659          591 ANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       591 ~NILld~~~~~kl~DFGla~~~  612 (805)
                      +||++++++.++|+|||++...
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=2.6e-16  Score=158.99  Aligned_cols=131  Identities=24%  Similarity=0.366  Sum_probs=107.0

Q ss_pred             eEeeeCceEEEEEEecCCcEEEEEEcCCCCc--------hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ--------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      +||+|+||.||+|.+. +..|++|.......        ...+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999864 68899997554321        11356778999999999887655555555666778999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ++++|.+.+....         ..++.+++++|.+||+   .+++|+|++|.||+++ ++.+++.|||+++..
T Consensus        80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998874322         0889999999999999   9999999999999999 789999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=3.1e-16  Score=182.24  Aligned_cols=138  Identities=21%  Similarity=0.275  Sum_probs=112.6

Q ss_pred             hcCCcccceEeeeCceEEEEEEecCCcEEEEEE-cCCC-C------chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKR-GNPR-S------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      ...|...++||+|+||.||+|.+.+.. +++|+ .... .      ....+.+.+|++++.+++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            344566789999999999999876443 44443 2111 1      1123568899999999999999988888877778


Q ss_pred             EEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .++||||+++++|.+++.          ....++.+++++|.+||+   .+++||||||+|||+ +++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999998873          467899999999999999   999999999999999 677999999999976


Q ss_pred             C
Q 003659          612 G  612 (805)
Q Consensus       612 ~  612 (805)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            3

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.62  E-value=1e-16  Score=173.77  Aligned_cols=172  Identities=27%  Similarity=0.361  Sum_probs=128.7

Q ss_pred             eEEEEEEeccCCcccccccCC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          531 EMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       531 ~~~lV~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      .+++.|++|...+|.+||.+. .....+|...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999743 34568899999999999999999      68999999999999999999999999998


Q ss_pred             CCCCCCC----CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCChhhhhhHHHHHHHHhh
Q 003659          610 KTGPEID----QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQN  684 (805)
Q Consensus       610 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  684 (805)
                      .......    .....+...||..||+||.+.+.+|+.|+||||||++|+||+. =...++...          +..-.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence            6544322    1223466789999999999999999999999999999999997 222221110          011112


Q ss_pred             cCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       685 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      .+    +++|....+.+.     =..+..+++...|.+||+..
T Consensus       474 ~g----~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  474 DG----IIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             cC----CCChHHhhcCcH-----HHHHHHHhcCCCcccCchHH
Confidence            22    222222222221     24678899999999999443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=4.9e-15  Score=141.58  Aligned_cols=135  Identities=21%  Similarity=0.231  Sum_probs=116.4

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCC--CceEEEEEEEccCCeEEEEEEeccCCc
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      .+.||+|.++.||+++.++ ..+++|.......  ...+..|+..+..++|  .++++++++....+..+++|||++++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            4679999999999999864 7899998766543  4678899999999977  589999999888889999999999877


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      +..+         ++.....++.+++++|++||.....+++|+|++|.||++++.+.+++.|||+++..
T Consensus        80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            7654         56778889999999999999855568999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.9e-15  Score=174.52  Aligned_cols=210  Identities=24%  Similarity=0.320  Sum_probs=144.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEe
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~  538 (805)
                      ..+|+.+++|-.|++|.||..+++. .+..|+|+ ++..-     ..+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----hhhc--cccccCCccee------------------
Confidence            4678889999999999999998774 56778743 22211     0000  22222233332                  


Q ss_pred             ccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCc
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~  618 (805)
                         |+-...+...+  ++.-.        ++.+++|||+   .+|+|||+||+|.+++.-|++|++|||+++........
T Consensus       136 ---gDc~tllk~~g--~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG--PLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCC--CCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               44444443333  22222        2788999999   99999999999999999999999999999864321111


Q ss_pred             c-------------eeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          619 H-------------VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       619 ~-------------~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      .             ....++||+.|.|||++..+.|....|.|++|+++||.+-|+.||....+++....+      ...
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------isd  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------ISD  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------hhh
Confidence            0             013468999999999999999999999999999999999999999988776653211      110


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCC
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS  725 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  725 (805)
                      .        ....+-......+..+++.+.|+.+|.+|--
T Consensus       274 ~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  274 D--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             h--------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            0        0000001222345677889999999999943

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=3.7e-14  Score=141.67  Aligned_cols=136  Identities=20%  Similarity=0.173  Sum_probs=98.1

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCch--hHHH----------------------HHHHHHHHhcCCCCc--eE
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ--GLAE----------------------FQTEIEMLSQFRHRH--LV  520 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--iv  520 (805)
                      +.||+|+||.||+|...+++.||||++......  ....                      ...|.+.+.++.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            579999999999999888999999987653211  1111                      135666666664432  44


Q ss_pred             EEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       521 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      +.+++    ...++||||++++.+.........  .. .+...++.+++.++.++|.  ..+|+||||||+||+++ ++.
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCc
Confidence            44443    235899999999654332111110  11 6678999999999999997  36899999999999999 899


Q ss_pred             EEEeecCCCCCC
Q 003659          601 AKVADFGLSKTG  612 (805)
Q Consensus       601 ~kl~DFGla~~~  612 (805)
                      ++|+|||++...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=9.2e-14  Score=144.08  Aligned_cols=134  Identities=20%  Similarity=0.193  Sum_probs=105.2

Q ss_pred             ceEe-eeCceEEEEEEecCCcEEEEEEcCCCC-------------chhHHHHHHHHHHHhcCCCCce--EEEEEEEccCC
Q 003659          467 WVIG-IGGFGKVYKGELNDGTKVAVKRGNPRS-------------QQGLAEFQTEIEMLSQFRHRHL--VSLIGYCDEKN  530 (805)
Q Consensus       467 ~~LG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~  530 (805)
                      ..|| .||.|+||+.... +..++||+.....             ......+.+|++++.+|+|+++  +..++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5798 8999999999886 6788998764311             1223567889999999998875  67777654322


Q ss_pred             ----eEEEEEEeccC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEee
Q 003659          531 ----EMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD  605 (805)
Q Consensus       531 ----~~~lV~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~D  605 (805)
                          ..++|||++++ .+|.+++...   .++..    .+.+++++|.+||+   .+|+||||||.|||++.++.++|+|
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEE
Confidence                23599999997 6898887542   34443    35789999999999   9999999999999999989999999


Q ss_pred             cCCCCC
Q 003659          606 FGLSKT  611 (805)
Q Consensus       606 FGla~~  611 (805)
                      ||.++.
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998875

>PLN03150 hypothetical protein; Provisional

Probab=99.45  E-value=9.2e-13  Score=155.07  Aligned_cols=151  Identities=19%  Similarity=0.251  Sum_probs=103.6

Q ss_pred             cEEEecCCCceee---eCCee---eEecCCCCccc-cCCCCcc--ccccc--ccCCCCCccccceeeeeecC---ceeEE
Q 003659           10 NYLIDCGSRTNTT---VGNRV---FVADNSASKFL-STPQNVV--ANISE--SVTSSNDSQLYQTARIFTGS---SKYTF   75 (805)
Q Consensus        10 ~~~idCG~~~~~~---~~~~~---~~~~~~d~~~~-~~~~~~~--~~~~~--~~~~~~~~~~~~t~R~f~~~---~~~~y   75 (805)
                      .|+|+||+.....   +.++.   +..|.+|..|. +....++  ..+..  ..+...+...|+|+|.+...   ..|.+
T Consensus       193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~  272 (623)
T PLN03150        193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQPDLSYTM  272 (623)
T ss_pred             EEEEEecCcccccccCCCCCcccCccccCcCcccCCCcccccccccccccccCCCccChHHHhhhhccccCCCCceEEEe
Confidence            3699999854322   11122   46666666663 2111221  11111  11222356689999999863   36777


Q ss_pred             eecCCceEEEEEEeeccCCCCcCcccceEEEEeCcEEEEeecCC-------CCcEEEEEEEeccCCcEEEEEecCCCCcc
Q 003659           76 SISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSV-------SSNVFKEFSVNVTSDSLDVIFSPSNNSFA  148 (805)
Q Consensus        76 ~~~~~~~ylvR~~F~~~~y~~~~~~~~~F~~~~~~~~~v~~~~~-------~~~~~~E~i~~~~~~~~~vc~~~~~~~~p  148 (805)
                      ++.++++|+||+||.--.........-.|||++||...++.++.       ..++++++.+.+.++.+.|+|+++....|
T Consensus       273 ~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~s~p  352 (623)
T PLN03150        273 DVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKGTHA  352 (623)
T ss_pred             ecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCCCcc
Confidence            77889999999999655432323334789999999988887654       25788899998888889999999877789


Q ss_pred             eeeeeeeEEeCC
Q 003659          149 FINALEVVSVPD  160 (805)
Q Consensus       149 fi~~iE~~~~~~  160 (805)
                      |||||||+.+-.
T Consensus       353 ilNaiEI~~~~~  364 (623)
T PLN03150        353 IINAIEVFEIIT  364 (623)
T ss_pred             eeeeeeeeeccc
Confidence            999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.5e-14  Score=167.89  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=187.5

Q ss_pred             CCcccceEeeeCceEEEEEEec--CCcEEEEEEcCCCC--chhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEE
Q 003659          462 NFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~  536 (805)
                      .|...+.||+|.|+.|-.....  ....+|+|......  ....+....|..+-..+. |+|++.+++...+....+++.
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            3445557999999999887653  34566777665543  233344455777777776 999999999999999999999


Q ss_pred             EeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCCeEeeccCCCcEEeCCCC-cEEEeecCCCCCCCC
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-TGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPE  614 (805)
Q Consensus       537 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dikp~NILld~~~-~~kl~DFGla~~~~~  614 (805)
                      +|..++++.+.+........+-...-....|+..++.|+| .   .++.|+||||+|.+++..+ ..|++|||+|.....
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            9999999999884333234566777888999999999999 6   8999999999999999999 999999999987655


Q ss_pred             -CCCcceeecccc-cccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccc
Q 003659          615 -IDQTHVSTAVKG-SFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       615 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                       ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++....... ....|....   +.    
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~----  249 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR----  249 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc----
Confidence             333444456678 9999999998874 556889999999999999999999875433221 111111110   00    


Q ss_pred             cCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                      ...    ..-........++..+++..+|..|.+.+++.
T Consensus       250 ~~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  250 FTQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccc----CccccCChhhhhcccccccCCchhcccccccc
Confidence            000    01112234466778888889999999988875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.44  E-value=5.1e-13  Score=150.44  Aligned_cols=144  Identities=22%  Similarity=0.266  Sum_probs=103.7

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhH----------------------------------------
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL----------------------------------------  501 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------  501 (805)
                      .|+. +.||.|++|.||+|++++|+.||||+..+......                                        
T Consensus       119 ~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            4443 68999999999999999999999998766521110                                        


Q ss_pred             HHHHHHHHHHhcCC-----CCceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 003659          502 AEFQTEIEMLSQFR-----HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR-GLHYL  575 (805)
Q Consensus       502 ~~~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yL  575 (805)
                      -+|.+|.+.+.+++     ++++.-..-|.......+|||||+++++|.+....... ..   .+.+++..+++ .+..+
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence            02445666665552     34433222223334567999999999999987643211 12   34567777766 46788


Q ss_pred             hccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       576 H~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      |.   .+++|+|+||.||++++++.++++|||++....
T Consensus       274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            88   899999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.37  E-value=5.3e-13  Score=130.95  Aligned_cols=141  Identities=18%  Similarity=0.266  Sum_probs=81.1

Q ss_pred             EEEEecCCCCCCCCCCcccccccCCCcceecccCCcccccC--CccccccCCCCcccCchhHHhhccccccCCCCCCcce
Q 003659          187 VHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNI--PAVKYVQGGATKESAPNTVYGTATRMNSDDDPNANFN  264 (805)
Q Consensus       187 ~~R~n~Gg~~~~~~~D~~~R~W~~d~~~~~~~~~~~~~s~~--~~i~~~~~~~~~~~~P~~V~~tA~~~~~~~~~~~~l~  264 (805)
                      ++|+|+||+..   .|.....|.+|..|.-..  +.-....  ..........-....++.+|||+|...        -+
T Consensus         2 ~~~IN~Gg~~~---~~~~g~~w~~D~~~~~g~--~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~--------~~   68 (174)
T PF11721_consen    2 VLRINAGGPAY---TDSSGIVWEADQYYTGGS--WGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP--------SS   68 (174)
T ss_dssp             EEEEEETSSSE---EETTTEEE-SSSSSTTSS-------------SSTTS--TTS-HHHHHTTT-----S--------SS
T ss_pred             EEEEECCCCcc---cCCCCCEEcCCCCCCCCC--cccccccccccccccccccccCCCchhhhHhhcCCC--------Cc
Confidence            68999999988   677889999999753222  2100000  000001111122346779999999843        15


Q ss_pred             EEEEeecCCCCceEEEEEecceeccC------CCceEEEEEeccccccccccccccccCcccceEEEee-EEEecCCCcE
Q 003659          265 VTWEFDVDSGFQYLVRFHFCDIVSDG------LNQLYFNVYIDSWIAVRDLDLSTYSTNTLAAAYYIDM-VTVQTASSKL  337 (805)
Q Consensus       265 ltw~~~~~~~~~ylv~LhFae~~~~~------~~~r~F~v~in~~~~~~~~d~~~~s~~~~~~~~~~~~-~~~~~~~~~~  337 (805)
                      ++|.+|+.++..|.|.|||||+....      .++|+|||++||+...++|||... .++...+....+ .+.+ ..+.+
T Consensus        69 f~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~-~G~~~~~~~~~~~~v~v-~dg~L  146 (174)
T PF11721_consen   69 FSYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAE-AGGFNKAAVRRFFNVTV-TDGTL  146 (174)
T ss_dssp             EEEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHH-HSSSS---EEEEEEEEE-ETTEE
T ss_pred             eEEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHH-cCCCceEEEEEEEEEEE-eCCcE
Confidence            78999977789999999999997666      899999999999999999999887 444444555544 4444 34556


Q ss_pred             EEEec
Q 003659          338 RISIG  342 (805)
Q Consensus       338 ~i~l~  342 (805)
                      +|.+.
T Consensus       147 ~i~f~  151 (174)
T PF11721_consen  147 NIQFV  151 (174)
T ss_dssp             ETTEE
T ss_pred             EEEEE
Confidence            65553

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=5e-13  Score=136.44  Aligned_cols=202  Identities=24%  Similarity=0.357  Sum_probs=140.3

Q ss_pred             HHHhcCCCCceEEEEEEEcc-----CCeEEEEEEeccCCcccccccCC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 003659          509 EMLSQFRHRHLVSLIGYCDE-----KNEMILIYEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGYAK  581 (805)
Q Consensus       509 ~~l~~l~H~niv~l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  581 (805)
                      .-|-++-|-|||++..|+.+     ..+..++.|||..|+|.++|++.  ....+......+|+.||..||.|||+ |.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            34566779999999998844     44688999999999999999763  33568888889999999999999998 678


Q ss_pred             CeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCC--CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHh
Q 003659          582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEID--QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC  659 (805)
Q Consensus       582 ~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ellt  659 (805)
                      +|+|+++..+-|++..++-+|++----........  .........+-++|.+||+-..-+.+.++|||+||+..+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999989875321111100000  0011123356789999999887888899999999999999987


Q ss_pred             CCCC-CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHH
Q 003659          660 ARPV-IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       660 G~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~  731 (805)
                      +..- -......+            .++.+...+- .+..       ..-...+.+|++..|..||+|++++.
T Consensus       278 lEiq~tnseS~~~------------~ee~ia~~i~-~len-------~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVE------------VEENIANVII-GLEN-------GLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceee------------hhhhhhhhee-eccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence            7532 11111000            0000000000 0000       00134578999999999999999875

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.21  E-value=4.9e-11  Score=116.94  Aligned_cols=130  Identities=21%  Similarity=0.130  Sum_probs=96.7

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceE-EEEEEEccCCeEEEEEEeccCCccc
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMENGTLK  545 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~  545 (805)
                      +.|+.|.++.||+++.. +..+++|....... ....+..|++++..+.+.+++ +++.+..  ...++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            47889999999999876 77899998765432 123467899999998765554 4444433  2357999999998876


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      +..          .....++.+++++|+.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            530          112345678999999999832  23369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.19  E-value=6e-10  Score=127.08  Aligned_cols=146  Identities=17%  Similarity=0.168  Sum_probs=94.0

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCCCchh------------------------------H----H--
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQG------------------------------L----A--  502 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~------------------------------~----~--  502 (805)
                      ...|+. +.||+|++|.||+|++++ |+.||||+..+.-.+.                              .    +  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 689999999999999987 9999999887542110                              0    1  


Q ss_pred             ----HHHHHHHHHhcCC----CCceEEEEEEE-ccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHH-HH
Q 003659          503 ----EFQTEIEMLSQFR----HRHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR-GL  572 (805)
Q Consensus       503 ----~~~~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL  572 (805)
                          +|.+|+..+.+++    +.+.+.+-.++ .-....+|||||++|+.|.+.-.-.. ...+   +..++...++ -+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d---~~~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTD---MKLLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCC---HHHHHHHHHHHHH
Confidence                1344555555542    33333332222 22456789999999999977421111 1122   1222222222 12


Q ss_pred             HHHhccCCCCeEeeccCCCcEEeCCCC----cEEEeecCCCCCCC
Q 003659          573 HYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFGLSKTGP  613 (805)
Q Consensus       573 ~yLH~~~~~~ivH~Dikp~NILld~~~----~~kl~DFGla~~~~  613 (805)
                      ..++.   .+++|+|+||.||+++.++    .+++.|||++...+
T Consensus       274 ~Qif~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        274 TQVFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            22333   7999999999999999988    99999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=3.5e-11  Score=133.65  Aligned_cols=247  Identities=19%  Similarity=0.180  Sum_probs=173.7

Q ss_pred             CCcccceEee--eCceEEEEEEe--c-CCcEEEEEEcCCC--CchhHHHHHHHHHHHhcC-CCCceEEEEEEEccCCeEE
Q 003659          462 NFDESWVIGI--GGFGKVYKGEL--N-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       462 ~f~~~~~LG~--G~~g~Vy~~~~--~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  533 (805)
                      .|.....+|.  |.+|.||++..  . ++..+|+|+-+..  .......=.+|+.....+ .|+|.++....+..++..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3455668999  99999999977  3 5788999973322  222222334666666666 4999999888899999999


Q ss_pred             EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCC
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR----GLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGL  608 (805)
Q Consensus       534 lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGl  608 (805)
                      +-.|++. .+|.++.+... ..+.....+.+..+..+    ||.++|.   ..++|-|+||.||++..+ ...+++|||+
T Consensus       195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence            9999986 68888876544 23556666777777777    9999999   999999999999999999 8899999999


Q ss_pred             CCCCCCCCCcce---eecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhc
Q 003659          609 SKTGPEIDQTHV---STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       609 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      .......+....   .....|...|++||..+ +-++.++|+|++|.+.+|..++..........      .|..     
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~-----  337 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ-----  337 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc-----
Confidence            987655332211   12235777899999874 45689999999999999999987554322100      1110     


Q ss_pred             CCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHH
Q 003659          686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL  730 (805)
Q Consensus       686 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl  730 (805)
                        +....   +..++-.....++...+..+++.++..|++.+.+.
T Consensus       338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence              01111   11111111233444578888899998888876665

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.13  E-value=6.6e-10  Score=113.90  Aligned_cols=142  Identities=18%  Similarity=0.296  Sum_probs=113.6

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCc-hhHHHHHHHHHHHhcCCC--CceEEEEEEEccCC---eEEEEEEecc
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKN---EMILIYEYME  540 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~  540 (805)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++  .++.+++.++....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            47899999999999887778999998765432 235578899999999976  44577788776643   5689999999


Q ss_pred             CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccC-----------------------------------------
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY-----------------------------------------  579 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------------  579 (805)
                      +.+|.+.+..   ..++..++..++.+++++|..||+..                                         
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988886632   35788888999999999999999521                                         


Q ss_pred             ------------CCCeEeeccCCCcEEeCC--CCcEEEeecCCCCC
Q 003659          580 ------------AKAVIHRDVKSANILLDE--NFMAKVADFGLSKT  611 (805)
Q Consensus       580 ------------~~~ivH~Dikp~NILld~--~~~~kl~DFGla~~  611 (805)
                                  ...++|+|+++.||+++.  +..+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        246799999999999998  66789999998865

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=1.1e-09  Score=122.72  Aligned_cols=166  Identities=16%  Similarity=0.204  Sum_probs=125.8

Q ss_pred             ecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHH
Q 003659          482 LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR  561 (805)
Q Consensus       482 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~  561 (805)
                      ..++.+|.|...+...........+-++.|+.++||||++++...++.+..|+|+|-+.  .|..++.+     +.-...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-----l~~~~v  106 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-----LGKEEV  106 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----hHHHHH
Confidence            34678888887776655445566788899999999999999999999999999999874  56666633     334566


Q ss_pred             HHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCC
Q 003659          562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL  641 (805)
Q Consensus       562 ~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  641 (805)
                      .-.+.||+.||.|||+.  .+++|++|.-..|+++..|+.||++|.++........  ......---.|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            66789999999999973  6799999999999999999999999998865432221  111112223466776553222 


Q ss_pred             CchhhHHHHHHHHHHHHhC
Q 003659          642 TEKSDVYSFGVVLFEVLCA  660 (805)
Q Consensus       642 s~ksDV~S~Gvvl~elltG  660 (805)
                       -..|.|-||++++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.00  E-value=3.8e-09  Score=105.02  Aligned_cols=135  Identities=13%  Similarity=0.115  Sum_probs=97.0

Q ss_pred             ceEeeeCceEEEEEEecC-------CcEEEEEEcCCCC----------------------chhHHHHH----HHHHHHhc
Q 003659          467 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRS----------------------QQGLAEFQ----TEIEMLSQ  513 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~  513 (805)
                      ..||.|.-+.||.|...+       +..+|||+.+...                      ....+.+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999997543       4789999533210                      01122333    79999999


Q ss_pred             CCC--CceEEEEEEEccCCeEEEEEEeccCCcccc-cccCCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCCeEeeccC
Q 003659          514 FRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVK  589 (805)
Q Consensus       514 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dik  589 (805)
                      +..  -++..++++    ..-+|||||+.+..+.. .+..   ..++..+..++..+++.+|..| |+   .++||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            853  456666654    45689999997654432 2211   1344556778889999999999 77   899999999


Q ss_pred             CCcEEeCCCCcEEEeecCCCCCC
Q 003659          590 SANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       590 p~NILld~~~~~kl~DFGla~~~  612 (805)
                      +.|||+++ +.+.|+|||.+...
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeC
Confidence            99999974 68999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=4.3e-09  Score=100.38  Aligned_cols=143  Identities=19%  Similarity=0.222  Sum_probs=106.1

Q ss_pred             ccceEeeeCceEEEEEEecCCcEEEEEEcCCCC--------chhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEE
Q 003659          465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ...+|-+|+-+.|+++.+. |+...||.-....        +-..+...+|+++|.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            3458999999999999887 7777787432221        122456778999999987555544444454555567889


Q ss_pred             EeccC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCC---cEEEeecCCCCC
Q 003659          537 EYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF---MAKVADFGLSKT  611 (805)
Q Consensus       537 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~---~~kl~DFGla~~  611 (805)
                      ||+++ .++.+++.......-.-.....++..|-+.+.-||.   .+|||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 478888865444344444447899999999999999   9999999999999996554   468999999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=4.7e-09  Score=100.77  Aligned_cols=130  Identities=24%  Similarity=0.349  Sum_probs=101.7

Q ss_pred             eEeeeCceEEEEEEecCCcEEEEEEcCCCC--c------hhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEec
Q 003659          468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRS--Q------QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~  539 (805)
                      ++++|+-+.+|.+.+. |..+++|.-.+..  .      -....-.+|+++|.+++--.|...+=+..+.+...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            6789999999999775 4457777322221  1      11234568999999997666666666667778889999999


Q ss_pred             cCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ++-.|.+.+...         +..++..+-+-+.-||.   .+|+|+||.++||++.... +.++||||+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888543         36778888888899999   9999999999999998875 99999999875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.93  E-value=1.7e-08  Score=109.79  Aligned_cols=167  Identities=16%  Similarity=0.215  Sum_probs=128.6

Q ss_pred             ceEEEEEEec-CCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEEEEEEEc----cCCeEEEEEEeccC-Cccccc
Q 003659          474 FGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD----EKNEMILIYEYMEN-GTLKGH  547 (805)
Q Consensus       474 ~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~e~~~~-gsL~~~  547 (805)
                      -.+.||+..+ ||..+++||+.....+.......-+++++++.|.|+|++..++.    .+..+++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            4578999665 79999999995443333333455688999999999999998874    45678999999986 567665


Q ss_pred             ccCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          548 LYGS-------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       548 l~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      ....             .....++..+|.++.|++.||.++|+   .|+.-+-|.+++||++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321             12357789999999999999999999   8999999999999999999999999888766443


Q ss_pred             CCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP  662 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~  662 (805)
                      ..              .  |-+..   -.+-|.=.||.+++.|.||..
T Consensus       446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            11              0  11111   246799999999999999964

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=5.4e-10  Score=124.33  Aligned_cols=248  Identities=18%  Similarity=0.167  Sum_probs=173.7

Q ss_pred             HHhcCCcccceEeeeCceEEEEEEec--CCcEEEEEEcCCCCchhHHH--HHHHHHHHhcC-CCCceEEEEEEEccCCeE
Q 003659          458 EATNNFDESWVIGIGGFGKVYKGELN--DGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQF-RHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       458 ~at~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  532 (805)
                      .-+.+|.....||.|.|+.|++...+  ++..+++|.+.........+  -..|+-+...+ .|.++++....+....+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888889999999999998654  57889999776654332222  13566666555 588888888778777888


Q ss_pred             EEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCC-CcEEEeecCCCCC
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN-FMAKVADFGLSKT  611 (805)
Q Consensus       533 ~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~-~~~kl~DFGla~~  611 (805)
                      ++--||+.++++...+  .....++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..+++|||++..
T Consensus       342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            8999999999887766  222357788899999999999999998   999999999999999886 7889999999864


Q ss_pred             CCCCCCcceeecccccccc-cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCccc
Q 003659          612 GPEIDQTHVSTAVKGSFGY-LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .....    ......+..| .+++......+..+.|++|||.-+.|.+++...-....        .|.  ..+.+.   
T Consensus       417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~---  479 (524)
T KOG0601|consen  417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGD---  479 (524)
T ss_pred             cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeeccc---
Confidence            22111    0111122234 35556667788899999999999999999875332111        110  001111   


Q ss_pred             ccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHHHHHHH
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE  734 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~evl~~L~  734 (805)
                            ....+ .....+..++......++..||...+...+.+
T Consensus       480 ------~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  480 ------TPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------ccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  11111 22255677788888889999998877765443

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=98.81  E-value=8.6e-09  Score=101.24  Aligned_cols=141  Identities=22%  Similarity=0.330  Sum_probs=79.9

Q ss_pred             cEEEecCCCceeeeCCeeeEecCCCCccccCCCC--c-------ccccccccCCCCCccccceeeeeecCceeEEeecCC
Q 003659           10 NYLIDCGSRTNTTVGNRVFVADNSASKFLSTPQN--V-------VANISESVTSSNDSQLYQTARIFTGSSKYTFSISGR   80 (805)
Q Consensus        10 ~~~idCG~~~~~~~~~~~~~~~~~d~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~t~R~f~~~~~~~y~~~~~   80 (805)
                      .++||||++..+..+   +..|.+|..|.+....  .       .............+.+|+|.|.=|...+|.+++.++
T Consensus         2 ~~~IN~Gg~~~~~~~---g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~   78 (174)
T PF11721_consen    2 VLRINAGGPAYTDSS---GIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPN   78 (174)
T ss_dssp             EEEEEETSSSEEETT---TEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-
T ss_pred             EEEEECCCCcccCCC---CCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCC
Confidence            479999996553334   4555555556333320  0       001111122233557899999977767888887789


Q ss_pred             ceEEEEEEeeccCCCC----cCcccceEEEEeCcEEEEeecCCC------C-cEEEEE-EEeccCCcEEEEEec------
Q 003659           81 GRHWIRLYFYPFVYQS----YNMSRASFSVSTNDHVLLNNFSVS------S-NVFKEF-SVNVTSDSLDVIFSP------  142 (805)
Q Consensus        81 ~~ylvR~~F~~~~y~~----~~~~~~~F~~~~~~~~~v~~~~~~------~-~~~~E~-i~~~~~~~~~vc~~~------  142 (805)
                      |.|-|||||-=-.+..    .....=.|||.+||-.++.+++..      . +..+++ -+.+.++.|.|+|..      
T Consensus        79 G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~  158 (174)
T PF11721_consen   79 GTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTL  158 (174)
T ss_dssp             EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEE
T ss_pred             cEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcE
Confidence            9999999994333322    112235799999999999998863      2 567777 456788999999996      


Q ss_pred             -----CCCCcceeeee
Q 003659          143 -----SNNSFAFINAL  153 (805)
Q Consensus       143 -----~~~~~pfi~~i  153 (805)
                           ...+.|.||||
T Consensus       159 ~i~~~~~~~~p~IsaI  174 (174)
T PF11721_consen  159 CIPFIGSYGNPLISAI  174 (174)
T ss_dssp             EEEEESSSSSSSEEEE
T ss_pred             EeeccccCCCcEEeeC
Confidence                 33456777776

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.79  E-value=4.5e-08  Score=102.78  Aligned_cols=141  Identities=13%  Similarity=0.080  Sum_probs=102.5

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCch-hH----------HHHHHHHHHHhcCCCCce--EEEEEEEcc-----
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ-GL----------AEFQTEIEMLSQFRHRHL--VSLIGYCDE-----  528 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~ni--v~l~g~~~~-----  528 (805)
                      +++-+-....|.+..+ +|+.+.||+....... ..          ..+.+|.+.+.++...+|  .+++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3555544555777766 4788999976543311 11          137789999988854443  345555533     


Q ss_pred             CCeEEEEEEeccCC-cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCC-------CCc
Q 003659          529 KNEMILIYEYMENG-TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-------NFM  600 (805)
Q Consensus       529 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~-------~~~  600 (805)
                      ...-+||+|++++- +|.+++......+.+...+..++.++++.+.-||.   .+|+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCce
Confidence            34578999999875 78888753222345667788999999999999999   99999999999999975       578


Q ss_pred             EEEeecCCCCC
Q 003659          601 AKVADFGLSKT  611 (805)
Q Consensus       601 ~kl~DFGla~~  611 (805)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.77  E-value=3e-09  Score=124.16  Aligned_cols=248  Identities=20%  Similarity=0.267  Sum_probs=161.4

Q ss_pred             hcCCcccceEeeeCceEEEEEEecC-CcEEEEEEcCCC---CchhHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEE
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       460 t~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      .+.|...+-+-+|.++.+..++-.. |...++|.....   .....+....+-.++-..+||-++....-+.-.....||
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            3455555677788898888775332 322233321111   111122222333333334456666555445566788999


Q ss_pred             EEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCC
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~  615 (805)
                      ++|..+++|...|+...  .++..-.......+...++|||.   ..+.|+|++|.|.|...++..+++|||+....+..
T Consensus       883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccc
Confidence            99999999999997655  34544455566677889999998   67999999999999999999999999843221100


Q ss_pred             ----------C-------------------CcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 003659          616 ----------D-------------------QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP  666 (805)
Q Consensus       616 ----------~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~~~  666 (805)
                                .                   .........||+.|++||...+......+|.|++|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                      0                   00112345689999999999999999999999999999999999999986


Q ss_pred             CChhhhhhHHHHHHHHhhcCCcccccCcccc-CCCChhHHHHHHHHHHhchhcCCCCCCCHH
Q 003659          667 TLPREMVNLAEWAMKWQNKGQLDQIIDPTLA-GKIRPDSLRKFGETAEKCLADFGVDRPSMG  727 (805)
Q Consensus       667 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~  727 (805)
                      ..+.....               .++..... ...+.+......+++...+..+|.+|-.|.
T Consensus      1038 ~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            65543210               11111000 011123344456677788888899996654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.4e-07  Score=93.57  Aligned_cols=124  Identities=23%  Similarity=0.261  Sum_probs=82.5

Q ss_pred             EEEEEEecCCcEEEEEEcCCCC--------------c------------hhHHHHHHHHHHHhcCCCC--ceEEEEEEEc
Q 003659          476 KVYKGELNDGTKVAVKRGNPRS--------------Q------------QGLAEFQTEIEMLSQFRHR--HLVSLIGYCD  527 (805)
Q Consensus       476 ~Vy~~~~~~g~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~  527 (805)
                      .||.|...+|..+|||......              .            .......+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999643210              0            0123466899999999765  456666553 


Q ss_pred             cCCeEEEEEEecc--CCcccccccCCCCCCCCHHHHHHHHHHHHHHHHH-HhccCCCCeEeeccCCCcEEeCCCCcEEEe
Q 003659          528 EKNEMILIYEYME--NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY-LHTGYAKAVIHRDVKSANILLDENFMAKVA  604 (805)
Q Consensus       528 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dikp~NILld~~~~~kl~  604 (805)
                         .-.+||||++  +..+..+. ...   ++......++.++++.+.. +|.   .+|+|+||.+.|||++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEE
Confidence               2379999998  54454432 211   2245567788888886655 467   899999999999999988 99999


Q ss_pred             ecCCCCC
Q 003659          605 DFGLSKT  611 (805)
Q Consensus       605 DFGla~~  611 (805)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.51  E-value=4.9e-07  Score=99.03  Aligned_cols=145  Identities=24%  Similarity=0.328  Sum_probs=95.2

Q ss_pred             cEEEecCCCc--eeeeCCeeeEecCC---CCcc--ccCCCCcccccccccCCCCCccccceeeeeecCc-----eeEEee
Q 003659           10 NYLIDCGSRT--NTTVGNRVFVADNS---ASKF--LSTPQNVVANISESVTSSNDSQLYQTARIFTGSS-----KYTFSI   77 (805)
Q Consensus        10 ~~~idCG~~~--~~~~~~~~~~~~~~---d~~~--~~~~~~~~~~~~~~~~~~~~~~~~~t~R~f~~~~-----~~~y~~   77 (805)
                      .++++||+..  ..|.+|.-++.|.+   +...  ..+...+. ..........+...|+|||.-....     .|.+ +
T Consensus       180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~-~~~~~~~~~~P~~V~~TA~~~~~~s~~~nltw~~-~  257 (347)
T PF12819_consen  180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN-INSSNNPYDAPSAVYQTARTPSNSSDPLNLTWSF-V  257 (347)
T ss_pred             EEeecCCCcccccCCCCCcceeeccccccCccccccccceeee-cccCCccCcChHHHHHhhhcccccccceEEEecc-C
Confidence            5799999965  55656555555543   2222  11111121 0111223344677899999887664     3444 4


Q ss_pred             cCCceEEEEEEeeccCCCCc--CcccceEEEEeCcEEEEeecCC------CCcEEEEEEEeccC-CcEEEEEecCCCC--
Q 003659           78 SGRGRHWIRLYFYPFVYQSY--NMSRASFSVSTNDHVLLNNFSV------SSNVFKEFSVNVTS-DSLDVIFSPSNNS--  146 (805)
Q Consensus        78 ~~~~~ylvR~~F~~~~y~~~--~~~~~~F~~~~~~~~~v~~~~~------~~~~~~E~i~~~~~-~~~~vc~~~~~~~--  146 (805)
                      .++..|+||+||  ++....  +...-.|||++||.......+.      ..+++..+++.+.+ +.+.|+|.++..+  
T Consensus       258 ~~~~~y~v~lHF--aEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~l  335 (347)
T PF12819_consen  258 DPGFSYYVRLHF--AEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTL  335 (347)
T ss_pred             CCCccEEEEEEE--eecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCc
Confidence            778899999999  777764  3324789999999776643333      13346678887765 5799999999776  


Q ss_pred             cceeeeeeeEEe
Q 003659          147 FAFINALEVVSV  158 (805)
Q Consensus       147 ~pfi~~iE~~~~  158 (805)
                      -|+|||+||+.|
T Consensus       336 ppiLNalEIy~v  347 (347)
T PF12819_consen  336 PPILNALEIYKV  347 (347)
T ss_pred             CceeEeeeeEeC
Confidence            699999999864

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=1.1e-06  Score=87.57  Aligned_cols=139  Identities=17%  Similarity=0.127  Sum_probs=106.2

Q ss_pred             EeeeCceEEEEEEecCCcEEEEEEcCCC---C---chhHHHHHHHHHHHhcCCCCc--eEEEEEEEcc----CCeEEEEE
Q 003659          469 IGIGGFGKVYKGELNDGTKVAVKRGNPR---S---QQGLAEFQTEIEMLSQFRHRH--LVSLIGYCDE----KNEMILIY  536 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~~g~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~----~~~~~lV~  536 (805)
                      -|+||-+.|+.-.++ |..+-+|+....   +   ..+...|.+|+..|.+|...+  +.+++.+...    ..+-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467899999998776 447889975421   1   335678999999999996433  4445422212    23568999


Q ss_pred             EeccC-CcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc--EEEeecCCCCC
Q 003659          537 EYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM--AKVADFGLSKT  611 (805)
Q Consensus       537 e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~--~kl~DFGla~~  611 (805)
                      |-+++ -+|.+++......+.+..++..+..++++.++-||+   .++.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98764 588888866555567888899999999999999999   99999999999999986666  99999987664

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.47  E-value=8.5e-07  Score=100.83  Aligned_cols=146  Identities=20%  Similarity=0.266  Sum_probs=98.0

Q ss_pred             cCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhH------------------------------HH-------
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL------------------------------AE-------  503 (805)
Q Consensus       461 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~~-------  503 (805)
                      ..|+. +.|+.++-|.||+|++++|+.||||+..+.-....                              ++       
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34543 58999999999999999999999998765522110                              11       


Q ss_pred             ---HHHHHHHHhcCC-----CCceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHH-HHH
Q 003659          504 ---FQTEIEMLSQFR-----HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG-LHY  574 (805)
Q Consensus       504 ---~~~E~~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~y  574 (805)
                         |.+|...+.+++     .+++.-.-=|++-.+...|+|||++|-.+.+...-.. ...+-   ..++..++++ +..
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~---k~ia~~~~~~f~~q  280 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDR---KELAELLVRAFLRQ  280 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCH---HHHHHHHHHHHHHH
Confidence               344555555552     3444333334445677899999999988888742222 23443   3333333332 222


Q ss_pred             HhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC
Q 003659          575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       575 LH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~  614 (805)
                      +-.   .+++|+|.+|.||+++.++++.+.|||+....+.
T Consensus       281 ~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222   6899999999999999999999999999876543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.45  E-value=6.4e-08  Score=109.34  Aligned_cols=152  Identities=20%  Similarity=0.287  Sum_probs=101.1

Q ss_pred             HHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCC-CC------CcceeecccccccccChhhhc
Q 003659          565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-ID------QTHVSTAVKGSFGYLDPEYFR  637 (805)
Q Consensus       565 ~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~-~~------~~~~~~~~~gt~~y~aPE~~~  637 (805)
                      +.+++.||.|+|.  ..++||++|.|++|.++.++..||+.|+.+..... .+      .........-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3445599999998  47899999999999999999999999998754322 11      111112223455799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCC-CCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhch
Q 003659          638 RQQLTEKSDVYSFGVVLFEVLCARPV-IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL  716 (805)
Q Consensus       638 ~~~~s~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  716 (805)
                      ....+.++|+||+||+++-+..|..+ +............         ....   +... ..+..+.+.++.+-+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------~~~~---~~~~-~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------RNLL---NAGA-FGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------hccc---cccc-ccccccCcHHHHHHHHHHh
Confidence            98889999999999999999955443 3322111110000         0000   0000 1112344556777778889


Q ss_pred             hcCCCCCCCHHHHHH
Q 003659          717 ADFGVDRPSMGDVLW  731 (805)
Q Consensus       717 ~~~p~~RPsm~evl~  731 (805)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.43  E-value=1.6e-06  Score=88.50  Aligned_cols=133  Identities=24%  Similarity=0.222  Sum_probs=95.1

Q ss_pred             ccceEeeeCceEEEEEEecCCcEEEEEEcCC--CC--------------------chhHHHHHHHHHHHhcCCCC--ceE
Q 003659          465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNP--RS--------------------QQGLAEFQTEIEMLSQFRHR--HLV  520 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~--~~--------------------~~~~~~~~~E~~~l~~l~H~--niv  520 (805)
                      ....||.|.-+.||.|....|.++|||.=..  .+                    .......++|.+.|.+|.-.  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            4468999999999999999999999993111  10                    01123467899999999755  666


Q ss_pred             EEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCc
Q 003659          521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM  600 (805)
Q Consensus       521 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~  600 (805)
                      +.+++    +.-.+||||+++-.|...-       ++....-.|+..|++-+.-+-.   .|+||+|+.+-||++++++.
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             Ccccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCC
Confidence            66654    4568999999886665432       1233333444444444444444   79999999999999999999


Q ss_pred             EEEeecCCCCC
Q 003659          601 AKVADFGLSKT  611 (805)
Q Consensus       601 ~kl~DFGla~~  611 (805)
                      +.++||--+..
T Consensus       241 ~~vIDwPQ~v~  251 (304)
T COG0478         241 IVVIDWPQAVP  251 (304)
T ss_pred             EEEEeCccccc
Confidence            99999976544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.41  E-value=1.3e-05  Score=85.74  Aligned_cols=256  Identities=14%  Similarity=0.166  Sum_probs=154.8

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-CCCceEEEEEE------E-ccCCeEEEEEE
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGY------C-DEKNEMILIYE  537 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~------~-~~~~~~~lV~e  537 (805)
                      .+.||+|+-+.+|..---  .-.+.|+..........   +.+.+|... .||-+-.=+.+      . ..+...-+.|.
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            457999999999964211  12234554433322222   223334443 45544321221      1 22233667788


Q ss_pred             eccCCc-cccccc----CCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          538 YMENGT-LKGHLY----GSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       538 ~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      .+++.. ...++.    +...+...|.-.++.++.+|.+.+-||+   .|.+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence            776542 222322    1233668999999999999999999999   89999999999999999999999985433332


Q ss_pred             CCCCCcceeecccccccccChhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhh-----hh-hHHH---
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPRE-----MV-NLAE---  677 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~S~Gvvl~elltG-~~p~~~~~~~~-----~~-~l~~---  677 (805)
                         .........+|...|++||.-.     +..-+...|.|.+||+++++|.| +.||.......     .. .+..   
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence               1222344567889999999754     34567889999999999999887 89986432110     00 0000   


Q ss_pred             -HHHHHhhcCCcccccCccccCCCCh-hHHHHHHHHHHhchhcC--CCCCCCHHHHHHHHHHHHHh
Q 003659          678 -WAMKWQNKGQLDQIIDPTLAGKIRP-DSLRKFGETAEKCLADF--GVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       678 -~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~--p~~RPsm~evl~~L~~~~~~  739 (805)
                       ++.+ .+.+..     +. ...++- -....+..+-.+|+...  +.-||+.+-.+..|..+.+.
T Consensus       245 ~ya~~-~~~g~~-----p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         245 AYASD-QRRGLK-----PP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eechh-ccCCCC-----CC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence             0000 000000     00 011111 11234556677787654  56899999999888766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.34  E-value=1.8e-06  Score=87.71  Aligned_cols=107  Identities=22%  Similarity=0.230  Sum_probs=84.6

Q ss_pred             HHHHHHHHHHHhcCCC--CceEEEEEEEccC----CeEEEEEEeccCC-cccccccCCCCCCCCHHHHHHHHHHHHHHHH
Q 003659          501 LAEFQTEIEMLSQFRH--RHLVSLIGYCDEK----NEMILIYEYMENG-TLKGHLYGSGLPSLSWKQRLEICIGSARGLH  573 (805)
Q Consensus       501 ~~~~~~E~~~l~~l~H--~niv~l~g~~~~~----~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~  573 (805)
                      ...+.+|.+.+.+|..  -...+.+++....    ...+||+|++++. +|.+++.....  ++......++.++++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            3467788888888853  3345666666543    2458999999874 79998865332  566778899999999999


Q ss_pred             HHhccCCCCeEeeccCCCcEEeCCCC---cEEEeecCCCCCC
Q 003659          574 YLHTGYAKAVIHRDVKSANILLDENF---MAKVADFGLSKTG  612 (805)
Q Consensus       574 yLH~~~~~~ivH~Dikp~NILld~~~---~~kl~DFGla~~~  612 (805)
                      -||+   .+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   9999999999999999887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.18  E-value=1.9e-05  Score=81.23  Aligned_cols=139  Identities=14%  Similarity=0.151  Sum_probs=86.1

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce--EEEEEEEccCCeEEEEEEeccCCc-
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL--VSLIGYCDEKNEMILIYEYMENGT-  543 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~~~~lV~e~~~~gs-  543 (805)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.+  .+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47999999999984   24467788876543  23456889999999865443  667788877778889999998863 


Q ss_pred             ccccc---------------------cCCCCCCCCHHHHHHHH-H----------HHHH-HHHHHhc-cCCCCeEeeccC
Q 003659          544 LKGHL---------------------YGSGLPSLSWKQRLEIC-I----------GSAR-GLHYLHT-GYAKAVIHRDVK  589 (805)
Q Consensus       544 L~~~l---------------------~~~~~~~l~~~~~~~i~-~----------~ia~-gL~yLH~-~~~~~ivH~Dik  589 (805)
                      +...+                     |.-.........+..-. .          .+.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     11100111111111000 0          0001 1222221 112457899999


Q ss_pred             CCcEEeCCCCcEEEeecCCCCC
Q 003659          590 SANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       590 p~NILld~~~~~kl~DFGla~~  611 (805)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999988 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.12  E-value=1.4e-05  Score=90.68  Aligned_cols=144  Identities=22%  Similarity=0.296  Sum_probs=93.1

Q ss_pred             CCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhH---------------------------H----------HH
Q 003659          462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL---------------------------A----------EF  504 (805)
Q Consensus       462 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~---------------------------~----------~~  504 (805)
                      .|+. +.||.-..|.||+|++++|+.||||+.++.-++..                           +          +|
T Consensus       163 ~f~~-~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF  241 (538)
T KOG1235|consen  163 EFDE-EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF  241 (538)
T ss_pred             hcCc-chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence            4443 58999999999999999999999998665532210                           0          14


Q ss_pred             HHHHHHHhcC----CCCc------eEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 003659          505 QTEIEMLSQF----RHRH------LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY  574 (805)
Q Consensus       505 ~~E~~~l~~l----~H~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y  574 (805)
                      .+|.+-..+.    .|-+      |.+++  +.-.....|+||||+|..+.+.-.-.. ..++-..+..-+.++     |
T Consensus       242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~-----~  313 (538)
T KOG1235|consen  242 TKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEA-----Y  313 (538)
T ss_pred             HHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHH-----H
Confidence            4444443333    3555      22222  334457899999999988776532111 234444333333332     2


Q ss_pred             HhccCCCCeEeeccCCCcEEeCC----CCcEEEeecCCCCCCCC
Q 003659          575 LHTGYAKAVIHRDVKSANILLDE----NFMAKVADFGLSKTGPE  614 (805)
Q Consensus       575 LH~~~~~~ivH~Dikp~NILld~----~~~~kl~DFGla~~~~~  614 (805)
                      ++.-...|++|+|-+|.||+++.    ++.+.+-|||+......
T Consensus       314 ~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22222368999999999999984    67899999999886543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.08  E-value=5.3e-05  Score=76.01  Aligned_cols=138  Identities=17%  Similarity=0.175  Sum_probs=92.3

Q ss_pred             HhcCCcccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHH---------HHHHHHHhcCC---CCceEEEEEEE
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF---------QTEIEMLSQFR---HRHLVSLIGYC  526 (805)
Q Consensus       459 at~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---H~niv~l~g~~  526 (805)
                      ..++|...+++-......|.+-..+ |..+++|..........+.|         .+++..+.+++   --..+.++.++
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3567777778877777777776665 68899997766543222222         23444444442   22233333322


Q ss_pred             -----ccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcE
Q 003659          527 -----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       527 -----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~  601 (805)
                           .-....+|+|||++|..|.++..      ++.    .++..+++++.-||+   .|+.|+|+.|.|++++++ .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cE
Confidence                 22345679999999988877641      222    355667788999999   999999999999999965 49


Q ss_pred             EEeecCCCCC
Q 003659          602 KVADFGLSKT  611 (805)
Q Consensus       602 kl~DFGla~~  611 (805)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.04  E-value=2.2e-05  Score=78.15  Aligned_cols=103  Identities=22%  Similarity=0.291  Sum_probs=82.9

Q ss_pred             HHHHHHHhcCCC-CceEEEEEEEccCCeEEEEEEeccCCcccccccC-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCC
Q 003659          505 QTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKA  582 (805)
Q Consensus       505 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  582 (805)
                      ..|.-+|+.+++ +++.+++|+|-.    ++|.||...+++...-.. .....-+|..|.+||.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999977 699999999944    789999987765422000 11124689999999999999999999876666


Q ss_pred             eEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          583 VIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       583 ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      +.-+|++++|+-+++++++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.02  E-value=3.7e-05  Score=79.09  Aligned_cols=142  Identities=18%  Similarity=0.183  Sum_probs=85.6

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCC--ceEEEEEEE---ccCCeEEEEEEeccC
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR--HLVSLIGYC---DEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~---~~~~~~~lV~e~~~~  541 (805)
                      +.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+.+++.++   ......+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            579999999999999887 58999986654  3456778888888888533  345666644   233457899999998


Q ss_pred             Ccccc----------------cc---cCC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHHhc-
Q 003659          542 GTLKG----------------HL---YGS--GLPSLSWKQ---------RLEI------------CIGSAR-GLHYLHT-  577 (805)
Q Consensus       542 gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-  577 (805)
                      ..+..                .+   +..  ...++.+..         ....            ...+.+ .++.+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87776                11   111  111111111         0000            111222 3333332 


Q ss_pred             ---cCCCCeEeeccCCCcEEeC-CCCcEEEeecCCCCC
Q 003659          578 ---GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKT  611 (805)
Q Consensus       578 ---~~~~~ivH~Dikp~NILld-~~~~~kl~DFGla~~  611 (805)
                         .....++|+|+.|.|||++ +++.+.|.||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               2346799999999999999 666678999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.95  E-value=0.00015  Score=73.60  Aligned_cols=153  Identities=18%  Similarity=0.167  Sum_probs=100.3

Q ss_pred             ccCHHHHHHHhcCCcccceEe---eeCceEEEEEEecCCcEEEEEEcCCCCchh-------------------H-----H
Q 003659          450 RFPFVAVQEATNNFDESWVIG---IGGFGKVYKGELNDGTKVAVKRGNPRSQQG-------------------L-----A  502 (805)
Q Consensus       450 ~~~~~el~~at~~f~~~~~LG---~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------~-----~  502 (805)
                      ..++..+....+......+.|   .|.-+.||+|...++..+|||+........                   .     .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            456677777776666666655   556678999988889999999765432111                   0     1


Q ss_pred             HHHHHHHHHhcCC--CCceEEEEEEEccCCeEEEEEEeccCC-cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccC
Q 003659          503 EFQTEIEMLSQFR--HRHLVSLIGYCDEKNEMILIYEYMENG-TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY  579 (805)
Q Consensus       503 ~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  579 (805)
                      -..+|+.-|.++.  +-.+.+.+++..    -.|||||+... .-.-.|..-   ++...+...+..++++.+.-|-.  
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--
Confidence            1235777777774  444555555443    36999999653 111222111   22233456666677777766654  


Q ss_pred             CCCeEeeccCCCcEEeCCCCcEEEeecCCCCCC
Q 003659          580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       580 ~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~  612 (805)
                      ..++||+||..-|||+. ++.+.|+|||-|...
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            26899999999999999 789999999987653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.94  E-value=8.3e-05  Score=77.56  Aligned_cols=139  Identities=16%  Similarity=0.147  Sum_probs=85.6

Q ss_pred             EeeeCc-eEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC-CCceEEEEEEEccCCeEEEEEEeccCCcccc
Q 003659          469 IGIGGF-GKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKG  546 (805)
Q Consensus       469 LG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~  546 (805)
                      |-.|.. ..||+...+ +..+.||+.....   ..+..+|+++++.+. +--+.++++++...+..++|||++++.+|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444544 788998765 4688888876543   345678898888884 3445677777776667899999999877764


Q ss_pred             cc-------------------cCCCCC--CCC--HHHHHHHHH--------------------HHHHHHHHHhc----cC
Q 003659          547 HL-------------------YGSGLP--SLS--WKQRLEICI--------------------GSARGLHYLHT----GY  579 (805)
Q Consensus       547 ~l-------------------~~~~~~--~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~  579 (805)
                      ..                   |.....  +..  +..++....                    .+.+.++.|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   111100  111  001111000                    01111222211    11


Q ss_pred             CCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       580 ~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ...++|+|+.|.|||++++..+.|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            35699999999999999987889999997754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.84  E-value=0.00024  Score=87.25  Aligned_cols=147  Identities=16%  Similarity=0.286  Sum_probs=92.8

Q ss_pred             cceEeeeCceEEEEEEecCC---cEEEEEEcCCCC-chhHHHHHHHHHHHhcCC-CCce--EEEEEEEccC---CeEEEE
Q 003659          466 SWVIGIGGFGKVYKGELNDG---TKVAVKRGNPRS-QQGLAEFQTEIEMLSQFR-HRHL--VSLIGYCDEK---NEMILI  535 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV  535 (805)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            45788899999999877653   467788765432 223456889999999995 6665  7888888664   467899


Q ss_pred             EEeccCCccccc-----------------------ccCCCC---------CCCCHH--HHHHHH---------------H
Q 003659          536 YEYMENGTLKGH-----------------------LYGSGL---------PSLSWK--QRLEIC---------------I  566 (805)
Q Consensus       536 ~e~~~~gsL~~~-----------------------l~~~~~---------~~l~~~--~~~~i~---------------~  566 (805)
                      |||+++..+.+.                       ||.-..         .+..+.  ++-.+.               .
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            999987654321                       111100         011110  111111               1


Q ss_pred             HHHHHHHHHhccCC--------CCeEeeccCCCcEEeCCC-C-cEEEeecCCCCCC
Q 003659          567 GSARGLHYLHTGYA--------KAVIHRDVKSANILLDEN-F-MAKVADFGLSKTG  612 (805)
Q Consensus       567 ~ia~gL~yLH~~~~--------~~ivH~Dikp~NILld~~-~-~~kl~DFGla~~~  612 (805)
                      .+.+.+++|....+        ..+||+|+++.|||++.+ . .+-|.||+++...
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            23344566644222        359999999999999853 3 3579999988653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.82  E-value=2.2e-06  Score=96.00  Aligned_cols=180  Identities=19%  Similarity=0.124  Sum_probs=130.4

Q ss_pred             eEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCc-eEEEEEEEccCCeEEEEEEeccCC-ccc
Q 003659          468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH-LVSLIGYCDEKNEMILIYEYMENG-TLK  545 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e~~~~g-sL~  545 (805)
                      -+++|++++++|.+--..+...++.....     ....-++++|.+++||| .+..++-+..+....++++++..+ +-.
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~  323 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA  323 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence            47899999999986443333335544332     34456899999999999 666666677777889999999876 222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeeccc
Q 003659          546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK  625 (805)
Q Consensus       546 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~  625 (805)
                      .-.... ...+..-+...+++.-+++|++||+   ..=+|+|    ||+..+ ...|..||+....+....   ..+...
T Consensus       324 ~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~  391 (829)
T KOG0576|consen  324 LEMTVS-EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAI  391 (829)
T ss_pred             ccCChh-hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCC
Confidence            211111 1124445566777888899999998   4458888    777766 688999999987665422   345567


Q ss_pred             ccccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 003659          626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVI  664 (805)
Q Consensus       626 gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~~p~  664 (805)
                      +|+.++|||+.....+..+-|+|+.|+-..++.-|-+|-
T Consensus       392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            999999999999999999999999998777777766554

>PRK10593 hypothetical protein; Provisional

Probab=97.69  E-value=0.0008  Score=72.32  Aligned_cols=78  Identities=13%  Similarity=0.063  Sum_probs=57.5

Q ss_pred             cccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCC---CceEEEEEEEcc---CCeEEEEEE
Q 003659          464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH---RHLVSLIGYCDE---KNEMILIYE  537 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~e  537 (805)
                      ...+.||.|..+.||+....++ .+.+|..+...  ....|..|.+.|+.|.-   -.+.+++++|..   .+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3445799999999999876655 46667643311  23578899999998853   467888888754   367899999


Q ss_pred             eccCCcc
Q 003659          538 YMENGTL  544 (805)
Q Consensus       538 ~~~~gsL  544 (805)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.67  E-value=0.00059  Score=68.33  Aligned_cols=132  Identities=21%  Similarity=0.324  Sum_probs=91.7

Q ss_pred             ccceEeeeCceEEEEEEecCCcEEEEEEcCCCC----------------chhHHHHHHHHHHHhcCC------CCceEEE
Q 003659          465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS----------------QQGLAEFQTEIEMLSQFR------HRHLVSL  522 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l  522 (805)
                      ....||+|+.-.||.  +.+.....||+.....                ....+++.+|+.-..++.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345899999999996  4445667888766654                223466677777666665      8899999


Q ss_pred             EEEEccCCeEEEEEEeccC--C----cccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeC
Q 003659          523 IGYCDEKNEMILIYEYMEN--G----TLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       523 ~g~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld  596 (805)
                      +|+.+.+....+|+|.+.+  |    +|.+++...   .++. .   +...+-+-.+||-+   ..|+.+|++|.||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-H---HHHHHHHHHHHHHH---cCCeecCCCcccEEEE
Confidence            9999999999999998743  3    456666333   2444 3   33333444566666   7899999999999995


Q ss_pred             CC---C-cEEEee-cCC
Q 003659          597 EN---F-MAKVAD-FGL  608 (805)
Q Consensus       597 ~~---~-~~kl~D-FGl  608 (805)
                      ..   . .+.|+| ||-
T Consensus       153 ~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  153 RRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             ecCCCceEEEEEeCCCC
Confidence            33   2 566776 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.60  E-value=0.00031  Score=67.56  Aligned_cols=128  Identities=19%  Similarity=0.216  Sum_probs=87.2

Q ss_pred             ccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceEE-EEEEEccCCeEEEEEEeccCCc
Q 003659          465 ESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS-LIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       465 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      ..+.|++|.+|.||+|.+. |..+|+|.-...+.  ...+..|+++|..+.-.++.+ ++.|..+    ++.|||+.+-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            3458999999999999987 45889998665543  467889999999998777654 4444333    34599998877


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccC-CCcEEeCCCCcEEEeecCCCCC
Q 003659          544 LKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVK-SANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       544 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dik-p~NILld~~~~~kl~DFGla~~  611 (805)
                      |.+.-...     +-++++    .+++.---|..   .+|-|+.|. |..++|-.+..+.|+||.-|..
T Consensus        99 L~~~~~~~-----~rk~l~----~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-----DRKHLL----RVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-----cHHHHH----HHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            76654321     222233    33333222333   789999986 5555555555999999998874

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.60  E-value=0.00049  Score=71.32  Aligned_cols=139  Identities=16%  Similarity=0.182  Sum_probs=77.8

Q ss_pred             ceEeeeCce-EEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCC---ceEEEEEEEccC---CeEEEEEEec
Q 003659          467 WVIGIGGFG-KVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR---HLVSLIGYCDEK---NEMILIYEYM  539 (805)
Q Consensus       467 ~~LG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lV~e~~  539 (805)
                      +.|+.|+.. .||+.    +..+++|.....  .....+.+|.++|..+...   -+.++++.+...   ...+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777766 48875    235677765442  2245788999999888532   234444444332   2357899999


Q ss_pred             cCCcccccc------------------cCCCCCC--C-------------CHHHHH--HHH-------HHHHH-HHHH-H
Q 003659          540 ENGTLKGHL------------------YGSGLPS--L-------------SWKQRL--EIC-------IGSAR-GLHY-L  575 (805)
Q Consensus       540 ~~gsL~~~l------------------~~~~~~~--l-------------~~~~~~--~i~-------~~ia~-gL~y-L  575 (805)
                      +|.++.+..                  |.-....  .             .|....  .+.       .+.+. .++. +
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            987775331                  1100000  0             111110  000       01111 1111 1


Q ss_pred             hc--cCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          576 HT--GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       576 H~--~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      +.  .....++|+|+.+.|||++++...-|.||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1234599999999999999876667999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.50  E-value=0.00095  Score=69.08  Aligned_cols=140  Identities=19%  Similarity=0.188  Sum_probs=81.9

Q ss_pred             ceEeeeCceEEEEEEecC--CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce-EEEEEEEccCCeEEEEEEeccCCc
Q 003659          467 WVIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGT  543 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs  543 (805)
                      +.|..|-...+|+....+  +..+++|+........ ..-.+|+.++..+...++ .++++.+. +   .++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            467778888999988764  6788899766443221 222478888888854444 34444433 2   37999999876


Q ss_pred             cccc-----------------ccCCCC---------CCC-CHHHHHHHHH----------------------HHHHHHHH
Q 003659          544 LKGH-----------------LYGSGL---------PSL-SWKQRLEICI----------------------GSARGLHY  574 (805)
Q Consensus       544 L~~~-----------------l~~~~~---------~~l-~~~~~~~i~~----------------------~ia~gL~y  574 (805)
                      +...                 +|....         ... -|..+..+..                      .+.+-+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 111110         011 1222112111                      11111112


Q ss_pred             H----hc-cCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCC
Q 003659          575 L----HT-GYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT  611 (805)
Q Consensus       575 L----H~-~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~  611 (805)
                      |    .. .....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            2    11 12357999999999999998 57899999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.39  E-value=0.00099  Score=70.03  Aligned_cols=137  Identities=18%  Similarity=0.174  Sum_probs=79.4

Q ss_pred             EeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce-EEEEEEEccCCeEEEEEEeccCCccccc
Q 003659          469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGTLKGH  547 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~  547 (805)
                      +..|-...+|+... ++..+++|..........-...+|.++++.+....+ .++++.+.    -.+||||+++..+...
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            45577788998874 466788887654332211234678889988864433 33444432    2689999998766432


Q ss_pred             -----------------ccCCC--CCCCCHHHHH-HHHH---------HHHHHHHHHhc-----cCCCCeEeeccCCCcE
Q 003659          548 -----------------LYGSG--LPSLSWKQRL-EICI---------GSARGLHYLHT-----GYAKAVIHRDVKSANI  593 (805)
Q Consensus       548 -----------------l~~~~--~~~l~~~~~~-~i~~---------~ia~gL~yLH~-----~~~~~ivH~Dikp~NI  593 (805)
                                       ||...  ..+++...++ ....         .+.+.+..+..     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             12211  1122222111 1110         11111222211     1134689999999999


Q ss_pred             EeCCCCcEEEeecCCCCC
Q 003659          594 LLDENFMAKVADFGLSKT  611 (805)
Q Consensus       594 Lld~~~~~kl~DFGla~~  611 (805)
                      ++++++ ++|.||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999876 78999998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.38  E-value=0.0017  Score=64.50  Aligned_cols=125  Identities=23%  Similarity=0.309  Sum_probs=89.2

Q ss_pred             cCCcccceEeeeCc-eEEEEEEecCCcEEEEEEcCC---CC---------c---------hhHHHHHHHHHHHhcCC---
Q 003659          461 NNFDESWVIGIGGF-GKVYKGELNDGTKVAVKRGNP---RS---------Q---------QGLAEFQTEIEMLSQFR---  515 (805)
Q Consensus       461 ~~f~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~~~~---~~---------~---------~~~~~~~~E~~~l~~l~---  515 (805)
                      ..++..+.||.|.- |.|||++.. |+.+|+|....   ..         .         .-...|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888889999999 999999987 77999998221   10         0         11235788999888775   


Q ss_pred             CCce--EEEEEEEccC------------------CeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 003659          516 HRHL--VSLIGYCDEK------------------NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL  575 (805)
Q Consensus       516 H~ni--v~l~g~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL  575 (805)
                      +.++  |+.+||..-.                  ....+|.||++...           .+    ..+-+.++.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHHH
Confidence            4566  8999987211                  12356777765422           12    233456677778899


Q ss_pred             hccCCCCeEeeccCCCcEEeCCCCcEEEeecCCC
Q 003659          576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLS  609 (805)
Q Consensus       576 H~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla  609 (805)
                      |.   .+|+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HH---CCeeeccCcccccc-----CCEEEecccC
Confidence            99   99999999999976     5589999864

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.31  E-value=0.0027  Score=70.49  Aligned_cols=74  Identities=20%  Similarity=0.239  Sum_probs=53.5

Q ss_pred             ceEeeeCceEEEEEEecCC-cEEEEEEcCCCC-------chhHHHHHHHHHHHhcCC---CCceEEEEEEEccCCeEEEE
Q 003659          467 WVIGIGGFGKVYKGELNDG-TKVAVKRGNPRS-------QQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV  535 (805)
                      +.||.|.+..||++...+| +.++||.-.+..       ....+.+..|.+.|..+.   ..++.+++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            4689999999999998877 589999744221       223566778888888763   245667776633  457899


Q ss_pred             EEeccCC
Q 003659          536 YEYMENG  542 (805)
Q Consensus       536 ~e~~~~g  542 (805)
                      ||++++.
T Consensus       110 ME~L~~~  116 (401)
T PRK09550        110 MEDLSDH  116 (401)
T ss_pred             EecCCCc
Confidence            9999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.20  E-value=0.0012  Score=79.42  Aligned_cols=199  Identities=19%  Similarity=0.213  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHhcCCCCceEEEEEEEccCCeEE----EEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 003659          501 LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI----LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH  576 (805)
Q Consensus       501 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH  576 (805)
                      ...-..|.+.+..+.|+|++.++.|..++...-    +.-|++..-++...+....  .++....+.+..++.+||+|+|
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH
Confidence            334456788889999999999999986654333    3345676667777664433  5778899999999999999999


Q ss_pred             ccCCCCeEeeccCCC---cEEeCCCCcEEEe--ecCCCCCCCCCCCcceeecccccccccChhhhccCCCC--chhhHHH
Q 003659          577 TGYAKAVIHRDVKSA---NILLDENFMAKVA--DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT--EKSDVYS  649 (805)
Q Consensus       577 ~~~~~~ivH~Dikp~---NILld~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~ksDV~S  649 (805)
                      +   ....|.-+..+   +.-.+.++...++  ||+.++..+......   ...-+..+.+||.......+  ...|+|+
T Consensus       304 ~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 S---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             H---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHH
Confidence            9   45555555444   5556677777777  999888765433221   22234457788877655444  4579999


Q ss_pred             HHHHHHHHHhCCCCCCCCChhhhhhHHHHHHHHhhcCCcccccCccccCCCChhHHHHHHHHHHhchhcCCCCCCCHHHH
Q 003659          650 FGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV  729 (805)
Q Consensus       650 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPsm~ev  729 (805)
                      +|.++..+..|..+-.....                  ...+++.        .....+.+...+|+..++++|+...++
T Consensus       378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhh
Confidence            99999999988644321100                  0001111        011145677889999999999999999


Q ss_pred             HHHH
Q 003659          730 LWNL  733 (805)
Q Consensus       730 l~~L  733 (805)
                      +.+.
T Consensus       432 l~~~  435 (1351)
T KOG1035|consen  432 LTHP  435 (1351)
T ss_pred             hhch
Confidence            8654

>PRK05231 homoserine kinase; Provisional

Probab=97.17  E-value=0.0057  Score=66.50  Aligned_cols=157  Identities=14%  Similarity=0.169  Sum_probs=85.3

Q ss_pred             cCHHHHHHHhcCCcc-----cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCc--eEEEE
Q 003659          451 FPFVAVQEATNNFDE-----SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLI  523 (805)
Q Consensus       451 ~~~~el~~at~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~  523 (805)
                      .+..++......|..     .+.|+.|....+|+....+| .+++|+.....   .+....|+.++..|...+  +.+.+
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            344455544445543     24566677778999887655 68888765222   233344555555553211  23333


Q ss_pred             E------EEccCCeEEEEEEeccCCcccc-----------c---ccCCC---------CCCCCH-HHHHHHH--------
Q 003659          524 G------YCDEKNEMILIYEYMENGTLKG-----------H---LYGSG---------LPSLSW-KQRLEIC--------  565 (805)
Q Consensus       524 g------~~~~~~~~~lV~e~~~~gsL~~-----------~---l~~~~---------~~~l~~-~~~~~i~--------  565 (805)
                      .      +....+..++++||++|..+..           .   +|...         ...+.| .....-.        
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            2      1123456789999998865421           0   11100         011222 2211111        


Q ss_pred             -----HHHHHHHHHHhc----cCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          566 -----IGSARGLHYLHT----GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       566 -----~~ia~gL~yLH~----~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                           ..+...++.+..    ..+.++||+|+++.|||++.+...-|.||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                 111122233321    1346899999999999999776668999998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.11  E-value=0.0031  Score=68.03  Aligned_cols=140  Identities=25%  Similarity=0.287  Sum_probs=83.9

Q ss_pred             ceEeeeCceEEEEEEecC-------CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce-EEEEEEEccCCeEEEEEEe
Q 003659          467 WVIGIGGFGKVYKGELND-------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~  538 (805)
                      +.|..|-...+|+....+       ++.+++|+....... .....+|.+++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            355556677899887665       578999986654322 2344678888888854333 345555542    358999


Q ss_pred             ccCCccccc-----------------ccCCCCC---------CCCHHHHHH--------------------------HHH
Q 003659          539 MENGTLKGH-----------------LYGSGLP---------SLSWKQRLE--------------------------ICI  566 (805)
Q Consensus       539 ~~~gsL~~~-----------------l~~~~~~---------~l~~~~~~~--------------------------i~~  566 (805)
                      ++|..+...                 +|.....         +.-|..+.+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988766431                 1111111         011111111                          111


Q ss_pred             HHHHHHHHHhc------cCCCCeEeeccCCCcEEeCCC----CcEEEeecCCCCC
Q 003659          567 GSARGLHYLHT------GYAKAVIHRDVKSANILLDEN----FMAKVADFGLSKT  611 (805)
Q Consensus       567 ~ia~gL~yLH~------~~~~~ivH~Dikp~NILld~~----~~~kl~DFGla~~  611 (805)
                      .+.+-+..|..      .....++|+|+.+.|||++++    ..++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      245689999999999999985    7899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.04  E-value=0.00093  Score=70.02  Aligned_cols=145  Identities=17%  Similarity=0.178  Sum_probs=98.0

Q ss_pred             cCHHHHHHHhcC---CcccceEeeeCceEEEEEEecCCcEEEEEE--cCCCC---------------ch-----hHHHHH
Q 003659          451 FPFVAVQEATNN---FDESWVIGIGGFGKVYKGELNDGTKVAVKR--GNPRS---------------QQ-----GLAEFQ  505 (805)
Q Consensus       451 ~~~~el~~at~~---f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~--~~~~~---------------~~-----~~~~~~  505 (805)
                      +.+..|+...++   +...+.||-|.-+.+|.+-..+|++.++|.  +...+               ..     ..-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            455666665543   456789999999999999999999999983  21111               00     112245


Q ss_pred             HHHHHHhcCCC--CceEEEEEEEccCCeEEEEEEeccCCcccccccCCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCe
Q 003659          506 TEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV  583 (805)
Q Consensus       506 ~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  583 (805)
                      +|...|+.|..  --+.+.+++    +..++|||++.+-.|.+.-+-.     +..++..-+.+   -+--|..   .|+
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm~---~Iv~la~---~Gl  223 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLMG---LIVRLAN---HGL  223 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHHHHHH---HHHHHHH---cCc
Confidence            78888888853  234444443    4568999999998887754322     22333333333   3334445   899


Q ss_pred             EeeccCCCcEEeCCCCcEEEeecCCCC
Q 003659          584 IHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       584 vH~Dikp~NILld~~~~~kl~DFGla~  610 (805)
                      ||||..-=||+++++..++++||--..
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhh
Confidence            999999999999999999999996543

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.03  E-value=0.01  Score=63.64  Aligned_cols=142  Identities=20%  Similarity=0.210  Sum_probs=86.5

Q ss_pred             cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCc--eEEEEEE------EccCCeEEEEEE
Q 003659          466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGY------CDEKNEMILIYE  537 (805)
Q Consensus       466 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e  537 (805)
                      .+.|..|....+|+....++ .+++|+....   .......|++++..|.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            34677777789999876544 6888887652   2345667888888875433  4444432      122345689999


Q ss_pred             eccCCcccc----c----------ccC--CC-------CCCCCHHHHHH----------HHHHHHHHHHHHhc----cCC
Q 003659          538 YMENGTLKG----H----------LYG--SG-------LPSLSWKQRLE----------ICIGSARGLHYLHT----GYA  580 (805)
Q Consensus       538 ~~~~gsL~~----~----------l~~--~~-------~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~  580 (805)
                      +++|..+..    .          +|.  ..       .....|.....          ....+...+.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876543    0          010  00       01123332211          11223344455543    234


Q ss_pred             CCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          581 KAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       581 ~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      .+++|+|+.|.|||++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987789999998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.93  E-value=0.013  Score=63.41  Aligned_cols=156  Identities=16%  Similarity=0.162  Sum_probs=89.8

Q ss_pred             HHHHHHHhcCCcc-----cceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCc--eEEEEEE
Q 003659          453 FVAVQEATNNFDE-----SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH--LVSLIGY  525 (805)
Q Consensus       453 ~~el~~at~~f~~-----~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~  525 (805)
                      .++|....+.|..     .+.++.|....+|+...++| .+++|+......  .++...|++++..|....  +.+++..
T Consensus         9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t   85 (307)
T TIGR00938         9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKS   85 (307)
T ss_pred             HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccC
Confidence            3455554445543     34566676788999876655 577787654321  234456777777774322  3444432


Q ss_pred             E------ccCCeEEEEEEeccCCccccc--------------ccC--CC--C------CCCCHHHHHH------------
Q 003659          526 C------DEKNEMILIYEYMENGTLKGH--------------LYG--SG--L------PSLSWKQRLE------------  563 (805)
Q Consensus       526 ~------~~~~~~~lV~e~~~~gsL~~~--------------l~~--~~--~------~~l~~~~~~~------------  563 (805)
                      .      ...+..++++||++|..+...              +|.  ..  .      ..-.|.....            
T Consensus        86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~  165 (307)
T TIGR00938        86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH  165 (307)
T ss_pred             CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence            1      224567899999988554311              111  00  0      0112221111            


Q ss_pred             HHHHHHHHHHHHhc----cCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          564 ICIGSARGLHYLHT----GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       564 i~~~ia~gL~yLH~----~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ....+.+.++++..    ....+++|+|+++.||+++++....|.||+.+..
T Consensus       166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            11223345555543    2357899999999999999987778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.59  E-value=0.015  Score=63.94  Aligned_cols=139  Identities=16%  Similarity=0.204  Sum_probs=82.6

Q ss_pred             eEeeeCceEEEEEEecC-----CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceE-EEEEEEccCCeEEEEEEeccC
Q 003659          468 VIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~  541 (805)
                      .|-.|-.-.+|+....+     ++.+++|+........... .+|..++..+...++. ++++.+..+    .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            44446677888886532     3678999877654433333 6788888888655544 455655433    58999987


Q ss_pred             Cccccc-----------------ccCCCC---C-CCCHHHHHHHHHHH-----------------HHHHHHHh----c-c
Q 003659          542 GTLKGH-----------------LYGSGL---P-SLSWKQRLEICIGS-----------------ARGLHYLH----T-G  578 (805)
Q Consensus       542 gsL~~~-----------------l~~~~~---~-~l~~~~~~~i~~~i-----------------a~gL~yLH----~-~  578 (805)
                      .+|...                 +|....   . ..-|.+..++..++                 ...+..|.    . .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            666421                 122110   1 12233333332111                 11122222    1 2


Q ss_pred             CCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCC
Q 003659          579 YAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT  611 (805)
Q Consensus       579 ~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~  611 (805)
                      ....++|+|+++.|||+++ +..++|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2357899999999999986 46899999988764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.39  E-value=0.031  Score=59.40  Aligned_cols=31  Identities=26%  Similarity=0.493  Sum_probs=26.1

Q ss_pred             CCeEeeccCCCcEEeCCCCc-EEEeecCCCCC
Q 003659          581 KAVIHRDVKSANILLDENFM-AKVADFGLSKT  611 (805)
Q Consensus       581 ~~ivH~Dikp~NILld~~~~-~kl~DFGla~~  611 (805)
                      ..++|+|+++.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 56999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.38  E-value=0.049  Score=58.49  Aligned_cols=121  Identities=19%  Similarity=0.288  Sum_probs=76.2

Q ss_pred             CcEEEEEEcCC--CCchhHHHHHHHHHHHhcCCC--CceEEEEEEEccCC--eEEEEEEeccCCcccccccCCCCCCCCH
Q 003659          485 GTKVAVKRGNP--RSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKN--EMILIYEYMENGTLKGHLYGSGLPSLSW  558 (805)
Q Consensus       485 g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~~~~~~l~~  558 (805)
                      ++..++. ...  ..........+|.++|+.+.-  --+...+++|.++.  ..+.||+|+++..+.+.+....   .  
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~---~--  121 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES---L--  121 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc---c--
Confidence            6677777 321  222334455678888887743  33455677787666  7799999999855544332111   0  


Q ss_pred             HHHHHHH-HHHHHHHHHHh--------------------------------------------------cc-----CCCC
Q 003659          559 KQRLEIC-IGSARGLHYLH--------------------------------------------------TG-----YAKA  582 (805)
Q Consensus       559 ~~~~~i~-~~ia~gL~yLH--------------------------------------------------~~-----~~~~  582 (805)
                      .  .+.+ ..+++.|+-||                                                  ..     ....
T Consensus       122 ~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~  199 (321)
T COG3173         122 G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPV  199 (321)
T ss_pred             h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCce
Confidence            0  1111 23344444443                                                  31     2356


Q ss_pred             eEeeccCCCcEEeCCCCcEEEeecCCCCCCC
Q 003659          583 VIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       583 ivH~Dikp~NILld~~~~~kl~DFGla~~~~  613 (805)
                      ++|+|+++.|++++.+.-+-|.||+++....
T Consensus       200 lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         200 LVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            9999999999999999889999999998643

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.14  E-value=0.04  Score=60.00  Aligned_cols=79  Identities=19%  Similarity=0.253  Sum_probs=49.3

Q ss_pred             eEeeeCceEEEEEEecCC-cEEEEEEcCC-------CCchhHHHHHHHHHHHhcCC--CCceE-EEEEEEccCCeEEEEE
Q 003659          468 VIGIGGFGKVYKGELNDG-TKVAVKRGNP-------RSQQGLAEFQTEIEMLSQFR--HRHLV-SLIGYCDEKNEMILIY  536 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~niv-~l~g~~~~~~~~~lV~  536 (805)
                      .||-|....||++..++| +.|+||.-.+       .-.-..++..-|.+.|+...  -|..+ +++.|  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478899999999998754 6899995321       11333455566777776653  35444 44433  344567999


Q ss_pred             EeccCC-cccccc
Q 003659          537 EYMENG-TLKGHL  548 (805)
Q Consensus       537 e~~~~g-sL~~~l  548 (805)
                      |+++.. .|++.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998553 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.13  E-value=0.031  Score=59.50  Aligned_cols=140  Identities=21%  Similarity=0.268  Sum_probs=72.7

Q ss_pred             cccceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCC---CCceEEEEEEEccCCeEEEEEEecc
Q 003659          464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       464 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~  540 (805)
                      ...+.|+-|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+++++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            344578889999999987 5578899998652   22356788888888883   4557788888877777799999998


Q ss_pred             CCccc--------c---cccC-CCC-------------------CCCCHHH-----HHHHHHH--------------HHH
Q 003659          541 NGTLK--------G---HLYG-SGL-------------------PSLSWKQ-----RLEICIG--------------SAR  570 (805)
Q Consensus       541 ~gsL~--------~---~l~~-~~~-------------------~~l~~~~-----~~~i~~~--------------ia~  570 (805)
                      .+...        .   .||. ...                   -.-+|.+     |+.-..+              +.+
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            76111        0   1222 110                   0133432     2221111              111


Q ss_pred             HH-HHHhc-cCCCCeEeeccCCCcEEeCCCCcEEEeecC
Q 003659          571 GL-HYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       571 gL-~yLH~-~~~~~ivH~Dikp~NILld~~~~~kl~DFG  607 (805)
                      .+ ..|+. ...+.++|+||.+.|++.+.++.+.|.|=.
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            11 12222 124679999999999999999889998843

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.80  E-value=0.086  Score=57.21  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=84.0

Q ss_pred             EeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce---EE---EEEEE--ccC--CeEEEEEEe
Q 003659          469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL---VS---LIGYC--DEK--NEMILIYEY  538 (805)
Q Consensus       469 LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni---v~---l~g~~--~~~--~~~~lV~e~  538 (805)
                      |.+ .-..+|+....+|+. ++|.....  ....+...|+..|..|.-..+   ++   +=|-.  .-.  ...+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 455789888887776 88887765  234566777888877742222   22   21211  122  377889999


Q ss_pred             ccCCcccc-cc--------------c--CCC--------CCCCCHHH-------------HHHHHHHHHHHHHHHhc---
Q 003659          539 MENGTLKG-HL--------------Y--GSG--------LPSLSWKQ-------------RLEICIGSARGLHYLHT---  577 (805)
Q Consensus       539 ~~~gsL~~-~l--------------~--~~~--------~~~l~~~~-------------~~~i~~~ia~gL~yLH~---  577 (805)
                      ++|..+.. .-              |  ..+        .....|..             ......++...+..+++   
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988873 10              1  011        11244431             11133344444444443   


Q ss_pred             -cCCCC---eEeeccCCCcEEeCCCCc-EEEeecCCCCC
Q 003659          578 -GYAKA---VIHRDVKSANILLDENFM-AKVADFGLSKT  611 (805)
Q Consensus       578 -~~~~~---ivH~Dikp~NILld~~~~-~kl~DFGla~~  611 (805)
                       ..+..   +||+|+.|.||+++.+.. +.+.||+-+..
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence             22233   999999999999999885 89999998764

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=95.70  E-value=0.012  Score=41.66  Aligned_cols=33  Identities=24%  Similarity=0.529  Sum_probs=19.4

Q ss_pred             CCCceEEEEehhHHHHHHHHHHHhheeeEeecc
Q 003659          375 SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRR  407 (805)
Q Consensus       375 ~~~~~~iiigivvgv~vl~ll~~i~~~~~rrrr  407 (805)
                      .++...|.+|+++.++++++++++++++++||+
T Consensus         7 ~~~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen    7 NSNTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             CCceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            445567777777776666555554444444443

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.70  E-value=0.0064  Score=75.06  Aligned_cols=158  Identities=15%  Similarity=0.043  Sum_probs=111.7

Q ss_pred             HHHHHHHhcCCCCceEEEEEEE--ccCCeEEEEEEeccCCcccccccCCC--CCCCCHHHHHHHHHHHHHHHHHHhc--c
Q 003659          505 QTEIEMLSQFRHRHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHYLHT--G  578 (805)
Q Consensus       505 ~~E~~~l~~l~H~niv~l~g~~--~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~--~  578 (805)
                      ..|...+++..|+++.....-.  .+..+.+.+++|+..|.+.+.|....  .+.++..-+...-.+......-+|.  .
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            3455556667899887665443  34456788999999999999886532  2344444443333333444444443  2


Q ss_pred             CCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccccChhhhccCCCCchhhHHHHHHHHHHHH
Q 003659          579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL  658 (805)
Q Consensus       579 ~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~S~Gvvl~ell  658 (805)
                      ...-.+|+++|+-|.+|..+.++|++++|+.+....  .........+++-|+.|+....-.++.++|+|..|+.++++.
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence            234579999999999999999999999999994322  122223456778899999998889999999999999999998


Q ss_pred             hCCCCC
Q 003659          659 CARPVI  664 (805)
Q Consensus       659 tG~~p~  664 (805)
                      -|.+++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            776654

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.66  E-value=0.16  Score=56.51  Aligned_cols=79  Identities=16%  Similarity=0.169  Sum_probs=51.8

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCC----Cc---hhHHHHHHHHHHHhcCC---CCceEEEEEEEccCCeEEEEE
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQ---QGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~  536 (805)
                      +.||-|....||+.... +..++||+-...    ..   .....-..|.+.|+.+.   ..++.+++.+|.+  ..+++|
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM  114 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM  114 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence            47899999999998764 557999975421    11   12333345566666553   3577888888873  467889


Q ss_pred             EeccC--Ccccccc
Q 003659          537 EYMEN--GTLKGHL  548 (805)
Q Consensus       537 e~~~~--gsL~~~l  548 (805)
                      |++++  ..+++-+
T Consensus       115 E~L~~~~~ilr~~L  128 (418)
T PLN02756        115 RYLEPPHIILRKGL  128 (418)
T ss_pred             eecCCcceehhhhh
Confidence            99976  3454433

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.54  E-value=0.13  Score=55.76  Aligned_cols=32  Identities=16%  Similarity=0.233  Sum_probs=28.9

Q ss_pred             CCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       580 ~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ..++||+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999988765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.51  E-value=0.074  Score=58.10  Aligned_cols=139  Identities=17%  Similarity=0.213  Sum_probs=79.5

Q ss_pred             eEeeeCceEEEEEEecC----CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCceE-EEEEEEccCCeEEEEEEeccCC
Q 003659          468 VIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV-SLIGYCDEKNEMILIYEYMENG  542 (805)
Q Consensus       468 ~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~g  542 (805)
                      .|..|=.-.+|+....+    +..|++|+.......... -.+|..+++.+..-++. ++++++..+    +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence            44446666788876543    237889987665433222 25788888888765553 456655322    589999776


Q ss_pred             cccc-----------------cccCCCC---C-CCCHHHHHHHHHHH----------------------HHHHHHHhc--
Q 003659          543 TLKG-----------------HLYGSGL---P-SLSWKQRLEICIGS----------------------ARGLHYLHT--  577 (805)
Q Consensus       543 sL~~-----------------~l~~~~~---~-~l~~~~~~~i~~~i----------------------a~gL~yLH~--  577 (805)
                      .|..                 .+|....   . +--|..+.++..++                      .+-+..+..  
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            5532                 1122110   1 11233332222221                      111111111  


Q ss_pred             ---cCCCCeEeeccCCCcEEeCC-CCcEEEeecCCCCC
Q 003659          578 ---GYAKAVIHRDVKSANILLDE-NFMAKVADFGLSKT  611 (805)
Q Consensus       578 ---~~~~~ivH~Dikp~NILld~-~~~~kl~DFGla~~  611 (805)
                         ..+.-++|+|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               12235899999999999975 57899999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.32  E-value=0.025  Score=57.47  Aligned_cols=122  Identities=18%  Similarity=0.220  Sum_probs=60.5

Q ss_pred             CcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCCce-EEEEEEEccCCeEEEEEEeccCCccccc-c--------------
Q 003659          485 GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYEYMENGTLKGH-L--------------  548 (805)
Q Consensus       485 g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l--------------  548 (805)
                      .+.|+||+....... .-.-..|..+++.+...++ .++++++..+    +|+||+++..|..- +              
T Consensus         2 ~~~~~~Ri~g~~t~~-~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTEN-FIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGCS-HHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCccc-ccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            467888887766433 3344678888888865444 4556655443    57799976655331 1              


Q ss_pred             --cCC-----CCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----cCCCCeEeeccCCCcEE
Q 003659          549 --YGS-----GLPSLSWKQRLEI----------------------CIGSARGLHYLHT-----GYAKAVIHRDVKSANIL  594 (805)
Q Consensus       549 --~~~-----~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~-----~~~~~ivH~Dikp~NIL  594 (805)
                        |..     ....--|....++                      ...+.+-+..+.+     ..+..++|+|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              110     0011112222222                      0111111222211     11246899999999999


Q ss_pred             e-CCCCcEEEeecCCCCC
Q 003659          595 L-DENFMAKVADFGLSKT  611 (805)
Q Consensus       595 l-d~~~~~kl~DFGla~~  611 (805)
                      + +.++.++++||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.01  E-value=0.13  Score=55.58  Aligned_cols=31  Identities=29%  Similarity=0.381  Sum_probs=26.7

Q ss_pred             CCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       580 ~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                      ..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            368999999999999998 5789999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK06148 hypothetical protein; Provisional

Probab=94.87  E-value=0.27  Score=61.86  Aligned_cols=142  Identities=18%  Similarity=0.247  Sum_probs=80.7

Q ss_pred             ceEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcC-------CCCceEEEE-----EEE-ccCC--e
Q 003659          467 WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-------RHRHLVSLI-----GYC-DEKN--E  531 (805)
Q Consensus       467 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~-----g~~-~~~~--~  531 (805)
                      +.|+ |..-.+|+.+..+|..+++|+.+.....  .....|.+.|..|       .-|.+++-.     ... ...+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            3454 4457789888888889999998865332  2333455555544       233444321     111 1122  4


Q ss_pred             EEEEEEeccCCccccccc-------------------------CCCCCCCCHHH-----------------HHHHHHHHH
Q 003659          532 MILIYEYMENGTLKGHLY-------------------------GSGLPSLSWKQ-----------------RLEICIGSA  569 (805)
Q Consensus       532 ~~lV~e~~~~gsL~~~l~-------------------------~~~~~~l~~~~-----------------~~~i~~~ia  569 (805)
                      .+-+++|+++..|.+...                         ......+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            677899999877754110                         00112244432                 112222333


Q ss_pred             HHHHH----HhccCCCCeEeeccCCCcEEeCCCC--cEE-EeecCCCCC
Q 003659          570 RGLHY----LHTGYAKAVIHRDVKSANILLDENF--MAK-VADFGLSKT  611 (805)
Q Consensus       570 ~gL~y----LH~~~~~~ivH~Dikp~NILld~~~--~~k-l~DFGla~~  611 (805)
                      +...-    .....+.++||+|+.+.|||++.+.  ++. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            22221    1123457899999999999999875  454 999998764

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.82  E-value=0.91  Score=49.48  Aligned_cols=159  Identities=13%  Similarity=0.091  Sum_probs=84.6

Q ss_pred             ccCHHHHHHHhcCCccc---c-eEeeeCceEEEEEEecCCcEEEEEEcCCCCchhHHHHHHHHHHHhcCCCC--ceEEEE
Q 003659          450 RFPFVAVQEATNNFDES---W-VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR--HLVSLI  523 (805)
Q Consensus       450 ~~~~~el~~at~~f~~~---~-~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~  523 (805)
                      .++...+..+...+...   + ..=.+.-..||+...+++..+++|...... ....+...|++.+..|...  .++..+
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~   88 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPL   88 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence            34445555555443221   1 122244567999988888889999875432 2345666788777766321  122211


Q ss_pred             ---E--EEccCCeEEEEEEeccCCcccc--------------cccC--C-----CCCCCCHHHH-----H----------
Q 003659          524 ---G--YCDEKNEMILIYEYMENGTLKG--------------HLYG--S-----GLPSLSWKQR-----L----------  562 (805)
Q Consensus       524 ---g--~~~~~~~~~lV~e~~~~gsL~~--------------~l~~--~-----~~~~l~~~~~-----~----------  562 (805)
                         |  ....++..+.++++++|.....              .||.  .     ..+.+++...     .          
T Consensus        89 ~~~G~~~~~~~g~~~~l~~~~~G~~~~~~~~~~~~~lG~~LarlH~~~~~~~~~~r~~~~~~~~~~~~~~~l~~~~~~~~  168 (325)
T PRK11768         89 AFNGQTLHEHQGFRFALFPRRGGRAPELDNLDQLEWVGRFLGRIHQVGAKRPFEHRPTLDLQEYGIEPRDWLLASDLIPS  168 (325)
T ss_pred             cCCCCEEEEECCEEEEEEeeeCCCCCCCCCHHHHHHHHHHHHHHHhhccCCCCCCCCcCCHHHHHHHHHHHHHhCCCCCH
Confidence               1  1222456788999998754321              1121  1     0112221111     0          


Q ss_pred             -------HHHHHHHHHHHH-Hhc-cCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCC
Q 003659          563 -------EICIGSARGLHY-LHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       563 -------~i~~~ia~gL~y-LH~-~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~  611 (805)
                             +++.++..-++- +.. ....++||+|+.+.|||++ + .+.|.||+.+..
T Consensus       169 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        169 DLRPAYLAAADQLLAAVEACWARGDVRLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhcCCCCccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence                   111111111111 111 1346789999999999996 4 578999998765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.75  E-value=0.16  Score=50.85  Aligned_cols=152  Identities=15%  Similarity=0.166  Sum_probs=92.9

Q ss_pred             eCceEEEEEEecCCcEEEEEEcCCCCch-hHHHHHHHHHHHhcCCCCceEEEEEEEccCCeEEEEEEeccCCcccccccC
Q 003659          472 GGFGKVYKGELNDGTKVAVKRGNPRSQQ-GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG  550 (805)
Q Consensus       472 G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~  550 (805)
                      ++..+.-+++.+-| +..+|++..-.-. ...-|..+.+++.+++  .|++|..  ......-++.|+|-.-        
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~--------  139 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKI--------  139 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCc--------
Confidence            44455555544433 3445554433222 4456788888888875  4666662  2444567888887320        


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCCeEeeccCCCcEEeCCCCcEEEeecCCCCCCCCCCCcceeecccccccc
Q 003659          551 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY  630 (805)
Q Consensus       551 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dikp~NILld~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  630 (805)
                          ..  . -..++..=++.|.-.|++. .+.+|+|-.|+||+-|..|.+||.|=+..-..              +.-|
T Consensus       140 ----~i--~-~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~~--------------~V~~  197 (308)
T PF07387_consen  140 ----KI--N-FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLEN--------------QVNM  197 (308)
T ss_pred             ----cc--c-hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhhh--------------eeeE
Confidence                01  0 1122222246778888644 68999999999999999999999997653210              0112


Q ss_pred             cChhhhccCCCCchhhHHHHHHHHHHHHhCC
Q 003659          631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR  661 (805)
Q Consensus       631 ~aPE~~~~~~~s~ksDV~S~Gvvl~elltG~  661 (805)
                      .--|   ....|.++.+=+|=.-++++....
T Consensus       198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             Eeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence            2211   234678888888888888887654

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	805
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-121
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-120
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-53
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-39
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-28
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-28
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-25
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-24
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-24
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-24
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-23
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-23
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-22
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-22
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-22
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-22
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-22
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-22
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-22
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-22
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-22
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-21
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-21
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-21
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-21
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-21
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-21
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-21
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-21
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-21
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-21
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-20
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-20
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-20
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-20
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-20
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-20
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-20
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-20
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-20
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-20
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-19
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-19
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-19
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		6e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-19
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-19
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		9e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		9e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-18
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-18
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-18
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-18
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-18
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-18
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		6e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-18
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-17
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-17
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-17
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		6e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-14
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		8e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-12
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-12
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		4e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		9e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-07
3soa_A	444	Full-Length Human Camkii Length = 444		9e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		7e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-04

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  434 bits (1115), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 219/324 (67%), Positives = 256/324 (79%), Gaps = 13/324 (4%)
Query: 431 MGSKYSHGTTTSANSNSG--------YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL 482
           MGSKYS  T +  ++ S         YR P V ++EATNNFD  ++IG G FGKVYKG L
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 483 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
            DG KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+CDE+NEMILIY+YMENG
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 543 TLKGHLYGSGLP--SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 600
            LK HLYGS LP  S+SW+QRLEICIG+ARGLHYLHT   +A+IHRDVKS NILLDENF+
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
            K+ DFG+SK G E+DQTH+   VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVLCA
Sbjct: 178 PKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 720
           R  I  +LPREMVNLAEWA++  N GQL+QI+DP LA KIRP+SLRKFG+TA KCLA   
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 721 VDRPSMGDVLWNLEYALQLQEAVV 744
            DRPSMGDVLW LEYAL+LQE+V+
Sbjct: 298 EDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  430 bits (1105), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 218/324 (67%), Positives = 255/324 (78%), Gaps = 13/324 (4%)
Query: 431 MGSKYSHGTTTSANSNSG--------YRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL 482
           MGSKYS  T +  ++ S         YR P V ++EATNNFD  ++IG G FGKVYKG L
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 483 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
            DG KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+CDE+NEMILIY+YMENG
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 543 TLKGHLYGSGLP--SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 600
            LK HLYGS LP  S+SW+QRLEICIG+ARGLHYLHT   +A+IHRDVKS NILLDENF+
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
            K+ DFG+SK G E+ QTH+   VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVLCA
Sbjct: 178 PKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 720
           R  I  +LPREMVNLAEWA++  N GQL+QI+DP LA KIRP+SLRKFG+TA KCLA   
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 721 VDRPSMGDVLWNLEYALQLQEAVV 744
            DRPSMGDVLW LEYAL+LQE+V+
Sbjct: 298 EDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  209 bits (532), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 120/292 (41%), Positives = 169/292 (57%), Gaps = 10/292 (3%)
Query: 450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKR-GNPRSQQGLAEFQTEI 508
           RF    +Q A++NF    ++G GGFGKVYKG L DGT VAVKR    R Q G  +FQTE+
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 509 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICI 566
           EM+S   HR+L+ L G+C    E +L+Y YM NG++   L       P L W +R  I +
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
           GSARGL YLH      +IHRDVK+ANILLDE F A V DFGL+K     D  HV  AV+G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRG 205
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR----EMVNLAEWAMKW 682
           + G++ PEY    + +EK+DV+ +GV+L E++  +   D  L R    + V L +W    
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 263
Query: 683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
             + +L+ ++D  L G  + + + +  + A  C     ++RP M +V+  LE
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  206 bits (525), Expect = 3e-53,   Method: Compositional matrix adjust.
 Identities = 119/292 (40%), Positives = 168/292 (57%), Gaps = 10/292 (3%)
Query: 450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKR-GNPRSQQGLAEFQTEI 508
           RF    +Q A++NF    ++G GGFGKVYKG L DG  VAVKR    R+Q G  +FQTE+
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 509 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICI 566
           EM+S   HR+L+ L G+C    E +L+Y YM NG++   L       P L W +R  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
           GSARGL YLH      +IHRDVK+ANILLDE F A V DFGL+K     D  HV  AV+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRG 197
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR----EMVNLAEWAMKW 682
             G++ PEY    + +EK+DV+ +GV+L E++  +   D  L R    + V L +W    
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 255
Query: 683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
             + +L+ ++D  L G  + + + +  + A  C     ++RP M +V+  LE
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (432), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/228 (40%), Positives = 143/228 (62%), Gaps = 16/228 (7%)
Query: 449 YRFPFVAVQEATNNFDESWV------IGIGGFGKVYKGELNDGTKVAVKR----GNPRSQ 498
           + F F  ++  TNNFDE  +      +G GGFG VYKG +N+ T VAVK+     +  ++
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 499 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLS 557
           +   +F  EI+++++ +H +LV L+G+  + +++ L+Y YM NG+L   L    G P LS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 558 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 617
           W  R +I  G+A G+++LH  +    IHRD+KSANILLDE F AK++DFGL++   +  Q
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           T + + + G+  Y+ PE   R ++T KSD+YSFGVVL E++   P +D
Sbjct: 189 TVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (430), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 92/228 (40%), Positives = 142/228 (62%), Gaps = 16/228 (7%)
Query: 449 YRFPFVAVQEATNNFDESWV------IGIGGFGKVYKGELNDGTKVAVKR----GNPRSQ 498
           + F F  ++  TNNFDE  +      +G GGFG VYKG +N+ T VAVK+     +  ++
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 499 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLS 557
           +   +F  EI+++++ +H +LV L+G+  + +++ L+Y YM NG+L   L    G P LS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 558 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 617
           W  R +I  G+A G+++LH  +    IHRD+KSANILLDE F AK++DFGL++   +  Q
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           T +   + G+  Y+ PE   R ++T KSD+YSFGVVL E++   P +D
Sbjct: 189 TVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  167 bits (424), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 91/228 (39%), Positives = 141/228 (61%), Gaps = 16/228 (7%)
Query: 449 YRFPFVAVQEATNNFDESWV------IGIGGFGKVYKGELNDGTKVAVKR----GNPRSQ 498
           + F F  ++  TNNFDE  +      +G GGFG VYKG +N+ T VAVK+     +  ++
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 65
Query: 499 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLS 557
           +   +F  EI+++++ +H +LV L+G+  + +++ L+Y YM NG+L   L    G P LS
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 558 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 617
           W  R +I  G+A G+++LH  +    IHRD+KSANILLDE F AK++DFGL++   +  Q
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
             +   + G+  Y+ PE   R ++T KSD+YSFGVVL E++   P +D
Sbjct: 183 XVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  160 bits (406), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/228 (39%), Positives = 137/228 (60%), Gaps = 16/228 (7%)
Query: 449 YRFPFVAVQEATNNFDESWV------IGIGGFGKVYKGELNDGTKVAVKR----GNPRSQ 498
           + F F  ++  TNNFDE  +       G GGFG VYKG +N+ T VAVK+     +  ++
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 62
Query: 499 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLS 557
           +   +F  EI++ ++ +H +LV L+G+  + +++ L+Y Y  NG+L   L    G P LS
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 558 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ 617
           W  R +I  G+A G+++LH  +    IHRD+KSANILLDE F AK++DFGL++   +  Q
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
               + + G+  Y  PE   R ++T KSD+YSFGVVL E++   P +D
Sbjct: 180 XVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  123 bits (308), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 78
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+ S       K+ ++I   +ARG+ YLH   AK++IHRD+
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 134
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  ++   +G L     P L+ K+R +  
Sbjct: 195 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 243
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           ++      +CL     +RPS   +L  +E
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  122 bits (306), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 139/269 (51%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+ S       K+ ++I   +ARG+ YLH   AK++IHRD+
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  ++   +G L     P L+ K+R +  
Sbjct: 207 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 255
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           ++      +CL     +RPS   +L  +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 138/269 (51%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
             ++ ++ ++ E  +L  HL+ S       K+ ++I   +ARG+ YLH   AK++IHRD+
Sbjct: 92  P-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  ++   +G L     P L+ K+R +  
Sbjct: 207 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 255
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           ++      +CL     +RPS   +L  +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (280), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 109/192 (56%), Gaps = 7/192 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V++ E + G+ VAVK    +    + + EF  E+ ++ + RH ++V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +   + ++ EY+  G+L   L+ SG    L  ++RL +    A+G++YLH      ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+KS N+L+D+ +  KV DFGLS+   +      S    G+  ++ PE  R +   EKS
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 646 DVYSFGVVLFEV 657
           DVYSFGV+L+E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 196 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 244
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 195
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 196 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 244
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 245 KAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  111 bits (278), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 191 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 239
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  111 bits (278), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 76
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 132
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 192
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 193 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 241
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 242 KAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 110/192 (57%), Gaps = 7/192 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V++ E + G+ VAVK    +    + + EF  E+ ++ + RH ++V  +G  
Sbjct: 45  IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +   + ++ EY+  G+L   L+ SG    L  ++RL +    A+G++YLH      ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           R++KS N+L+D+ +  KV DFGLS+       +  S A  G+  ++ PE  R +   EKS
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKS 220
Query: 646 DVYSFGVVLFEV 657
           DVYSFGV+L+E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 191 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 239
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 158
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 219 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 267
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 101
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 157
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 217
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 218 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 266
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 267 KAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 150
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 210
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 211 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 259
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 260 KAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 135/269 (50%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 158
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 218
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 219 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 267
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 134/269 (49%), Gaps = 19/269 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
             ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH   AK++IHRD+
Sbjct: 76  P-QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +S
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVY+FG+VL+E++  +      LP   +N  +  +    +G L     P L+ K+R +  
Sbjct: 191 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSNCP 239
Query: 706 RKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       +CL     +RP    +L ++E
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 113/207 (54%), Gaps = 28/207 (13%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQ--QGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +IGIGGFGKVY+   + D   V   R +P     Q +   + E ++ +  +H ++++L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPS---LSWKQRLEICIGSARGLHYLHTGYAK 581
            C ++  + L+ E+   G L   L G  +P    ++W  ++      ARG++YLH     
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAIV 127
Query: 582 AVIHRDVKSANILLDE--------NFMAKVADFGLSKTGPEIDQTHVST--AVKGSFGYL 631
            +IHRD+KS+NIL+ +        N + K+ DFGL++      + H +T  +  G++ ++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWM 181
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            PE  R    ++ SDV+S+GV+L+E+L
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELL 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  108 bits (270), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 111/200 (55%), Gaps = 12/200 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           V+G G FG V K +      VA+K+    S++    F  E+  LS+  H ++V L G C 
Sbjct: 16  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 528 EKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             N + L+ EY E G+L   L+G+  LP  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 72  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 587 DVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           D+K  N+LL     + K+ DFG   T  +I QTH+ T  KGS  ++ PE F     +EK 
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFG---TACDI-QTHM-TNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 646 DVYSFGVVLFEVLCARPVID 665
           DV+S+G++L+EV+  R   D
Sbjct: 186 DVFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 111/200 (55%), Gaps = 12/200 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           V+G G FG V K +      VA+K+    S++    F  E+  LS+  H ++V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 528 EKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             N + L+ EY E G+L   L+G+  LP  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 587 DVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           D+K  N+LL     + K+ DFG   T  +I QTH+ T  KGS  ++ PE F     +EK 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFG---TACDI-QTHM-TNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 646 DVYSFGVVLFEVLCARPVID 665
           DV+S+G++L+EV+  R   D
Sbjct: 185 DVFSWGIILWEVITRRKPFD 204

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 146
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV+  E        D   VAVK     S     +F  E E+L+  +H H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 523 IGYCDEKNEMILIYEYMENGTL----KGH-----LYGSGLP--SLSWKQRLEICIGSARG 571
            G C E + +I+++EYM++G L    + H     L   G P   L+  Q L I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL + +    +HRD+ + N L+ EN + K+ DFG+S+     D   V         ++
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            PE    ++ T +SDV+S GVVL+E+ 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 92  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 207
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELM 290

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 125/237 (52%), Gaps = 14/237 (5%)
Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL--NDGTKV 488
           MGS   H   ++ N         V +  ++     + VIG G FG VY G L  NDG K+
Sbjct: 5   MGSNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKI 64
Query: 489 --AVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIYEYMENGTL 544
             AVK  N  +  G +++F TE  ++  F H +++SL+G C   +   +++  YM++G L
Sbjct: 65  HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 124
Query: 545 KGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 603
           +  +      P++  K  +   +  A+G+ +L    +K  +HRD+ + N +LDE F  KV
Sbjct: 125 RNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKV 179
Query: 604 ADFGLSKT--GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           ADFGL++     E D  H  T  K    ++  E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 180 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 34  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 149
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 107/193 (55%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 527 DEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            E+  + L++E+ME+G L  +L    GL   + +  L +C+    G+ YL      +VIH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---SVIH 126
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 646 DVYSFGVVLFEVL 658
           DV+SFGV+++EV 
Sbjct: 186 DVWSFGVLMWEVF 198

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 117/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ +
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKF 148
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 527 DEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            E+  + L++E+ME+G L  +L    GL   + +  L +C+    G+ YL       VIH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---CVIH 126
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 646 DVYSFGVVLFEVL 658
           DV+SFGV+++EV 
Sbjct: 186 DVWSFGVLMWEVF 198

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 527 DEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            E+  + L++E+ME+G L  +L    GL   + +  L +C+    G+ YL       VIH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---CVIH 124
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 646 DVYSFGVVLFEVL 658
           DV+SFGV+++EV 
Sbjct: 184 DVWSFGVLMWEVF 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 106/193 (54%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 527 DEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            E+  + L++E+ME+G L  +L    GL   + +  L +C+    G+ YL       VIH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---CVIH 129
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 646 DVYSFGVVLFEVL 658
           DV+SFGV+++EV 
Sbjct: 189 DVWSFGVLMWEVF 201

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 35/277 (12%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG VYKG+ +    V + +    + +    F+ E+ +L + RH +++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
            N + ++ ++ E  +L  HL+          Q ++I   +A+G+ YLH   AK +IHRD+
Sbjct: 104 DN-LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDM 158
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEKS 645
           KS NI L E    K+ DFGL+        +       GS  ++ PE  R Q     + +S
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           DVYS+G+VL+E++         LP   +N              DQII     G   PD L
Sbjct: 219 DVYSYGIVLYELMTGE------LPYSHIN------------NRDQIIFMVGRGYASPD-L 259
Query: 706 RKFGETAEK--------CLADFGVDRPSMGDVLWNLE 734
            K  +   K        C+     +RP    +L ++E
Sbjct: 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 466 SWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            W +G G FGKV+  E +      D   VAVK     S+    +FQ E E+L+  +H+H+
Sbjct: 23  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-------------LSWKQRLEICI 566
           V   G C E   +++++EYM +G L   L   G  +             L   Q L +  
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A G+ YL   +    +HRD+ + N L+ +  + K+ DFG+S+     D   V      
Sbjct: 143 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIF 231

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 466 SWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            W +G G FGKV+  E +      D   VAVK     S+    +FQ E E+L+  +H+H+
Sbjct: 17  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-------------LSWKQRLEICI 566
           V   G C E   +++++EYM +G L   L   G  +             L   Q L +  
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A G+ YL   +    +HRD+ + N L+ +  + K+ DFG+S+     D   V      
Sbjct: 137 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 466 SWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            W +G G FGKV+  E +      D   VAVK     S+    +FQ E E+L+  +H+H+
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-------------LSWKQRLEICI 566
           V   G C E   +++++EYM +G L   L   G  +             L   Q L +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A G+ YL   +    +HRD+ + N L+ +  + K+ DFG+S+     D   V      
Sbjct: 166 QVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++ PE    ++ T +SDV+SFGVVL+E+ 
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/193 (35%), Positives = 105/193 (54%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 527 DEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            E+  + L+ E+ME+G L  +L    GL   + +  L +C+    G+ YL       VIH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---CVIH 127
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 646 DVYSFGVVLFEVL 658
           DV+SFGV+++EV 
Sbjct: 187 DVWSFGVLMWEVF 199

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 51  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 166
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 103/191 (53%), Gaps = 8/191 (4%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG V+ G   +  KVA+K     S     +F  E E++ +  H  LV L G C E
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 529 KNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           +  + L++E+ME+G L  +L    GL   + +  L +C+    G+ YL       VIHRD
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEA---CVIHRD 148
Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           + + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   + + KSDV
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 648 YSFGVVLFEVL 658
           +SFGV+++EV 
Sbjct: 208 WSFGVLMWEVF 218

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 52  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 167
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 25  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 140
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L +   K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 141 LAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 32  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 147
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 33  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 148
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 145
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 28  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 143
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 116/206 (56%), Gaps = 16/206 (7%)
Query: 462 NFDESWVIGIGGFGKVYKGEL--NDGTKV--AVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L  NDG K+  AVK  N  +  G +++F TE  ++  F H
Sbjct: 31  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHY 574
            +++SL+G C   +   +++  YM++G L+  +      P++  K  +   +  A+G+ Y
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKY 146
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GPEIDQTHVSTAVKGSFGYLD 632
           L    +K  +HRD+ + N +LDE F  KVADFGL++     E    H  T  K    ++ 
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E  + Q+ T KSDV+SFGV+L+E++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV+  E        D   VAVK     +     +FQ E E+L+  +H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLEICIGS 568
            G C + + +I+++EYM++G L   L   G  +              L   Q L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A G+ YL + +    +HRD+ + N L+  N + K+ DFG+S+     D   V        
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++ PE    ++ T +SDV+SFGV+L+E+ 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 70/200 (35%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 468 VIGIGGFGKVYKGEL--NDGTK---VAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G FG+VYKG L  + G K   VA+K      +++   +F  E  ++ QF H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L G   +   M++I EYMENG L   L        S  Q + +  G A G+ YL      
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---M 166
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             +HRD+ + NIL++ N + KV+DFGLS+     PE   T+ ++  K    +  PE    
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSGGKIPIRWTAPEAISY 224
Query: 639 QQLTEKSDVYSFGVVLFEVL 658
           ++ T  SDV+SFG+V++EV+
Sbjct: 225 RKFTSASDVWSFGIVMWEVM 244

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK-------RGNPRSQQGLAEFQTEIEM 510
           A N  +    IG GGFG V+KG L  D + VA+K        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +S   H ++V L G       M++  E++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 571 GLHYLHTGYAKAVIHRDVKSANILL---DEN--FMAKVADFGLSKTGPEIDQTHVSTAVK 625
           G+ Y+       ++HRD++S NI L   DEN    AKVADFGLS+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLL 187
Query: 626 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           G+F ++ PE      +  TEK+D YSF ++L+ +L      D
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           +    ++ PE    +  T +SDV+SFGV+L+E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY- 525
           IG G FG V  G+   G KVAVK  + +  +Q  LAE      +++Q RH +LV L+G  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE----ASVMTQLRHSNLVQLLGVI 68
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R ++ + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 180
Query: 646 DVYSFGVVLFEVLCARPVIDPTLP 669
           DV+SFG++L+E+     V  P +P
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIP 204

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 145 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 235

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N+ TKVAVK   P +   +  F  E  ++   +H  LV L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM  G+L   L       +   + ++     A G+ Y+     K  IHRD+
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 136
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++AN+L+ E+ M K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 137 RAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 649 SFGVVLFEVL 658
           SFG++L+E++
Sbjct: 196 SFGILLYEIV 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY- 525
           IG G FG V  G+   G KVAVK  + +  +Q  LAE      +++Q RH +LV L+G  
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE----ASVMTQLRHSNLVQLLGVI 83
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R ++ + KS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 195
Query: 646 DVYSFGVVLFEVLCARPVIDPTLP 669
           DV+SFG++L+E+     V  P +P
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIP 219

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 149 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 239

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY- 525
           IG G FG V  G+   G KVAVK  + +  +Q  LAE      +++Q RH +LV L+G  
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAE----ASVMTQLRHSNLVQLLGVI 255
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R ++ + KS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREKKFSTKS 367
Query: 646 DVYSFGVVLFEVLCARPVIDPTLP 669
           DV+SFG++L+E+     V  P +P
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIP 391

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+L+E+        P +P E
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           +    ++ PE    +  T +SDV+SFGV+L+E+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 148 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 238

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 111/213 (52%), Gaps = 27/213 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
           +    ++ PE    +  T +SDV+SFGV+L+E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 111/214 (51%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVY--------KGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V         K + N  TKVAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW--------------KQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P L +              K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T  
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 246

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK-------RGNPRSQQGLAEFQTEIEM 510
           A N  +    IG GGFG V+KG L  D + VA+K        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +S   H ++V L G       M++  E++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 571 GLHYLHTGYAKAVIHRDVKSANILL---DEN--FMAKVADFGLSKTGPEIDQTHVSTAVK 625
           G+ Y+       ++HRD++S NI L   DEN    AKVADFG S+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLL 187
Query: 626 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           G+F ++ PE      +  TEK+D YSF ++L+ +L      D
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 75  EP-IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 131 RAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 190 SFGILLTEL 198

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +   I+I EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 649 SFGVVLFEVLCARPVIDPTLP-REMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK-------RGNPRSQQGLAEFQTEIEM 510
           A N  +    IG GGFG V+KG L  D + VA+K        G     +   EFQ E+ +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +S   H ++V L G       M++  E++  G L   L     P + W  +L + +  A 
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 571 GLHYLHTGYAKAVIHRDVKSANILL---DEN--FMAKVADFGLSKTGPEIDQTHVSTAVK 625
           G+ Y+       ++HRD++S NI L   DEN    AKVADF LS+        H  + + 
Sbjct: 134 GIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLL 187
Query: 626 GSFGYLDPEYF--RRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           G+F ++ PE      +  TEK+D YSF ++L+ +L      D
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 334 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 389
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 390 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 649 SFGVVLFEVLCARPVIDPTL-PREMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 649 SFGVVLFEVLCARPVIDPTLP-REMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/189 (34%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +   I+I EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 101/203 (49%), Gaps = 14/203 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY-C 526
           IG G FG V  G+   G KVAVK   N  + Q    F  E  +++Q RH +LV L+G   
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIV 75
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +HR
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 132
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R    + KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALREAAFSTKSD 187
Query: 647 VYSFGVVLFEVLCARPVIDPTLP 669
           V+SFG++L+E+     V  P +P
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIP 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 78  EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 133
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 134 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 193 SFGILLTEL 201

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 7/210 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 251 E-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 307 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 649 SFGVVLFEVLCARPVIDPTLP-REMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 74  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 129
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 130 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 189 SFGILLTEL 197

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 76  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 131
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 132 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 191 SFGILLTEL 199

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 82  EP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDL 137
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 197 SFGILLTEL 205

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 82  EP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDL 137
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 138 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 197 SFGILLTEL 205

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 98/189 (51%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 82  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 137
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 138 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 197 SFGILLTEIV 206

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 107/210 (50%), Gaps = 7/210 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 252 E-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 307
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL +   E ++       K    +  PE     + T KSDV+
Sbjct: 308 RAANILVGENLVCKVADFGLGRL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 649 SFGVVLFEVLCARPVIDPTLP-REMVNLAE 677
           SFG++L E+     V  P +  RE+++  E
Sbjct: 367 SFGILLTELTTKGRVPYPGMVNREVLDQVE 396

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 99/189 (52%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 195 SFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 81  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 136
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 137 RAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 196 SFGILLTEIV 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 89  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 144
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 145 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 204 SFGILLTEIV 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 86  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 201 SFGILLTEIV 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 98/189 (51%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 RAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 195 SFGILLTEIV 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 469 IGIGGFGKVYKGE---LNDGTKVAVKRG--NPRS-QQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G GG   VY  E   LN   KVA+K     PR  ++ L  F+ E+   SQ  H+++VS+
Sbjct: 19  LGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           I   +E +   L+ EY+E  TL  ++   G   LS    +        G+ + H      
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHD---MR 131
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           ++HRD+K  NIL+D N   K+ DFG++K   E   T  +  V G+  Y  PE  + +   
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATD 190
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           E +D+YS G+VL+E+L   P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEP 210

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 88  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 143
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 144 RAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 203 SFGILLTEIV 212

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N+ TKVAVK   P +   +  F  E  ++   +H  LV L     +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I E+M  G+L   L       +   + ++     A G+ Y+     K  IHRD+
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++AN+L+ E+ M K+ADFGL++   E ++       K    +  PE       T KS+V+
Sbjct: 136 RAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L+E++
Sbjct: 195 SFGILLYEIV 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 86  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 141
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 142 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 201 SFGILLTEIV 210

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 195 SFGILLTEIV 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 85  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 141 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 200 SFGILLTEIV 209

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/189 (33%), Positives = 98/189 (51%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  T+VA+K   P +    A F  E +++ + RH  LV L     E
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+        +HRD+
Sbjct: 85  EP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            +ANIL+ EN + KVADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 141 AAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 649 SFGVVLFEV 657
           SFG++L E+
Sbjct: 200 SFGILLTEL 208

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 461 NNFDESWVIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQ 513
           NN +    IG G FG+V++            T VAVK     +   + A+FQ E  ++++
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTL----------------------KGHLYGS 551
           F + ++V L+G C     M L++EYM  G L                      +  +   
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 552 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
           G P LS  ++L I    A G+ YL     +  +HRD+ + N L+ EN + K+ADFGLS+ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               D             ++ PE     + T +SDV+++GVVL+E+ 
Sbjct: 224 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 75  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 131 RAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 190 SFGILLTEIV 199

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 90  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 145
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 146 RAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 205 SFGILLTEIV 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 9   FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 125
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE    + + 
Sbjct: 126 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTR 179
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 449 YRFPFVAVQEATNNFDES-----WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE 503
           Y  P   V E     D +      V+G G FG+V  G L   +K  +       + G  E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 504 -----FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW 558
                F  E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTV 146
Query: 559 KQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPE 614
            Q + +  G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               + +   K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 203 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 449 YRFPFVAVQEATNNFDES-----WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE 503
           Y  P   V E     D +      V+G G FG+V  G L   +K  +       + G  E
Sbjct: 26  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 85
Query: 504 -----FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW 558
                F  E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        + 
Sbjct: 86  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTV 144
Query: 559 KQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPE 614
            Q + +  G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE
Sbjct: 145 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 200
Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               + +   K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 201 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 21/224 (9%)
Query: 449 YRFPFVAVQEATNNFDES-----WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE 503
           Y  P   V E     D +      V+G G FG+V  G L   +K  +       + G  E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 504 -----FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW 558
                F  E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTV 146
Query: 559 KQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPE 614
            Q + +  G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               + +   K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 203 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 113/218 (51%), Gaps = 23/218 (10%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEF 504
           F    +ATN + D+  V+G G FG+V  G L   +K    VA+K    G    Q+   +F
Sbjct: 26  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDF 81
Query: 505 QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI 564
             E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGM 140
Query: 565 CIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHV 620
             G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE    + 
Sbjct: 141 LRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYT 194
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +   K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 195 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 27/214 (12%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+++E+ 
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE    + + 
Sbjct: 155 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTR 208
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           ++ L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 150 TYQLARGMEYLAS---QKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 253

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE    + + 
Sbjct: 155 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTR 208
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 155 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 258

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 152 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 255

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)
Query: 468 VIGIGGFGKVYKGELN-DGTKV--AVKRGNP-RSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +  DG ++  A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L  S +               +LS +Q L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+ G E+        VK + 
Sbjct: 142 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 190
Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)
Query: 468 VIGIGGFGKVYKGELN-DGTKV--AVKRGNP-RSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +  DG ++  A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L  S +               +LS +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+ G E+        VK + 
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 200
Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 113/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + ++ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/237 (32%), Positives = 116/237 (48%), Gaps = 26/237 (10%)
Query: 438 GTTTSANSNSGYRFPFVAVQEATNNFDESW-----VIGIGGFGKVYKGELNDGTK--VAV 490
           GT T  +  + Y  P  AV +     D S      VIG G FG+V  G L    K  VAV
Sbjct: 16  GTKTYIDPET-YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAV 74
Query: 491 -----KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 545
                K G    Q+   +F  E  ++ QF H ++V L G       ++++ E+MENG L 
Sbjct: 75  AIKTLKVGYTEKQR--RDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALD 132
Query: 546 GHLYGSGLPSLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVA 604
             L        +  Q + +  G A G+ YL   GY    +HRD+ + NIL++ N + KV+
Sbjct: 133 AFLRKHD-GQFTVIQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVS 187
Query: 605 DFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           DFGLS+     PE    + +T  K    +  PE  + ++ T  SDV+S+G+V++EV+
Sbjct: 188 DFGLSRVIEDDPE--AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 23/222 (10%)
Query: 452 PFVAVQEATNNFDESW-----VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQ 499
           P  AV+E     D S      VIG+G FG+V  G L    K    VA+K    G    Q+
Sbjct: 15  PNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR 74
Query: 500 GLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK 559
              +F +E  ++ QF H +++ L G   +   +++I EYMENG+L   L  +     +  
Sbjct: 75  --RDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKND-GRFTVI 131
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEID 616
           Q + +  G   G+ YL    A   +HRD+ + NIL++ N + KV+DFG+S+     PE  
Sbjct: 132 QLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE-- 186
Query: 617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             + +   K    +  PE    ++ T  SDV+S+G+V++EV+
Sbjct: 187 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 228

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/190 (33%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G  G+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD+
Sbjct: 80  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   + + T    A K    +  PE       T KSDV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGA-KFPIKWTAPEAINYGTFTIKSDVW 194
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 195 SFGILLTEIV 204

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVAVK     S    A F  E  ++ Q +H+ LV L     +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYMENG+L   L       L+  + L++    A G+ ++     +  IHR++
Sbjct: 76  E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRNL 131
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+ +    K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 132 RAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 191 SFGILLTEIV 200

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 21/222 (9%)
Query: 452 PFVAVQEATNNFDESWV-----IGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQG 500
           P  AV+E     D S+V     IG G FG+V +G L    K    VA+K  +G    +Q 
Sbjct: 2   PNEAVREFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ- 60
Query: 501 LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWK 559
             EF +E  ++ QF H +++ L G       ++++ E+MENG L   L    G    +  
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVI 118
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 619
           Q + +  G A G+ YL      + +HRD+ + NIL++ N + KV+DFGLS+   E     
Sbjct: 119 QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 175
Query: 620 VSTAVKGS---FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             T+  G      +  PE    ++ T  SD +S+G+V++EV+
Sbjct: 176 TETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVM 217

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 12/193 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VAVK     S     EF  E + + +  H  LV   G C +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 529 KNEMILIYEYMENGTLKGHL--YGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           +  + ++ EY+ NG L  +L  +G GL PS    Q LE+C     G+ +L +      IH
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPS----QLLEMCYDVCEGMAFLES---HQFIH 127
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+D +   KV+DFG+++   + DQ   S   K    +  PE F   + + KS
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 646 DVYSFGVVLFEVL 658
           DV++FG++++EV 
Sbjct: 187 DVWAFGILMWEVF 199

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGL++     PE    + + 
Sbjct: 155 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPE--AAYTTR 208
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTA 623
           G A G+ YL        +HRD+ + NIL++ N + KV+DFGLS+     PE    + +  
Sbjct: 155 GIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRG 209
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+ G L  D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +K  + ++ E ++ G     L   G   L  K  L++   +A G+ YL +   K  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA--VKGSFGYLDPEYFRRQQLTEK 644
           D+ + N L+ E  + K++DFG+S+   E D  + ++    +    +  PE     + + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 645 SDVYSFGVVLFE 656
           SDV+SFG++L+E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G FG+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 134
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 646 DVYSFGVVLFEV----LCARPVIDPTLPREMVN 674
           DV++FGV+L+E+    +   P IDP+   E++ 
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I  Y   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ EYMENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGL +     PE    + + 
Sbjct: 155 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTR 208
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 113/233 (48%), Gaps = 13/233 (5%)
Query: 455 AVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS--QQGLAE-FQTEIEM 510
            + E   +F    ++G G F  VY+ E ++ G +VA+K  + ++  + G+ +  Q E+++
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
             Q +H  ++ L  Y ++ N + L+ E   NG +  +L     P  S  +          
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIIT 123
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ YLH+     ++HRD+  +N+LL  N   K+ADFGL+       + H +    G+  Y
Sbjct: 124 GMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNY 178
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN---LAEWAM 680
           + PE   R     +SDV+S G + + +L  RP  D    +  +N   LA++ M
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 112/215 (52%), Gaps = 35/215 (16%)
Query: 468 VIGIGGFGKVYKGELN-DGTKV--AVKRGNP-RSQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +  DG ++  A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGL--------------PSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L  S +               +LS +Q L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHR++ + NIL+ EN++AK+ADFGLS+ G E+        VK + 
Sbjct: 149 ARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 197
Query: 629 GYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVL 658
           G L   +   + L     T  SDV+S+GV+L+E++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 134
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 646 DVYSFGVVLFEV----LCARPVIDPTLPREMVN 674
           DV++FGV+L+E+    +   P IDP+   E++ 
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+ G L  D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +K  + ++ E ++ G     L   G   L  K  L++   +A G+ YL +   K  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLES---KCCIHR 237
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA--VKGSFGYLDPEYFRRQQLTEK 644
           D+ + N L+ E  + K++DFG+S+   E D    ++    +    +  PE     + + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSRE--EADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 645 SDVYSFGVVLFE 656
           SDV+SFG++L+E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 9   FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 66
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ E MENG+L   L        +  Q + +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLR 125
Query: 567 GSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVST 622
           G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE    + + 
Sbjct: 126 GIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTR 179
Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 180 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 112/227 (49%), Gaps = 27/227 (11%)
Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK   +  +++ L++  +E+EM+    +H++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP--------------SLSWKQRLEI 564
           +++L+G C +   + +I  Y   G L+ +L     P               +++K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL +   +  IHRD+ + N+L+ EN + K+ADFGL++    ID    +T  
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +    ++ PE    +  T +SDV+SFGV+++E+        P +P E
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 106/224 (47%), Gaps = 21/224 (9%)
Query: 449 YRFPFVAVQEATNNFDES-----WVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE 503
           Y  P   V E     D +      V+G G FG+V  G L   +K  +       + G  E
Sbjct: 28  YEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87
Query: 504 -----FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSW 558
                F  E  ++ QF H +++ L G   +   ++++ E MENG+L   L        + 
Sbjct: 88  KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTV 146
Query: 559 KQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPE 614
            Q + +  G A G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+     PE
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE 202
Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               + +   K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 203 --AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 455 AVQEATNNFDESW-----VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLA 502
           AV+E     D S      VIG+G FG+V  G L    K    VA+K    G    Q+   
Sbjct: 3   AVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--R 60
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           +F +E  ++ QF H +++ L G   +   +++I EYMENG+L   L  +     +  Q +
Sbjct: 61  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKND-GRFTVIQLV 119
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTH 619
            +  G   G+ YL      + +HRD+ + NIL++ N + KV+DFG+S+     PE    +
Sbjct: 120 GMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAY 174
Query: 620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            +   K    +  PE    ++ T  SDV+S+G+V++EV+
Sbjct: 175 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVK--RGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+   +L D   VAVK  R +  R       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANIL+      KV DFG+++    +G  + QT    AV G+
Sbjct: 129 LNFSHQ---NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT---AAVIGT 182
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 468 VIGIGGFGKVYKGELNDGTK----VAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G FG+V +G L    K    VA+K  +G    +Q   EF +E  ++ QF H +++ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           L G       ++++ E+MENG L   L    G    +  Q + +  G A G+ YL     
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAE--- 134
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE--IDQTHVST-AVKGSFGYLDPEYFR 637
            + +HRD+ + NIL++ N + KV+DFGLS+   E   D T+ S+   K    +  PE   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 638 RQQLTEKSDVYSFGVVLFEVLC--ARPVID 665
            ++ T  SD +S+G+V++EV+    RP  D
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMSFGERPYWD 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 469 IGIGGFGKVYKG--ELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G+G FGKV  G  EL  G KVAVK   R   RS   + + + EI+ L  FRH H++ L 
Sbjct: 24  LGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                 +++ ++ EY+  G L  ++  +G       +RL   I S  G+ Y H      V
Sbjct: 83  QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHR---HMV 137
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLT 642
           +HRD+K  N+LLD +  AK+ADFGLS    + +    S    GS  Y  PE    R    
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVISGRLYAG 194
Query: 643 EKSDVYSFGVVLFEVLCARPVID----PTLPREMVN 674
            + D++S GV+L+ +LC     D    PTL +++ +
Sbjct: 195 PEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD 230

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 115/228 (50%), Gaps = 27/228 (11%)
Query: 469 IGIGGFGKV---YKGELNDGT--KVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FGKV        NDGT   VAVK       P+ + G   ++ EI++L    H H+
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEHI 95
Query: 520 VSLIGYCDEKN--EMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYL 575
           +   G C++     + L+ EY+  G+L+ +L  +  GL  L    + +IC G A    YL
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ-QICEGMA----YL 150
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPE 634
           H   A+  IHRD+ + N+LLD + + K+ DFGL+K  PE  + + V         +  PE
Sbjct: 151 H---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPE 207
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 680
             +  +    SDV+SFGV L+E+L  C      PT   E++ +A+  M
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/228 (32%), Positives = 117/228 (51%), Gaps = 27/228 (11%)
Query: 469 IGIGGFGKV---YKGELNDGT--KVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FGKV        NDGT   VAVK       P+ + G   ++ EI++L    H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 520 VSLIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYL 575
           +   G C+++ E  + L+ EY+  G+L+ +L  +  GL  L    + +IC G A    YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ-QICEGMA----YL 133
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPE 634
           H   A+  IHR++ + N+LLD + + K+ DFGL+K  PE  + + V         +  PE
Sbjct: 134 H---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 680
             +  +    SDV+SFGV L+E+L  C      PT   E++ +A+  M
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 117/231 (50%), Gaps = 19/231 (8%)
Query: 452 PFVAVQEATNNFDESWV-----IGIGGFGKVYKGELNDGTK----VAVKR-GNPRSQQGL 501
           P  AV+E     D S V     IG G FG+V  G L    K    VA+K   +  +++  
Sbjct: 19  PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR 78
Query: 502 AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR 561
            +F +E  ++ QF H +++ L G   +   +++I E+MENG+L   L  +     +  Q 
Sbjct: 79  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQL 137
Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTH 619
           + +  G A G+ YL        +HRD+ + NIL++ N + KV+DFGLS+       D T+
Sbjct: 138 VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 194
Query: 620 VST-AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC--ARPVIDPT 667
            S    K    +  PE  + ++ T  SDV+S+G+V++EV+    RP  D T
Sbjct: 195 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 245

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 134
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG---DTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 646 DVYSFGVVLFEV----LCARPVIDPTLPREMVN 674
           DV++FGV+L+E+    +   P IDP+   E++ 
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE 224

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 453 FVAVQEATN-NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAE-----FQT 506
           F    +ATN + D+  V+G G FG+V  G L   +K  +       + G  E     F  
Sbjct: 38  FAKELDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG 95
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E  ++ QF H +++ L G   +   ++++ E MENG+L   L        +  Q + +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHD-AQFTVIQLVGMLR 154
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTA 623
           G A G+ YL    A   +HRD+ + NIL++ N + KV+DFGLS+     PE    + +  
Sbjct: 155 GIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPE--AAYTTRG 209
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            K    +  PE    ++ T  SDV+S+G+VL+EV+
Sbjct: 210 GKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVK--RGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+   +L D   VAVK  R +  R       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANI++      KV DFG+++    +G  + QT    AV G+
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGT 182
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 119/262 (45%), Gaps = 27/262 (10%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G FG+  K    +  +V V +   R  ++    F  E++++    H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +   +  I EY++ GTL+G +  S      W QR+      A G+ YLH+     +IHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 587 DVKSANILLDENFMAKVADFGLS------KTGPE-------IDQTHVSTAVKGSFGYLDP 633
           D+ S N L+ EN    VADFGL+      KT PE        D+    T V   + ++ P
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMAP 191
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPT-LPREMVNLAEWAMKWQNKGQLDQII 692
           E    +   EK DV+SFG+VL E++  R   DP  LPR M            +G LD+  
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTM------DFGLNVRGFLDRYC 244
Query: 693 DPTLAGKIRPDSLRKFGETAEK 714
            P       P ++R      EK
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEK 266

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVK--RGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+   +L D   VAVK  R +  R       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANI++      KV DFG+++    +G  + QT    AV G+
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGT 182
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 29/228 (12%)
Query: 449 YRFPFVAVQEATNNFDESW-----VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA- 502
           Y  P  AV E     + S      VIG G FG+V  G L    K+  KR  P + + L  
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRL----KLPGKRELPVAIKTLKV 60
Query: 503 --------EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP 554
                   +F  E  ++ QF H +++ L G   +   ++++ EYMENG+L   L  +   
Sbjct: 61  GYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKND-G 119
Query: 555 SLSWKQRLEICIGSARGLHYL-HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-- 611
             +  Q + +  G + G+ YL   GY    +HRD+ + NIL++ N + KV+DFGLS+   
Sbjct: 120 QFTVIQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 612 -GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             PE    + +   K    +  PE    ++ T  SDV+S+G+V++EV+
Sbjct: 176 DDPE--AAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G+G FGKV  GE    G KVAVK   R   RS   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
                 +  ++ EY+  G L  ++   G       +RL   I SA  + Y H      V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR---HMVV 133
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 643
           HRD+K  N+LLD +  AK+ADFGLS    + +    S    GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAGP 190
Query: 644 KSDVYSFGVVLFEVLCAR-PVIDPTLP 669
           + D++S GV+L+ +LC   P  D  +P
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 117/228 (51%), Gaps = 27/228 (11%)
Query: 469 IGIGGFGKV---YKGELNDGT--KVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FGKV        NDGT   VAVK       P+ + G   ++ EI++L    H H+
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEHI 78
Query: 520 VSLIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYL 575
           +   G C+++ E  + L+ EY+  G+L+ +L  +  GL  L    + +IC G A    YL
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQ-QICEGMA----YL 133
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPE 634
           H+   +  IHR++ + N+LLD + + K+ DFGL+K  PE  + + V         +  PE
Sbjct: 134 HS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 190
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREMVNLAEWAM 680
             +  +    SDV+SFGV L+E+L  C      PT   E++ +A+  M
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 146
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + ++T  S   K    +  PE     + + KSD++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 206 AFGVLMWEI 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 18/201 (8%)
Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           VIG+G FG+V  G L    K    VA+K    G    Q+   +F +E  ++ QF H +++
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHPNII 72
Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L G   +   +++I EYMENG+L   L  +     +  Q + +  G   G+ YL     
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKND-GRFTVIQLVGMLRGIGSGMKYLSD--- 128
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFR 637
            + +HRD+ + NIL++ N + KV+DFG+S+     PE    + +   K    +  PE   
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYTTRGGKIPIRWTAPEAIA 186
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            ++ T  SDV+S+G+V++EV+
Sbjct: 187 YRKFTSASDVWSYGIVMWEVM 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 75  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 130
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 190 AFGVLMWEI 198

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 131
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 191 AFGVLMWEI 199

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 91  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 146
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 206 AFGVLMWEI 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++     D    +   KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
            ++ PE  +    T  SD++SFGVVL+E+
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HRD+ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 71  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 126
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 186 AFGVLMWEI 194

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 82  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 137
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 197 AFGVLMWEI 205

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 25/204 (12%)
Query: 469 IGIGGFGKV---YKGELNDGT--KVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FGKV        NDGT   VAVK       P+ + G   +Q EIE+L    H H+
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 73
Query: 520 VSLIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYL 575
           V   G C+++ E  + L+ EY+  G+L+ +L  +  GL  L    + +IC G A    YL
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQ-QICEGMA----YL 128
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPE 634
           H   A+  IHR + + N+LLD + + K+ DFGL+K  PE  + + V         +  PE
Sbjct: 129 H---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 185
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL 658
             +  +    SDV+SFGV L+E+L
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELL 209

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 94/189 (49%), Gaps = 6/189 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG V  G+      VA+K     S     EF  E +++    H  LV L G C +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + +I EYM NG L  +L          +Q LE+C      + YL +   K  +HRD+
Sbjct: 76  QRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDL 131
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     + + KSD++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 649 SFGVVLFEV 657
           +FGV+++E+
Sbjct: 191 AFGVLMWEI 199

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 106/204 (51%), Gaps = 25/204 (12%)
Query: 469 IGIGGFGKV---YKGELNDGT--KVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FGKV        NDGT   VAVK       P+ + G   +Q EIE+L    H H+
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSG---WQREIEILRTLYHEHI 72
Query: 520 VSLIGYCDEKNE--MILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYL 575
           V   G C+++ E  + L+ EY+  G+L+ +L  +  GL  L    + +IC G A    YL
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLLFAQ-QICEGMA----YL 127
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPE 634
           H   A+  IHR + + N+LLD + + K+ DFGL+K  PE  + + V         +  PE
Sbjct: 128 H---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPE 184
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVL 658
             +  +    SDV+SFGV L+E+L
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELL 208

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G+G FGKV  GE    G KVAVK   R   RS   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
                 +  ++ EY+  G L  ++   G       +RL   I SA  + Y H      V+
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA--VDYCHR---HMVV 133
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 643
           HRD+K  N+LLD +  AK+ADFGLS    + +    S    GS  Y  PE    R     
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVISGRLYAGP 190
Query: 644 KSDVYSFGVVLFEVLCAR-PVIDPTLP 669
           + D++S GV+L+ +LC   P  D  +P
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+ G  N  TKVA+K   P +      F  E +++ + +H  LV L     E
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           +  + ++ EYM  G+L   L      +L     +++    A G+ Y+        IHRD+
Sbjct: 76  E-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 131
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           +SANIL+    + K+ADFGL++   E ++       K    +  PE     + T KSDV+
Sbjct: 132 RSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 191 SFGILLTELV 200

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HR++ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 469 IGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY+G   D       T+VAVK  N   S +   EF  E  ++  F   H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG--------SGLPSLSWKQRLEICIGSARGLH 573
           L+G   +    +++ E M +G LK +L           G P  + ++ +++    A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL+   AK  +HR++ + N ++  +F  K+ DFG+++   E D             ++ P
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  +    T  SD++SFGVVL+E+
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGS----------GLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 144
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 145 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +S    G+  YL 
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLP 175
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGS----------GLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 135
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 136 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA---------EFQTEIEMLSQFRHRH 518
           +IG G  G+V  G L    +V  +R  P + + L          +F +E  ++ QF H +
Sbjct: 56  IIGSGDSGEVCYGRL----RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-T 577
           ++ L G        +++ EYMENG+L   L        +  Q + +  G   G+ YL   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYF 636
           GY    +HRD+ + N+L+D N + KV+DFGLS+    + D  + +T  K    +  PE  
Sbjct: 171 GY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 637 RRQQLTEKSDVYSFGVVLFEVLC 659
             +  +  SDV+SFGVV++EVL 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 137
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 198 FSVASDVWSFGVVLYELF 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 139
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 200 FSVASDVWSFGVVLYELF 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 164
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 225 FSVASDVWSFGVVLYELF 242

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 132
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 193 FSVASDVWSFGVVLYELF 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q    +FD    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANAL 125
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL  N   K+ADFG S   P    +   T + G+  YL 
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 178
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L   P  +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 138
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 199 FSVASDVWSFGVVLYELF 216

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 469 IGIGGFGKV----YKGEL-NDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV    Y  E  N G +VAVK   P S    +A+ + EIE+L    H ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 523 IGYCDEK--NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C E   N + LI E++ +G+LK +L       ++ KQ+L+  +   +G+ YL +   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGS--- 144
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS-----FGYLDPEY 635
           +  +HRD+ + N+L++     K+ DFGL+K    I+       VK       F Y  PE 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEXXTVKDDRDSPVFWYA-PEC 200
Query: 636 FRRQQLTEKSDVYSFGVVLFEVL 658
             + +    SDV+SFGV L E+L
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELL 223

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY     +   +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +    A+ G+  YL 
Sbjct: 122 SYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 141
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 140
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 201 FSVASDVWSFGVVLYELF 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE---LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+      L+    V V R +  R       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANI++      KV DFG+++    +G  + QT    AV G+
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGT 182
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 131
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 192 FSVASDVWSFGVVLYELF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 151
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 469 IGIGGFGKV----YKGEL-NDGTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FGKV    Y  E  N G +VAVK   P S    +A+ + EIE+L    H ++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 523 IGYCDEK--NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C E   N + LI E++ +G+LK +L       ++ KQ+L+  +   +G+ YL +   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGS--- 132
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS-----FGYLDPEY 635
           +  +HRD+ + N+L++     K+ DFGL+K    I+       VK       F Y  PE 
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKA---IETDKEXXTVKDDRDSPVFWYA-PEC 188
Query: 636 FRRQQLTEKSDVYSFGVVLFEVL 658
             + +    SDV+SFGV L E+L
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELL 211

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 141
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 151
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 141
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA---------EFQTEIEMLSQFRHRH 518
           +IG G  G+V  G L    +V  +R  P + + L          +F +E  ++ QF H +
Sbjct: 56  IIGSGDSGEVCYGRL----RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-T 577
           ++ L G        +++ EYMENG+L   L        +  Q + +  G   G+ YL   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYF 636
           GY    +HRD+ + N+L+D N + KV+DFGLS+    + D    +T  K    +  PE  
Sbjct: 171 GY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAI 226
Query: 637 RRQQLTEKSDVYSFGVVLFEVLC 659
             +  +  SDV+SFGVV++EVL 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 14/210 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG+V  G L    K    VA+K   +  +++   +F +E  ++ QF H +++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            G   +   +++I E+MENG+L   L  +     +  Q + +  G A G+ YL       
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MN 129
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVST-AVKGSFGYLDPEYFRRQ 639
            +HR + + NIL++ N + KV+DFGLS+       D T+ S    K    +  PE  + +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 640 QLTEKSDVYSFGVVLFEVLC--ARPVIDPT 667
           + T  SDV+S+G+V++EV+    RP  D T
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERPYWDMT 219

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 137
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG---DTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 195 DVWAFGVLLWEI 206

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGEIADG 150
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 141
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 143
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 144 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLP 175
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +T +     G+  YL 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLP 179
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS--KMIQMAGEIADG 140
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 141 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 147
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 200
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 125
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 178
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 133
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-THVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE---LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+      L+    V V R +  R       F+ E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANI++      KV DFG+++    +G  + QT    AV G+
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGT 182
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 143
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 144 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 140
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 198 DVWAFGVLLWEI 209

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 120
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 121 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 173
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 141
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 142 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 177
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 136
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 194 DVWAFGVLLWEI 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 179
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 150
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 151 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +    A+ G+  YL 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLP 177
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +    A+ G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 144
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 145 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 201
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 137
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 195 DVWAFGVLLWEI 206

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 172
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 173 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 229
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 177
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 137
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D             ++
Sbjct: 138 MAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 138
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 196 DVWAFGVLLWEI 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 138
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 139 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 191
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 179
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 141
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 199 DVWAFGVLLWEI 210

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRN 343
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 401 DVWAFGVLLWEI 412

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 138
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 196 DVWAFGVLLWEI 207

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE---LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFR 515
           ++ ++   ++G GG  +V+      L+    V V R +  R       F+ E +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 516 HRHLVSLIGYCDEKNEM----ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           H  +V++    + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 145
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----TGPEIDQTHVSTAVKGS 627
           L++ H      +IHRDVK ANI++      KV DFG+++    +G  + QT    AV G+
Sbjct: 146 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGT 199
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE  R   +  +SDVYS G VL+EVL   P
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI E++  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 136
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+    N  TKVAVK   P S   +  F  E  ++   +H  LV L      
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT- 80
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K  + +I E+M  G+L   L           + ++     A G+ ++     +  IHRD+
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 137
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+  + + K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 197 SFGILLMEIV 206

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 524 GYCDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL T   K
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---K 134
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH-VSTAVKGSFGYLDPEYFRRQQ 640
             IHR++ + NIL++     K+ DFGL+K  P+  + + V    +    +  PE     +
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 641 LTEKSDVYSFGVVLFEVL 658
            +  SDV+SFGVVL+E+ 
Sbjct: 195 FSVASDVWSFGVVLYELF 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 149
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 207 DVWAFGVLLWEI 218

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 118
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 119 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 171
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 13/218 (5%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTE 507
           P  + Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 508 IEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG 567
           +E+ S  RH +++ L GY  +   + LI EY   GT+   L    L     ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A  L Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +  +     G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GT 172
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
             YL PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRD 138
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 196 DVWAFGVLLWEI 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   G +   L    L     ++        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANAL 126
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +   T + G+  YL 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLP 179
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 13/210 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q    +FD    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQS 67
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANAL 125
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL  N   K+ADFG S   P    +     + G+  YL 
Sbjct: 126 SYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLCGTLDYLP 178
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE    +   EK D++S GV+ +E L   P
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 16/190 (8%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+    N  TKVAVK   P S   +  F  E  ++   +H  LV L      
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT- 247
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K  + +I E+M  G+L   L           + ++     A G+ ++     +  IHRD+
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 304
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+  + + K+ADFGL++ G            K    +  PE       T KSDV+
Sbjct: 305 RAANILVSASLVCKIADFGLARVG-----------AKFPIKWTAPEAINFGSFTIKSDVW 353
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 354 SFGILLMEIV 363

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 6/190 (3%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           +G G FG+V+    N  TKVAVK   P S   +  F  E  ++   +H  LV L      
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT- 253
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
           K  + +I E+M  G+L   L           + ++     A G+ ++     +  IHRD+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDL 310
Query: 589 KSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           ++ANIL+  + + K+ADFGL++   E ++       K    +  PE       T KSDV+
Sbjct: 311 RAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 649 SFGVVLFEVL 658
           SFG++L E++
Sbjct: 370 SFGILLMEIV 379

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVY----KGELNDG--TKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG VY    KG + D   T+VA+K  N   S +   EF  E  ++ +F   H+V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYG----------SGLPSLSWKQRLEICIGSARG 571
           L+G   +    ++I E M  G LK +L               PSLS  + +++    A G
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS--KMIQMAGEIADG 137
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL+   A   +HRD+ + N  + E+F  K+ DFG+++   E D             ++
Sbjct: 138 MAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 194
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE  +    T  SDV+SFGVVL+E+
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +  +     G+  YL 
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLP 176
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+A+FG S   P    +   T + G+  YL 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLP 177
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +  +     G+  YL 
Sbjct: 122 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLP 174
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+A+FG S   P    +   T + G+  YL 
Sbjct: 124 SYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLCGTLDYLP 176
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 94/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   G +   L    L     ++        A  L
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANAL 126
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +     + G+  YL 
Sbjct: 127 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGTLDYLP 179
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +  +     G+  YL 
Sbjct: 125 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLP 177
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 147
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P   +  +     G+  YL 
Sbjct: 148 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLP 200
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 201 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLA----EFQTEIEMLS 512
           Q A  +F+    +G G FG VY         +   +   ++Q   A    + + E+E+ S
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
             RH +++ L GY  +   + LI EY   GT+   L    L     ++        A  L
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            Y H+   K VIHRD+K  N+LL      K+ADFG S   P    +     + G+  YL 
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLCGTLDYLP 175
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           PE    +   EK D++S GV+ +E L  +P  +
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    ++ EYM  G L  +L       ++    L +    +  + YL     K  IHRD
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFIHRD 155
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE       + KS
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 213 DVWAFGVLLWEI 224

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 10/192 (5%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
            +    +I E+M  G L  +L       ++    L +    +  + YL     K  IHR+
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRN 382
Query: 588 VKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           + + N L+ EN + KVADFGLS+  TG   D        K    +  PE     + + KS
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 646 DVYSFGVVLFEV 657
           DV++FGV+L+E+
Sbjct: 440 DVWAFGVLLWEI 451

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 468 VIGIGGFGKVYKGELN--DGT--KVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V +G L   DGT  KVAVK  + +  SQ+ + EF +E   +  F H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 522 LIGYCDEKNEM-----ILIYEYMENGTLKGHLYGSGLPS----LSWKQRLEICIGSARGL 572
           L+G C E +       ++I  +M+ G L  +L  S L +    +  +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YL     +  +HRD+ + N +L ++    VADFGLSK     D        K    ++ 
Sbjct: 161 EYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEV 657
            E    +  T KSDV++FGV ++E+
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ---QGLA-EFQTEIEMLSQFRH 516
           ++FD    +G G FG VY         +   +   +SQ   +G+  + + EIE+ S  RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            +++ +  Y  ++  + L+ E+   G L   L   G      ++        A  LHY H
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH 132
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
               + VIHRD+K  N+L+      K+ADFG S   P + +  +     G+  YL PE  
Sbjct: 133 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMI 185
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVID 665
             +   EK D++  GV+ +E L   P  D
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  L  HL G+ L  L   Q L    IC       RGL Y+H+ 
Sbjct: 107 ---NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 164 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ---QGLA-EFQTEIEMLSQFRH 516
           ++FD    +G G FG VY         +   +   +SQ   +G+  + + EIE+ S  RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            +++ +  Y  ++  + L+ E+   G L   L   G      ++        A  LHY H
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH 131
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
               + VIHRD+K  N+L+      K+ADFG S   P + +  +     G+  YL PE  
Sbjct: 132 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYLPPEMI 184
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVID 665
             +   EK D++  GV+ +E L   P  D
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFR 515
           N+     +G G FGKV        G KVA+K  N +       QG    + EI  L   R
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 71
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H H++ L      K+E+I++ EY  N      +    +     ++  +  I +    H  
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 129
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                  ++HRD+K  N+LLDE+   K+ADFGLS      D   + T+  GS  Y  PE 
Sbjct: 130 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEV 182
Query: 636 FRRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
              +     + DV+S GV+L+ +LC R P  D ++P    N++           L + + 
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------TLPKFLS 236
Query: 694 PTLAGKIR 701
           P  AG I+
Sbjct: 237 PGAAGLIK 244

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFR 515
           N+     +G G FGKV        G KVA+K  N +       QG    + EI  L   R
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H H++ L      K+E+I++ EY  N      +    +     ++  +  I +    H  
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 130
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                  ++HRD+K  N+LLDE+   K+ADFGLS      D   + T+  GS  Y  PE 
Sbjct: 131 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEV 183
Query: 636 FRRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
              +     + DV+S GV+L+ +LC R P  D ++P    N++           L + + 
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------TLPKFLS 237
Query: 694 PTLAGKIR 701
           P  AG I+
Sbjct: 238 PGAAGLIK 245

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFR 515
           N+     +G G FGKV        G KVA+K  N +       QG    + EI  L   R
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H H++ L      K+E+I++ EY  N      +    +     ++  +  I +    H  
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 120
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                  ++HRD+K  N+LLDE+   K+ADFGLS      D   + T+  GS  Y  PE 
Sbjct: 121 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEV 173
Query: 636 FRRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
              +     + DV+S GV+L+ +LC R P  D ++P    N++           L + + 
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------TLPKFLS 227
Query: 694 PTLAGKIR 701
           P  AG I+
Sbjct: 228 PGAAGLIK 235

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 25/248 (10%)
Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR-----SQQGLAEFQTEIEMLSQFR 515
           N+     +G G FGKV        G KVA+K  N +       QG    + EI  L   R
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLR 66
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H H++ L      K+E+I++ EY  N      +    +     ++  +  I +    H  
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 124
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                  ++HRD+K  N+LLDE+   K+ADFGLS      D   + T+  GS  Y  PE 
Sbjct: 125 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEV 177
Query: 636 FRRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
              +     + DV+S GV+L+ +LC R P  D ++P    N++           L + + 
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------TLPKFLS 231
Query: 694 PTLAGKIR 701
           P  AG I+
Sbjct: 232 PGAAGLIK 239

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 136/323 (42%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 577 TGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 267
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 319
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 320 DPDVINTALPIEYGPLVEEEEKV 342

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 136/323 (42%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 267
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 319
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 320 DPDVINTALPIEYGPLVEEEEKV 342

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 136/323 (42%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 252
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 304
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 305 DPDVINTALPIEYGPLVEEEEKV 327

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 136/323 (42%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 252
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 304
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 305 DPDVINTALPIEYGPLVEEEEKV 327

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 136/323 (42%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 226
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 269
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 270 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 321
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 322 DPDVINTALPIEYGPLVEEEEKV 344

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 253
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 305
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 306 DPDVINTALPIEYGPLVEE 324

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 216
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 259
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 260 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 311
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 312 DPDVINTALPIEYGPLVEE 330

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 468 VIGIGGFGKVYKG---------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           V+G G FG VYKG         ++    K+  +   P++     EF  E  +++   H H
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN---VEFMDEALIMASMDHPH 78
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGL 572
           LV L+G C     + L+ + M +G L  +++      GS L  L+W      C+  A+G+
Sbjct: 79  LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL-LLNW------CVQIAKGM 130
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YL     + ++HRD+ + N+L+      K+ DFGL++     ++ + +   K    ++ 
Sbjct: 131 MYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 187
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E    ++ T +SDV+S+GV ++E++
Sbjct: 188 LECIHYRKFTHQSDVWSYGVTIWELM 213

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 577 TGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 201
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 244
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 245 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 296
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 297 DPDVINTALPIEYGPLVEE 315

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-----DIYRASYYRKGGCAMLPV 210
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 253
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 305
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 306 DPDVINTALPIEYGPLVEE 324

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FGKVYK + N  T V  A K  + +S++ L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQ-NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             +N + ++ E+   G +   +     P L+  Q   +C  +   L+YLH      +IHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF-----RRQQL 641
           D+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 642 TEKSDVYSFGVVLFEVLCARP 662
             K+DV+S G+ L E+    P
Sbjct: 218 DYKADVWSLGITLIEMAEIEP 238

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 468 VIGIGGFGKVYKG---------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           V+G G FG VYKG         ++    K+  +   P++     EF  E  +++   H H
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN---VEFMDEALIMASMDHPH 101
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY------GSGLPSLSWKQRLEICIGSARGL 572
           LV L+G C     + L+ + M +G L  +++      GS L  L+W      C+  A+G+
Sbjct: 102 LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL-LLNW------CVQIAKGM 153
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YL     + ++HRD+ + N+L+      K+ DFGL++     ++ + +   K    ++ 
Sbjct: 154 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 210
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
            E    ++ T +SDV+S+GV ++E++
Sbjct: 211 LECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FGKVYK + N  T V  A K  + +S++ L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQ-NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             +N + ++ E+   G +   +     P L+  Q   +C  +   L+YLH      +IHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF-----RRQQL 641
           D+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 642 TEKSDVYSFGVVLFEVLCARP 662
             K+DV+S G+ L E+    P
Sbjct: 218 DYKADVWSLGITLIEMAEIEP 238

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 110/247 (44%), Gaps = 30/247 (12%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 544 LKGHL------------YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           L   L            +     +LS +  L      A+G+ +L +   K  IHRDV + 
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAAR 193
Query: 592 NILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 651
           N+LL    +AK+ DFGL++         V    +    ++ PE       T +SDV+S+G
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 652 VVLFEVL 658
           ++L+E+ 
Sbjct: 254 ILLWEIF 260

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G GGFG V +    D G +VA+K+     S +    +  EI+++ +  H ++VS     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 527 DEKNEM------ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG--------- 571
           D   ++      +L  EY E G L+ +L            + E C G   G         
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-----------NQFENCCGLKEGPIRTLLSDI 130
Query: 572 ---LHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              L YLH      +IHRD+K  NI+L    +  + K+ D G +K   E+DQ  + T   
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 184
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVI 664
           G+  YL PE   +++ T   D +SFG + FE +   RP +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 41/220 (18%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G GGFG V +    D G +VA+K+     S +    +  EI+++ +  H ++VS     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 527 DEKNEM------ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG--------- 571
           D   ++      +L  EY E G L+ +L            + E C G   G         
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-----------NQFENCCGLKEGPIRTLLSDI 131
Query: 572 ---LHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              L YLH      +IHRD+K  NI+L    +  + K+ D G +K   E+DQ  + T   
Sbjct: 132 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 185
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVI 664
           G+  YL PE   +++ T   D +SFG + FE +   RP +
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 85/319 (26%), Positives = 134/319 (42%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 236
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 279
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 280 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 331
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 332 DPDVINTALPIEYGPLVEE 350

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 22/233 (9%)
Query: 442 SANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 501
           S  S SG   PF+  +           +G G +G+V++G    G  VAVK  + R ++  
Sbjct: 18  SCTSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSW 76
Query: 502 AEFQTEIEMLSQFRHRHLVSLIGY----CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS 557
              +TE+      RH +++  I           ++ LI  Y E G+L  +L  + L ++S
Sbjct: 77  FR-ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS 135
Query: 558 WKQRLEICIGSARGLHYLH-----TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 612
               L I +  A GL +LH     T    A+ HRD+KS NIL+ +N    +AD GL+   
Sbjct: 136 C---LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 192
Query: 613 PE-IDQTHVSTAVK-GSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEV 657
            +  +Q  V    + G+  Y+ PE        +      + D+++FG+VL+EV
Sbjct: 193 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 32/249 (12%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 544 LKGHLYGSGLPSLSW--------------KQRLEICIGSARGLHYLHTGYAKAVIHRDVK 589
           L   L     P L +              +  L      A+G+ +L +   K  IHRDV 
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS---KNCIHRDVA 193
Query: 590 SANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYS 649
           + N+LL    +AK+ DFGL++         V    +    ++ PE       T +SDV+S
Sbjct: 194 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 253
Query: 650 FGVVLFEVL 658
           +G++L+E+ 
Sbjct: 254 YGILLWEIF 262

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 28/244 (11%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 16  GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 68
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 69  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 544 LKGHLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL 594
           L   L            G P L  +  L      A+G+ +L +   K  IHRDV + N+L
Sbjct: 129 LLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 184
Query: 595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           L    +AK+ DFGL++         V    +    ++ PE       T +SDV+S+G++L
Sbjct: 185 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 244
Query: 655 FEVL 658
           +E+ 
Sbjct: 245 WEIF 248

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 85/323 (26%), Positives = 135/323 (41%), Gaps = 55/323 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+  H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLY-----GSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 267
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 268 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 319
Query: 747 DPDENSTNLIGELSPQIHNFSQV 769
           DPD  +T L  E  P +    +V
Sbjct: 320 DPDVINTALPIEYGPLVEEEEKV 342

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG   E N + +I E    G L+  L      SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 640
            +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE    ++
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 641 LTEKSDVYSFGVVLFEVL 658
            T  SDV+ FGV ++E+L
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 469 IGIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FGKVYK + N  T V  A K  + +S++ L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQ-NKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             +N + ++ E+   G +   +     P L+  Q   +C  +   L+YLH      +IHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDN---KIIHR 159
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF-----RRQQL 641
           D+K+ NIL   +   K+ADFG+S       Q        G+  ++ PE       + +  
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRR--DXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 642 TEKSDVYSFGVVLFEVLCARP 662
             K+DV+S G+ L E+    P
Sbjct: 218 DYKADVWSLGITLIEMAEIEP 238

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 45/314 (14%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
             +    IHRD+ + N LL       +AK+ DFG+++                   ++ P
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           E F     T K+D +SFGV+L+E+                  +   M + +K   + +  
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQEVLEF 298
Query: 694 PTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDEN 751
            T  G++ P  +          +C      DRP+   +L  +EY  Q        DPD  
Sbjct: 299 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ--------DPDVI 350
Query: 752 STNLIGELSPQIHN 765
           +T L  E  P +  
Sbjct: 351 NTALPIEYGPLVEE 364

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 28/244 (11%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 544 LKGHLYGS---------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANIL 594
           L   L            G P L  +  L      A+G+ +L +   K  IHRDV + N+L
Sbjct: 137 LLNFLRRKAEADLDKEDGRP-LELRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 192
Query: 595 LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVL 654
           L    +AK+ DFGL++         V    +    ++ PE       T +SDV+S+G++L
Sbjct: 193 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 252
Query: 655 FEVL 658
           +E+ 
Sbjct: 253 WEIF 256

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 133/319 (41%), Gaps = 55/319 (17%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+  H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLY-----GSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 577 TGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---- 629
             +    IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 630 -YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
            ++ PE F     T K+D +SFGV+L+E+                  +   M + +K   
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQ 253
Query: 689 DQIIDPTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHG 746
           + +   T  G++ P  +          +C      DRP+   +L  +EY  Q        
Sbjct: 254 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ-------- 305
Query: 747 DPDENSTNLIGELSPQIHN 765
           DPD  +T L  E  P +  
Sbjct: 306 DPDVINTALPIEYGPLVEE 324

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 130/314 (41%), Gaps = 45/314 (14%)
Query: 469 IGIGGFGKVYKGEL----NDGT--KVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG+VY+G++    ND +  +VAVK      S+Q   +F  E  ++S+F H+++V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLH 576
            IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 577 TGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
             +    IHRD+ + N LL       +AK+ DFG+++                   ++ P
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           E F     T K+D +SFGV+L+E+                  +   M + +K   + +  
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEI-----------------FSLGYMPYPSKSNQEVLEF 275
Query: 694 PTLAGKIRP--DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDEN 751
            T  G++ P  +          +C      DRP+   +L  +EY  Q        DPD  
Sbjct: 276 VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ--------DPDVI 327
Query: 752 STNLIGELSPQIHN 765
           +T L  E  P +  
Sbjct: 328 NTALPIEYGPLVEE 341

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 110/230 (47%), Gaps = 44/230 (19%)
Query: 472 GGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM--LSQFRHRHLVSLIGYCDEK 529
           G FG V+K +L +   VAVK    + +Q    +Q E E+  L   +H +++  IG   EK
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQS---WQNEYEVYSLPGMKHENILQFIGA--EK 88
Query: 530 N------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT------ 577
                  ++ LI  + E G+L   L  +    +SW +   I    ARGL YLH       
Sbjct: 89  RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 578 -GYAKAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDP 633
            G+  A+ HRD+KS N+LL  N  A +ADFGL+   + G     TH      G+  Y+ P
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV---GTRRYMAP 202
Query: 634 EY------FRRQQLTEKSDVYSFGVVLFEVLCAR------PVIDPTLPRE 671
           E       F+R     + D+Y+ G+VL+E L +R      PV +  LP E
Sbjct: 203 EVLEGAINFQRDAFL-RIDMYAMGLVLWE-LASRCTAADGPVDEYMLPFE 250

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           N F +  V+G GGFG+V   ++    K+     +++   + ++G A    E ++L +   
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 572
           R +VSL    + K+ + L+   M  G LK H+Y  G       + +    EIC G    L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----L 299
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
             LH    + +++RD+K  NILLD++   +++D GL+   PE           G+ GY+ 
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMA 353
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE  + ++ T   D ++ G +L+E++
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 464 DESWVI----GIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           +E W I    G G FGKVYK +  + G   A K    +S++ L ++  EIE+L+   H +
Sbjct: 10  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V L+G      ++ ++ E+   G +   +       L+  Q   +C      L++LH+ 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHS- 127
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             K +IHRD+K+ N+L+      ++ADFG+S    +  Q   S    G+  ++ PE    
Sbjct: 128 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMC 183
Query: 639 QQLTE-----KSDVYSFGVVLFEVLCARP 662
           + + +     K+D++S G+ L E+    P
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           N F +  V+G GGFG+V   ++    K+     +++   + ++G A    E ++L +   
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARGL 572
           R +VSL    + K+ + L+   M  G LK H+Y  G       + +    EIC G    L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG----L 299
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
             LH    + +++RD+K  NILLD++   +++D GL+   PE           G+ GY+ 
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMA 353
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE  + ++ T   D ++ G +L+E++
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 109/247 (44%), Gaps = 30/247 (12%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 24  GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 77  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 544 LKGHL------------YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           L   L            +     + S +  L      A+G+ +L +   K  IHRDV + 
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAAR 193
Query: 592 NILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 651
           N+LL    +AK+ DFGL++         V    +    ++ PE       T +SDV+S+G
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253
Query: 652 VVLFEVL 658
           ++L+E+ 
Sbjct: 254 ILLWEIF 260

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 464 DESWVI----GIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           +E W I    G G FGKVYK +  + G   A K    +S++ L ++  EIE+L+   H +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V L+G      ++ ++ E+   G +   +       L+  Q   +C      L++LH+ 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFLHS- 135
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             K +IHRD+K+ N+L+      ++ADFG+S    +  Q   S    G+  ++ PE    
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI--GTPYWMAPEVVMC 191
Query: 639 QQLTE-----KSDVYSFGVVLFEVLCARP 662
           + + +     K+D++S G+ L E+    P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 129
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 184
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 105 IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 157
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 212
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 213 NFRRFTSASDVWMFGVCMWEIL 234

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 129
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 184
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 134
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 189
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 79  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 131
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 186
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 187 NFRRFTSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 126
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 181
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 182 NFRRFTSASDVWMFGVCMWEIL 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 103/243 (42%), Gaps = 16/243 (6%)
Query: 424 NGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDE-SWVIGIGGFGKVYKG-- 480
            G  SHT+    +       +    Y  P     E      E    IG G FG V++G  
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIY 411
Query: 481 --ELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 537
               N    VA+K   N  S     +F  E   + QF H H+V LIG   E N + +I E
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470
Query: 538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 597
               G L+  L      SL     +      +  L YL +   K  +HRD+ + N+L+  
Sbjct: 471 LCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSS 526
Query: 598 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLF 655
           N   K+ DFGLS+    ++ +    A KG     ++ PE    ++ T  SDV+ FGV ++
Sbjct: 527 NDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 656 EVL 658
           E+L
Sbjct: 584 EIL 586

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           IG   E N + +I E    G L+  L    Y   L SL     +      +  L YL + 
Sbjct: 80  IGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLES- 132
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYF 636
             K  +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE  
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESI 187
Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
             ++ T  SDV+ FGV ++E+L
Sbjct: 188 NFRRFTSASDVWMFGVCMWEIL 209

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    E + G +VAVK+ + R QQ       E+ ++  + H ++V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   R L YLH    + VIHRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRD 166
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYWMAPEVISRLPYGTEVD 223
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 224 IWSLGIMVIEMIDGEP 239

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 42/237 (17%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FGKV K            T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGL-----------------PSLSWK 559
           L G C +   ++LI EY + G+L+G L      G G                   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 619
             +      ++G+ YL      +++HRD+ + NIL+ E    K++DFGLS+   E D   
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED--- 204
Query: 620 VSTAVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
             + VK S G +  ++   + L     T +SDV+SFGV+L+E++       P +P E
Sbjct: 205 --SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 144 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 144 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+          +FQ EI++L       +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 524 G--YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G  Y   + E+ L+ EY+ +G L+  L       L   + L       +G+ YL +   +
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS---R 130
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGP-EIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +HRD+ + NIL++     K+ADFGL+K  P + D   V    +    +  PE      
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 641 LTEKSDVYSFGVVLFEVL 658
            + +SDV+SFGVVL+E+ 
Sbjct: 191 FSRQSDVWSFGVVLYELF 208

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 144 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 31/260 (11%)
Query: 487 KVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT-- 543
           KVA+KR N  + Q  + E   EI+ +SQ  H ++VS       K+E+ L+ + +  G+  
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 544 -LKGHLYGSGLPS---LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 599
            +  H+   G      L       I      GL YLH       IHRDVK+ NILL E+ 
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG 158
Query: 600 MAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLF 655
             ++ADFG+S    TG +I +  V     G+  ++ PE   + +  + K+D++SFG+   
Sbjct: 159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218
Query: 656 EVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR-PDSLRKFGETAEK 714
           E+           P +++ L       QN         P+L   ++  + L+K+G++  K
Sbjct: 219 ELATGAAPYHKYPPMKVLMLT-----LQND-------PPSLETGVQDKEMLKKYGKSFRK 266
Query: 715 ----CLADFGVDRPSMGDVL 730
               CL      RP+  ++L
Sbjct: 267 MISLCLQKDPEKRPTAAELL 286

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 146 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 142 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 13/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ---QGLA-EFQTEIEMLSQFRH 516
           ++F+    +G G FG VY         +   +   +SQ   +G+  + + EIE+ +   H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            +++ L  Y  ++  + LI EY   G L   L  S   +   ++   I    A  L Y H
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADALMYCH 140
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
               K VIHRD+K  N+LL      K+ADFG S   P + +  +     G+  YL PE  
Sbjct: 141 ---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYLPPEMI 193
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   EK D++  GV+ +E+L   P
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 469 IGIGGFGKVY--KGELND---GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG+V+  +   N      KV  K    R +Q +     E  MLS   H  ++ + 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFIIRMW 72
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWK-QRLEICIGSARGLHYLHTGYAK 581
           G   +  ++ +I +Y+E G L   L  S   P+   K    E+C+     L YLH   +K
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEYLH---SK 125
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +I+RD+K  NILLD+N   K+ DFG +K  P+     V+  + G+  Y+ PE    +  
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVVSTKPY 180
Query: 642 TEKSDVYSFGVVLFEVLCA 660
            +  D +SFG++++E+L  
Sbjct: 181 NKSIDWWSFGILIYEMLAG 199

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 94
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 95  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 152 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 144 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 459 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLA-EFQTEIEMLSQ-- 513
           AT+ ++    IG+G +G VYK  + + G  VA+K    P  ++GL      E+ +L +  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 514 -FRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG 567
            F H ++V L+  C     D + ++ L++E+++   L+ +L  +  P L  +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKG 626
             RGL +LH   A  ++HRD+K  NIL+      K+ADFGL++    I    ++ A V  
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQMALAPVVV 173
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
           +  Y  PE   +       D++S G +  E+   +P+
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 149 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 93  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 149
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 150 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 84  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 140
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 141 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 85  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 142 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 119/260 (45%), Gaps = 31/260 (11%)
Query: 487 KVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT-- 543
           KVA+KR N  + Q  + E   EI+ +SQ  H ++VS       K+E+ L+ + +  G+  
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 544 -LKGHLYGSGLPS---LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF 599
            +  H+   G      L       I      GL YLH       IHRDVK+ NILL E+ 
Sbjct: 97  DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDG 153
Query: 600 MAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE-KSDVYSFGVVLF 655
             ++ADFG+S    TG +I +  V     G+  ++ PE   + +  + K+D++SFG+   
Sbjct: 154 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 213
Query: 656 EVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR-PDSLRKFGETAEK 714
           E+           P +++ L       QN         P+L   ++  + L+K+G++  K
Sbjct: 214 ELATGAAPYHKYPPMKVLMLT-----LQND-------PPSLETGVQDKEMLKKYGKSFRK 261
Query: 715 ----CLADFGVDRPSMGDVL 730
               CL      RP+  ++L
Sbjct: 262 MISLCLQKDPEKRPTAAELL 281

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FGKV K            T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGL-----------------PSLSWK 559
           L G C +   ++LI EY + G+L+G L      G G                   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 619
             +      ++G+ YL       ++HRD+ + NIL+ E    K++DFGLS+   E D   
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED--- 204
Query: 620 VSTAVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
             + VK S G +  ++   + L     T +SDV+SFGV+L+E++       P +P E
Sbjct: 205 --SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G +G+V+ G+   G KVAVK      +      +TEI      RH +++  I   D 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFIA-ADI 101
Query: 529 K-----NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY---- 579
           K      ++ LI +Y ENG+L  +L  + L +   K  L++   S  GL +LHT      
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTTLDA---KSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 580 -AKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF 636
              A+ HRD+KS NIL+ +N    +AD GL+ K   + ++  +    + G+  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 637 RRQ------QLTEKSDVYSFGVVLFEV 657
                    Q    +D+YSFG++L+EV
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 469 IGIGGFGKVYKG-------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +G       +++   KV +K+G  ++     E   E +++ Q  + ++V 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADT--EEMMREAQIMHQLDNPYIVR 74
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLHYLHTGYA 580
           LIG C +   ++L+ E    G L   L G         +R EI + + A  LH +  G  
Sbjct: 75  LIGVC-QAEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMK 124
Query: 581 ----KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K  +HRD+ + N+LL     AK++DFGLSK  G +       +A K    +  PE 
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 184
Query: 636 FRRQQLTEKSDVYSFGVVLFEVL 658
              ++ + +SDV+S+GV ++E L
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEAL 207

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 11/212 (5%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
            V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGY 630
           L +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  ST V G+  +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYW 182
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R+    K D++S G++  E++   P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 86
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 87  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 144 ---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 107 ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 164 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 638 RQQLTEKS-DVYSFGVVLFEVLCARPV 663
             +   KS D++S G +L E+L  RP+
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 526
           +G GGF  V   E L+DG   A+KR     QQ   E Q E +M   F H +++ L+ YC 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 527 ---DEKNEMILIYEYMENGTL---------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
                K+E  L+  + + GTL         KG+        L+  Q L + +G  RGL  
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-------LTEDQILWLLLGICRGLEA 149
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVS------TAVKGS 627
           +H   AK   HRD+K  NILL +     + D G +++    ++ +  +       A + +
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 628 FGYLDPEYFRRQQ---LTEKSDVYSFGVVLFEVL 658
             Y  PE F  Q    + E++DV+S G VL+ ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 468 VIGIGGFGKVYKG----ELNDGTKVAVKRG-NPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K   N  S     +F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG   E N + +I E    G L+  L      SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 640
            +HRD+ + N+L+      K+ DFGLS+    ++ +    A KG     ++ PE    ++
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 641 LTEKSDVYSFGVVLFEVL 658
            T  SDV+ FGV ++E+L
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L  FRH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 146 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FGKV K            T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGL-----------------PSLSWK 559
           L G C +   ++LI EY + G+L+G L      G G                   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH 619
             +      ++G+ YL       ++HRD+ + NIL+ E    K++DFGLS+   E D   
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED--- 204
Query: 620 VSTAVKGSFGYLDPEYFRRQQL-----TEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
             + VK S G +  ++   + L     T +SDV+SFGV+L+E++       P +P E
Sbjct: 205 --SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 459 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLA-EFQTEIEMLSQ-- 513
           AT+ ++    IG+G +G VYK  + + G  VA+K    P  ++GL      E+ +L +  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 514 -FRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG 567
            F H ++V L+  C     D + ++ L++E+++   L+ +L  +  P L  +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
             RGL +LH   A  ++HRD+K  NIL+      K+ADFGL++             V  +
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             Y  PE   +       D++S G +  E+   +P+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+++ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG---NPRSQQGLAEFQTEIEMLSQFRHR 517
           NF     IG G F +VY+   L DG  VA+K+    +    +  A+   EI++L Q  H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLK---GHLYGSG--LPSLS-WKQRLEICIGSARG 571
           +++       E NE+ ++ E  + G L     H       +P  + WK  +++C      
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L ++H+   + V+HRD+K AN+ +    + K+ D GL +      +T  + ++ G+  Y+
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYM 203
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEV 657
            PE         KSD++S G +L+E+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY-- 525
            +G G +G+V++G L  G  VAVK  + R +Q     +TEI      RH +++  I    
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVLLRHDNILGFIASDM 72
Query: 526 --CDEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLH-----T 577
              +   ++ LI  Y E+G+L   L    L P L+    L + + +A GL +LH     T
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFGT 128
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVK-GSFGYLDPEY 635
               A+ HRD KS N+L+  N    +AD GL+    +  D   +    + G+  Y+ PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 636 FRRQQLTEK------SDVYSFGVVLFEV 657
              Q  T+       +D+++FG+VL+E+
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 18/216 (8%)
Query: 459 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLA-EFQTEIEMLSQ-- 513
           AT+ ++    IG+G +G VYK  + + G  VA+K    P  ++GL      E+ +L +  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 514 -FRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIG 567
            F H ++V L+  C     D + ++ L++E+++   L+ +L  +  P L  +   ++   
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
             RGL +LH   A  ++HRD+K  NIL+      K+ADFGL++             V  +
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             Y  PE   +       D++S G +  E+   +P+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 468 VIGIGGFGKVYKGELN--DGT--KVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V + +L   DG+  KVAVK  + +  +   + EF  E   + +F H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 522 LIGYC---DEKNEM---ILIYEYMENGTLKGHLYGSGLP----SLSWKQRLEICIGSARG 571
           L+G       K  +   ++I  +M++G L   L  S +     +L  +  +   +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL +   +  IHRD+ + N +L E+    VADFGLS+     D      A K    +L
Sbjct: 150 MEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             E       T  SDV++FGV ++E++
Sbjct: 207 ALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L  FRH +++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 89  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  PE   
Sbjct: 146 ---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 638 RQQLTEKS-DVYSFGVVLFEVLCARPV 663
             +   KS D++S G +L E+L  RP+
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 13/200 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G F +V   E     K VA+K    ++ +G     + EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +    + LI + +  G L   +   G  +     RL   +  A  + YLH      ++H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---LGIVH 139
Query: 586 RDVKSANIL---LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           RD+K  N+L   LDE+    ++DFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           +  D +S GV+ + +LC  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 39/256 (15%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYK------GELNDG 485
           G+ Y+    T    N  + FP        NN      +G G FGKV +      G+ +  
Sbjct: 9   GNSYTFIDPTQLPYNEKWEFP-------RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAV 61
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
            KVAVK     +     E   +E++++S   +H ++V+L+G C     +++I EY   G 
Sbjct: 62  LKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 544 LKGHL-------YGSGLPS--------------LSWKQRLEICIGSARGLHYLHTGYAKA 582
           L   L        G  L                L  +  L      A+G+ +L +   K 
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLAS---KN 178
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
            IHRDV + N+LL    +AK+ DFGL++         V    +    ++ PE       T
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 238
Query: 643 EKSDVYSFGVVLFEVL 658
            +SDV+S+G++L+E+ 
Sbjct: 239 VQSDVWSYGILLWEIF 254

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 102/243 (41%), Gaps = 16/243 (6%)
Query: 424 NGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDE-SWVIGIGGFGKVYKG-- 480
            G  SHT+    +       +    Y  P     E      E    IG G FG V++G  
Sbjct: 352 QGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIY 411
Query: 481 --ELNDGTKVAVKR-GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE 537
               N    VA+K   N  S     +F  E   + QF H H+V LIG   E N + +I E
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIME 470
Query: 538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE 597
               G L+  L      SL     +      +  L YL +   K  +HRD+ + N+L+  
Sbjct: 471 LCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSA 526
Query: 598 NFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLF 655
               K+ DFGLS+    ++ +    A KG     ++ PE    ++ T  SDV+ FGV ++
Sbjct: 527 TDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 656 EVL 658
           E+L
Sbjct: 584 EIL 586

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 455 AVQEATNNF---DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEM 510
           A Q A N+F    ++ ++G G FG+V+K E    G K+A K    R  +   E + EI +
Sbjct: 80  AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISV 139
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIG 567
           ++Q  H +L+ L    + KN+++L+ EY++ G L   +             L   +IC  
Sbjct: 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC-- 197
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              G+ ++H  Y   ++H D+K  NIL    +    K+ DFGL++     ++  V+    
Sbjct: 198 --EGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--- 249
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           G+  +L PE      ++  +D++S GV+ + +L
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 26/264 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   +V A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            + +++ +I EY+  G+    L             L+  +   +GL YLH+   +  IHR
Sbjct: 91  LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIHR 144
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E    K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 202
Query: 647 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 706
           ++S G+   E+    P      P  ++ L            + +   PTL G    D  +
Sbjct: 203 IWSLGITAIELAKGEPPNSDMHPMRVLFL------------IPKNNPPTLVG----DFTK 246
Query: 707 KFGETAEKCLADFGVDRPSMGDVL 730
            F E  + CL      RP+  ++L
Sbjct: 247 SFKEFIDACLNKDPSFRPTAKELL 270

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 91  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T        +  Y  PE   
Sbjct: 148 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 469 IGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V     N +  +VA+K+ +P   Q   +    EI++L +FRH +++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 527 DEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTG 578
              N++I     E M++  +   L  + L  L   Q L    IC       RGL Y+H+ 
Sbjct: 92  ---NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K +N+LL+     K+ DFGL++   P+ D T        +  Y  PE   
Sbjct: 149 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 638 RQQ-LTEKSDVYSFGVVLFEVLCARPV 663
             +  T+  D++S G +L E+L  RP+
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 49/253 (19%)
Query: 469 IGIGGFGKVYKG-------ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +G       +++   KV +K+G  ++     E   E +++ Q  + ++V 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADT--EEMMREAQIMHQLDNPYIVR 400
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLHYLHTGYA 580
           LIG C +   ++L+ E    G L   L G         +R EI + + A  LH +  G  
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMK 450
Query: 581 ----KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K  +HR++ + N+LL     AK++DFGLSK  G +       +A K    +  PE 
Sbjct: 451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLC---------------------ARPVIDPTLPREMVN 674
              ++ + +SDV+S+GV ++E L                       R    P  P E+  
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570
Query: 675 LAE--WAMKWQNK 685
           L    W  KW+++
Sbjct: 571 LMSDCWIYKWEDR 583

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G V    +    T+VA+K+ +P   Q   +    EI++L +FRH    ++IG  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHE---NVIGIR 107
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI---GSARGLHYLHTGYA 580
           D      L  E M +  +   L  + L  L   Q+L    IC       RGL Y+H+   
Sbjct: 108 DILRASTL--EAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
             V+HRD+K +N+L++     K+ DFGL++   PE D T   T    +  Y  PE     
Sbjct: 164 -NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 640 QLTEKS-DVYSFGVVLFEVLCARPV 663
           +   KS D++S G +L E+L  RP+
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 145
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 202
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 203 IWSLGIMVIEMVDGEP 218

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 141
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 198
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 199 IWSLGIMVIEMVDGEP 214

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 152
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 209
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 210 IWSLGIMVIEMVDGEP 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 27/214 (12%)
Query: 462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           +F E  +IG GGFG+V+K +   DG    +KR    +++     + E++ L++  H ++V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 521 SLIGYCD---------------EKNEMILI-YEYMENGTLKGHLYGSGLPSLSWKQRLEI 564
              G  D                K + + I  E+ + GTL+  +       L     LE+
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                +G+ Y+H   +K +I+RD+K +NI L +    K+ DFGL  T  + D     +  
Sbjct: 128 FEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV-TSLKNDGKRXRS-- 181
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           KG+  Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 150
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 207
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 208 IWSLGIMVIEMVDGEP 223

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 118/245 (48%), Gaps = 28/245 (11%)
Query: 436 SHGTTTS------ANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVA 489
           S GTT          S SG   P +  +           IG G FG+V++G+   G +VA
Sbjct: 11  SEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVA 69
Query: 490 VKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLK 545
           VK  + R ++     + EI      RH +++  I   ++ N    ++ L+ +Y E+G+L 
Sbjct: 70  VKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 128
Query: 546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TGYAKAVIHRDVKSANILLDENFM 600
            +L      +++ +  +++ + +A GL +LH     T    A+ HRD+KS NIL+ +N  
Sbjct: 129 DYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185
Query: 601 AKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF------RRQQLTEKSDVYSFGV 652
             +AD GL+ +     D   ++   + G+  Y+ PE        +  +  +++D+Y+ G+
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245
Query: 653 VLFEV 657
           V +E+
Sbjct: 246 VFWEI 250

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G F +V   E     K VA+K     + +G     + EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +    + LI + +  G L   +   G  +     RL   +  A  + YLH      ++H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---LGIVH 139
Query: 586 RDVKSANIL---LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           RD+K  N+L   LDE+    ++DFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           +  D +S GV+ + +LC  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGL-AEFQTEIEMLSQF 514
           ++  + +D   V+G G F +V   E     K VA+K     + +G     + EI +L + 
Sbjct: 14  EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKI 73
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           +H ++V+L    +    + LI + +  G L   +   G  +     RL   +  A  + Y
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKY 131
Query: 575 LHTGYAKAVIHRDVKSANIL---LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           LH      ++HRD+K  N+L   LDE+    ++DFGLSK     D   V +   G+ GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYV 185
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE   ++  ++  D +S GV+ + +LC  P
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 468 VIGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G F +V   E     K VA+K     + +G     + EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +    + LI + +  G L   +   G  +     RL   +  A  + YLH      ++H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLHD---LGIVH 139
Query: 586 RDVKSANIL---LDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           RD+K  N+L   LDE+    ++DFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           +  D +S GV+ + +LC  P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+          +FQ EI++L       +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 524 G--YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G  Y   +  + L+ EY+ +G L+  L       L   + L       +G+ YL +   +
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS---R 133
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGP-EIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +HRD+ + NIL++     K+ADFGL+K  P + D   V    +    +  PE      
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 641 LTEKSDVYSFGVVLFEVL 658
            + +SDV+SFGVVL+E+ 
Sbjct: 194 FSRQSDVWSFGVVLYELF 211

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 123/256 (48%), Gaps = 34/256 (13%)
Query: 455 AVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ 513
           A+++    F+   ++G G +G+VYKG  +  G   A+K  +    +   E + EI ML +
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKK 76
Query: 514 F-RHRHLVSLIGYCDEKN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           +  HR++ +  G   +KN      ++ L+ E+   G++   +  +   +L  +    IC 
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 136
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAV 624
              RGL +LH      VIHRD+K  N+LL EN   K+ DFG+S    ++D+T    +T +
Sbjct: 137 EILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI 190
Query: 625 KGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVL-CARPVID----------PTL 668
            G+  ++ PE     +  +     KSD++S G+   E+   A P+ D          P  
Sbjct: 191 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249
Query: 669 PREMVNLAEWAMKWQN 684
           P   +   +W+ K+Q+
Sbjct: 250 PAPRLKSKKWSKKFQS 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 469 IGIGGFGK-VYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G FGK +      DG +  +K  N    S +   E + E+ +L+  +H ++V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 526 CDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
            +E   + ++ +Y E G L       KG L+      L W   ++IC+     L ++H  
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-QILDW--FVQICLA----LKHVHD- 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT-HVSTAVKGSFGYLDPEYFR 637
             + ++HRD+KS NI L ++   ++ DFG+++    ++ T  ++ A  G+  YL PE   
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEICE 198
Query: 638 RQQLTEKSDVYSFGVVLFEVLC 659
            +    KSD+++ G VL+E LC
Sbjct: 199 NKPYNNKSDIWALGCVLYE-LC 219

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
            V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGY 630
           L +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  S  V G+  +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMV-GTPYW 182
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R+    K D++S G++  E++   P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
            V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGY 630
           L +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  S  V G+  +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSEMV-GTPYW 182
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R+    K D++S G++  E++   P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 114/230 (49%), Gaps = 22/230 (9%)
Query: 445 SNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEF 504
           S SG   P +  +           IG G FG+V++G+   G +VAVK  + R ++     
Sbjct: 13  SGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR- 70
Query: 505 QTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           + EI      RH +++  I   ++ N    ++ L+ +Y E+G+L  +L      +++ + 
Sbjct: 71  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEG 127
Query: 561 RLEICIGSARGLHYLH-----TGYAKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPE 614
            +++ + +A GL +LH     T    A+ HRD+KS NIL+ +N    +AD GL+ +    
Sbjct: 128 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 187
Query: 615 IDQTHVSTAVK-GSFGYLDPEYF------RRQQLTEKSDVYSFGVVLFEV 657
            D   ++   + G+  Y+ PE        +  +  +++D+Y+ G+V +E+
Sbjct: 188 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 11/212 (5%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
            V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 129
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGY 630
           L +LH+     VIHR++KS NILL  +   K+ DFG  ++  PE  Q+  ST V G+  +
Sbjct: 130 LEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYW 183
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R+    K D++S G++  E++   P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 122
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 177
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 40/227 (17%)
Query: 462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           +F E  +IG GGFG+V+K +   DG    ++R    +++     + E++ L++  H ++V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIV 68
Query: 521 SLIGYCD----------------------------EKNEMILI-YEYMENGTLKGHLYGS 551
              G  D                             K + + I  E+ + GTL+  +   
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 552 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
               L     LE+     +G+ Y+H   +K +IHRD+K +NI L +    K+ DFGL  +
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              +      T  KG+  Y+ PE    Q   ++ D+Y+ G++L E+L
Sbjct: 186 ---LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 468 VIGIGGFGKVYKG---ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVS 521
           V+G G FG V+KG      +  K+ V       + G   FQ     +  +    H H+V 
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           L+G C   + + L+ +Y+  G+L  H+    G+  P L     ++I    A+G++YL   
Sbjct: 98  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEE- 151
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
               ++HR++ + N+LL      +VADFG++   P  D+  + +  K    ++  E    
Sbjct: 152 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 639 QQLTEKSDVYSFGVVLFEVL 658
            + T +SDV+S+GV ++E++
Sbjct: 210 GKYTHQSDVWSYGVTVWELM 229

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 29/215 (13%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG--- 524
           +IG G +G VYKG L D   VAVK  +  ++Q     +  I  +    H ++   I    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDE 77
Query: 525 --YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG---- 578
               D + E +L+ EY  NG+L  +L    L +  W     +     RGL YLHT     
Sbjct: 78  RVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 579 --YAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEI----DQTHVSTAVKGSFGY 630
             Y  A+ HRD+ S N+L+  +    ++DFGLS   TG  +    ++ + + +  G+  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 631 LDPEYFR-------RQQLTEKSDVYSFGVVLFEVL 658
           + PE           +   ++ D+Y+ G++ +E+ 
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 125
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 126 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 180
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+          +FQ EI++L       +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 524 G--YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G  Y   +  + L+ EY+ +G L+  L       L   + L       +G+ YL +   +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGS---R 146
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGP-EIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +HRD+ + NIL++     K+ADFGL+K  P + D   V    +    +  PE      
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 641 LTEKSDVYSFGVVLFEVL 658
            + +SDV+SFGVVL+E+ 
Sbjct: 207 FSRQSDVWSFGVVLYELF 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 122
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPEVL 177
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 28/265 (10%)
Query: 469 IGIGGFGKVYKGELNDGTK--VAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G FG+VYKG +++ TK  VA+K  +   ++  + + Q EI +LSQ    ++    G 
Sbjct: 27  IGKGSFGEVYKG-IDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             +  ++ +I EY+  G+    L    L        L   +   +GL YLH+   +  IH
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS---ERKIH 139
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+K+AN+LL E    K+ADFG++  G   D         G+  ++ PE  ++     K+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           D++S G+   E+    P      P  ++ L            + +   PTL G+      
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLFL------------IPKNSPPTLEGQ----HS 241
Query: 706 RKFGETAEKCLADFGVDRPSMGDVL 730
           + F E  E CL      RP+  ++L
Sbjct: 242 KPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
            V+V +    +     IG G  G VY   ++  G +VA+++ N + Q        EI ++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            + ++ ++V+ +      +E+ ++ EY+  G+L   +  +    +   Q   +C    + 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 129
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGY 630
           L +LH+     VIHRD+KS NILL  +   K+ DFG  ++  PE  Q+  S  V G+  +
Sbjct: 130 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSXMV-GTPYW 183
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R+    K D++S G++  E++   P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 122
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPEVL 177
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 469 IGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V          N G  VAVK+          +FQ EI++L       +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 524 G--YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           G  Y   +  + L+ EY+ +G L+  L       L   + L       +G+ YL +   +
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGS---R 134
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGP-EIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             +HRD+ + NIL++     K+ADFGL+K  P + D   V    +    +  PE      
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 641 LTEKSDVYSFGVVLFEVL 658
            + +SDV+SFGVVL+E+ 
Sbjct: 195 FSRQSDVWSFGVVLYELF 212

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 122
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPEVL 177
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG VY GE  D  +     A+K  +  ++ Q +  F  E  ++    H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR-------LEICIGSARGLHYL 575
           IG       ++L  E + +  L    +G  L  +   QR       +   +  ARG+ YL
Sbjct: 88  IG-------IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID----QTHVSTAVKGSFGYL 631
                +  +HRD+ + N +LDE+F  KVADFGL++   + +    Q H    +   +  L
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             E  +  + T KSDV+SFGV+L+E+L
Sbjct: 198 --ESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 130
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  P
Sbjct: 131 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E  + +  +  SD + FGV L+E+ 
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMF 212

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 127
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 128 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPEVL 182
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-- 516
            ++F+E  V+G G FG+V K     D    A+K+    +++ L+   +E+ +L+   H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 517 -----------RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS---WKQRL 562
                      R+ V  +    +K+ + +  EY ENGTL   ++   L       W+   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP------EID 616
           +I       L Y+H+   + +IHRD+K  NI +DE+   K+ DFGL+K         ++D
Sbjct: 124 QIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 617 QTHVS------TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL 658
             ++       T+  G+  Y+  E         EK D+YS G++ FE++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 468 VIGIGGFGKVYKG---ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVS 521
           V+G G FG V+KG      +  K+ V       + G   FQ     +  +    H H+V 
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           L+G C   + + L+ +Y+  G+L  H+    G+  P L     ++I    A+G++YL   
Sbjct: 80  LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----AKGMYYLEE- 133
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
               ++HR++ + N+LL      +VADFG++   P  D+  + +  K    ++  E    
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 639 QQLTEKSDVYSFGVVLFEVL 658
            + T +SDV+S+GV ++E++
Sbjct: 192 GKYTHQSDVWSYGVTVWELM 211

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 272
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 329
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 330 IWSLGIMVIEMVDGEP 345

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 122/260 (46%), Gaps = 49/260 (18%)
Query: 472 GGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ--FRHRHLVSLIGYCDE 528
           G FG V+K +L ND   VAVK    + +Q    +Q+E E+ S    +H +L+  I    E
Sbjct: 26  GRFGCVWKAQLMNDF--VAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIAA--E 78
Query: 529 KN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT----- 577
           K       E+ LI  + + G+L  +L G+    ++W +   +    +RGL YLH      
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 578 ---GYAKAVIHRDVKSANILLDENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYL 631
              G+  ++ HRD KS N+LL  +  A +ADFGL+   + G     TH      G+  Y+
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYM 192
Query: 632 DPEY------FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 685
            PE       F+R     + D+Y+ G+VL+E++      D  +   M+   E        
Sbjct: 193 APEVLEGAINFQRDAFL-RIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEE------EI 245
Query: 686 GQ---LDQIIDPTLAGKIRP 702
           GQ   L+++ +  +  K+RP
Sbjct: 246 GQHPSLEELQEVVVHKKMRP 265

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + +    +     I SA  L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA--LEYLH 122
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPEVL 177
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY-- 525
            +G G +G+V++G    G  VAVK  + R ++     +TE+      RH +++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 526 --CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TG 578
                  ++ LI  Y E G+L  +L  + L ++S    L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGLAHLHIEIFGTQ 129
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVK-GSFGYLDPEYF 636
              A+ HRD+KS NIL+ +N    +AD GL+    +  +Q  V    + G+  Y+ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 637 RRQQLTE------KSDVYSFGVVLFEV 657
                 +      + D+++FG+VL+EV
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 469 IGIGGFGKVYKGEL-NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G  G V    + + G  VAVK+ + R QQ       E+ ++  ++H ++V +     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
             +E+ ++ E++E G L   +  +    ++ +Q   +C+   + L  LH   A+ VIHRD
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 195
Query: 588 VKSANILLDENFMAKVADFGL-SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           +KS +ILL  +   K++DFG  ++   E+ +      + G+  ++ PE   R     + D
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISRLPYGPEVD 252
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+++ E++   P
Sbjct: 253 IWSLGIMVIEMVDGEP 268

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 16/217 (7%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTE 507
           P + ++    +F+   ++G G FGKV+  E     +     A+K+        +     E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 508 IEMLS-QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEI 564
             +LS  + H  L  +      K  +  + EY+  G L  H+       LS       EI
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            +G    L +LH+   K +++RD+K  NILLD++   K+ADFG+ K     D    +   
Sbjct: 129 ILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEF 179
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            G+  Y+ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 22/207 (10%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY-- 525
            +G G +G+V++G    G  VAVK  + R ++     +TE+      RH +++  I    
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFIASDM 72
Query: 526 --CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TG 578
                  ++ LI  Y E G+L  +L  + L ++S    L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC---LRIVLSIASGLAHLHIEIFGTQ 129
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVK-GSFGYLDPEYF 636
              A+ HRD+KS NIL+ +N    +AD GL+    +  +Q  V    + G+  Y+ PE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 637 RRQQLTE------KSDVYSFGVVLFEV 657
                 +      + D+++FG+VL+EV
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 461 NNFDESWVIGIGGFGKVYK----GELNDGTKVAVKRGNPRSQQGLAEFQTEIE--MLSQF 514
           ++F+   V+G G FGKV+        + G   A+K     + +     +T++E  +L+  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLH 573
            H  +V L      + ++ LI +++  G L   L    + +   ++ ++  +   A GL 
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALGLD 144
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           +LH+     +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+  Y+ P
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEA--IDHEKKAYSFCGTVEYMAP 199
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCA 660
           E   RQ  +  +D +S+GV++FE+L  
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   KV A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +  ++ +I EY+  G+    L       L   Q   I     +GL YLH+   +  IHR
Sbjct: 95  LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHR 148
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 206
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+   E+    P
Sbjct: 207 IWSLGITAIELARGEP 222

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   KV A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +  ++ +I EY+  G+    L       L   Q   I     +GL YLH+   +  IHR
Sbjct: 90  LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHR 143
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 201
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+   E+    P
Sbjct: 202 IWSLGITAIELARGEP 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 459 ATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR---GNPRSQQGLAEFQTEIEM---- 510
           AT+ ++    IG+G +G VYK  + + G  VA+K     N     G     T  E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 511 -LSQFRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI 564
            L  F H ++V L+  C     D + ++ L++E+++   L+ +L  +  P L  +   ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                RGL +LH   A  ++HRD+K  NIL+      K+ADFGL++           T V
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPV 179
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             +  Y  PE   +       D++S G +  E+   +P+
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 126
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  P
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  + +  +  SD + FGV L+E+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 22/249 (8%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIE--MLSQF 514
           + F+   V+G G FGKV+  +   G+      A+K     + +     +T++E  +L + 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLH 573
            H  +V L      + ++ LI +++  G L   L    + +   ++ ++  +   A  L 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALD 140
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           +LH+     +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+  Y+ P
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAP 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE-WAMKWQNKGQLDQII 692
           E   R+  T+ +D +SFGV++FE+L        TLP +  +  E   M  + K  + Q +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG------TLPFQGKDRKETMTMILKAKLGMPQFL 249
Query: 693 DPTLAGKIR 701
            P     +R
Sbjct: 250 SPEAQSLLR 258

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   KV A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +  ++ +I EY+  G+    L       L   Q   I     +GL YLH+   +  IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHR 128
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+   E+    P
Sbjct: 187 IWSLGITAIELARGEP 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 126
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  P
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  + +  +  SD + FGV L+E+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 27/205 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 136
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  P
Sbjct: 137 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E  + +  +  SD + FGV L+E+ 
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMF 218

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 28/269 (10%)
Query: 469 IGIGGFGKVY-KGELNDGTKVAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           +G G FG V+   E + G +  +K  N  RSQ  + + + EIE+L    H +++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
           ++ + M ++ E  E G L   +  +     +LS     E+       L Y H+ +   V+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 585 HRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
           H+D+K  NIL  +   +   K+ DFGL++          ST   G+  Y+ PE F+R  +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKR-DV 202
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 701
           T K D++S GVV++ +L         LP    +L E   K   K       +P  A + R
Sbjct: 203 TFKCDIWSAGVVMYFLLTG------CLPFTGTSLEEVQQKATYK-------EPNYAVECR 249
Query: 702 PDSLRKFGETAEKCLADFGVDRPSMGDVL 730
           P + +   +  ++ L      RPS   VL
Sbjct: 250 PLTPQAV-DLLKQMLTKDPERRPSAAQVL 277

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 130
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  P
Sbjct: 131 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  + +  +  SD + FGV L+E+
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 10/196 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG+V+KG  N   KV A+K  +   ++  + + Q EI +LSQ    ++    G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +  ++ +I EY+  G+    L       L   Q   I     +GL YLH+   +  IHR
Sbjct: 75  LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHR 128
Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE  ++     K+D
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKAD 186
Query: 647 VYSFGVVLFEVLCARP 662
           ++S G+   E+    P
Sbjct: 187 IWSLGITAIELARGEP 202

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 140
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D     T   G+  Y+ PE   ++  
Sbjct: 141 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 198
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 252
Query: 701 R 701
           +
Sbjct: 253 Q 253

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 463 FDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLSQF 514
           F+   V+G GG+GKV++     G         KV  K    R+ +  A  + E  +L + 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGL----PSLSWKQRLEICIGSAR 570
           +H  +V LI       ++ LI EY+  G L   L   G+     +  +   + + +G   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG--- 135
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
              +LH    K +I+RD+K  NI+L+     K+ DFGL K    I    V+    G+  Y
Sbjct: 136 ---HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEY 187
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R       D +S G +++++L   P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 136
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D     T   G+  Y+ PE   ++  
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 194
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 248
Query: 701 R 701
           +
Sbjct: 249 Q 249

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 108/206 (52%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I   ++
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 69
Query: 529 KN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TGY 579
            N    ++ L+ +Y E+G+L  +L      +++ +  +++ + +A GL +LH     T  
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF- 636
             A+ HRD+KS NIL+ +N    +AD GL+ +     D   ++   + G+  Y+ PE   
Sbjct: 127 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 186
Query: 637 -----RRQQLTEKSDVYSFGVVLFEV 657
                +  +  +++D+Y+ G+V +E+
Sbjct: 187 DSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 136
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D     T   G+  Y+ PE   ++  
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKTLC-GTPNYIAPEVLSKKGH 194
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 248
Query: 701 R 701
           +
Sbjct: 249 Q 249

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 463 FDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLSQF 514
           F+   V+G GG+GKV++     G         KV  K    R+ +  A  + E  +L + 
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGL----PSLSWKQRLEICIGSAR 570
           +H  +V LI       ++ LI EY+  G L   L   G+     +  +   + + +G   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG--- 135
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
              +LH    K +I+RD+K  NI+L+     K+ DFGL K    I    V+    G+  Y
Sbjct: 136 ---HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHXFCGTIEY 187
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   R       D +S G +++++L   P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 465 ESW-----VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           E W     V+G GGFG+V+  ++    K+     + +   + ++G      E ++L++  
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLH 573
            R +VSL    + K ++ L+   M  G ++ H+Y      P     + +        GL 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLD 632
           +LH    + +I+RD+K  N+LLD++   +++D GL+    E+      T    G+ G++ 
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMA 357
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           PE    ++     D ++ GV L+E++ AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 465 ESW-----VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           E W     V+G GGFG+V+  ++    K+     + +   + ++G      E ++L++  
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLH 573
            R +VSL    + K ++ L+   M  G ++ H+Y      P     + +        GL 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLD 632
           +LH    + +I+RD+K  N+LLD++   +++D GL+    E+      T    G+ G++ 
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMA 357
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           PE    ++     D ++ GV L+E++ AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 108/206 (52%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I   ++
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68
Query: 529 KN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TGY 579
            N    ++ L+ +Y E+G+L  +L      +++ +  +++ + +A GL +LH     T  
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF- 636
             A+ HRD+KS NIL+ +N    +AD GL+ +     D   ++   + G+  Y+ PE   
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 637 -----RRQQLTEKSDVYSFGVVLFEV 657
                +  +  +++D+Y+ G+V +E+
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 22/249 (8%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIE--MLSQF 514
           + F+   V+G G FGKV+  +   G+      A+K     + +     +T++E  +L + 
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLH 573
            H  +V L      + ++ LI +++  G L   L    + +   ++ ++  +   A  L 
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALD 141
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           +LH+     +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+  Y+ P
Sbjct: 142 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAP 196
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE-WAMKWQNKGQLDQII 692
           E   R+  T+ +D +SFGV++FE+L        TLP +  +  E   M  + K  + Q +
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTG------TLPFQGKDRKETMTMILKAKLGMPQFL 250
Query: 693 DPTLAGKIR 701
            P     +R
Sbjct: 251 SPEAQSLLR 259

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 16/217 (7%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTE 507
           P + ++    +F    ++G G FGKV+  E     +     A+K+        +     E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 508 IEMLS-QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEI 564
             +LS  + H  L  +      K  +  + EY+  G L  H+       LS       EI
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            +G    L +LH+   K +++RD+K  NILLD++   K+ADFG+ K     D    +   
Sbjct: 128 ILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXF 178
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            G+  Y+ PE    Q+     D +SFGV+L+E+L  +
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 108/206 (52%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I   ++
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 71
Query: 529 KN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TGY 579
            N    ++ L+ +Y E+G+L  +L      +++ +  +++ + +A GL +LH     T  
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF- 636
             A+ HRD+KS NIL+ +N    +AD GL+ +     D   ++   + G+  Y+ PE   
Sbjct: 129 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 637 -----RRQQLTEKSDVYSFGVVLFEV 657
                +  +  +++D+Y+ G+V +E+
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 108/234 (46%), Gaps = 20/234 (8%)
Query: 435 YSHGTTTSANSNSGYRFPFVAVQEATNNFDESWV-IGIGGFGKVYKG-ELNDGTKVAVKR 492
           +  G  T     +  R   V  Q       +S+V IG G  G V    E + G +VAVK 
Sbjct: 20  FQSGVVTHEQFKAALRM--VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKM 77
Query: 493 GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG 552
            + R QQ       E+ ++  ++H ++V +        E+ ++ E+++ G L   +    
Sbjct: 78  MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV- 136
Query: 553 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG----L 608
              L+ +Q   +C    + L YLH   A+ VIHRD+KS +ILL  +   K++DFG    +
Sbjct: 137 --RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191
Query: 609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           SK  P+         + G+  ++ PE   R     + D++S G+++ E++   P
Sbjct: 192 SKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 32/227 (14%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTK------VAVKRGNPRSQQGLAE-FQTEIEMLSQ 513
            N +   V+G G FGKV        +K      VAVK    ++     E   +E++M++Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 514 F-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG---------------------S 551
              H ++V+L+G C     + LI+EY   G L  +L                        
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 552 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
            L  L+++  L      A+G+ +L     K+ +HRD+ + N+L+    + K+ DFGL++ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                   V    +    ++ PE       T KSDV+S+G++L+E+ 
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 108/206 (52%), Gaps = 22/206 (10%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I   ++
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 74
Query: 529 KN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TGY 579
            N    ++ L+ +Y E+G+L  +L      +++ +  +++ + +A GL +LH     T  
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLS-KTGPEIDQTHVSTAVK-GSFGYLDPEYF- 636
             A+ HRD+KS NIL+ +N    +AD GL+ +     D   ++   + G+  Y+ PE   
Sbjct: 132 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 637 -----RRQQLTEKSDVYSFGVVLFEV 657
                +  +  +++D+Y+ G+V +E+
Sbjct: 192 DSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 465 ESW-----VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           E W     V+G GGFG+V+  ++    K+     + +   + ++G      E ++L++  
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLH 573
            R +VSL    + K ++ L+   M  G ++ H+Y      P     + +        GL 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLD 632
           +LH    + +I+RD+K  N+LLD++   +++D GL+    E+      T    G+ G++ 
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMA 357
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           PE    ++     D ++ GV L+E++ AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 119/249 (47%), Gaps = 22/249 (8%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIE--MLSQF 514
           + F+   V+G G FGKV+  +   G+      A+K     + +     +T++E  +L + 
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-ARGLH 573
            H  +V L      + ++ LI +++  G L   L    + +   ++ ++  +   A  L 
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALD 140
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           +LH+     +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+  Y+ P
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAP 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE-WAMKWQNKGQLDQII 692
           E   R+  T+ +D +SFGV++FE+L        TLP +  +  E   M  + K  + Q +
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG------TLPFQGKDRKETMTMILKAKLGMPQFL 249
Query: 693 DPTLAGKIR 701
            P     +R
Sbjct: 250 SPEAQSLLR 258

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 126
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D   V     K  F +  P
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  + +  +  SD + FGV L+E+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N F+   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + S    +     I SA  L YLH
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 265
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVL 321
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 9/201 (4%)
Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           FD    +G G +G VYK      G  VA+K+    S   L E   EI ++ Q    H+V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
             G   +  ++ ++ EY   G++   +      +L+  +   I   + +GL YLH     
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
             IHRD+K+ NILL+    AK+ADFG++  G   D       V G+  ++ PE  +    
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 642 TEKSDVYSFGVVLFEVLCARP 662
              +D++S G+   E+   +P
Sbjct: 203 NCVADIWSLGITAIEMAEGKP 223

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 465 ESW-----VIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFR 515
           E W     V+G GGFG+V+  ++    K+     + +   + ++G      E ++L++  
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICIGSARGLH 573
            R +VSL    + K ++ L+   M  G ++ H+Y      P     + +        GL 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLD 632
           +LH    + +I+RD+K  N+LLD++   +++D GL+    E+      T    G+ G++ 
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV---ELKAGQTKTKGYAGTPGFMA 357
Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           PE    ++     D ++ GV L+E++ AR
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 463 FDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLV 520
           F+    +G G F +V   E     K+ AVK    ++ +G  +  + EI +L + +H ++V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +L    +  N + L+ + +  G L   +   G    + K    +       ++YLH    
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTLIRQVLDAVYYLHR--- 138
Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+L    DE     ++DFGLSK   + D   V +   G+ GY+ PE   
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEVLA 195
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           ++  ++  D +S GV+ + +LC  P
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYP 220

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 453 FVAVQEATNNFDESWVIGIGGFGKVYKGELNDGT---------KVAVKRGNPRSQQGLAE 503
           + A +E    +D   VIG  G   V +  ++  T         +V  +R +P   + + E
Sbjct: 86  WAAAKEFYQKYDPKDVIG-RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 504 F-QTEIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR 561
             + E  +L Q   H H+++LI   +  + M L+++ M  G L  +L      +LS K+ 
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKET 202
Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS 621
             I       + +LH   A  ++HRD+K  NILLD+N   +++DFG S         H+ 
Sbjct: 203 RSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFS--------CHLE 251
Query: 622 TAVK-----GSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARP 662
              K     G+ GYL PE  +           ++ D+++ GV+LF +L   P
Sbjct: 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N F+   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + S    +     I SA  L YLH
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 125
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 126 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEYLAPEVL 181
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVLCA 660
             +R++   E  DV+S G+VL  +L  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N F+   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + S    +     I SA  L YLH
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 127
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 128 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEYLAPEVL 183
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 469 IGIGGFGKVYKGELN----DGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 522 LIGYCDEKNEMILIYEYMENGTL-------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L G       M ++ E    G+L       +GH     L +LS        +  A G+ Y
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFL---LGTLS-----RYAVQVAEGMGY 136
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDP 633
           L +   K  IHRD+ + N+LL    + K+ DFGL +  P+ D   V     K  F +  P
Sbjct: 137 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEV 657
           E  + +  +  SD + FGV L+E+
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N F+   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + S    +     I SA  L YLH
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 268
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 269 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVL 324
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
           N F+   ++G G FGKV    E   G   A+K        ++  +A   TE  +L   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL    + S    +     I SA  L YLH
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLH 126
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K V++RD+K  N++LD++   K+ DFGL K G  I          G+  YL PE  
Sbjct: 127 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEYLAPEVL 182
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCAR 661
                    D +  GVV++E++C R
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVLCA 660
             +R++   E  DV+S G+VL  +L  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 158
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 159 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 216
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 270
Query: 701 R 701
           +
Sbjct: 271 Q 271

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 469 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQTEIEM-----LSQFRHRHLVS 521
           IG G +GKV+K     N G  VA+KR   ++ +      T  E+     L  F H ++V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 522 LIGYC-----DEKNEMILIYEYMENG--TLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L   C     D + ++ L++E+++    T    +   G+P+ + K   ++     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH+     V+HRD+K  NIL+  +   K+ADFGL++           T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
              +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 459 ATNNFDESWVIGIGGFGKVYKG---ELNDGTKVAVKRGNPRSQQGLAEF-QTEIEMLSQF 514
             +NF+   V+G G FGKV      E  D   V V + +   Q    E   TE  +LS  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 515 R-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
           R H  L  L       + +  + E++  G L  H+  S     +  +     I SA  L 
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA--LM 138
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           +LH    K +I+RD+K  N+LLD     K+ADFG+ K G  I     +    G+  Y+ P
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--ICNGVTTATFCGTPDYIAP 193
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCA 660
           E  +        D ++ GV+L+E+LC 
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 468 VIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGL---AEFQTEIEMLSQFRHRHLVSL 522
           ++G G FG+VY+G   +  G K+ V     +    L    +F +E  ++    H H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG  +E+   I I E    G L GH       SL     +   +   + + YL +     
Sbjct: 75  IGIIEEEPTWI-IMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
            +HRD+   NIL+      K+ DFGLS+   E +  + ++  +    ++ PE    ++ T
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 643 EKSDVYSFGVVLFEVL 658
             SDV+ F V ++E+L
Sbjct: 189 TASDVWMFAVCMWEIL 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 160
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 218
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 272
Query: 701 R 701
           +
Sbjct: 273 Q 273

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQQGLAEFQTEIEM 510
           Q    N+     IG G F KV     +  G +VAVK     + NP S Q L     E+ +
Sbjct: 11  QPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR---EVRI 67
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +    H ++V L    + +  + L+ EY   G +  +L   G   +  K+          
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVS 125
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGS 627
            + Y H  Y   ++HRD+K+ N+LLD +   K+ADFG S     G ++D         GS
Sbjct: 126 AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD------TFCGS 176
Query: 628 FGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             Y  PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K ++    D  +V   +  P+S         +   EI +     H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     L  P   +  R +I +G      YLH     
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRN--- 134
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+E+   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGER-KKVLCGTPNYIAPEVLSKKGH 192
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + DV+S G +++ +L  +P      P E   L E  ++  +N+  + + I+P  A  I
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKP------PFETSCLKETYLRIKKNEYSIPKHINPVAASLI 246
Query: 701 R 701
           +
Sbjct: 247 Q 247

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 462 NFDESWV---IGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQT---EIEMLSQF 514
           NFD   +   IG G FGKV   + ND  K+ A+K  N +      E +    E++++   
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ---RLEICIGSARG 571
            H  LV+L     ++ +M ++ + +  G L+ HL  +    + +K+   +L IC      
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFIC-ELVMA 127
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L YL     + +IHRD+K  NILLDE+    + DF ++   P   Q    T + G+  Y+
Sbjct: 128 LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYM 181
Query: 632 DPEYFRRQQLTEKS---DVYSFGVVLFEVLCAR 661
            PE F  ++    S   D +S GV  +E+L  R
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVLCA 660
             +R++   E  DV+S G+VL  +L  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 468 VIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGL---AEFQTEIEMLSQFRHRHLVSL 522
           ++G G FG+VY+G   +  G K+ V     +    L    +F +E  ++    H H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG  +E+   I I E    G L GH       SL     +   +   + + YL +     
Sbjct: 91  IGIIEEEPTWI-IMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
            +HRD+   NIL+      K+ DFGLS+   E +  + ++  +    ++ PE    ++ T
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 643 EKSDVYSFGVVLFEVL 658
             SDV+ F V ++E+L
Sbjct: 205 TASDVWMFAVCMWEIL 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-- 516
            ++F+E  V+G G FG+V K     D    A+K+    +++ L+   +E+ +L+   H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 517 -----------RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS---WKQRL 562
                      R+ V  +    +K+ + +  EY EN TL   ++   L       W+   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP------EID 616
           +I       L Y+H+   + +IHRD+K  NI +DE+   K+ DFGL+K         ++D
Sbjct: 124 QIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 617 QTHVS------TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL 658
             ++       T+  G+  Y+  E         EK D+YS G++ FE++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K Y+    D  +V   +  P+S         +  TEI +     + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     +  P   +  R  I     +G+ YLH     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+++   K+ DFGL+ T  E D     T   G+  Y+ PE   ++  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGERKKTLC-GTPNYIAPEVLCKKGH 219
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + D++S G +L+ +L  +P      P E   L E  ++  +N+  + + I+P  +  I
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP------PFETSCLKETYIRIKKNEYSVPRHINPVASALI 273
Query: 701 R 701
           R
Sbjct: 274 R 274

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 468 VIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGL---AEFQTEIEMLSQFRHRHLVSL 522
           ++G G FG+VY+G   +  G K+ V     +    L    +F +E  ++    H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG  +E+   I I E    G L GH       SL     +   +   + + YL +     
Sbjct: 79  IGIIEEEPTWI-IMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
            +HRD+   NIL+      K+ DFGLS+   E +  + ++  +    ++ PE    ++ T
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 643 EKSDVYSFGVVLFEVL 658
             SDV+ F V ++E+L
Sbjct: 193 TASDVWMFAVCMWEIL 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI + +   
Sbjct: 5   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 468 VIGIGGFGKVYKG-ELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           V+G G FG VYKG  + DG      VA+K  R N  S +   E   E  +++     ++ 
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVS 82
Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L+G C   + + L+ + M  G L  H+       L  +  L  C+  A+G+ YL     
Sbjct: 83  RLLGIC-LTSTVQLVTQLMPYGCLLDHVR-ENRGRLGSQDLLNWCMQIAKGMSYLED--- 137
Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFRRQ 639
             ++HRD+ + N+L+      K+ DFGL++   +ID+T   +   K    ++  E   R+
Sbjct: 138 VRLVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVPIKWMALESILRR 196
Query: 640 QLTEKSDVYSFGVVLFEVLC--ARPVIDPTLPREMVNLAE 677
           + T +SDV+S+GV ++E++   A+P  D    RE+ +L E
Sbjct: 197 RFTHQSDVWSYGVTVWELMTFGAKPY-DGIPAREIPDLLE 235

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 469 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQTEIEM-----LSQFRHRHLVS 521
           IG G +GKV+K     N G  VA+KR   ++ +      T  E+     L  F H ++V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 522 LIGYC-----DEKNEMILIYEYMENG--TLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L   C     D + ++ L++E+++    T    +   G+P+ + K   ++     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH+     V+HRD+K  NIL+  +   K+ADFGL++           T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
              +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 133
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 189
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 118
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 136
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 192
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 106/254 (41%), Gaps = 20/254 (7%)
Query: 419 IPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVY 478
           IP + N      MGS             SG     + +Q    +FD   VIG G + KV 
Sbjct: 14  IPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ----DFDLLRVIGRGSYAKVL 69
Query: 479 KGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI 533
              L    ++     VK+      + +   QTE  +  Q   H  LV L      ++ + 
Sbjct: 70  LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129
Query: 534 LIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
            + EY+  G L  H+     LP    +    EI +     L+YLH    + +I+RD+K  
Sbjct: 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLH---ERGIIYRDLKLD 182
Query: 592 NILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFG 651
           N+LLD     K+ D+G+ K G     T  ++   G+  Y+ PE  R +      D ++ G
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALG 240
Query: 652 VVLFEVLCARPVID 665
           V++FE++  R   D
Sbjct: 241 VLMFEMMAGRSPFD 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQQGLAEFQTEIEM 510
           Q    N+     IG G F KV     +  G +VA+K     + NP S Q L     E+ +
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRI 67
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +    H ++V L    + +  + LI EY   G +  +L   G   +  K+          
Sbjct: 68  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVS 125
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGS 627
            + Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D      A  G+
Sbjct: 126 AVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------AFCGA 176
Query: 628 FGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             Y  PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 76  DNPHVCRLLGIC-LTSTVQLIMQLMPFGXLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 133
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 134 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 189
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 191
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 469 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQTEIEM-----LSQFRHRHLVS 521
           IG G +GKV+K     N G  VA+KR   ++ +      T  E+     L  F H ++V 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 522 LIGYC-----DEKNEMILIYEYMENG--TLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           L   C     D + ++ L++E+++    T    +   G+P+ + K   ++     RGL +
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH+     V+HRD+K  NIL+  +   K+ADFGL++           T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
              +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGT-LKGHLY----GSGLPSLS 557
           +F+ E+++++  ++ + ++  G     +E+ +IYEYMEN + LK   Y            
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 558 WKQRLEICIGSA-RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 616
             Q ++  I S      Y+H    K + HRDVK +NIL+D+N   K++DFG S       
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGES------- 199
Query: 617 QTHVSTAVKGSFG---YLDPEYFRRQQLTE--KSDVYSFGVVLF 655
           +  V   +KGS G   ++ PE+F  +      K D++S G+ L+
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 5   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 120
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 81  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 138
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 139 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 194
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 195 ESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 69  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 126
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 182
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 36/226 (15%)
Query: 462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHL 519
           +F+    +G GGFG V++ +   D    A+KR   P  +    +   E++ L++  H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLY--------------GSGLPSLSWKQR---L 562
           V       EKN      E ++  + K +LY               +G  ++  ++R   L
Sbjct: 66  VRYFNAWLEKNTT----EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL--SKTGPEIDQTHV 620
            I +  A  + +LH+   K ++HRD+K +NI    + + KV DFGL  +    E +QT +
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 621 S--------TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +        T   G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 85  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 142
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 143 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 198
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 191
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 100 DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 157
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 158 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 213
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 109 DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 166
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 167 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 222
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 223 ESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 191
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 135
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 136 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 191
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   ++ V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +  ++ SD+++ G ++++++   P
Sbjct: 206 LTEKSASKSSDLWALGCIIYQLVAGLP 232

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 108/216 (50%), Gaps = 14/216 (6%)
Query: 456 VQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR----GNPRSQQGLAEFQT-EIE 509
           V+     +++   +G G F  VYK  + N    VA+K+        ++ G+      EI+
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L +  H +++ L+     K+ + L++++ME   L+  +  + L  L+        + + 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL-VLTPSHIKAYMLMTL 122
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
           +GL YLH  +   ++HRD+K  N+LLDEN + K+ADFGL+K+    ++ +    V  +  
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRW 177
Query: 630 YLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPVI 664
           Y  PE  F  +      D+++ G +L E+L   P +
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL 213

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGXLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 468 VIGIGGFGKVY--KGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G F +V+  K  L  G   A+K          +  + EI +L + +H ++V+L   
Sbjct: 16  VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGL-----PSLSWKQRLEICIGSARGLHYLHTGYA 580
            +      L+ + +  G L   +   G+      SL  +Q L         + YLH    
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVL-------SAVKYLHEN-- 125
Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+L    +EN    + DFGLSK    ++Q  + +   G+ GY+ PE   
Sbjct: 126 -GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLA 180
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           ++  ++  D +S GV+ + +LC  P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYP 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQQGLAEFQTEIEM 510
           Q    N+     IG G F KV     +  G +VA+K     + NP S Q L     E+ +
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRI 64
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           +    H ++V L    + +  + LI EY   G +  +L   G   +  K+          
Sbjct: 65  MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVS 122
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGS 627
            + Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D         GS
Sbjct: 123 AVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------TFCGS 173
Query: 628 FGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             Y  PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 218

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G +G VY G +L++  ++A+K    R  +       EI +    +H+++V  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVIH 585
            E   + +  E +  G+L   L     P    +Q +         GL YLH      ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 586 RDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLT 642
           RD+K  N+L++  + + K++DFG SK    I+    +    G+  Y+ PE   +  +   
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYG 203
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           + +D++S G  + E+   +P
Sbjct: 204 KAADIWSLGCTIIEMATGKP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G +G VY G +L++  ++A+K    R  +       EI +    +H+++V  +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTGYAKAVIH 585
            E   + +  E +  G+L   L     P    +Q +         GL YLH      ++H
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVH 131
Query: 586 RDVKSANILLDE-NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR--QQLT 642
           RD+K  N+L++  + + K++DFG SK    I+    +    G+  Y+ PE   +  +   
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYG 189
Query: 643 EKSDVYSFGVVLFEVLCARP 662
           + +D++S G  + E+   +P
Sbjct: 190 KAADIWSLGCTIIEMATGKP 209

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-R 515
            +FD   VIG G + KV    L    ++     VK+      + +   QTE  +  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLH 573
           H  LV L      ++ +  + EY+  G L  H+     LP    +    EI +     L+
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 120
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLH    + +I+RD+K  N+LLD     K+ D+G+ K G     T  ++   G+  Y+ P
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAP 175
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           E  R +      D ++ GV++FE++  R   D
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K Y+    D  +V   +  P+S         +  TEI +     + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     +  P   +  R  I     +G+ YLH     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+++   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGER-KKXLCGTPNYIAPEVLCKKGH 219
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + D++S G +L+ +L  +P      P E   L E  ++  +N+  + + I+P  +  I
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP------PFETSCLKETYIRIKKNEYSVPRHINPVASALI 273
Query: 701 R 701
           R
Sbjct: 274 R 274

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-R 515
            +FD   VIG G + KV    L    ++     VK+      + +   QTE  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLH 573
           H  LV L      ++ +  + EY+  G L  H+     LP    +    EI +     L+
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 124
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLH    + +I+RD+K  N+LLD     K+ D+G+ K G     T  ++   G+  Y+ P
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAP 179
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           E  R +      D ++ GV++FE++  R   D
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   ++ V G+  Y+ PE 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 206
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 16/212 (7%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQF-R 515
            +FD   VIG G + KV    L    ++     VK+      + +   QTE  +  Q   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWK-QRLEICIGSARGLH 573
           H  LV L      ++ +  + EY+  G L  H+     LP    +    EI +     L+
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LN 135
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLH    + +I+RD+K  N+LLD     K+ D+G+ K G     T  ++   G+  Y+ P
Sbjct: 136 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAP 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           E  R +      D ++ GV++FE++  R   D
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVS 521
           +G   FGKVYKG L           VA+K    +++  L  EF+ E  + ++ +H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLE------ICIG 567
           L+G   +   + +I+ Y  +G L   L         GS     + K  LE      +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A G+ YL + +   V+H+D+ + N+L+ +    K++D GL +     D   +       
Sbjct: 154 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 517 RHLVSLIGYCDEKNEMILI-YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
              V L  +C + +E +     Y +NG L  ++   G    +  +     I SA  L YL
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYL 153
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPE 634
           H    K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPE 209
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
               +   + SD+++ G ++++++   P
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLP 237

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 469 IGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVS 521
           +G   FGKVYKG L           VA+K    +++  L  EF+ E  + ++ +H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLE------ICIG 567
           L+G   +   + +I+ Y  +G L   L         GS     + K  LE      +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A G+ YL + +   V+H+D+ + N+L+ +    K++D GL +     D   +       
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE     + +  SD++S+GVVL+EV 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A G++Y
Sbjct: 72  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAEGMNY 129
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 130 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 185
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 469 IGIGGFGKVYKG-----ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V KG     ++     V + +          E   E  ++ Q  + ++V +I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G C+ ++ M L+ E  E G L  +L  +    +  K  +E+    + G+ YL        
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL     AK++DFGLSK     D+ +      G +   +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 642 TEKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 208 SSKSDVWSFGVLMWEAF 224

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 14/197 (7%)
Query: 469 IGIGGFGKVYKG-----ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FG V KG     ++     V + +          E   E  ++ Q  + ++V +I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G C+ ++ M L+ E  E G L  +L  +    +  K  +E+    + G+ YL        
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NF 148
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQL 641
           +HRD+ + N+LL     AK++DFGLSK     D+ +      G +   +  PE     + 
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 642 TEKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 208 SSKSDVWSFGVLMWEAF 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 458 EATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE--FQTEIEMLSQF 514
           ++   ++   ++G G +G V K    D G  VA+K+        + +     EI++L Q 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLH 573
           RH +LV+L+  C +K    L++E++++  L    L+ +GL     ++ L   I    G+ 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN---GIG 138
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT--GP-EIDQTHVSTAVKGSFGY 630
           + H+     +IHRD+K  NIL+ ++ + K+ DFG ++T   P E+    V+T       Y
Sbjct: 139 FCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WY 190
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPV 663
             PE         K+ DV++ G ++ E+    P+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 19/227 (8%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELND--GTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFR 515
           +++ F +   +G G +  VYKG LN   G  VA+K     S++G       EI ++ + +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG-LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS------A 569
           H ++V L      +N++ L++E+M+N   K   Y       +  + LE+ +         
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKK---YMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
           +GL + H      ++HRD+K  N+L+++    K+ DFGL++       T  S  V  +  
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 630 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
           Y  P+     +    S D++S G +L E++  +P+   T   E + L
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFR-HRHLVSLIG 524
           +G G +G V+K  +   G  VAVK+     Q      +T  EI +L++   H ++V+L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 525 Y--CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
               D   ++ L+++YME   L   +  + L  +    +  +     + + YLH+G    
Sbjct: 77  VLRADNDRDVYLVFDYMETD-LHAVIRANILEPV---HKQYVVYQLIKVIKYLHSG---G 129
Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEI-------------------DQTHVSTA 623
           ++HRD+K +NILL+     KVADFGLS++   I                   D   + T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 624 VKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 663
              +  Y  PE      + T+  D++S G +L E+LC +P+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   ++ V G+  Y+ PE 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPEL 202
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 173
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 174 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 227
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 273

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 108
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 109 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKA 164
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 165 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 202

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQYVSPEL 203
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K Y+    D  +V   +  P+S         +  TEI +     + H+V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     +  P   +  R  I     +G+ YLH     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 161
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+++   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGER-KKDLCGTPNYIAPEVLCKKGH 219
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + D++S G +L+ +L  +P      P E   L E  ++  +N+  + + I+P  +  I
Sbjct: 220 SFEVDIWSLGCILYTLLVGKP------PFETSCLKETYIRIKKNEYSVPRHINPVASALI 273
Query: 701 R 701
           R
Sbjct: 274 R 274

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 110
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKA 166
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 114
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKA 170
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 171 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 152
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 153 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 208
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 209 LTEKSACKSSDLWALGCIIYQLVAGLP 235

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNII 128
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 129 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKA 184
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 113/271 (41%), Gaps = 40/271 (14%)
Query: 447 SGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYKGELNDGTKVAVKRGNP 495
           S   FP  A Q  T+ F + W           +IG G FG+VY G  +    + +     
Sbjct: 10  SARSFPRKASQ--TSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIER 67
Query: 496 RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS 555
            ++  L  F+ E+    Q RH ++V  +G C     + +I    +  TL   +  + +  
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI-V 126
Query: 556 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL------S 609
           L   +  +I     +G+ YLH   AK ++H+D+KS N+  D N    + DFGL       
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182
Query: 610 KTGPEIDQTHVSTAVKGSFGYLDPEYFR---------RQQLTEKSDVYSFGVVLFEVLCA 660
           + G   D+  +     G   +L PE  R         +   ++ SDV++ G + +E L A
Sbjct: 183 QAGRREDKLRIQN---GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE-LHA 238
Query: 661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 691
           R     T P E +    W M    K  L QI
Sbjct: 239 REWPFKTQPAEAII---WQMGTGMKPNLSQI 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G  G+V    +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLA-VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNII 472
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 473 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKA 528
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 566

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLS 512
           ++   +F    ++G G F  V    EL    + A+K    R    +  +     E +++S
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           +  H   V L     +  ++     Y +NG L  ++   G    +  +     I SA  L
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 123
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 631
            YLH    K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 179
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE    +   + SD+++ G ++++++   P
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLS 512
           ++   +F    ++G G F  V    EL    + A+K    R    +  +     E +++S
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           +  H   V L     +  ++     Y +NG L  ++   G    +  +     I SA  L
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 122
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 631
            YLH    K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 178
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE    +   + SD+++ G ++++++   P
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 209

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 120
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 121 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKA 176
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 177 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR--HVKDKNII 473
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     D+ +   
Sbjct: 474 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKA 529
Query: 623 AVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              G +   +  PE     + + KSDV+SFGV+++E  
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 567

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGK-VYKGELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F   V   EL    + A+K    R    +  +     E +++S+  H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 147
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 148 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 203
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 150
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 151 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 206
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 207 LTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 468 VIGIGGFGKVYKG-----ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FGKV        E+    KV  K+   + ++          +L   +H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC-IGSARGLHYLHTGYAK 581
                  +++  + +Y+  G L  HL       L  + R     I SA G  YLH+    
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALG--YLHS---L 158
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +++RD+K  NILLD      + DFGL K    I+    ++   G+  YL PE   +Q  
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKEN--IEHNSTTSTFCGTPEYLAPEVLHKQPY 216
Query: 642 TEKSDVYSFGVVLFEVLCARP 662
               D +  G VL+E+L   P
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLP 237

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLS 512
           ++   +F    ++G G F  V    EL    + A+K    R    +  +     E +++S
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           +  H   V L     +  ++     Y +NG L  ++   G    +  +     I SA  L
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 120
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 631
            YLH    K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 176
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE    +   + SD+++ G ++++++   P
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHR 517
            +++  + IG G +G+  K       K+ V +         AE Q   +E+ +L + +H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 518 HLVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQR--------LEICIG 567
           ++V       ++    + ++ EY E G L      + + +   K+R        L +   
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 568 SARGLHYLH--TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
               L   H  +     V+HRD+K AN+ LD     K+ DFGL++       T  + A  
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFV 177
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
           G+  Y+ PE   R    EKSD++S G +L+E LCA
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 111/241 (46%), Gaps = 24/241 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ----QGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GGF K Y+    D  +V   +  P+S         +  TEI +     + H+V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 525 YCDEKNEMILIYEYMENGTL-KGHLYGSGL--PSLSWKQRLEICIGSARGLHYLHTGYAK 581
           + ++ + + ++ E     +L + H     +  P   +  R  I     +G+ YLH     
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNN--- 145
Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            VIHRD+K  N+ L+++   K+ DFGL+ T  E D       + G+  Y+ PE   ++  
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLA-TKIEFDGER-KKDLCGTPNYIAPEVLCKKGH 203
Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-QNKGQLDQIIDPTLAGKI 700
           + + D++S G +L+ +L  +P      P E   L E  ++  +N+  + + I+P  +  I
Sbjct: 204 SFEVDIWSLGCILYTLLVGKP------PFETSCLKETYIRIKKNEYSVPRHINPVASALI 257
Query: 701 R 701
           R
Sbjct: 258 R 258

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 11/211 (5%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLS 512
           ++   +F    ++G G F  V    EL    + A+K    R    +  +     E +++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGL 572
           +  H   V L     +  ++     Y +NG L  ++   G    +  +     I SA  L
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--L 121
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYL 631
            YLH    K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYV 177
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE    +   + SD+++ G ++++++   P
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 455 AVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQQGLAEFQTEIEM 510
            +Q    ++D   VIG G FG+V         KV   +   +     +   A F  E ++
Sbjct: 69  GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
           ++      +V L     +   + ++ EYM  G L   +    +P   W +       +A 
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK-----FYTAE 182
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            +  L   ++  +IHRDVK  N+LLD++   K+ADFG      E    H  TAV G+  Y
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDY 241
Query: 631 LDPEYFRRQ----QLTEKSDVYSFGVVLFEVL 658
           + PE  + Q        + D +S GV LFE+L
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 149
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 150 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 205
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 463 FDESW----VIGIGGFGKVYKGELNDGTK--VAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           F E W     +G G +G+V +  +N  T+  VAVK  + +      E  + EI +     
Sbjct: 4   FVEDWDLVQTLGEGAYGEV-QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-GLPSLSWKQRLEICIGSARGLHY 574
           H ++V   G+  E N   L  EY   G L   +    G+P    ++     +    G+ Y
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVY 119
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           LH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  Y+ PE
Sbjct: 120 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 635 YFRRQQL-TEKSDVYSFGVVLFEVL 658
             +R++   E  DV+S G+VL  +L
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 146
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 147 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 202
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 203 LTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 79  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 136
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 137 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 192
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
              V L     +  ++     Y +NG L  ++   G    +  +     I SA  L YLH
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA--LEYLH 131
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEY 635
               K +IHRD+K  NILL+E+   ++ DFG +K   PE  Q   +  V G+  Y+ PE 
Sbjct: 132 ---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQYVSPEL 187
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +   + SD+++ G ++++++   P
Sbjct: 188 LTEKSACKSSDLWALGCIIYQLVAGLP 214

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   E  ++ Q  + ++V +IG C+ ++ M L+ E  E G L  +L  +    +  K  +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 114
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID-----Q 617
           E+    + G+ YL        +HRD+ + N+LL     AK++DFGLSK     +     Q
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           TH    VK    +  PE     + + KSDV+SFGV+++E  
Sbjct: 172 THGKWPVK----WYAPECINYYKFSSKSDVWSFGVLMWEAF 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+  G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 111
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 165
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 111
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 165
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           +G G +G VYK + + G  VA+KR    ++ +G+      EI +L +  H ++VSLI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 527 DEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +  + L++E+ME   LK  L    +GL     K  L   +   RG+ + H      ++
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ---HRIL 141
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 643
           HRD+K  N+L++ +   K+ADFGL++      +++    V  +  Y  P+     ++ + 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYST 199
Query: 644 KSDVYSFGVVLFEVLCARPVI-----DPTLPR 670
             D++S G +  E++  +P+      D  LP+
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+  G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLIMQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF 514
           E   NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L + 
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            H ++V L+     +N++ L++E++    LK  +  S L  +             +GL +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
            H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 126 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 180
Query: 635 YFR-RQQLTEKSDVYSFGVVLFEVLCAR 661
                +  +   D++S G +  E++  R
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 86/323 (26%), Positives = 133/323 (41%), Gaps = 59/323 (18%)
Query: 469 IGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIGY 525
           IG G +G V+K    D G  VA+K+        + +     EI ML Q +H +LV+L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 526 CDEKNEMILIYEYMENGTLKG-HLYGSGLP-----SLSWKQRLEICIGSARGLHYLHTGY 579
              K  + L++EY ++  L     Y  G+P     S++W+        + + +++ H   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCH--- 119
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               IHRDVK  NIL+ ++ + K+ DFG ++  TGP  D      A +    Y  PE   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDDEVATR---WYRSPELLV 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ--IIDP 694
              Q     DV++ G V  E+L   P+                  W  K  +DQ  +I  
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPL------------------WPGKSDVDQLYLIRK 217
Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV------LWNLEY-ALQLQEAVVHGD 747
           TL G + P   + F           GV  P   D+        N+ Y AL L +  +H D
Sbjct: 218 TL-GDLIPRHQQVFSTNQYFS----GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMD 272
Query: 748 PDENSTNLIGELSPQIHNFSQVD 770
           P E  T       P   N  +++
Sbjct: 273 PTERLTCEQLLHHPYFENIREIE 295

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+  G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFGL+K  G E  + H     K    ++  
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-KVPIKWMAL 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQ-QGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           +G G +G VYK + + G  VA+KR    ++ +G+      EI +L +  H ++VSLI   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 527 DEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +  + L++E+ME   LK  L    +GL     K  L   +   RG+ + H      ++
Sbjct: 89  HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQ---HRIL 141
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTE 643
           HRD+K  N+L++ +   K+ADFGL++      +++    V  +  Y  P+     ++ + 
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKYST 199
Query: 644 KSDVYSFGVVLFEVLCARPVI-----DPTLPR 670
             D++S G +  E++  +P+      D  LP+
Sbjct: 200 SVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 12/168 (7%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRL-EI 564
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G +P    +Q L ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKV 109
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            I   +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ + 
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 163
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
            G+  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 12/168 (7%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRL-EI 564
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G +P    +Q L ++
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKV 109
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            I   +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ + 
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 163
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
            G+  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 8/165 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 111
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 165
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 8/166 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 138
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 192
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 134
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 135 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 190
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 132
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 188
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 17/208 (8%)
Query: 469 IGIGGFGKV-----YKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           +G G FGKV     YK +     K   ++   +S   +   + EI  L   RH H++ L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM-RVEREISYLKLLRHPHIIKLY 75
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
                  +++++ EY   G L  ++      +    +R    I  A  + Y H      +
Sbjct: 76  DVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHR---HKI 129
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT- 642
           +HRD+K  N+LLD+N   K+ADFGLS      D   + T+  GS  Y  PE    +    
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSC-GSPNYAAPEVINGKLYAG 186
Query: 643 EKSDVYSFGVVLFEVLCAR-PVIDPTLP 669
            + DV+S G+VL+ +L  R P  D  +P
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRG-----NPRSQQGLAEFQTEIEMLSQF 514
             F +  V+G G FG VYKG  + +G KV +           S +   E   E  +++  
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            + H+  L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++Y
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNY 139
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDP 633
           L     + ++HRD+ + N+L+      K+ DFG +K  G E  + H     K    ++  
Sbjct: 140 LED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG-KVPIKWMAL 195
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    +  T +SDV+S+GV ++E++
Sbjct: 196 ESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHR 517
            +++  + IG G +G+  K       K+ V +         AE Q   +E+ +L + +H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 518 HLVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQR--------LEICIG 567
           ++V       ++    + ++ EY E G L      + + +   K+R        L +   
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 568 SARGLHYLH--TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
               L   H  +     V+HRD+K AN+ LD     K+ DFGL++     D +   T V 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKTFV- 177
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
           G+  Y+ PE   R    EKSD++S G +L+E LCA
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G VYK + N G   A+K+    +  +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 DEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             K  ++L++E+++    K   +   GL S++ K  L   +    G+ Y H    + V+H
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHD---RRVLH 123
Query: 586 RDVKSANILLDENFMAKVADFGLSKTG--PEIDQTHVSTAVKGSFGYLDPEYFR-RQQLT 642
           RD+K  N+L++     K+ADFGL++    P    TH       +  Y  P+     ++ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 643 EKSDVYSFGVVLFEVLCARPV 663
              D++S G +  E++   P+
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPL 200

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G F KV     +  G +VAVK       +   L +   E+ ++    H ++V L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            + +  + L+ EY   G +  +L   G     W +  E      + +  +   + K ++H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARAKFRQIVSAVQYCHQKFIVH 129
Query: 586 RDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           RD+K+ N+LLD +   K+ADFG S     G ++D         GS  Y  PE F+ ++  
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPELFQGKKYD 183
Query: 643 -EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 184 GPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G VYK + N G   A+K+    +  +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 DEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             K  ++L++E+++    K   +   GL S++ K  L   +    G+ Y H    + V+H
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHD---RRVLH 123
Query: 586 RDVKSANILLDENFMAKVADFGLSKTG--PEIDQTHVSTAVKGSFGYLDPEYFR-RQQLT 642
           RD+K  N+L++     K+ADFGL++    P    TH       +  Y  P+     ++ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAPDVLMGSKKYS 179
Query: 643 EKSDVYSFGVVLFEVLCARPV 663
              D++S G +  E++   P+
Sbjct: 180 TTIDIWSVGCIFAEMVNGAPL 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAVK       +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G   +  K+           + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVSAVQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D      A  G+  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------AFCGAPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 460 TNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
            ++F+E  V+G G FG+V K     D    A+K+    +++ L+   +E+ +L+   H++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQY 63
Query: 519 LVSLIGY-------------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS---WKQRL 562
           +V                    +K+ + +  EY EN TL   ++   L       W+   
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFR 123
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP------EID 616
           +I       L Y+H+   + +IHR++K  NI +DE+   K+ DFGL+K         ++D
Sbjct: 124 QIL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 617 QTHVS------TAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVL 658
             ++       T+  G+  Y+  E         EK D YS G++ FE +
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 458 EATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF 514
           E   NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L + 
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            H ++V L+     +N++ L++E++    LK  +  S L  +             +GL +
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
            H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 126 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 180
Query: 635 YFRR-QQLTEKSDVYSFGVVLFEVLCAR 661
                +  +   D++S G +  E++  R
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGYC 526
           IG G +G VYK + N G   A+K+    +  +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 527 DEKNEMILIYEYMENGTLKG-HLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             K  ++L++E+++    K   +   GL S++ K  L   +    G+ Y H    + V+H
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL---LQLLNGIAYCHD---RRVLH 123
Query: 586 RDVKSANILLDENFMAKVADFGLSKTG--PEIDQTHVSTAVKGSFGYLDPEYFR-RQQLT 642
           RD+K  N+L++     K+ADFGL++    P    TH       +  Y  P+     ++ +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYS 179
Query: 643 EKSDVYSFGVVLFEVLCARPV 663
              D++S G +  E++   P+
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPL 200

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAVK       +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G   +  K+           + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVSAVQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D         GS  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAVK       +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G   +  K+           + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVSAVQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D         GS  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FRR-QQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FRR-QQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 126 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 180
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FRR-QQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 124 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 178
Query: 636 FRR-QQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 24/226 (10%)
Query: 448 GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEF 504
           G  F   A  + ++N+D    +G G F  V +      G + A K  N +  S +   + 
Sbjct: 16  GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL 75
Query: 505 QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWK 559
           + E  +  + +H ++V L     E++   L+++ +  G L         Y     S   +
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135
Query: 560 QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEID 616
           Q LE        + Y H+     ++HR++K  N+LL    +    K+ADFGL+    E++
Sbjct: 136 QILE-------SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVN 182
Query: 617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            +       G+ GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++    LK  +  S L  +             +GL + 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 120 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G++  E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAV+       +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G   +  K+           + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVSAVQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D+        GS  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE------FCGSPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPAFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 123 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G++  E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G++  E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G++  E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           N+F    +IG GGFG+VY     D  K+   +   + +  + + +T          R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIML 243
Query: 521 SLI--GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICI 566
           SL+  G C             +++  I + M  G L  HL   G+ S +  +    EI +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVST 622
           G    L ++H  +   V++RD+K ANILLDE+   +++D GL    SK  P     H S 
Sbjct: 304 G----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV 351
Query: 623 AVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
              G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           N+F    +IG GGFG+VY     D  K+   +   + +  + + +T          R ++
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIML 242
Query: 521 SLI--GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICI 566
           SL+  G C             +++  I + M  G L  HL   G+ S +  +    EI +
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 302
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVST 622
           G    L ++H  +   V++RD+K ANILLDE+   +++D GL    SK  P     H S 
Sbjct: 303 G----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV 350
Query: 623 AVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
              G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 351 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G++  E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++ +  LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++ +  LK  +  S L  +             +GL + 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 122 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++ +  LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           N+F    +IG GGFG+VY     D  K+   +   + +  + + +T          R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIML 243
Query: 521 SLI--GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICI 566
           SL+  G C             +++  I + M  G L  HL   G+ S +  +    EI +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVST 622
           G    L ++H  +   V++RD+K ANILLDE+   +++D GL    SK  P     H S 
Sbjct: 304 G----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV 351
Query: 623 AVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
              G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           N+F    +IG GGFG+VY     D  K+   +   + +  + + +T          R ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIML 243
Query: 521 SLI--GYC----------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICI 566
           SL+  G C             +++  I + M  G L  HL   G+ S +  +    EI +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL----SKTGPEIDQTHVST 622
           G    L ++H  +   V++RD+K ANILLDE+   +++D GL    SK  P     H S 
Sbjct: 304 G----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV 351
Query: 623 AVKGSFGYLDPEYFRRQQLTEKS-DVYSFGVVLFEVL 658
              G+ GY+ PE  ++    + S D +S G +LF++L
Sbjct: 352 ---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E++ +  LK  +  S L  +             +GL + 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 121 HS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 636 FR-RQQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR 515
           +  NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++V L+     +N++ L++E+++   LK  +  S L  +             +GL + 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+     V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE 
Sbjct: 123 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 636 FRR-QQLTEKSDVYSFGVVLFEVLCAR 661
               +  +   D++S G +  E++  R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 84/166 (50%), Gaps = 8/166 (4%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +    +  +   ++ I
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSI 121
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              RGL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ +  G
Sbjct: 122 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVG 175
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREM 672
           +  Y+ PE  +    + +SD++S G+ L E+   R  I P   +E+
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKEL 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFRHRHLVSLIGYCDEKN 530
           G GK Y        K   KR    S++G++  E + E+ +L + RH ++++L    + K 
Sbjct: 28  GTGKEY------AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81
Query: 531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 590
           +++LI E +  G L   L  +   SL+  +  +       G+HYLH+   K + H D+K 
Sbjct: 82  DVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 136
Query: 591 ANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
            NI LLD+N      K+ DFG++    +I+  +    + G+  ++ PE    + L  ++D
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 193
Query: 647 VYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
           ++S GV+ + +L  A P +  T    + N++
Sbjct: 194 MWSIGVITYILLSGASPFLGETKQETLTNIS 224

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFRHRHLVSLIGYCDEKN 530
           G GK Y        K   KR    S++G++  E + E+ +L + RH ++++L    + K 
Sbjct: 49  GTGKEY------AAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 102
Query: 531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 590
           +++LI E +  G L   L  +   SL+  +  +       G+HYLH+   K + H D+K 
Sbjct: 103 DVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 157
Query: 591 ANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
            NI LLD+N      K+ DFG++    +I+  +    + G+  ++ PE    + L  ++D
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 214
Query: 647 VYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
           ++S GV+ + +L  A P +  T    + N++
Sbjct: 215 MWSIGVITYILLSGASPFLGETKQETLTNIS 245

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G          L + Q L         
Sbjct: 75  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 126
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 180
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFRHRHLVSLIGYCDEKN 530
           G GK Y        K   KR    S++G++  E + E+ +L + RH ++++L    + K 
Sbjct: 35  GTGKEY------AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 88
Query: 531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 590
           +++LI E +  G L   L  +   SL+  +  +       G+HYLH+   K + H D+K 
Sbjct: 89  DVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 143
Query: 591 ANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
            NI LLD+N      K+ DFG++    +I+  +    + G+  ++ PE    + L  ++D
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEAD 200
Query: 647 VYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
           ++S GV+ + +L  A P +  T    + N++
Sbjct: 201 MWSIGVITYILLSGASPFLGETKQETLTNIS 231

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G          L + Q L         
Sbjct: 75  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 126
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 180
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G          L + Q L         
Sbjct: 74  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 125
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 126 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 179
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAV+       +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G   +  K+           + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--RMKEKEARAKFRQIVSAVQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D         GS  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 94
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K+  E            IC
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V   
Sbjct: 155 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 210
Query: 624 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 50/270 (18%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG------ELNDG 485
           G+ Y +   T    +  + FP        N       +G G FGKV +       + +  
Sbjct: 19  GNNYVYIDPTQLPYDHKWEFP-------RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAA 71
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
             VAVK   P +     E   +E+++LS    H ++V+L+G C      ++I EY     
Sbjct: 72  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC---- 127
Query: 544 LKGHLYGSGLPSLSWKQRLEICIGS------------------------ARGLHYLHTGY 579
                YG  L  L  K+   IC  +                        A+G+ +L +  
Sbjct: 128 ----CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-- 181
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K  IHRD+ + NILL    + K+ DFGL++         V    +    ++ PE     
Sbjct: 182 -KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 240
Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLP 669
             T +SDV+S+G+ L+E+        P +P
Sbjct: 241 VYTFESDVWSYGIFLWELFSLGSSPYPGMP 270

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G          L + Q L         
Sbjct: 75  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 126
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 180
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSI 114
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID+  ++    G
Sbjct: 115 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVG 168
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
           +  Y+ PE  +    + +SD++S G+ L E+   R
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAV----KR----GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+    KR    G+ R        +TEIE+L +  H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G+         L + Q L         
Sbjct: 214 PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 265
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 266 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 319
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 356

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 50/270 (18%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG------ELNDG 485
           G+ Y +   T    +  + FP        N       +G G FGKV +       + +  
Sbjct: 1   GNNYVYIDPTQLPYDHKWEFP-------RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAA 53
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
             VAVK   P +     E   +E+++LS    H ++V+L+G C      ++I EY     
Sbjct: 54  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC---- 109
Query: 544 LKGHLYGSGLPSLSWKQRLEICIGS------------------------ARGLHYLHTGY 579
                YG  L  L  K+   IC  +                        A+G+ +L +  
Sbjct: 110 ----CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-- 163
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K  IHRD+ + NILL    + K+ DFGL++         V    +    ++ PE     
Sbjct: 164 -KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 222
Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLP 669
             T +SDV+S+G+ L+E+        P +P
Sbjct: 223 VYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-----SGLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G          L + Q L         
Sbjct: 81  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 132
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 133 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 186
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 223

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHR 517
            +++  + IG G +G+  K       K+ V +         AE Q   +E+ +L + +H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 518 HLVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQR--------LEICIG 567
           ++V       ++    + ++ EY E G L      + + +   K+R        L +   
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDL------ASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 568 SARGLHYLH--TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
               L   H  +     V+HRD+K AN+ LD     K+ DFGL++     D+      V 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DEDFAKEFV- 177
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
           G+  Y+ PE   R    EKSD++S G +L+E LCA
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE-LCA 211

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 20/231 (8%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIE 509
           Q+  + +D    +G G F  V K       L    K   KR +  S++G+   E + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +L Q  H ++++L    + + +++LI E +  G L   L  +   SLS ++         
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQIL 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVK 625
            G++YLHT   K + H D+K  NI LLD+N      K+ DFGL+    EI+       + 
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF 179
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL 675
           G+  ++ PE    + L  ++D++S GV+ + +L  A P +  T    + N+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 34/217 (15%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAV----KR----GNPRSQQGLAEFQTEIEMLSQFRH 516
           S  +G G  G+V    E     KVA+    KR    G+ R        +TEIE+L +  H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS-----GLPSLSWKQRLEICIGSARG 571
             ++ +  + D ++  I++ E ME G L   + G+         L + Q L         
Sbjct: 200 PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQML-------LA 251
Query: 572 LHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+ 
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTP 305
Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARP 662
            YL PE              D +S GV+LF  L   P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +         
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 50/270 (18%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG------ELNDG 485
           G+ Y +   T    +  + FP        N       +G G FGKV +       + +  
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFP-------RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAA 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
             VAVK   P +     E   +E+++LS    H ++V+L+G C      ++I EY     
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC---- 132
Query: 544 LKGHLYGSGLPSLSWKQRLEICIGS------------------------ARGLHYLHTGY 579
                YG  L  L  K+   IC  +                        A+G+ +L +  
Sbjct: 133 ----CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-- 186
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K  IHRD+ + NILL    + K+ DFGL++         V    +    ++ PE     
Sbjct: 187 -KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC 245
Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLP 669
             T +SDV+S+G+ L+E+        P +P
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGMP 275

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 469 IGIGGFGKVYKG------ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLV 520
           +G G FGKV +       + +    VAVK   P +     E   +E+++LS    H ++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS------------ 568
           +L+G C      ++I EY          YG  L  L  K+   IC  +            
Sbjct: 107 NLLGACTIGGPTLVITEYC--------CYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 569 ------------ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 616
                       A+G+ +L +   K  IHRD+ + NILL    + K+ DFGL++      
Sbjct: 159 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP 669
              V    +    ++ PE       T +SDV+S+G+ L+E+        P +P
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 268

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 183
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 93
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGS-------GLPSLSWKQRLE----IC- 565
           +V+L+G C +    +++I E+ + G L  +L            P   +K  L     IC 
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 566 -IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +          
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 127/304 (41%), Gaps = 46/304 (15%)
Query: 469 IGIGGFGKVY-KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           IG G FG VY   ++ +   VA+K+ +   +Q   ++Q    E+  L + RH + +   G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK--QRLEICI---GSARGLHYLHTGY 579
               ++   L+ EY            S L  +  K  Q +EI     G+ +GL YLH+  
Sbjct: 122 CYLREHTAWLVMEYCLGS-------ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 172
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY--- 635
              +IHRDVK+ NILL E  + K+ DFG  S   P       +    G+  ++ PE    
Sbjct: 173 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 224
Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
               Q   K DV+S G+   E+   +P         + N+   +  +     + Q   P 
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPA 272
Query: 696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNL 755
           L      +  R F    + CL     DRP+  +VL    + L+ +   V  D  + + + 
Sbjct: 273 LQSGHWSEYFRNF---VDSCLQKIPQDRPT-SEVLLKHRFVLRERPPTVIMDLIQRTKDA 328
Query: 756 IGEL 759
           + EL
Sbjct: 329 VREL 332

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 83/157 (52%), Gaps = 12/157 (7%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRL-EI 564
           E+++L +    ++V   G      E+ +  E+M+ G+L   L  +G +P    +Q L ++
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP----EQILGKV 128
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
            I   +GL YL   +   ++HRDVK +NIL++     K+ DFG+S  G  ID   ++ + 
Sbjct: 129 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 182
Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            G+  Y+ PE  +    + +SD++S G+ L E+   R
Sbjct: 183 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 457 QEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQ 513
           Q    N+     IG G F KV     +  G +VAVK       +   L +   E+ +   
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV 69
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
             H ++V L    + +  + L+ EY   G +  +L   G       +     I SA  + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA--VQ 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVKGSFGY 630
           Y H    K ++HRD+K+ N+LLD +   K+ADFG S     G ++D      A  G+  Y
Sbjct: 128 YCHQ---KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD------AFCGAPPY 178
Query: 631 LDPEYFRRQQLT-EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             PE F+ ++    + DV+S GV+L+ ++        +LP +  NL E
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 107/270 (39%), Gaps = 50/270 (18%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG------ELNDG 485
           G+ Y +   T    +  + FP        N       +G G FGKV +       + +  
Sbjct: 24  GNNYVYIDPTQLPYDHKWEFP-------RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAA 76
Query: 486 TKVAVKRGNPRSQQGLAE-FQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGT 543
             VAVK   P +     E   +E+++LS    H ++V+L+G C      ++I EY     
Sbjct: 77  MTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC---- 132
Query: 544 LKGHLYGSGLPSLSWKQRLEICIGS------------------------ARGLHYLHTGY 579
                YG  L  L  K+   IC  +                        A+G+ +L +  
Sbjct: 133 ----CYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-- 186
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K  IHRD+ + NILL    + K+ DFGL++         V    +    ++ PE     
Sbjct: 187 -KNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNC 245
Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLP 669
             T +SDV+S+G+ L+E+        P +P
Sbjct: 246 VYTFESDVWSYGIFLWELFSLGSSPYPGMP 275

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           IG G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +         
Sbjct: 144 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 129
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 183
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 127/302 (42%), Gaps = 42/302 (13%)
Query: 469 IGIGGFGKVY-KGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRHRHLVSLIG 524
           IG G FG VY   ++ +   VA+K+ +   +Q   ++Q    E+  L + RH + +   G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI---GSARGLHYLHTGYAK 581
               ++   L+ EY   G+    L     P     Q +EI     G+ +GL YLH+    
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPL----QEVEIAAVTHGALQGLAYLHS---H 134
Query: 582 AVIHRDVKSANILLDENFMAKVADFG-LSKTGPEIDQTHVSTAVKGSFGYLDPEY---FR 637
            +IHRDVK+ NILL E  + K+ DFG  S   P       +    G+  ++ PE      
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMD 187
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 697
             Q   K DV+S G+   E+   +P         + N+   +  +     + Q   P L 
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP--------PLFNMNAMSALY----HIAQNESPALQ 235
Query: 698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIG 757
                +  R F    + CL     DRP+  +VL    + L+ +   V  D  + + + + 
Sbjct: 236 SGHWSEYFRNF---VDSCLQKIPQDRPT-SEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
Query: 758 EL 759
           EL
Sbjct: 292 EL 293

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 457 QEATNNFDESWVIGIGGFGKVY--KGELNDGTKVA--VKRGNPRSQQGLAEFQTEIEMLS 512
           Q  ++ +     +G G +G+V   K +L    +    +K+ +  +         E+ +L 
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIG 567
           Q  H +++ L  + ++K    L+ E    G L   +     +     ++  KQ L     
Sbjct: 77  QLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---- 132
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAV 624
              G  YLH      ++HRD+K  N+LL+    + + K+ DFGLS          V   +
Sbjct: 133 ---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKM 180
Query: 625 KGSFG---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
           K   G   Y+ PE  R++   EK DV+S GV+L+ +LC  P       +E++   E
Sbjct: 181 KERLGTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 24/169 (14%)
Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           E   EI +L    H +++ L    ++K    L+ E+ E G L           +  + + 
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--------FEQIINRHKF 143
Query: 563 EICIGS------ARGLHYLHTGYAKAVIHRDVKSANILLDEN---FMAKVADFGLSKTGP 613
           + C  +        G+ YLH      ++HRD+K  NILL+        K+ DFGLS    
Sbjct: 144 DECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-- 198
Query: 614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              + +      G+  Y+ PE  +++   EK DV+S GV+++ +LC  P
Sbjct: 199 -FSKDYKLRDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYP 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE--------IC--IG 567
           +V+L+G C +    +++I E+ + G L  +L       + +K   +        IC    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKG 626
            A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     + 
Sbjct: 153 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARL 208
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 32/224 (14%)
Query: 469 IGIGGFGKVY--KGELNDGTKVA--VKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G G +G+V   K +L    +    +K+ +  +         E+ +L Q  H +++ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 525 YCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           + ++K    L+ E    G L   +     +     ++  KQ L        G  YLH   
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS-------GTTYLH--- 121
Query: 580 AKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDP 633
              ++HRD+K  N+LL+    + + K+ DFGLS          V   +K   G   Y+ P
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSA------HFEVGGKMKERLGTAYYIAP 175
Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
           E  R++   EK DV+S GV+L+ +LC  P       +E++   E
Sbjct: 176 EVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRH 516
           ++N+D    +G G F  V +      G + A K  N +  S +   + + E  +  + +H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARG 571
            ++V L     E++   L+++ +  G L         Y     S   +Q LE        
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 116
Query: 572 LHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + Y H+     ++HR++K  N+LL    +    K+ADFGL+    E++ +       G+ 
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 170
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 171 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 48/249 (19%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  QG A    E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 549 YGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKV 603
           + S     LP +  K  +       R L Y+H+     + HRD+K  N+LLD +  + K+
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLF---RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164
Query: 604 ADFGLSKTGPEIDQTHVSTAVKG--SFGYLDPEYFRRQQL-------TEKSDVYSFGVVL 654
            DFG +K             V+G  +  Y+   Y+R  +L       T   DV+S G VL
Sbjct: 165 CDFGSAK-----------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 655 FEVLCARPV 663
            E+L  +P+
Sbjct: 214 AELLLGQPI 222

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +         
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +         
Sbjct: 144 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRH 516
           ++N+D    +G G F  V +      G + A K  N +  S +   + + E  +  + +H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARG 571
            ++V L     E++   L+++ +  G L         Y     S   +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 572 LHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + Y H+     ++HR++K  N+LL    +    K+ADFGL+    E++ +       G+ 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 171
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRH 516
           ++N+D    +G G F  V +      G + A K  N +  S +   + + E  +  + +H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARG 571
            ++V L     E++   L+++ +  G L         Y     S   +Q LE        
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------S 117
Query: 572 LHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           + Y H+     ++HR++K  N+LL    +    K+ADFGL+    E++ +       G+ 
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTP 171
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           GYL PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 115/249 (46%), Gaps = 48/249 (19%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  QG A    E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 549 YGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKV 603
           + S     LP +  K  +       R L Y+H+     + HRD+K  N+LLD +  + K+
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLF---RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164
Query: 604 ADFGLSKTGPEIDQTHVSTAVKG--SFGYLDPEYFRRQQL-------TEKSDVYSFGVVL 654
            DFG +K             V+G  +  Y+   Y+R  +L       T   DV+S G VL
Sbjct: 165 CDFGSAK-----------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213
Query: 655 FEVLCARPV 663
            E+L  +P+
Sbjct: 214 AELLLGQPI 222

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +IHRD+K +N+ ++E+   K+ DFGL++        H +  +    GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADEMT---GYVATRWYRAP 198
Query: 640 QLT-------EKSDVYSFGVVLFEVLCAR 661
           ++        +  D++S G ++ E+L  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +IHRD+K +N+ ++E+   K+ DFGL++        H +  +    GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADEMT---GYVATRWYRAP 198
Query: 640 QLT-------EKSDVYSFGVVLFEVLCAR 661
           ++        +  D++S G ++ E+L  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 26/201 (12%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           IG G F  VYKG L+  T V V     +    ++     F+ E E L   +H ++V    
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSL----SWKQRLEICIGSARGLHYLH 576
             +     K  ++L+ E   +GTLK +L    +  +    SW      C    +GL +LH
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQFLH 146
Query: 577 TGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           T     +IHRD+K  NI +       K+ D GL+     + +   + AV G+  +  PE 
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFXAPEX 201
Query: 636 FRRQQLTEKSDVYSFGVVLFE 656
           +  ++  E  DVY+FG    E
Sbjct: 202 Y-EEKYDESVDVYAFGXCXLE 221

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 469 IGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRHRHLVSLIGY 525
           +G G +  VYKG+  L D   VA+K      ++G       E+ +L   +H ++V+L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
              +  + L++EY++   LK +L   G   ++            RGL Y H    + V+H
Sbjct: 69  IHTEKSLTLVFEYLDKD-LKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLH 123
Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEK 644
           RD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+        + +
Sbjct: 124 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYSTQ 181
Query: 645 SDVYSFGVVLFEVLCARPV 663
            D++  G + +E+   RP+
Sbjct: 182 IDMWGVGCIFYEMATGRPL 200

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V   
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 208
Query: 624 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +IHRD+K +N+ ++E+   K+ DFGL++        H +  +    GY+   ++R  
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTADEMT---GYVATRWYRAP 198
Query: 640 QLT-------EKSDVYSFGVVLFEVLCAR 661
           ++        +  D++S G ++ E+L  R
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 23/237 (9%)
Query: 436 SHGTTTSANSNSGYRFPF-VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRG 493
           SH    S    + YR      + E    +     +G G +G V    +   G +VAVK+ 
Sbjct: 1   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 60
Query: 494 NPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS 551
           +   Q  +   +T  E+ +L   +H +++ L+        +    E   +  L  HL G+
Sbjct: 61  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGA 116
Query: 552 GLPSLSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
            L ++   Q+L       +     RGL Y+H+     +IHRD+K +N+ ++E+   K+ D
Sbjct: 117 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 173
Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR 661
           FGL++   +    +V+T       Y  PE         +  D++S G ++ E+L  R
Sbjct: 174 FGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+   R +  ++   +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 122 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR 517
            NF +   IG G +G VYK      G  VA+   R +  ++   +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
           ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                V+HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE   
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 638 -RQQLTEKSDVYSFGVVLFEVLCAR 661
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRR 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNA 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 88  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 195
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 196 MHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 27/175 (15%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTE 507
           PF    +  + +++   IG G FG+V+K      G KVA+K+    N +    +   + E
Sbjct: 12  PFC---DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-E 67
Query: 508 IEMLSQFRHRHLVSLIGYCDEK--------NEMILIYEYMEN---GTLKGHLYGSGLPSL 556
           I++L   +H ++V+LI  C  K          + L++++ E+   G L   L    L  +
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
             K+ +++ +    GL+Y+H      ++HRD+K+AN+L+  + + K+ADFGL++ 
Sbjct: 128 --KRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 113 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPEIMLNW 220
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 221 MHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 87  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 194
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 195 MHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYF 636
              +IHRD+K +N+ ++E+   K+ DFGL++        H    + G      Y  PE  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMTGXVATRWYRAPEIM 194
Query: 637 RR-QQLTEKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E+L  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 95  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 202
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 203 MHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 89  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 196
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 197 MHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 20/226 (8%)
Query: 463 FDESWVIGIGGFGKVYKGE-----LNDGTKVAVKRGNPRSQQGLA--EFQTEIEMLSQFR 515
           +D    +G G F  V K       L    K   KR    S++G++  + + E+ +L + +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H ++++L    + K ++ILI E +  G L   L  +   SL+ ++  E       G++YL
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 576 HTGYAKAVIHRDVKSANI-LLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           H+     + H D+K  NI LLD N      K+ DFGL+    +ID  +    + G+  ++
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFV 184
Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLA 676
            PE    + L  ++D++S GV+ + +L  A P +  T    + N++
Sbjct: 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 32/241 (13%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  QG A    E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVAR 110
Query: 549 YGS----GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKV 603
           + S     LP +  K  +       R L Y+H+     + HRD+K  N+LLD +  + K+
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLF---RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164
Query: 604 ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  +P
Sbjct: 165 CDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
Query: 663 V 663
           +
Sbjct: 222 I 222

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 97  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 204
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 109/239 (45%), Gaps = 32/239 (13%)
Query: 441 TSANSNSGYRFPFVAVQEATNNFDESW----VIGIGGFGKVY--KGELNDGTKVAVKRGN 494
           +S   N  ++ P + VQ +T  F + +    V+G G FG+V   K ++  G + AVK  +
Sbjct: 8   SSGRENLYFQGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVIS 66
Query: 495 PRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS 551
            R  +   + ++   E+++L Q  H +++ L  + ++K    L+ E    G L   +   
Sbjct: 67  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 126
Query: 552 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGL 608
                S      I      G+ Y+H      ++HRD+K  N+LL+   ++   ++ DFGL
Sbjct: 127 --KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 181
Query: 609 SKTGPEIDQTHVSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           S        TH   + K     G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 182 S--------THFEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 231

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 129
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V   
Sbjct: 190 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 245
Query: 624 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 281

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V   
Sbjct: 144 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 199
Query: 624 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 83
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------------IC 565
           +V+L+G C +    +++I E+ + G L  +L       + +K   E            IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 566 --IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V   
Sbjct: 144 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKG 199
Query: 624 -VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             +    ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 102 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 209
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 210 MHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 27/175 (15%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTE 507
           PF    +  + +++   IG G FG+V+K      G KVA+K+    N +    +   + E
Sbjct: 11  PFC---DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-E 66
Query: 508 IEMLSQFRHRHLVSLIGYCDEK--------NEMILIYEYMEN---GTLKGHLYGSGLPSL 556
           I++L   +H ++V+LI  C  K          + L++++ E+   G L   L    L  +
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
             K+ +++ +    GL+Y+H      ++HRD+K+AN+L+  + + K+ADFGL++ 
Sbjct: 127 --KRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 173

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 23/237 (9%)
Query: 436 SHGTTTSANSNSGYRFPF-VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRG 493
           SH    S    + YR      + E    +     +G G +G V    +   G +VAVK+ 
Sbjct: 19  SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 78
Query: 494 NPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS 551
           +   Q  +   +T  E+ +L   +H +++ L+        +    E   +  L  HL G+
Sbjct: 79  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGA 134
Query: 552 GLPSLSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
            L ++   Q+L       +     RGL Y+H+     +IHRD+K +N+ ++E+   K+ D
Sbjct: 135 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 191
Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR 661
           FGL++   +    +V+T       Y  PE         +  D++S G ++ E+L  R
Sbjct: 192 FGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 23/237 (9%)
Query: 436 SHGTTTSANSNSGYRFPF-VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRG 493
           SH    S    + YR      + E    +     +G G +G V    +   G +VAVK+ 
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 494 NPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS 551
           +   Q  +   +T  E+ +L   +H +++ L+        +    E   +  L  HL G+
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGA 117
Query: 552 GLPSLSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
            L ++   Q+L       +     RGL Y+H+     +IHRD+K +N+ ++E+   K+ D
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 174
Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR 661
           FGL++   +    +V+T       Y  PE         +  D++S G ++ E+L  R
Sbjct: 175 FGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 101 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +++D    +G G FG V++  E   G   A K      +      + EI+ +S  RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V+L    ++ NEM++IYE+M  G L   +       +S  + +E      +GL ++H   
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMH--- 272
Query: 580 AKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               +H D+K  NI+     +   K+ DFGL+     +D         G+  +  PE   
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            + +   +D++S GV+ + +L
Sbjct: 330 GKPVGYYTDMWSVGVLSYILL 350

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 94
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSGLPSLSWKQR--------LEICIG-- 567
           +V+L+G C +    +++I E+ + G L  +L       + +K          LE  I   
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 568 --SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +          +
Sbjct: 155 FQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
               ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL +   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 101 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 208
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 209 MHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 109 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 100 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 154
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 207
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 208 MHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 10/203 (4%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +++D    +G G FG V++  E   G   A K      +      + EI+ +S  RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V+L    ++ NEM++IYE+M  G L   +       +S  + +E      +GL ++H   
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHEN- 168
Query: 580 AKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               +H D+K  NI+     +   K+ DFGL+     +D         G+  +  PE   
Sbjct: 169 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 638 RQQLTEKSDVYSFGVVLFEVLCA 660
            + +   +D++S GV+ + +L  
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 92  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 199
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 200 MHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 27/175 (15%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTE 507
           PF    +  + +++   IG G FG+V+K      G KVA+K+    N +    +   + E
Sbjct: 12  PFC---DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-E 67
Query: 508 IEMLSQFRHRHLVSLIGYCDEK--------NEMILIYEYMEN---GTLKGHLYGSGLPSL 556
           I++L   +H ++V+LI  C  K          + L++++ E+   G L   L    L  +
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
             K+ +++ +    GL+Y+H      ++HRD+K+AN+L+  + + K+ADFGL++ 
Sbjct: 128 --KRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 91/175 (52%), Gaps = 27/175 (15%)
Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTE 507
           PF    +  + +++   IG G FG+V+K      G KVA+K+    N +    +   + E
Sbjct: 12  PFC---DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-E 67
Query: 508 IEMLSQFRHRHLVSLIGYCDEKNE--------MILIYEYMEN---GTLKGHLYGSGLPSL 556
           I++L   +H ++V+LI  C  K          + L++++ E+   G L   L    L  +
Sbjct: 68  IKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
             K+ +++ +    GL+Y+H      ++HRD+K+AN+L+  + + K+ADFGL++ 
Sbjct: 128 --KRVMQMLLN---GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARA 174

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 469 IGIGGFGKVYKGELNDGTKVA---------VKRGNPRSQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V + +     K A         +K G   S+       +E+++L     H +
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEH--RALMSELKILIHIGHHLN 92
Query: 519 LVSLIGYCDEKN-EMILIYEYMENGTLKGHLYGSG---LPS-------LSWKQRLEICIG 567
           +V+L+G C +    +++I E+ + G L  +L       +P        L+ +  +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKG 626
            A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     + 
Sbjct: 153 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK-DPDYVRKGDARL 208
Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 23/237 (9%)
Query: 436 SHGTTTSANSNSGYRFPF-VAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRG 493
           SH    S    + YR      + E    +     +G G +G V    +   G +VAVK+ 
Sbjct: 2   SHMLEMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 61
Query: 494 NPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGS 551
           +   Q  +   +T  E+ +L   +H +++ L+        +    E   +  L  HL G+
Sbjct: 62  SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGA 117
Query: 552 GLPSLSWKQRLE------ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
            L ++   Q+L       +     RGL Y+H+     +IHRD+K +N+ ++E+   K+ D
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILD 174
Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCAR 661
           FGL++   +    +V+T       Y  PE         +  D++S G ++ E+L  R
Sbjct: 175 FGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    ++  G K+AVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 119 FTPATSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
              +IHRD+K +N+ ++E+   K+ DFGL++        H    +    GY+   ++R  
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMT---GYVATRWYRAP 220
Query: 640 QLT-------EKSDVYSFGVVLFEVLCAR 661
           ++           D++S G ++ E+L  R
Sbjct: 221 EIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEMLSQFRHR 517
           +F+   VIG G FG+V   +L +  KV A+K  N       AE   F+ E ++L     +
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICIGSARGL 572
            + +L     + N + L+ +Y   G L   L  +   LP   +  +   + I I S   L
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           HY         +HRD+K  NIL+D N   ++ADFG      E D T  S+   G+  Y+ 
Sbjct: 195 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYIS 244
Query: 633 PEYFR-----RQQLTEKSDVYSFGVVLFEVL 658
           PE  +     + +   + D +S GV ++E+L
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYF 636
              +IHRD+K +N+ ++E+   K+ DFGL++        H    + G      Y  PE  
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMXGXVATRWYRAPEIM 214
Query: 637 RR-QQLTEKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E+L  R
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 109 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 216
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 217 MHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 110 FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 217
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 218 MHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYF 636
              +IHRD+K +N+ ++E+   K+ DFGL++        H    + G      Y  PE  
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYRAPEIM 190
Query: 637 RR-QQLTEKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E+L  R
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 62/297 (20%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLI 523
           V+G+G  GKV +      G K A+K    +P+++Q       E++   Q     H+V ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------EVDHHWQASGGPHIVCIL 88
Query: 524 GYCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
              +     K  +++I E ME G L   +   G  + + ++  EI       + +LH+  
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-- 146
Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              + HRDVK  N+L    +++ + K+ DFG +K   E  Q  + T     + Y+ PE  
Sbjct: 147 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVL 201
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             ++  +  D++S GV+++ +LC  P                   + N G   Q I P +
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPF-----------------YSNTG---QAISPGM 241
Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 753
             +IR              L  +G   P   +V    E A QL   ++  DP E  T
Sbjct: 242 KRRIR--------------LGQYGFPNPEWSEV---SEDAKQLIRLLLKTDPTERLT 281

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 96  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 203
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 204 MHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 62/297 (20%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLI 523
           V+G+G  GKV +      G K A+K    +P+++Q       E++   Q     H+V ++
Sbjct: 17  VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-------EVDHHWQASGGPHIVCIL 69
Query: 524 GYCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
              +     K  +++I E ME G L   +   G  + + ++  EI       + +LH+  
Sbjct: 70  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-- 127
Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              + HRDVK  N+L    +++ + K+ DFG +K   E  Q  + T     + Y+ PE  
Sbjct: 128 -HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVL 182
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             ++  +  D++S GV+++ +LC  P                   + N G   Q I P +
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPF-----------------YSNTG---QAISPGM 222
Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 753
             +IR              L  +G   P   +V    E A QL   ++  DP E  T
Sbjct: 223 KRRIR--------------LGQYGFPNPEWSEV---SEDAKQLIRLLLKTDPTERLT 262

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYF 636
              +IHRD+K +N+ ++E+   K+ DFGL++        H    + G      Y  PE  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYRAPEIM 194
Query: 637 RR-QQLTEKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E+L  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYF 636
              +IHRD+K +N+ ++E+   K+ DFGL++        H    + G      Y  PE  
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR--------HTDDEMAGFVATRWYRAPEIM 194
Query: 637 RR-QQLTEKSDVYSFGVVLFEVLCAR 661
                  +  D++S G ++ E+L  R
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ D+GL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 452 PFVAVQEATNNFDESW----VIGIGGFGKVY--KGELNDGTKVAVKRGNPRSQQGLAEFQ 505
           P + VQ +T  F + +    V+G G FG+V   K ++  G + AVK  + R  +   + +
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 506 T---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           +   E+++L Q  H +++ L  + ++K    L+ E    G L   +        S     
Sbjct: 72  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAA 129
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTH 619
            I      G+ Y+H      ++HRD+K  N+LL+   ++   ++ DFGLS        TH
Sbjct: 130 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--------TH 178
Query: 620 VSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              + K     G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 225

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 452 PFVAVQEATNNFDESW----VIGIGGFGKVY--KGELNDGTKVAVKRGNPRSQQGLAEFQ 505
           P + VQ +T  F + +    V+G G FG+V   K ++  G + AVK  + R  +   + +
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 95
Query: 506 T---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           +   E+++L Q  H +++ L  + ++K    L+ E    G L   +        S     
Sbjct: 96  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAA 153
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTH 619
            I      G+ Y+H      ++HRD+K  N+LL+   ++   ++ DFGLS        TH
Sbjct: 154 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--------TH 202
Query: 620 VSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              + K     G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 203 FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 249

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 23/164 (14%)
Query: 505 QTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSW 558
           +TEI +L +  H +++ L    +   E+ L+ E +  G L      KG+ Y     + + 
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAV 154
Query: 559 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEI 615
           KQ LE        + YLH      ++HRD+K  N+L      +   K+ADFGLSK    +
Sbjct: 155 KQILE-------AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---V 201
Query: 616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           +   +   V G+ GY  PE  R      + D++S G++ + +LC
Sbjct: 202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 32/228 (14%)
Query: 452 PFVAVQEATNNFDESW----VIGIGGFGKVY--KGELNDGTKVAVKRGNPRSQQGLAEFQ 505
           P + VQ +T  F + +    V+G G FG+V   K ++  G + AVK  + R  +   + +
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 94
Query: 506 T---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           +   E+++L Q  H +++ L  + ++K    L+ E    G L   +        S     
Sbjct: 95  SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAA 152
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTH 619
            I      G+ Y+H      ++HRD+K  N+LL+   ++   ++ DFGLS        TH
Sbjct: 153 RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--------TH 201
Query: 620 VSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              + K     G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 202 FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 248

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 462 NFDESWVIGIGGFGKVYKGELNDGTK----VAVKRGNPRSQQGLAEF-QTEIEMLSQFRH 516
           +F+   V+G G FGKV   +   GT+    + + + +   Q    E    E  +L+    
Sbjct: 20  DFNFLMVLGKGSFGKVMLAD-RKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDK 78
Query: 517 RHLVSLIGYCDEK-NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
              ++ +  C +  + +  + EY+  G L  H+   G       Q +      + GL +L
Sbjct: 79  PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISIGLFFL 136
Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK-----GSFGY 630
           H    + +I+RD+K  N++LD     K+ADFG+ K        H+   V      G+  Y
Sbjct: 137 HK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMMDGVTTREFCGTPDY 186
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID 665
           + PE    Q   +  D +++GV+L+E+L  +P  D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 50/260 (19%)
Query: 455 AVQEATNNFDESWVIGIGGFGKVY---------KGELNDGTKVAVKRGNPRSQQGLAEFQ 505
           A +    NF+   V+G G +GKV+          G+L    KV  K    +  +     +
Sbjct: 48  AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLY-AMKVLKKATIVQKAKTTEHTR 106
Query: 506 TEIEMLSQFRHRHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR--- 561
           TE ++L   R    +  + Y    + ++ LI +Y+  G L  HL        S ++R   
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--------SQRERFTE 158
Query: 562 --LEICIGS-ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 618
             ++I +G     L +LH      +I+RD+K  NILLD N    + DFGLSK     D+T
Sbjct: 159 HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADET 214
Query: 619 HVSTAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFEVL-----------------C 659
             +    G+  Y+ P+  R       +  D +S GV+++E+L                  
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 660 ARPVI--DPTLPREMVNLAE 677
           +R ++  +P  P+EM  LA+
Sbjct: 275 SRRILKSEPPYPQEMSALAK 294

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGY 525
           +G G +G+VYK  +      VA+KR      ++G+      E+ +L + +HR+++ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
               + + LI+EY EN   K   Y    P +S +           G+++ H+   +  +H
Sbjct: 102 IHHNHRLHLIFEYAENDLKK---YMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLH 155
Query: 586 RDVKSANILL-----DENFMAKVADFGLSKT-GPEIDQ-THVSTAVKGSFGYLDPEYFR- 637
           RD+K  N+LL      E  + K+ DFGL++  G  I Q TH       +  Y  PE    
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILLG 211
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARPV 663
            +  +   D++S   +  E+L   P+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPL 237

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 469 IGIGGFGKVYKGELNDGTK-VAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL----- 522
           +G GG G V+    ND  K VA+K+      Q +     EI+++ +  H ++V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 523 ---------IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
                    +G   E N + ++ EYME      ++   G P L    RL       RGL 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDL--ANVLEQG-PLLEEHARL-FMYQLLRGLK 134
Query: 574 YLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           Y+H+     V+HRD+K AN+ ++ E+ + K+ DFGL++    I   H S     S G L 
Sbjct: 135 YIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLAR----IMDPHYSHKGHLSEG-LV 186
Query: 633 PEYFRRQQL-------TEKSDVYSFGVVLFEVLCAR 661
            +++R  +L       T+  D+++ G +  E+L  +
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEI 564
           EI +L +  H ++V L+   D+ NE  + +++E +  G +   +    L  LS  Q    
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                +G+ YLH  Y K +IHRD+K +N+L+ E+   K+ADFG+S      D    +T  
Sbjct: 143 FQDLIKGIEYLH--YQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV- 198
Query: 625 KGSFGYLDPEYFR--RQQLTEKS-DVYSFGVVLF 655
            G+  ++ PE     R+  + K+ DV++ GV L+
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLA-EFQTEI 508
            P   V   +++F    ++G G +G V        G  VA+K+  P  +   A     EI
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 509 EMLSQFRHRHLVSLIGY-----CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE 563
           ++L  F+H +++++         +  NE+ +I E M+    +  +  + +  LS      
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQM--LSDDHIQY 116
Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE--IDQTHVS 621
               + R +  LH      VIHRD+K +N+L++ N   KV DFGL++   E   D +  +
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKS-------DVYSFGVVLFEVLCARPV 663
               G   Y+   ++R  ++   S       DV+S G +L E+   RP+
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 34/247 (13%)
Query: 507 EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQR 561
           E+ +L    H +++ L  + ++K    L+ E  + G L   +     +     ++  KQ 
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQT 618
           L        G+ YLH      ++HRD+K  N+LL+   ++ + K+ DFGLS      +Q 
Sbjct: 146 LS-------GVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQK 193
Query: 619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 678
            +   + G+  Y+ PE  R++   EK DV+S GV+LF +L   P       +E++   E 
Sbjct: 194 KMKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 679 AM------KWQN-----KGQLDQIIDPTLAGKIRPDSLRKFGETAEKC-LADFGVDRPSM 726
                   +W+N     K  + Q++      +I      +     E C   + G++ PS+
Sbjct: 252 GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSL 311
Query: 727 GDVLWNL 733
            + + N+
Sbjct: 312 ANAIENM 318

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++    +L       +     RGL Y+H+  
Sbjct: 86  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y  PE     
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 193
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 39/248 (15%)
Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVA 489
           MGSK    TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA
Sbjct: 3   MGSKV---TTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVA 53
Query: 490 VKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGT 543
           +K    +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+    
Sbjct: 54  IK----KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 109
Query: 544 LKGHLYGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD- 596
            +   + S       KQ L +           R L Y+H+     + HRD+K  N+LLD 
Sbjct: 110 YRVARHYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDP 161
Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLF 655
           +  + K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL 
Sbjct: 162 DTAVLKLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 218
Query: 656 EVLCARPV 663
           E+L  +P+
Sbjct: 219 ELLLGQPI 226

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 23/229 (10%)
Query: 451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLA-EFQTEI 508
            P   V   +++F    ++G G +G V        G  VA+K+  P  +   A     EI
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 509 EMLSQFRHRHLVSLIGY-----CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE 563
           ++L  F+H +++++         +  NE+ +I E M+    +  +  + +  LS      
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQM--LSDDHIQY 116
Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE--IDQTHVS 621
               + R +  LH      VIHRD+K +N+L++ N   KV DFGL++   E   D +  +
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKS-------DVYSFGVVLFEVLCARPV 663
               G   ++   ++R  ++   S       DV+S G +L E+   RP+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLA--EFQTEIEMLSQFRHRHLVS 521
           VIG G F  V +      G + AVK        S  GL+  + + E  +    +H H+V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 522 LIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGLPSLSWKQRLEICIGSARGL 572
           L+        + +++E+M+   L          G +Y   + S   +Q LE        L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143
Query: 573 HYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            Y H      +IHRDVK  N+LL   + +   K+ DFG++    E     V+    G+  
Sbjct: 144 RYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE--SGLVAGGRVGTPH 198
Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           ++ PE  +R+   +  DV+  GV+LF +L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+  FGL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ D GL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 466 SWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLI 523
           S ++G G + KV     L +G + AVK    ++    +    E+E L Q + +++++ LI
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
            + ++     L++E ++ G++  H+        + ++   +    A  L +LHT   K +
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQ--KHFNEREASRVVRDVAAALDFLHT---KGI 132
Query: 584 IHRDVKSANILLDENFM---AKVADFGLSK-----------TGPEIDQTHVSTAVKGSFG 629
            HRD+K  NIL +        K+ DF L             T PE+      T   GS  
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL------TTPCGSAE 186
Query: 630 YLDPEYFR--RQQLT---EKSDVYSFGVVLFEVLCARP 662
           Y+ PE       Q T   ++ D++S GVVL+ +L   P
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ DF L++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ D GL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY---CDEKNEMI---LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     EK +++   L+ +Y+     +   
Sbjct: 52  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVAR 110
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 111 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 163 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 661 RPV 663
           +P+
Sbjct: 220 QPI 222

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 110
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 165
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 211
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 9   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 59
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 60  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 118
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 119 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 170
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 171 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227
Query: 661 RPV 663
           +P+
Sbjct: 228 QPI 230

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 52/251 (20%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 14  SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 64
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 65  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 123
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 124 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 175
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKG--SFGYLDPEYFRRQQL-------TEKSDVYSFGV 652
           K+ DFG +K             V+G  +  Y+   Y+R  +L       T   DV+S G 
Sbjct: 176 KLCDFGSAK-----------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 224
Query: 653 VLFEVLCARPV 663
           VL E+L  +P+
Sbjct: 225 VLAELLLGQPI 235

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 20  SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 70
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 71  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 129
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 130 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 181
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 182 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238
Query: 661 RPV 663
           +P+
Sbjct: 239 QPI 241

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 81
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 136
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 182
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 183 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 227

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 104
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 159
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 205
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 206 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 250

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 114
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 169
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 170 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 215
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 216 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 260

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 463 FDESWVIGIGGFGKVYKG---ELND-----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQF 514
           F+ES  +G G F K++KG   E+ D      T+V +K  +   +     F     M+S+ 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGSARGLH 573
            H+HLV   G C   +E IL+ E+++ G+L  +L       ++ WK  LE+    A  +H
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMH 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAV-KGSFGYL 631
           +L       +IH +V + NILL      K  +    K + P I  T +   + +    ++
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 632 DPEYFRR-QQLTEKSDVYSFGVVLFEV 657
            PE     + L   +D +SFG  L+E+
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 112
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 167
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 168 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 213
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 214 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 258

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G +VAVK+ +   Q  +   +T  E+ +L   +H +++ L+  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHTGY 579
                 +    E   +  L  HL G+ L ++   Q+L       +     RGL Y+H+  
Sbjct: 90  FTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR- 638
              +IHRD+K +N+ ++E+   K+ D GL++   +    +V+T       Y  PE     
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPEIMLNW 197
Query: 639 QQLTEKSDVYSFGVVLFEVLCAR 661
               +  D++S G ++ E+L  R
Sbjct: 198 MHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 13  SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 63
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 64  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 123 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 174
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 175 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 661 RPV 663
           +P+
Sbjct: 232 QPI 234

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 46/225 (20%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 155
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 210
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG- 626
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K             V+G 
Sbjct: 211 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK-----------QLVRGE 256
Query: 627 -SFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
            +  Y+   Y+R  +L       T   DV+S G VL E+L  +P+
Sbjct: 257 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 301

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 463 FDESWVIGIGGFGKVYKG---ELND-----GTKVAVKRGNPRSQQGLAEFQTEIEMLSQF 514
           F+ES  +G G F K++KG   E+ D      T+V +K  +   +     F     M+S+ 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69
Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPSLSWKQRLEICIGSARGLH 573
            H+HLV   G C   +E IL+ E+++ G+L  +L       ++ WK  LE+    A  +H
Sbjct: 70  SHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAWAMH 127
Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAV-KGSFGYL 631
           +L       +IH +V + NILL      K  +    K + P I  T +   + +    ++
Sbjct: 128 FLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184
Query: 632 DPEYFRR-QQLTEKSDVYSFGVVLFEV 657
            PE     + L   +D +SFG  L+E+
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 462 NFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           ++ ++ VIG G FG VY+ +L D G  VA+K    +  Q       E++++ +  H ++V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDKRFKNRELQIMRKLDHCNIV 110
Query: 521 SLIGYC----DEKNEMI--LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA----- 569
            L  +     ++K+E+   L+ +Y+     +   + S       KQ L +          
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-----RAKQTLPVIYVKLYMYQL 165
Query: 570 -RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            R L Y+H+     + HRD+K  N+LLD +  + K+ DFG +K   ++ +   + +   S
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSXICS 219
Query: 628 FGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             Y  PE  F     T   DV+S G VL E+L  +P+
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 13  SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 63
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 64  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 122
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 123 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 174
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 175 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231
Query: 661 RPV 663
           +P+
Sbjct: 232 QPI 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 454 VAVQEATNNFDESWVIGIGGFG--KVYKGELNDGTKVAVK---RGNPRSQQGLAEFQTEI 508
           + +   ++ +D    IG G FG  ++ + +L     VAVK   RG    +      Q EI
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDEN----VQREI 67
Query: 509 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS-----LSWKQRLE 563
                 RH ++V           + +I EY   G L   +  +G  S       ++Q L 
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA--KVADFGLSKTGPEIDQTHVS 621
                  G+ Y H+     + HRD+K  N LLD +     K+ DFG SK+   +  +   
Sbjct: 128 -------GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPK 175
Query: 622 TAVKGSFGYLDPEYFRRQQLTEK-SDVYSFGVVLFEVLC-ARPVIDPTLPRE 671
           + V G+  Y+ PE   RQ+   K +DV+S GV L+ +L  A P  DP  PR+
Sbjct: 176 STV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 452 PFVAVQEATNNFDESW----VIGIGGFGKVY--KGELNDGTKVAVKRGNPRSQQGLAEFQ 505
           P   VQ +T  F + +    V+G G FG+V   K ++  G + AVK  + R  +   + +
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKE 71
Query: 506 T---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           +   E+++L Q  H ++  L  + ++K    L+ E    G L   +        S     
Sbjct: 72  SLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAA 129
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTH 619
            I      G+ Y H      ++HRD+K  N+LL+   ++   ++ DFGLS        TH
Sbjct: 130 RIIRQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS--------TH 178
Query: 620 VSTAVK-----GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              + K     G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 179 FEASKKXKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCP 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 52/251 (20%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 111 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKG--SFGYLDPEYFRRQQL-------TEKSDVYSFGV 652
           K+ DFG +K             V+G  +  Y+   Y+R  +L       T   DV+S G 
Sbjct: 163 KLCDFGSAK-----------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211
Query: 653 VLFEVLCARPV 663
           VL E+L  +P+
Sbjct: 212 VLAELLLGQPI 222

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 111 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 163 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 661 RPV 663
           +P+
Sbjct: 220 QPI 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 20/168 (11%)
Query: 500 GLAEFQTEIEMLSQFRHRHLVSLIG--YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS 557
           G A  + EI++L + RH++++ L+   Y +EK +M ++ EY   G  +       L S+ 
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEM------LDSVP 102
Query: 558 WKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
            K R  +C           GL YLH+   + ++H+D+K  N+LL      K++  G+++ 
Sbjct: 103 EK-RFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158
Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE--KSDVYSFGVVLFEV 657
                        +GS  +  PE           K D++S GV L+ +
Sbjct: 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 2   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 52
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 53  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 111
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 112 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 163
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 164 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220
Query: 661 RPV 663
           +P+
Sbjct: 221 QPI 223

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 111/243 (45%), Gaps = 36/243 (14%)
Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGN 494
           S  TT  A    G   P    QE +  + ++ VIG G FG VY+ +L D G  VA+K   
Sbjct: 1   SKVTTVVATPGQGPDRP----QEVS--YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--- 51
Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMI--LIYEYMENGTLKGHL 548
            +  Q       E++++ +  H ++V L  +     ++K+E+   L+ +Y+     +   
Sbjct: 52  -KVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 549 YGSGLPSLSWKQRLEICIGSA------RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMA 601
           + S       KQ L +           R L Y+H+     + HRD+K  N+LLD +  + 
Sbjct: 111 HYS-----RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL 162
Query: 602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCA 660
           K+ DFG +K   ++ +   + +   S  Y  PE  F     T   DV+S G VL E+L  
Sbjct: 163 KLCDFGSAK---QLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 661 RPV 663
           +P+
Sbjct: 220 QPI 222

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ +L +   +  IHRD+ + NILL EN + K+ DFGL++   +          +   
Sbjct: 209 ARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++ PE    +  + KSDV+S+GV+L+E+ 
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIF 295

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 99/237 (41%), Gaps = 26/237 (10%)
Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAV 490
           GS  S G  T   +  G R+     Q   N+ +    +G G  G+V+K      G  +AV
Sbjct: 1   GSSGSSGKQTGYLTIGGQRY-----QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 491 KRGNPRSQQGLAEFQTEIEM-----LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 545
           K+     + G  E    I M     L      ++V   G      ++ +  E M  GT  
Sbjct: 56  KQ---MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCA 110
Query: 546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
             L       +  +   ++ +   + L+YL   +   VIHRDVK +NILLDE    K+ D
Sbjct: 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCD 168
Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEV 657
           FG+S  G  +D      +  G   Y+ PE       T+     ++DV+S G+ L E+
Sbjct: 169 FGIS--GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 25/230 (10%)
Query: 451 FPFVAVQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLA-EFQTEI 508
            P   V   +++F    ++G G +G V        G  VA+K+  P  +   A     EI
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 509 EMLSQFRHRHLVSLIGY-----CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE 563
           ++L  F+H +++++         +  NE+ +I E M+    +  +  + +  LS      
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR--VISTQM--LSDDHIQY 116
Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---------TGPE 614
               + R +  LH      VIHRD+K +N+L++ N   KV DFGL++         + P 
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 615 IDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCARPV 663
             Q+ ++  V   + Y  PE      + +   DV+S G +L E+   RP+
Sbjct: 174 GQQSGMTEXVATRW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 507 EIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           EIE+L ++ +H ++++L    D+   + L+ E M  G L   +      S      +   
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT 129
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANIL-LDEN---FMAKVADFGLSKTGPEIDQTHVS 621
           IG  + + YLH+   + V+HRD+K +NIL +DE+      ++ DFG +K     +   ++
Sbjct: 130 IG--KTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                +F  + PE  +RQ   E  D++S G++L+ +L
Sbjct: 185 PCYTANF--VAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           +I + + + L++L       +IHRD+K +NILLD +   K+ DFG+S  G  +D     T
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKT 183
Query: 623 AVKGSFGYLDPEYF----RRQQLTEKSDVYSFGVVLFEVLCAR 661
              G   Y+ PE       RQ    +SDV+S G+ L+E+   R
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG+V K +      + AVK  N  S +    +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             ++ +   ++ E    G L   +        S      I      G+ Y+H      ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 585 HRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYFRR 638
           HRD+K  NILL+   ++   K+ DFGLS    +      +T +K   G   Y+ PE  R 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLR- 196
Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
               EK DV+S GV+L+ +L   P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP 220

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 507 EIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           EIE+L ++ +H ++++L    D+   + L+ E M  G L   +      S      +   
Sbjct: 70  EIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT 129
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANIL-LDEN---FMAKVADFGLSKTGPEIDQTHVS 621
           IG  + + YLH+   + V+HRD+K +NIL +DE+      ++ DFG +K     +   ++
Sbjct: 130 IG--KTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT 184
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                +F  + PE  +RQ   E  D++S G++L+ +L
Sbjct: 185 PCYTANF--VAPEVLKRQGYDEGCDIWSLGILLYTML 219

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 469 IGIGGFG------KVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G F       KV  G+      +  K+ + R  Q L   + E  +    +H ++V L
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL---EREARICRLLKHPNIVRL 86
Query: 523 IGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                E+    LI++ +  G L         Y     S   +Q LE        LH    
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQM 140
Query: 578 GYAKAVIHRDVKSANILLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           G    V+HRD+K  N+LL         K+ADFGL+       Q     A  G+ GYL PE
Sbjct: 141 G----VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPE 194
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             R+    +  D+++ GV+L+ +L   P
Sbjct: 195 VLRKDPYGKPVDLWACGVILYILLVGYP 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKG 626
           RGL Y+H+     VIHRD+K +N+L++EN   K+ DFG+++   T P   Q  ++  V  
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 627 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            + Y  PE      + T+  D++S G +  E+L  R
Sbjct: 227 RW-YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E ME         T +G L      S  W+      + + R 
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 129
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 130 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 179
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           VIG G FG+V         KV   +   +     +   A F  E ++++      +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
               +   + ++ EYM  G L   +    +P   W +       +A  +  L   ++   
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FYTAEVVLALDAIHSMGF 189
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ---- 639
           IHRDVK  N+LLD++   K+ADFG      +       TAV G+  Y+ PE  + Q    
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248
Query: 640 QLTEKSDVYSFGVVLFEVLCA 660
               + D +S GV L+E+L  
Sbjct: 249 YYGRECDWWSVGVFLYEMLVG 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG G F  V +  +L  G + A K  N +  S +   + + E  +    +H ++V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 526 CDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             E+    L+++ +  G L         Y     S   +Q LE        LH    G  
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQMG-- 123
Query: 581 KAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             V+HRD+K  N+LL    +    K+ADFGL+       Q     A  G+ GYL PE  R
Sbjct: 124 --VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLR 179
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           ++   +  D+++ GV+L+ +L   P
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYP 204

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           VIG G FG+V         KV   +   +     +   A F  E ++++      +V L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
               +   + ++ EYM  G L   +    +P   W +       +A  +  L   ++   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FYTAEVVLALDAIHSMGF 194
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ---- 639
           IHRDVK  N+LLD++   K+ADFG      +       TAV G+  Y+ PE  + Q    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 253
Query: 640 QLTEKSDVYSFGVVLFEVLCA 660
               + D +S GV L+E+L  
Sbjct: 254 YYGRECDWWSVGVFLYEMLVG 274

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 456 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEML 511
           +Q    +F+   VIG G FG+V   ++ +  ++ A+K  N       AE   F+ E ++L
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICI 566
                + + +L     ++N + L+ +Y   G L   L  +   LP   +  +   + + I
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
            S   LHY         +HRD+K  N+LLD N   ++ADFG S      D T  S+   G
Sbjct: 189 DSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVG 238
Query: 627 SFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 658
           +  Y+ PE  +  +        + D +S GV ++E+L
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKG 626
           RGL Y+H+     VIHRD+K +N+L++EN   K+ DFG+++   T P   Q  ++  V  
Sbjct: 169 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 627 SFGYLDPE-YFRRQQLTEKSDVYSFGVVLFEVLCAR 661
            + Y  PE      + T+  D++S G +  E+L  R
Sbjct: 226 RW-YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG+V K +      + AVK  N  S +    +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             ++ +   ++ E    G L   +        S      I      G+ Y+H      ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 585 HRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYFRR 638
           HRD+K  NILL+   ++   K+ DFGLS    +      +T +K   G   Y+ PE  R 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLR- 196
Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
               EK DV+S GV+L+ +L   P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 37/214 (17%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 526
           VIG G FG V++ +L +  +VA+K    +  Q       E++++   +H ++V L  +  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 527 ---DEKNEMI--LIYEYMENGTLKGHLYGSGL----PSLSWKQRLEICIGSARGLHYLHT 577
              D+K+E+   L+ EY+     +   + + L    P L  K  +   +   R L Y+H+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIHS 159
Query: 578 GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                + HRD+K  N+LLD  + + K+ DFG +K         +  A + +   +   Y+
Sbjct: 160 ---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---------ILIAGEPNVSXICSRYY 207
Query: 637 RRQQL-------TEKSDVYSFGVVLFEVLCARPV 663
           R  +L       T   D++S G V+ E++  +P+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS--ARGLHYLHTGYAKAVIHRD 587
           + +  + EY+  G L  H+   G     +K+   +   +  A GL +L +   K +I+RD
Sbjct: 94  DRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRD 146
Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           +K  N++LD     K+ADFG+ K    I     +    G+  Y+ PE    Q   +  D 
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 648 YSFGVVLFEVLCAR 661
           ++FGV+L+E+L  +
Sbjct: 205 WAFGVLLYEMLAGQ 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR----SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           VIG G FG+V         KV   +   +     +   A F  E ++++      +V L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
               +   + ++ EYM  G L   +    +P   W +       +A  +  L   ++   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE-KWAR-----FYTAEVVLALDAIHSMGF 194
Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ---- 639
           IHRDVK  N+LLD++   K+ADFG      +       TAV G+  Y+ PE  + Q    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 253
Query: 640 QLTEKSDVYSFGVVLFEVLCA 660
               + D +S GV L+E+L  
Sbjct: 254 YYGRECDWWSVGVFLYEMLVG 274

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 530 NEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS--ARGLHYLHTGYAKAVIHRD 587
           + +  + EY+  G L  H+   G     +K+   +   +  A GL +L +   K +I+RD
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRD 467
Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           +K  N++LD     K+ADFG+ K    I     +    G+  Y+ PE    Q   +  D 
Sbjct: 468 LKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 648 YSFGVVLFEVLCAR 661
           ++FGV+L+E+L  +
Sbjct: 526 WAFGVLLYEMLAGQ 539

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 21/204 (10%)
Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG+V K +      + AVK  N  S +    +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             ++ +   ++ E    G L   +        S      I      G+ Y+H      ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 585 HRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG---YLDPEYFRR 638
           HRD+K  NILL+   ++   K+ DFGLS    +      +T +K   G   Y+ PE  R 
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPEVLR- 196
Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
               EK DV+S GV+L+ +L   P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP 220

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 456 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEML 511
           +Q    +F+   VIG G FG+V   ++ +  ++ A+K  N       AE   F+ E ++L
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLP---SLSWKQRLEICI 566
                + + +L     ++N + L+ +Y   G L   L  +   LP   +  +   + + I
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
            S   LHY         +HRD+K  N+LLD N   ++ADFG S      D T  S+   G
Sbjct: 205 DSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVG 254
Query: 627 SFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVL 658
           +  Y+ PE  +  +        + D +S GV ++E+L
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 13/107 (12%)
Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL--SKTGPEIDQTH 619
           L I I  A  + +LH+   K ++HRD+K +NI    + + KV DFGL  +    E +QT 
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 620 VSTAVK--------GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           ++            G+  Y+ PE       + K D++S G++LFE+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 12/157 (7%)
Query: 507 EIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           EIE+L ++ +H ++++L    D+   + ++ E M+ G L   +        S ++   + 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVL 122
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANIL-LDEN---FMAKVADFGLSKTGPEIDQTHVS 621
               + + YLH   A+ V+HRD+K +NIL +DE+      ++ DFG +K     +   ++
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                +F  + PE   RQ      D++S GV+L+ +L
Sbjct: 180 PCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTML 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 469 IGIGGFGKVYKGELNDGTK-VAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           IG G +G V+K +  +  + VA+KR        G P S         EI +L + +H+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 63
Query: 520 VSLIGYCDEKNEMILIYEYME----------NGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           V L        ++ L++E+ +          NG L   +  S L  L             
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------------L 111
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
           +GL + H+   + V+HRD+K  N+L++ N   K+ADFGL++      + + +  V  +  
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLW 166
Query: 630 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVL-CARPV 663
           Y  P+     +L   S D++S G +  E+   ARP+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 85/208 (40%), Gaps = 29/208 (13%)
Query: 469 IGIGGFG------KVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G F       KV  G+      +  K+ + R  Q L   + E  +    +H ++V L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRLLKHPNIVRL 75
Query: 523 IGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                E+    LI++ +  G L         Y     S   +Q LE        LH    
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV------LHCHQM 129
Query: 578 GYAKAVIHRDVKSANILLDENF---MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           G    V+HR++K  N+LL         K+ADFGL+       Q     A  G+ GYL PE
Sbjct: 130 G----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPE 183
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             R+    +  D+++ GV+L+ +L   P
Sbjct: 184 VLRKDPYGKPVDLWACGVILYILLVGYP 211

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    IG G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EYM  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    KVADFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    IG G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EYM  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    KVADFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG           ++   +   R ++  A  + EI      RH ++V        
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + ++ EY   G L   +  +G    S  +          G+ Y H   A  V HRD+
Sbjct: 87  PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH---AMQVCHRDL 141
Query: 589 KSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK-S 645
           K  N LLD +     K+ DFG SK+   +  +   + V G+  Y+ PE   +++   K +
Sbjct: 142 KLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVA 198
Query: 646 DVYSFGVVLFEVLC-ARPVIDPTLPR 670
           DV+S GV L+ +L  A P  DP  P+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG           ++   +   R ++     + EI      RH ++V        
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + ++ EY   G L   +  +G    S  +          G+ Y H   A  V HRD+
Sbjct: 87  PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYAH---AMQVAHRDL 141
Query: 589 KSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK-S 645
           K  N LLD +     K+ADFG SK    +  +   +AV G+  Y+ PE   +++   K +
Sbjct: 142 KLENTLLDGSPAPRLKIADFGYSKAS--VLHSQPKSAV-GTPAYIAPEVLLKKEYDGKVA 198
Query: 646 DVYSFGVVLFEVLC-ARPVIDPTLPR 670
           DV+S GV L+ +L  A P  DP  P+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 27  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 82
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 83  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 139
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 140 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 196
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 197 PEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 627
           A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     +  
Sbjct: 203 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARLP 258
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 29  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 84
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 85  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 141
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 142 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 198
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 199 PEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 22  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 77
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 78  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 134
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 135 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 191
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 192 PEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 627
           A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     +  
Sbjct: 210 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARLP 265
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           ++++ E ++ G L   +   G  + + ++  EI       + YLH+     + HRDVK  
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 592 NILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           N+L      N + K+ DFG +K         ++T     + Y+ PE    ++  +  D++
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMW 217
Query: 649 SFGVVLFEVLCARP 662
           S GV+++ +LC  P
Sbjct: 218 SLGVIMYILLCGYP 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 627
           A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     +  
Sbjct: 208 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARLP 263
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-VKGS 627
           A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   + D  +V     +  
Sbjct: 201 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK-DPDYVRKGDARLP 256
Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             ++ PE    +  T +SDV+SFGV+L+E+ 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 28  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 83
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 84  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 140
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 141 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 197
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 198 PEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 21  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 76
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 133
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 190
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           ++++ E ++ G L   +   G  + + ++  EI       + YLH+     + HRDVK  
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 190
Query: 592 NILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           N+L      N + K+ DFG +K         ++T     + Y+ PE    ++  +  D++
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMW 247
Query: 649 SFGVVLFEVLCARP 662
           S GV+++ +LC  P
Sbjct: 248 SLGVIMYILLCGYP 261

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 23  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   +
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 135
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 192
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 193 PEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 26/217 (11%)
Query: 458 EATNNFDESWVI-----GIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIE 509
           ++  NF+  +++     G G F  V +    + G + A K  +   R Q   AE   EI 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 510 MLSQFRH-RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL----SWKQRLEI 564
           +L   +    +++L    +  +E+ILI EY   G     ++   LP L    S    + +
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRL 136
Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFGLSKTGPEIDQTHVS 621
                 G++YLH      ++H D+K  NILL   +     K+ DFG+S+   +I      
Sbjct: 137 IKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACEL 190
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             + G+  YL PE      +T  +D+++ G++ + +L
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G KVA+K+   P   +  A+    E+ +L   RH +++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 526 ------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA-RGLHYLHTG 578
                  D+  +  L+  +M  GT  G L          + R++  +    +GL Y+H  
Sbjct: 93  FTPDETLDDFTDFYLVMPFM--GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH-- 145
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            A  +IHRD+K  N+ ++E+   K+ DFGL++   + D       V  +  Y  PE    
Sbjct: 146 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV--TRWYRAPEVILN 199
Query: 639 -QQLTEKSDVYSFGVVLFEVLCAR 661
             + T+  D++S G ++ E++  +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           ++++ E ++ G L   +   G  + + ++  EI       + YLH+     + HRDVK  
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 196
Query: 592 NILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           N+L      N + K+ DFG +K         ++T     + Y+ PE    ++  +  D++
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMW 253
Query: 649 SFGVVLFEVLCARP 662
           S GV+++ +LC  P
Sbjct: 254 SLGVIMYILLCGYP 267

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 64/134 (47%), Gaps = 9/134 (6%)
Query: 532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           ++++ E ++ G L   +   G  + + ++  EI       + YLH+     + HRDVK  
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 146
Query: 592 NILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
           N+L      N + K+ DFG +K         ++T     + Y+ PE    ++  +  D++
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMW 203
Query: 649 SFGVVLFEVLCARP 662
           S GV+++ +LC  P
Sbjct: 204 SLGVIMYILLCGYP 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRDVK  NIL+  +  A + DFG++    +   T +   V G+  Y  PE F     T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 645 SDVYSFGVVLFEVLCARP 662
           +D+Y+   VL+E L   P
Sbjct: 216 ADIYALTCVLYECLTGSP 233

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 25/180 (13%)
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           +I +   + L +LH+  +  VIHRDVK +N+L++     K+ DFG+S  G  +D     T
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKT 211
Query: 623 AVKGSFGYLDPEY----FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 678
              G   Y+ PE       ++  + KSD++S G+ + E+   R   D            W
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SW 260
Query: 679 AMKWQNKGQLDQIIDPTLAGKIRPDSLR-KFGETAEKCLADFGVDRPSMGDVLWNLEYAL 737
              +Q   QL Q+++   + ++  D    +F +   +CL     +RP+  +++ +  + L
Sbjct: 261 GTPFQ---QLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 316

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/280 (21%), Positives = 111/280 (39%), Gaps = 59/280 (21%)
Query: 424 NGGNSHTMGSKYSHG-----------TTTSANSNSGYRFPFVAVQEATNNFDESWVIGIG 472
           N G  HT+      G           T +    +S ++ P        + ++   +IG G
Sbjct: 13  NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIP--------DRYEIRHLIGTG 64
Query: 473 GFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGYCDEK 529
            +G V +       +V   +   R  + L + +    EI +L++  H H+V ++     K
Sbjct: 65  SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK 124
Query: 530 N-----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
           +     E+ ++ E  ++   K       L  L  K  L   +    G+ Y+H+     ++
Sbjct: 125 DVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLV---GVKYVHSA---GIL 178
Query: 585 HRDVKSANILLDENFMAKVADFGLSKT-------------GPEIDQT------HVSTAVK 625
           HRD+K AN L++++   KV DFGL++T              P  D        H     +
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 626 GSFGYLDPEYFRRQQL-------TEKSDVYSFGVVLFEVL 658
              G++   ++R  +L       TE  DV+S G +  E+L
Sbjct: 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 33/179 (18%)
Query: 507 EIEMLSQFRHRHLVSL----IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
           EI +L + +H +++SL    + + D K  + L+++Y E+     H+      S + K+ +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPV 123
Query: 563 EICIGSAR--------GLHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSK 610
           ++  G  +        G+HYLH  +   V+HRD+K ANIL+     E    K+AD G ++
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 611 -----TGPEIDQTHVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPV 663
                  P  D   V      +F Y  PE     +  T+  D+++ G +  E+L + P+
Sbjct: 181 LFNSPLKPLADLDPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 21  SQVLGLGINGKV----LQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVD 76
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH+   
Sbjct: 77  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS--- 133
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K   E    +  T    +  Y+ PE   
Sbjct: 134 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLG 190
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D++S GV+++ +LC  P
Sbjct: 191 PEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 125
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 126 CH------NXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 175
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 158
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 159 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 208
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 158
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 159 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 208
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 157
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 158 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 207
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 157
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 158 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 207
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 157
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 158 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 207
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 158
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 159 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 208
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
           +G G +G V   Y   L    KVAVK+ +   Q  +   +T  E+ +L   +H +++ L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHT 577
                   +    E      L   L G+ L ++   Q L       +     RGL Y+H+
Sbjct: 86  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +N+ ++E+   ++ DFGL++   E    +V+T       Y  PE   
Sbjct: 142 A---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 193
Query: 638 R-QQLTEKSDVYSFGVVLFEVL 658
                 +  D++S G ++ E+L
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELL 215

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 144
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 145 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 194
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 157
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 158 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 207
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 144
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 145 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 194
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 158
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 159 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 208
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 129
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 130 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 179
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 145
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 146 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 195
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 130
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 131 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 180
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 130
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 131 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 180
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 172
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 173 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 222
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 125
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 126 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 175
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 172
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 173 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 222
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 125
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 126 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 175
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 164
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 165 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 214
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    IG G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    KVADFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 145
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 146 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 195
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 130
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 131 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 180
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 145
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 146 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 195
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 128
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 129 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 178
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W Q LE    + R 
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-QVLE----AVRH 177
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 178 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 227
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
           +G G +G V   Y   L    KVAVK+ +   Q  +   +T  E+ +L   +H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHT 577
                   +    E      L   L G+ L ++   Q L       +     RGL Y+H+
Sbjct: 94  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +N+ ++E+   ++ DFGL++   E    +V+T       Y  PE   
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 638 R-QQLTEKSDVYSFGVVLFEVLCAR 661
                 +  D++S G ++ E+L  +
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQ------TEIEMLSQFR--HRH 518
           ++G GGFG VY G  ++D   VA+K           E         E+ +L +       
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 519 LVSLIGYCDEKNEMILIYEYMENG-------TLKGHLYGSGLPSLSWKQRLEICIGSARG 571
           ++ L+ + +  +  +LI E  E         T +G L      S  W+      + + R 
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ-----VLEAVRH 152
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            H         V+HRD+K  NIL+D N    K+ DFG   +G  +  T V T   G+  Y
Sbjct: 153 CHNC------GVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVY 202
Query: 631 LDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA 660
             PE+ R  +   +S  V+S G++L++++C 
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 44/216 (20%)
Query: 469 IGIGGFGKVYKGELNDGTK-VAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           IG G +G V+K +  +  + VA+KR        G P S         EI +L + +H+++
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL------REICLLKELKHKNI 63
Query: 520 VSLIGYCDEKNEMILIYEYME----------NGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           V L        ++ L++E+ +          NG L   +  S L  L             
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------------L 111
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
           +GL + H+   + V+HRD+K  N+L++ N   K+A+FGL++      + + +  V  +  
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLW 166
Query: 630 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCA-RPV 663
           Y  P+     +L   S D++S G +  E+  A RP+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 466 SWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM-LSQFRHRHLVSLIG 524
           S V+G+G  GKV    L    K   ++   +  Q   + + E+E+     +  H+V ++ 
Sbjct: 67  SQVLGLGINGKV----LQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 525 YCDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH+   
Sbjct: 123 VYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI-- 180
Query: 581 KAVIHRDVKSANILLDE---NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             + HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE   
Sbjct: 181 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET--TSHNSLTTPCYTPY-YVAPEVLG 236
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  +  D +S GV+ + +LC  P
Sbjct: 237 PEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 32/210 (15%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLA--EFQTEIEMLSQFRHRHLVS 521
           VIG G F  V +      G + AVK        S  GL+  + + E  +    +H H+V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 522 LIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGLPSLSWKQRLEICIGSARGL 572
           L+        + +++E+M+   L          G +Y   + S   +Q LE        L
Sbjct: 93  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 145
Query: 573 HYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLS-KTGPEIDQTHVSTAVKGSF 628
            Y H      +IHRDVK   +LL   + +   K+  FG++ + G   +   V+    G+ 
Sbjct: 146 RYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG---ESGLVAGGRVGTP 199
Query: 629 GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            ++ PE  +R+   +  DV+  GV+LF +L
Sbjct: 200 HFMAPEVVKREPYGKPVDVWGCGVILFILL 229

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLA--EFQTEIEMLSQFRHRHLVS 521
           VIG G F  V +      G + AVK        S  GL+  + + E  +    +H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 522 LIGYCDEKNEMILIYEYMENGTL---------KGHLYGSGLPSLSWKQRLEICIGSARGL 572
           L+        + +++E+M+   L          G +Y   + S   +Q LE        L
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-------AL 143
Query: 573 HYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            Y H      +IHRDVK   +LL   + +   K+  FG++    E     V+    G+  
Sbjct: 144 RYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPH 198
Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           ++ PE  +R+   +  DV+  GV+LF +L
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILL 227

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
           +G G +G V   Y   L    KVAVK+ +   Q  +   +T  E+ +L   +H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYLHT 577
                   +    E      L   L G+ L ++   Q L       +     RGL Y+H+
Sbjct: 94  DVFTPATSI----EDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +N+ ++E+   ++ DFGL++   E    +V+T       Y  PE   
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 638 R-QQLTEKSDVYSFGVVLFEVL 658
                 +  D++S G ++ E+L
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELL 223

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           +G G F  V +  ++  G + A K  N +  S +   + + E  +    +H ++V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 526 CDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             E+    L+++ +  G L         Y     S   +Q LE        +++ H    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLN-- 122
Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+LL    +    K+ADFGL+       Q     A  G+ GYL PE  R
Sbjct: 123 -GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLR 179
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           +    +  D+++ GV+L+ +L   P
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYP 204

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 507 EIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           EIE+L ++ +H ++++L    D+   + ++ E  + G L   +        S ++   + 
Sbjct: 65  EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF--FSEREASAVL 122
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANIL-LDEN---FMAKVADFGLSKTGPEIDQTHVS 621
               + + YLH   A+ V+HRD+K +NIL +DE+      ++ DFG +K     +    +
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXT 179
Query: 622 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                +F  + PE   RQ      D++S GV+L+  L
Sbjct: 180 PCYTANF--VAPEVLERQGYDAACDIWSLGVLLYTXL 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           +G G F  V +  ++  G + A K  N +  S +   + + E  +    +H ++V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 526 CDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
             E+    L+++ +  G L         Y     S   +Q LE        +++ H    
Sbjct: 72  ISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE-------SVNHCHLN-- 122
Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+LL    +    K+ADFGL+       Q     A  G+ GYL PE  R
Sbjct: 123 -GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPEVLR 179
Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           +    +  D+++ GV+L+ +L   P
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYP 204

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L E +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFGL+K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG           ++   +   R ++     + EI      RH ++V        
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + ++ EY   G L   +  +G    S  +          G+ Y H   A  V HRD+
Sbjct: 86  PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH---AMQVCHRDL 140
Query: 589 KSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK-S 645
           K  N LLD +     K+ DFG SK+   +  +   + V G+  Y+ PE   +++   K +
Sbjct: 141 KLENTLLDGSPAPRLKICDFGYSKSS--VLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVA 197
Query: 646 DVYSFGVVLFEVLC-ARPVIDPTLPR 670
           DV+S GV L+ +L  A P  DP  P+
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPK 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 507 EIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           E+++L +   H +++ L    +      L+++ M+ G L  +L  +   +LS K+  +I 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIM 130
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
                 +  LH      ++HRD+K  NILLD++   K+ DFG S    ++D      +V 
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLRSVC 184
Query: 626 GSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARP 662
           G+  YL PE              ++ D++S GV+++ +L   P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLAEFQT---EIEMLSQFR----H 516
           ++G GGFG V+ G  L D  +VA+K   R        L++  T   E+ +L +      H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 517 RHLVSLIGYCDEKNEMILIYE-------YMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
             ++ L+ + + +   +L+ E         +  T KG L G G PS  +  ++   I   
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPL-GEG-PSRCFFGQVVAAIQHC 155
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
                    +++ V+HRD+K  NIL+D     AK+ DFG       +      T   G+ 
Sbjct: 156 ---------HSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA----LLHDEPYTDFDGTR 202
Query: 629 GYLDPEYFRRQQLTE-KSDVYSFGVVLFEVLCA 660
            Y  PE+  R Q     + V+S G++L++++C 
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           +I +   + L +LH+  +  VIHRDVK +N+L++     K+ DFG+S  G  +D      
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVAKDI 168
Query: 623 AVKGSFGYLDPEY----FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEW 678
              G   Y+ PE       ++  + KSD++S G+ + E+   R   D            W
Sbjct: 169 DA-GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SW 216
Query: 679 AMKWQNKGQLDQIIDPTLAGKIRPDSLR-KFGETAEKCLADFGVDRPSMGDVLWNLEYAL 737
              +Q   QL Q+++   + ++  D    +F +   +CL     +RP+  +++ +  + L
Sbjct: 217 GTPFQ---QLKQVVEEP-SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
Query: 738 Q 738
Sbjct: 273 H 273

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 507 EIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           E+++L +   H +++ L    +      L+++ M+ G L  +L  +   +LS K+  +I 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIM 117
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
                 +  LH      ++HRD+K  NILLD++   K+ DFG S    ++D       V 
Sbjct: 118 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVC 171
Query: 626 GSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCARP 662
           G+  YL PE              ++ D++S GV+++ +L   P
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 145
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+DE    +V DFG +K          +  + G+  YL PE  
Sbjct: 146 S---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 197
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 198 LSKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 507 EIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC 565
           E+++L +   H +++ L    +      L+++ M+ G L  +L  +   +LS K+  +I 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIM 130
Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
                 +  LH      ++HRD+K  NILLD++   K+ DFG S    ++D       V 
Sbjct: 131 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVC 184
Query: 626 GSFGYLDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARP 662
           G+  YL PE              ++ D++S GV+++ +L   P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 179
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGATWTLCGTPEYLAPEII 231
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLXGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 85/190 (44%), Gaps = 14/190 (7%)
Query: 475 GKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN-- 530
           G+++KG    G  + VK    R  S +   +F  E   L  F H +++ ++G C      
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS 590
              LI  +M  G+L   L+      +   Q ++  +  ARG+ +LHT     +    + S
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNS 141
Query: 591 ANILLDENFMAKV--ADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            ++++DE+  A++  AD   S   P   + +    V        PE   R+     +D++
Sbjct: 142 RSVMIDEDMTARISMADVKFSFQSP--GRMYAPAWVAPEALQKKPEDTNRRS----ADMW 195
Query: 649 SFGVVLFEVL 658
           SF V+L+E++
Sbjct: 196 SFAVLLWELV 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLAGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 89/181 (49%), Gaps = 18/181 (9%)
Query: 441 TSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ 499
           +S   N  ++   +   +  +N++   +IG G +G VY   + N    VA+K+ N R  +
Sbjct: 8   SSGRENLYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVN-RMFE 66
Query: 500 GLAEFQT---EIEMLSQFRHRHLVSLIGYCDEKN-----EMILIYEYMENGTLKGHLYGS 551
            L + +    EI +L++ +  +++ L      ++     E+ ++ E  ++   K  L+ +
Sbjct: 67  DLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK--LFKT 124
Query: 552 GLPSLSWKQRLE-ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
             P    +Q ++ I      G  ++H      +IHRD+K AN LL+++   K+ DFGL++
Sbjct: 125 --PIFLTEQHVKTILYNLLLGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLAR 179
Query: 611 T 611
           T
Sbjct: 180 T 180

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 25/209 (11%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQ 513
            +F     +G G +G+V+K     DG   AVKR      G     + LAE  +  E + Q
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH-EKVGQ 115
Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLS-WKQRLEICIGSAR 570
             H   V L    +E   + L  E +   +L+ H   +G+ LP    W    +  +    
Sbjct: 116 --HPCCVRLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLA--- 169
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            L +LH+   + ++H DVK ANI L      K+ DFGL     E+         +G   Y
Sbjct: 170 -LAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRY 222
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           + PE  +    T  +DV+S G+ + EV C
Sbjct: 223 MAPELLQGSYGT-AADVFSLGLTILEVAC 250

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 87/208 (41%), Gaps = 29/208 (13%)
Query: 469 IGIGGFGKVYKGELNDGTK------VAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G F  V +      T+      +  K+ + R  Q L   + E  +    +H ++V L
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL---EREARICRLLKHPNIVRL 95
Query: 523 IGYCDEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                E+    L+++ +  G L         Y     S    Q LE        ++++H 
Sbjct: 96  HDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE-------SVNHIHQ 148
Query: 578 GYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
                ++HRD+K  N+LL    +    K+ADFGL+       Q     A  G+ GYL PE
Sbjct: 149 ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPGYLSPE 203
Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             R+    +  D+++ GV+L+ +L   P
Sbjct: 204 VLRKDPYGKPVDIWACGVILYILLVGYP 231

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L E +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    +V DFGL+K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 143 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
             PE        E  D++S G ++ E++C +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 82/182 (45%), Gaps = 19/182 (10%)
Query: 485 GTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY------CDEKNEMILIY 536
           G  VAVK+   P   Q  A+    E+ +L    H++++SL+         +E  ++ L+ 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
           E M+    +          +S+     +C     G+ +LH+     +IHRD+K +NI++ 
Sbjct: 107 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 158
Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
            +   K+ DFGL++T        + T    +  Y  PE        E  D++S G ++ E
Sbjct: 159 SDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 657 VL 658
           ++
Sbjct: 216 LV 217

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/91 (28%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR 661
             PE        E  D++S G ++ E++C +
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 17/221 (7%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAE 677
             +   +  D ++ GV+++E+    P   P    E + + E
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP---PFFADEPIQIYE 248

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 456 VQEATNNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAE---FQTEIEML 511
           V+   ++F+   VIG G F +V   ++    +V A+K  N        E   F+ E ++L
Sbjct: 56  VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL 115
Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSA 569
                R +  L     ++N + L+ EY   G L   L  +G  +P+   +  L   + + 
Sbjct: 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAI 175
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
             +H L  GY    +HRD+K  NILLD     ++ADFG S      D T  S    G+  
Sbjct: 176 DSVHRL--GY----VHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPD 228
Query: 630 YLDPEYFR-------RQQLTEKSDVYSFGVVLFEVL 658
           YL PE  +             + D ++ GV  +E+ 
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 26/101 (25%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T              G+   
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------------GTSFM 181
Query: 631 LDPE----YFRRQQLT------EKSDVYSFGVVLFEVLCAR 661
           ++PE    Y+R  ++       E  D++S G ++ E++C +
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G KVA+K+   P   +  A+    E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 526 CDEKNEMILIYE-YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
               + +   Y+ Y+    ++  L        S ++   +     +GL Y+H+     V+
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVV 148
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT-- 642
           HRD+K  N+ ++E+   K+ DFGL++        H    +    GY+   ++R  ++   
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMT---GYVVTRWYRAPEVILS 197
Query: 643 -----EKSDVYSFGVVLFEVLCAR 661
                +  D++S G ++ E+L  +
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 92/204 (45%), Gaps = 25/204 (12%)
Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY 525
           +G G +G V    +   G KVA+K+   P   +  A+    E+ +L   +H +++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 526 CDEKNEMILIYE-YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
               + +   Y+ Y+    ++  L        S ++   +     +GL Y+H+     V+
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVV 166
Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT-- 642
           HRD+K  N+ ++E+   K+ DFGL++        H    +    GY+   ++R  ++   
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMT---GYVVTRWYRAPEVILS 215
Query: 643 -----EKSDVYSFGVVLFEVLCAR 661
                +  D++S G ++ E+L  +
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 144
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K       T     + G+  YL PE  
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEII 196
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K       T     + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 512
           T  F E   IG G FG V+K  +  DG   A+KR      G+   Q  L E      +L 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 64
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE---ICIGSA 569
           Q  H H+V       E + M++  EY   G+L   +       +S+ +  E   + +   
Sbjct: 65  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 121
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA-------DFGLSKTGPEI-DQTHVS 621
           RGL Y+H+    +++H D+K +NI +    +   A       D+  +K   +I D  HV+
Sbjct: 122 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 178
Query: 622 TAVKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
                     D  +   + L E      K+D+++  + +     A P     LPR   N 
Sbjct: 179 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEP-----LPR---NG 230
Query: 676 AEWAMKWQNK-----GQLDQIIDPTLAGKIRPDSLRK 707
            +W    Q +       L Q     L   I PD  R+
Sbjct: 231 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 267

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILY 258

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 26/101 (25%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T              G+   
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA-------------GTSFM 181
Query: 631 LDPE----YFRRQQLT------EKSDVYSFGVVLFEVLCAR 661
           ++PE    Y+R  ++       E  D++S G ++ E++C +
Sbjct: 182 MEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 36  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 144 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILY 230

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 35/178 (19%)
Query: 507 EIEMLSQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR---- 561
           E+EML Q + HR+++ LI + +E++   L++E M  G++  H++         K+R    
Sbjct: 60  EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH---------KRRHFNE 110
Query: 562 LEICI---GSARGLHYLHTGYAKAVIHRDVKSANILLDENFM---AKVADFGLSKTGPEI 615
           LE  +     A  L +LH    K + HRD+K  NIL +        K+ DFGL  +G ++
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLG-SGIKL 166
Query: 616 --DQTHVST----AVKGSFGYLDPEY---FRRQQ--LTEKSDVYSFGVVLFEVLCARP 662
             D + +ST       GS  Y+ PE    F  +     ++ D++S GV+L+ +L   P
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 20  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 77
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 78  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 127
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 128 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILY 214

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKR-----GNPRSQQGLAE------FQTEIEMLSQFRHR 517
           I  G +G V  G  ++G  VA+KR      + R+   L++         EI +L+ F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 518 HLVSLIGYCDEKNEMILIYE--YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY- 574
           +++ L        ++ + +E   M    L   L  + L  +   QR+ I     +   Y 
Sbjct: 90  NILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 575 ----LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFG 629
               LH  +   V+HRD+   NILL +N    + DF L++    + ++TH  T       
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT----HRW 198
Query: 630 YLDPEYFRR-QQLTEKSDVYSFGVVLFEVL 658
           Y  PE   + +  T+  D++S G V+ E+ 
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 12/206 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG           ++   +   R ++     + EI      RH ++V        
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + ++ EY   G L   +  +G    S  +          G+ Y H   A  V HRD+
Sbjct: 87  PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH---AMQVCHRDL 141
Query: 589 KSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK-S 645
           K  N LLD +     K+  FG SK+   +  +   + V G+  Y+ PE   +++   K +
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSS--VLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVA 198
Query: 646 DVYSFGVVLFEVLC-ARPVIDPTLPR 670
           DV+S GV L+ +L  A P  DP  P+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRH 516
           +N+    +IG G +G VY   + N    VA+K+ N R  + L + +    EI +L++ + 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKS 84
Query: 517 RHLVSLIGYCDEKN-----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            +++ L       +     E+ ++ E  ++   K  L+ + +  L+ +    I      G
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK--LFKTPI-FLTEEHIKTILYNLLLG 141
Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
            +++H      +IHRD+K AN LL+++   KV DFGL++T
Sbjct: 142 ENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKR-----GNPRSQQGLAE------FQTEIEMLSQFRHR 517
           I  G +G V  G  ++G  VA+KR      + R+   L++         EI +L+ F H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 518 HLVSLIGYCDEKNEMILIYE--YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY- 574
           +++ L        ++ + +E   M    L   L  + L  +   QR+ I     +   Y 
Sbjct: 90  NILGL-------RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 575 ----LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSFG 629
               LH  +   V+HRD+   NILL +N    + DF L++    + ++TH  T       
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT----HRW 198
Query: 630 YLDPEYFRR-QQLTEKSDVYSFGVVLFEVL 658
           Y  PE   + +  T+  D++S G V+ E+ 
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  +    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++++    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYQMAAGYP 236

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 ISKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 36  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 143
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++          V  +  G+  Y+ PE  + 
Sbjct: 144 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILY 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 151
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 203
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 582 AVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            V+HRD+K  N+L    ++N   K+ DFG ++  P  +Q   +     +  Y  PE   +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQ 183
Query: 639 QQLTEKSDVYSFGVVLFEVL 658
               E  D++S GV+L+ +L
Sbjct: 184 NGYDESCDLWSLGVILYTML 203

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 16  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 73
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 74  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 123
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 124 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILY 210

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 512
           T  F E   IG G FG V+K  +  DG   A+KR      G+   Q  L E      +L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE---ICIGSA 569
           Q  H H+V       E + M++  EY   G+L   +       +S+ +  E   + +   
Sbjct: 67  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 123
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA-------DFGLSKTGPEI-DQTHVS 621
           RGL Y+H+    +++H D+K +NI +    +   A       D+  +K   +I D  HV+
Sbjct: 124 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 622 TAVKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
                     D  +   + L E      K+D+++  + +     A P     LPR   N 
Sbjct: 181 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR---NG 232
Query: 676 AEWAMKWQNK-----GQLDQIIDPTLAGKIRPDSLRK 707
            +W    Q +       L Q     L   I PD  R+
Sbjct: 233 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 269

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILY 258

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 171
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 172 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILY 258

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 41/256 (16%)
Query: 431 MGSKYSHGTTTSANSNSGY-----RFPFVAVQEATNNFDESWVIGIGGFGKV---YKGEL 482
           + +K   G T   N N GY      +  V        ++   VIG G FG+V   Y  ++
Sbjct: 63  LNAKKRQGMTGGPN-NGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 483 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
           +    + + R   R  +  AE   EI +L   R +         D+ N M +I+  +EN 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQ---------DKDNTMNVIH-MLENF 168
Query: 543 TLKGH------LYGSGLPSLSWKQRLE-ICIGSARG-----LHYLHTGYAKAVIHRDVKS 590
           T + H      L    L  L  K + +   +   R      L  L   +   +IH D+K 
Sbjct: 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 591 ANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            NILL +   +  KV DFG S      +   V T ++  F Y  PE     +     D++
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSC----YEHQRVYTXIQSRF-YRAPEVILGARYGMPIDMW 283
Query: 649 SFGVVLFEVLCARPVI 664
           S G +L E+L   P++
Sbjct: 284 SLGCILAELLTGYPLL 299

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 469 IGIGGFGKVYKGELNDGTKV-AVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           IG GG  KV++  LN+  ++ A+K  N      Q L  ++ EI  L++ + +H   +I  
Sbjct: 17  IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 74
Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHTG 578
            D +     IY  ME G +  + +     S+        WK  LE           +HT 
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----------VHTI 124
Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           +   ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  + 
Sbjct: 125 HQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 639 QQLTEKS-----------DVYSFGVVLF 655
              + ++           DV+S G +L+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILY 211

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 179
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 231
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 12/206 (5%)
Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG G FG           ++   +   R ++     + EI      RH ++V        
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDV 588
              + ++ EY   G L   +  +G    S  +          G+ Y H   A  V HRD+
Sbjct: 87  PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCH---AMQVCHRDL 141
Query: 589 KSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK-S 645
           K  N LLD +     K+  FG SK+     Q   +    G+  Y+ PE   +++   K +
Sbjct: 142 KLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV---GTPAYIAPEVLLKKEYDGKVA 198
Query: 646 DVYSFGVVLFEVLC-ARPVIDPTLPR 670
           DV+S GV L+ +L  A P  DP  P+
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 41/256 (16%)
Query: 431 MGSKYSHGTTTSANSNSGY-----RFPFVAVQEATNNFDESWVIGIGGFGKV---YKGEL 482
           + +K   G T   N N GY      +  V        ++   VIG G FG+V   Y  ++
Sbjct: 63  LNAKKRQGMTGGPN-NGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKV 121
Query: 483 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
           +    + + R   R  +  AE   EI +L   R +         D+ N M +I+  +EN 
Sbjct: 122 HQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQ---------DKDNTMNVIH-MLENF 168
Query: 543 TLKGH------LYGSGLPSLSWKQRLE-ICIGSARG-----LHYLHTGYAKAVIHRDVKS 590
           T + H      L    L  L  K + +   +   R      L  L   +   +IH D+K 
Sbjct: 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228
Query: 591 ANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVY 648
            NILL +   +  KV DFG S      +   V T ++  F Y  PE     +     D++
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSC----YEHQRVYTXIQSRF-YRAPEVILGARYGMPIDMW 283
Query: 649 SFGVVLFEVLCARPVI 664
           S G +L E+L   P++
Sbjct: 284 SLGCILAELLTGYPLL 299

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 132
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 133 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFM 181
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 109/277 (39%), Gaps = 44/277 (15%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 512
           T  F E   IG G FG V+K  +  DG   A+KR      G+   Q  L E      +L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 66
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE---ICIGSA 569
           Q  H H+V       E + M++  EY   G+L   +       +S+ +  E   + +   
Sbjct: 67  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 123
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA-------DFGLSKTGPEI-DQTHVS 621
           RGL Y+H+    +++H D+K +NI +    +   A       D+  +K   +I D  HV+
Sbjct: 124 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 622 TAVKGSFGYLDPEYFRRQQLTE------KSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
                     D  +   + L E      K+D+++  + +     A P     LPR   N 
Sbjct: 181 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR---NG 232
Query: 676 AEWAMKWQNK-----GQLDQIIDPTLAGKIRPDSLRK 707
            +W    Q +       L Q     L   I PD  R+
Sbjct: 233 DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 269

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 182
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 183 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 236
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 237 GMGYKENVDIWSVGCIMGEMV 257

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 109/281 (38%), Gaps = 52/281 (18%)
Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLS 512
           T  F E   IG G FG V+K  +  DG   A+KR      G+   Q  L E      +L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 68
Query: 513 QFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE---ICIGSA 569
           Q  H H+V       E + M++  EY   G+L   +       +S+ +  E   + +   
Sbjct: 69  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 125
Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK-GSF 628
           RGL Y+H+    +++H D+K +NI +    +   A    S+ G E D        K G  
Sbjct: 126 RGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAA----SEEGDEDDWASNKVMFKIGDL 178
Query: 629 GYL-----------DPEYFRRQQLTE------KSDVYSFGVVLFEVLCARPVIDPTLPRE 671
           G++           D  +   + L E      K+D+++  + +     A P     LPR 
Sbjct: 179 GHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR- 232
Query: 672 MVNLAEWAMKWQNK-----GQLDQIIDPTLAGKIRPDSLRK 707
             N  +W    Q +       L Q     L   I PD  R+
Sbjct: 233 --NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 271

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             PE        E  D++S GV++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +      
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    KVADFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             PE        E  D++S GV++ E++
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 153
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 154 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 205
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 206 LSKGYNKAVDWWALGVLIYEMAAGYP 231

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLL 132
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 133 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFM 181
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 182 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 145
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 146 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 199
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 200 GMGYKENVDIWSVGCIMGEMV 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 144
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 145 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 198
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 199 GMGYKENVDIWSVGCIMGEMV 219

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 88/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 179
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 231
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 143
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 144 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 197
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 198 GMGYKENVDIWSVGCIMGEMV 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 126
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 127 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFM 175
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 133
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 134 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFM 182
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 126
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 127 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFM 175
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 176 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 17/158 (10%)
Query: 507 EIEMLSQFRHRHLVSLIGY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
           E+ ++    H++++SL+         +E  ++ L+ E M+    +          +S+  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 170
Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
              +C     G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + +
Sbjct: 171 YQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFM 219
Query: 621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            T    +  Y  PE        E  D++S G ++ E++
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 469 IGIGGFGKV---YKGELNDGTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLI 523
           IG G  G V   Y   L+    VA+K+   P   Q  A+    E+ ++    H++++SL+
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 524 GY------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                    +E  ++ L+ E M+    +          +S+     +C     G+ +LH+
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLHS 137
Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
                +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE   
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVIL 191
Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
                E  D++S G ++ E++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMV 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)
Query: 485 GTKVAVKR-GNPRSQQGLAEFQ-TEIEMLSQFRHRHLVSLIGY------CDEKNEMILIY 536
           G  VAVK+   P   Q  A+    E+ +L    H++++SL+         +E  ++ L+ 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
           E M+    +          +S+     +C     G+ +LH+     +IHRD+K +NI++ 
Sbjct: 109 ELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVK 160
Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
            +   K+ DFGL++T        + T    +  Y  PE           D++S G ++ E
Sbjct: 161 SDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 657 VL 658
           ++
Sbjct: 218 LV 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L  L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 86/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKV-YKGELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  + G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL P   
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWXLCGTPEYLAPAII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY   G +  HL   G       +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQI--VLTFEYLH 158
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFG +K          +  + G+  YL PE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 210
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 85/206 (41%), Gaps = 14/206 (6%)
Query: 461 NNFDESWVIGIGGFGKVYK-GELNDGTKVAVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + F+    +G G FG+V     +  G   A+K  + +    L + +    E  +L     
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L  L     + + + ++ EY   G +  HL   G  S    +     I       YLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQI--VLTFEYLH 159
Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +     +I+RD+K  N+++D+    KV DFG +K          +  + G+  YL PE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKR-----VKGRTWXLCGTPEYLAPEII 211
Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             PE        E  D++S G ++ E++
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G +G+V K  +  GT++  A K+      + +  F+ EIE++    H +++ L    
Sbjct: 17  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           ++  ++ L+ E    G L   +    +   S   R+   + SA  + Y H      V HR
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA--VAYCH---KLNVAHR 130
Query: 587 DVKSANILL---DENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           D+K  N L      +   K+ DFGL+   K G ++ +T V T       Y+ P+      
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPY-----YVSPQVLEGLY 184
Query: 641 LTEKSDVYSFGVVLFEVLCARPVID-PTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 699
             E  D +S GV+++ +LC  P    PT    M+ + E    +  K  L+  + P     
Sbjct: 185 GPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN--VSPQAESL 241
Query: 700 IR 701
           IR
Sbjct: 242 IR 243

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 24/242 (9%)
Query: 469 IGIGGFGKVYKGELNDGTKV--AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G +G+V K  +  GT++  A K+      + +  F+ EIE++    H +++ L    
Sbjct: 34  IGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           ++  ++ L+ E    G L   +    +   S   R+   + SA  + Y H      V HR
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA--VAYCH---KLNVAHR 147
Query: 587 DVKSANILL---DENFMAKVADFGLS---KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           D+K  N L      +   K+ DFGL+   K G ++ +T V T       Y+ P+      
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPY-----YVSPQVLEGLY 201
Query: 641 LTEKSDVYSFGVVLFEVLCARPVID-PTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 699
             E  D +S GV+++ +LC  P    PT    M+ + E    +  K  L+  + P     
Sbjct: 202 GPE-CDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLN--VSPQAESL 258
Query: 700 IR 701
           IR
Sbjct: 259 IR 260
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	805
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-132
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-84
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-66
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-64
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-44
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-43
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-43
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-42
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-42
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-42
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-42
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-42
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-41
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-41
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-39
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-38
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-38
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-31
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-29
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-27
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	7e-27
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	2e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-27
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-26
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-25
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-24
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-24
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	8e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-17
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-16
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-16
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-15
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-14
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  596 bits (1538), Expect = 0.0
 Identities = 220/324 (67%), Positives = 257/324 (79%), Gaps = 13/324 (4%)

Query: 431 MGSKYSHGTTTSANSNS--------GYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL 482
           MGSKYS  T +  ++ S         YR P V ++EATNNFD  ++IG G FGKVYKG L
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60

Query: 483 NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENG 542
            DG KVA+KR  P S QG+ EF+TEIE LS  RH HLVSLIG+CDE+NEMILIY+YMENG
Sbjct: 61  RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120

Query: 543 TLKGHLYGSGLPS--LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFM 600
            LK HLYGS LP+  +SW+QRLEICIG+ARGLHYLHT    A+IHRDVKS NILLDENF+
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177

Query: 601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
            K+ DFG+SK G E+DQTH+ST VKG+ GY+DPEYF + +LTEKSDVYSFGVVLFEVLCA
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237

Query: 661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFG 720
           R  I  +LPREMVNLAEWA++  N GQL+QI+DP LA KIRP+SLRKFG+TA KCLA   
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297

Query: 721 VDRPSMGDVLWNLEYALQLQEAVV 744
            DRPSMGDVLW LEYAL+LQE+V+
Sbjct: 298 EDRPSMGDVLWKLEYALRLQESVI 321

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  394 bits (1014), Expect = e-132
 Identities = 104/306 (33%), Positives = 166/306 (54%), Gaps = 20/306 (6%)

Query: 442 SANSNSGYRFPFVAVQEATNNFDESW------VIGIGGFGKVYKGELNDGTKVAVKR--- 492
             +    + F F  ++  TNNFDE         +G GGFG VYKG + + T VAVK+   
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64

Query: 493 -GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG- 550
             +  +++   +F  EI+++++ +H +LV L+G+  + +++ L+Y YM NG+L   L   
Sbjct: 65  MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124

Query: 551 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
            G P LSW  R +I  G+A G+++LH       IHRD+KSANILLDE F AK++DFGL++
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 670
              +  QT +++ + G+  Y+ PE   R ++T KSD+YSFGVVL E++   P +D    R
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238

Query: 671 EMVNLAEWAMK-WQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV 729
           E   L +   +    +  ++  ID  +       S+      A +CL +    RP +  V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 730 LWNLEY 735
              L+ 
Sbjct: 298 QQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  380 bits (977), Expect = e-126
 Identities = 118/290 (40%), Positives = 168/290 (57%), Gaps = 6/290 (2%)

Query: 450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL-AEFQTEI 508
           RF    +Q A++NF    ++G GGFGKVYKG L DGT VAVKR      QG   +FQTE+
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 509 EMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--SGLPSLSWKQRLEICI 566
           EM+S   HR+L+ L G+C    E +L+Y YM NG++   L       P L W +R  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
           GSARGL YLH      +IHRDVK+ANILLDE F A V DFGL+K       THV+TAV+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRG 197

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR--EMVNLAEWAMKWQN 684
           + G++ PEY    + +EK+DV+ +GV+L E++  +   D       + V L +W      
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           + +L+ ++D  L G  + + + +  + A  C     ++RP M +V+  LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  269 bits (690), Expect = 5e-84
 Identities = 78/326 (23%), Positives = 129/326 (39%), Gaps = 34/326 (10%)

Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAV 490
           MG  + H    S+  + G           +       V   G FG V+K +L     VAV
Sbjct: 1   MGHHHHH---HSSGVDLGTENL----YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAV 52

Query: 491 KRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLKG 546
           K    + +Q   + + E+  L   +H +++  IG          ++ LI  + E G+L  
Sbjct: 53  KIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD 111

Query: 547 HLYGSGLPSLSWKQRLEICIGSARGLHYLHT-------GYAKAVIHRDVKSANILLDENF 599
            L       +SW +   I    ARGL YLH        G+  A+ HRD+KS N+LL  N 
Sbjct: 112 FLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168

Query: 600 MAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVL 654
            A +ADFGL+           +    G+  Y+ PE        ++    + D+Y+ G+VL
Sbjct: 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228

Query: 655 FEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII-----DPTLAGKIRPDS-LRKF 708
           +E+       D  +   M+   E   +  +   + +++      P L    +  + +   
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAML 288

Query: 709 GETAEKCLADFGVDRPSMGDVLWNLE 734
            ET E+C       R S G V   + 
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  222 bits (569), Expect = 1e-66
 Identities = 81/295 (27%), Positives = 138/295 (46%), Gaps = 36/295 (12%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG V++ E + G+ VAVK    +    + + EF  E+ ++ + RH ++V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGL-PSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +   + ++ EY+  G+L   L+ SG    L  ++RL +    A+G++YLH      ++
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HR++KS N+L+D+ +  KV DFGLS+   +      S +  G+  ++ PE  R +   EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP-- 702
           SDVYSFGV+L+E+   +       P            W N     Q++        R   
Sbjct: 220 SDVYSFGVILWELATLQ------QP------------WGNLNPA-QVVAAVGFKCKRLEI 260

Query: 703 --DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNL 755
             +   +     E C  +    RPS   ++  L     L ++ V   P  N ++L
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR---PLIKSAV---PPPNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  221 bits (566), Expect = 3e-66
 Identities = 78/273 (28%), Positives = 123/273 (45%), Gaps = 34/273 (12%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           V+G G FG V K +      VA+K+    S+     F  E+  LS+  H ++V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWR-AKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC- 70

Query: 528 EKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             N + L+ EY E G+L   L+G+  LP  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 587 DVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           D+K  N+LL       K+ DFG +      D     T  KGS  ++ PE F     +EK 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP--- 702
           DV+S+G++L+EV+  R       P            +   G     I   +    RP   
Sbjct: 185 DVFSWGIILWEVITRR------KP------------FDEIGGPAFRIMWAVHNGTRPPLI 226

Query: 703 -DSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
            +  +       +C +     RPSM +++  + 
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  217 bits (554), Expect = 3e-64
 Identities = 69/330 (20%), Positives = 122/330 (36%), Gaps = 40/330 (12%)

Query: 459 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
             +N     +IG G +G VYKG L+    VAVK  +  ++Q        I  +    H +
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQNFINE-KNIYRVPLMEHDN 68

Query: 519 LVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
           +   I        D + E +L+ EY  NG+L  +L      +  W     +     RGL 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLA 125

Query: 574 YLHT------GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT------GPEIDQTHVS 621
           YLHT       Y  A+ HRD+ S N+L+  +    ++DFGLS            ++ + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 622 TAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 674
            +  G+  Y+ PE           +   ++ D+Y+ G++ +E+      + P        
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 675 LAEWAMKWQNKGQLDQIIDPTLAGKIRPD----------SLRKFGETAEKCLADFGVDRP 724
           +A       +    + +       K RP           ++R   ET E C       R 
Sbjct: 246 MAFQTEVGNH-PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304

Query: 725 SMGDVLWNLEYALQLQEAVVHGDPDENSTN 754
           +       +   + + E      P  +  +
Sbjct: 305 TAQXAEERMAELMMIWERNKSVSPTAHHHH 334

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  209 bits (533), Expect = 1e-61
 Identities = 87/278 (31%), Positives = 135/278 (48%), Gaps = 37/278 (13%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           IG G FG VYKG+ +    VAVK  N    + Q L  F+ E+ +L + RH +++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
                 I + ++ E  +L  HL+ S       K+ ++I   +ARG+ YLH   AK++IHR
Sbjct: 90  TAPQLAI-VTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL---TE 643
           D+KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 703
           +SDVY+FG+VL+E++  +      LP            + N    DQII+    G + PD
Sbjct: 205 QSDVYAFGIVLYELMTGQ------LP------------YSNINNRDQIIEMVGRGSLSPD 246

Query: 704 SLR-------KFGETAEKCLADFGVDRPSMGDVLWNLE 734
             +       +      +CL     +RPS   +L  +E
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  206 bits (527), Expect = 4e-61
 Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 43/283 (15%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQ----GLAEFQTEIEMLSQFRHRHLVSLI 523
           +IGIGGFGKVY+     G +VAVK       +     +   + E ++ +  +H ++++L 
Sbjct: 14  IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G C ++  + L+ E+   G L   L G     +     +   +  ARG++YLH      +
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 584 IHRDVKSANILLDE--------NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           IHRD+KS+NIL+ +        N + K+ DFGL++   E  +T   +A  G++ ++ PE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAPEV 185

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
            R    ++ SDV+S+GV+L+E+L         +P            ++    L  +    
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VP------------FRGIDGL-AVAYGV 226

Query: 696 LAGKIRPDSLR----KFGETAEKCLADFGVDRPSMGDVLWNLE 734
              K+           F +  E C       RPS  ++L  L 
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (527), Expect = 4e-61
 Identities = 55/274 (20%), Positives = 111/274 (40%), Gaps = 31/274 (11%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            +     G+++KG    G  + VK    R  S +   +F  E   L  F H +++ ++G 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 526 CDE--KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           C         LI  +M  G+L   L+      +   Q ++  +  ARG+ +LHT     +
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-- 641
               + S ++++DE+  A+++   +         +  S     +  ++ PE  +++    
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187

Query: 642 -TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 700
               +D++SF V+L+E++         +P   ++  E  MK   +G       PT    I
Sbjct: 188 NRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR-----PT----I 232

Query: 701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
            P       +  + C+ +    RP    ++  LE
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  205 bits (523), Expect = 2e-60
 Identities = 71/252 (28%), Positives = 111/252 (44%), Gaps = 49/252 (19%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR-------GNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            IG GGFG V+KG  + D + VA+K        G     +   EFQ E+ ++S   H ++
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V L G     N   ++ E++  G L   L     P + W  +L + +  A G+ Y+    
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 580 AKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
              ++HRD++S NI L          AKVADFGLS+        H  + + G+F ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPE 196

Query: 635 YFRRQQL--TEKSDVYSFGVVLFEVLC-----------------------ARPVIDPTLP 669
               ++   TEK+D YSF ++L+ +L                         RP I    P
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256

Query: 670 REMVNLAE--WA 679
             + N+ E  W+
Sbjct: 257 PRLRNVIELCWS 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  200 bits (510), Expect = 4e-58
 Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 38/282 (13%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           +IG G FG+VY G  +   +VA++  +    ++  L  F+ E+    Q RH ++V  +G 
Sbjct: 40  LIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           C     + +I    +  TL   +  +    L   +  +I     +G+ YLH   AK ++H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 586 RDVKSANILLDENFMAKVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL- 641
           +D+KS N+  D      + DFGL           +        G   +L PE  R+    
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 642 --------TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ-NKGQLDQII 692
                   ++ SDV++ G + +E+           P +       A+ WQ   G    + 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE------WPFK--TQPAEAIIWQMGTGMKPNLS 264

Query: 693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
              +        +         C A    +RP+   ++  LE
Sbjct: 265 QIGM-----GKEISDI---LLFCWAFEQEERPTFTKLMDMLE 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (508), Expect = 5e-58
 Identities = 73/280 (26%), Positives = 114/280 (40%), Gaps = 31/280 (11%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G FG+  K    + G  + +K      ++    F  E++++    H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            +   +  I EY++ GTL+G +         W QR+      A G+ YLH   +  +IHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLH---SMNIIHR 132

Query: 587 DVKSANILLDENFMAKVADFGLSK------------TGPEIDQTHVSTAVKGSFGYLDPE 634
           D+ S N L+ EN    VADFGL++               +         V G+  ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 694
               +   EK DV+SFG+VL E++         LPR M            +G LD+   P
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------NVRGFLDRYCPP 246

Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
                  P S         +C       RPS   +   LE
Sbjct: 247 NC-----PPSFFPI---TVRCCDLDPEKRPSFVKLEHWLE 278

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  195 bits (497), Expect = 3e-56
 Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 35/319 (10%)

Query: 442 SANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 501
           S +S SG   P +  +           IG G +G+V+ G+   G KVAVK      +   
Sbjct: 18  SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA-S 75

Query: 502 AEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIYEYMENGTLKGHLYGSGLPSLS 557
              +TEI      RH +++  I    +      ++ LI +Y ENG+L  +L      +L 
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLD 132

Query: 558 WKQRLEICIGSARGLHYLHT-----GYAKAVIHRDVKSANILLDENFMAKVADFGLS--K 610
            K  L++   S  GL +LHT         A+ HRD+KS NIL+ +N    +AD GL+   
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192

Query: 611 TGPEIDQTHVSTAVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARPVI 664
                +         G+  Y+ PE           Q    +D+YSFG++L+EV       
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 665 DPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP---------DSLRKFGETAEKC 715
                 ++     +     +    + + +     K+RP         + LR+ G+   +C
Sbjct: 253 GIVEEYQL----PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

Query: 716 LADFGVDRPSMGDVLWNLE 734
            A     R +   V   L 
Sbjct: 309 WAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  190 bits (484), Expect = 9e-55
 Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 39/295 (13%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEM--LSQFRHRHLVSLIGY 525
            +G G +G+V++G    G  VAVK  + R ++    +  E E+      RH +++  I  
Sbjct: 15  CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIAS 70

Query: 526 C----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT---- 577
                    ++ LI  Y E G+L  +L      +L     L I +  A GL +LH     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 578 -GYAKAVIHRDVKSANILLDENFMAKVADFGLS--KTGPEIDQTHVSTAVKGSFGYLDPE 634
                A+ HRD+KS NIL+ +N    +AD GL+   +         +    G+  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 635 ------YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
                         ++ D+++FG+VL+EV             +      +     N    
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP----FYDVVPNDPSF 243

Query: 689 DQIIDPTLAGKIRPD---------SLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           + +       + RP+         +L    +  ++C       R +   +   L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  187 bits (476), Expect = 3e-53
 Identities = 63/293 (21%), Positives = 126/293 (43%), Gaps = 35/293 (11%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 526
            IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I    
Sbjct: 49  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 106

Query: 527 ---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH-----TG 578
                  ++ L+ +Y E+G+L  +L      +++ +  +++ + +A GL +LH     T 
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH--VSTAVKGSFGYLDPE-- 634
              A+ HRD+KS NIL+ +N    +AD GL+        T         G+  Y+ PE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 635 ----YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 690
                 +  +  +++D+Y+ G+V +E+     +       ++     +     +   +++
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----PYYDLVPSDPSVEE 279

Query: 691 IIDPTLAGKIRP---------DSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           +       K+RP         ++LR   +   +C    G  R +   +   L 
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  164 bits (417), Expect = 1e-44
 Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 6/193 (3%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG+V+ G L  D T VAVK           A+F  E  +L Q+ H ++V LIG 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           C +K  + ++ E ++ G     L   G   L  K  L++   +A G+ YL    +K  IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+ + N L+ E  + K++DFG+S+   +          +    +  PE     + + +S
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSES 296

Query: 646 DVYSFGVVLFEVL 658
           DV+SFG++L+E  
Sbjct: 297 DVWSFGILLWETF 309

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  157 bits (400), Expect = 2e-43
 Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 22/199 (11%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            +G G FG+V+ G  N  TKVAVK     S      F  E  ++ Q +H+ LV L     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           ++   I I EYMENG+L   L       L+  + L++    A G+ ++     +  IHRD
Sbjct: 79  QEPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFRRQ 639
           +++ANIL+ +    K+ADFGL++   + + T           TA         PE     
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------PEAINYG 185

Query: 640 QLTEKSDVYSFGVVLFEVL 658
             T KSDV+SFG++L E++
Sbjct: 186 TFTIKSDVWSFGILLTEIV 204

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  161 bits (410), Expect = 5e-43
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 10/193 (5%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            +G G FG+V+ G  N  T+VA+K  +    S +    F  E +++ + RH  LV L   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             E+   I + EYM  G+L   L G     L   Q +++    A G+ Y+        +H
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+++ANIL+ EN + KVADFGL++   + + T      K    +  PE     + T KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 646 DVYSFGVVLFEVL 658
           DV+SFG++L E+ 
Sbjct: 363 DVWSFGILLTELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  161 bits (409), Expect = 2e-42
 Identities = 63/193 (32%), Positives = 98/193 (50%), Gaps = 10/193 (5%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            +G G FG+V+ G  N  T+VA+K  +    S +    F  E +++ + RH  LV L   
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             E+   I + EYM  G+L   L G     L   Q +++    A G+ Y+        +H
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+++ANIL+ EN + KVADFGL++   + + T      K    +  PE     + T KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 646 DVYSFGVVLFEVL 658
           DV+SFG++L E+ 
Sbjct: 446 DVWSFGILLTELT 458

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  160 bits (406), Expect = 3e-42
 Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 10/194 (5%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G +G+VY+G        VAVK  + +    +   EF  E  ++ + +H +LV L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 283

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
            C  +    +I E+M  G L  +L       +S    L +    +  + YL     K  I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 340

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HR++ + N L+ EN + KVADFGLS+     D        K    +  PE     + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 645 SDVYSFGVVLFEVL 658
           SDV++FGV+L+E+ 
Sbjct: 400 SDVWAFGVLLWEIA 413

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (390), Expect = 3e-42
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 22/199 (11%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            +G G FG V  G+      VAVK     S     EF  E + + +  H  LV   G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           ++  + ++ EY+ NG L  +L   G   L   Q LE+C     G+ +L    +   IHRD
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRD 129

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFRRQ 639
           + + N L+D +   KV+DFG+++   +               +A         PE F   
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA---------PEVFHYF 180

Query: 640 QLTEKSDVYSFGVVLFEVL 658
           + + KSDV++FG++++EV 
Sbjct: 181 KYSSKSDVWAFGILMWEVF 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  153 bits (390), Expect = 4e-42
 Identities = 65/199 (32%), Positives = 99/199 (49%), Gaps = 26/199 (13%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 526
            IG G FG V  G+   G KVAVK     +      F  E  +++Q RH +LV L+G   
Sbjct: 28  TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +HR
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS-------TAVKGSFGYLDPEYFRRQ 639
           D+ + N+L+ E+ +AKV+DFGL+K   E   T  +       TA         PE  R +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA---------PEALREK 189

Query: 640 QLTEKSDVYSFGVVLFEVL 658
           + + KSDV+SFG++L+E+ 
Sbjct: 190 KFSTKSDVWSFGILLWEIY 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  154 bits (391), Expect = 5e-42
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 15/227 (6%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FGKV          N G +VAVK   P      +A+ + EIE+L    H ++V 
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87

Query: 522 LIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
             G C E     + LI E++ +G+LK +L  +    ++ KQ+L+  +   +G+ YL    
Sbjct: 88  YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG--- 143

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRR 638
           ++  +HRD+ + N+L++     K+ DFGL+K    + +   V         +  PE   +
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 639 QQLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ 683
            +    SDV+SFGV L E+   C        L  +M+      M   
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  155 bits (393), Expect = 5e-42
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 14/226 (6%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G FG V          N G  VAVK+          +FQ EI++L       +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89

Query: 523 IGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G         + L+ EY+ +G L+  L       L   + L       +G+ YL    +
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---S 145

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
           +  +HRD+ + NIL++     K+ADFGL+K    + D   V    +    +  PE     
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205

Query: 640 QLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMKWQ 683
             + +SDV+SFGVVL+E+   C +          M+          
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  153 bits (389), Expect = 8e-42
 Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG VY GE  D      + A+K  +     Q +  F  E  ++    H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87

Query: 523 IGYCDEKNEMILI-YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           IG       +  +   YM +G L   +      + + K  +   +  ARG+ YL     +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA---EQ 143

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYF 636
             +HRD+ + N +LDE+F  KVADFGL++   +I      +  +     L       E  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALESL 200

Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
           +  + T KSDV+SFGV+L+E+L
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELL 222

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  153 bits (389), Expect = 9e-42
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 522
           VIG G FG VY G L D        AVK  N       +++F TE  ++  F H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91

Query: 523 IGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           +G C   +   +++  YM++G L+  +      + + K  +   +  A+G+ YL    +K
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA---SK 147

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYF 636
             +HRD+ + N +LDE F  KVADFGL++   ++      +    +   L       E  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 637 RRQQLTEKSDVYSFGVVLFEVL 658
           + Q+ T KSDV+SFGV+L+E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  155 bits (393), Expect = 2e-41
 Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 18/261 (6%)

Query: 409 LPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWV 468
           +  +      +       N +  G+   H   ++ N         V +  ++     + V
Sbjct: 37  ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96

Query: 469 IGIGGFGKVYKGELNDG----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           IG G FG VY G L D        AVK  N       +++F TE  ++  F H +++SL+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156

Query: 524 GYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           G C   +   +++  YM++G L+  +      + + K  +   +  A+G+ +L    +K 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKK 212

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPEYFR 637
            +HRD+ + N +LDE F  KVADFGL++   ++      +    +   L       E  +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
            Q+ T KSDV+SFGV+L+E++
Sbjct: 270 TQKFTTKSDVWSFGVLLWELM 290

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  152 bits (386), Expect = 2e-41
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 26/201 (12%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            +G G FG V  G+      VA+K  +    S+    EF  E +++    H  LV L G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           C ++  + +I EYM NG L  +L          +Q LE+C      + YL    +K  +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS--------TAVKGSFGYLDPEYFR 637
           RD+ + N L+++  + KV+DFGLS+   + + T           +          PE   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------PEVLM 194

Query: 638 RQQLTEKSDVYSFGVVLFEVL 658
             + + KSD+++FGV+++E+ 
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY 215

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (390), Expect = 2e-41
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 11/197 (5%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G G FG VYKG            VA+K      S +   E   E  +++   + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C   + + LI + M  G L  ++      ++  +  L  C+  A+G++YL     +
Sbjct: 82  LLGIC-LTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DR 136

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+K     ++ + +   K    ++  E    +  
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 642 TEKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  151 bits (384), Expect = 2e-41
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 14/195 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG V+ G   +  KVA+K  R    S++   +F  E E++ +  H  LV L G 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
           C E+  + L+ E+ME+G L  +L        + +  L +C+    G+ YL       VIH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIH 127

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY--LDPEYFRRQQLTE 643
           RD+ + N L+ EN + KV+DFG+++    +     +++    F      PE F   + + 
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 644 KSDVYSFGVVLFEVL 658
           KSDV+SFGV+++EV 
Sbjct: 185 KSDVWSFGVLMWEVF 199

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  157 bits (398), Expect = 2e-41
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 6/191 (3%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            +G G FG+V+    N  TKVAVK   P S   +  F  E  ++   +H  LV L     
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
           ++   I I E+M  G+L   L           + ++     A G+ ++     +  IHRD
Sbjct: 254 KEPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDV 647
           +++ANIL+  + + K+ADFGL++   + ++       K    +  PE       T KSDV
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368

Query: 648 YSFGVVLFEVL 658
           +SFG++L E++
Sbjct: 369 WSFGILLMEIV 379

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  155 bits (395), Expect = 4e-41
 Identities = 64/194 (32%), Positives = 99/194 (51%), Gaps = 16/194 (8%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            IG G FG V  G+   G KVAVK     +      F  E  +++Q RH +LV L+G   
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 528 EKNEMI-LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           E+   + ++ EYM  G+L  +L   G   L     L+  +     + YL        +HR
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST--AVKGSFGYLDPEYFRRQQLTEK 644
           D+ + N+L+ E+ +AKV+DFGL+K   E   T  +    VK    +  PE  R ++ + K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFSTK 366

Query: 645 SDVYSFGVVLFEVL 658
           SDV+SFG++L+E+ 
Sbjct: 367 SDVWSFGILLWEIY 380

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  151 bits (383), Expect = 5e-41
 Identities = 51/199 (25%), Positives = 81/199 (40%), Gaps = 13/199 (6%)

Query: 468 VIGIGGFGKVYKGELN----DGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG V +GE +        VAVK          + + +F  E+  +    HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L G        + + E    G+L   L                 +  A G+ YL    +
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---S 139

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
           K  IHRD+ + N+LL    + K+ DFGL +      D   +    K  F +  PE  + +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 640 QLTEKSDVYSFGVVLFEVL 658
             +  SD + FGV L+E+ 
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (382), Expect = 8e-41
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 14/215 (6%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V  
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76

Query: 523 IGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C       + LI EY+  G+L+ +L       +   + L+      +G+ YL     
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---T 132

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQ 639
           K  IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192

Query: 640 QLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREM 672
           + +  SDV+SFGVVL+E+     +    P     M
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  150 bits (381), Expect = 9e-41
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 15/198 (7%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           ++G G FG+VY+G   +       VAVK      +     +F +E  ++    H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG  +E+   I I E    G L  +L  +   SL     +   +   + + YL    +  
Sbjct: 79  IGIIEEEPTWI-IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SIN 133

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 640
            +HRD+   NIL+      K+ DFGLS+    I+      A        ++ PE    ++
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFRR 190

Query: 641 LTEKSDVYSFGVVLFEVL 658
            T  SDV+ F V ++E+L
Sbjct: 191 FTTASDVWMFAVCMWEIL 208

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  150 bits (381), Expect = 2e-40
 Identities = 67/249 (26%), Positives = 104/249 (41%), Gaps = 22/249 (8%)

Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVA 489
           MGS + H   +S   N  ++   V +     ++     +G GGF  V   E L+DG   A
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGHMVIIDN--KHYLFIQKLGEGGFSYVDLVEGLHDGHFYA 58

Query: 490 VKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC----DEKNEMILIYEYMENGTLK 545
           +KR     QQ   E Q E +M   F H +++ L+ YC      K+E  L+  + + GTL 
Sbjct: 59  LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118

Query: 546 GHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV 603
             +         L+  Q L + +G  RGL  +H    K   HRD+K  NILL +     +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVL 175

Query: 604 ADFGLSKTGP-------EIDQTHVSTAVKGSFGYLDPEYF---RRQQLTEKSDVYSFGVV 653
            D G             +        A + +  Y  PE F       + E++DV+S G V
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235

Query: 654 LFEVLCARP 662
           L+ ++    
Sbjct: 236 LYAMMFGEG 244

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (381), Expect = 2e-40
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 14/215 (6%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G FG V          N G  VAVK+    +++ L +F+ EIE+L   +H ++V  
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107

Query: 523 IGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            G C    +  + LI EY+  G+L+ +L       +   + L+      +G+ YL     
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---T 163

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRRQ 639
           K  IHRD+ + NIL++     K+ DFGL+K  P+  +   V    +    +  PE     
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223

Query: 640 QLTEKSDVYSFGVVLFEVL--CARPVIDPTLPREM 672
           + +  SDV+SFGVVL+E+     +    P     M
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  148 bits (377), Expect = 3e-40
 Identities = 61/198 (30%), Positives = 89/198 (44%), Gaps = 15/198 (7%)

Query: 468 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K      S     +F  E   + QF H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG   E    I I E    G L+  L      SL     +      +  L YL    +K 
Sbjct: 82  IGVITENPVWI-IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKR 136

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQ 640
            +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE    ++
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 641 LTEKSDVYSFGVVLFEVL 658
            T  SDV+ FGV ++E+L
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  149 bits (379), Expect = 3e-40
 Identities = 67/225 (29%), Positives = 106/225 (47%), Gaps = 17/225 (7%)

Query: 468 VIGIGGFGKVYKGELND-----GTKVAVKRGNPRSQ-QGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FGKV     +      G  VAVK     +  Q  + ++ EI++L    H H++ 
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97

Query: 522 LIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
             G C++     + L+ EY+  G+L+ +L      S+   Q L        G+ YLH   
Sbjct: 98  YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH--- 151

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE-IDQTHVSTAVKGSFGYLDPEYFRR 638
           A+  IHRD+ + N+LLD + + K+ DFGL+K  PE  +   V         +  PE  + 
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 639 QQLTEKSDVYSFGVVLFEV--LCARPVIDPTLPREMVNLAEWAMK 681
            +    SDV+SFGV L+E+   C      PT   E++ +A+  M 
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  149 bits (379), Expect = 4e-40
 Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 18/216 (8%)

Query: 455 AVQEATNNFDESW-----VIGIGGFGKVYKGEL-----NDGTKVAVK--RGNPRSQQGLA 502
           A++     F E+      V+G G FG V+KG       +    V +K        +Q   
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQ 60

Query: 503 EFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL 562
                +  +    H H+V L+G C   +  + + +Y+  G+L  H+      +L  +  L
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHR-GALGPQLLL 118

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
              +  A+G++YL       ++HR++ + N+LL      +VADFG++   P  D+  + +
Sbjct: 119 NWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175

Query: 623 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
             K    ++  E     + T +SDV+S+GV ++E++
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  148 bits (376), Expect = 4e-40
 Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 37/213 (17%)

Query: 468 VIGIGGFGKVYKGELND--------GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            +G G F K++KG   +         T+V +K  +   +     F     M+S+  H+HL
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V   G C   +E IL+ E+++ G+L  +L  +    ++   +LE+    A  +H+L    
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE--- 130

Query: 580 AKAVIHRDVKSANILLD--------ENFMAKVADFGLSKTGPEIDQTHVS---TAVKGSF 628
              +IH +V + NILL              K++D G+S T    D               
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP----- 185

Query: 629 GYLDPE---YFRRQQLTEKSDVYSFGVVLFEVL 658
               PE     +   L   +D +SFG  L+E+ 
Sbjct: 186 ----PECIENPKN--LNLATDKWSFGTTLWEIC 212

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  149 bits (379), Expect = 5e-40
 Identities = 63/221 (28%), Positives = 98/221 (44%), Gaps = 34/221 (15%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            +G G FGKV+  E ++         VAVK     S+    +FQ E E+L+  +H+H+V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHL-------------YGSGLPSLSWKQRLEICIGS 568
             G C E   +++++EYM +G L   L                    L   Q L +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           A G+ YL        +HRD+ + N L+ +  + K+ DFG+S+     D         G  
Sbjct: 168 AAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VGGR 219

Query: 629 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
             L      PE    ++ T +SDV+SFGVVL+E+     +P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  149 bits (379), Expect = 5e-40
 Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 29/207 (14%)

Query: 468 VIGIGGFGKVYKGELNDGT-----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G FG+VYKG L   +      VA+K      +++   +F  E  ++ QF H +++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L G   +   M++I EYMENG L   L        S  Q + +  G A G+ YL      
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NM 166

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS----------TAVKGSFGYL 631
             +HRD+ + NIL++ N + KV+DFGLS+   +  +   +          TA        
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA-------- 218

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
            PE    ++ T  SDV+SFG+V++EV+
Sbjct: 219 -PEAISYRKFTSASDVWSFGIVMWEVM 244

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  148 bits (375), Expect = 7e-40
 Identities = 59/192 (30%), Positives = 93/192 (48%), Gaps = 6/192 (3%)

Query: 468 VIGIGGFGKVYKGELNDG-TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +LV L+G C
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             +    +I E+M  G L  +L       +S    L +    +  + YL     K  IHR
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+ + N L+ EN + KVADFGLS+     D        K    +  PE     + + KSD
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194

Query: 647 VYSFGVVLFEVL 658
           V++FGV+L+E+ 
Sbjct: 195 VWAFGVLLWEIA 206

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  148 bits (375), Expect = 7e-40
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)

Query: 467 WVIGIGGFGKVYKGELNDG------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
             +G G FGKV+  E  +         VAVK     +     +FQ E E+L+  +H H+V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICI 566
              G C + + +I+++EYM++G L   L                     L   Q L I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A G+ YL    ++  +HRD+ + N L+  N + K+ DFG+S+     D         G
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VG 192

Query: 627 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
               L      PE    ++ T +SDV+SFGV+L+E+     +P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  149 bits (377), Expect = 8e-40
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V + +L        KVAVK  + +  +   + EF  E   + +F H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 522 LIGYC------DEKNEMILIYEYMENGTLKGHLYGSGLP----SLSWKQRLEICIGSARG 571
           L+G              ++I  +M++G L   L  S +     +L  +  +   +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL    ++  IHRD+ + N +L E+    VADFGLS+   +I         +G    L
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSG--DYYRQGCASKL 201

Query: 632 -----DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                  E       T  SDV++FGV ++E++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  147 bits (373), Expect = 9e-40
 Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 32/206 (15%)

Query: 469 IGIGGFGKVYKGELNDG---TKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +G G FG V +G          VA+K   +G  ++     E   E +++ Q  + ++V L
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG C  +  M+ + E    G L   L G     +      E+    + G+ YL     K 
Sbjct: 76  IGVCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KN 130

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVS----------TAVKGSFGYLD 632
            +HRD+ + N+LL     AK++DFGLSK     D  + +           A         
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA--------- 181

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVL 658
           PE    ++ + +SDV+S+GV ++E L
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEAL 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  148 bits (376), Expect = 1e-39
 Identities = 49/197 (24%), Positives = 93/197 (47%), Gaps = 11/197 (5%)

Query: 468 VIGIGGFGKVYKGEL-----NDGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G G FG VYKG            VA+K     +  +   E   E  +++   + H+  
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+G C      + I + M  G L  ++      ++  +  L  C+  A+G++YL     +
Sbjct: 82  LLGICLTSTVQL-ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DR 136

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            ++HRD+ + N+L+      K+ DFGL+K     ++ + +   K    ++  E    +  
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 642 TEKSDVYSFGVVLFEVL 658
           T +SDV+S+GV ++E++
Sbjct: 197 THQSDVWSYGVTVWELM 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  148 bits (376), Expect = 1e-39
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 468 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 522
           +IG G  G+V  G L         VA+K      +++   +F +E  ++ QF H +++ L
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            G        +++ EYMENG+L   L        +  Q + +  G   G+ YL       
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLG 171

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +HRD+ + N+L+D N + KV+DFGLS+    + D  + +T  K    +  PE    +  
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231

Query: 642 TEKSDVYSFGVVLFEVL 658
           +  SDV+SFGVV++EVL
Sbjct: 232 SSASDVWSFGVVMWEVL 248

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (375), Expect = 1e-39
 Identities = 59/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 468 VIGIGGFGKVYKGELNDG----TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G G FG V +G L        KVAVK  + +  SQ+ + EF +E   +  F H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 522 LIGYCDEKN-----EMILIYEYMENGTLKGHL----YGSGLPSLSWKQRLEICIGSARGL 572
           L+G C E +     + ++I  +M+ G L  +L      +G   +  +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 631
            YL     +  +HRD+ + N +L ++    VADFGLSK   +I         +G    + 
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKMP 212

Query: 632 ----DPEYFRRQQLTEKSDVYSFGVVLFEVL 658
                 E    +  T KSDV++FGV ++E+ 
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (375), Expect = 1e-39
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG VY+G           T+VA+K  N   S +   EF  E  ++ +F   H+V
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL--------YGSGLPSLSWKQRLEICIGSARGL 572
            L+G   +    ++I E M  G LK +L            L   S  + +++    A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 631
            YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D        KG  G L 
Sbjct: 152 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGLLP 203

Query: 632 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
                PE  +    T  SDV+SFGVVL+E+  L  +P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  147 bits (372), Expect = 2e-39
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 468 VIGIGGFGKVYKGELNDG---TKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G FG V KG          VAVK  +          E   E  ++ Q  + ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG C+ ++ M+ + E  E G L  +L  +    +  K  +E+    + G+ YL       
Sbjct: 84  IGICEAESWML-VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SN 137

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +HRD+ + N+LL     AK++DFGLSK    + +     T  K    +  PE     + 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 642 TEKSDVYSFGVVLFEVL 658
           + KSDV+SFGV+++E  
Sbjct: 198 SSKSDVWSFGVLMWEAF 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (391), Expect = 2e-39
 Identities = 73/293 (24%), Positives = 110/293 (37%), Gaps = 27/293 (9%)

Query: 384 GVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKAWIPVSINGGNSHTMGSKYSHGTTTSA 443
            +TI  ++A L+ G    L     Q   +   K       +         +     T S 
Sbjct: 303 SLTIAENMADLIDG-YCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSV 361

Query: 444 NSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYKGEL----NDGTKV 488
           +    Y          T      +            IG G FG V++G      N    V
Sbjct: 362 SETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAV 421

Query: 489 AVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGH 547
           A+K      S     +F  E   + QF H H+V LIG   E    I I E    G L+  
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSF 480

Query: 548 LYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG 607
           L      SL     +      +  L YL    +K  +HRD+ + N+L+  N   K+ DFG
Sbjct: 481 LQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536

Query: 608 LSKTGPEIDQTHVSTAVKGSF--GYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
           LS+    ++ +    A KG     ++ PE    ++ T  SDV+ FGV ++E+L
Sbjct: 537 LSR---YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  147 bits (372), Expect = 4e-39
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 35/214 (16%)

Query: 468 VIGIGGFGKVYKGELNDG---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSL 522
           VIG G FG+V K  +         A+KR     S+    +F  E+E+L +   H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGS 568
           +G C+ +  + L  EY  +G L   L                S   +LS +Q L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF 628
           ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+             VK + 
Sbjct: 152 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVYVKKTM 200

Query: 629 GYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
           G L       E       T  SDV+S+GV+L+E+
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  147 bits (374), Expect = 6e-39
 Identities = 59/197 (29%), Positives = 102/197 (51%), Gaps = 10/197 (5%)

Query: 468 VIGIGGFGKVYKGELNDGTK----VAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSL 522
           V+G G FG+V  G L   +K    VA+K      +++   +F  E  ++ QF H +++ L
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            G   +   ++++ EYMENG+L   L        +  Q + +  G A G+ YL       
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMG 167

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +HRD+ + NIL++ N + KV+DFGL +    + +  + +   K    +  PE    ++ 
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227

Query: 642 TEKSDVYSFGVVLFEVL 658
           T  SDV+S+G+VL+EV+
Sbjct: 228 TSASDVWSYGIVLWEVM 244

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  145 bits (368), Expect = 1e-38
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG+VY+G+++         +VAVK      S+Q   +F  E  ++S+F H+++V
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYL 575
             IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL
Sbjct: 97  RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156

Query: 576 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 631
                   IHRD+ + N LL       +AK+ DFG+++              KG    L 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAMLP 208

Query: 632 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
                PE F     T K+D +SFGV+L+E+  L   P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  145 bits (369), Expect = 3e-38
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 48/278 (17%)

Query: 420 PVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------V 468
            V+++  +S +M S       T+  S++        V E     D  W            
Sbjct: 29  QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP 88

Query: 469 IGIGGFGKVYKGEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRH 518
           +G G FG+V   E          +   VAVK      +++ L++  +E+EM+    +H++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 564
           +++L+G C +   + +I EY   G L+ +L                     +++K  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               ARG+ YL    ++  IHRD+ + N+L+ EN + K+ADFGL++    ID        
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYK 260

Query: 625 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
           K + G L      PE    +  T +SDV+SFGV+++E+
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (362), Expect = 3e-38
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G F  VYKG +     +VA    +    ++     F+ E EML   +H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 525 Y----CDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
                   K  ++L+ E M +GTLK +L  +      +  K     C    +GL +LHT 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147

Query: 579 YAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               +IHRD+K  NI +       K+ D GL+     + +   + AV G+  ++ PE + 
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY- 202

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            ++  E  DVY+FG+ + E+  +  
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEY 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  143 bits (362), Expect = 3e-38
 Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 36/223 (16%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G   FGKVYKG L           VA+K    +       EF+ E  + ++ +H ++V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICI 566
            L+G   +   + +I+ Y  +G L   L                +   +L     + +  
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             A G+ YL    +  V+H+D+ + N+L+ +    K++D GL +   E+           
Sbjct: 136 QIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKLL 187

Query: 627 SFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
               L      PE     + +  SD++S+GVVL+EV     +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  143 bits (364), Expect = 5e-38
 Identities = 68/267 (25%), Positives = 117/267 (43%), Gaps = 55/267 (20%)

Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYK 479
           MGS + H      + +         V E     D  W            +G G FG+V  
Sbjct: 1   MGSSHHH---HHHSQDPML----AGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVM 53

Query: 480 GEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEK 529
            E          +   VAVK      +++ L++  +E+EM+    +H+++++L+G C + 
Sbjct: 54  AEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113

Query: 530 NEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGSARGLHYL 575
             + +I EY   G L+ +L                     +++K  +      ARG+ YL
Sbjct: 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL---- 631
               ++  IHRD+ + N+L+ EN + K+ADFGL++    ID        K + G L    
Sbjct: 174 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKW 225

Query: 632 -DPEYFRRQQLTEKSDVYSFGVVLFEV 657
             PE    +  T +SDV+SFGV+++E+
Sbjct: 226 MAPEALFDRVYTHQSDVWSFGVLMWEI 252

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  144 bits (364), Expect = 1e-37
 Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 30/217 (13%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG+VY+G+++         +VAVK      S+Q   +F  E  ++S+F H+++V
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL-----YGSGLPSLSWKQRLEICIGSARGLHYL 575
             IG   +     ++ E M  G LK  L       S   SL+    L +    A G  YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197

Query: 576 HTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL- 631
                   IHRD+ + N LL       +AK+ DFG+++              KG    L 
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLP 249

Query: 632 ----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
                PE F     T K+D +SFGV+L+E+  L   P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  141 bits (357), Expect = 3e-37
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 42/224 (18%)

Query: 468 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FGKV K            T VAVK      S   L +  +E  +L Q  H H++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL----------------------YGSGLPSLSW 558
            L G C +   ++LI EY + G+L+G L                            +L+ 
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 559 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 618
              +      ++G+ YL       ++HRD+ + NIL+ E    K++DFGLS+   E D  
Sbjct: 150 GDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED-- 204

Query: 619 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
              + VK S G +       E       T +SDV+SFGV+L+E+
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  141 bits (357), Expect = 5e-37
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 33/215 (15%)

Query: 468 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 519
            +G G FGKV +         +   KVAVK               +E++++S   +H ++
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHL------------YGSGLPSLSWKQRLEICIG 567
           V+L+G C     +++I EY   G L   L            +     + S +  L     
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
            A+G+ +L    +K  IHRDV + N+LL    +AK+ DFGL++     D  + S  +   
Sbjct: 173 VAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKG 224

Query: 628 FGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
              L      PE       T +SDV+S+G++L+E+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  139 bits (353), Expect = 1e-36
 Identities = 53/218 (24%), Positives = 94/218 (43%), Gaps = 36/218 (16%)

Query: 468 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 519
            +G G FG+V + +            VAVK      +        +E+++L     H ++
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93

Query: 520 VSLIGYC-DEKNEMILIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEI 564
           V+L+G C      +++I E+ + G L  +L                     L+ +  +  
Sbjct: 94  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               A+G+ +L    ++  IHRD+ + NILL E  + K+ DFGL++   +         V
Sbjct: 154 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----DYV 205

Query: 625 KGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
           +     L      PE    +  T +SDV+SFGV+L+E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  139 bits (352), Expect = 1e-36
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 35/218 (16%)

Query: 468 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 519
            +G G FGKV +              VAVK   P           +E+++LS    H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHL----------------YGSGLPSLSWKQRLE 563
           V+L+G C      ++I EY   G L   L                      +L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L    +K  IHRD+ + NILL    + K+ DFGL++         V   
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 624 ----VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV 657
               VK    ++ PE       T +SDV+S+G+ L+E+
Sbjct: 207 ARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWEL 240

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  139 bits (352), Expect = 1e-36
 Identities = 53/248 (21%), Positives = 94/248 (37%), Gaps = 36/248 (14%)

Query: 437 HGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGN-- 494
           H   +S          F ++      +     IG GG  KV++         A+K  N  
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLE 63

Query: 495 PRSQQGLAEFQTEIEMLSQFRH--RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG 552
               Q L  ++ EI  L++ +     ++ L  Y      + ++ E   N  L   L    
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122

Query: 553 LPSLS-------WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
             S+        WK  LE        +H +H      ++H D+K AN L+ +  M K+ D
Sbjct: 123 --SIDPWERKSYWKNMLE-------AVHTIH---QHGIVHSDLKPANFLIVDG-MLKLID 169

Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPE-----------YFRRQQLTEKSDVYSFGVVL 654
           FG++        + V  +  G+  Y+ PE              + +++ KSDV+S G +L
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

Query: 655 FEVLCARP 662
           + +   + 
Sbjct: 230 YYMTYGKT 237

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (353), Expect = 2e-36
 Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 8/198 (4%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G FGK    +   DG +  +K    +  S +   E + E+ +L+  +H ++V    
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +E   + ++ +Y E G L   +           Q L+  +     L ++H    + ++
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRD+KS NI L ++   ++ DFG+++         ++ A  G+  YL PE    +    K
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNK 205

Query: 645 SDVYSFGVVLFEVLCARP 662
           SD+++ G VL+E+   + 
Sbjct: 206 SDIWALGCVLYELCTLKH 223

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (366), Expect = 2e-36
 Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 31/265 (11%)

Query: 414 HSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDE-------- 465
             +    ++ +G                     S +  PF   +E  +            
Sbjct: 280 PQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLI 339

Query: 466 -SWVIGIGGFGKVYKGEL---NDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
               +G G FG V +G          VA+K   +G  ++     E   E +++ Q  + +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPY 397

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V LIG C  +  M+ + E    G L   L G     +      E+    + G+ YL   
Sbjct: 398 IVRLIGVCQAEALML-VMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE- 454

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA-----VKGSFGYLDP 633
             K  +HR++ + N+LL     AK++DFGLSK     D  + + +     +K    +  P
Sbjct: 455 --KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK----WYAP 508

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVL 658
           E    ++ + +SDV+S+GV ++E L
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEAL 533

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (349), Expect = 3e-36
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 15/203 (7%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR---GNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
            IG G F +VY+   L DG  VA+K+    +    +  A+   EI++L Q  H +++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 524 GYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
               E NE+ ++ E  + G L   +  +      +  +   +  +     L ++H   ++
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SR 155

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA--VKGSFGYLDPEYFRRQ 639
            V+HRD+K AN+ +    + K+ D GL +       +  + A  + G+  Y+ PE     
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGR----FFSSKTTAAHSLVGTPYYMSPERIHEN 211

Query: 640 QLTEKSDVYSFGVVLFEVLCARP 662
               KSD++S G +L+E+   + 
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQS 234

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  138 bits (350), Expect = 4e-36
 Identities = 66/231 (28%), Positives = 100/231 (43%), Gaps = 44/231 (19%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLV 520
            IG G FG+V++            T VAVK      S    A+FQ E  ++++F + ++V
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHL----------------------YGSGLPSLSW 558
            L+G C     M L++EYM  G L   L                         G P LS 
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173

Query: 559 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 618
            ++L I    A G+ YL     +  +HRD+ + N L+ EN + K+ADFGLS+     D  
Sbjct: 174 AEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-- 228

Query: 619 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV--LCARP 662
                       +      PE     + T +SDV+++GVVL+E+     +P
Sbjct: 229 ---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  137 bits (346), Expect = 4e-36
 Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 48/287 (16%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            +F E  +IG GGFG+V+K +   DG    +KR    ++    + + E++ L++  H ++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 520 VSLIGY----------------CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE 563
           V   G                   +   + +  E+ + GTL+  +       L     LE
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
           +     +G+ Y+H+   K +I+RD+K +NI L +    K+ DFGL  +   +      T 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180

Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 683
            KG+  Y+ PE    Q   ++ D+Y+ G++L E+L            E            
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF----FTDL 231

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
             G +  I D      ++            K L+    DRP+  ++L
Sbjct: 232 RDGIISDIFDKKEKTLLQ------------KLLSKKPEDRPNTSEIL 266

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  138 bits (350), Expect = 4e-36
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 42/224 (18%)

Query: 468 VIGIGGFGKVYKGELNDG------TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 519
           V+G G FGKV               +VAVK    +          +E++M++Q   H ++
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHL---------------------YGSGLPSLSW 558
           V+L+G C     + LI+EY   G L  +L                         L  L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171

Query: 559 KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT 618
           +  L      A+G+ +L     K+ +HRD+ + N+L+    + K+ DFGL++     D  
Sbjct: 172 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----DIM 223

Query: 619 HVSTAVKGSFGYL-----DPEYFRRQQLTEKSDVYSFGVVLFEV 657
             S  V      L      PE       T KSDV+S+G++L+E+
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  139 bits (352), Expect = 5e-36
 Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 48/263 (18%)

Query: 435 YSHGTTTSANSNSGYRFPFVAVQEATNNFDESW-----------VIGIGGFGKVYKGEL- 482
           + H        N  ++     V E     D  W            +G G FG+V   E  
Sbjct: 32  HHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAI 91

Query: 483 -------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMI 533
                  N  TKVAVK      +++ L++  +E+EM+    +H+++++L+G C +   + 
Sbjct: 92  GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 151

Query: 534 LIYEYMENGTLKGHL--------------YGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           +I EY   G L+ +L                +    LS K  +      ARG+ YL    
Sbjct: 152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--- 208

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL-----DPE 634
           +K  IHRD+ + N+L+ E+ + K+ADFGL++    ID        K + G L      PE
Sbjct: 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYKKTTNGRLPVKWMAPE 263

Query: 635 YFRRQQLTEKSDVYSFGVVLFEV 657
               +  T +SDV+SFGV+L+E+
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEI 286

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  138 bits (349), Expect = 5e-36
 Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRH--RHLVSLI 523
            IG GG  KV++         A+K  N      Q L  ++ EI  L++ +     ++ L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 576
            Y      + ++ E   N  L   L      S+        WK  LE        +H +H
Sbjct: 76  DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLE-------AVHTIH 125

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 634
                 ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  
Sbjct: 126 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 635 ---------YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                       + +++ KSDV+S G +L+ +   + 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (352), Expect = 6e-36
 Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRH--RHLVSLI 523
            IG GG  KV++         A+K  N      Q L  ++ EI  L++ +     ++ L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 576
            Y      + ++ E   N  L   L      S+        WK  LE        +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLE-------AVHTIH 172

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-- 634
                 ++H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE  
Sbjct: 173 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 635 ---------YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                       + +++ KSDV+S G +L+ +   + 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  136 bits (344), Expect = 7e-36
 Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 13/205 (6%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G +G+  K    +DG  +  K  +    ++       +E+ +L + +H ++V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 525 -YCDEKNEMILIY-EYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLHYLHT--G 578
              D  N  + I  EY E G L   +         L  +  L +       L   H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K AN+ LD     K+ DFGL++    +       T V G+  Y+ PE   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYMSPEQMN 189

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           R    EKSD++S G +L+E+    P
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP 214

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (345), Expect = 9e-36
 Identities = 58/231 (25%), Positives = 107/231 (46%), Gaps = 40/231 (17%)

Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
            ++F+E  V+G G FG+V K     D    A+K+    +++ L+   +E+ +L+   H++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63

Query: 519 LVSLIG-YCDEKNEMIL---------IY---EYMENGTLKGHLYGSGLPS---LSWKQRL 562
           +V     + + +N +           ++   EY ENGTL   ++   L       W+   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK------------ 610
           +I       L Y+H   ++ +IHRD+K  NI +DE+   K+ DFGL+K            
Sbjct: 124 QIL----EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 611 -TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLC 659
                    ++++A+ G+  Y+  E         EK D+YS G++ FE++ 
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (343), Expect = 2e-35
 Identities = 59/244 (24%), Positives = 91/244 (37%), Gaps = 19/244 (7%)

Query: 426 GNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELND 484
                   + S     S    S    P         +F     +G G +G+V+K     D
Sbjct: 22  SMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKED 81

Query: 485 GTKVAVKRGN--PRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDEKNEMILIYEYMEN 541
           G   AVKR     R  +  A    E+    +  +H   V L    +E   + L  E    
Sbjct: 82  GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG- 140

Query: 542 GTLKGHL--YGSGLP-SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDEN 598
            +L+ H   +G+ LP +  W    +        L +LH+   + ++H DVK ANI L   
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTL----LALAHLHS---QGLVHLDVKPANIFLGPR 193

Query: 599 FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVL 658
              K+ DFGL     E+         +G   Y+ PE   +      +DV+S G+ + EV 
Sbjct: 194 GRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL-QGSYGTAADVFSLGLTILEVA 249

Query: 659 CARP 662
           C   
Sbjct: 250 CNME 253

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (341), Expect = 3e-35
 Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 28/225 (12%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRH 518
            +F+    +G GGFG V++ +   D    A+KR   P  +    +   E++ L++  H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 519 LVSLIGYCDEKNEM---------ILIY---EYMENGTLKGHL-YGSGLPSLSWKQRLEIC 565
           +V       EKN           + +Y   +      LK  +     +        L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----------TGPEI 615
           +  A  + +LH   +K ++HRD+K +NI    + + KV DFGL                +
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA 660
                 T   G+  Y+ PE       + K D++S G++LFE+L  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  136 bits (343), Expect = 4e-35
 Identities = 46/220 (20%), Positives = 94/220 (42%), Gaps = 32/220 (14%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK-----------------RGNPRSQQGLAEFQTEIEM 510
            +  G F K+   E  D    A+K                       +    +F+ E+++
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 511 LSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS-- 568
           ++  ++ + ++  G     +E+ +IYEYMEN ++        +   ++   + I +    
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 569 ----ARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                    Y+H    K + HRDVK +NIL+D+N   K++DFG S+   +     +  + 
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR 211

Query: 625 KGSFGYLDPEYFRRQQLT--EKSDVYSFGVVLFEVLCARP 662
            G++ ++ PE+F  +      K D++S G+ L+ +     
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  135 bits (342), Expect = 2e-33
 Identities = 68/251 (27%), Positives = 112/251 (44%), Gaps = 33/251 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G GGFG V +    + G +VA+K      +P++++       EI+++ +  H ++VS 
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSA 77

Query: 523 IGYCDEKNEM------ILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLH 573
               D   ++      +L  EY E G L+ +L        L       +   I SA  L 
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LR 135

Query: 574 YLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           YLH      +IHRD+K  NI+L    +  + K+ D G +K   E+DQ  + T   G+  Y
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQY 189

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ 690
           L PE   +++ T   D +SFG + FE +       P LP       +W  K + K     
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR---PFLPNW--QPVQWHGKVREKSNEHI 244

Query: 691 IIDPTLAGKIR 701
           ++   L G ++
Sbjct: 245 VVYDDLTGAVK 255

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (324), Expect = 5e-33
 Identities = 54/208 (25%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G +G VY G +L++  ++A+K    R  +       EI +    +H+++V  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87

Query: 527 DEKNEMILIY-EYMENGTLKG---HLYGSGLPSLSW-----KQRLEICIGSARGLHYLHT 577
             +N  I I+ E +  G+L       +G    +        KQ LE       GL YLH 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILE-------GLKYLH- 139

Query: 578 GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                ++HRD+K  N+L++  + + K++DFG SK    I+    +    G+  Y+ PE  
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195

Query: 637 RRQQL--TEKSDVYSFGVVLFEVLCARP 662
            +      + +D++S G  + E+   +P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 1e-32
 Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 525
           ++G G    V++G     G   A+K  N  S     +    E E+L +  H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 526 --CDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLHYLHTGYA 580
                    +LI E+   G+L   L        L   + L +   +     +++L     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130

Query: 581 KAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
             ++HR++K  NI+     D   + K+ DFG ++   E++      ++ G+  YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMY 187

Query: 637 RRQQL--------TEKSDVYSFGVVLFEVLCARP 662
            R  L            D++S GV  +       
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  127 bits (321), Expect = 1e-32
 Identities = 64/240 (26%), Positives = 105/240 (43%), Gaps = 34/240 (14%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G GG   VY  E      KVA+K         ++ L  F+ E+   SQ  H+++VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
             +E +   L+ EY+E  TL  ++   G   LS    +        G+ + H      ++
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIV 133

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRD+K  NIL+D N   K+ DFG++K   E   T  +  + G+  Y  PE  + +   E 
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDEC 192

Query: 645 SDVYSFGVVLFEVLCARP------------------------VIDPTLPREMVNLAEWAM 680
           +D+YS G+VL+E+L   P                         +   +P+ + N+   A 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (317), Expect = 5e-32
 Identities = 61/286 (21%), Positives = 98/286 (34%), Gaps = 52/286 (18%)

Query: 468 VIGIGGFGKVYKGELND---GTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVS 521
           ++G GG G VY+ E  D      VA+K  +             Q E     + +  H+V 
Sbjct: 41  LVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           +  + +   ++ +    +    L   L   G   L+  + + I       L   H   A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AA 153

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
              HRDVK  NIL+  +  A + DFG++    +   T +   V G+  Y+ PE F     
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212

Query: 642 TEKSDVYSFGVVLFEVLCARP----------------------VIDPTLPREMVNLAEWA 679
           T ++D+Y+   VL+E L   P                       + P +P     +    
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272

Query: 680 M-KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP 724
           M K           +P      R  +       A   LA    DR 
Sbjct: 273 MAK-----------NPED----RYVTCGDLSAAAHAALATADQDRA 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (313), Expect = 9e-32
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 17/208 (8%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAE-FQTEIEMLSQFRH 516
            +F+    +G G FG VY   E      +A+K        + G+    + E+E+ S  RH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LP-SLSWKQRLEICIGSARGLHY 574
            +++ L GY  +   + LI EY   GT+   L          +     E+       L Y
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSY 124

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
            H   +K VIHRD+K  N+LL      K+ADFG S   P            G+  YL PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC--GTLDYLPPE 177

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
               +   EK D++S GV+ +E L  +P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (313), Expect = 1e-31
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 39/212 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G GGF K ++  + +     A K        + + R +        EI +     H+H+
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHV 77

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR-------- 570
           V   G+ ++ + + ++ E     +L              ++ L E     AR        
Sbjct: 78  VGFHGFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEP---EARYYLRQIVL 126

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G  YLH      VIHRD+K  N+ L+E+   K+ DFGL+ T  E D         G+  Y
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNY 181

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   ++  + + DV+S G +++ +L  +P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  126 bits (317), Expect = 2e-31
 Identities = 45/214 (21%), Positives = 84/214 (39%), Gaps = 27/214 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGY 525
           ++G G    V++G     G   A+K  N  S     +    E E+L +  H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 526 --CDEKNEMILIYEYMENGTLKGHLYGSG-LPSLSWKQRLEI--CIGSARGLHYLHTGYA 580
                    +LI E+   G+L   L        L   + L +   +     +++L     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLR---E 130

Query: 581 KAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
             ++HR++K  NI+     D   + K+ DFG ++   E++      ++ G+  YL P+ +
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPDMY 187

Query: 637 RRQQL--------TEKSDVYSFGVVLFEVLCARP 662
            R  L            D++S GV  +       
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (312), Expect = 4e-31
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 39/212 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G GGF K ++  + +     A K        + + R +        EI +     H+H+
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-----MSMEISIHRSLAHQHV 103

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR-------- 570
           V   G+ ++ + + ++ E     +L              ++ L E     AR        
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELH--------KRRKALTEP---EARYYLRQIVL 152

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           G  YLH      VIHRD+K  N+ L+E+   K+ DFGL+ T  E D         G+  Y
Sbjct: 153 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLC-GTPNY 207

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           + PE   ++  + + DV+S G +++ +L  +P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (308), Expect = 5e-31
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 19/209 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQ---QGLAE-FQTEIEMLSQFR 515
           ++FD    +G G FG VY   E  +   +A+K    +SQ   +G+    + EIE+ S  R
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF-KSQLEKEGVEHQLRREIEIQSHLR 72

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG-LP-SLSWKQRLEICIGSARGLH 573
           H +++ +  Y  ++  + L+ E+   G L   L   G      S     E+    A  LH
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALH 128

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           Y H    + VIHRD+K  N+L+      K+ADFG S   P   +        G+  YL P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPP 181

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           E    +   EK D++  GV+ +E L   P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMP 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  122 bits (309), Expect = 6e-31
 Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 41/248 (16%)

Query: 467 WVIGIGGFGKVYKGELND---GTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLV 520
            ++G GG  +V+     D      VAVK       R       F+ E +  +   H  +V
Sbjct: 18  EILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 521 SLIGYCDEKNEMILIY----EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
           ++    + +     +     EY++  TL+  ++  G   ++ K+ +E+   + + L++ H
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH 133

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST-AVKGSFGYLDPEY 635
                 +IHRDVK ANI++      KV DFG+++   +   +   T AV G+  YL PE 
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP-----------------------VIDPTLPREM 672
            R   +  +SDVYS G VL+EVL   P                            L  ++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 250

Query: 673 VNLAEWAM 680
             +   A+
Sbjct: 251 DAVVLKAL 258

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 7e-31
 Identities = 52/261 (19%), Positives = 99/261 (37%), Gaps = 29/261 (11%)

Query: 414 HSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGG 473
           HS A +  + + G++                     +      +E  +       +G G 
Sbjct: 11  HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGS 70

Query: 474 FGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEF-QTEIEMLSQFRHRHLVSLIGYCDEKNE 531
           FG+V++  +   G + AVK      +  L  F   E+   +      +V L G    +  
Sbjct: 71  FGEVHRMKDKQTGFQCAVK------KVRLEVFRVEELVACAGLSSPRIVPLYG-AVREGP 123

Query: 532 MILIY-EYMENGTLKGHL--YGS---GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            + I+ E +E G+L   +   G            Q LE       GL YLH    + ++H
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE-------GLEYLH---TRRILH 173

Query: 586 RDVKSANILLDEN-FMAKVADFGLSK--TGPEIDQTHVST-AVKGSFGYLDPEYFRRQQL 641
            DVK+ N+LL  +   A + DFG +       + ++ ++   + G+  ++ PE    +  
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233

Query: 642 TEKSDVYSFGVVLFEVLCARP 662
             K D++S   ++  +L    
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH 254

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 9e-31
 Identities = 47/218 (21%), Positives = 85/218 (38%), Gaps = 24/218 (11%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 525
           V+  GGF  VY+ + +  G + A+KR     ++       E+  + +   H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 526 C-------DEKNEMILIYEYMENGTLKGHLYGSGLP-SLSWKQRLEICIGSARGLHYLHT 577
                   D      L+   +  G L   L        LS    L+I   + R + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT---GPEIDQTHVSTAVK-------GS 627
                +IHRD+K  N+LL      K+ DFG + T    P+   +    A+         +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 628 FGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             Y  PE    +    + EK D+++ G +L+ +   + 
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (306), Expect = 3e-30
 Identities = 35/231 (15%), Positives = 69/231 (29%), Gaps = 23/231 (9%)

Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE------LNDGTKVAVKRGNPRSQQGLAEFQ 505
           P    Q  +       ++G G F +VY+          +  K  +K   P +        
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115

Query: 506 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS---LSWKQRL 562
             +E L        +        +N  +L+ E    GTL   +          +     +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILL-----------DENFMAKVADFGLSKT 611
              +     +  +H      +IH D+K  N +L           D +    + D G S  
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                +  + TA   + G+   E    +    + D +     ++ +L    
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  119 bits (300), Expect = 5e-30
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G F  VY+   ++ G +VA+K        +     +      Q E+++  Q +H  +
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-----VQNEVKIHCQLKHPSI 73

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR---LEICIGSARGLHYLH 576
           + L  Y ++ N + L+ E   NG +  +L     P    + R    +I      G+ YLH
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI----ITGMLYLH 129

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              +  ++HRD+  +N+LL  N   K+ADFGL+ T  ++      T   G+  Y+ PE  
Sbjct: 130 ---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLC-GTPNYISPEIA 184

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
            R     +SDV+S G + + +L  RP
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRP 210

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (308), Expect = 6e-30
 Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 30/214 (14%)

Query: 462 NFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLV 520
           +F    V+G G  G +    + D   VAVKR  P           E+++L +   H +++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
                  ++    +  E     TL      K   +    P    +Q          GL +
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTS-------GLAH 133

Query: 575 LHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSK-TGPEIDQTHVSTAVKGSF 628
           LH   +  ++HRD+K  NIL+          A ++DFGL K            + V G+ 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 629 GYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLC 659
           G++ PE       +  T   D++S G V + V+ 
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (300), Expect = 8e-30
 Identities = 42/143 (29%), Positives = 73/143 (51%), Gaps = 5/143 (3%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FGKVYK      G   A K    +S++ L ++  EIE+L+   H ++V L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
               ++ ++ E+   G +   +       L+  Q   +C      L++LH   +K +IHR
Sbjct: 86  YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141

Query: 587 DVKSANILLDENFMAKVADFGLS 609
           D+K+ N+L+      ++ADFG+S
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVS 164

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (314), Expect = 8e-30
 Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 27/205 (13%)

Query: 468 VIGIGGFGKVYKGE---LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            I  GG G +Y      + +G  V +K    +    +  A    E + L++  H  +V +
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 523 --IGYCDEKNEMILIY---EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
                  +++   + Y   EY+   +LK          L   + +   +     L YLH 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH- 199

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             +  +++ D+K  NI+L E    K+ D G       I+       + G+ G+  PE  R
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR---INSF---GYLYGTPGFQAPEIVR 250

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
               T  +D+Y+ G  L  +    P
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  121 bits (304), Expect = 2e-29
 Identities = 49/221 (22%), Positives = 86/221 (38%), Gaps = 37/221 (16%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGYC 526
           ++G G  G V       G  VAVKR              EI++L++   H +++      
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYYCSE 78

Query: 527 DEKNEMILIYEYMENGTL-----KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
                + +  E      L       ++    L        + +    A G+ +LH   + 
Sbjct: 79  TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134

Query: 582 AVIHRDVKSANILLD-------------ENFMAKVADFGLSK---TGPEIDQTHVSTAVK 625
            +IHRD+K  NIL+              EN    ++DFGL K   +G    +T+++    
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193

Query: 626 GSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLC 659
           G+ G+  PE          +++LT   D++S G V + +L 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (296), Expect = 2e-29
 Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 13/197 (6%)

Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +     IG G  G VY   ++  G +VA+++ N + Q        EI ++ + ++ ++V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
            +      +E+ ++ EY+  G+L   +       +   Q   +C    + L +LH   + 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT-DVVTET--CMDEGQIAAVCRECLQALEFLH---SN 135

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQ 639
            VIHRD+KS NILL  +   K+ DFG      +I       ST V G+  ++ PE   R+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 640 QLTEKSDVYSFGVVLFE 656
               K D++S G++  E
Sbjct: 192 AYGPKVDIWSLGIMAIE 208

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  119 bits (300), Expect = 3e-29
 Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 22/201 (10%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FG V++  E   G     K  N          + EI +++Q  H  L++L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 527 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           ++K EM+LI E++  G L      + +           +Q  E       GL ++H    
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------GLKHMH---E 167

Query: 581 KAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            +++H D+K  NI+    +    K+ DFGL+    +++   +      +  +  PE   R
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDR 224

Query: 639 QQLTEKSDVYSFGVVLFEVLC 659
           + +   +D+++ GV+ + +L 
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLS 245

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  117 bits (296), Expect = 3e-29
 Identities = 53/205 (25%), Positives = 93/205 (45%), Gaps = 25/205 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           V+G G F +V+   +   G   A+K          +  + EI +L + +H ++V+L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 527 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +      L+ + +  G L      +G  Y     SL  +Q L         + YLH    
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLS-------AVKYLH---E 124

Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+L    +EN    + DFGLSK    ++Q  + +   G+ GY+ PE   
Sbjct: 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLA 180

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
           ++  ++  D +S GV+ + +LC  P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYP 205

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (296), Expect = 4e-29
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)

Query: 463 FDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            D    IG G  G V    E + G +VAVK  + R QQ       E+ ++  ++H ++V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           +        E+ ++ E+++ G L   +       L+ +Q   +C    + L YLH   A+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT-DIVSQV--RLNEEQIATVCEAVLQALAYLH---AQ 160

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQ 639
            VIHRD+KS +ILL  +   K++DFG      +I +      + V G+  ++ PE   R 
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 640 QLTEKSDVYSFGVVLFE 656
               + D++S G+++ E
Sbjct: 217 LYATEVDIWSLGIMVIE 233

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 4e-29
 Identities = 22/231 (9%), Positives = 48/231 (20%), Gaps = 44/231 (19%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
            + +G    V+   ++      A+K    G   S+  L          ++          
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 524 GYC--------------------------DEKNEMILIYEYM--ENGTLKGHL--YGSGL 553
                                              +L+      +   L   L       
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 554 PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP 613
                     +     R    L    +K ++H      N+ +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 614 EIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARP 662
                           Y   E+        T   + +  G+ ++ V C   
Sbjct: 246 TRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 5e-29
 Identities = 46/229 (20%), Positives = 82/229 (35%), Gaps = 35/229 (15%)

Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGN--PRSQQGLAEFQTEIEMLSQ-FR 515
           T  F E   IG G FG V+K  +  DG   A+KR                E+   +   +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGSARGLH 573
           H H+V       E + M++  EY   G+L   +      +      +  ++ +   RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 574 YLHTGYAKAVIHRDVKSANILLDEN-------------------FMAKVADFGLSKTGPE 614
           Y+H   + +++H D+K +NI +                       M K+ D G       
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182

Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARP 662
             +       +G   +L  E  +       K+D+++  + +     A P
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  119 bits (300), Expect = 1e-28
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 32/228 (14%)

Query: 452 PFVAVQEATNNFDESW----VIGIGGFGKVYKG-ELNDGTKVAVK---RGNPRSQQGLAE 503
           P + VQ +T  F + +    V+G G FG+V    +   G + AVK   +   + +     
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72

Query: 504 FQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLS 557
              E+++L Q  H +++ L  + ++K    L+ E    G L      +           S
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--------FS 124

Query: 558 WKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPE 614
                 I      G+ Y+H      ++HRD+K  N+LL    ++   ++ DFGLS     
Sbjct: 125 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---H 178

Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            + +       G+  Y+ PE        EK DV+S GV+L+ +L   P
Sbjct: 179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCP 225

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 2e-28
 Identities = 30/235 (12%), Positives = 67/235 (28%), Gaps = 44/235 (18%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFR-------- 515
           V+G        +      G    V             + + + E+  L   R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 516 --------------HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL---------YGSG 552
                               +I    ++ +M ++  +     ++ +L         + S 
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 553 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 612
             SL    RL++ +   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 613 PEIDQTHVSTAVKGSFGYLDPEYFRRQQ-----LTEKSDVYSFGVVLFEVLCARP 662
                + +                   Q     +T   D ++ G+ ++ + CA  
Sbjct: 262 GASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (289), Expect = 2e-28
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 13/200 (6%)

Query: 460 TNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRH 518
              FD    +G G +G VYK      G  VA+K+    S   L E   EI ++ Q    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V   G   +  ++ ++ EY   G++   +      +L+  +   I   + +GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYF 636
                IHRD+K+ NILL+    AK+ADFG++    ++  T    +T + G+  ++ PE  
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 637 RRQQLTEKSDVYSFGVVLFE 656
           +       +D++S G+   E
Sbjct: 198 QEIGYNCVADIWSLGITAIE 217

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (291), Expect = 4e-28
 Identities = 36/241 (14%), Positives = 74/241 (30%), Gaps = 55/241 (22%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK----------------------------RGNPRSQ 498
           V+G        +  +   G    V                               N +  
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 499 QGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM--ILIYEYME--NGTLKGHL--YGSG 552
           +    F    +++   + + ++ +     +   +    +Y  M+    T    L  + S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 553 LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG 612
             SL    RL++ +   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 613 PEIDQTHVSTAVKGSFGYLDPEYF-----------RRQQLTEKSDVYSFGVVLFEVLCAR 661
               +         S G+  PE             RR  +T   D ++ G+V++ + CA 
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 662 P 662
            
Sbjct: 311 L 311

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 7e-28
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G +G+V    +     + A+K       S    ++   E+ +L    H +++ L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
           + ++K    L+ E  + G L   +        +      I      G+ YLH      ++
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIV 158

Query: 585 HRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
           HRD+K  N+LL   +++ + K+ DFGLS      +         G+  Y+ PE  R+ + 
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMKERLGTAYYIAPEVLRK-KY 214

Query: 642 TEKSDVYSFGVVLFEVLCARP 662
            EK DV+S GV+LF +L   P
Sbjct: 215 DEKCDVWSIGVILFILLAGYP 235

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (283), Expect = 1e-27
 Identities = 43/205 (20%), Positives = 76/205 (37%), Gaps = 25/205 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            IG G +G+V    +     + A K+      + +  F+ EIE++    H +++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 527 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           ++  ++ L+ E    G L      K                  I       + Y H    
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRV--------FRESDAARIMKDVLSAVAYCH---K 124

Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             V HRD+K  N L      +   K+ DFGL+          +     G+  Y+ P+   
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVLE 181

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
                 + D +S GV+++ +LC  P
Sbjct: 182 G-LYGPECDEWSAGVMMYVLLCGYP 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (290), Expect = 1e-27
 Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 36/216 (16%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
            +G G  G+V    E     KVA++         G+ R        +TEIE+L +  H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGL 572
           ++ +  + D ++   ++ E ME G L                 L               +
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--------LKEATCKLYFYQMLLAV 252

Query: 573 HYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G+  
Sbjct: 253 QYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPT 306

Query: 630 YLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           YL PE              D +S GV+LF  L   P
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  116 bits (292), Expect = 2e-27
 Identities = 54/218 (24%), Positives = 89/218 (40%), Gaps = 38/218 (17%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK-------------RGNPRSQQGLAEFQTEIEMLSQ 513
            +G G +G+V    E N  ++ A+K               N   ++   E   EI +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIG 567
             H +++ L    ++K    L+ E+ E G L      +                  I   
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--------FDECDAANIMKQ 154

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAV 624
              G+ YLH      ++HRD+K  NILL   +     K+ DFGLS       + +     
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDR 208

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            G+  Y+ PE  ++ +  EK DV+S GV+++ +LC  P
Sbjct: 209 LGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYP 245

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  112 bits (283), Expect = 2e-27
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 42/219 (19%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
            +G G  G+V    E     KVA+K         G+ R        +TEIE+L +  H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSA 569
           ++ +  + D ++   ++ E ME G L         L            + Q L       
Sbjct: 77  IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLY----FYQMLL------ 125

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
             + YLH      +IHRD+K  N+LL   +E+ + K+ DFG SK    + +T +   + G
Sbjct: 126 -AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCG 178

Query: 627 SFGYLDPE---YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           +  YL PE              D +S GV+LF  L   P
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 2e-27
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 14/193 (7%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G FG+V+KG +      VA+K  +   ++  + + Q EI +LSQ    ++    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             +  ++ +I EY+  G+    L   G   L   Q   I     +GL YLH+   +  IH
Sbjct: 89  YLKDTKLWIIMEYLGGGSAL-DLLEPG--PLDETQIATILREILKGLDYLHS---EKKIH 142

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVKGSFGYLDPEYFRRQQLTE 643
           RD+K+AN+LL E+   K+ADFG++    ++  T +  +T V G+  ++ PE  ++     
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDS 198

Query: 644 KSDVYSFGVVLFE 656
           K+D++S G+   E
Sbjct: 199 KADIWSLGITAIE 211

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  111 bits (280), Expect = 2e-27
 Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 26/207 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G F  V +      G + A K  N +  S +   + + E  +  + +H ++V L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 525 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
              E++   L+++ +  G L      +           S              + Y H  
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREF--------YSEADASHCIQQILESIAYCH-- 122

Query: 579 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
            +  ++HR++K  N+LL    +    K+ADFGL+    E++ +       G+ GYL PE 
Sbjct: 123 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEV 178

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            ++   ++  D+++ GV+L+ +L   P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYP 205

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  113 bits (285), Expect = 3e-27
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
              ++ ++G G FG+V+K  E   G K+A K    R  +   E + EI +++Q  H +L+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            L    + KN+++L+ EY++ G L      + +        L  KQ  E       G+ +
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE-------GIRH 202

Query: 575 LHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           +H      ++H D+K  NIL    +    K+ DFGL++               G+  +L 
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPEFLA 256

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           PE      ++  +D++S GV+ + +L 
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLS 283

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  113 bits (285), Expect = 3e-27
 Identities = 44/200 (22%), Positives = 75/200 (37%), Gaps = 19/200 (9%)

Query: 470 GIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQ--GLAEFQTEIEMLSQFRHRHLVSLIGYC 526
           G      V        G  V V+R N  +     +   Q E+ +   F H ++V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPS-LSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
              NE+ ++  +M  G+ K  L  +     ++      I  G  + L Y+H       +H
Sbjct: 96  IADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVH 151

Query: 586 RDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFG---YLDPEYFRR 638
           R VK+++IL+  +    ++       +   G    Q  V    K S     +L PE  ++
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQR--QRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 639 QQL--TEKSDVYSFGVVLFE 656
                  KSD+YS G+   E
Sbjct: 210 NLQGYDAKSDIYSVGITACE 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  112 bits (281), Expect = 5e-27
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           IG G F KV     +  G +VA+K     + NP S Q L     E+ ++    H ++V L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL---FREVRIMKILNHPNIVKL 79

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGYA 580
               + +  + LI EY   G +  +L   G   +  K+       I SA  + Y H    
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSA--VQYCH---Q 132

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           K ++HRD+K+ N+LLD +   K+ADFG S          +     G+  Y  PE F+ ++
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELFQGKK 189

Query: 641 LT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 669
               + DV+S GV+L+ ++    P     L 
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  106 bits (267), Expect = 7e-27
 Identities = 28/185 (15%), Positives = 56/185 (30%), Gaps = 24/185 (12%)

Query: 184 FETVHRVNMGGPLVTPENDTLWRTWVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAP 243
            + +  VN GG       D     +  D         +     +P               
Sbjct: 4   DKVIWAVNAGGESHV---DVHGIHYRKDPLEGRVGRASDYGMKLPI-------LRSNPED 53

Query: 244 NTVYGTATRMNSDDDPNANFNVTWEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYIDSW 303
             +Y T              +  ++  +    +Y++   F ++      Q  F+V ++  
Sbjct: 54  QVLYQTERYNED--------SFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGH 105

Query: 304 IAVRDLDLSTYSTNTLAAAYYID------MVTVQTASSKLRISIGRSTLHDTYPDAILNG 357
             V+DLD+     ++ A    I        ++VQ   S     +    +   Y +  +  
Sbjct: 106 TVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCA 165

Query: 358 LEIMK 362
           L IMK
Sbjct: 166 LFIMK 170

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  102 bits (256), Expect = 2e-25
 Identities = 25/168 (14%), Positives = 52/168 (30%), Gaps = 22/168 (13%)

Query: 11  YLIDCGSRTNTTVGNRVFVADNSASKFLSTPQNVVANISESVTSSNDSQLYQTARIFTGS 70
           + ++ G  ++  V    +  D    +      +    +    ++  D  LYQT R    S
Sbjct: 8   WAVNAGGESHVDVHGIHYRKDPLEGRV-GRASDYGMKLPILRSNPEDQVLYQTERYNEDS 66

Query: 71  SKYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNV------F 124
             Y   I   G + + L F    +      +  F V  N H ++ +  +   V       
Sbjct: 67  FGYDIPIKEEGEYVLVLKFAEVYFAQSQ--QKVFDVRVNGHTVVKDLDIFDRVGHSTAHD 124

Query: 125 KEFSVNVTSDSLDVIFSPSNNS-------------FAFINALEVVSVP 159
           +   +++    L V    S  +                + AL ++   
Sbjct: 125 EIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGT 172

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (280), Expect = 9e-27
 Identities = 53/245 (21%), Positives = 102/245 (41%), Gaps = 16/245 (6%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
            +G G  G V+K      G  +A K       P  +  +     E+++L +    ++V  
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI---IRELQVLHECNSPYIVGF 96

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
            G      E+ +  E+M+ G+L   +       +  +   ++ I   +GL YL       
Sbjct: 97  YGAFYSDGEISICMEHMDGGSLD-QVLKKAGR-IPEQILGKVSIAVIKGLTYLRE--KHK 152

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           ++HRDVK +NIL++     K+ DFG+S    ++  +  ++ V G+  Y+ PE  +    +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYS 208

Query: 643 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 702
            +SD++S G+ L E+   R  I P   +E+  +    ++        +   P        
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268

Query: 703 DSLRK 707
              R 
Sbjct: 269 MDSRP 273

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  114 bits (286), Expect = 9e-27
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 27/207 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG+V K  +     + AVK  N      +  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 525 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
             ++ +   ++ E    G L      +           S      I      G+ Y+H  
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH-- 138

Query: 579 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
               ++HRD+K  NILL   +++   K+ DFGLS       Q        G+  Y+ PE 
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEV 194

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            R     EK DV+S GV+L+ +L   P
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTP 220

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  110 bits (278), Expect = 9e-27
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 31/209 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G F  V K  E + G + A K          R      E + E+ +L Q  H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           +L    + + +++LI E +  G L      K  L      S   KQ L+       G++Y
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130

Query: 575 LHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           LH    K + H D+K  NI+L          K+ DFGL+    EI+       + G+  +
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (277), Expect = 1e-26
 Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
           VIG G    V          KVA+KR N  + Q  + E   EI+ +SQ  H ++VS    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL--EICIGSA-----RGLHYLHTG 578
              K+E+ L+ + +  G++   +    +     K  +  E  I +       GL YLH  
Sbjct: 82  FVVKDELWLVMKLLSGGSVL-DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFG----LSKTGPEIDQTHVSTAVKGSFGYLDPE 634
                IHRDVK+ NILL E+   ++ADFG    L+  G         T V G+  ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPE 196

Query: 635 YFRRQQL-TEKSDVYSFGVVLFE 656
              + +    K+D++SFG+   E
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIE 219

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (274), Expect = 1e-26
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 26/203 (12%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 526
           +G G +G+V           VAVK  + +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTG 578
            E N   L  EY   G L   +             +      A+        G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFR 637
               + HRD+K  N+LLDE    K++DFGL+      ++  + +    G+  Y+ PE  +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 638 RQQLT-EKSDVYSFGVVLFEVLC 659
           R++   E  DV+S G+VL  +L 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (276), Expect = 1e-26
 Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 30/221 (13%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSL 522
           ++G G +GKV +        + AVK    +   R   G A  + EI++L + RH++++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 523 --IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GL 572
             + Y +EK +M ++ EY   G  +             ++R  +C   A         GL
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-------EKRFPVC--QAHGYFCQLIDGL 122

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            YLH   ++ ++H+D+K  N+LL      K++  G+++              +GS  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 633 PEYFRRQQLTE--KSDVYSFGVVLFEVLCAR-PVIDPTLPR 670
           PE           K D++S GV L+ +     P     + +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 37/212 (17%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G F  V K  +   G + A K        + R      E + E+ +L + RH +++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARG 571
           +L    + K +++LI E +  G L      K  L     +       KQ L+       G
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF----LKQILD-------G 120

Query: 572 LHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
           +HYLH+   K + H D+K  NI+L      N   K+ DFG++    +I+  +    + G+
Sbjct: 121 VHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGT 174

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
             ++ PE    + L  ++D++S GV+ + +L 
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  110 bits (277), Expect = 2e-26
 Identities = 46/210 (21%), Positives = 78/210 (37%), Gaps = 24/210 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           VIG G F  V +      G + AVK     +          + + E  +    +H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 522 LIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           L+        + +++E+M+   L      +           S              L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF----VYSEAVASHYMRQILEALRYC 146

Query: 576 HTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           H      +IHRDVK   +LL   + +   K+  FG++    E         V G+  ++ 
Sbjct: 147 H---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHFMA 201

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE  +R+   +  DV+  GV+LF +L    
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCL 231

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 2e-26
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 22/206 (10%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            +G G FG V+   E + G +  +K  N  RSQ  + + + EIE+L    H +++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 526 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
            ++ + M ++ E  E G L                +LS     E+       L Y H   
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGK----ALSEGYVAELMKQMMNALAYFH--- 141

Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           ++ V+H+D+K  NIL      +   K+ DFGL++          ST   G+  Y+ PE F
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVF 198

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
           +R  +T K D++S GVV++ +L    
Sbjct: 199 KR-DVTFKCDIWSAGVVMYFLLTGCL 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  110 bits (277), Expect = 2e-26
 Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G F  V +      G + A K  N +  S +   + + E  +  + +H ++V L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 525 YCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARGLHYL 575
              E++   L+++ +  G L      +        S       +Q LE        + Y 
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC----IQQILE-------SIAYC 144

Query: 576 HTGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
           H   +  ++HR++K  N+LL    +    K+ADFGL+    E++ +       G+ GYL 
Sbjct: 145 H---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLS 198

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           PE  ++   ++  D+++ GV+L+ +L   P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  109 bits (274), Expect = 2e-26
 Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 43/221 (19%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK---------RGNPRSQQGLAEFQTEIEMLSQ-FRH 516
           ++G G    V +        + AVK               Q+       E+++L +   H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIG 567
            +++ L    +      L+++ M+ G L      K  L       +     +  LE    
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI----MRALLE---- 135

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
               +  LH      ++HRD+K  NILLD++   K+ DFG S    ++D       V G+
Sbjct: 136 ---VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGT 186

Query: 628 FGYLDPE------YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             YL PE              ++ D++S GV+++ +L   P
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  110 bits (276), Expect = 2e-26
 Identities = 48/246 (19%), Positives = 85/246 (34%), Gaps = 55/246 (22%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK-----RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
            IG G +G V    E       A+K     +    + + +   +TE+ ++ +  H ++  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 522 LIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSAR----- 570
           L    +++  + L+ E    G L                    K ++  C          
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 571 ---------------------------GLHYLHTGYAKAVIHRDVKSANILL--DENFMA 601
                                       LHYLH    + + HRD+K  N L   +++F  
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209

Query: 602 KVADFGLSK---TGPEIDQTHVSTAVKGSFGYLDPEYFR--RQQLTEKSDVYSFGVVLFE 656
           K+ DFGLSK        +   ++T   G+  ++ PE      +    K D +S GV+L  
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 657 VLCARP 662
           +L    
Sbjct: 269 LLMGAV 274

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  110 bits (277), Expect = 3e-26
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G F  V K  E + G + A K          R      E + E+ +L Q  H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           +L    + + +++LI E +  G L      K  L      S   KQ L+       G++Y
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-IKQILD-------GVNY 130

Query: 575 LHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
           LHT   K + H D+K  NI+L          K+ DFGL+    EI+       + G+  +
Sbjct: 131 LHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEF 184

Query: 631 LDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
           + PE    + L  ++D++S GV+ + +L 
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLS 213

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  108 bits (271), Expect = 3e-26
 Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G+G FGKV  GE    G KVAVK   R   RS   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 576
                 +  ++ EY+  G L  ++            R+E     AR         + Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYI--------CKHGRVEE--MEARRLFQQILSAVDYCH 128

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                 V+HRD+K  N+LLD +  AK+ADFGLS      D   + T+  GS  Y  PE  
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSC-GSPNYAAPEVI 182

Query: 637 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPR 670
             +     + D++S GV+L+ +LC   P  D  +P 
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 4e-26
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 12/150 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIG- 524
           ++G G +G+VYKG  +  G   A+K  +    +   E + EI ML ++  HR++ +  G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 89

Query: 525 -----YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
                     +++ L+ E+   G++   +  +   +L  +    IC    RGL +LH   
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--- 146

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLS 609
              VIHRD+K  N+LL EN   K+ DFG+S
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 4e-26
 Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 9/146 (6%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRHLVSLI 523
            IG G FG VY   ++ +   VA+K+ +   +Q      +   E+  L + RH + +   
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           G    ++   L+ EY         L       L   +   +  G+ +GL YLH+     +
Sbjct: 121 GCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNM 175

Query: 584 IHRDVKSANILLDENFMAKVADFGLS 609
           IHRDVK+ NILL E  + K+ DFG +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  108 bits (273), Expect = 5e-26
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 37/215 (17%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK------RGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G F  V K  E + G + A K        + R      + + E+ +L + +H +++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 521 SLIGYCDEKNEMILIYEYMENGTL------KGHLY---GSGLPSLSWKQRLEICIGSARG 571
           +L    + K ++ILI E +  G L      K  L     +       KQ L        G
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF----LKQILN-------G 126

Query: 572 LHYLHTGYAKAVIHRDVKSANILL----DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
           ++YLH+     + H D+K  NI+L          K+ DFGL+    +ID  +    + G+
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGT 180

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             ++ PE    + L  ++D++S GV+ + +L    
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  108 bits (272), Expect = 6e-26
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 26/203 (12%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSLIGYC 526
           +G G +G+V           VAVK  + +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTG 578
            E N   L  EY   G L   +             +      A+        G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDI--------GMPE--PDAQRFFHQLMAGVVYLH-- 122

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFR 637
               + HRD+K  N+LLDE    K++DFGL+      ++  + +    G+  Y+ PE  +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 638 RQQLT-EKSDVYSFGVVLFEVLC 659
           R++   E  DV+S G+VL  +L 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (271), Expect = 7e-26
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 37/212 (17%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHR--H 518
           ++G GGFG VY G  ++D   VA+K        +            E+ +L +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR------- 570
           ++ L+ + +  +  +LI E  E       L+      ++ +  L E     AR       
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV---QDLFDF----ITERGALQE---ELARSFFWQVL 159

Query: 571 -GLHYLHTGYAKAVIHRDVKSANILLDENFM-AKVADFGLSKTGPEIDQTHVSTAVKGSF 628
             + + H      V+HRD+K  NIL+D N    K+ DFG       +  T  +    G+ 
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---LKDTVYTDFD-GTR 212

Query: 629 GYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 659
            Y  PE+ R  +     + V+S G++L++++C
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (271), Expect = 8e-26
 Identities = 36/204 (17%), Positives = 80/204 (39%), Gaps = 23/204 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FG V++  E +       K    +        + EI +L+  RHR+++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 527 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +   E+++I+E++    +                     Q  E        L +LH   +
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------ALQFLH---S 120

Query: 581 KAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
             + H D++  NI+     +   K+ +FG ++   ++        +  +  Y  PE  + 
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 639 QQLTEKSDVYSFGVVLFEVLCARP 662
             ++  +D++S G +++ +L    
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGIN 201

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (269), Expect = 8e-26
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 27/207 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           ++G G FG+V K  +     + AVK  N      +  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 525 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
             ++ +   ++ E    G L      +           S      I      G+ Y+H  
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--------FSEHDAARIIKQVFSGITYMH-- 138

Query: 579 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
               ++HRD+K  NILL   +++   K+ DFGLS       Q        G+  Y+ PE 
Sbjct: 139 -KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEV 194

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            R     EK DV+S GV+L+ +L   P
Sbjct: 195 LRG-TYDEKCDVWSAGVILYILLSGTP 220

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  108 bits (271), Expect = 1e-25
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 36/217 (16%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK-------RGNPRSQQGLAE-FQTEIEMLSQ-FRHR 517
           VIG G    V +      G + AVK       R +P   + + E  + E  +L Q   H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARG 571
           H+++LI   +  + M L+++ M  G L      K  L        S K+   I       
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL--------SEKETRSIMRSLLEA 212

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + +LH   A  ++HRD+K  NILLD+N   +++DFG S     ++       + G+ GYL
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYL 266

Query: 632 DPEYFRRQQL------TEKSDVYSFGVVLFEVLCARP 662
            PE  +           ++ D+++ GV+LF +L   P
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  111 bits (278), Expect = 2e-25
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           N F +  V+G GGFG+V   ++    K+ A K   +   + ++G A    E ++L +   
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 517 RHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----EICIGSARG 571
           R +VSL  Y  E K+ + L+   M  G LK H+Y  G       + +    EIC G    
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L  LH    + +++RD+K  NILLD++   +++D GL+   PE         V G+ GY+
Sbjct: 299 LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE  + ++ T   D ++ G +L+E++  + 
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (265), Expect = 4e-25
 Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 39/214 (18%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK-----RGNPRSQ-QGLAEFQTEIEMLSQFR----H 516
           ++G GGFG V+ G  L D  +VA+K     R    S          E+ +L +      H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL-EICIGSAR----- 570
             ++ L+ + + +   +L+ E          L+      ++ K  L E   G +R     
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDY----ITEKGPLGE---GPSRCFFGQ 147

Query: 571 ---GLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
               + + H+   + V+HRD+K  NIL+D     AK+ DFG       +     +    G
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-G 200

Query: 627 SFGYLDPEYFRRQQLT-EKSDVYSFGVVLFEVLC 659
           +  Y  PE+  R Q     + V+S G++L++++C
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  106 bits (267), Expect = 4e-25
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G    VY+  +       A+K       +     +TEI +L +  H +++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 527 DEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +   E+ L+ E +  G L      KG+ Y     + + KQ LE        + YLH    
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILE-------AVAYLH---E 166

Query: 581 KAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
             ++HRD+K  N+L      +   K+ADFGLSK    ++   +   V G+ GY  PE  R
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAPEILR 223

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
                 + D++S G++ + +LC   
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFE 248

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (274), Expect = 5e-25
 Identities = 52/250 (20%), Positives = 97/250 (38%), Gaps = 28/250 (11%)

Query: 427 NSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW----VIGIGGFGKVYKG-E 481
                G         +   +   ++    V+   ++  + +     +G G FG V++  E
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178

Query: 482 LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 541
              G   A K      +      + EI+ +S  RH  LV+L    ++ NEM++IYE+M  
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238

Query: 542 GTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL 595
           G L      + +           +Q  +       GL ++H       +H D+K  NI+ 
Sbjct: 239 GELFEKVADEHNKMSEDEAVEYMRQVCK-------GLCHMHE---NNYVHLDLKPENIMF 288

Query: 596 ---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 652
                N + K+ DFGL+     +D         G+  +  PE    + +   +D++S GV
Sbjct: 289 TTKRSNEL-KLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344

Query: 653 VLFEVLCARP 662
           + + +L    
Sbjct: 345 LSYILLSGLS 354

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  109 bits (273), Expect = 6e-25
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 21/213 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           + F +  V+G GGFG+V+  ++    K+ A K   +   + ++G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 517 RHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL------EICIGSA 569
           R +VSL  Y  E K ++ L+   M  G ++ H+Y     +  +++        +I  G  
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
             L +LH    + +I+RD+K  N+LLD++   +++D GL+                G+ G
Sbjct: 302 --LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPG 354

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           ++ PE    ++     D ++ GV L+E++ AR 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  107 bits (270), Expect = 7e-25
 Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G+G FGKV  G+    G KVAVK   R   RS   + + + EI+ L  FRH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 576
                +++ ++ EY+  G L  ++            RL+     +R        G+ Y H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI--------CKNGRLDE--KESRRLFQQILSGVDYCH 133

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                 V+HRD+K  N+LLD +  AK+ADFGLS      D   + T+  GS  Y  PE  
Sbjct: 134 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSC-GSPNYAAPEVI 187

Query: 637 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 669
             +     + D++S GV+L+ +LC   P  D  +P
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (263), Expect = 1e-24
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 27/206 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHR-HLVSLI 523
            +G G F  V +    + G + A K  +   R Q   AE   EI +L   +    +++L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 524 GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLH 576
              +  +E+ILI EY   G +           +S        KQ LE       G++YLH
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE-------GVYYLH 148

Query: 577 TGYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
                 ++H D+K  NILL         K+ DFG+S+   +I        + G+  YL P
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMGTPEYLAP 202

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLC 659
           E      +T  +D+++ G++ + +L 
Sbjct: 203 EILNYDPITTATDMWNIGIIAYMLLT 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (263), Expect = 1e-24
 Identities = 46/209 (22%), Positives = 80/209 (38%), Gaps = 33/209 (15%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK--------RGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +G G FG V+         +V VK                 L +   EI +LS+  H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------G 571
           + ++   + +    L+ E   +G     L+      +    RL+     A          
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG---LDLFAF----IDRHPRLDE--PLASYIFRQLVSA 142

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + YL     K +IHRD+K  NI++ E+F  K+ DFG +            T   G+  Y 
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYC 196

Query: 632 DPEYFRRQQLT-EKSDVYSFGVVLFEVLC 659
            PE          + +++S GV L+ ++ 
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  105 bits (263), Expect = 2e-24
 Identities = 62/215 (28%), Positives = 84/215 (39%), Gaps = 30/215 (13%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
           IG G FG             VAVK    R        Q EI      RH ++V       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLHTGY 579
               + +I EY   G L   +  +G        R       AR        G+ Y H   
Sbjct: 87  TPTHLAIIMEYASGGELYERICNAG--------RFSE--DEARFFFQQLLSGVSYCH--- 133

Query: 580 AKAVIHRDVKSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
           +  + HRD+K  N LLD +     K+ DFG SK+     Q    + V G+  Y+ PE   
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLL 190

Query: 638 RQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLPR 670
           RQ+   + +DV+S GV L+ +L    P  DP  PR
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  106 bits (267), Expect = 2e-24
 Identities = 45/207 (21%), Positives = 81/207 (39%), Gaps = 25/207 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE--FQTEIEMLSQFRHRHLVSLIG 524
            +G G F  V +  ++  G + A    N +          + E  +    +H ++V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 525 YCDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
              E+    LI++ +  G L      + +         S              + + H  
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYY--------SEADASHCIQQILEAVLHCHQ- 128

Query: 579 YAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
               V+HR++K  N+LL    +    K+ADFGL+      +Q        G+ GYL PE 
Sbjct: 129 --MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEV 184

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            R+    +  D+++ GV+L+ +L   P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYP 211

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (259), Expect = 2e-24
 Identities = 55/242 (22%), Positives = 97/242 (40%), Gaps = 57/242 (23%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK---------------RGNPRSQQGLAEFQT------ 506
           IG G +G V      ND T  A+K               R  PR  +             
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 507 -----EIEMLSQFRHRHLVSLIGYCD--EKNEMILIYEYMENGTLKGHLYGSGLPSLSWK 559
                EI +L +  H ++V L+   D   ++ + +++E +  G +           +   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---------MEVPTL 131

Query: 560 QRLEICIGSAR--------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
           + L      AR        G+ YLH    + +IHRD+K +N+L+ E+   K+ADFG+S  
Sbjct: 132 KPLSE--DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT---EKSDVYSFGVVLFEVLCAR-PVIDPT 667
             +     +S  V G+  ++ PE     +     +  DV++ GV L+  +  + P +D  
Sbjct: 187 -FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 668 LP 669
           + 
Sbjct: 245 IM 246

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  103 bits (259), Expect = 4e-24
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 31/215 (14%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
           +G G FGKV          KVA+K   R   +        + EI  L   RH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR--------GLHYLH 576
                 +++++ EY   G L  ++          K+R+       R         + Y H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYI--------VEKKRMTE--DEGRRFFQQIICAIEYCH 125

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                 ++HRD+K  N+LLD+N   K+ADFGLS      D   + T+  GS  Y  PE  
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSC-GSPNYAAPEVI 179

Query: 637 RRQQLT-EKSDVYSFGVVLFEVLCAR-PVIDPTLP 669
             +     + DV+S G+VL+ +L  R P  D  +P
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (257), Expect = 5e-24
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 14/174 (8%)

Query: 497 SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHL-YGSGLPS 555
           S   +     +I  +  F  ++ V  +     K  + +  +      LK  +     L  
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 556 LSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK----- 610
                 L I I  A  + +LH   +K ++HRD+K +NI    + + KV DFGL       
Sbjct: 161 REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 611 -----TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC 659
                    +      T   G+  Y+ PE       + K D++S G++LFE+L 
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY 271

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  102 bits (257), Expect = 5e-24
 Identities = 52/208 (25%), Positives = 83/208 (39%), Gaps = 31/208 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 525
            +G G F    K          AVK  + R     A  Q EI  L     H ++V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 526 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHT 577
             ++    L+ E +  G L      K H         S  +   I   + SA  + ++H 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHF--------SETEASYIMRKLVSA--VSHMHD 124

Query: 578 GYAKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
                V+HRD+K  N+L    ++N   K+ DFG ++  P  +Q  + T    +  Y  PE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPE 179

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              +    E  D++S GV+L+ +L  + 
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQV 207

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (257), Expect = 6e-24
 Identities = 56/235 (23%), Positives = 103/235 (43%), Gaps = 30/235 (12%)

Query: 444 NSNSGYRFPFVAVQEATNNFDE-----SWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRS 497
           + +SG    F   +       +       V+G+G  GKV +      G K A+K      
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65

Query: 498 QQGLAEFQTEIEMLSQF-RHRHLVSLIG-YCDEKNEMILIY---EYMENGTLKGHLYGSG 552
                + + E++   Q     H+V ++  Y +  +    +    E ME G L   +   G
Sbjct: 66  ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121

Query: 553 LPSLSWKQRLEIC--IGSARGLHYLHTGYAKAVIHRDVKSANILL---DENFMAKVADFG 607
             + + ++  EI   IG+A  + +LH   +  + HRDVK  N+L    +++ + K+ DFG
Sbjct: 122 DQAFTEREAAEIMRDIGTA--IQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176

Query: 608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            +K   E  Q  + T    +  Y+ PE    ++  +  D++S GV+++ +LC  P
Sbjct: 177 FAK---ETTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  101 bits (255), Expect = 9e-24
 Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 34/217 (15%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGY 525
           V+G G   +V     L    + AVK    +     +    E+EML Q + HR+++ LI +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 526 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
            +E++   L++E M  G++      + H         +  +   +    A  L +LH   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRH--------FNELEASVVVQDVASALDFLHN-- 129

Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSK------TGPEIDQTHVSTAVKGSFGY 630
            K + HRD+K  NIL    ++    K+ DF L            I    + T   GS  Y
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEY 187

Query: 631 LDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 662
           + PE                D++S GV+L+ +L   P
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  100 bits (252), Expect = 2e-23
 Identities = 67/314 (21%), Positives = 115/314 (36%), Gaps = 47/314 (14%)

Query: 432 GSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGELN-DGTKVAV 490
           GS  S G  T   +  G R+         N+ +    +G G  G+V+K      G  +AV
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55

Query: 491 KR----GNPRSQQGLAEFQTEIEML-SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLK 545
           K+    GN    + +     +++++       ++V   G      ++ +  E M     K
Sbjct: 56  KQMRRSGNKEENKRI---LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK 112

Query: 546 GHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD 605
             L       +  +   ++ +   + L+YL       VIHRDVK +NILLDE    K+ D
Sbjct: 113 --LKKRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCD 168

Query: 606 FGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE-----KSDVYSFGVVLFEVLCA 660
           FG+S     +          G   Y+ PE       T+     ++DV+S G+ L E+   
Sbjct: 169 FGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 661 RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID---PTLAGKIR-PDSLRKFGETAEKCL 716
           +                   +      L +++    P L G +      + F    + CL
Sbjct: 226 QFPYKNCKT---------DFE-----VLTKVLQEEPPLLPGHMGFSGDFQSF---VKDCL 268

Query: 717 ADFGVDRPSMGDVL 730
                 RP    +L
Sbjct: 269 TKDHRKRPKYNKLL 282

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 49/282 (17%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIEM-LSQFRHRHLVS 521
            +G G +G V K      G  +AVKR     N + Q+ L     ++++ +        V+
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL---LMDLDISMRTVDCPFTVT 70

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYL 575
             G    + ++ +  E M+    K   Y   +      Q +       I +   + L +L
Sbjct: 71  FYGALFREGDVWICMELMDTSLDK--FYKQVIDK---GQTIPEDILGKIAVSIVKALEHL 125

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 634
           H+    +VIHRDVK +N+L++     K+ DFG+S     +          G   Y+ PE 
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPER 180

Query: 635 ---YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 691
                 ++  + KSD++S G+ + E+   R    P           W   +Q   QL Q+
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRF---P--------YDSWGTPFQ---QLKQV 226

Query: 692 ID---PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
           ++   P L           F     +CL     +RP+  +++
Sbjct: 227 VEEPSPQLPADKFSAEFVDF---TSQCLKKNSKERPTYPELM 265

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (259), Expect = 4e-23
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 25/214 (11%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQ--- 513
           N+F    +IG GGFG+VY     D  K+ A+K   +   + +QG      E  MLS    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 514 FRHRHLVSLIGYCDE-KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSA 569
                +V +  Y     +++  I + M  G L  HL   G+ S +   R    EI +G  
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILG-- 304

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
             L ++H    + V++RD+K ANILLDE+   +++D GL+    +  + H   +V G+ G
Sbjct: 305 --LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV-GTHG 355

Query: 630 YLDPEYFRRQQLTEKS-DVYSFGVVLFEVLCARP 662
           Y+ PE  ++    + S D +S G +LF++L    
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 99.7 bits (249), Expect = 1e-22
 Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 21/212 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           ++F+    IG G FGKV   + ND  K+ A+K   +     +  +     E++++    H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 517 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC-IGSARGLH 573
             LV+L  Y   DE++ M ++ + +  G L+ HL  +         +L IC +  A  L 
Sbjct: 75  PFLVNLW-YSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEE-TVKLFICELVMA--LD 129

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YL     + +IHRD+K  NILLDE+    + DF ++     + +    T + G+  Y+ P
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAP 183

Query: 634 EYFRRQQLTEKS---DVYSFGVVLFEVLCARP 662
           E F  ++    S   D +S GV  +E+L  R 
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.7 bits (244), Expect = 3e-22
 Identities = 46/207 (22%), Positives = 87/207 (42%), Gaps = 29/207 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIE-MLSQFRHRHLVSLIGY 525
            IG+G +    +        + AVK  +   +        EIE +L   +H ++++L   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84

Query: 526 CDEKNEMILIYEYMENGTL------KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
            D+   + ++ E M+ G L      +           S ++   +     + + YLH   
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFF--------SEREASAVLFTITKTVEYLH--- 133

Query: 580 AKAVIHRDVKSANILL---DENFMA-KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           A+ V+HRD+K +NIL      N  + ++ DFG +K     +   + T    +  ++ PE 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC-YTANFVAPEV 191

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
             RQ      D++S GV+L+ +L    
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYT 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 28/211 (13%)

Query: 468 VIGIGGFGKVYKGELN-DGTKVAVKR----GNPRSQQGLAEFQTEIE-MLSQFRHRHLVS 521
            IG G +G V K      G  +AVKR     + + Q+   +   +++ ++      ++V 
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK---QLLMDLDVVMRSSDCPYIVQ 85

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARGLHYL 575
             G    + +  +  E M     K   Y      L     +       I + + + L++L
Sbjct: 86  FYGALFREGDCWICMELMSTSFDK--FYKYVYSVL--DDVIPEEILGKITLATVKALNHL 141

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE- 634
                  +IHRD+K +NILLD +   K+ DFG+S    ++  +   T   G   Y+ PE 
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196

Query: 635 ---YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                 RQ    +SDV+S G+ L+E+   R 
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRF 227

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.5 bits (230), Expect = 8e-21
 Identities = 31/264 (11%), Positives = 67/264 (25%), Gaps = 54/264 (20%)

Query: 468 VIGIGGFGKVYKGELND---GTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
             G     + ++    D     +VA+             L E  +    LS+     +  
Sbjct: 38  FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           ++     +   +++ E++  G+L+     S  P       +      A      H     
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAH---RA 148

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            V       + + +  +    +A                          +          
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179

Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 701
             + D+   G  L+ +L  R  +     R  +  A          + D    P     I 
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----------ERDTAGQPIEPADID 229

Query: 702 PDSLRKFGETAEKCLADFGVDRPS 725
            D   +    A + +   G  R +
Sbjct: 230 RDIPFQISAVAARSVQGDGGIRSA 253

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 46/190 (24%), Positives = 90/190 (47%), Gaps = 26/190 (13%)

Query: 431 MGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKG-ELNDGTKVA 489
           MG  + H ++          F      ++   ++   ++G G +G V K    + G  VA
Sbjct: 1   MGHHHHHHSSGVDLGTENLYF------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA 54

Query: 490 VKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGH 547
           +K+        + +     EI++L Q RH +LV+L+  C +K    L++E++++ T+   
Sbjct: 55  IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDD 113

Query: 548 L--YGSGLPSLSWK----QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 601
           L  + +GL     +    Q +        G+ + H   +  +IHRD+K  NIL+ ++ + 
Sbjct: 114 LELFPNGLDYQVVQKYLFQII-------NGIGFCH---SHNIIHRDIKPENILVSQSGVV 163

Query: 602 KVADFGLSKT 611
           K+ DFG ++T
Sbjct: 164 KLCDFGFART 173

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 40/225 (17%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           ++F+   VIG G F +V   ++    +V A+K   + +   +  ++ F+ E ++L     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120

Query: 517 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR---- 570
           R +  L  +   DE   + L+ EY   G L   L            +    I +      
Sbjct: 121 RWITQLH-FAFQDENY-LYLVMEYYVGGDLLTLL-----------SKFGERIPAEMARFY 167

Query: 571 ------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                  +  +H       +HRD+K  NILLD     ++ADFG               AV
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVY-------SFGVVLFEVLCARP 662
            G+  YL PE  +       +  Y       + GV  +E+   + 
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 23/166 (13%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLIGY 525
           IG G +G V+K    + G  VA+K+        + +     EI ML Q +H +LV+L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 526 CDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSARGLHYLHTGY 579
              K  + L++EY ++ T+   L  Y  G+P    K    Q L       + +++ H   
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL-------QAVNFCH--- 119

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQ-TH-VST 622
               IHRDVK  NIL+ ++ + K+ DFG ++      D     V+T
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.1 bits (229), Expect = 6e-20
 Identities = 50/206 (24%), Positives = 95/206 (46%), Gaps = 24/206 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQF-RHRHLVSLIGY 525
           V+G+G  GKV +        K A+K           + + E+E+  +  +  H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123

Query: 526 CDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGY 579
            +     +  ++++ E ++ G L   +   G  + + ++  EI   IG A  + YLH+  
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS-- 179

Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              + HRDVK  N+L      N + K+ DFG +K   E    +  T    +  Y+ PE  
Sbjct: 180 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL 235

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             ++  +  D++S GV+++ +LC  P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYP 261

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 91.4 bits (227), Expect = 1e-19
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 38/223 (17%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
            +F+   VIG G FG+V   +L +  KV A+K   +     +   A F+ E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 517 RHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR---- 570
           + + +L  Y   D+ N + L+ +Y   G L   L            + E  +        
Sbjct: 134 KWITTLH-YAFQDDNN-LYLVMDYYVGGDLLTLL-----------SKFEDRLPEEMARFY 180

Query: 571 ------GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                  +  +H       +HRD+K  NIL+D N   ++ADFG      E      S AV
Sbjct: 181 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237

Query: 625 KGSFGYLDPEYFRRQQLTEKS-----DVYSFGVVLFEVLCARP 662
            G+  Y+ PE  +  +  +       D +S GV ++E+L    
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 15/209 (7%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRS---QQGLAEFQTEIEMLSQFRH 516
            +F    ++G G F  V        ++  A+K    R    +  +     E +++S+  H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLH 573
              V L     +  ++     Y +NG L  ++   G    +   R    EI       L 
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSA----LE 144

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           YLH    K +IHRD+K  NILL+E+   ++ DFG +K      +   + +  G+  Y+ P
Sbjct: 145 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           E    +   + SD+++ G ++++++   P
Sbjct: 202 ELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.5 bits (220), Expect = 6e-19
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 43/221 (19%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKR--GNPRSQQGLAEFQT---------EIEMLSQFRH 516
            I  G +G V  G  ++G  VA+KR        + +              EI +L+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 517 RHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWK-------QRLEI 564
            +++ L            +++ L+ E M   T    +       +S +         L  
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMR--TDLAQVIHDQRIVISPQHIQYFMYHIL-- 144

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVST 622
                 GLH LH      V+HRD+   NILL +N    + DF L++          +V+ 
Sbjct: 145 -----LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 623 AVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 662
                  Y  PE   + +  T+  D++S G V+ E+   + 
Sbjct: 197 RW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 86.0 bits (214), Expect = 1e-18
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 25/155 (16%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT---EIEMLSQFRH 516
           IG G +G VYK      G  VA+K+        G P          T   EI +L +  H
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS---------TAIREISLLKELNH 61

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            ++V L+     +N++ L++E++    LK  +  S L  +             +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
              +  V+HRD+K  N+L++     K+ADFGL++ 
Sbjct: 121 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA 152

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGN-----PRSQQGLAEFQTEIEMLSQF 514
            +++   VIG G FG+V         KV A+K  +      RS    A F  E ++++  
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFA 126

Query: 515 RHRHLVSLIGYC--DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---------- 562
               +V L  Y   D++  + ++ EYM  G L   +             +          
Sbjct: 127 NSPWVVQLF-YAFQDDRY-LYMVMEYMPGGDLVNLMS---------NYDVPEKWARFYTA 175

Query: 563 EICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVST 622
           E+ +     L  +H   +   IHRDVK  N+LLD++   K+ADFG      +       T
Sbjct: 176 EVVLA----LDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228

Query: 623 AVKGSFGYLDPEYFRRQQLTEK----SDVYSFGVVLFEVLCARP 662
           AV G+  Y+ PE  + Q          D +S GV L+E+L    
Sbjct: 229 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 46/157 (29%), Positives = 81/157 (51%), Gaps = 27/157 (17%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR----GNPRSQQGLAEFQT---EIEMLSQFRHRHLV 520
           +G G F  VYK  + N    VA+K+        ++ G+   +T   EI++L +  H +++
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNII 75

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL-----SW-KQRLEICIGSARGLHY 574
            L+     K+ + L++++ME   L+  +  + L        ++    L       +GL Y
Sbjct: 76  GLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTL-------QGLEY 127

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
           LH      ++HRD+K  N+LLDEN + K+ADFGL+K+
Sbjct: 128 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 161

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.7 bits (215), Expect = 4e-18
 Identities = 62/246 (25%), Positives = 99/246 (40%), Gaps = 12/246 (4%)

Query: 422 SINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE 481
            +    +  M  +    +  S              +   N F+   ++G G FGKV   +
Sbjct: 109 GLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVK 168

Query: 482 LNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC-DEKNEMILIY 536
                +      +K+    ++  +A   TE  +L   RH  L +L  Y     + +  + 
Sbjct: 169 EKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVM 227

Query: 537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD 596
           EY   G L  HL    + S    +     I SA  L YLH+   K V++RD+K  N++LD
Sbjct: 228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LDYLHS--EKNVVYRDLKLENLMLD 283

Query: 597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
           ++   K+ DFGL K G  I          G+  YL PE           D +  GVV++E
Sbjct: 284 KDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 341

Query: 657 VLCARP 662
           ++C R 
Sbjct: 342 MMCGRL 347

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 7e-18
 Identities = 49/160 (30%), Positives = 76/160 (47%), Gaps = 39/160 (24%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFRH 516
           +G G +G VYK + + G  VA+KR        G P    R          EI +L +  H
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR----------EISLLKELHH 78

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 570
            ++VSLI     +  + L++E+ME   LK  L    +GL     K    Q L       R
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL-------R 130

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           G+ + H      ++HRD+K  N+L++ +   K+ADFGL++
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 86.0 bits (213), Expect = 8e-18
 Identities = 43/199 (21%), Positives = 80/199 (40%), Gaps = 44/199 (22%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
           +IG G +G VY   + N    VA+K+           + +   EI +L++ +  +++ L 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RILREITILNRLKSDYIIRLY 91

Query: 524 -----GYCDEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEI 564
                    + +E+ ++ E  +            L   H    LY            L  
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY----------NLL-- 139

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                 G +++H      +IHRD+K AN LL+++   KV DFGL++T      T++   +
Sbjct: 140 -----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 625 KGSFGYLDPEYFRRQQLTE 643
           + +          ++QLT 
Sbjct: 192 EENEEPGPHNKNLKKQLTS 210

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.0 bits (211), Expect = 9e-18
 Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 50/231 (21%)

Query: 458 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQF 514
           +    +     IG G +G V    +  +  +VA+K+ +P   Q   + +T  EI++L +F
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRF 82

Query: 515 RHRHLVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ 563
           RH +++ +         ++  ++ ++ + ME          + L  L   Q L       
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLME----------TDLYKLLKTQHLSNDHICY 132

Query: 564 ----ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQT 618
               I     RGL Y+H+     V+HRD+K +N+LL+     K+ DFGL++   P+ D T
Sbjct: 133 FLYQIL----RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 619 HVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARP 662
              T       Y+   ++R        +  T+  D++S G +L E+L  RP
Sbjct: 186 GFLT------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 83.3 bits (207), Expect = 1e-17
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 38/160 (23%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNPRSQQGLAEFQT---EIEMLSQFRH 516
           IG G +G V+K         VA+KR        G P          +   EI +L + +H
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---------SALREICLLKELKH 60

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 570
           +++V L        ++ L++E+ +   LK +       L     K    Q L       +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL-------K 112

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           GL + H   ++ V+HRD+K  N+L++ N   K+A+FGL++
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 19/166 (11%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGN-PRSQQGLAEF-QT---EI---EMLSQFRHRHL 519
           IG+G +G VYK  + + G  VA+K    P    G      +   E+     L  F H ++
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 520 VSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
           V L+        D + ++ L++E+++   L+ +L  +  P L  +   ++     RGL +
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTH 619
           LH   A  ++HRD+K  NIL+      K+ADFGL++    ++  T 
Sbjct: 136 LH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 60/316 (18%), Positives = 120/316 (37%), Gaps = 54/316 (17%)

Query: 420 PVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFV---AVQEATNNFDESWVIGIGGFGK 476
                G +     S  +     S +      +      +       +     IG G  G 
Sbjct: 18  IAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGI 77

Query: 477 VYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI------GYC 526
           V    +      VA+K+   P   Q  A+ +   E+ ++    H++++SL+         
Sbjct: 78  VCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKNIISLLNVFTPQKTL 136

Query: 527 DEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAV 583
           +E  ++ L+ E M+      ++  L    +  L + Q L        G+ +LH+     +
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-QML-------CGIKHLHSA---GI 185

Query: 584 IHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAVKGSFGYLDPEYFRRQQL 641
           IHRD+K +NI++  +   K+ DFGL++T         +V T       Y  PE       
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGY 240

Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 700
            E  D++S G ++ E++  + +     P R+ ++            Q +++I+    G  
Sbjct: 241 KENVDIWSVGCIMGEMVRHKILF----PGRDYID------------QWNKVIE--QLGTP 282

Query: 701 RPDSLRKFGETAEKCL 716
            P+ ++K   T    +
Sbjct: 283 CPEFMKKLQPTVRNYV 298

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 62/265 (23%), Positives = 106/265 (40%), Gaps = 56/265 (21%)

Query: 428 SHTMGSKYSHGTTTSANSNSGYRFPFVAVQEATNNFDESW------VIGIGGFGKVYKGE 481
           S TM +   +G   +   +   +   V   +               VIG G FG V++ +
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPN-KVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK 60

Query: 482 LNDGTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGY----CDEKNEMI--L 534
           L +  +VA+K+     Q     F+  E++++   +H ++V L  +     D+K+E+   L
Sbjct: 61  LVESDEVAIKK---VLQD--KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115

Query: 535 IYEYMENGTLKGHLY-----GSGLPSLSWK----QRLEICIGSARGLHYLHTGYAKAVIH 585
           + EY+   T+             +P L  K    Q L       R L Y+H+     + H
Sbjct: 116 VLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL-------RSLAYIHS---IGICH 164

Query: 586 RDVKSANILLDENFMA-KVADFGLSKT-GPEIDQTH-VST----AVKGSFGYLDPE-YFR 637
           RD+K  N+LLD      K+ DFG +K           + +    A         PE  F 
Sbjct: 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRA---------PELIFG 215

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
               T   D++S G V+ E++  +P
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQP 240

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 13/162 (8%)

Query: 501 LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ 560
             + +  +  +     R L S+       +   +  + + +   +          L+ + 
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 561 RLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV 620
            +      A+G+ +L    ++  IHRD+ + NILL E  + K+ DFGL++     D    
Sbjct: 195 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246

Query: 621 STAVKGSFGYLD-----PEYFRRQQLTEKSDVYSFGVVLFEV 657
              V+     L      PE    +  T +SDV+SFGV+L+E+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 29/152 (19%), Positives = 56/152 (36%), Gaps = 18/152 (11%)

Query: 468 VIGIGGFGKVYKGELND------GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHL 519
            +G G FG+V + +            VAVK      +        +E+++L     H ++
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88

Query: 520 VSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           V+L+G C      +++I E+ + G L  +L           +R E      +G  +    
Sbjct: 89  VNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQGK 139

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
                I  D+K     +  +  +  + F   K
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 45/222 (20%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI- 523
           ++G G +G V        G  VA+K+  P  +   A  +T  EI++L  F+H +++++  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENIITIFN 76

Query: 524 ----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIGSA 569
                  +  NE+ +I E M+          + L  +   Q L                 
Sbjct: 77  IQRPDSFENFNEVYIIQELMQ----------TDLHRVISTQMLSDDHIQYFIYQTL---- 122

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF- 628
           R +  LH      VIHRD+K +N+L++ N   KV DFGL++   E    +     + S  
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 629 -GYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARP 662
             ++   ++R         + +   DV+S G +L E+   RP
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 53/273 (19%), Positives = 110/273 (40%), Gaps = 47/273 (17%)

Query: 458 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQ 513
                +     IG G  G V    +      VA+K+   P   Q  A+ +   E+ ++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAYRELVLMKC 80

Query: 514 FRHRHLVSLI------GYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEI 564
             H++++ L+         +E  ++ ++ E M+      ++  L    +  L + Q L  
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY-QML-- 137

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
                 G+ +LH+     +IHRD+K +NI++  +   K+ DFGL++T      + + T  
Sbjct: 138 -----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPY 186

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQ 683
             +  Y  PE        E  D++S G ++ E++    +     P  + ++         
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF----PGTDHID--------- 233

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCL 716
              Q +++I+    G   P+ ++K   T    +
Sbjct: 234 ---QWNKVIE--QLGTPCPEFMKKLQPTVRTYV 261

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 48/167 (28%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFR 515
           IG G FG+V+K      G KVA+K+        G P    R          EI++L   +
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----------EIKILQLLK 74

Query: 516 HRHLVSLIG--------YCDEKNEMILIYEYMENGTLKGHLYGSGLP-SLS-----WKQR 561
           H ++V+LI         Y   K  + L++++ E+  L G L    +  +LS      +  
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML 133

Query: 562 LEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL 608
           L        GL+Y+H      ++HRD+K+AN+L+  + + K+ADFGL
Sbjct: 134 LN-------GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 2e-17
 Identities = 47/261 (18%), Positives = 90/261 (34%), Gaps = 54/261 (20%)

Query: 415 SKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRFPFVAVQ---EATNNFDESWVIGI 471
            +A      N G  HT+      G     + +S             +  + ++   +IG 
Sbjct: 4   HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63

Query: 472 GGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI--- 523
           G +G V +  +  +   VA+K+             +    EI +L++  H H+V ++   
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRLNHDHVVKVLDIV 121

Query: 524 --GYCDEKNEMILIYEYME---------NGTLKG-H----LYGSGLPSLSWKQRLEICIG 567
                ++ +E+ ++ E  +            L   H    LY            L     
Sbjct: 122 IPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----------NLL----- 166

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLS-----KTGPEIDQTHVST 622
              G+ Y+H+     ++HRD+K AN L++++   KV DFGL+                  
Sbjct: 167 --VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 623 AVKGSFGYLDPEYFRRQQLTE 643
               +          ++QLT 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTG 242

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 46/209 (22%), Positives = 88/209 (42%), Gaps = 31/209 (14%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
            +G G +G V    +   G KVA+K+   P   +  A+ +   E+ +L   +H +++ L+
Sbjct: 31  HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRELLLLKHMQHENVIGLL 89

Query: 524 ------GYCDEKNEMILIYEYME---NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
                        +  L+  +M+      +        +  L + Q L       +GL Y
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY-QML-------KGLKY 141

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           +H+     V+HRD+K  N+ ++E+   K+ DFGL++        +V T       Y  PE
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193

Query: 635 -YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
                    +  D++S G ++ E+L  + 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 39/160 (24%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKR--------GNP----RSQQGLAEFQTEIEMLSQFRH 516
           IG G +G VYK + N G   A+K+        G P    R          EI +L + +H
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR----------EISILKELKH 59

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 570
            ++V L      K  ++L++E+++   LK  L     GL S++ K    Q L        
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL-------N 111

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           G+ Y H    + V+HRD+K  N+L++     K+ADFGL++
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 23/160 (14%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRH 516
             + +   +G G +  VYKG        VA+K      ++G     T   E+ +L   +H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLKH 59

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHL--YGSGLPSLSWK----QRLEICIGSAR 570
            ++V+L      +  + L++EY++   LK +L   G+ +   + K    Q L       R
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-------R 111

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           GL Y H    + V+HRD+K  N+L++E    K+ADFGL++
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 468 VIGIGGFGKVY---KGELNDGTKV-AVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           V+G G FGKV+   K   +D  ++ A+K  +      +     + E ++L +  H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 522 LIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICIGSARGLHYL 575
           L  Y    + K  + LI +++  G L   L    + +     +    E+ +     L +L
Sbjct: 91  LH-YAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALA----LDHL 142

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H   +  +I+RD+K  NILLDE    K+ DFGLSK    ID    + +  G+  Y+ PE 
Sbjct: 143 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEV 197

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARP 662
             R+  T+ +D +SFGV++FE+L    
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTL 224

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 82.2 bits (204), Expect = 4e-17
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIG 524
           +G G +  VYKG     G  VA+K     S++G     T   EI ++ + +H ++V L  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRLYD 70

Query: 525 YCDEKNEMILIYEYMEN---GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
               +N++ L++E+M+N     +     G+    L             +GL + H     
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-- 128

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLS 609
            ++HRD+K  N+L+++    K+ DFGL+
Sbjct: 129 -ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.9 bits (203), Expect = 7e-17
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV         +      +++    ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 517 RHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARG 571
             L +L  Y     ++  +  + EY   G L  HL    + +    +    EI       
Sbjct: 65  PFLTALK-YAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA---- 117

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF-G 629
           L YLH   ++ V++RD+K  N++LD++   K+ DFGL K G  +            +F G
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFCG 167

Query: 630 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              YL PE           D +  GVV++E++C R 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 82.0 bits (203), Expect = 7e-17
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 36/228 (15%)

Query: 456 VQEATNNFDESWVIGIGGFGKVYKGELND-GTKVAVKR--GNPRSQQGLAEFQTEIEMLS 512
            ++  + F    + G G FG V  G+    G  VA+K+   +PR +    E Q  ++ L+
Sbjct: 18  SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN--RELQ-IMQDLA 74

Query: 513 QFRHRHLVSLIGY-----CDEKNEM--ILIYEYMENGTLKGHL-----YGSGLPSLSWK- 559
              H ++V L  Y       ++ ++   ++ EY+ + TL              P +  K 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV 133

Query: 560 ---QRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEI 615
              Q +       R +  LH      V HRD+K  N+L++  +   K+ DFG +K     
Sbjct: 134 FLFQLI-------RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP- 184

Query: 616 DQTHVSTAVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 662
            + +V+     S  Y  PE  F  Q  T   D++S G +  E++   P
Sbjct: 185 SEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 48/194 (24%), Positives = 83/194 (42%), Gaps = 34/194 (17%)

Query: 436 SHGTTTSANSNSGYRFPFVAVQEATN--NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKR 492
            H  T  A +         A   AT+   +     +G G +G+VYK  +      VA+KR
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 493 --------GNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN 541
                   G P          T   E+ +L + +HR+++ L       + + LI+EY EN
Sbjct: 67  IRLEHEEEGVPG---------TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN 117

Query: 542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA 601
             LK ++     P +S +           G+++ H+   +  +HRD+K  N+LL  +  +
Sbjct: 118 -DLKKYM--DKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDAS 171

Query: 602 -----KVADFGLSK 610
                K+ DFGL++
Sbjct: 172 ETPVLKIGDFGLAR 185

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 52/221 (23%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT-EIEMLSQFRHRHLVSLIGY 525
           VIG G FG VY+ +L D G  VA+K+     Q     F+  E++++ +  H ++V L  +
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKK---VLQD--KRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 526 ----CDEKNEMIL--IYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIGSA 569
                ++K+E+ L  + +Y+   T+              KQ L           +     
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA----KQTLPVIYVKLYMYQLF---- 166

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMA-KVADFGLSKT-GPEIDQTH-VST---- 622
           R L Y+H+     + HRD+K  N+LLD +    K+ DFG +K           + +    
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 623 AVKGSFGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 662
           A         PE  F     T   DV+S G VL E+L  +P
Sbjct: 224 A---------PELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 62/221 (28%), Positives = 94/221 (42%), Gaps = 37/221 (16%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLS 512
             F+   V+G GG+GKV++     G         KV  K    R+ +  A  + E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 513 QFRHRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EICI 566
           + +H  +V LI Y      K  + LI EY+  G L   L   G+            EI +
Sbjct: 77  EVKHPFIVDLI-YAFQTGGK--LYLILEYLSGGELFMQLEREGIFMED-TACFYLAEISM 132

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVK 625
                L +LH    K +I+RD+K  NI+L+     K+ DFGL K    +   TH      
Sbjct: 133 A----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH------ 179

Query: 626 GSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            +F G   Y+ PE   R       D +S G +++++L   P
Sbjct: 180 -TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 31/172 (18%)

Query: 469 IGIGGFGKVYKG--ELNDGTKVAVKR--------GNPRSQQGLAEFQTEIEMLSQFRHRH 518
           IG G +GKV+K     N G  VA+KR        G P S   + E    +  L  F H +
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREVAV-LRHLETFEHPN 75

Query: 519 LVSLI-----GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQR----LEICIGSA 569
           +V L         D + ++ L++E+++   L  +L     P +  +       ++     
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL---- 130

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHV 620
           RGL +LH   +  V+HRD+K  NIL+  +   K+ADFGL++    ++  T V
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 14/206 (6%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQ---TEIEMLSQFRH 516
           + FD    +G G FG+V   +  +     A+K  + +    L + +    E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G  S    +     I       YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT--FEYLH 158

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              +  +I+RD+K  N+L+D+    +V DFG +K       T   T        L PE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP-----EALAPEII 210

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             +   +  D ++ GV+++E+    P
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.4 bits (203), Expect = 2e-16
 Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 30/216 (13%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
            +F+   V+G G FGKV   E     ++     +K+        +     E  +L+   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
              L  L   C    ++  +  + EY+  G L  H+   G            EI IG   
Sbjct: 401 PPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG--- 454

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G 629
            L +L    +K +I+RD+K  N++LD     K+ADFG+ K       T   T    +F G
Sbjct: 455 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TK---TFCG 504

Query: 630 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              Y+ PE    Q   +  D ++FGV+L+E+L  + 
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 44/216 (20%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
            +G G +G V    +   G KVA+K+   P   +  A+ +   E+ +L   RH +++ L+
Sbjct: 32  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKHMRHENVIGLL 90

Query: 524 ------GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE----------ICIG 567
                    D+  +  L+  +M           + L  L   ++L           +   
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMG----------TDLGKLMKHEKLGEDRIQFLVYQML-- 138

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
             +GL Y+H      +IHRD+K  N+ ++E+   K+ DFGL++        +V T     
Sbjct: 139 --KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--- 190

Query: 628 FGYLDPEY-FRRQQLTEKSDVYSFGVVLFEVLCARP 662
             Y  PE      + T+  D++S G ++ E++  + 
Sbjct: 191 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 79.8 bits (197), Expect = 6e-16
 Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 30/160 (18%)

Query: 469 IGIGGFGKVYKG---ELNDGTKVAVKR----GNPRSQQGLAEFQTEIEMLSQFRHRHLVS 521
           +G G +G VYK    +  D    A+K+    G   S         EI +L + +H +++S
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNVIS 82

Query: 522 LIGYCDEKNEMI--LIYEYMENGTLKGHL--YGSGLPSLSWKQRLEICIGS-----ARGL 572
           L        +    L+++Y E+  L   +  + +   +    Q     + S       G+
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 573 HYLHTGYAKAVIHRDVKSANILLDENFMA----KVADFGL 608
           HYLH   A  V+HRD+K ANIL+          K+AD G 
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 80.7 bits (198), Expect = 1e-15
 Identities = 80/489 (16%), Positives = 150/489 (30%), Gaps = 126/489 (25%)

Query: 344 STLHDTYPDAILNGLEIMK----MKNLQGSLGNSSSKKHVGVIVGVTIGVSVAALLAGIL 399
                 Y D +    +        K++Q    +  SK+ +  I+     VS    L    
Sbjct: 12  GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRL---F 68

Query: 400 FMLCRKRRQLPQ------LGHSKAWIPVSINGGNSHTMGSKYSHGTTTSANSNSGYRF-- 451
           + L  K+ ++ Q      L  +  ++   I             +        N    F  
Sbjct: 69  WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAK 128

Query: 452 -------PFVAVQEATNNF-DESWVI--GIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 501
                  P++ +++A         V+  G+ G GK         T VA+        Q  
Sbjct: 129 YNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK---------TWVALDVCLSYKVQCK 179

Query: 502 AEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI-----LIYEYMENGTLKG-HLYGSGLPS 555
            +F+  I  L+          +  C+    ++     L+Y+   N T +  H     L  
Sbjct: 180 MDFK--IFWLN----------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 556 LSWKQRLEICIGSARGLHYLHTGYAKA-VIHRDVKSANILLDENFMAKVADFGLSKTGPE 614
            S +  L       R L      Y    ++  +V++A       F     +         
Sbjct: 228 HSIQAEL-------RRL-LKSKPYENCLLVLLNVQNAKAW--NAF-----NLSC------ 266

Query: 615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEV--LCARPV-IDPT-LPR 670
             +  ++T  K    +L         L   S      +   EV  L  + +   P  LPR
Sbjct: 267 --KILLTTRFKQVTDFLSAATTTHISLDHHSM----TLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 671 EMVN------------LAEWAMKWQN-----KGQLDQIIDPTLAGKIRPDSLRK-FGETA 712
           E++             + +    W N       +L  II+ +L   + P   RK F    
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKMF---- 375

Query: 713 EKCLADF--GVDRPSMG-DVLW-NLEYALQLQEAVVH---------GDPDENSTNLIG-- 757
              L+ F      P++   ++W ++         VV+           P E++ ++    
Sbjct: 376 -DRLSVFPPSAHIPTILLSLIWFDVIK--SDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 758 -ELSPQIHN 765
            EL  ++ N
Sbjct: 433 LELKVKLEN 441

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 6e-08
 Identities = 89/756 (11%), Positives = 188/756 (24%), Gaps = 275/756 (36%)

Query: 104 FSVSTNDH-------VLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSNNSFAFINALEVV 156
           F    + +       V  + F         F      D    I S             ++
Sbjct: 9   FETGEHQYQYKDILSVFEDAF------VDNFDCKDVQDMPKSILSKEEID-------HII 55

Query: 157 SVPDQ---------LITDDASSISPPGKYQGLVFQTFETVHRVNMGGPLVTPENDTLWRT 207
              D           +      +         V +  E V R                  
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEM---------VQKFVEEVLR------------------ 88

Query: 208 WVPDQSFLVNRNLAKSVSNIPAVKYVQGGATKESAPNTVYGTA-TRMNSDDDPNANFNVT 266
              +  FL++    K+    P            S    +Y     R+ +D+   A +NV+
Sbjct: 89  --INYKFLMSP--IKTEQRQP------------SMMTRMYIEQRDRLYNDNQVFAKYNVS 132

Query: 267 WEFDVDSGFQYLVRFHFCDIVSDGLNQLYFNVYI---------DSWIA---VRDLDLSTY 314
                        R      +   L +L     +          +W+A        +   
Sbjct: 133 -------------RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179

Query: 315 STNTLAAAYYIDMVTVQTASSKLRISIGRSTLHDTYPDAILNGLEIMKMKNLQGSLGNSS 374
                   +++++    +  + L                +L  L      N      +SS
Sbjct: 180 MDF---KIFWLNLKNCNSPETVL---------------EMLQKLLYQIDPNWTSRSDHSS 221

Query: 375 SKKHVGVIVGVTIGVSVAALLAGILFMLCRKRRQLPQLGHSKA-------WIPVSIN--G 425
           + K                    I  +    RR L    +              + N   
Sbjct: 222 NIKL------------------RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 426 GNSHTMGSKYSHGTTTS----ANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGE 481
            +   +        TT      +  S      +++   +       V  +    K     
Sbjct: 264 LSCKIL-------LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSL--LLKYLDCR 314

Query: 482 LNDGTKVAVKRGNPRSQQGLAEF-QTEIEMLSQFRHRHLVSLIGYCDEKNEMI-LIYEYM 539
             D  +  +   NPR    +AE  +  +     ++H +       CD+   +I      +
Sbjct: 315 PQDLPREVLT-TNPRRLSIIAESIRDGLATWDNWKHVN-------CDKLTTIIESSLNVL 366

Query: 540 ENGTLKGHLY--------GSGLPS--LS--WKQRLEICI---------------GSARGL 572
           E    +  ++         + +P+  LS  W   ++  +                     
Sbjct: 367 EPAEYR-KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKEST 425

Query: 573 HYLHTGYAKAVIHRDVKSA--NILLDE-NFMAKVADFGLSKTGPEIDQ---THVSTAVKG 626
             + + Y +  +  + + A    ++D  N         L    P +DQ   +H       
Sbjct: 426 ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP--PYLDQYFYSH------- 476

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 686
             G+    + +  +  E+         LF                 ++      ++    
Sbjct: 477 -IGH----HLKNIEHPERMT-------LF-------------RMVFLDF-----RF---- 502

Query: 687 QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE-YALQLQEAVVH 745
                    L  KIR DS      TA            S+ + L  L+ Y   +      
Sbjct: 503 ---------LEQKIRHDS------TAWNA-------SGSILNTLQQLKFYKPYIC----- 535

Query: 746 GDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDV 781
            D D     L+  +   +    +++ ++  +  +D+
Sbjct: 536 -DNDPKYERLVNAI---LDFLPKIEENLICSKYTDL 567

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
            +FD   VIG G + KV    L    ++     VK+      + +   QTE  +  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
           H  LV L   C   + +  +  + EY+  G L  H+           +    EI +    
Sbjct: 69  HPFLVGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 122

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 628
            L+YLH    + +I+RD+K  N+LLD     K+ D+G+ K G    D T        +F 
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFC 171

Query: 629 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           G   Y+ PE  R +      D ++ GV++FE++  R 
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 55/217 (25%), Positives = 91/217 (41%), Gaps = 32/217 (14%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
            +F+   V+G G FGKV   E     ++     +K+        +     E  +L+   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
              L  L   C    ++  +  + EY+  G L  H+   G            EI IG   
Sbjct: 80  PPFLTQLH-SCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG--- 133

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 628
            L +L    +K +I+RD+K  N++LD     K+ADFG+ K    +   T        +F 
Sbjct: 134 -LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-------TFC 182

Query: 629 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           G   Y+ PE    Q   +  D ++FGV+L+E+L  + 
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 30/216 (13%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
           +NF+   V+G G FGKV    + +   +     +K+        +    TE  +LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
           H  L  L   C    ++  +  + E++  G L  H+  S     +  +    EI      
Sbjct: 83  HPFLTQLF-CCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA--- 136

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G 629
            L +LH    K +I+RD+K  N+LLD     K+ADFG+ K G     T   TA   +F G
Sbjct: 137 -LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TA---TFCG 186

Query: 630 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              Y+ PE  +        D ++ GV+L+E+LC   
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 49/196 (25%), Positives = 92/196 (46%), Gaps = 42/196 (21%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFR-HRHLVSL 522
            +G G +G V+K  +   G  VAVK+  +       A+ +T  EI +L++   H ++V+L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-RTFREIMILTELSGHENIVNL 74

Query: 523 --IGYCDEKNEMILIYEYME---NGTLKG------H----LYGSGLPSLSWKQRLEICIG 567
             +   D   ++ L+++YME   +  ++       H    +Y          Q +     
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY----------QLI----- 119

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
             + + YLH+G    ++HRD+K +NILL+     KVADFGLS++   I +   +  +  +
Sbjct: 120 --KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 628 FGYLDPEYFRRQQLTE 643
               + +   +  LT+
Sbjct: 175 ENTENFDD-DQPILTD 189

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 46/206 (22%), Positives = 86/206 (41%), Gaps = 45/206 (21%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIE-MLSQFRHRHLVSLIGY 525
           V+G+G  GKV +        K A+K       Q   + + E+E      +  H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 526 CDE----KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEIC--IGSARGLHYLHTGY 579
            +     +  ++++ E ++ G L   +   G  + + ++  EI   IG A  + YLH   
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLH--- 134

Query: 580 AKAVIHRDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +  + HRDVK  N+L      N + K+ DFG +    E                      
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KET--------------------- 170

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARP 662
             ++  +  D++S GV+++ +LC  P
Sbjct: 171 TGEKYDKSCDMWSLGVIMYILLCGYP 196

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 32/217 (14%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
            +FD   VIG G + KV    L    ++     VK+      + +   QTE  +  Q   
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
           H  LV L   C   + +  +  + EY+  G L  H+           +    EI +    
Sbjct: 112 HPFLVGLH-SCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--- 165

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG-PEIDQTHVSTAVKGSF- 628
            L+YLH    + +I+RD+K  N+LLD     K+ D+G+ K G    D T        +F 
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS-------TFC 214

Query: 629 G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           G   Y+ PE  R +      D ++ GV++FE++  R 
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 92/288 (31%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR---GNPRSQQGLAEFQT--EIEMLSQFRHRHLVS 521
            +G GG G V+   + +   +VA+K+    +P+S +         EI+++ +  H ++V 
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-----HALREIKIIRRLDHDNIVK 72

Query: 522 LI--------------GYCDEKNEMILIYEYME--------NGTL-KGH----LYGSGLP 554
           +               G   E N + ++ EYME         G L + H    +Y     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY----- 127

Query: 555 SLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKT-G 612
                Q L       RGL Y+H+     V+HRD+K AN+ ++ E+ + K+ DFGL++   
Sbjct: 128 -----QLL-------RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 613 PEIDQTHVSTAVKGSFGYLDPEYFR-------RQQLTEKSDVYSFGVVLFEVLCARPVID 665
           P        +        L  +++R           T+  D+++ G +  E+L  + +  
Sbjct: 173 PHYSHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL-- 224

Query: 666 PTLP-REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 712
                   +             Q+  I++      +  +  ++     
Sbjct: 225 --FAGAHELE------------QMQLILE--SIPVVHEEDRQELLSVI 256

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 60/209 (28%), Positives = 85/209 (40%), Gaps = 30/209 (14%)

Query: 468 VIGIGGFGKVYKGELNDGTKV-AVK---RGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSL 522
           VIG G FGKV            AVK   +     ++      +E  +L +  +H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 523 IGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSARGLHYLHT 577
             +     +K   +L  +Y+  G L  HL           +    EI       L YLH 
Sbjct: 105 H-FSFQTADKLYFVL--DYINGGELFYHLQRERCFLEPRARFYAAEIASA----LGYLH- 156

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G---YLDP 633
             +  +++RD+K  NILLD      + DFGL K   E + T   T    +F G   YL P
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---T---STFCGTPEYLAP 208

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           E   +Q      D +  G VL+E+L   P
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR-GNPRSQQGLAEFQT--EIEMLSQFRHRHLVSLI 523
            +G G +G V    +   G +VAVK+   P      A+ +T  E+ +L   +H +++ L+
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHENVIGLL 94

Query: 524 ------GYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLE------ICIGSARG 571
                    +E N++ L+   M           + L ++   Q+L       +     RG
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG----------ADLNNIVKCQKLTDDHVQFLIYQILRG 144

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           L Y+H+     +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T       Y 
Sbjct: 145 LKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YR 196

Query: 632 DPE-YFRRQQLTEKSDVYSFGVVLFEVLCARP 662
            PE         +  D++S G ++ E+L  R 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.0 bits (188), Expect = 5e-15
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 46/222 (20%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV-AVKRGNPRSQQGLAEFQ-----TEIEMLSQF 514
            +F     +G G FG+V+        +  A+K    + +  +   Q      E  MLS  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIV 63

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL----------EI 564
            H  ++ + G   +  ++ +I +Y+E G L   L  S         R           E+
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEV 115

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
           C+     L YLH   +K +I+RD+K  NILLD+N   K+ DFG +K  P  D T+     
Sbjct: 116 CLA----LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP--DVTY----- 161

Query: 625 KGSF-G---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
             +  G   Y+ PE    +   +  D +SFG++++E+L    
Sbjct: 162 --TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.1 bits (188), Expect = 6e-15
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKV----AVKRGNPRSQQGLAEFQTEIEMLSQ-FR 515
            +F    ++G G FGKV+  E     +     A+K+        +     E  +LS  + 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 516 HRHLVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQ--RLEICIGSAR 570
           H  L  +        E    ++  EY+  G L  H+       LS       EI +G   
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILG--- 130

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSF-G 629
            L +LH   +K +++RD+K  NILLD++   K+ADFG+ K     D     T    +F G
Sbjct: 131 -LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TN---TFCG 180

Query: 630 ---YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
              Y+ PE    Q+     D +SFGV+L+E+L  + 
Sbjct: 181 TPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 46/205 (22%), Positives = 94/205 (45%), Gaps = 38/205 (18%)

Query: 469 IGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSL--IG 524
           +G G + +V++   + +  KV VK   P  ++   + + EI++L   R   ++++L  I 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLS-------WKQRLEICIGSARGLHYLHT 577
                    L++E++ N   K  LY     +L+         + L       + L Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-QLY----QTLTDYDIRFYMYEIL-------KALDYCHS 148

Query: 578 GYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTG-PEIDQTH-VSTAVKGSFGYLDPE 634
                ++HRDVK  N+++D E+   ++ D+GL++   P  +    V++       +  PE
Sbjct: 149 ---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE 200

Query: 635 YFRRQQLTEKS-DVYSFGVVLFEVL 658
                Q+ + S D++S G +L  ++
Sbjct: 201 LLVDYQMYDYSLDMWSLGCMLASMI 225

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 44/249 (17%), Positives = 90/249 (36%), Gaps = 76/249 (30%)

Query: 468 VIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQT---EIEMLSQFRHRHLVSLI 523
            +G G FG V +    + G + A+K+        L + +    E++++    H +++ L+
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 524 GY--------------------------------------CDEKNEMILIYEYMENGTLK 545
            Y                                        +   + +I EY+ + TL 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125

Query: 546 GHLYGSGLPSLSWKQRLE----------ICIGSARGLHYLHTGYAKAVIHRDVKSANILL 595
             L       +   + +           +     R + ++H+     + HRD+K  N+L+
Sbjct: 126 KVLKSF----IRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLV 174

Query: 596 D-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE-YFRRQQLTEKSDVYSFGVV 653
           + ++   K+ DFG +K      +  V+     S  Y  PE      + T   D++S G V
Sbjct: 175 NSKDNTLKLCDFGSAKKLIP-SEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCV 231

Query: 654 LFEVLCARP 662
             E++  +P
Sbjct: 232 FGELILGKP 240

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 41/225 (18%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGT--------KVAVKRGNPRSQQGLAEFQTEIEMLS 512
            NF+   V+G G +GKV+      G         KV  K    +  +     +TE ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 513 QFRHRH-LVSLIGYC---DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRL---EIC 565
             R    LV+L  Y    + K  +IL  +Y+  G L  HL      +     ++   EI 
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLIL--DYINGGELFTHLSQRERFTEHEV-QIYVGEIV 169

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTG--PEIDQTHVSTA 623
           +     L +LH      +I+RD+K  NILLD N    + DFGLSK     E ++ +    
Sbjct: 170 LA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY---- 218

Query: 624 VKGSF-G---YLDPEYFRRQQL--TEKSDVYSFGVVLFEVLCARP 662
               F G   Y+ P+  R       +  D +S GV+++E+L    
Sbjct: 219 ---DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.3 bits (171), Expect = 4e-13
 Identities = 35/200 (17%), Positives = 54/200 (27%), Gaps = 53/200 (26%)

Query: 459 ATNNFDESWVIGIGGFGKVYKGELNDGTKVAVK--------RGNPRSQQGLAEFQTEIEM 510
            T        IG G FG+V++    D T VA+K          N   Q+   E   EI +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 511 L-----------------SQFRHRHLV------SLIGYCDE----------------KNE 531
                                   H V       L+   D                  ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSA 591
           + ++ E+   G     L        S      I       L            HRD+   
Sbjct: 137 LFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWG 191

Query: 592 NILLDENFMAKVADFGLSKT 611
           N+LL +  + K+      K+
Sbjct: 192 NVLLKKTSLKKLHYTLNGKS 211

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 64/307 (20%), Positives = 120/307 (39%), Gaps = 73/307 (23%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFR-------- 515
            +G G F  V+  + + + T VA+K  RG+   ++      + EI++L +          
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKED 81

Query: 516 ---HRHLVSLIGYCDEKNE----MILIYEYMENGTLKGHLY-------GSGLPSLSW--- 558
                H++ L+ + + K      +++++E      L  +L          G+P L +   
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIP-LIYVKQ 135

Query: 559 --KQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE------NFMAKVADFGLSK 610
             KQ L        GL Y+H      +IH D+K  N+L++           K+AD G + 
Sbjct: 136 ISKQLLL-------GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186

Query: 611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 670
              E    H + +++    Y  PE          +D++S   ++FE++    + +P    
Sbjct: 187 WYDE----HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP---- 237

Query: 671 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                 E     ++   + QII+  L G++ P  L + G+         G+ R       
Sbjct: 238 -----DEGHSYTKDDDHIAQIIE--LLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKF 289

Query: 731 WNLEYAL 737
           W LE  L
Sbjct: 290 WPLEDVL 296

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 41/209 (19%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR------ 517
           VIG G FG+V K         VA+K  R   R  +Q       EI +L   R +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159

Query: 518 HLVSLIGYCDEKNEMILI--------YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +++ ++     +N + +         YE ++    +G          S     +      
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG---------FSLPLVRKFAHSIL 210

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMA--KVADFGLSKTGPEIDQTHVSTAVKGS 627
           + L  LH      +IH D+K  NILL +   +  KV DFG S      +   V T ++  
Sbjct: 211 QCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVYTYIQSR 263

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFE 656
           F Y  PE     +     D++S G +L E
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAE 291

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 33/157 (21%), Positives = 56/157 (35%), Gaps = 30/157 (19%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYC 526
           IG G FG +++G  L +  +VA+K    RS         E            + ++  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYFG 75

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSL--------SWKQRLEICIGSARGLHYLHTG 578
            E    +L+   ++       L G  L  L        S K            +  +H  
Sbjct: 76  QEGLHNVLV---ID-------LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE- 124

Query: 579 YAKAVIHRDVKSANILLDENFMAK-----VADFGLSK 610
             K++++RD+K  N L+            V DFG+ K
Sbjct: 125 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 34/176 (19%), Positives = 62/176 (35%), Gaps = 50/176 (28%)

Query: 469 IGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE 528
           IG GGFG +Y  ++N    V                   +++     +  L + + +   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDA------------PCVVKVEPS-DNGPLFTELKFYQR 89

Query: 529 KNEMILIYEYMENGTLKG----HLYGSGL-----------------PSL----------- 556
             +   I +++    LK       +GSGL                   L           
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSK 610
           S K  L++ +     L Y+H       +H D+K++N+LL+     +V   D+GL+ 
Sbjct: 150 SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 26/165 (15%), Positives = 57/165 (34%), Gaps = 28/165 (16%)

Query: 469 IGIGGFGKVYKGE---------LNDGTKVAVK----RGNPRSQQGLAEFQTEIEMLSQFR 515
                 G +Y+                K ++K     G   ++Q   +   +   +++++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 516 HRHLVSLIG-----YC--DEKNEMILIYEYMENGT-LKGHLYGSGLPSLSWKQRLEICIG 567
             +   L+           +     L+   +  G  L+  L  S    LS +  L++   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 568 SARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKV--ADFGLSK 610
               L +LH       +H +V + NI +D    ++V  A +G + 
Sbjct: 168 LLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 47/215 (21%), Positives = 77/215 (35%), Gaps = 39/215 (18%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR------ 517
           +IG G FG+V K     +   VA+K  +       Q       E+ +L            
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116

Query: 518 HLVSLIGYCDEKNEMILI--------YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           ++V L  +   +N + L+        Y+ + N   +G         +S     +      
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG---------VSLNLTRKFAQQMC 167

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGS 627
             L +L T     +IH D+K  NILL   +    K+ DFG S          +   ++  
Sbjct: 168 TALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG-SSC---QLGQRIYQYIQSR 222

Query: 628 FGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARP 662
           F Y  PE           D++S G +L E+    P
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 32/157 (20%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLI---G 524
           IG G FG +Y G  +  G +VA+K    +++        E ++    +    +  I   G
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWCG 74

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSL--------SWKQRLEICIGSARGLHYLH 576
              + N M+     ME       L G  L  L        S K  L +       + Y+H
Sbjct: 75  AEGDYNVMV-----ME-------LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 577 TGYAKAVIHRDVKSANILLDENFMAK---VADFGLSK 610
              +K  IHRDVK  N L+          + DFGL+K
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 45/211 (21%), Positives = 72/211 (34%), Gaps = 41/211 (19%)

Query: 431 MGSKYSHGTTTSANSNSGYRF--PFVAVQEATNNFDESWV----IGIGGFGKVYKGE-LN 483
           M   + H +     + + Y    PF   +   +     WV    IG GGFG +Y     N
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN 60

Query: 484 DGTKVA---VKRGNPRSQQGLAEFQTEI-----EMLSQFRHRHLVSLIG-----YCDEKN 530
              K A   VK     +    +E +        + + ++  R  +  +G           
Sbjct: 61  KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120

Query: 531 EMILIYEY--MENGTLKGHLYGSGLPSL-------SWKQRLEICIGSARGLHYLHTGYAK 581
                Y +  ME         G  L  +            L++ I     L Y+H     
Sbjct: 121 FKGRSYRFMVME-------RLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH---EN 170

Query: 582 AVIHRDVKSANILLDENFMAKV--ADFGLSK 610
             +H D+K+AN+LL      +V  AD+GLS 
Sbjct: 171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 59/372 (15%), Positives = 101/372 (27%), Gaps = 136/372 (36%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFR--------HR 517
           +G G F  V+    +     VA+K  +      +       EI +L   R          
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA---LDEIRLLKSVRNSDPNDPNRE 101

Query: 518 HLVSLIGY-----------CDEKNEMILIYEYM-EN-GTLKGHLYGSGLPSLSWKQRLEI 564
            +V L+             C       +++E +  +           GLP    K+   I
Sbjct: 102 MVVQLLDDFKISGVNGTHIC-------MVFEVLGHHLLKWIIKSNYQGLPLPCVKK---I 151

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILL----------------------------- 595
                +GL YLHT     +IH D+K  NILL                             
Sbjct: 152 IQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209

Query: 596 --------------------DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
                                E    K+AD G +    +     + T       Y   E 
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR----------EMVNL-----AEWAM 680
                    +D++S   + FE+     + +P               ++ L      +  +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 681 KWQN-------KGQLDQIIDPTLAGKIRPDSL-------RKFGETAEKCLADFGV----- 721
             +        KG L  I       K++P  L        ++ +       DF +     
Sbjct: 325 AGKYSKEFFTKKGDLKHIT------KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378

Query: 722 ---DRPSMGDVL 730
               R +  + L
Sbjct: 379 IPEKRATAAECL 390

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 40/160 (25%), Positives = 60/160 (37%), Gaps = 36/160 (22%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYC 526
           IG G FG++  G+ L     VA+K    +S+        E     Q      +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSL-----------SWKQRLEICIGSARGLHYL 575
                  ++   +E       L G   PSL           S K  L I I     + Y+
Sbjct: 75  PCGKYNAMV---LE-------LLG---PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121

Query: 576 HTGYAKAVIHRDVKSANILL--DENFMAKVA---DFGLSK 610
           H+   K +I+RDVK  N L+    N   +V    DF L+K
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 12/147 (8%)

Query: 469 IGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYC 526
           IG G FG++Y G  +    +VA+K  N +++     +  E ++    +    + ++  + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
            E +  +L+ + +  G     L+      LS K  L +       + ++H+   K+ +HR
Sbjct: 73  VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127

Query: 587 DVKSANILLDENFMAK---VADFGLSK 610
           D+K  N L+     A    + DFGL+K
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 50/228 (21%), Positives = 85/228 (37%), Gaps = 57/228 (25%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR-----H 518
            +G G FG+V   + +++    AVK  R   + ++      + E ++L + ++      +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNN 97

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLY----GSGLPSLSWKQRLEICIGSARGLHY 574
           +V   G     + M LI+E      L   LY     +       +     CI   + L+Y
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV--STAVK----GSF 628
           L      ++ H D+K  NILLD+ +  K        T  +  Q +   ST +K    G  
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 629 GYLD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 656
            +                PE      +         SD++SFG VL E
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAE 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 46/233 (19%), Positives = 78/233 (33%), Gaps = 71/233 (30%)

Query: 468 VIGIGGFGKVYKG--ELNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR----- 517
            +G G FGKV +        ++VA+K  R   +  +      + EI +L + + +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENK 81

Query: 518 -HLVSLIGYCDEKNEMIL--------IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGS 568
              V +  + +    M +         +E+++    +                  +    
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP---------YPLPHVRHMAYQL 132

Query: 569 ARGLHYLHTGYAKAVIHRDVKSANILLDENFMA-------------------KVADFGLS 609
              L +LH      + H D+K  NIL   +                      +VADFG S
Sbjct: 133 CHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S 188

Query: 610 KTGPEIDQTHVSTAVKGSFGYLDPE------YFRRQQLTEKSDVYSFGVVLFE 656
            T    D  H +T V     Y  PE      +       +  DV+S G +LFE
Sbjct: 189 AT---FDHEHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 42/227 (18%), Positives = 86/227 (37%), Gaps = 59/227 (25%)

Query: 468 VIGIGGFGKVYKG--ELNDGTKVAVK--RGNPR-SQQGLAEFQTEIEMLSQFRHR----- 517
            +G G FGKV +       G  VAVK  +   R  +      ++EI++L           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNST 76

Query: 518 -HLVSLIGYCDEKNEMILIYEYMENGT---LKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
              V ++ + +    + +++E +   T   +K + +      L   ++  +     + ++
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF-LPFR-LDHIRK--MAYQICKSVN 132

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK----GSFG 629
           +LH+     + H D+K  NIL  ++   +  +          ++T ++  +K    GS  
Sbjct: 133 FLHS---NKLTHTDLKPENILFVQSDYTEAYN----PKIKRDERTLINPDIKVVDFGSAT 185

Query: 630 YLD--------------PE------YFRRQQLTEKSDVYSFGVVLFE 656
           Y D              PE      +      ++  DV+S G +L E
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	805
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-75
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-65
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-64
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-58
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-53
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-51
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	9e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 2e-75
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 19/270 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            IG G FG VYKG+ +    V +      + Q L  F+ E+ +L + RH +++  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74

Query: 528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRD 587
              ++ ++ ++ E  +L  HL+          + ++I   +A+G+ YLH    K++IHRD
Sbjct: 75  A-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129

Query: 588 VKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ---LTEK 644
           +KS NI L E+   K+ DFGL+        +H    + GS  ++ PE  R Q     + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 704
           SDVY+FG+VL+E++  +       P   +N  +  +    +G L   +      K+R + 
Sbjct: 190 SDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLS-----KVRSNC 238

Query: 705 LRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
            +       +CL     +RP    +L ++E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 2e-65
 Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 32/283 (11%)

Query: 463 FDESW-----------VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEML 511
           +++ W            +G G FG+V+ G  N  TKVAVK    +       F  E  ++
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLM 62

Query: 512 SQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
            Q +H+ LV L     +   + +I EYMENG+L   L       L+  + L++    A G
Sbjct: 63  KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           + ++     +  IHRD+++ANIL+ +    K+ADFGL++   + ++       K    + 
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWT 177

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 691
            PE       T KSDV+SFG++L E++    +  P +    V         QN  +  ++
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRM 229

Query: 692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
           + P       P+ L +       C  +   DRP+   +   LE
Sbjct: 230 VRPDNC----PEELYQL---MRLCWKERPEDRPTFDYLRSVLE 265

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 2e-65
 Identities = 67/298 (22%), Positives = 132/298 (44%), Gaps = 28/298 (9%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD 527
            IG G FG+V++G+   G +VAVK  + R ++     + EI      RH +++  I   +
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67

Query: 528 EKN----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA--- 580
           + N    ++ L+ +Y E+G+L  +L    +     +  +++ + +A GL +LH       
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT---VEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 581 --KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT--HVSTAVKGSFGYLDPEYF 636
              A+ HRD+KS NIL+ +N    +AD GL+        T         G+  Y+ PE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 637 RRQ------QLTEKSDVYSFGVVLFEVLCARPVIDPTL----PREMVNLAEWAMKWQNKG 686
                    +  +++D+Y+ G+V +E+     +         P   +  ++ +++   K 
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 687 QLDQIIDPTLAGKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 743
             +Q + P +  + +  ++LR   +   +C    G  R +   +   L   L  QE +
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS-QLSQQEGI 301

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 4e-64
 Identities = 77/282 (27%), Positives = 126/282 (44%), Gaps = 24/282 (8%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
           +       IG G FG V+ G   +  KVA+K           +F  E E++ +  H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L G C E+  + L++E+ME+G L      +     + +  L +C+    G+ YL     
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
             VIHRD+ + N L+ EN + KV+DFG+++   + DQ   ST  K    +  PE F   +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 641 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 700
            + KSDV+SFGV+++EV          +P E  + +E            ++  P LA   
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGK-----IPYENRSNSEVVEDISTG---FRLYKPRLA--- 227

Query: 701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 742
               + +       C  +   DRP+   +L  L    ++ E+
Sbjct: 228 -STHVYQI---MNHCWKERPEDRPAFSRLLRQLA---EIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 6e-64
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 21/274 (7%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +      +G G FG V  G+      VA+K     S     EF  E +++    H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L G C ++  + +I EYM NG L  +L          +Q LE+C      + YL +   
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES--- 118

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
           K  +HRD+ + N L+++  + KV+DFGLS+   + D+   S   K    +  PE     +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 641 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 700
            + KSD+++FGV+++E+          +P E    +E A       +L     P LA   
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAEHIAQGLRLY---RPHLA--- 226

Query: 701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
             + +         C  +   +RP+   +L N+ 
Sbjct: 227 -SEKVYTI---MYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 2e-63
 Identities = 70/279 (25%), Positives = 114/279 (40%), Gaps = 21/279 (7%)

Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
            +      +G G +G+VY+G        VAVK     + + + EF  E  ++ + +H +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V L+G C  +    +I E+M  G L  +L       +S    L +    +  + YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQ 639
            K  IHRD+ + N L+ EN + KVADFGLS+     D        K    +  PE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191

Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 699
           + + KSDV++FGV+L+E+        P +                  Q+ ++++     +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYELLEKDYRME 236

Query: 700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
                  K  E    C      DRPS  ++    E   Q
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 5e-63
 Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 27/269 (10%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC- 526
            IG G FG V  G+   G KVAVK    ++      F  E  +++Q RH +LV L+G   
Sbjct: 14  TIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           +EK  + ++ EYM  G+L  +L   G   L     L+  +     + YL        +HR
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE  R ++ + KSD
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSD 182

Query: 647 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 706
           V+SFG++L+E+          +P   + L +   + +   ++D            P ++ 
Sbjct: 183 VWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDG-------CPPAVY 230

Query: 707 KFGETAEKCLADFGVDRPSMGDVLWNLEY 735
           +     + C       RPS   +   LE+
Sbjct: 231 EV---MKNCWHLDAAMRPSFLQLREQLEH 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 2e-62
 Identities = 60/294 (20%), Positives = 120/294 (40%), Gaps = 11/294 (3%)

Query: 459 ATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGL-AEFQTEIEMLSQFRH 516
             ++F++   +G G  G V+K      G  +A K  +   +  +  +   E+++L +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            ++V   G      E+ +  E+M+ G+L   L  +G   +  +   ++ I   +GL YL 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR 121

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
                 ++HRDVK +NIL++     K+ DFG+S    +     ++ +  G+  Y+ PE  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
           +    + +SD++S G+ L E+   R  I P   +E+  +    ++        +   P  
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 750
                    R      E          P +   +++LE         +  +P E
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE-FQDFVNKCLIKNPAE 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 9e-62
 Identities = 83/302 (27%), Positives = 139/302 (46%), Gaps = 29/302 (9%)

Query: 462 NFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRH 516
           +F+E  VIG G FG VY G L D        AVK  N  +  G +++F TE  ++  F H
Sbjct: 30  HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 517 RHLVSLIGYC-DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
            +++SL+G C   +   +++  YM++G L+ +   +   + + K  +   +  A+G+ +L
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFL 146

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGSFGYLDP 633
            +   K  +HRD+ + N +LDE F  KVADFGL++     E D  H  T  K    ++  
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           E  + Q+ T KSDV+SFGV+L+E++          P   VN  +  +      +L Q   
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLLQ--- 255

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENST 753
                +  PD L +      KC       RPS  +++  +           +   +    
Sbjct: 256 ----PEYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYV 308

Query: 754 NL 755
           N+
Sbjct: 309 NV 310

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  208 bits (529), Expect = 1e-61
 Identities = 77/307 (25%), Positives = 121/307 (39%), Gaps = 47/307 (15%)

Query: 461 NNFDESWVIGIGGFGKVYKGEL------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQ 513
           NN +    IG G FG+V++            T VAVK      S    A+FQ E  ++++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG----------------------S 551
           F + ++V L+G C     M L++EYM  G L   L                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 552 GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT 611
           G P LS  ++L I    A G+ YL     +  +HRD+ + N L+ EN + K+ADFGLS+ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE 671
               D             ++ PE     + T +SDV+++GVVL+E+          +   
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 248

Query: 672 MVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW 731
                E  + +   G +    +        P  L         C +    DRPS   +  
Sbjct: 249 -----EEVIYYVRDGNILACPENC------PLELYNL---MRLCWSKLPADRPSFCSIHR 294

Query: 732 NLEYALQ 738
            L+   +
Sbjct: 295 ILQRMCE 301

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 2e-61
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 21/274 (7%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +      +G G FG+V+ G  N  T+VA+K   P        F  E +++ + RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L      +  + ++ EYM  G+L   L G     L   Q +++    A G+ Y+     
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQ 640
              +HRD+++ANIL+ EN + KVADFGL++   + ++       K    +  PE     +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 641 LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKI 700
            T KSDV+SFG++L E+     V  P +                  ++   ++       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMPC 235

Query: 701 RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
            P+      +   +C      +RP+   +   LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 8e-61
 Identities = 75/305 (24%), Positives = 130/305 (42%), Gaps = 36/305 (11%)

Query: 451 FPFVAVQEATNNFDESW---------VIGIGGFGKVYKGELNDGTK----VAVKRGNPR- 496
           F F    EA   F +           VIG G FG+V  G L    K    VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 497 SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSL 556
           +++   +F +E  ++ QF H +++ L G   +   +++I E+MENG+L            
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQF 125

Query: 557 SWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID 616
           +  Q + +  G A G+ YL        +HRD+ + NIL++ N + KV+DFGLS+   +  
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 617 QTHVSTAV---KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV 673
                T+    K    +  PE  + ++ T  SDV+S+G+V++EV+          P   +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYWDM 237

Query: 674 NLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNL 733
              +     +   +L   +D        P +L +       C       RP  G ++  L
Sbjct: 238 TNQDVINAIEQDYRLPPPMD-------CPSALHQL---MLDCWQKDRNHRPKFGQIVNTL 287

Query: 734 EYALQ 738
           +  ++
Sbjct: 288 DKMIR 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-59
 Identities = 72/290 (24%), Positives = 126/290 (43%), Gaps = 26/290 (8%)

Query: 461 NNFDESWVIGIGGFGKVYKGELNDGT-----KVAVKRGNP-RSQQGLAEFQTEIEMLSQF 514
           +      VIG G FG+VYKG L   +      VA+K      +++   +F  E  ++ QF
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 515 RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHY 574
            H +++ L G   +   M++I EYMENG              S  Q + +  G A G+ Y
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDP 633
           L        +HRD+ + NIL++ N + KV+DFGLS+    + + T+ ++  K    +  P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 634 EYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID 693
           E    ++ T  SDV+SFG+V++EV+         L                  ++ + I+
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAIN 227

Query: 694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV 743
                    D      +   +C       RP   D++  L+  ++  +++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-59
 Identities = 65/271 (23%), Positives = 109/271 (40%), Gaps = 25/271 (9%)

Query: 469 IGIGGFGKVYKGEL---NDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIG 524
           +G G FG V +G          VA+K     +++    E   E +++ Q  + ++V LIG
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
            C +   ++L+ E    G L   L G     +      E+    + G+ YL     K  +
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFV 131

Query: 585 HRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTE 643
           HRD+ + N+LL     AK++DFGLSK  G +       +A K    +  PE    ++ + 
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 644 KSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPD 703
           +SDV+S+GV ++E L          P + +   E     +   +++    P       P 
Sbjct: 192 RSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRME--CPPEC-----PP 239

Query: 704 SLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
            L         C      DRP    V   + 
Sbjct: 240 ELYAL---MSDCWIYKWEDRPDFLTVEQRMR 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 8e-59
 Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 26/269 (9%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FGKVYK +        A K  + +S++ L ++  EI++L+   H ++V L+   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
             +N + ++ E+   G +   +     P L+  Q   +C  +   L+YLH      +IHR
Sbjct: 79  YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF-----RRQQL 641
           D+K+ NIL   +   K+ADFG+S       Q     +  G+  ++ PE       + +  
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192

Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 701
             K+DV+S G+ L E+    P      P   +N     +K                    
Sbjct: 193 DYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRW----- 241

Query: 702 PDSLRKFGETAEKCLADFGVDRPSMGDVL 730
             + + F    +KCL      R +   +L
Sbjct: 242 SSNFKDF---LKKCLEKNVDARWTTSQLL 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-58
 Identities = 83/324 (25%), Positives = 139/324 (42%), Gaps = 44/324 (13%)

Query: 450 RFPFVAVQEATNNFDESWVIGIGGFGKVYKGELNDG---TKVAVKRGNPR-SQQGLAEFQ 505
            +P +      N+     VIG G FG+V K  +         A+KR     S+    +F 
Sbjct: 3   IYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 506 TEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-------------- 550
            E+E+L +   H ++++L+G C+ +  + L  EY  +G L   L                
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 551 SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK 610
           S   +LS +Q L      ARG+ YL     K  IHRD+ + NIL+ EN++AK+ADFGLS+
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPR 670
                 +    T  +    ++  E       T  SDV+S+GV+L+E++          P 
Sbjct: 176 GQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPY 227

Query: 671 EMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
             +  AE   K     +L++ ++         D +        +C  +   +RPS   +L
Sbjct: 228 CGMTCAELYEKLPQGYRLEKPLNC-------DDEVYDL---MRQCWREKPYERPSFAQIL 277

Query: 731 WNLEYALQLQEAVVHGDPDENSTN 754
            +L   L+ ++  V+    E  T 
Sbjct: 278 VSLNRMLEERKTYVNTTLYEKFTY 301

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-58
 Identities = 63/273 (23%), Positives = 105/273 (38%), Gaps = 27/273 (9%)

Query: 468 VIGIGGFGKVYKGELND---GTKVAVKRGNPRSQQG--LAEFQTEIEMLSQFRHRHLVSL 522
            +G G FG V KG          VAVK     +       E   E  ++ Q  + ++V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG C E    +L+ E  E G L  +L  +    +  K  +E+    + G+ YL       
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SN 127

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSK-TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            +HRD+ + N+LL     AK++DFGLSK    + +     T  K    +  PE     + 
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 642 TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIR 701
           + KSDV+SFGV+++E                    +   +     ++  +++        
Sbjct: 188 SSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERMGCP 232

Query: 702 PDSLRKFGETAEKCLADFGVDRPSMGDVLWNLE 734
               R+  +    C      +RP    V   L 
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 4e-58
 Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 41/295 (13%)

Query: 468 VIGIGGFGKVYKGEL------NDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQF-RHRHL 519
            +G G FGKV +         +    VAVK   P +         +E+++LS    H ++
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLP----------------SLSWKQRLE 563
           V+L+G C      ++I EY   G L   L                      +L  +  L 
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149

Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                A+G+ +L +   K  IHRD+ + NILL    + K+ DFGL++         V   
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206

Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 683
            +    ++ PE       T +SDV+S+G+ L+E+        P +P +            
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------------ 254

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
              +  ++I           +  +  +  + C     + RP+   ++  +E  + 
Sbjct: 255 --SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-58
 Identities = 67/322 (20%), Positives = 119/322 (36%), Gaps = 57/322 (17%)

Query: 453 FVAVQEATNNFDESW-----------VIGIGGFGKVYKGELND------GTKVAVKRGNP 495
           +  V      +D  W           V+G G FGKV               +VAVK    
Sbjct: 18  YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77

Query: 496 RSQQG-LAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG--- 550
           ++         +E++M++Q   H ++V+L+G C     + LI+EY   G L  +L     
Sbjct: 78  KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137

Query: 551 ------------------SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSAN 592
                               L  L+++  L      A+G+ +L     K+ +HRD+ + N
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 194

Query: 593 ILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGV 652
           +L+    + K+ DFGL++         V    +    ++ PE       T KSDV+S+G+
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254

Query: 653 VLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA 712
           +L+E+        P +P +                  ++I           +  +     
Sbjct: 255 LLWEIFSLGVNPYPGIPVD--------------ANFYKLIQNGFKMDQPFYATEEIYIIM 300

Query: 713 EKCLADFGVDRPSMGDVLWNLE 734
           + C A     RPS  ++   L 
Sbjct: 301 QSCWAFDSRKRPSFPNLTSFLG 322

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-58
 Identities = 69/276 (25%), Positives = 112/276 (40%), Gaps = 32/276 (11%)

Query: 463 FDESWVIGIGGFGKVYKGELND-GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHL 519
           FD    IG G F  VYKG   +   +VA      R  ++     F+ E EML   +H ++
Sbjct: 13  FDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 520 VSLIGYC----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           V            K  ++L+ E M +GTLK +L       +  K     C    +GL +L
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFL 128

Query: 576 HTGYAKAVIHRDVKSANILL-DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPE 634
           HT     +IHRD+K  NI +       K+ D GL+     + +   + AV G+  ++ PE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPE 183

Query: 635 YFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP 694
            +  ++  E  DVY+FG+ + E+  +        P      A    +    G      D 
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEY------PYSECQNAAQIYRRVTSGVKPASFDK 236

Query: 695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                     +++     E C+     +R S+ D+L
Sbjct: 237 VA-----IPEVKEI---IEGCIRQNKDERYSIKDLL 264

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-57
 Identities = 68/330 (20%), Positives = 124/330 (37%), Gaps = 32/330 (9%)

Query: 463 FDESWVIGIGGFGKVYKGELND-----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRH 516
           F +  V+G G FG VYKG            VA+K      S +   E   E  +++   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            H+  L+G C       LI + M  G L  ++          +  L  C+  A+G++YL 
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
               + ++HRD+ + N+L+      K+ DFGL+K     ++ + +   K    ++  E  
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             +  T +SDV+S+GV ++E++         +P                 ++  I++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EISSILEKGE 230

Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLI 756
                P           KC       RP   +++       +  +  +    DE      
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL-- 288

Query: 757 GELSPQIHNFSQVDTSVNAAAQSDVSAVDD 786
              SP   NF +    ++     DV   D+
Sbjct: 289 --PSPTDSNFYR--ALMDEEDMDDVVDADE 314

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (498), Expect = 4e-57
 Identities = 64/275 (23%), Positives = 105/275 (38%), Gaps = 33/275 (12%)

Query: 463 FDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQG---LAEFQTEIEMLSQFRHRH 518
           F +   IG G FG VY    + +   VA+K+ +   +Q      +   E+  L + RH +
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
            +   G    ++   L+ EY                 L   +   +  G+ +GL YLH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH-- 132

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR- 637
            +  +IHRDVK+ NILL E  + K+ DFG +           + +  G+  ++ PE    
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPYWMAPEVILA 185

Query: 638 --RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
               Q   K DV+S G+   E+   +P +        +              + Q   P 
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPA 233

Query: 696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
           L      +  R F    + CL     DRP+   +L
Sbjct: 234 LQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLL 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 63/282 (22%), Positives = 105/282 (37%), Gaps = 28/282 (9%)

Query: 452 PFVAVQEATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNP-RSQQGLAEFQTEIE 509
           PFV       ++D    +G G +G+V           VAVK  +  R+       + EI 
Sbjct: 2   PFV------EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 510 MLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +     H ++V   G+  E N   L  EY   G L   +       +             
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLM 113

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
            G+ YLH      + HRD+K  N+LLDE    K++DFGL+      ++  +   + G+  
Sbjct: 114 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

Query: 630 YLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQL 688
           Y+ PE  +R++   E  DV+S G+VL  +L      D     +  +  +    W+ K   
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD-----QPSDSCQEYSDWKEKKTY 225

Query: 689 DQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                          +         K L +    R ++ D+ 
Sbjct: 226 LNPWKKI------DSAPLAL---LHKILVENPSARITIPDIK 258

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 26/280 (9%)

Query: 468 VIGIGGFGKVYKGEL----NDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFRHRHLVSL 522
            IG G FG V++G      N    VA+K     +   + E F  E   + QF H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 523 IGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA 582
           IG   E N + +I E    G L+         SL     +      +  L YL +   K 
Sbjct: 74  IGVITE-NPVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128

Query: 583 VIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
            +HRD+ + N+L+  N   K+ DFGLS+   +    + ++  K    ++ PE    ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187

Query: 643 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 702
             SDV+ FGV ++E+L          P + V   +   + +N  +L   + P       P
Sbjct: 188 SASDVWMFGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGERLP--MPPNC-----P 235

Query: 703 DSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA 742
            +L        KC A     RP   ++   L   L+ ++A
Sbjct: 236 PTLYSL---MTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 27/278 (9%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRH 518
           +++  + IG G +G+  K    +DG  +  K  +  S  +       +E+ +L + +H +
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 519 LVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSG--LPSLSWKQRLEICIGSARGLHY 574
           +V       ++    + ++ EY E G L   +         L  +  L +       L  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 575 LH--TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLD 632
            H  +     V+HRD+K AN+ LD     K+ DFGL++       T  + A  G+  Y+ 
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYMS 182

Query: 633 PEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 692
           PE   R    EKSD++S G +L+E+    P      P    +  E A K +  G+  +I 
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKELAGKIRE-GKFRRIP 235

Query: 693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                     D L +      + L      RPS+ ++L
Sbjct: 236 YRY------SDELNEI---ITRMLNLKDYHRPSVEEIL 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-56
 Identities = 67/274 (24%), Positives = 105/274 (38%), Gaps = 30/274 (10%)

Query: 461 NNFDESWVIGIGGFGKVYKGEL-NDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
            +F+    +G G FG VY          +A+K   +          + + E+E+ S  RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
            +++ L GY  +   + LI EY   GT+   L          ++        A  L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K VIHRD+K  N+LL      K+ADFG S   P        T + G+  YL PE  
Sbjct: 124 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMI 176

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             +   EK D++S GV+ +E L  +P  +    +E           + +      +    
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-----RVEFTFPDFVTEGA 231

Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
              I             + L      RP + +VL
Sbjct: 232 RDLIS------------RLLKHNPSQRPMLREVL 253

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-54
 Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 23/264 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            IG G  G VY   ++  G +VA+++ N + Q        EI ++ + ++ ++V+ +   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
              +E+ ++ EY+  G+L   +  + +      Q   +C    + L +LH   +  VIHR
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQALEFLH---SNQVIHR 140

Query: 587 DVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSD 646
           D+KS NILL  +   K+ DFG         +    + + G+  ++ PE   R+    K D
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 647 VYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLR 706
           ++S G++  E++   P      P    N           G  +      L         R
Sbjct: 199 IWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNPEKL-----SAIFR 247

Query: 707 KFGETAEKCLADFGVDRPSMGDVL 730
            F     +CL      R S  ++L
Sbjct: 248 DF---LNRCLDMDVEKRGSAKELL 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-53
 Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 30/281 (10%)

Query: 468 VIGIGGFGKVYKGELN----DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G FG V +GE +        VAVK   P      + + +F  E+  +    HR+L+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
            L G       M ++ E    G+L   L                 +  A G+ YL    +
Sbjct: 75  RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---S 129

Query: 581 KAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV-STAVKGSFGYLDPEYFRRQ 639
           K  IHRD+ + N+LL    + K+ DFGL +  P+ D  +V     K  F +  PE  + +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189

Query: 640 QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK 699
             +  SD + FGV L+E+           P   +N ++   K   +G+     +      
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERLPRPEDC---- 240

Query: 700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 740
             P  +        +C A    DRP+   +    ++ L+ Q
Sbjct: 241 --PQDIYNV---MVQCWAHKPEDRPTFVAL---RDFLLEAQ 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-53
 Identities = 74/296 (25%), Positives = 131/296 (44%), Gaps = 42/296 (14%)

Query: 468 VIGIGGFGKVYKGEL--------NDGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHR 517
            +G G FG+V   E         N  TKVAVK      +++ L++  +E+EM+    +H+
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPS--------------LSWKQRLE 563
           ++++L+G C +   + +I EY   G L+ +L     P               LS K  + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139

Query: 564 ICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTA 623
                ARG+ YL    +K  IHRD+ + N+L+ E+ + K+ADFGL++    ID    +T 
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196

Query: 624 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 683
            +    ++ PE    +  T +SDV+SFGV+L+E+        P +P E            
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------------ 244

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL 739
              +L +++          +   +       C       RP+   ++ +L+  + L
Sbjct: 245 ---ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-53
 Identities = 72/293 (24%), Positives = 123/293 (41%), Gaps = 33/293 (11%)

Query: 461 NNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQ 513
                S  +G G FG VY+G           T+VA+K  N   S +   EF  E  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSG--------LPSLSWKQRLEIC 565
           F   H+V L+G   +    ++I E M  G LK +L            L   S  + +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 566 IGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVK 625
              A G+ YL+   A   +HRD+ + N ++ E+F  K+ DFG+++   E D         
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 626 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK 685
               ++ PE  +    T  SDV+SFGVVL+E+           P + ++  +        
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSNEQVLRFVMEG 251

Query: 686 GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
           G LD+  +        PD L +       C       RPS  +++ +++  ++
Sbjct: 252 GLLDKPDN-------CPDMLFEL---MRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-52
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 9/205 (4%)

Query: 462 NFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHR 517
           +F    ++G G F  V    EL    + A+K    R    +  +     E +++S+  H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
             V L     +  ++     Y +NG L  ++   G  S                L YLH 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH- 125

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
              K +IHRD+K  NILL+E+   ++ DFG +K      +   + +  G+  Y+ PE   
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARP 662
            +   + SD+++ G ++++++   P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  183 bits (465), Expect = 4e-52
 Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 23/273 (8%)

Query: 461 NNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL 519
           +++D    +G G FG V++  E   G   A K      +      + EI+ +S  RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 520 VSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
           V+L    ++ NEM++IYE+M  G L   +       +S  + +E      +GL ++H   
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE-- 142

Query: 580 AKAVIHRDVKSANILL--DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               +H D+K  NI+     +   K+ DFGL+     +D         G+  +  PE   
Sbjct: 143 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 697
            + +   +D++S GV+ + +L            E +   +          +D      + 
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-----SCDWNMDDSAFSGI- 252

Query: 698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                +  + F     K L      R ++   L
Sbjct: 253 ----SEDGKDF---IRKLLLADPNTRMTIHQAL 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 3e-51
 Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 40/294 (13%)

Query: 468 VIGIGGFGKVYKG------ELNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRH-L 519
            +G G FG+V +       +      VAVK     +         +E+++L    H   +
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79

Query: 520 VSLIGYCDEKNEMILI-YEYMENGTLKGHLYGSGLPS--------------LSWKQRLEI 564
           V+L+G C +    +++  E+ + G L  +L                     L+ +  +  
Sbjct: 80  VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139

Query: 565 CIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAV 624
               A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++   +          
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196

Query: 625 KGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 684
           +    ++ PE    +  T +SDV+SFGV+L+E+           P   V + E   +   
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLK 251

Query: 685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
           +G   +  D T         + +       C       RP+  +++ +L   LQ
Sbjct: 252 EGTRMRAPDYT------TPEMYQT---MLDCWHGEPSQRPTFSELVEHLGNLLQ 296

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-49
 Identities = 55/335 (16%), Positives = 128/335 (38%), Gaps = 37/335 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FG V++  E +       K    +        + EI +L+  RHR+++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           +   E+++I+E++    +   +  S    L+ ++ +         L +LH   +  + H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH---SHNIGHF 126

Query: 587 DVKSANILLD--ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           D++  NI+     +   K+ +FG ++   ++        +  +  Y  PE  +   ++  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 704
           +D++S G +++ +L           ++++           +   D+     +        
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEYTFDEEAFKEI-----SIE 233

Query: 705 LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDENSTNLIGELSPQIH 764
              F    ++ L      R +  +          LQ   +    +  ST +I  L  + +
Sbjct: 234 AMDF---VDRLLVKERKSRMTASEA---------LQHPWLKQKIERVSTKVIRTLKHRRY 281

Query: 765 NFS----QVDTSVNAAAQSDVSAVDDISGVSMSRV 795
             +     ++  V+AA  S   A+    GVS+++V
Sbjct: 282 YHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKV 316

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  174 bits (441), Expect = 8e-49
 Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 23/266 (8%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            +G G FG V++  E   G     K  N          + EI +++Q  H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 527 DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHR 586
           ++K EM+LI E++  G L   +       +S  + +     +  GL ++H     +++H 
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHSIVHL 151

Query: 587 DVKSANILLD--ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           D+K  NI+ +  +    K+ DFGL+    +++   +      +  +  PE   R+ +   
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 645 SDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDS 704
           +D+++ GV+ + +L            E           QN  + D   D      +    
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLET---------LQNVKRCDWEFDEDAFSSV-SPE 258

Query: 705 LRKFGETAEKCLADFGVDRPSMGDVL 730
            + F    +  L      R ++ D L
Sbjct: 259 AKDF---IKNLLQKEPRKRLTVHDAL 281

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  170 bits (432), Expect = 2e-48
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 28/277 (10%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNP---RSQQGLAEFQTEIEMLSQFRHRHLVSLI 523
           ++G GG  +V+    L     VAVK       R       F+ E +  +   H  +V++ 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 524 GYCDEKNE----MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGY 579
              + +        ++ EY++  TL+  ++  G   ++ K+ +E+   + + L++ H   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--- 128

Query: 580 AKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDPEYFRR 638
              +IHRDVK ANI++      KV DFG+++      +    + AV G+  YL PE  R 
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188

Query: 639 QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 698
             +  +SDVYS G VL+EVL   P      P    +    A +   +      I P+   
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVRED----PIPPSARH 238

Query: 699 KIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLE 734
           +     L        K LA    +R  +  ++  +L 
Sbjct: 239 EGLSADLDAV---VLKALAKNPENRYQTAAEMRADLV 272

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 4e-46
 Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 26/268 (9%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQG-LAEFQTEIEMLSQFRHRHLVSLIGY 525
           V+G G F +V   E       VA+K    ++ +G     + EI +L + +H ++V+L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
            +    + LI + +  G L   +   G    + +    +       + YLH      ++H
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IVH 130

Query: 586 RDVKSANILL---DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLT 642
           RD+K  N+L    DE+    ++DFGLSK     D   V +   G+ GY+ PE   ++  +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 643 EKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRP 702
           +  D +S GV+ + +LC  P        ++     +    + + + D      +      
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKL-----FEQILKAEYEFDSPYWDDI-----S 237

Query: 703 DSLRKFGETAEKCLADFGVDRPSMGDVL 730
           DS + F       +      R +    L
Sbjct: 238 DSAKDF---IRHLMEKDPEKRFTCEQAL 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  166 bits (422), Expect = 5e-46
 Identities = 73/357 (20%), Positives = 132/357 (36%), Gaps = 36/357 (10%)

Query: 461 NNFDESWVIGIGGFGKVYKGELND-GTKVAVKRGNP---RSQQGLAEFQTE---IEMLSQ 513
           N+F    +IG GGFG+VY     D G   A+K  +    + +QG      E   + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 514 FRHRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLH 573
                +V +       +++  I + M  G L  HL   G+   S             GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEIILGLE 121

Query: 574 YLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP 633
           ++H    + V++RD+K ANILLDE+   +++D GL+    +           G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAP 174

Query: 634 EYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 692
           E  ++       +D +S G +LF++L           ++   +    M      +L    
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTMAVELPDSF 232

Query: 693 DPTLAGKIR------PDS-LRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVH 745
            P L   +        +  L   G  A++         P    + W + +  +    ++ 
Sbjct: 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES-----PFFRSLDWQMVFLQKYPPPLI- 286

Query: 746 GDPDENSTNLIGELSPQIHNFSQVDTSVNAAAQSDVSAVDDISGVSMSRVFSQLVKS 802
             P     N        I +F + DT       SD     +       R   ++ ++
Sbjct: 287 --PPRGEVNAADAF--DIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAET 339

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  162 bits (412), Expect = 1e-45
 Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 38/286 (13%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS---------QQGLAEFQTEIEML 511
           N++   ++G G    V +        + AVK  +            Q+       E+++L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 512 SQFR-HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSAR 570
            +   H +++ L    +      L+++ M+ G L  +L      +LS K+  +I      
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 121

Query: 571 GLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGY 630
            +  LH      ++HRD+K  NILLD++   K+ DFG S    ++D       V G+  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSY 175

Query: 631 LDPEYFR------RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQN 684
           L PE              ++ D++S GV+++ +L   P         M+      M    
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----MIMSG 230

Query: 685 KGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
             Q               D+++       + L      R +  + L
Sbjct: 231 NYQFGSPEWDDY-----SDTVKDL---VSRFLVVQPQKRYTAEEAL 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 3e-44
 Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 29/294 (9%)

Query: 459 ATNNFDESWVIGIGGFGKVYKGE--LNDGTKVAVKRGNPRSQQGLAEFQTEIE-----ML 511
           A   ++    IG G +GKV+K     N G  VA+KR   ++ +      T  E      L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 512 SQFRHRHLVSLIGYC-----DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICI 566
             F H ++V L   C     D + ++ L++E+++      +L     P +  +   ++  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMF 123

Query: 567 GSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKG 626
              RGL +LH+     V+HRD+K  NIL+  +   K+ADFGL++           T+V  
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVV 177

Query: 627 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM------ 680
           +  Y  PE   +       D++S G +  E+   +P+   +   + +      +      
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 730
            W     L +    + + +     +    E       KCL      R S    L
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  158 bits (401), Expect = 9e-44
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 14/218 (6%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRH 516
            +F     +G G FG+V+     ++G   A+K          + +     E  MLS   H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             ++ + G   +  ++ +I +Y+E G L   L  S        +     +     L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   K +I+RD+K  NILLD+N   K+ DFG +K  P++  T       G+  Y+ PE  
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 674
             +   +  D +SFG++++E+L        +   +   
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 4e-43
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 12/219 (5%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLS-QFR 515
            +F    ++G G FGKV+  E        A+K   +        +     E  +LS  + 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYL 575
           H  L  +      K  +  + EY+  G L  H+           +          GL +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFL 119

Query: 576 HTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           H+   K +++RD+K  NILLD++   K+ADFG+ K     D         G+  Y+ PE 
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVN 674
              Q+     D +SFGV+L+E+L  +         E+ +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 1e-42
 Identities = 48/281 (17%), Positives = 92/281 (32%), Gaps = 26/281 (9%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYC 526
            IG G FG +Y G  +  G +VA+K    +++    +   E ++    +    +  I +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 527 -DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             E +  +++ E +         + S     S K  L +       + Y+H   +K  IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIH 126

Query: 586 RDVKSANIL---LDENFMAKVADFGLSK-----TGPEIDQTHVSTAVKGSFGYLDPEYFR 637
           RDVK  N L     +  +  + DFGL+K        +      +  + G+  Y       
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 638 RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA 697
             + + + D+ S G VL                      E   + +    ++ +      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY-- 244

Query: 698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
               P     +      C +    D+P    +         
Sbjct: 245 ----PSEFATY---LNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-42
 Identities = 52/272 (19%), Positives = 110/272 (40%), Gaps = 29/272 (10%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGY 525
           V+G+G  GKV +        K A+K      +      + E+E+  +  +  H+V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 526 CD----EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
            +     +  ++++ E ++ G L   +   G  + + ++  EI       + YLH   + 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 582 AVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            + HRDVK  N+L      N + K+ DFG +K   E    +  T    +  Y+ PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGP 187

Query: 639 QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG 698
           ++  +  D++S GV+++ +LC  P      P    +    +   + + ++ Q   P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
               + ++         L      R ++ + +
Sbjct: 242 SEVSEEVKML---IRNLLKTEPTQRMTITEFM 270

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 53/277 (19%), Positives = 102/277 (36%), Gaps = 20/277 (7%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGY 525
            IG G +G VYK + N G   A+K  R     +   +    EI +L + +H ++V L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
              K  ++L++E+++    K      G   L         +    G+ Y H    + V+H
Sbjct: 69  IHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKS 645
           RD+K  N+L++     K+ADFGL++          +  +   +          ++ +   
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 646 DVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSL 705
           D++S G +  E++   P+       + +      +   N      + +            
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 706 RKFGETAEKCLADFGVD------------RPSMGDVL 730
               E+  K L + G+D            R +    L
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-42
 Identities = 59/281 (20%), Positives = 112/281 (39%), Gaps = 25/281 (8%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAE-----FQTEIEMLSQFRHRHLVS 521
            +G G F  VYK    N    VA+K+     +    +        EI++L +  H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 522 LIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK 581
           L+     K+ + L++++ME       +       L+        + + +GL YLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 582 AVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL 641
            ++HRD+K  N+LLDEN + K+ADFGL+K+    ++ +  T    +  Y  PE     ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177

Query: 642 -TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM------KWQNKGQL-DQIID 693
                D+++ G +L E+L   P +      + +      +      +W +   L D +  
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 694 PTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 730
            +  G          G+      +         R +    L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 9e-42
 Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 20/284 (7%)

Query: 462 NFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRH 518
           NF +   IG G +G VYK      G  VA+K  R +  ++   +    EI +L +  H +
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           +V L+     +N++ L++E++     K  +  S L  +             +GL + H  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            +  V+HRD+K  N+L++     K+ADFGL++          +  V   +          
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGC 177

Query: 639 QQLTEKSDVYSFGVVLFEVLCARPVIDPT--------LPREMVNLAEWAMKWQNKGQLDQ 690
           +  +   D++S G +  E++  R +            + R +    E            +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 691 IIDPTLAGKIRPDSLRKFGETA----EKCLADFGVDRPSMGDVL 730
              P  A +     +    E       + L      R S    L
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-41
 Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 22/292 (7%)

Query: 458 EATNNFDESWVIGIGGFGKVYKG-ELNDGTKVAVKRGNPRSQQGLAE-FQTEIEMLSQFR 515
           +    +     IG G +G V    +  +  +VA+K+ +P   Q   +    EI++L +FR
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 516 HRHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHY 574
           H +++ +           +   Y+    +   LY       LS            RGL Y
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 575 LHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT-GPEIDQTHVSTAVKGSFGYLDP 633
           +H+     V+HRD+K +N+LL+     K+ DFGL++   P+ D T   T    +  Y  P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 634 EYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII 692
           E     +  T+  D++S G +L E+L  RP+       + +N     +   ++  L+ II
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 693 --------------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                         +     ++ P++  K  +  +K L      R  +   L
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 32/274 (11%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRHLV 520
            +G G F  V K  E + G + A K        + R      + + E+ +L + +H +++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 521 SLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYA 580
           +L    + K ++ILI E +  G L   L      SL+ ++  E       G++YLH+   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS--- 131

Query: 581 KAVIHRDVKSANILLDENFMA----KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
             + H D+K  NI+L +  +     K+ DFGL+    +ID  +    + G+  ++ PE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIV 188

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             + L  ++D++S GV+ + +L           +E       A       + +       
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFEDEYFSNT 243

Query: 697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                    + F     + L      R ++ D L
Sbjct: 244 -----SALAKDF---IRRLLVKDPKKRMTIQDSL 269

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 44/283 (15%), Positives = 86/283 (30%), Gaps = 28/283 (9%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR-HLVSLIGY 525
            IG G FG +++G  L +  +VA+K    RS     + + E            + ++  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH 585
             E    +L+ + +  G     L        S K            +  +H    K++++
Sbjct: 70  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVY 124

Query: 586 RDVKSANILLDENFM-----AKVADFGLSK-----TGPEIDQTHVSTAVKGSFGYLDPEY 635
           RD+K  N L+            V DFG+ K        +         + G+  Y+    
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 636 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT 695
              ++ + + D+ + G V    L                      K++  G+  Q     
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN------KQKYERIGEKKQSTPLR 238

Query: 696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ 738
                 P+   K+               P    +       L+
Sbjct: 239 ELCAGFPEEFYKY---MHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 5e-40
 Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 32/239 (13%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVKR------GNPRSQQGLAEFQTEIEMLSQFRHRH-- 518
           ++G GGFG VY G  ++D   VA+K        +            E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 519 LVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
           ++ L+ + +  +  +LI E  E               L  +            + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128

Query: 579 YAKAVIHRDVKSANILLDEN-FMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 637
               V+HRD+K  NIL+D N    K+ DFG       + +  V T   G+  Y  PE+ R
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPPEWIR 182

Query: 638 RQQL-TEKSDVYSFGVVLFEVLCARP-------------VIDPTLPREMVNLAEWAMKW 682
             +     + V+S G++L++++C                     +  E  +L  W +  
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLAL 241

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 5e-40
 Identities = 62/316 (19%), Positives = 113/316 (35%), Gaps = 36/316 (11%)

Query: 436 SHGTTTSANSNSGYRFPFVAVQEATNNFDESWVIGIGGFGKVYKGEL-NDGTKVAVKRGN 494
           S  TT  A    G   P         ++ ++ VIG G FG VY+ +L + G  VA+K+  
Sbjct: 1   SKVTTVVATPGQGPDRPQ------EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 54

Query: 495 PRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE------MILIYEYMENGTLKGHL 548
              +        E++++ +  H ++V L  +     E      + L+ +Y+     +   
Sbjct: 55  QDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110

Query: 549 -YGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADF 606
            Y     +L             R L Y+H   +  + HRD+K  N+LLD +  + K+ DF
Sbjct: 111 HYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 167

Query: 607 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDP 666
           G +K    +      + +   +       F     T   DV+S G VL E+L  +P+   
Sbjct: 168 GSAK--QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

Query: 667 TLPREMVNLAEWAM------------KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEK 714
               + +      +                + +  QI         RP +  +      +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285

Query: 715 CLADFGVDRPSMGDVL 730
            L      R +  +  
Sbjct: 286 LLEYTPTARLTPLEAC 301

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-38
 Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 11/219 (5%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           N+FD   ++G G FGKV        G   A+K   +    ++  +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             L +L       + +  + EY   G L  HL        + ++           L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH 122

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
           +   + V++RD+K  N++LD++   K+ DFGL K G     T       G+  YL PE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNL 675
                    D +  GVV++E++C R          +  L
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 3e-38
 Identities = 60/299 (20%), Positives = 120/299 (40%), Gaps = 34/299 (11%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHR 517
           + +++   IG G FG+V+K      G KVA+K+    +  +        EI++L   +H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 518 HLVSLIGYCDE--------KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           ++V+LI  C          K  + L++++ E+             +LS  +R+   +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK--TGPEIDQTHVSTAVKGS 627
             L+ L+  +   ++HRD+K+AN+L+  + + K+ADFGL++  +  +  Q +  T    +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 628 FGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKG 686
             Y  PE    ++      D++  G ++ E+    P++     +  + L           
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 687 QLDQIIDPTLAGKIR---------PDSLRKFGETAE------KCLADFGVDRPSMGDVL 730
               + +  L  K+           D L+ +           K L      R    D L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 55/287 (19%), Positives = 102/287 (35%), Gaps = 23/287 (8%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK---RGNPRSQQGLAEFQTEIEMLSQFRH 516
           + FD    +G G FG+V   +    G   A+K   +      + +     E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
             LV L     + + + ++ EY+  G +  HL   G    S                YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH 158

Query: 577 TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYF 636
              +  +I+RD+K  N+L+D+    +V DFG +K       T     + G+   L PE  
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210

Query: 637 RRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL 696
             +   +  D ++ GV+++E+    P      P ++      + K +        +   L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE-KIVSGKVRFPSHFSSDLKDLL 269

Query: 697 AGKIRPDSLRKFG---ETAEKCLADFGVDRPSMGDVLWNLEYALQLQ 740
              ++ D  ++FG                        W   Y  +++
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNH-----KWFATTDWIAIYQRKVE 311

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-37
 Identities = 56/279 (20%), Positives = 109/279 (39%), Gaps = 22/279 (7%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G +G V+K +       VA+K  R +   +   +    EI +L + +H+++V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 525 YCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVI 584
                 ++ L++E+ +    K     +G      +          +GL + H+   + V+
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 585 HRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEK 644
           HRD+K  N+L++ N   K+A+FGL++    I     S  V   +       F  +  +  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 645 SDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAM------KWQNKGQLDQIIDPTLA 697
            D++S G +  E+  A RP+       + +      +      +W +  +L       + 
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 698 GKIRP--DSLRKFGETA----EKCLADFGVDRPSMGDVL 730
                  + + K   T     +  L    V R S  + L
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-36
 Identities = 58/287 (20%), Positives = 106/287 (36%), Gaps = 36/287 (12%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            +G G +G V    +   G KVA+K      +S+        E+ +L   RH +++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 525 YCDEKN------EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
                       +  L+  +M  GT  G L       L   +   +     +GL Y+H  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH-- 138

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
            A  +IHRD+K  N+ ++E+   K+ DFGL++         ++  V   +          
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNW 193

Query: 639 QQLTEKSDVYSFGVVLFEVLCARP---------------VIDPTLPREMVNLAEWAMKWQ 683
            + T+  D++S G ++ E++  +                 +  T P E V   +      
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
               L ++     A  I  ++        EK L      R + G+ L
Sbjct: 254 YMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 7e-32
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 17/213 (7%)

Query: 461 NNFDESWVIGIGGFGKVYKGEL----NDGTKVAVKRGNP----RSQQGLAEFQTEIEMLS 512
            NF+   V+G G +GKV+        + G   A+K        +  +     +TE ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 513 QFRHR-HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARG 571
             R    LV+L      + ++ LI +Y+  G L  HL      +        + I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 572 LHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
           +  L   +   +I+RD+K  NILLD N    + DFGLSK     +    +    G+  Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 197

Query: 632 DPEYFRRQQ--LTEKSDVYSFGVVLFEVLCARP 662
            P+  R       +  D +S GV+++E+L    
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 40/212 (18%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 461 NNFDESWVIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRH 518
           +++     +G G + +V++   + +  KV VK   P  ++   + + EI++L   R   +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91

Query: 519 LVSLIGYCDEKNE--MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLH 576
           +++L     +       L++E++ N   K         +L+            + L Y H
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDYCH 146

Query: 577 TGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 635
           +     ++HRDVK  N+++D E+   ++ D+GL++                S  +  PE 
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKGPEL 200

Query: 636 FRRQQL-TEKSDVYSFGVVLFEVLCARPVIDP 666
               Q+     D++S G +L  ++  +     
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 3e-31
 Identities = 59/301 (19%), Positives = 110/301 (36%), Gaps = 53/301 (17%)

Query: 468 VIGIGGFGKVYKG-ELNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIG 524
            IG G  G V    +      VA+K      ++Q        E+ ++    H++++SL+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 525 YC------DEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG 578
                   +E  ++ L+ E M+    +             ++   +      G+ +LH+ 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSA 138

Query: 579 YAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRR 638
               +IHRD+K +NI++  +   K+ DFGL++T      + + T    +  Y  PE    
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILG 192

Query: 639 QQLTEKSDVYSFGVVLFEVLCARP----------------VIDPTLPREMVNLAEWAMKW 682
               E  D++S G ++ E++  +                  +    P  M  L      +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 683 -QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVD------------RPSMGDV 729
            +N+ +   +  P    K+ PDSL        K  A    D            R S+ D 
Sbjct: 253 VENRPKYAGLTFP----KLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

Query: 730 L 730
           L
Sbjct: 309 L 309

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 5e-30
 Identities = 52/296 (17%), Positives = 101/296 (34%), Gaps = 34/296 (11%)

Query: 458 EATNNFDESWVIGIGGFGKVYKGE-LNDGTKVAVK--RGNPRSQQGLAEFQTEIEMLSQF 514
           E    +     +G G +G V        G +VAVK      +S         E+ +L   
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 515 RHRHLVSLIGYCDEKN-----EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSA 569
           +H +++ L+              + +  ++    L   +    L          +     
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT---DDHVQFLIYQIL 131

Query: 570 RGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFG 629
           RGL Y+H   +  +IHRD+K +N+ ++E+   K+ DFGL++   +    +V+T     + 
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184

Query: 630 YLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV---------------IDPTLPREMVN 674
                        +  D++S G ++ E+L  R +               +  T   E++ 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 675 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVL 730
                        L Q+     A  +   +     +  EK L      R +    L
Sbjct: 245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (274), Expect = 1e-26
 Identities = 51/299 (17%), Positives = 103/299 (34%), Gaps = 31/299 (10%)

Query: 468 VIGIGGFGKVYKGE-LNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH---------- 516
            +G G F  V+  + + + T VA+K      +      + EI++L +             
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 517 -RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLY---GSGLPSLSWKQRLEICIGSARGL 572
             H++ L+ + + K    +    +     +  L          +      +I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 573 HYLHTGYAKAVIHRDVKSANILLD-ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 631
            Y+H      +IH D+K  N+L++  +    +    ++  G         T    +  Y 
Sbjct: 139 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 632 DPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI 691
            PE          +D++S   ++FE++    + +P                ++   + QI
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY---------TKDDDHIAQI 247

Query: 692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVHGDPDE 750
           I+  L G++ P  L + G+         G+ R       W LE  L  +      +  E
Sbjct: 248 IE--LLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.4 bits (208), Expect = 2e-19
 Identities = 32/198 (16%), Positives = 60/198 (30%), Gaps = 36/198 (18%)

Query: 468 VIGIGGFGKVYKGELNDGTKVAVK----------RGNPRSQQGLAEFQTEIEMLSQFRHR 517
           ++G G    V+        +  VK          +   +   G   F       ++   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 518 HLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT 577
            L  L G       +  +Y +  N  L   +    L  +  +   E+       +   + 
Sbjct: 67  ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 578 GYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDP---- 633
              + ++H D+   N+L+ E     + DF  S          V    +G    L+     
Sbjct: 121 --HRGIVHGDLSQYNVLVSE-EGIWIIDFPQS----------VEVGEEGWREILERDVRN 167

Query: 634 --EYFRRQQLTEKSDVYS 649
              YF R     + D+ S
Sbjct: 168 IITYFSRTY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	805
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.61
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.17
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.83
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.81
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.78
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	96.5

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=386.17  Aligned_cols=273  Identities=26%  Similarity=0.421  Sum_probs=219.5

Q ss_pred             CCHHHHHHHHCC---------CCCCCEEEEECCEEEEEEEECC-C---CEEEEEECCCC-CCHHHHHHHHHHHHHHCCCC
Q ss_conf             477879998419---------8642357540846999999369-9---19999983889-90109999999999860899
Q 003659          451 FPFVAVQEATNN---------FDESWVIGIGGFGKVYKGELND-G---TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRH  516 (805)
Q Consensus       451 ~~~~~l~~at~~---------f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H  516 (805)
                      ++++++..++.+         |...++||+|+||.||+|..+. +   ..||||++... .....+.|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf             88798999996046220800427856980278829999999579978899999997844598999999999999985799


Q ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC
Q ss_conf             73678999981499199999755687500011279999999878999999999999997506999768530688947868
Q 003659          517 RHLVSLIGYCDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       517 ~niv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~  596 (805)
                      |||++++|+|.+.+..++|||||++|+|.+++.... ..++|.+++.++.|+|+||+|||+   ++++||||||+|||++
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~  162 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVN  162 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEC
T ss_conf             888618999962887799997227985300210456-799999999999999998898852---7983576150448988


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCC---EEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf             99939994317877799998752---0002224565459432312899960358999999999993-8999999981222
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTH---VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREM  672 (805)
Q Consensus       597 ~~~~~ki~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~  672 (805)
                      .++.+||+|||+++.........   ......||+.|+|||++.++.++.++|||||||++|||+| |++||......+.
T Consensus       163 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~  242 (299)
T d1jpaa_         163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV  242 (299)
T ss_dssp             TTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred             CCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf             99919988844315756777765365025666883003878883699786121445357899998679999999999999


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf             10999999983029863014821249999569999999998610007999999789999999999866663
Q 003659          673 VNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAV  743 (805)
Q Consensus       673 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~~~~  743 (805)
                      ...      ... +         .....+.+++..+.+++.+||+.+|.+||+|.+|++.|+++++....+
T Consensus       243 ~~~------i~~-~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~sl  297 (299)
T d1jpaa_         243 INA------IEQ-D---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL  297 (299)
T ss_dssp             HHH------HHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             HHH------HHC-C---------CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCHHHC
T ss_conf             999------973-7---------889997422699999999975879768929999999999984186217

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.90  Aligned_cols=261  Identities=29%  Similarity=0.516  Sum_probs=212.5

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf             4198642357540846999999369919999983889--90109999999999860899736789999814991999997
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  537 (805)
                      .++|...+.||+|+||.||+|+++.  .||||++...  +....+.|.+|++++.+++||||++++|++.+ ..+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             CCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf             4518998898307885899999999--89999997346998999999999999984799878645679715-58999996


Q ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             55687500011279999999878999999999999997506999768530688947868999399943178777999987
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++.... ..+++.+++.++.|+|+||+|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf             589988899985235-789999999999999999888750---9995161478997981899788750022133355677


Q ss_pred             CCEEECCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             520002224565459432312---89996035899999999999389999999812221099999998302986301482
Q 003659          618 THVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ........||+.|+|||++.+   ..++.++|||||||++|||+||+.||..........  .    ....+.    ..+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~----~~~~~~----~~p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--F----MVGRGY----LSP  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--H----HHHHTS----CCC
T ss_pred             CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--H----HHHCCC----CCC
T ss_conf             631256655743179999950568999953151635999999997889989989699999--9----996588----898


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             12499995699999999986100079999997899999999998
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                      .+ ...+..++..+.+++.+||+.+|.+|||+.++++.|+.+.+
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             60-00365554999999999758897689299999999999997

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=379.96  Aligned_cols=256  Identities=29%  Similarity=0.424  Sum_probs=212.5

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEECC
Q ss_conf             19864235754084699999936991999998388990109999999999860899736789999814991999997556
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  540 (805)
                      ++|...+.||+|+||.||+|++.+++.||||++..... ..++|.+|++++++++||||++++|+|...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf             99588889820888299999988999999999878867-68999999999996689975653524315993379998369


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCE
Q ss_conf             87500011279999999878999999999999997506999768530688947868999399943178777999987520
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++.... ..+++..++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++.... .....
T Consensus        84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~-~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTS  158 (263)
T ss_dssp             TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCC-CCCEE
T ss_conf             991899752013-478899999999999998776531---6431044315326666887768655321002368-87335


Q ss_pred             EECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             0022245654594323128999603589999999999938-999999981222109999999830298630148212499
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....||..|+|||++.+..++.++|||||||++|||+|+ ++|+......+....      ... +.         ...
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~------i~~-~~---------~~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED------IST-GF---------RLY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH------HHH-TC---------CCC
T ss_pred             ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHH------HHH-CC---------CCC
T ss_conf             04300176667857860799984033210599999998789888778999999999------980-68---------889


Q ss_pred             CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             995699999999986100079999997899999999998
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       700 ~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                      .+..++..+.+++.+||+.+|.+||+|++++++|+++++
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             954367999999999765797689199999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=377.70  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=210.5

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEEC
Q ss_conf             41986423575408469999993699199999838899010999999999986089973678999981499199999755
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  539 (805)
                      .++|...+.||+|+||.||+|.++++..||||++..... ..+.|.+|++++++++||||++++|+|.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf             899388679810798289999999999999999864768-88999999999986799988578731045-9769999957


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             68750001127999999987899999999999999750699976853068894786899939994317877799998752
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++......++++.++++|+.|+|+||+|||+   ++|+||||||+|||+++++.+||+|||+++.... ....
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS-SCEE
T ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCC-CCCC
T ss_conf             89828888751478988788999999999999999974---8954675642251562024404234101477358-8644


Q ss_pred             EEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             00022245654594323128999603589999999999938999-99998122210999999983029863014821249
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPV-IDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..| +......+..   .   . ...+     ..+    
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~---~-i~~~-----~~~----  229 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q---N-LERG-----YRM----  229 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H---H-HHTT-----CCC----
T ss_pred             CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H---H-HHHC-----CCC----
T ss_conf             2035677444458289837999824564525799999996898888888999999---9---9-9706-----888----


Q ss_pred             CCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             9995699999999986100079999997899999999998
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       699 ~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                      ..+..++..+.+++.+||+.+|++||||++|++.|+....
T Consensus       230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             8965571999999999758897689399999998611321

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=384.58  Aligned_cols=259  Identities=27%  Similarity=0.391  Sum_probs=215.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEE
Q ss_conf             419864235754084699999936-9919999983889901099999999998608997367899998149919999975
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  538 (805)
                      .++|...+.||+|+||.||+|.++ +++.||||++..... ..++|.+|++++++++||||++++|+|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf             7993986598208880899999999996999999777610-399999999999867999882677527457854787631


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             56875000112799999998789999999999999975069997685306889478689993999431787779999875
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~  618 (805)
                      +++|+|.+++.......+++..++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++.... +..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS-SSS
T ss_pred             CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCC-CCC
T ss_conf             467606777530355415799999999999997888987---8930576045768998999289832445465378-872


Q ss_pred             CEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             20002224565459432312899960358999999999993899999998122210999999983029863014821249
Q 003659          619 HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      .......|+..|+|||++.+..++.++|||||||++|||++|..|+........  +..    ....+         ...
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~---------~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD---------YRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTT---------CCC
T ss_pred             EEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHH----HHHCC---------CCC
T ss_conf             210355665466692787279998104302178999999867998877425999--999----98558---------888


Q ss_pred             CCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             9995699999999986100079999997899999999998
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       699 ~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                      ..+..++..+.+++.+||+.+|.+||+|.++++.|+.+.+
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             8874330999999999757797689399999999999987

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=371.87  Aligned_cols=262  Identities=29%  Similarity=0.443  Sum_probs=212.6

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCC-----CEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEE
Q ss_conf             1986423575408469999993699-----19999983889-90109999999999860899736789999814991999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDG-----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      ..|...++||+|+||.||+|.++..     ..||||++... ......+|.+|++++++++||||++++|+|.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf             99686159811779099999996899878799999998844596899999999999985689878323677833880389


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             99755687500011279999999878999999999999997506999768530688947868999399943178777999
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~  614 (805)
                      ||||+.+|+|.+.+.... ..++|.+++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEECCCCCCHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCC
T ss_conf             997213574022210234-542089999999999985412121---2342576564427888998499845510300357


Q ss_pred             CCC-CCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf             987-520002224565459432312899960358999999999993899999-998122210999999983029863014
Q 003659          615 IDQ-THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID-PTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       615 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      ... ........||+.|+|||++.++.++.++|||||||++|||+|+..|+. .....+..   .   . ...+      
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~---~---~-i~~~------  229 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---K---A-INDG------  229 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---H-HHTT------
T ss_pred             CCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHH---H---H-HHCC------
T ss_conf             8765267426777734348888704999973556344898999996798865568999999---9---9-8635------


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf             82124999956999999999861000799999978999999999986666
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA  742 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (805)
                         .....+.+++..+.+++.+||+.+|++||+|.||++.|+.+++..+.
T Consensus       230 ---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~  276 (283)
T d1mqba_         230 ---FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  276 (283)
T ss_dssp             ---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             ---CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCCC
T ss_conf             ---78998504579999999997767976893999999999998669564

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=375.69  Aligned_cols=258  Identities=24%  Similarity=0.355  Sum_probs=211.5

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEECC-C-----CEEEEEECCCC-CCHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCCE
Q ss_conf             4198642357540846999999369-9-----19999983889-901099999999998608-99736789999814991
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND-G-----TKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      .++|...++||+|+||.||+|+... +     ..||+|.+... .......+.+|+.++.++ +||||++++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf             89939701983078819999998578855420499999966335878999999999999971589968687788862995


Q ss_pred             EEEEEEECCCCCCCCCCCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCC
Q ss_conf             9999975568750001127999---------------------9999878999999999999997506999768530688
Q 003659          532 MILIYEYMENGTLKGHLYGSGL---------------------PSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKS  590 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp  590 (805)
                      .++||||+++|+|.++|.....                     ..+++..++.++.|++.||+|||+   ++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCH
T ss_conf             8999972799959999986257775102210000122200125778999999999999999999973---9905052703


Q ss_pred             CCEEECCCCCEEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf             947868999399943178777999987520002224565459432312899960358999999999993-8999999981
Q 003659          591 ANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLP  669 (805)
Q Consensus       591 ~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~  669 (805)
                      +|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |++||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf             21443459828985142222045778615623435787657838872799996330300039999998389999999898


Q ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHH
Q ss_conf             222109999999830298630148212499995699999999986100079999997899999999
Q 003659          670 REMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       670 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~  735 (805)
                      .+..  ..    ....+         .....+..++..+.+++.+||+.+|++|||++||+++|..
T Consensus       273 ~~~~--~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         273 DANF--YK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             SHHH--HH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHH--HH----HHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             9999--99----98569---------9899887678999999999758896689399999999748

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.00  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=209.6

Q ss_pred             CCCCCCC-EEEEECCEEEEEEEEC---CCCEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEE
Q ss_conf             1986423-5754084699999936---9919999983889-901099999999998608997367899998149919999
Q 003659          461 NNFDESW-VIGIGGFGKVYKGELN---DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      +++...+ .||+|+||.||+|.++   ++..||||++... .....++|.+|++++++++||||++++|+|.. +.+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf             4718878487306080999999960897689999998820397899999999999986799888068656036-807999


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             97556875000112799999998789999999999999975069997685306889478689993999431787779999
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~  615 (805)
                      |||+++|+|.+++...+ ..+++.+++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf             98078996899752125-699999999999999998789986---88105767646604546885420331342115543


Q ss_pred             CCC-CEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             875-20002224565459432312899960358999999999993-8999999981222109999999830298630148
Q 003659          616 DQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       616 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ... .......||+.|+|||++..+.++.++|||||||++|||+| |+.||......+....       ...+..     
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-------i~~~~~-----  230 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKR-----  230 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTCC-----
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHCCCC-----
T ss_conf             43211356211374335868872799995412322017899999389999999799999999-------981899-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             212499995699999999986100079999997899999999998
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                          ...+..++..+.+++.+||+.+|.+||++.+|++.|+....
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             ----99997678999999999757797689099999999999999

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=370.80  Aligned_cols=253  Identities=23%  Similarity=0.301  Sum_probs=207.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf             419864235754084699999936-99199999838899-0109999999999860899736789999814991999997
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  537 (805)
                      .++|+..+.||+|+||.||+|+.+ +++.||+|++.... .+..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf             74608998972174809999999999979999998456641279999999999985799888469654046743679886


Q ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             55687500011279999999878999999999999997506999768530688947868999399943178777999987
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~  617 (805)
                      |+++|+|.+++...  ..+++.++..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus        84 y~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          84 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf             45898089997537--999999999999999999999997---5983575468997887899879832314224046886


Q ss_pred             CCEEECCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             520002224565459432312899-9603589999999999938999999981222109999999830298630148212
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      ....+...||+.|+|||++.+..+ +.++|||||||++|||+||++||.......... .    ........        
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~----~~~~~~~~--------  225 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S----DWKEKKTY--------  225 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-H----HHHTTCTT--------
T ss_pred             CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH-H----HHHCCCCC--------
T ss_conf             5311132557474287286189999971016173799999982997888898599999-9----98638887--------


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             49999569999999998610007999999789999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                       .......+..+.+++.+||+.+|.+|||+.|+++
T Consensus       226 -~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 -LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -8864469999999999976799668909999961

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.74  Aligned_cols=249  Identities=23%  Similarity=0.343  Sum_probs=208.7

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEEC
Q ss_conf             19864235754084699999936-99199999838899010999999999986089973678999981499199999755
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  539 (805)
                      ++|...+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf             05388789812858299999998999899999984301727999999999998679998805857798899989999703


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             68750001127999999987899999999999999750699976853068894786899939994317877799998752
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++...   .+++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.....  ..
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QS  171 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--TC
T ss_pred             CCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC--CC
T ss_conf             798089886415---99999999999999999999998---79722677688868878996864251564132136--66


Q ss_pred             EEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             00022245654594323128999603589999999999938999999981222109999999830298630148212499
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+...      .....+.      +.  ..
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~------~~--~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PE--LQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------CC--CS
T ss_pred             CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHHCCC------CC--CC
T ss_conf             4444444777368266447998801203137299999804889989979999999------9985799------98--88


Q ss_pred             CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             99569999999998610007999999789999
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       700 ~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      .+...+..+.+++.+||+.+|.+||++.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             85537999999999986699668909999964

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=365.22  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=210.9

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEE
Q ss_conf             419864235754084699999936-9919999983889901099999999998608997367899998149919999975
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  538 (805)
                      -++|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+.+.+++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             65758988984076819999998899989999998452431699999999999867997999299999989999999985


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf             56875000112799999998789999999999999975069997685306889478689--9939994317877799998
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~ki~DFGla~~~~~~~  616 (805)
                      |++|+|.+++.... ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.  ++.+||+|||+++....  
T Consensus       105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--  178 (350)
T d1koaa2         105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--  178 (350)
T ss_dssp             CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred             CCCCCHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC--
T ss_conf             79988999997623-789999999999999999999975---697600015467364168898699954521044256--


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                       ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+....      .....       ...
T Consensus       179 -~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~~~~-------~~~  244 (350)
T d1koaa2         179 -KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN------VKSCD-------WNM  244 (350)
T ss_dssp             -TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTC-------CCS
T ss_pred             -CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHHCC-------CCC
T ss_conf             -5432000686242188997589987267655465999999859899899799999999------98478-------898


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             499995699999999986100079999997899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      ........+..+.+++.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             942235899999999999756896679089998629

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.82  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=213.2

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEECC
Q ss_conf             19864235754084699999936991999998388990109999999999860899736789999814991999997556
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  540 (805)
                      ++|+..++||+|+||.||+|+.+++..||||++..... ..++|.+|++++++++||||++++|+|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf             99799689820788399999988998999999874757-78999999999996689860158899850781699997048


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCE
Q ss_conf             87500011279999999878999999999999997506999768530688947868999399943178777999987520
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~  620 (805)
                      +|+|.+++.... ..+++..+++++.|+|+||.|||+   ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus        83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTS  157 (258)
T ss_dssp             TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCC
T ss_pred             CCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCC-CCEE
T ss_conf             993888641024-677689999999999999998754---68434665413588769984798861442023578-7225


Q ss_pred             EECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             002224565459432312899960358999999999993-8999999981222109999999830298630148212499
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....||..|+|||.+.+..++.++||||||+++|||+| |+.||......+....      .. .+.         ...
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~------i~-~~~---------~~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH------IA-QGL---------RLY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH------HH-TTC---------CCC
T ss_pred             ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHH------HH-HCC---------CCC
T ss_conf             24657887757807863799885210336432467397559999889999999999------98-079---------789


Q ss_pred             CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHH
Q ss_conf             995699999999986100079999997899999999
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEY  735 (805)
Q Consensus       700 ~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~  735 (805)
                      .+...+..+.+++.+||+.+|.+|||+++++++|..
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf             965465999999999766897689399999987418

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.75  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=214.5

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCC----EEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEE
Q ss_conf             19864235754084699999936-991----9999983889-90109999999999860899736789999814991999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGT----KVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      .+|+..++||+|+||.||+|.+. +|+    +||+|++... +.+..++|.+|++++++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf             999783198208992999999958998898999999965134979999999999999867998881589999619-8369


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             99755687500011279999999878999999999999997506999768530688947868999399943178777999
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~  614 (805)
                      ++|++.+|+|.+++.... ..+++..+++++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEECCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf             998426874010111334-579999999999999999999987---6950476212031167998758602552223354


Q ss_pred             CCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             987520002224565459432312899960358999999999993-8999999981222109999999830298630148
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      ...........||+.|+|||++.++.++.++|||||||++|||+| |++||......+......       .+.      
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~------  230 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE------  230 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC------
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------CCC------
T ss_conf             4453223651058644670887469998356544079999999977999999999899999997-------599------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf             2124999956999999999861000799999978999999999986666
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA  742 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (805)
                         ....+..++..+.+++.+||+.+|.+||++.|+++.|+.+.+....
T Consensus       231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~~  276 (317)
T d1xkka_         231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR  276 (317)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHHH
T ss_pred             ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCHHH
T ss_conf             ---8999855689999999984789934691999999999998758686

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=370.41  Aligned_cols=264  Identities=28%  Similarity=0.426  Sum_probs=217.5

Q ss_pred             HHHHHHCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCEEEEEEEEC
Q ss_conf             79998419864235754084699999936------99199999838899-010999999999986089973678999981
Q 003659          455 AVQEATNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCD  527 (805)
Q Consensus       455 ~l~~at~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  527 (805)
                      +++...++|+..+.||+|+||.||+|+.+      +++.||||++.... .+..++|.+|++++++++|+||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf             11389889388679820788399999988876577882999999882108579999999999999668997655246660


Q ss_pred             CCCEEEEEEEECCCCCCCCCCCCCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEE
Q ss_conf             4991999997556875000112799----------------------999998789999999999999975069997685
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSG----------------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIH  585 (805)
Q Consensus       528 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH  585 (805)
                      .....+++|||+++|+|.+++....                      ...+++..++.++.|+|.||+|||+   ++++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEE
T ss_conf             598038999815899299999852755421000011100121034678898999999999999998554135---78685


Q ss_pred             ECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCC
Q ss_conf             3068894786899939994317877799998752000222456545943231289996035899999999999389-999
Q 003659          586 RDVKSANILLDENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVI  664 (805)
Q Consensus       586 ~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~-~p~  664 (805)
                      |||||+|||++.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCC
T ss_conf             48840116898999289833144211367764111577776767679899726889805630252362999980689999


Q ss_pred             CCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf             9998122210999999983029863014821249999569999999998610007999999789999999999
Q 003659          665 DPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       665 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~  737 (805)
                      ......+....       ..++...         ..+..++..+.+++.+||+.+|.+||||.||+++|+++.
T Consensus       244 ~~~~~~e~~~~-------v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEVIYY-------VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHHHHH-------HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHHHHH-------HHCCCCC---------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf             99899999999-------9739978---------887325299999999974889657939999999999842

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.18  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=204.7

Q ss_pred             CEEEEECCEEEEEEEECC---CCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEECCC
Q ss_conf             357540846999999369---919999983889--901099999999998608997367899998149919999975568
Q 003659          467 WVIGIGGFGKVYKGELND---GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMEN  541 (805)
Q Consensus       467 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~~  541 (805)
                      ++||+|+||.||+|.+++   ++.||||++...  +....++|.+|++++++++||||++++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf             7834587829999998169738599999988010898999999999999986799898527777505-977999974788


Q ss_pred             CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC-CCE
Q ss_conf             7500011279999999878999999999999997506999768530688947868999399943178777999987-520
Q 003659          542 GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ-THV  620 (805)
Q Consensus       542 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~-~~~  620 (805)
                      |+|.+++....  .+++.+++.++.|+|.||+|||+   ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCC
T ss_conf             96899975225--78999999999999999766874---79556777611310235675123413453313432344322


Q ss_pred             EECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             002224565459432312899960358999999999993-8999999981222109999999830298630148212499
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |++||......+....       ...+.         ...
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-------i~~~~---------~~~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---------RMG  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------CCC
T ss_pred             CCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHCCC---------CCC
T ss_conf             44567784203916653799984344303403132896589999999899999999-------98289---------999


Q ss_pred             CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf             99569999999998610007999999789999999999
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       700 ~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~  737 (805)
                      .+..++..+.+++.+||+.+|.+||++++|++.|+...
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf             98656799999999975889768909899999852887

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=362.69  Aligned_cols=253  Identities=19%  Similarity=0.266  Sum_probs=210.8

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEE
Q ss_conf             419864235754084699999936-9919999983889901099999999998608997367899998149919999975
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  538 (805)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..........+.+|+++|++++||||+++++++.+++.+++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf             40359989993177829999999899979999998872646799999999999867997989199999989999999982


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC--CCCCEEEEECCCCCCCCCCC
Q ss_conf             5687500011279999999878999999999999997506999768530688947868--99939994317877799998
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD--ENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~--~~~~~ki~DFGla~~~~~~~  616 (805)
                      |++|+|.+++.... .++++.++..++.|++.||+|||+   .+|+||||||+|||++  .++.+||+|||+++....  
T Consensus       108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--  181 (352)
T d1koba_         108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--  181 (352)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred             CCCCHHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC--
T ss_conf             89980888898638-998999999999999999999997---792651314455311346788489952563034378--


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                       ........||+.|+|||++.+..++.++||||+||++|||+||++||......+....      ... ..      ...
T Consensus       182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~-~~------~~~  247 (352)
T d1koba_         182 -DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN------VKR-CD------WEF  247 (352)
T ss_dssp             -TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HHH-CC------CCC
T ss_pred             -CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHH-CC------CCC
T ss_conf             -8720100476453489997479989763338989999999968899899799999999------984-78------898


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             499995699999999986100079999997899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      ........+..+.+++.+||+.+|.+||++.|++++
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             930024799999999999756996689189999609

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.19  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=210.6

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEECC
Q ss_conf             19864235754084699999936991999998388990109999999999860899736789999814991999997556
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYME  540 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~~  540 (805)
                      ++|...+.||+|+||.||+|+++++..||||++.... ...+.|.+|+.++++++|+||++++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECC
T ss_conf             9979846993079809999999999999999988044-888999999999986666788689999823-97599999447


Q ss_pred             CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCE
Q ss_conf             87500011279999999878999999999999997506999768530688947868999399943178777999987520
Q 003659          541 NGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTHV  620 (805)
Q Consensus       541 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~~  620 (805)
                      +|+|..++.......++|.+++.++.|+|.||+|||+   ++++||||||+|||++.++.+||+|||+++.... .....
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-~~~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCC-CCCEE
T ss_conf             9943542000035530599999999999999998754---1143353123079998999299844255542568-87335


Q ss_pred             EECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf             002224565459432312899960358999999999993899999-9981222109999999830298630148212499
Q 003659          621 STAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVID-PTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAGK  699 (805)
Q Consensus       621 ~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  699 (805)
                      .....||+.|+|||++..+.++.++||||||+++|||+||..|+. .....+....   .   . .+         ....
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i---~-~~---------~~~~  234 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---V---E-RG---------YRMP  234 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---H---H-TT---------CCCC
T ss_pred             ECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHH---H---H-HC---------CCCC
T ss_conf             24545566545808983799891774132358999998689999988889999999---9---8-26---------8999


Q ss_pred             CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf             99569999999998610007999999789999999999
Q 003659          700 IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYAL  737 (805)
Q Consensus       700 ~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~  737 (805)
                      .+..++..+.+++.+||+.+|++||+|.+|+++|+...
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf             98323799999999975669758919999999876662

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.19  Aligned_cols=246  Identities=27%  Similarity=0.390  Sum_probs=207.4

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             EECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCCC-
T ss_conf             5047985898875048--99999999999999999999998---89465220234414668998711555633544888-


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....      .. ...      .  
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~------i~-~~~------~--  221 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------IS-RVE------F--  221 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-TTC------C--
T ss_pred             ---CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH------HH-CCC------C--
T ss_conf             ---52355788763499997589989314404675999998329999888999999999------97-189------9--


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             499995699999999986100079999997899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                        .++...+..+.+++.+||+.+|.+|||+.|++++
T Consensus       222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             --9986689999999999764797689099999719

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.54  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEEC
Q ss_conf             19864235754084699999936-99199999838899010999999999986089973678999981499199999755
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  539 (805)
                      +.|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf             37598479930778199999999999399999987289999999999999998679999884988980099589999627


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             68750001127999999987899999999999999750699976853068894786899939994317877799998752
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++.... .++++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....  ...
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred             CCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC--CCC
T ss_conf             9981889998628-999999999999999999999998---8988714070031487899989971612303577--864


Q ss_pred             EEECCCCCCCCCCHHHHC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf             000222456545943231-----289996035899999999999389999999812221099999998302986301482
Q 003659          620 VSTAVKGSFGYLDPEYFR-----RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP  694 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  694 (805)
                      ......||+.|+|||++.     ...++.++|||||||++|||+||+.||....+.+...      ..... ....+   
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~------~i~~~-~~~~~---  235 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL------KIAKS-EPPTL---  235 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHHS-CCCCC---
T ss_pred             CCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHCC-CCCCC---
T ss_conf             100102562647999983202578888806657878999999820889999989999999------99707-99877---


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             1249999569999999998610007999999789999
Q 003659          695 TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       695 ~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                          ..+...+..+.+++.+||+.+|.+|||+.|+++
T Consensus       236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ----765669999999999976699668919999962

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=372.25  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=207.5

Q ss_pred             HHCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             8419864235754084699999936-9919999983889-9010999999999986089973678999981499199999
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       459 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++... .......+.+|+++|++++||||++++++|.+....++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             75688897897127780999999989996999999875409789999999999998679999994999999899999999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCC-CEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             755687500011279999999878999999999999997506999-7685306889478689993999431787779999
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAK-AVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~  615 (805)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+   + +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus        84 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             ECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             ECCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC-
T ss_conf             7679986899874249--99999999999999999999998---59997144577994687899899954877625678-


Q ss_pred             CCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH--------------
Q ss_conf             875200022245654594323128999603589999999999938999999981222109999999--------------
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMK--------------  681 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~--------------  681 (805)
                         ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||......+..........              
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf             ---86211137714119468758998948889989999999998889989988789999998875177545774212333


Q ss_pred             -HHH--------CCCCCCCCCCCCC---CCCC-HHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             -830--------2986301482124---9999-5699999999986100079999997899999
Q 003659          682 -WQN--------KGQLDQIIDPTLA---GKIR-PDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       682 -~~~--------~~~~~~~~d~~l~---~~~~-~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                       ...        .....+..+....   ...+ ...+..+.+++.+||+.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             2211112223541347788766502687667644489999999999868994679089999609

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=365.34  Aligned_cols=253  Identities=24%  Similarity=0.390  Sum_probs=206.7

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC--CCEEEEE
Q ss_conf             19864235754084699999936-9919999983889--90109999999999860899736789999814--9919999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--KNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV  535 (805)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|.+...  .....+.+.+|++++++++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf             33799679830889199999999999799999987465797999999999999997789998248999991789989999


Q ss_pred             EEECCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             9755687500011279--9999998789999999999999975069--99768530688947868999399943178777
Q 003659          536 YEYMENGTLKGHLYGS--GLPSLSWKQRLEICIGSARGLHYLHTGY--AKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       536 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf             95689993899998515457899999999999999999999997167788788586765425747888579800100032


Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             99998752000222456545943231289996035899999999999389999999812221099999998302986301
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ...  .........||+.|+|||++.+..++.++|||||||++|||+||++||......+...      . ...+...  
T Consensus       164 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~------~-i~~~~~~--  232 (269)
T d2java1         164 LNH--DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------K-IREGKFR--  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------H-HHHTCCC--
T ss_pred             CCC--CCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH------H-HHCCCCC--
T ss_conf             245--7775566778823279999839999938988752789999801889989989999999------9-9718998--


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             4821249999569999999998610007999999789999
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                             .++...+..+.+++.+||+.+|.+||++.|+++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             -------897435999999999976799557918999972

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.39  Aligned_cols=250  Identities=21%  Similarity=0.303  Sum_probs=210.1

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.. +++.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+++......
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf             7048987777653159--99999999999999999976216---508847677412366888538860321024225677


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                      .........||+.|+|||++.+..++.++|||||||++|||+||+.||....+.+...      ... .+.      .  
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~-~~~------~--  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KII-KLE------Y--  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-TTC------C--
T ss_pred             CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-CCC------C--
T ss_conf             6433355567755258440026898966623045699999803889989959999999------997-189------9--


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             499995699999999986100079999997899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                        .++...+..+.+++.+||+.+|.+|||++|++..
T Consensus       228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf             --9985479999999999855797689197897377

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=363.05  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-99199999838899---010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..|+..+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      |||++|+|..++...  .++++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....  
T Consensus        95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC--
T ss_conf             806999457899737--999999999999999999999986---8976667884217987999789844365334677--


Q ss_pred             CCCEEECCCCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             7520002224565459432312---8999603589999999999938999999981222109999999830298630148
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRR---QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                          .....||+.|+|||++.+   +.++.++|||||||++|||++|+.||......+...      ..... ..     
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~-~~-----  231 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN-ES-----  231 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-CC-----
T ss_pred             ----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHHC-CC-----
T ss_conf             ----873134766368899834678886721454558999999987889999979999999------99828-99-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             21249999569999999998610007999999789999
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      +.+   .....+..+.+++.+||+.+|.+|||+.|+++
T Consensus       232 ~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         232 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             988---87888999999999977379657918999971

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=361.26  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=208.1

Q ss_pred             HHCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             8419864235754084699999936-99199999838899-010999999999986089973678999981499199999
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       459 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ..+.|...+.||+|+||.||+|+.+ +++.||+|++.... ......+.+|++++++++||||+++++++.+.+.+++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             76666998899406583999999999998999999815773128999999999998679989991989999899888988


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC---CCCCEEEEECCCCCCCC
Q ss_conf             755687500011279999999878999999999999997506999768530688947868---99939994317877799
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGP  613 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~ki~DFGla~~~~  613 (805)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||+   ++|+||||||+|||+.   +++.+||+|||+++...
T Consensus        87 E~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          87 QLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf             526898488865303--678878999999999999875241---305568704630011046888249983154358725


Q ss_pred             CCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             99875200022245654594323128999603589999999999938999999981222109999999830298630148
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      .   ........||+.|+|||++.+..++.++|||||||++|||++|++||......+...      ..... .      
T Consensus       162 ~---~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~-~------  225 (307)
T d1a06a_         162 P---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE------QILKA-E------  225 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHTT-C------
T ss_pred             C---CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHCC-C------
T ss_conf             8---970440032842259188737999807873451599999985979999989999999------98616-8------


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             212499995699999999986100079999997899999
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      ...........+..+.+++.+||+.+|.+|||+.|++++
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             777876666789999999999760897579189998629

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.23  Aligned_cols=261  Identities=26%  Similarity=0.364  Sum_probs=215.0

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEECC----CCEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEE
Q ss_conf             4198642357540846999999369----919999983889-90109999999999860899736789999814991999
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELND----GTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l  534 (805)
                      .++|...+.||+|+||.||+|+...    +..||+|.+... .....+.|.+|++++++++||||++++|++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf             89969877993078829999999369964499999993656687999999999999986899998569889953-74799


Q ss_pred             EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf             99755687500011279999999878999999999999997506999768530688947868999399943178777999
Q 003659          535 IYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPE  614 (805)
Q Consensus       535 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~  614 (805)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++....
T Consensus        85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEECCCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf             998406980776542247-899999999999999877523022---6744141026553206789678765034213367


Q ss_pred             CCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             987520002224565459432312899960358999999999993-8999999981222109999999830298630148
Q 003659          615 IDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       615 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                       ......+...||+.|+|||++.+..++.++|||||||++|||+| |++|+......+....   .    ..+..     
T Consensus       161 -~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~---i----~~~~~-----  227 (273)
T d1mp8a_         161 -STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---I----ENGER-----  227 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH---H----HTTCC-----
T ss_pred             -CCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHH---H----HCCCC-----
T ss_conf             -7623305400583103266751699887452444247899998269999888999999999---9----81899-----


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHHHH
Q ss_conf             2124999956999999999861000799999978999999999986666
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEA  742 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~~~  742 (805)
                          ...+..++..+.+++.+||+.+|.+||++.||++.|+.+++..++
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k~  272 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  272 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHC
T ss_conf             ----989877799999999997687976892999999999999778617

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.90  Aligned_cols=262  Identities=23%  Similarity=0.346  Sum_probs=214.7

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCCC-CHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCCE
Q ss_conf             419864235754084699999936------99199999838899-01099999999998608-99736789999814991
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  531 (805)
                      .++|...++||+|+||.||+|++.      .++.||||++.... .....+|.+|+.++.++ +||||++++|+|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf             89969854982068829999998066447788699999987424877999999999998762699988789989831997


Q ss_pred             EEEEEEECCCCCCCCCCCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEE
Q ss_conf             999997556875000112799----------------9999987899999999999999750699976853068894786
Q 003659          532 MILIYEYMENGTLKGHLYGSG----------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILL  595 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll  595 (805)
                      .++||||+++|+|.++++...                ...+++..++.++.|+|.||+|||+   ++++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCC
T ss_conf             89999737998799999853566544444533222334588999999999999999998875---792666241021000


Q ss_pred             CCCCCEEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHH
Q ss_conf             89993999431787779999875200022245654594323128999603589999999999938-99999998122210
Q 003659          596 DENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVN  674 (805)
Q Consensus       596 ~~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG-~~p~~~~~~~~~~~  674 (805)
                      +.++.+|++|||+++...............||+.|+|||++.++.++.++||||||+++|||+|+ .+|+......+.. 
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH-
T ss_conf             0257521023401023367886158620135968767788617999974001025899999985899887789989999-


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             99999998302986301482124999956999999999861000799999978999999999986
Q 003659          675 LAEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       675 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~  739 (805)
                       ..    ....+         .....+...+..+.+++.+||+.+|.+||+|.+++++|++.+..
T Consensus       258 -~~----~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 -YK----MIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             -HH----HHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HH----HHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf             -99----98668---------98898543659999999997577965792999999999876534

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.68  Aligned_cols=244  Identities=27%  Similarity=0.403  Sum_probs=195.6

Q ss_pred             CCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC----CCEEEEEE
Q ss_conf             64235754084699999936-9919999983889--90109999999999860899736789999814----99199999
Q 003659          464 DESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE----KNEMILIY  536 (805)
Q Consensus       464 ~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~  536 (805)
                      ...+.||+|+||.||+|... ++..||+|++...  .....+.+.+|++++++++||||+++++++..    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf             85169700828499999999999599999985122798999999999999985799985069999840334588899999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC--EEEECCCCCCEEEC-CCCCEEEEECCCCCCCC
Q ss_conf             7556875000112799999998789999999999999975069997--68530688947868-99939994317877799
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKA--VIHRDVKSANILLD-ENFMAKVADFGLSKTGP  613 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~Dikp~NIll~-~~~~~ki~DFGla~~~~  613 (805)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+   ++  |+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             ECCCCCCHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf             578989489997513--554699999999999999999997---899799687674351166799988980057654236


Q ss_pred             CCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf             99875200022245654594323128999603589999999999938999999981222109999999830298630148
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIID  693 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  693 (805)
                      .    .......||+.|+|||++.+ .++.++|||||||++|||+||+.||........  +.   ... ..+..    .
T Consensus       167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~---~~i-~~~~~----~  231 (270)
T d1t4ha_         167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGVK----P  231 (270)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTCC----C
T ss_pred             C----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH--HH---HHH-HCCCC----C
T ss_conf             8----76677553813008988478-999867110079999999878899987655999--99---999-73899----8


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             21249999569999999998610007999999789999
Q 003659          694 PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       694 ~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      +...    ......+.+++.+||+.+|++|||+.|+++
T Consensus       232 ~~~~----~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ASFD----KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGG----GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             6567----557899999999976379758929999967

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.69  Aligned_cols=257  Identities=30%  Similarity=0.455  Sum_probs=210.8

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECC-CC--EEEEEECCCC-CCHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCCEEEEE
Q ss_conf             198642357540846999999369-91--9999983889-901099999999998608-997367899998149919999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND-GT--KVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...++||+|+||.||+|++++ +.  .||||++... .....+.|.+|+++|.++ +||||++++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf             99688779820788289999998999699999999782338579999999999998622899883678888418736999


Q ss_pred             EEECCCCCCCCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCE
Q ss_conf             9755687500011279--------------99999987899999999999999750699976853068894786899939
Q 003659          536 YEYMENGTLKGHLYGS--------------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMA  601 (805)
Q Consensus       536 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~  601 (805)
                      |||+++|+|.++|+..              ....+++.+++.++.|+|.||.|||+   ++++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCCE
T ss_conf             98028986999986403555551231012345789999999999999999876630---895455505204898688763


Q ss_pred             EEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHHHH
Q ss_conf             994317877799998752000222456545943231289996035899999999999389-9999998122210999999
Q 003659          602 KVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAM  680 (805)
Q Consensus       602 ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~-~p~~~~~~~~~~~l~~~~~  680 (805)
                      ||+|||+++....   ........||..|+|||.+..+.++.++||||||+++|||++|. +|+......+..      .
T Consensus       167 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~------~  237 (309)
T d1fvra_         167 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E  237 (309)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred             EECCCCCCCCCCC---CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHH------H
T ss_conf             8743443224442---234553013775555387526999962215313889999983689999999999999------9


Q ss_pred             HHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             98302986301482124999956999999999861000799999978999999999986
Q 003659          681 KWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       681 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~  739 (805)
                      . ..++.         ....+..++..+.+++.+||+.+|++||+|.||++.|+.+++.
T Consensus       238 ~-i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         238 K-LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             H-GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             H-HHHCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             9-98268---------8888766789999999997678966894999999999999861

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.65  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=205.2

Q ss_pred             CCEEEEECCEEEEEEEECCC----CEEEEEECCC-CCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC-CCEEEEEEEEC
Q ss_conf             23575408469999993699----1999998388-990109999999999860899736789999814-99199999755
Q 003659          466 SWVIGIGGFGKVYKGELNDG----TKVAVKRGNP-RSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYEYM  539 (805)
Q Consensus       466 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~  539 (805)
                      .++||+|+||+||+|++.++    ..||||++.. .+....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf             66981368809999999779987999999998843697899999999999986789998678678980699438999874


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC--
Q ss_conf             687500011279999999878999999999999997506999768530688947868999399943178777999987--
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ--  617 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~--  617 (805)
                      ++|+|.+++.... ..+++..+++++.|+|+||.|||+   ++|+||||||+|||+++++.+||+|||+++.......  
T Consensus       112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ECCCHHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf             0674144210134-540489999999998876520033---676257766875767799988991065232255665553


Q ss_pred             CCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             52000222456545943231289996035899999999999389999999812221099999998302986301482124
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLA  697 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  697 (805)
                      ........||..|+|||++..+.++.++||||||+++|||+||+.|+.......  ....+.    ..+..     +   
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~-----~---  253 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRR-----L---  253 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC-----C---
T ss_pred             CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HCCCC-----C---
T ss_conf             100256555645567688743799974574661999999997899998889999--999999----80898-----8---


Q ss_pred             CCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             99995699999999986100079999997899999999998
Q 003659          698 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       698 ~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                       ..+..++..+.+++.+||+.+|.+||+|.||++.|+.+++
T Consensus       254 -~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         254 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             -9964475999999999768897689399999999999997

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.82  Aligned_cols=251  Identities=29%  Similarity=0.430  Sum_probs=209.1

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC-CCEEEEEEEEC
Q ss_conf             19864235754084699999936991999998388990109999999999860899736789999814-99199999755
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-KNEMILIYEYM  539 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E~~  539 (805)
                      ++|...+.||+|+||.||+|.++ |..||||+++...  ..+.|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf             99488579820798089999999-9099999988577--79999999999986789898549878872389289999636


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             68750001127999999987899999999999999750699976853068894786899939994317877799998752
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~  619 (805)
                      ++|+|.+++.......++|..+++|+.|+|.||+|||+   ++++||||||+|||++.++.+||+|||+++....     
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----  155 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----  155 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCC-----
T ss_conf             99989999874578888999999999999852321133---7655366656760146899776324560034478-----


Q ss_pred             EEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf             0002224565459432312899960358999999999993-899999998122210999999983029863014821249
Q 003659          620 VSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTLAG  698 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  698 (805)
                      ......++..|+|||++.++.++.++||||||+++|||+| |++|+......+.   ..+.    ..+         ...
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~~---------~~~  219 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EKG---------YKM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TTT---------CCC
T ss_pred             CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HCC---------CCC
T ss_conf             776556664677817872798885887775799999999789999999999999---9999----808---------999


Q ss_pred             CCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             9995699999999986100079999997899999999998
Q 003659          699 KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       699 ~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                      .++...+..+.+++.+||+.+|.+||++.+++++|+.+..
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf             9976579999999999756697689399999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.50  Aligned_cols=262  Identities=23%  Similarity=0.352  Sum_probs=210.0

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCC-CCHHHHHHHHHHHHHHCC-CCCCEEEEEEEECC-CC
Q ss_conf             419864235754084699999936------9919999983889-901099999999998608-99736789999814-99
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDE-KN  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~  530 (805)
                      .++|...+.||+|+||.||+|...      +++.||||++... .....+.+..|...+.++ +|+||+.+++++.+ ..
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf             79979844984167839999998677755578399999986001717899999999998861499849974115404797


Q ss_pred             EEEEEEEECCCCCCCCCCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC
Q ss_conf             1999997556875000112799--------------99999878999999999999997506999768530688947868
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~  596 (805)
                      .+++|||||++|+|.+++....              ...+++.+++.++.|+|.||+|||+   ++|+||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEC
T ss_conf             5799998458992999998536666653222023321468999999999999999998873---7971786773106577


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHH
Q ss_conf             9993999431787779999875200022245654594323128999603589999999999938-999999981222109
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCA-RPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG-~~p~~~~~~~~~~~l  675 (805)
                      +++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|| .+||......+..  
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~--  246 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--  246 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--
T ss_pred             CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHH--
T ss_conf             998289845752001135665222475166721020368646889966322136789999986889999899989999--


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             9999998302986301482124999956999999999861000799999978999999999986
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~  739 (805)
                          ......+..     +    ..+...+..+.+++.+||+.+|.+|||+.|++++|+.++|.
T Consensus       247 ----~~~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         247 ----CRRLKEGTR-----M----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ----HHHHHHTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHCCCC-----C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ----999963898-----8----88865789999999997677966791999999999799867

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.55  Aligned_cols=260  Identities=27%  Similarity=0.440  Sum_probs=214.7

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECC--------CCEEEEEECCCCC-CHHHHHHHHHHHHHHCC-CCCCEEEEEEEECCCC
Q ss_conf             198642357540846999999369--------9199999838899-01099999999998608-9973678999981499
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND--------GTKVAVKRGNPRS-QQGLAEFQTEIEMLSQF-RHRHLVSLIGYCDEKN  530 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  530 (805)
                      ++|...+.||+|+||.||+|+...        +..||||++.... .....++.+|...+.++ +||||++++++|.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf             99697009851678289999985787555667549999998811286889999999999998139996973465220188


Q ss_pred             EEEEEEEECCCCCCCCCCCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC
Q ss_conf             1999997556875000112799--------------99999878999999999999997506999768530688947868
Q 003659          531 EMILIYEYMENGTLKGHLYGSG--------------LPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD  596 (805)
Q Consensus       531 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~  596 (805)
                      ..++||||+++|+|.+++....              ...+++.+++.++.|+|.||+|||+   .+++||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCEEEC
T ss_conf             6899997369990999998606776432223345743467999999999999999987663---7978630221022454


Q ss_pred             CCCCEEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHH
Q ss_conf             999399943178777999987520002224565459432312899960358999999999993-8999999981222109
Q 003659          597 ENFMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNL  675 (805)
Q Consensus       597 ~~~~~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l  675 (805)
                      .++.+||+|||+++...............|++.|+|||.+.++.++.++||||||+++|||+| |++||......+... 
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~-  248 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-  248 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred             CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH-
T ss_conf             7897676221110113555554314667888466326675179888255547758888874017989899999999999-


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             9999998302986301482124999956999999999861000799999978999999999986
Q 003659          676 AEWAMKWQNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQL  739 (805)
Q Consensus       676 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~  739 (805)
                            ....+.         ....+...+..+.+++.+||+.+|.+|||+.||++.|++++.+
T Consensus       249 ------~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         249 ------LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ------HHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHCCC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf             ------997288---------8898743529999999997667976793999999999888604

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.41  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=207.1

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|+..+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|+++|++++||||+++++++.+...+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf             74289889831768499999998999899999981565449799999999999998679998877876403564211100


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      |||++|+|.+++....  .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             ECCCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf             0357986055553256--77599999999999652113431---596224647778476589988882056520035678


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                        ......+||+.|+|||++.+..++.++||||+||++|||++|++||......+....      .. .+.      .  
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~-~~~------~--  222 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------IL-MEE------I--  222 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HH-HCC------C--
T ss_pred             --CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH------HH-CCC------C--
T ss_conf             --620551008899666650489888333102230678899878999999699999999------85-289------9--


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCC-----HHHHHH
Q ss_conf             49999569999999998610007999999-----789999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs-----~~evl~  731 (805)
                        .++...+..+.+++.+||+.+|.+|++     +.|+++
T Consensus       223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             --89866899999999866638934422565234999972

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.49  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=206.4

Q ss_pred             HHCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC------CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCE
Q ss_conf             8419864235754084699999936-99199999838899------0109999999999860899736789999814991
Q 003659          459 ATNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS------QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNE  531 (805)
Q Consensus       459 at~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  531 (805)
                      ..++|...+.||+|+||.||+|+.+ +|+.||||++....      ....+.+.+|+++|++++||||+++++++.+...
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf             55677982798117895999999999998999999875663213406899999999999986799899938899997998


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC----CEEEEECC
Q ss_conf             99999755687500011279999999878999999999999997506999768530688947868999----39994317
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF----MAKVADFG  607 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~----~~ki~DFG  607 (805)
                      +++|||||++|+|.+++....  .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++    .+||+|||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEECCCCCCCCCHHCCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             999998677864310010356--42155789999999999876662---5422113330127982589866646964334


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             87779999875200022245654594323128999603589999999999938999999981222109999999830298
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      +++....   ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+....      ... ..
T Consensus       163 ~a~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~-~~  232 (293)
T d1jksa_         163 LAHKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------VSA-VN  232 (293)
T ss_dssp             TCEECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHT-TC
T ss_pred             HHHHCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHH------HHH-CC
T ss_conf             4210577---7631224777743099998189999766522140999999708899889999999999------981-68


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             63014821249999569999999998610007999999789999
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      .  -..+..    ....+..+.+++.+||+.+|.+||++.|+++
T Consensus       233 ~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 Y--EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C--CCCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CCCCHH----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             8--887010----4788999999999986389668919999961

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.81  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=212.3

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC------CCCEEEEEECCCC-CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEE
Q ss_conf             419864235754084699999936------9919999983889-901099999999998608997367899998149919
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN------DGTKVAVKRGNPR-SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  532 (805)
                      .++|...+.||+|+||.||+|.++      .++.||||++... .......|.+|++++++++||||++++|+|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf             89918835982078818999998786447789689999987012868999999999999976999884125478428810


Q ss_pred             EEEEEECCCCCCCCCCCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEE
Q ss_conf             9999755687500011279--------99999987899999999999999750699976853068894786899939994
Q 003659          533 ILIYEYMENGTLKGHLYGS--------GLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVA  604 (805)
Q Consensus       533 ~lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~  604 (805)
                      ++||||+++|+|.+++...        ....+++..+++++.|+|+||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEEEEE
T ss_conf             67776048998899987503321134446887999999999999999998764---796543286775403599649994


Q ss_pred             ECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             317877799998752000222456545943231289996035899999999999389-9999998122210999999983
Q 003659          605 DFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCAR-PVIDPTLPREMVNLAEWAMKWQ  683 (805)
Q Consensus       605 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~  683 (805)
                      |||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+ +|+......+...      ...
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~------~i~  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR------FVM  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH------HHH
T ss_pred             ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH------HHH
T ss_conf             24542023577630313402316323788887369988333444378999999968999999989999999------998


Q ss_pred             HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf             0298630148212499995699999999986100079999997899999999998
Q 003659          684 NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQ  738 (805)
Q Consensus       684 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~  738 (805)
                       .+..         ...+..++..+.+++.+||+.+|.+||+|.+|+++|+..++
T Consensus       250 -~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 -EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HCCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf             -0888---------88863353999999999757796589399999999787617

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=349.48  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=198.5

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC---CHHHHHHH---HHHHHHHCCCCCCEEEEEEEECCCCEEE
Q ss_conf             19864235754084699999936-99199999838899---01099999---9999986089973678999981499199
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS---QQGLAEFQ---TEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ++|...++||+|+||.||+|+.. +|+.||+|++....   ......+.   .++++++.++||||+++++++.+.+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf             76851018842889099999999999799999984587542667999999999999985089985889999999899889


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             99975568750001127999999987899999999999999750699976853068894786899939994317877799
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~  613 (805)
                      +||||+++|+|.+++....  .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf             9999148983899987325--53278999999999999999997---796220444221678588967982201023337


Q ss_pred             CCCCCCEEECCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf             9987520002224565459432312-899960358999999999993899999998122210999999983029863014
Q 003659          614 EIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII  692 (805)
Q Consensus       614 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  692 (805)
                      ..    ......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...+..    ....       
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~-------  223 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT-------  223 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSS-------
T ss_pred             CC----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----HCCC-------
T ss_conf             88----64331134554216876038999844104677899999985999888899899999998----6046-------


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCC-----HHHHHH
Q ss_conf             821249999569999999998610007999999-----789999
Q 003659          693 DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW  731 (805)
Q Consensus       693 d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs-----~~evl~  731 (805)
                       .  ...++...+..+.+++.+||+.+|.+||+     ++|+++
T Consensus       224 -~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 -M--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -C--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -C--CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             -8--8878877899999999998566988808874357999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=349.54  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=205.9

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|...+.||+|+||.||+|+.+ +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf             47088889720768089999998999799999984577548899999999999998636967533035685288005676


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      ||+++|+|..++....  .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EECCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECCC-
T ss_conf             5037863223432222--11100799999999876554124---76770556810503868998898317521671245-


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                          .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+...      ..... .         
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~-~---------  217 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KILNA-E---------  217 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHC-C---------
T ss_pred             ----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH------HHHCC-C---------
T ss_conf             ----643457634359999838999804304653336899975989999969999999------99708-9---------


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCC-----CHHHHHHH
Q ss_conf             4999956999999999861000799999-----97899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----s~~evl~~  732 (805)
                       ..+++..+..+.+++.+||+.+|.+|+     ++++++++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf             -8899778999999999995449976664310219999819

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.48  Aligned_cols=270  Identities=24%  Similarity=0.340  Sum_probs=203.2

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC----EEEEEE
Q ss_conf             1986423575408469999993699199999838899010999999999986089973678999981499----199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV~  536 (805)
                      +.|...+.||+|+||.||+|+++ |+.||||++...... ......|+..+.+++||||++++++|.+..    .+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf             68999889820788199999999-989999998720046-7999999999962799868326889983798604899999


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             755687500011279999999878999999999999997506-----999768530688947868999399943178777
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTG-----YAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      |||++|+|.++|...   +++|.++++++.++|.||+|||+.     ..++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ECCCCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
T ss_conf             646698989998658---99989999999999999999887665204689866153173135786887768876386623


Q ss_pred             CCCCCCC--CEEECCCCCCCCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----H-----HH
Q ss_conf             9999875--2000222456545943231289------9960358999999999993899999998122----2-----10
Q 003659          612 GPEIDQT--HVSTAVKGSFGYLDPEYFRRQQ------LTEKSDVYSFGVVLFEVLCARPVIDPTLPRE----M-----VN  674 (805)
Q Consensus       612 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~ksDV~SlGvil~elltG~~p~~~~~~~~----~-----~~  674 (805)
                      .......  .......||+.|+|||++.+..      ++.++|||||||+||||+||.+|+.......    .     ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             CCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCH
T ss_conf             46777620013552503547678221056545467776750122015999999962899887663112410122556430


Q ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             99999998302986301482124999-9569999999998610007999999789999999999866
Q 003659          675 LAEWAMKWQNKGQLDQIIDPTLAGKI-RPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       675 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~  740 (805)
                      .... ......    ...+|.+.... ..+....+.+++.+||+.+|.+||++.||++.|+++.+..
T Consensus       238 ~~~~-~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  299 (303)
T d1vjya_         238 VEEM-RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHH-HHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH-HHHHHC----CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             9999-998750----2468887765577689999999999976069858959999999999888865

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=348.37  Aligned_cols=244  Identities=21%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986089973678999981499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~  536 (805)
                      ++|+..+.||+|+||.||+|+.+ +|+.||||++...   .....+.+.+|+++|+.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf             75568750001127999999987899999999999999750699976853068894786899939994317877799998
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~  616 (805)
                      ||+.+|+|.+++....  .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred             CCCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC--
T ss_conf             2334662266675158--98999999999999998999985---9986176799993607789788610103332256--


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                         ......||+.|+|||++.+..++.++|||||||++|||+||++||...........      ... +.      .  
T Consensus       194 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~-~~------~--  255 (350)
T d1rdqe_         194 ---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVS-GK------V--  255 (350)
T ss_dssp             ---CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHH-CC------C--
T ss_pred             ---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHH------HHC-CC------C--
T ss_conf             ---66433676356788997179988533114500789999758899899599999999------861-79------8--


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCC-----CHHHHHH
Q ss_conf             4999956999999999861000799999-----9789999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRP-----SMGDVLW  731 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RP-----s~~evl~  731 (805)
                        ..+...+..+.+++.+||+.+|.+|+     +++++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             --89766899999999998340998606553454999971

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=353.99  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=208.2

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECC--C--CEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEE
Q ss_conf             198642357540846999999369--9--19999983889---9010999999999986089973678999981499199
Q 003659          461 NNFDESWVIGIGGFGKVYKGELND--G--TKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMI  533 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  533 (805)
                      ++|+..+.||+|+||.||+|++..  +  ..||||++...   ..+..++|.+|++++++++||||++++|+|.+. ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf             8919978980388839999999889990799999999835557989999999999999868999987898777401-001


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             99975568750001127999999987899999999999999750699976853068894786899939994317877799
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~  613 (805)
                      +||||+++|+|.+++.... ..+++..++.++.|+|+||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEECCCCHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf             1465423861254442126-899999999999999999987521---787520566888156556543325611555303


Q ss_pred             CCCCC-CEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf             99875-20002224565459432312899960358999999999993-89999999812221099999998302986301
Q 003659          614 EIDQT-HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLC-ARPVIDPTLPREMVNLAEWAMKWQNKGQLDQI  691 (805)
Q Consensus       614 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  691 (805)
                      ..... .......|+..|+|||++.+..++.++||||||+++|||+| |+.||......+..   .   ...+.+     
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~---~---~i~~~~-----  231 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---H---KIDKEG-----  231 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---HHHTSC-----
T ss_pred             CCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---H---HHHHCC-----
T ss_conf             58875265476325731079999837999942156614899999996899999996999999---9---998479-----


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHH
Q ss_conf             482124999956999999999861000799999978999999999
Q 003659          692 IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYA  736 (805)
Q Consensus       692 ~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~  736 (805)
                          .....+...+..+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus       232 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf             ----99998544539999999997688966792999999999964

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=344.51  Aligned_cols=260  Identities=24%  Similarity=0.374  Sum_probs=210.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC----E
Q ss_conf             419864235754084699999936-9919999983889---9010999999999986089973678999981499----1
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----E  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~  531 (805)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+...   +......+.+|+++++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             99999755687500011279999999878999999999999997506999768530688947868999399943178777
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      .++||||+++|+|.+++....  ++++.+++.++.|++.||+|||+   ++|+||||||+|||++.++..+++|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEEHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf             999997788987101120358--99999999999999999999985---7952763467556657543201003444322


Q ss_pred             CCCC-CCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             9999-875200022245654594323128999603589999999999938999999981222109999999830298630
Q 003659          612 GPEI-DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       612 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      .... ..........||+.|+|||++.+..++.++|||||||++|||+||++||....+.+..      .......... 
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~~-  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP-  233 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC-
T ss_pred             HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHH------HHHHHCCCCC-
T ss_conf             123544333346425762436999983999996632026528999997697998996999999------9998469999-


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCC-CHHHHHHHHHHHH
Q ss_conf             1482124999956999999999861000799999-9789999999999
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRP-SMGDVLWNLEYAL  737 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RP-s~~evl~~L~~~~  737 (805)
                         +   .......+..+.+++.+||+.+|.+|| ++++++..|.++.
T Consensus       234 ---~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 ---P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ---G---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---C---CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf             ---7---10034789999999999866797677739999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.86  Aligned_cols=252  Identities=16%  Similarity=0.240  Sum_probs=207.0

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEE
Q ss_conf             419864235754084699999936-9919999983889901099999999998608997367899998149919999975
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  538 (805)
                      .++|...+.||+|+||.||+|..+ +++.||+|.+...... ...+.+|+++|++++||||+++++++.+.+.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf             01058878983177839999999899969999997578665-99999999999857997989098999889988999953


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC--CCCEEEEECCCCCCCCCCC
Q ss_conf             56875000112799999998789999999999999975069997685306889478689--9939994317877799998
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE--NFMAKVADFGLSKTGPEID  616 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~--~~~~ki~DFGla~~~~~~~  616 (805)
                      |++|+|.+++.... ..+++.++..++.|++.||+|||+   .+|+||||||+|||++.  ...+||+|||+++....  
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--  156 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--  156 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred             CCCCCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC--
T ss_conf             89980889987538-999999999999999999999987---699751355444344378851899764411100346--


Q ss_pred             CCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf             75200022245654594323128999603589999999999938999999981222109999999830298630148212
Q 003659          617 QTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPTL  696 (805)
Q Consensus       617 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  696 (805)
                       ........|++.|+|||.+.+..++.++||||+||++|||++|+.||......+....      .... ..  ..+...
T Consensus       157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~------i~~~-~~--~~~~~~  226 (321)
T d1tkia_         157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNA-EY--TFDEEA  226 (321)
T ss_dssp             -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHT-CC--CCCHHH
T ss_pred             -CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHH------HHHC-CC--CCCHHH
T ss_conf             -7753212233222340210487778401130279999999828999999899999999------9838-99--988022


Q ss_pred             CCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             499995699999999986100079999997899999
Q 003659          697 AGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       697 ~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      .    ...+..+.+++.+||+.+|.+||++.|++++
T Consensus       227 ~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             3----6789999999999866996689099999639

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.52  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=204.0

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC---CCHHHHHHHHHHHHHH-CCCCCCEEEEEEEECCCCEEEEE
Q ss_conf             19864235754084699999936-9919999983889---9010999999999986-08997367899998149919999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR---SQQGLAEFQTEIEMLS-QFRHRHLVSLIGYCDEKNEMILI  535 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV  535 (805)
                      ++|...+.||+|+||+||+|+.. +++.||||++...   .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf             97556875000112799999998789999999999999975069997685306889478689993999431787779999
Q 003659          536 YEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       536 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~  615 (805)
                      |||+++|+|.+++....  .+++.++..++.|++.||+|||+   ++++||||||+|||++.++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEECCCCCHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf             75037980899864047--89999999999999999999986---89340347654044448996301555302323566


Q ss_pred             CCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf             87520002224565459432312899960358999999999993899999998122210999999983029863014821
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDPT  695 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  695 (805)
                        ....+...||+.|+|||++.+..++.++|||||||++|||+||+.||....+.+.....       ..+      .+ 
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~------~~-  220 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMD------NP-  220 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHC------CC-
T ss_pred             --CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HCC------CC-
T ss_conf             --53345457877768999982799883232011227898987388999998999999999-------718------99-


Q ss_pred             CCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHH-HHHH
Q ss_conf             24999956999999999861000799999978-9999
Q 003659          696 LAGKIRPDSLRKFGETAEKCLADFGVDRPSMG-DVLW  731 (805)
Q Consensus       696 l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~-evl~  731 (805)
                         .++...+..+.+++.+||+.+|.+||++. ++++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             ---8975679999999999654489878388999980

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.39  Aligned_cols=259  Identities=22%  Similarity=0.241  Sum_probs=199.4

Q ss_pred             CCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHH-----HHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEEC
Q ss_conf             235754084699999936-99199999838899010-----999999999986089973678999981499199999755
Q 003659          466 SWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQG-----LAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYM  539 (805)
Q Consensus       466 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~~  539 (805)
                      .++||+|+||+||+|+.+ +|+.||||++.......     .+.+.+|++++++++||||+++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf             63851272829999999999969999998420212456799999999999998679999868985422587402204553


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf             68750001127999999987899999999999999750699976853068894786899939994317877799998752
Q 003659          540 ENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQTH  619 (805)
Q Consensus       540 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~~  619 (805)
                      .++++.......  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++......  .
T Consensus        83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~  155 (299)
T d1ua2a_          83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--R  155 (299)
T ss_dssp             SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--C
T ss_pred             CCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC--C
T ss_conf             450776554126--677899999999999999988631---635503577625885377841146576100057875--5


Q ss_pred             EEECCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC---C
Q ss_conf             0002224565459432312-89996035899999999999389999999812221099999998302986301482---1
Q 003659          620 VSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQIIDP---T  695 (805)
Q Consensus       620 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~---~  695 (805)
                      ......||+.|+|||++.. ..++.++|||||||++|||+||++||....+.+.......................   .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf             43302047333639997267788805643630428999985969999999999999999851899725452100021344


Q ss_pred             -C--CCCC-----CHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             -2--4999-----9569999999998610007999999789999
Q 003659          696 -L--AGKI-----RPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       696 -l--~~~~-----~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                       .  ....     .......+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             30347898867856568999999999976389456908999967

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.80  Aligned_cols=253  Identities=20%  Similarity=0.311  Sum_probs=199.0

Q ss_pred             HCCCCCC-CEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHC-CCCCCEEEEEEEECC----CCEE
Q ss_conf             4198642-35754084699999936-991999998388990109999999999860-899736789999814----9919
Q 003659          460 TNNFDES-WVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQ-FRHRHLVSLIGYCDE----KNEM  532 (805)
Q Consensus       460 t~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~  532 (805)
                      .++|.+. ++||+|+||.||+|+.. +++.||||++...     ..+.+|++++.+ .+||||+++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf             148798107965454869999998899989999998974-----779999999998669999782989995034689789


Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC---CCCEEEEECCCC
Q ss_conf             99997556875000112799999998789999999999999975069997685306889478689---993999431787
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE---NFMAKVADFGLS  609 (805)
Q Consensus       533 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~---~~~~ki~DFGla  609 (805)
                      ++|||||++|+|.+++.......+++.++..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf             999977899849999986278775799999999999999999997---69864441002201135555663113545512


Q ss_pred             CCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             77999987520002224565459432312899960358999999999993899999998122210999999983029863
Q 003659          610 KTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       610 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      +......   ......||+.|+|||++.+..++.++|||||||++|||+||++||...........   .......+.  
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~--  233 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ--  233 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred             EECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH---HHHHHHCCC--
T ss_conf             3336888---64322677563792777489888888887645167788658899889887788999---999985388--


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             0148212499995699999999986100079999997899999
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                          ...........+..+.+++.+||+.+|.+||++.|++++
T Consensus       234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             ----888985434699999999999756996579099999709

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=339.10  Aligned_cols=251  Identities=22%  Similarity=0.279  Sum_probs=205.7

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCC---------HHHHHHHHHHHHHHCCC-CCCEEEEEEEECC
Q ss_conf             419864235754084699999936-991999998388990---------10999999999986089-9736789999814
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ---------QGLAEFQTEIEMLSQFR-HRHLVSLIGYCDE  528 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  528 (805)
                      .++|+..+.||+|+||+||+|+.. +++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf             99199999755687500011279999999878999999999999997506999768530688947868999399943178
Q 003659          529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       529 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGl  608 (805)
                      .+..++||||+++|+|.+++....  ++++.++..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCCEEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf             760599997689866899998659--99999999999999999999987---5994323462548986899838712403


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCHHHHCC------CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf             777999987520002224565459432312------89996035899999999999389999999812221099999998
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRR------QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW  682 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~  682 (805)
                      ++....   ....+...||..|+|||++.+      ..++.++||||+||++|||+||+.||....+.+....      .
T Consensus       157 a~~~~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~------i  227 (277)
T d1phka_         157 SCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------I  227 (277)
T ss_dssp             CEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------H
T ss_pred             EEECCC---CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHH------H
T ss_conf             167268---8721345246788898886053445678899233185656023103228889889999999999------9


Q ss_pred             HHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             3029863014821249999569999999998610007999999789999
Q 003659          683 QNKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       683 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      .. +..      ..........+..+.+++.+||+.+|.+||++.|+++
T Consensus       228 ~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MS-GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HH-TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH-CCC------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             81-898------8898543468999999999976589668919999973

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=335.49  Aligned_cols=266  Identities=21%  Similarity=0.284  Sum_probs=203.3

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf             19864235754084699999936-99199999838899--0109999999999860899736789999814991999997
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  537 (805)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....  ....+++.+|++++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99776517723768099999999999799999980222575899999999999986799838874453322432037886


Q ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             55687500011279999999878999999999999997506999768530688947868999399943178777999987
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~  617 (805)
                      |+.+ ++.+++.......+++..+..++.|++.||+|||+   ++|+||||||+|||++.+..+||+|||+++.....  
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--
T ss_pred             ECCC-CHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCC--
T ss_conf             2377-44555442025688889999999999999998652---88992135711401134676210357861343688--


Q ss_pred             CCEEECCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-CCC
Q ss_conf             52000222456545943231289-9960358999999999993899999998122210999999983029863014-821
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQII-DPT  695 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-d~~  695 (805)
                      ........||+.|+|||.+.... ++.++||||+||++|||++|+.||......+.............+....... .+.
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf             64100103652154112213665777422103333134279668799898899999999998328983331444222421


Q ss_pred             CCCC-----------CCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             2499-----------995699999999986100079999997899999
Q 003659          696 LAGK-----------IRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       696 l~~~-----------~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      ....           ..+.....+.+++.+||+.+|.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             243454322220444166789999999999763995579189999678

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=331.51  Aligned_cols=264  Identities=20%  Similarity=0.232  Sum_probs=205.5

Q ss_pred             CCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEEE
Q ss_conf             1986423575408469999993699199999838899--01099999999998608997367899998149919999975
Q 003659          461 NNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E~  538 (805)
                      ++|...++||+|+||.||+|+.++++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf             99634318722778189999968999999999812326858999999999999867998687660120467731589974


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf             56875000112799999998789999999999999975069997685306889478689993999431787779999875
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQT  618 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~~  618 (805)
                      +.++.+..+....  ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||++.......  
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (286)
T ss_dssp             CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             EHHHHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC--
T ss_conf             0045678998604--775144568999999999998605---748826787750568689978732366430114676--


Q ss_pred             CEEECCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC---CC---
Q ss_conf             20002224565459432312-899960358999999999993899999998122210999999983029863---01---
Q 003659          619 HVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD---QI---  691 (805)
Q Consensus       619 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~---  691 (805)
                      .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+..................   ..   
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             54101024311013788717888884100211175899997797998988989999999986389971104212333221


Q ss_pred             ------CCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             ------4821249999569999999998610007999999789999
Q 003659          692 ------IDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       692 ------~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                            ..+.............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4333335676466651258999999999986689668909999856

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=329.95  Aligned_cols=266  Identities=22%  Similarity=0.286  Sum_probs=198.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-C-CCEEEEEECCCC--CCHHHHHHHHHHHHHHCC---CCCCEEEEEEEEC-----
Q ss_conf             419864235754084699999936-9-919999983889--901099999999998608---9973678999981-----
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-D-GTKVAVKRGNPR--SQQGLAEFQTEIEMLSQF---RHRHLVSLIGYCD-----  527 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~-----  527 (805)
                      .++|+..+.||+|+||.||+|+.. + ++.||||++...  .......+.+|+.+++.+   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf             58979888992155869999999888998999999802324516799999999999987425898802366322146666


Q ss_pred             CCCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECC
Q ss_conf             49919999975568750001127999999987899999999999999750699976853068894786899939994317
Q 003659          528 EKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFG  607 (805)
Q Consensus       528 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFG  607 (805)
                      .....++++|++.++.+...... ....+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCCEEEEEEEECCCCCHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECCHH
T ss_conf             67469999974058714444430-37899989999999999999999975---889835798627898589975421000


Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             87779999875200022245654594323128999603589999999999938999999981222109999999830298
Q 003659          608 LSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       608 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      +++...   .........||+.|+|||++.+..++.++||||+||++|||+||++||....+.+................
T Consensus       162 ~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         162 LARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             HHHHHC---CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHC
T ss_conf             101100---23457776548511483100179888111000328999999878799899898999999998407996110


Q ss_pred             ------CCCCCC----CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             ------630148----212499995699999999986100079999997899999
Q 003659          688 ------LDQIID----PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       688 ------~~~~~d----~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                            ......    ......+.......+.+++.+||+.||.+|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             5321111033302234564544044589999999999874896679189999669

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=325.30  Aligned_cols=261  Identities=22%  Similarity=0.247  Sum_probs=195.1

Q ss_pred             CCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC------CCEEEE
Q ss_conf             9864235754084699999936-991999998388990109999999999860899736789999814------991999
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE------KNEMIL  534 (805)
Q Consensus       462 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~~l  534 (805)
                      .|...++||+|+||+||+|+.. +++.||||++......    ..+|+++|++++|+||+++++++..      ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf             767516982176839999999999979999998816068----9999999986689898738789974476577318999


Q ss_pred             EEEECCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf             9975568750001127-9999999878999999999999997506999768530688947868999-3999431787779
Q 003659          535 IYEYMENGTLKGHLYG-SGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTG  612 (805)
Q Consensus       535 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~ki~DFGla~~~  612 (805)
                      ||||++++.+...... .....+++.++..++.|++.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf             98416886078888631036899999999999999999999986---687645788603787358971167336605440


Q ss_pred             CCCCCCCEEECCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH---------HHH
Q ss_conf             99987520002224565459432312-89996035899999999999389999999812221099999---------998
Q 003659          613 PEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA---------MKW  682 (805)
Q Consensus       613 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~---------~~~  682 (805)
                      ...   .......|+..|+|||.+.+ ..++.++||||+||++|||++|++||......+........         ...
T Consensus       174 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTT---SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             477---65320025555568277640468882100024652778550287998987999999999997489817765430


Q ss_pred             H---HCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             3---0298630148212499995699999999986100079999997899999
Q 003659          683 Q---NKGQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       683 ~---~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      .   ........................+.+++.+||+.||.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             62101103554456744443156899999999999765895579299999669

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=322.56  Aligned_cols=267  Identities=22%  Similarity=0.291  Sum_probs=201.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECC--------
Q ss_conf             419864235754084699999936-9919999983889--90109999999999860899736789999814--------
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE--------  528 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------  528 (805)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++...  .......+.+|+++|++++|+|++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf             27988999972274829999999899979999998422246378999999999999835999660676540246544445


Q ss_pred             CCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCC
Q ss_conf             99199999755687500011279999999878999999999999997506999768530688947868999399943178
Q 003659          529 KNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGL  608 (805)
Q Consensus       529 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGl  608 (805)
                      ....++||||+.++.+......  ...++...+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEECCCCCCCCHHHHC--CCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf             7638999853578741012220--3443308999999999999988522---9988567672220366899687631350


Q ss_pred             CCCCCCCCC--CCEEECCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHC
Q ss_conf             777999987--5200022245654594323128-9996035899999999999389999999812221099999998302
Q 003659          609 SKTGPEIDQ--THVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNK  685 (805)
Q Consensus       609 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  685 (805)
                      ++.......  ........||+.|+|||++.+. .++.++||||+||++|||++|++||....+.+..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf             02235544432113566024978742899707999891787006786466174487998998999999999984189982


Q ss_pred             CCCCCCCCCCC--------CCCCC-HH------HHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             98630148212--------49999-56------9999999998610007999999789999
Q 003659          686 GQLDQIIDPTL--------AGKIR-PD------SLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       686 ~~~~~~~d~~l--------~~~~~-~~------~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      ...........        ..... .+      ....+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5534432034443320133445550334044459989999999987389658909999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=332.52  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=194.0

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCC------HHHHHHHHHHHHHHCCC--CCCEEEEEEEECCCC
Q ss_conf             419864235754084699999936-991999998388990------10999999999986089--973678999981499
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQ------QGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEKN  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~  530 (805)
                      .++|...++||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC-CCCEEEEECCC
Q ss_conf             19999975568-75000112799999998789999999999999975069997685306889478689-99399943178
Q 003659          531 EMILIYEYMEN-GTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-NFMAKVADFGL  608 (805)
Q Consensus       531 ~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-~~~~ki~DFGl  608 (805)
                      ..++||||+.+ +++.+++...  ..+++.++..++.|++.||+|||+   ++|+||||||+|||++. ++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEEECCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCCC
T ss_conf             6899998336862289998615--899999999999999999999987---79755667611147744788489775465


Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             777999987520002224565459432312899-9603589999999999938999999981222109999999830298
Q 003659          609 SKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQL-TEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       609 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      ++....    ...+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....            ..+ +.
T Consensus       158 a~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~-~~  220 (273)
T d1xwsa_         158 GALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIR-GQ  220 (273)
T ss_dssp             CEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH-CC
T ss_pred             CEECCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH------------HHH-CC
T ss_conf             353244----4556656587747999984899788653325540345367568899887367------------761-54


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             63014821249999569999999998610007999999789999
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                            .    .++...+..+.+++.+||+.+|.+|||+.|+++
T Consensus       221 ------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             ------4----778779999999999976089758939999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.76  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=200.2

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC-CHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC----EEE
Q ss_conf             419864235754084699999936-99199999838899-010999999999986089973678999981499----199
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS-QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN----EMI  533 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  533 (805)
                      +.+|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|+++|++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             89859978994064809999999999949999998031095899999999999997689898858889950564554149


Q ss_pred             EEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             99975568750001127999999987899999999999999750699976853068894786899939994317877799
Q 003659          534 LIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       534 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~  613 (805)
                      ++++++.+|+|.+++...   .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEECCCCHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECC
T ss_conf             999962598656644058---99999999999999999999997---898677787643788799977875457056504


Q ss_pred             CCCC-CCEEECCCCCCCCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC-
Q ss_conf             9987-52000222456545943231-28999603589999999999938999999981222109999999830298630-
Q 003659          614 EIDQ-THVSTAVKGSFGYLDPEYFR-RQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ-  690 (805)
Q Consensus       614 ~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-  690 (805)
                      .... ........||+.|+|||++. ...++.++||||+||++|||++|+.||......+................... 
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf             77764101011026520003878604788874101004670133776697997888889999987652069975664234


Q ss_pred             ---------CCCCCCCC----CCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             ---------14821249----9995699999999986100079999997899999
Q 003659          691 ---------IIDPTLAG----KIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       691 ---------~~d~~l~~----~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                               ...+....    ...+....++.+++.+||+.||.+||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             3322220244677557787778378999999999999764895679089998619

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=318.59  Aligned_cols=264  Identities=19%  Similarity=0.224  Sum_probs=201.1

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCEEE-EEEEECCCCEEEEEEEE
Q ss_conf             19864235754084699999936-99199999838899010999999999986089973678-99998149919999975
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVS-LIGYCDEKNEMILIYEY  538 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lV~E~  538 (805)
                      ++|...+.||+|+||.||+|+.. +++.||||.+......  .++..|+++++.++|++++. +.++..+....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf             8899968985078809999999889989999997210058--88999999999703899601799999519877899987


Q ss_pred             CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEEC---CCCCEEEEECCCCCCCCCC
Q ss_conf             5687500011279999999878999999999999997506999768530688947868---9993999431787779999
Q 003659          539 MENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLD---ENFMAKVADFGLSKTGPEI  615 (805)
Q Consensus       539 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~---~~~~~ki~DFGla~~~~~~  615 (805)
                      +. ++|.+.+.... ..+++..++.++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+++.....
T Consensus        85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             CC-CCHHHHHHHCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCC
T ss_conf             38-71333244306-887689999999999999999997---99442667876606433577761565046751342554


Q ss_pred             CCC-----CEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf             875-----200022245654594323128999603589999999999938999999981222109999999830298630
Q 003659          616 DQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLDQ  690 (805)
Q Consensus       616 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  690 (805)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........................  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred             CCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH--
T ss_conf             455410001357767873532999991899898321886177899998498766553057799999985235678983--


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             14821249999569999999998610007999999789999999999866
Q 003659          691 IIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       691 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~  740 (805)
                         +.+.    ..++..+.+++.+|++.+|.+||++.++.+.|+.+....
T Consensus       238 ---~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         238 ---EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             ---HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ---HHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf             ---5753----478899999999984399557919999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=323.96  Aligned_cols=260  Identities=20%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCC------
Q ss_conf             419864235754084699999936-9919999983889--9010999999999986089973678999981499------
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKN------  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  530 (805)
                      .++|...+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+++|++++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259699999999999998668987547999863576555541


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             19999975568750001127999999987899999999999999750699976853068894786899939994317877
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~  610 (805)
                      .+++||||+ +.+|......   ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEECC-CCCHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf             599998405-5218999874---022699999999999999999873---787645668511112100122113431022


Q ss_pred             CCCCCCCCCEEECCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH-----HH
Q ss_conf             7999987520002224565459432312-89996035899999999999389999999812221099999998-----30
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRR-QQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-----QN  684 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~  684 (805)
                      ....     ..+...||..|+|||++.+ ..++.++||||+||++|||++|++||......+...........     ..
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             CCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf             0687-----63102455333588998178789965010300389999997869988897689999998503788488886


Q ss_pred             CC----------CCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             29----------8630148212499995699999999986100079999997899999
Q 003659          685 KG----------QLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       685 ~~----------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                      ..          .+.......+. .........+.+++.+||+.+|.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             53000344331157866655667-7556899999999999772995579299999639

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=316.14  Aligned_cols=265  Identities=17%  Similarity=0.168  Sum_probs=207.7

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCC-CCEEEEEEEECCCCEEEEEEE
Q ss_conf             419864235754084699999936-991999998388990109999999999860899-736789999814991999997
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E  537 (805)
                      .++|.+.+.||+|+||.||+|+.. +++.||||.+.....  ...+.+|++.+..++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf             9806997998417882999999988997999999750258--29999999999996489998779999601881179999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECC-----CCCEEEEECCCCCCC
Q ss_conf             556875000112799999998789999999999999975069997685306889478689-----993999431787779
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDE-----NFMAKVADFGLSKTG  612 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~-----~~~~ki~DFGla~~~  612 (805)
                      |+ +++|.+++.... ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.     ++.+||+|||+++..
T Consensus        82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EC-CCCHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf             64-888799997520-311068999999999999999997---7966266771315234754344795687236605771


Q ss_pred             CCCCCC-----CEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCC
Q ss_conf             999875-----200022245654594323128999603589999999999938999999981222109999999830298
Q 003659          613 PEIDQT-----HVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQ  687 (805)
Q Consensus       613 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  687 (805)
                      ......     .......||+.|+|||++.+..++.++||||||+++|||+||+.||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf             46766541110246762775102679896488888699989831999999869876788530219999999970567999


Q ss_pred             CCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf             63014821249999569999999998610007999999789999999999866
Q 003659          688 LDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQ  740 (805)
Q Consensus       688 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~L~~~~~~~  740 (805)
                      .     +.+..    ..+..+.+++..|+..+|++||+++.+.+.|+.+++..
T Consensus       237 ~-----~~l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         237 L-----RELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             H-----HHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-----HHHCC----CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf             5-----89657----99899999999984399300859999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=310.09  Aligned_cols=257  Identities=17%  Similarity=0.210  Sum_probs=196.7

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCC-CCCEEEEEEEEC--CCCEEEEEE
Q ss_conf             19864235754084699999936-99199999838899010999999999986089-973678999981--499199999
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCD--EKNEMILIY  536 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~--~~~~~~lV~  536 (805)
                      ++|...++||+|+||+||+|+.. +++.||+|++....   .+.+.+|+++|..++ ||||+++++++.  .....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf             67189789831748199999988999799999988899---999999999998515799876799999816877126888


Q ss_pred             EECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC-CEEEEECCCCCCCCCC
Q ss_conf             755687500011279999999878999999999999997506999768530688947868999-3999431787779999
Q 003659          537 EYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF-MAKVADFGLSKTGPEI  615 (805)
Q Consensus       537 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~-~~ki~DFGla~~~~~~  615 (805)
                      ||+.+++|....     ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+. .+||+|||+++.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EECCCCCHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCC
T ss_conf             631798589974-----689999999999999999988764---334434564412377489983664156542664688


Q ss_pred             CCCCEEECCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHH------HHHHHHCCC
Q ss_conf             875200022245654594323128-99960358999999999993899999998122-2109999------999830298
Q 003659          616 DQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPRE-MVNLAEW------AMKWQNKGQ  687 (805)
Q Consensus       616 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvil~elltG~~p~~~~~~~~-~~~l~~~------~~~~~~~~~  687 (805)
                         .......||..|+|||.+.+. .++.++||||+||+++||++|+.||....... .......      ...+.....
T Consensus       184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             ---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf             ---74443224864247610268888884523233545558760488999887601899999999878841555554225


Q ss_pred             C------CCCC--------CCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             6------3014--------821249999569999999998610007999999789999
Q 003659          688 L------DQII--------DPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       688 ~------~~~~--------d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      .      ....        ...............+.+++.+||+.+|.+|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4447430000033343311211552112448999999999986699568908999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=310.98  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=203.5

Q ss_pred             CCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf             19864235754084699999936-9919999983889--90109999999999860899736789999814991999997
Q 003659          461 NNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E  537 (805)
                      ++|...+.||+|+||+||+|+.. +++.||||++...  .......+.+|+.+++.++|+||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf             99786269712868199999999999699999980321786899999999999985675788821354444431158863


Q ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf             55687500011279999999878999999999999997506999768530688947868999399943178777999987
Q 003659          538 YMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQ  617 (805)
Q Consensus       538 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~~~~~  617 (805)
                      ++.+++|..++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||++.+..+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ECCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCC
T ss_conf             02332221121235--654036789999999999877433---9986001467612113378266520460110468875


Q ss_pred             CCEEECCCCCCCCCCHHHHCCCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHHHHHHCCCC---CCCC
Q ss_conf             52000222456545943231289-99603589999999999938999999981-2221099999998302986---3014
Q 003659          618 THVSTAVKGSFGYLDPEYFRRQQ-LTEKSDVYSFGVVLFEVLCARPVIDPTLP-REMVNLAEWAMKWQNKGQL---DQII  692 (805)
Q Consensus       618 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDV~SlGvil~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~---~~~~  692 (805)
                        ......++..|+|||.+.... ++.++||||+||++|||++|+.||..... .+.............+...   ....
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf             --100103443101466750698888044402654188998518999988999999999998611899735513443222


Q ss_pred             C---------CCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHH
Q ss_conf             8---------21249999569999999998610007999999789999
Q 003659          693 D---------PTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLW  731 (805)
Q Consensus       693 d---------~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~  731 (805)
                      +         ..............+.+++.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             113344454431043306568999999999986499668909999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=315.92  Aligned_cols=262  Identities=19%  Similarity=0.227  Sum_probs=202.2

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCC--CCHHHHHHHHHHHHHHCCCCCCEEEEEEEEC------CCC
Q ss_conf             419864235754084699999936-9919999983889--9010999999999986089973678999981------499
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPR--SQQGLAEFQTEIEMLSQFRHRHLVSLIGYCD------EKN  530 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~------~~~  530 (805)
                      .++|...++||+|+||+||+|... +|+.||||++...  .......+.+|+.++++++||||+++++++.      ...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             37759988962175859999999999989999998823369799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCC
Q ss_conf             19999975568750001127999999987899999999999999750699976853068894786899939994317877
Q 003659          531 EMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSK  610 (805)
Q Consensus       531 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~  610 (805)
                      .+++||||+.++.+. .+.    ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||+++
T Consensus        96 ~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEEEECCCHHHHH-HHH----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf             269998414467787-650----389999999999999999988652---211245677632113654431320102321


Q ss_pred             CCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH-----------
Q ss_conf             799998752000222456545943231289996035899999999999389999999812221099999-----------
Q 003659          611 TGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWA-----------  679 (805)
Q Consensus       611 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~-----------  679 (805)
                      ....   ....+...||..|+|||++.+..++.++||||+||+++||++|++||...............           
T Consensus       168 ~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             CCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             1466---6553322146555581331477778774333566257898659899888977889999997205898799987


Q ss_pred             -----HHHHHC-CCC-----CCCCCCCCCCCC---CHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             -----998302-986-----301482124999---95699999999986100079999997899999
Q 003659          680 -----MKWQNK-GQL-----DQIIDPTLAGKI---RPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       680 -----~~~~~~-~~~-----~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                           ...... ...     ............   .......+.+++.+||+.+|++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             6566777764175435666421264333543210133379999999999876994579089999669

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=318.19  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=202.0

Q ss_pred             CCCCCCCEEEEECCEEEEEEEE---C-CCCEEEEEECCCCC----CHHHHHHHHHHHHHHCCCC-CCEEEEEEEECCCCE
Q ss_conf             1986423575408469999993---6-99199999838899----0109999999999860899-736789999814991
Q 003659          461 NNFDESWVIGIGGFGKVYKGEL---N-DGTKVAVKRGNPRS----QQGLAEFQTEIEMLSQFRH-RHLVSLIGYCDEKNE  531 (805)
Q Consensus       461 ~~f~~~~~LG~G~fg~Vy~~~~---~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~  531 (805)
                      ++|+..+.||+|+||.||+|+.   + +|+.||+|.+....    ....+.+.+|++++++++| +||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             99999755687500011279999999878999999999999997506999768530688947868999399943178777
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      .++++||+.+|+|.+++....  .+.......++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEEEEECCCCCHHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf             001231234117999987304--54378888889999999988514---9989654773201246999888741320222


Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHCCC--CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCC
Q ss_conf             9999875200022245654594323128--99960358999999999993899999998122210999999983029863
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQ--QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQNKGQLD  689 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  689 (805)
                      ... ..........|++.|++||.+.+.  .++.++|||||||+||||++|+.||......+......  ......    
T Consensus       179 ~~~-~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~----  251 (322)
T d1vzoa_         179 FVA-DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS----  251 (322)
T ss_dssp             CCG-GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC----
T ss_pred             HCC-CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--HHCCCC----
T ss_conf             034-4443221222333331068760577688713251777799999976899988887777999999--833568----


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCC-----HHHHHH
Q ss_conf             014821249999569999999998610007999999-----789999
Q 003659          690 QIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPS-----MGDVLW  731 (805)
Q Consensus       690 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs-----~~evl~  731 (805)
                             ...++...+..+.+++.+||+.+|.+||+     ++|+++
T Consensus       252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             -------9988654799999999997445898819997450999974

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.77  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=199.3

Q ss_pred             HCCCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCC--CHHHHHHHHHHHHHHCCCCCCEEEEEEEECC-----CCE
Q ss_conf             419864235754084699999936-99199999838899--0109999999999860899736789999814-----991
Q 003659          460 TNNFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRS--QQGLAEFQTEIEMLSQFRHRHLVSLIGYCDE-----KNE  531 (805)
Q Consensus       460 t~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~  531 (805)
                      .++|...+.||+|+||+||+|+.. +|+.||||++....  ....+.+.+|+++|++++|+|++++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf             98718888983178839999999999979999998820028689999999999998668987425999996346456686


Q ss_pred             EEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             99999755687500011279999999878999999999999997506999768530688947868999399943178777
Q 003659          532 MILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       532 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      .+++++++.+|+|.+++...   .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEEEEEEECCCCHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCC
T ss_conf             49999962588623200224---53099999999999999999973---8876516677633455432200132100012


Q ss_pred             CCCCCCCCEEECCCCCCCCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHH-----HHC
Q ss_conf             9999875200022245654594323128-9996035899999999999389999999812221099999998-----302
Q 003659          612 GPEIDQTHVSTAVKGSFGYLDPEYFRRQ-QLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKW-----QNK  685 (805)
Q Consensus       612 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~~  685 (805)
                      ...     ......|+..|+|||.+.+. .++.++||||+||++|||++|++||..................     ...
T Consensus       171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             CCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             575-----444434543555835533775678551243205899999768899788988999999997307997577320


Q ss_pred             ----------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHHHHH
Q ss_conf             ----------98630148212499995699999999986100079999997899999
Q 003659          686 ----------GQLDQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWN  732 (805)
Q Consensus       686 ----------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~evl~~  732 (805)
                                ..........+.. ........+.+++.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHCCCCCCCCHHH-HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             01024454443035578755566-267899999999999775883459389998559

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-45  Score=274.36  Aligned_cols=262  Identities=19%  Similarity=0.206  Sum_probs=192.2

Q ss_pred             CCCCCCEEEEECCEEEEEEEEC-CCCEEEEEECCCCCCHHHHHHHHHHHHHHCCC-----------CCCEEEEEEEECC-
Q ss_conf             9864235754084699999936-99199999838899010999999999986089-----------9736789999814-
Q 003659          462 NFDESWVIGIGGFGKVYKGELN-DGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-----------HRHLVSLIGYCDE-  528 (805)
Q Consensus       462 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~-  528 (805)
                      +|...++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|++++++++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf             5799899750778189999999999799999983431-336899999999998401455555422767647899876312


Q ss_pred             -CCEEEEEEEECCCCCC-CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCC------C
Q ss_conf             -9919999975568750-0011279999999878999999999999997506999768530688947868999------3
Q 003659          529 -KNEMILIYEYMENGTL-KGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENF------M  600 (805)
Q Consensus       529 -~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~------~  600 (805)
                       ....+++++++..+.. ...........+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECCCCCCCCCE
T ss_conf             565202343200035420000012234678689999999999999888764--058646567705705630576564430


Q ss_pred             EEEEECCCCCCCCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHH
Q ss_conf             9994317877799998752000222456545943231289996035899999999999389999999812221----099
Q 003659          601 AKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMV----NLA  676 (805)
Q Consensus       601 ~ki~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV~SlGvil~elltG~~p~~~~~~~~~~----~l~  676 (805)
                      +|++|||.+.....     ......||+.|+|||++....++.++||||+||+++||++|+.||.........    .+.
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             EEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHH
T ss_conf             56753144212344-----5422366521057132146677764320123789999987889989875543210268999


Q ss_pred             HHHHHHH-----------------HCCCCCCCCCC----------CCCCCCCHHHHHHHHHHHHHCHHCCCCCCCCHHHH
Q ss_conf             9999983-----------------02986301482----------12499995699999999986100079999997899
Q 003659          677 EWAMKWQ-----------------NKGQLDQIIDP----------TLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDV  729 (805)
Q Consensus       677 ~~~~~~~-----------------~~~~~~~~~d~----------~l~~~~~~~~~~~l~~li~~Cl~~~p~~RPs~~ev  729 (805)
                      .......                 ........+..          .............+.+++.+||+.||.+|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf             99998379987886245322000132012202432357764442100015674358999999999877994579089999


Q ss_pred             HH
Q ss_conf             99
Q 003659          730 LW  731 (805)
Q Consensus       730 l~  731 (805)
                      ++
T Consensus       326 L~  327 (362)
T d1q8ya_         326 VN  327 (362)
T ss_dssp             HT
T ss_pred             HC
T ss_conf             66

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=6.1e-26  Score=164.16  Aligned_cols=164  Identities=15%  Similarity=0.141  Sum_probs=120.9

Q ss_pred             CCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCC------------------HHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf             64235754084699999936991999998388990------------------109999999999860899736789999
Q 003659          464 DESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQ------------------QGLAEFQTEIEMLSQFRHRHLVSLIGY  525 (805)
Q Consensus       464 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~  525 (805)
                      .+.++||+|+||.||+|...+|+.||||.+.....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf             22778024856599999979999999999860443466655656300088899999977899999998169991449986


Q ss_pred             ECCCCEEEEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEECCCCCCEEECCCCCEEEEE
Q ss_conf             81499199999755687500011279999999878999999999999997506999768530688947868999399943
Q 003659          526 CDEKNEMILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHTGYAKAVIHRDVKSANILLDENFMAKVAD  605 (805)
Q Consensus       526 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~Dikp~NIll~~~~~~ki~D  605 (805)
                      ..    .+++|||++++.+.+         ++......++.|++++|+|||+   .+++||||||+|||++++ .++|+|
T Consensus        83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred             CC----CEEEEEEECCCCCCC---------HHHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEECC-CEEEEE
T ss_conf             28----889999504565420---------0157899999999999999826---888983689036114289-899987


Q ss_pred             CCCCCCCCCCCCCCEEECCCCCCCCCC------HHHHCCCCCCCHHHHHHHHHHHH
Q ss_conf             178777999987520002224565459------43231289996035899999999
Q 003659          606 FGLSKTGPEIDQTHVSTAVKGSFGYLD------PEYFRRQQLTEKSDVYSFGVVLF  655 (805)
Q Consensus       606 FGla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~ksDV~SlGvil~  655 (805)
                      ||+|....+....          .|+.      .+.+ .+.++.++|+||..--++
T Consensus       146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         146 FPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred             CCCCCCCCCCCCH----------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf             7884308998709----------99987799999997-578998446899999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.98  E-value=1.8e-09  Score=69.07  Aligned_cols=150  Identities=13%  Similarity=0.089  Sum_probs=97.9

Q ss_pred             HHHHHHHCCCCCCCEEEEECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCC-CCCEEEEEEEECCCCEE
Q ss_conf             87999841986423575408469999993699199999838899010999999999986089-97367899998149919
Q 003659          454 VAVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR-HRHLVSLIGYCDEKNEM  532 (805)
Q Consensus       454 ~~l~~at~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~  532 (805)
                      .++...-..|...+..+-+....||+.... +..+.+|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf             999975135279976789987718999908-9869999848876532556999999999876069987289997508964


Q ss_pred             EEEEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q ss_conf             999975568750001127999999987899999999999999750-----------------------------------
Q 003659          533 ILIYEYMENGTLKGHLYGSGLPSLSWKQRLEICIGSARGLHYLHT-----------------------------------  577 (805)
Q Consensus       533 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----------------------------------  577 (805)
                      ++||+++++.++.+.....       .....++.++++.++.||+                                   
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEECCCCCCCCCCCCC-------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf             9999860433435433440-------269999998999999985568421435764465655577899877655554303


Q ss_pred             ------------------C---CCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             ------------------6---999768530688947868999399943178777
Q 003659          578 ------------------G---YAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       578 ------------------~---~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                                        .   ....++|+|+.+.|||++++...-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf             3232005799999999844986781789860047642364996599960231441

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.61  E-value=6.1e-07  Score=54.45  Aligned_cols=131  Identities=20%  Similarity=0.162  Sum_probs=85.5

Q ss_pred             EEEEEC-CEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCC--CCCEEEEEEEECCCCEEEEEEEECCCCCC
Q ss_conf             575408-469999993699199999838899010999999999986089--97367899998149919999975568750
Q 003659          468 VIGIGG-FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR--HRHLVSLIGYCDEKNEMILIYEYMENGTL  544 (805)
Q Consensus       468 ~LG~G~-fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~E~~~~gsL  544 (805)
                      .+..|. ...||+....++..+++|........   .+..|...++.+.  .-.+.++++++.+.+..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf             767865477589999389878999958966776---89999999999986599988613222456615999874413554


Q ss_pred             CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q ss_conf             00112799999998789999999999999975------------------------------------------------
Q 003659          545 KGHLYGSGLPSLSWKQRLEICIGSARGLHYLH------------------------------------------------  576 (805)
Q Consensus       545 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------------------------  576 (805)
                      .+..       +.   ....+.++++.|+-||                                                
T Consensus        94 ~~~~-------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          94 LSSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TTSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             CCCC-------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHH
T ss_conf             3221-------26---8999999999999873688544887554124688999999875411011340112137999999


Q ss_pred             ---C----CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             ---0----6999768530688947868999399943178777
Q 003659          577 ---T----GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       577 ---~----~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                         .    .....++|+|+.+.|||++++..+-|.||+.+..
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf             998718765795678678887635773796589998533265

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.17  E-value=3.6e-06  Score=49.99  Aligned_cols=142  Identities=17%  Similarity=0.115  Sum_probs=79.3

Q ss_pred             CCEEEEECCEEEEEEEECC-CCEEEEEECCCC-------CCHHHHHHHHHHHHHHCCC---CCCEEEEEEEECCCCEEEE
Q ss_conf             2357540846999999369-919999983889-------9010999999999986089---9736789999814991999
Q 003659          466 SWVIGIGGFGKVYKGELND-GTKVAVKRGNPR-------SQQGLAEFQTEIEMLSQFR---HRHLVSLIGYCDEKNEMIL  534 (805)
Q Consensus       466 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l  534 (805)
                      .+.||.|....||+....+ ++.+++|.-...       ..........|.+.|..+.   ...+.+++.++.+  ..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCC--CCEE
T ss_conf             99807985276899995799848999617713034677788877899999999998650579885528998598--8779


Q ss_pred             EEEECCCCCCC-CCCCCCCCCCCCHHHHHHHHHHHHH-------------------------------------------
Q ss_conf             99755687500-0112799999998789999999999-------------------------------------------
Q 003659          535 IYEYMENGTLK-GHLYGSGLPSLSWKQRLEICIGSAR-------------------------------------------  570 (805)
Q Consensus       535 V~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~-------------------------------------------  570 (805)
                      |||++++..+. ..+......   ......++..+++                                           
T Consensus       109 vmE~L~~~~~~~~~l~~~~~~---~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~  185 (392)
T d2pula1         109 VMEDLSHLKIARKGLIEGENY---PHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDH  185 (392)
T ss_dssp             EECCCTTSEEHHHHHHHTCCC---TTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTC
T ss_pred             EEECCCCCCCCHHHHCCCCHH---HHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHH
T ss_conf             871357765302220154212---89999999999999987350334421110123344657888777764010478898


Q ss_pred             ------------------------HHHHHH---CCCCCCEEEECCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf             ------------------------999975---0699976853068894786899939994317877799
Q 003659          571 ------------------------GLHYLH---TGYAKAVIHRDVKSANILLDENFMAKVADFGLSKTGP  613 (805)
Q Consensus       571 ------------------------gL~yLH---~~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~~~  613 (805)
                                              ....|.   ......++|+|+.+.|||++++ .++|.||..+...+
T Consensus       186 ~~~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~G~  254 (392)
T d2pula1         186 DTNDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEH-ETKVIDPEFAFYGP  254 (392)
T ss_dssp             TTCCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSS-CEEECCCTTCEEEC
T ss_pred             HHHHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCC-CEEEECHHHCCCCC
T ss_conf             8741065455778765520789999999874323688600335776784667599-30895226522287

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.83  E-value=1.6e-05  Score=46.23  Aligned_cols=136  Identities=13%  Similarity=0.182  Sum_probs=76.6

Q ss_pred             CEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCE--EEEEE-----EECCCCEEEEEEEECCCCCCCC
Q ss_conf             4699999936991999998388990109999999999860899736--78999-----9814991999997556875000
Q 003659          474 FGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL--VSLIG-----YCDEKNEMILIYEYMENGTLKG  546 (805)
Q Consensus       474 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~  546 (805)
                      --.||++...+|..+++|....... ..+++..|...+..|....+  +..+.     ........+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             CCEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf             2026999838999799998478778-899999999999999855998787520689805665347999986527768899


Q ss_pred             C----C----------C----CC---CCCCCCHH-------------------H---HHHHHHHHHHHHHHH-HCCCCCC
Q ss_conf             1----1----------2----79---99999987-------------------8---999999999999997-5069997
Q 003659          547 H----L----------Y----GS---GLPSLSWK-------------------Q---RLEICIGSARGLHYL-HTGYAKA  582 (805)
Q Consensus       547 ~----l----------~----~~---~~~~l~~~-------------------~---~~~i~~~ia~gL~yL-H~~~~~~  582 (805)
                      .    +          +    ..   ....+++.                   .   ....+..+...+.-+ ......+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf             99999999899999988630357865567789788766568999874769988989999999999999998454568712


Q ss_pred             EEEECCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf             685306889478689993999431787779
Q 003659          583 VIHRDVKSANILLDENFMAKVADFGLSKTG  612 (805)
Q Consensus       583 iiH~Dikp~NIll~~~~~~ki~DFGla~~~  612 (805)
                      +||+|+.+.|||++++  ..+.||+-+...
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~g  221 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARNG  221 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred             EECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf             0247888042878389--358865201468

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.81  E-value=4.6e-05  Score=43.59  Aligned_cols=158  Identities=11%  Similarity=0.042  Sum_probs=81.1

Q ss_pred             CCHHHHHHHHCCCCCCCEEE-----EECCEEEEEEEECCCCEEEEEECCCCCCHHHHHHHHHHHHHHCCCC-----CCEE
Q ss_conf             47787999841986423575-----4084699999936991999998388990109999999999860899-----7367
Q 003659          451 FPFVAVQEATNNFDESWVIG-----IGGFGKVYKGELNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRH-----RHLV  520 (805)
Q Consensus       451 ~~~~~l~~at~~f~~~~~LG-----~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-----~niv  520 (805)
                      .+..+++....+|...++..     .|---+.|+.+..+|+ +++|+.......  ++...|++++..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf             89999999998679998568523788852673899978972-899980789998--899999999875430255545564


Q ss_pred             EEE-E--EECCCCEEEEEEEECCCCCCCCCCC------------------CCC----CCC-----------------CCH
Q ss_conf             899-9--9814991999997556875000112------------------799----999-----------------998
Q 003659          521 SLI-G--YCDEKNEMILIYEYMENGTLKGHLY------------------GSG----LPS-----------------LSW  558 (805)
Q Consensus       521 ~l~-g--~~~~~~~~~lV~E~~~~gsL~~~l~------------------~~~----~~~-----------------l~~  558 (805)
                      ... |  +.........++.+..+......-.                  ...    ...                 ...
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf             10489762134125502453114655333204678888899876454443202453101110120024567777653114


Q ss_pred             HHHHHHHHHHHHHHHHHHC-CCCCCEEEECCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf             7899999999999999750-6999768530688947868999399943178777
Q 003659          559 KQRLEICIGSARGLHYLHT-GYAKAVIHRDVKSANILLDENFMAKVADFGLSKT  611 (805)
Q Consensus       559 ~~~~~i~~~ia~gL~yLH~-~~~~~iiH~Dikp~NIll~~~~~~ki~DFGla~~  611 (805)
                      ......+......+...+. ..+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf             127999999987642048554545033378636564020454126742221236

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.78  E-value=0.00014  Score=40.92  Aligned_cols=73  Identities=19%  Similarity=0.188  Sum_probs=47.5

Q ss_pred             CEEEEECCEEEEEEEECCC--------CEEEEEECCCCCCHHHHHHHHHHHHHHCCCCCCE-EEEEEEECCCCEEEEEEE
Q ss_conf             3575408469999993699--------1999998388990109999999999860899736-789999814991999997
Q 003659          467 WVIGIGGFGKVYKGELNDG--------TKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHL-VSLIGYCDEKNEMILIYE  537 (805)
Q Consensus       467 ~~LG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E  537 (805)
                      +.|+.|-.-.+|+....++        ..|.++.... ... .....+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CCH-HHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf             9917853343489996887754457898179996599-611-65899999999999757999808998189----56999


Q ss_pred             ECCCCCCC
Q ss_conf             55687500
Q 003659          538 YMENGTLK  545 (805)
Q Consensus       538 ~~~~gsL~  545 (805)
                      |+++.+|.
T Consensus       122 fi~g~~l~  129 (395)
T d1nw1a_         122 YIPSRPLS  129 (395)
T ss_dssp             CCCEEECC
T ss_pred             EECCCCCC
T ss_conf             73455488

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=96.50  E-value=0.015  Score=29.17  Aligned_cols=78  Identities=15%  Similarity=0.242  Sum_probs=47.4

Q ss_pred             EEEEEECCCCEEEEEEEEECCCCCCCCCCCCEEEEEECCEEEEEECCCCCCEEEEEEEECCCCCEEEEEECCC-CCCCEE
Q ss_conf             1688614785499999752567778676542699982857998304898737999998516993899972289-974203
Q 003659           72 KYTFSISGRGRHWIRLYFYPFVYQSYNMSRASFSVSTNDHVLLNNFSVSSNVFKEFSVNVTSDSLDVIFSPSN-NSFAFI  150 (805)
Q Consensus        72 ~~~~~~~~~~~ylvR~~f~~~~y~~~~~~~~~f~~~~~~~~~v~~~~~~~~~~~e~~~~~~~~~~~vc~~~~~-~~~pfi  150 (805)
                      .|.+.| ++|.|-|.+.|  |+      . ...++.+.+-..+..+.. ....+.+.+.+.++.|++-|.... ...|=|
T Consensus        66 ~f~v~v-PnG~Y~Vtv~~--Gd------~-~~~~~~~eg~~~~~~~~g-~~~~~~~~V~VtDG~L~l~ft~~~~G~~~~i  134 (146)
T d2o14a1          66 TFNVDL-PNGLYEVKVTL--GN------T-ARASVAAEGVFQVINMTG-DGAEDTFQIPVTDGQLNLLVTEGKAGTAFTL  134 (146)
T ss_dssp             CEEEEC-CSEEEEEEEEE--SS------C-SEEEEEETTEEEEEEEES-TTCEEEEEEEECSSEEEEEEEESSTTSCCEE
T ss_pred             EEEEEC-CCCEEEEEEEE--EC------C-CCCCEEEEEEEECCCCCC-CCEEEEEEEEEECCEEEEEEECCCCCCCCEE
T ss_conf             699988-99718999999--36------7-776277851780026687-3177899999879948799843778986388


Q ss_pred             EEEEEEEECC
Q ss_conf             3113388078
Q 003659          151 NALEVVSVPD  160 (805)
Q Consensus       151 s~iE~~~~~~  160 (805)
                      |+|||.+..+
T Consensus       135 n~l~I~~~~d  144 (146)
T d2o14a1         135 SALKIKKLSD  144 (146)
T ss_dssp             EEEEEEEEES
T ss_pred             EEEEEEECCC
T ss_conf             7999982266